PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baum, JK; Myers, RA; Kehler, DG; Worm, B; Harley, SJ; Doherty, PA				Baum, JK; Myers, RA; Kehler, DG; Worm, B; Harley, SJ; Doherty, PA			Collapse and conservation of shark populations in the Northwest Atlantic	SCIENCE			English	Article							EXTINCTION; MANAGEMENT	Overexploitation threatens the future of many large vertebrates. In the ocean, tunas and sea turtles are current conservation concerns because of this intense pressure. The status of most shark species, in contrast, remains uncertain. Using the largest data set in the Northwest Atlantic, we show rapid large declines in large coastal and oceanic shark populations. Scalloped hammerhead, white, and thresher sharks are each estimated to have declined by over 75% in the past 15 years. Closed-area models highlight priority areas for shark conservation, and the need to consider effort reallocation and site selection if marine reserves are to benefit multiple threatened species.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Dalhousie University	Baum, JK (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.		Baum, Julia K/A-4693-2008	Worm, Boris/0000-0002-5742-8716; Baum, Julia/0000-0002-9827-1612				Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; AU D, 1985, SCRS8475 INT COMM CO; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R., 1994, 341 FAO; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Castro J. I., 1999, 380 FAO; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; COMPAGNO LJV, 1984, FISH SYNOP, V125; Essington TE, 2002, ECOL APPL, V12, P724; Fernandez de Oviedo Gonzalo, 1959, HIST GEN NATURAL IND; GROGGER JT, 1991, J APPL ECONOM, V6, P225, DOI 10.1002/jae.3950060302; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; IUCN, 2002, 2002 IUCN RED LIST T; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; NAKANO H, 1993, SCRS92145 INT COMM C; National Marine Fisheries Service (NMFS), 1999, FIN FISH MAN PLAN AT; *NMFS, 2001, US NAT PLAN ACT CONS; *NMFS, 2002, STOCK ASS FISH EV AT; ROSE DA, 1996, OVERVIEW WORLD TRADE; Safina C., 1998, SONG BLUE OCEAN; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; FED REG, V66, P36711; FED REG, V67, P5393	28	816	859	8	502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					389	392		10.1126/science.1079777	http://dx.doi.org/10.1126/science.1079777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532016				2022-12-24	WOS:000180426800044
J	Dial, KP				Dial, KP			Wing-assisted incline running and the evolution of flight	SCIENCE			English	Article							BIRDS	Flapping wings of galliform birds are routinely used to produce aerodynamic forces oriented toward the substrate to enhance hindlimb traction. Here, I document this behavior in natural and laboratory settings. Adult birds fully capable of aerial flight preferentially employ wing-assisted incline running (WAIR), rather than flying, to reach elevated refuges (such as cliffs, trees, and boulders). From the day of hatching and before attaining sustained aerial flight, developing ground birds use WAIR to enhance their locomotor performance through improved foot traction, ultimately permitting vertical running. WAIR provides insight from behaviors observable in living birds into the possible role of incipient wings in feathered theropod dinosaurs and offers a previously unstudied explanation for the evolution of avian flight.	Univ Montana, Div Biol Sci, Avian Studies Program, Flight Lab, Missoula, MT 59812 USA	University of Montana System; University of Montana	Dial, KP (corresponding author), Univ Montana, Div Biol Sci, Avian Studies Program, Flight Lab, Missoula, MT 59812 USA.	kdial@selway.umt.edu						BERGERS P, 2001, NATURE, V399, P60; BILO D, 1985, BIONA REPORT, V3, P87; Bock W.J., 1985, P199; CAPLE G, 1983, AM NAT, V121, P455, DOI 10.1086/284076; Chatterjee S., 1997, THE RISE OF BIRDS; Darwin C., 1859, ORIGIN SPECIES FACSI; Feduccia A., 1996, ORIGIN EVOLUTION BIR; Gall L.F., 2002, NEW PERSPECTIVES ORI; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; Hecht M.K., 1985, BEGINNINGS BIRDS; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; OSTROM JH, 1979, AM SCI, V67, P46; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Starck J.M., 1998, AVIAN GROWTH DEV; Tobalske BW, 1996, J EXP BIOL, V199, P263	18	144	152	2	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					402	404		10.1126/science.1078237	http://dx.doi.org/10.1126/science.1078237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532020	Green Submitted			2022-12-24	WOS:000180426800048
J	Ruggero, D; Grisendi, S; Piazza, F; Rego, E; Mari, F; Rao, PH; Cordon-Cardo, C; Pandolfi, PP				Ruggero, D; Grisendi, S; Piazza, F; Rego, E; Mari, F; Rao, PH; Cordon-Cardo, C; Pandolfi, PP			Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification	SCIENCE			English	Article							HOYERAAL-HREIDARSSON-SYNDROME; TELOMERASE; MUTATIONS; GENE; YEAST; IDENTIFICATION; PSEUDOURIDINE; COMPONENT; PROTEIN; DKC1	Mutations in DKC1 cause dyskeratosis congenita (DC), a disease characterized by premature aging and increased tumor susceptibility. The DKC1 protein binds to the box H + ACA small nucleolar RNAs and the RNA component of telomerase. Here we show that hypomorphic Dkc1 mutant (Dkc1(m)) mice recapitulate in the first and second generations (G1 and G2) the clinical features of DC. Dkc1(m) cells from G1 and G2 mice were impaired in ribosomal RNA pseudouridylation before the onset of disease. Reductions of telomere length in Dkc1(m) mice became evident only in later generations. These results suggest that deregulated ribosome function is important in the initiation of DC, whereas telomere shortening may modify and/or exacerbate DC.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Univ Sao Paulo, FUNDHERP, Ctr Cell Based Therapy, BR-14049900 Ribeirao Preto, SP, Brazil; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Universidade de Sao Paulo; Baylor College of Medicine	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.		Piazza, Francesco/AAD-1600-2019; Rego, Eduardo M/A-1058-2012; Mari, Francesca/E-7737-2012; Rego, Eduardo M./Y-5572-2019; Piazza, Francesco/K-6695-2016; Rego, Eduardo/AFS-7973-2022	Piazza, Francesco/0000-0002-2831-623X; Rego, Eduardo M/0000-0003-1567-4086; Mari, Francesca/0000-0003-1992-1654; Rego, Eduardo M./0000-0003-1567-4086; Piazza, Francesco/0000-0002-2831-623X; Rego, Eduardo/0000-0003-1567-4086				Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; MASUREKAR M, 1981, J MOL BIOL, V147, P381, DOI 10.1016/0022-2836(81)90490-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Phillips B, 1998, MOL GEN GENET, V260, P20, DOI 10.1007/s004380050866; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Yaghmai R, 2000, J PEDIATR-US, V136, P390, DOI 10.1067/mpd.2000.104295; Yang YF, 2000, MOL BIOL CELL, V11, P567, DOI 10.1091/mbc.11.2.567; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	22	312	331	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					259	262		10.1126/science.1079447	http://dx.doi.org/10.1126/science.1079447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522253				2022-12-24	WOS:000180284000042
J	Shi, SH; Jan, LY; Jan, YN				Shi, SH; Jan, LY; Jan, YN			Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity	CELL			English	Article							PROTEIN-KINASE-C; EPITHELIAL TIGHT JUNCTION; ASYMMETRIC CELL-DIVISION; ANTERIOR-POSTERIOR AXIS; TUMOR-SUPPRESSOR PTEN; CAENORHABDITIS-ELEGANS; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC POLARITY; AXON FORMATION; RHO-GTPASES	How a neuron becomes polarized remains an outstanding question. Here, we report that selection of the future axon among neurites of a cultured hippocampal neuron requires the activity of growth factor receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI 3-kinase), as well as atypical protein kinase C (aPKC). The PI 3-kinase activity, highly localized to the tip of the newly specified axon of stage 3 neurons, is essential for the proper subcellular localization of mPar3, the mammalian homolog of C. elegans polarity protein Par3. Polarized distribution of not only mPar3 but also mPar6 is important for axon formation; ectopic expression of mPar6 or mPar3, or just the N terminus of mPar3, leaves neurons with no axon specified. Thus, neuronal polarity is likely to be controlled by the mPar3/mPar6/aPKC complex and the PI 3-kinase signaling pathway, both serving evolutionarily conserved roles in specifying cell polarity.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, 533 Parnassus Ave, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; CHANT J, 1994, TRENDS GENET, V10, P328, DOI 10.1016/0168-9525(94)90036-1; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GOSLIN K, 1989, J CELL BIOL, V108, P1506; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Hirose T, 2002, J CELL SCI, V115, P2485; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kabir N, 2001, J CELL BIOL, V152, P1033, DOI 10.1083/jcb.152.5.1033; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Namikawa K, 2000, J NEUROSCI, V20, P2875; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; TEJERODIEZ P, 1995, FEBS LETT, V363, P293, DOI 10.1016/0014-5793(95)00303-Q; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; TURING A, 1952, PHILOS T R SOC B, V237, P32; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	61	489	502	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					63	75		10.1016/S0092-8674(02)01249-7	http://dx.doi.org/10.1016/S0092-8674(02)01249-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526794	Bronze			2022-12-24	WOS:000181191500007
J	Keeling, MJ; Woolhouse, MEJ; May, RM; Davies, G; Grenfell, BT				Keeling, MJ; Woolhouse, MEJ; May, RM; Davies, G; Grenfell, BT			Modelling vaccination strategies against foot-and-mouth disease	NATURE			English	Article							GREAT-BRITAIN; EPIDEMIC; TRANSMISSION; DYNAMICS; SPREAD; DESIGN; IMPACT; FMD	Vaccination has proved a powerful defence against a range of infectious diseases of humans and animals. However, its potential to control major epidemics of foot-and-mouth disease (FMD) in livestock is contentious. Using an individual farm-based model, we consider either national prophylactic vaccination campaigns in advance of an outbreak, or combinations of reactive vaccination and culling strategies during an epidemic. Consistent with standard epidemiological theory, mass prophylactic vaccination could reduce greatly the potential for a major epidemic, while the targeting of high-risk farms increases efficiency. Given sufficient resources and preparation, a combination of reactive vaccination and culling might control ongoing epidemics. We also explore a reactive strategy, 'predictive' vaccination, which targets key spatial transmission loci and can reduce markedly the long tail that characterizes many FMD epidemics. These analyses have broader implications for the control of human and livestock infectious diseases in heterogeneous spatial landscapes.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Zinnia, Woking GU21 4JJ, Surrey, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Warwick; University of Warwick; University of Edinburgh; University of Oxford; University of Cambridge	Keeling, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	m.j.keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765				ANDERSON R M, 1991; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; *COMM INQ FOOT MOU, 1968, REP COMM INQ FOOT MO; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAYDON DT, 2001, IN PRESS P R SOC L B; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Muller J, 2000, J MATH BIOL, V41, P143, DOI 10.1007/s002850070003; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Salt J. S., 1997, VET VACCINOLOGY, P641; *SCI COMM AN HLTH, EU STRAT EM VACC FOO; Verschueren, 1997, VET VACCINOLOGY; Williams JR, 1996, J EPIDEMIOL COMMUN H, V50, P667, DOI 10.1136/jech.50.6.667; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; Woolhouse M.E.J., 1997, VET VACCINOLOGY, P565; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731	28	321	326	2	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					136	142		10.1038/nature01343	http://dx.doi.org/10.1038/nature01343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12508120	Bronze			2022-12-24	WOS:000180267200032
J	Haider, AW; Larson, MG; Franklin, SS; Levy, D				Haider, AW; Larson, MG; Franklin, SS; Levy, D			Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ARTERIAL DISTENSIBILITY; SUBENDOCARDIAL ISCHEMIA; MYOCARDIAL-INFARCTION; AORTIC COMPLIANCE; HYPERTENSION; DISEASE; DOGS; PROGRESSION; PREVENTION	Background: Although hypertension is a principal precursor of congestive heart failure (CHF), the separate relations of systolic, diastolic, and pulse pressure with risk for heart failure have not been fully elucidated. Objective: To examine the value of blood pressure predictors of heart failure. Design: Community-based inception cohort study. Setting: Framingham, Massachusetts. Patients: 2040 free-living Framingham Heart Study participants (mean age, 61 years [range, 50 to 79 years]). Measurements: The association of baseline systolic, diastolic, and pulse pressure with risk for incident CHF was examined in 894 men and 1146 women. Framingham Heart Study participants free of CHF at the baseline examination (performed from 1968 to 1973) were monitored for up to 24 years (mean, 17.4 years) for new-onset heart failure. Cox proportional hazards models were used to adjust for age, sex, smoking, left ventricular hypertrophy, body mass index, diabetes mellitus, high-density lipoprotein cholesterol level, and heart rate; hazard ratios and 95% Cis for blood pressure variables were estimated. Results: CHF developed in 234 participants (11.8%) during the follow-up period. All three blood pressure components were related to the risk for CHF, but the relation was strongest for systolic and pulse pressure. A 1-SD (20 mm Hg) increment in systolic pressure conferred a 56% increased risk for CHF (hazard ratio, 1.56 [95% Cl, 1.37 to 1.77]); similarly, a 1-SD (16 mm Hg) increment in pulse pressure conferred a 55% increased risk for CHF (hazard ratio, 1.55 [Cl, 1.37 to 1.75]). These associations were unrelated to age, duration of follow-up, and initiation of treatment for hypertension during follow-up; they were also observed in patients with systolic hypertension (systolic blood pressure greater than or equal to 140 mm Hg) at the baseline examination (hazard ratio, 1.41 [Cl, 1.18 to 1.69] for pulse pressure and 1.42 [Cl, 1.14 to 1.76] for systolic pressure). Conclusions: Although each component of blood pressure was associated with risk for CHF, pulse and systolic pressure conferred greater risk than diastolic pressure. Increased pulse pressure may help identify hypertensive patients at high risk for overt CHF who are candidates for aggressive blood pressure control.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Calif Irvine, Irvine, CA 92717 USA; Vet Adm Med Ctr, W Roxbury, MA USA; MCP Hahnemann Univ Hosp, Philadelphia, PA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Drexel University	Levy, D (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERNETHY J, 1986, American Journal of Preventive Medicine, V2, P123; [Anonymous], 1991, JAMA, V265, P3255; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; BAUMBACH GL, 1991, CIRC RES, V68, P338, DOI 10.1161/01.RES.68.2.338; BENETOS A, 1993, ARTERIOSCLER THROMB, V13, P90, DOI 10.1161/01.ATV.13.1.90; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; BOUTHIER JD, 1985, AM HEART J, V109, P1345, DOI 10.1016/0002-8703(85)90364-3; BUCKBERG GD, 1972, CIRC RES, V30, P67, DOI 10.1161/01.RES.30.1.67; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; CHRISTENSEN KL, 1991, HYPERTENSION, V18, P722, DOI 10.1161/01.HYP.18.6.722; CUPPLES LA, 1998, PUBLICATION; Cutler Jeffrey A., 1995, P253; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Franklin SS, 1997, CIRCULATION, V96, P308; FRANKLIN SS, 1994, AM HEART J, V128, P793, DOI 10.1016/0002-8703(94)90278-X; FREIS ED, 1982, JAMA-J AM MED ASSOC, V248, P2004; GIRERD X, 1991, AM HEART J, V122, P1210, DOI 10.1016/0002-8703(91)90941-A; KANNEL WB, 1981, JAMA-J AM MED ASSOC, V245, P1225, DOI 10.1001/jama.245.12.1225; KANNEL WB, 1972, NEW ENGL J MED, V287, P782; Kass DA, 1996, CIRCULATION, V93, P1533, DOI 10.1161/01.CIR.93.8.1533; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Lee MLT, 1999, ANN EPIDEMIOL, V9, P101, DOI 10.1016/S1047-2797(98)00034-9; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; LYON RT, 1987, J VASC SURG, V5, P59, DOI 10.1067/mva.1987.avs0050059; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; MATERSON BJ, 1982, JAMA-J AM MED ASSOC, V248, P1996; Mitchell GF, 1997, CIRCULATION, V96, P4254; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; NICHOLS WW, 1990, MCDONALDS BLOOD FLOW, P216; OROURKE MF, 1989, AM J CARDIOL, V63, pI38, DOI 10.1016/0002-9149(89)90127-6; OROURKE MF, 1992, ARTERIAL PULSE, P201; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; *SAS I INC, 1996, SAS STAT SOFTW CHANG, P381; Smulyan H, 2000, ANN INTERN MED, V132, P233, DOI 10.7326/0003-4819-132-3-200002010-00010; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Vasan RS, 1996, ARCH INTERN MED, V156, P1789, DOI 10.1001/archinte.156.16.1789; WATANABE H, 1993, J AM COLL CARDIOL, V21, P1497, DOI 10.1016/0735-1097(93)90330-4; WATANABE H, 1992, CARDIOVASC RES, V26, P1212, DOI 10.1093/cvr/26.12.1212	45	346	362	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					10	16		10.7326/0003-4819-138-1-200301070-00006	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513039				2022-12-24	WOS:000180996200002
J	Knoll, R; Hoshijima, M; Hoffman, HM; Person, V; Lorenzen-Schmidt, I; Bang, ML; Hayashi, T; Shiga, N; Yasukawa, H; Schaper, W; McKenna, W; Yokoyama, M; Schork, NJ; Omens, JH; McCulloch, AD; Kimura, A; Gregorio, CC; Poller, W; Schaper, J; Schultheiss, HP; Chien, KR				Knoll, R; Hoshijima, M; Hoffman, HM; Person, V; Lorenzen-Schmidt, I; Bang, ML; Hayashi, T; Shiga, N; Yasukawa, H; Schaper, W; McKenna, W; Yokoyama, M; Schork, NJ; Omens, JH; McCulloch, AD; Kimura, A; Gregorio, CC; Poller, W; Schaper, J; Schultheiss, HP; Chien, KR			The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy	CELL			English	Article							CYSTEINE-RICH PROTEIN; HEART-FAILURE; BIOMECHANICAL STRESS; T-CAP; TITIN; HYPERTROPHY; DOMAIN; PATHWAYS; MYOCYTES; MUSCLE	Muscle cells respond to mechanical stretch stimuli by triggering downstream signals for myocyte growth and survival. The molecular components of the muscle stretch sensor are unknown, and their role in muscle disease is unclear. Here, we present biophysical/biochemical studies in muscle LIM protein (MLP) deficient cardiac muscle that support a selective role for this Z disc protein in mechanical stretch sensing. MLP interacts with and colocalizes with telethonin (T-cap), a titin interacting protein. Further, a human MLP mutation (W4R) associated with dilated cardiomyopathy (DCM) results in a marked defect in T-cap interaction/localization. We propose that a Z disc MLP/T-cap complex is a key component of the in vivo cardiomyocyte stretch sensor machinery, and that defects in the complex can lead to human DCM and associated heart failure.	Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Max Planck Inst, D-61231 Bad Nauheim, Germany; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1010062, Japan; Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med, Kobe, Hyogo 6500017, Japan; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA; Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 2, D-12200 Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Tokyo Medical & Dental University (TMDU); Kobe University; St Georges University London; University of Arizona; University of Arizona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Chien, KR (corresponding author), Univ Calif San Diego, Inst Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Ralph, Knoell/AAE-5990-2020; McKenna, William J/C-3243-2008; Bang, Marie-Louise/B-5683-2015; Knöll, Ralph/GOH-3587-2022; Poller, Wolfgang/AAB-2185-2021; Kimura, Akinori/I-5989-2018	Ralph, Knoell/0000-0001-8871-112X; McKenna, William J/0000-0001-7994-2460; Bang, Marie-Louise/0000-0001-8859-5034; Kimura, Akinori/0000-0002-4933-2132; Schork, Nicholas/0000-0003-0920-5013; Poller, Wolfgang/0000-0002-2805-6634				Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Granzier H, 2002, J PHYSIOL-LONDON, V541, P335, DOI 10.1113/jphysiol.2001.014381; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Harper BD, 2000, BIOCHEM J, V350, P269, DOI 10.1042/0264-6021:3500269; Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; HUNTER JJ, 1999, MOL BASIS CARDIOVASC, P211; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Maisel A, 2002, CIRCULATION, V105, P2328, DOI 10.1161/01.CIR.0000019121.91548.C2; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Rana BK, 1999, GENETICS, V151, P1547; Reid ME, 2000, TRANSFUSION, V40, P48, DOI 10.1046/j.1537-2995.2000.40010048.x; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Trombitas K, 2000, ADV EXP MED BIOL, V481, P405; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Yamazaki T, 1998, CIRC RES, V82, P430, DOI 10.1161/01.RES.82.4.430; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zolk O, 2000, CIRCULATION, V101, P2674, DOI 10.1161/01.CIR.101.23.2674	46	583	600	0	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					943	955		10.1016/s0092-8674(02)01226-6	http://dx.doi.org/10.1016/s0092-8674(02)01226-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507422	Bronze			2022-12-24	WOS:000180086000005
J	Aldhous, P				Aldhous, P			Agribiotech - More heat than light	NATURE			English	Editorial Material																		Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Kaplinsky N, 2002, NATURE, V416, P601, DOI 10.1038/nature739; Metz M, 2002, NATURE, V416, P600, DOI 10.1038/nature738; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Quist D, 2002, NATURE, V416, P602, DOI 10.1038/nature740; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Surridge C, 2002, NATURE, V416, P576, DOI 10.1038/416576a; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	9	5	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					730	731		10.1038/420730a	http://dx.doi.org/10.1038/420730a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490904				2022-12-24	WOS:000179897300013
J	He, K; Rimm, EB; Merchant, A; Rosner, BA; Stampfer, MJ; Willett, WC; Ascherio, A				He, K; Rimm, EB; Merchant, A; Rosner, BA; Stampfer, MJ; Willett, WC; Ascherio, A			Fish consumption and risk of stroke in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; FOOD FREQUENCY QUESTIONNAIRE; ISCHEMIC-HEART-DISEASE; EICOSAPENTAENOIC ACID; PLATELET-FUNCTION; CORONARY-DISEASE; DOSE-RESPONSE; VITAMIN-E; REPRODUCIBILITY; INHIBITION	Context The effect of fish consumption or long-chain omega-3 polyunsaturated fatty acid (PUFA) intake on risk of stroke remains uncertain. Objective To examine the relation of fish consumption and long-chain omega-3 PUFA intake and risk of stroke in men. Design and Setting The Health Professional Follow-up Study, a US prospective cohort study with 12 years of follow-up. Participants A total of 43 671 men aged 40 to 75 years who completed a detailed and validated semiquantitative food frequency questionnaire and who were free of cardiovascular disease at baseline in 1986. Main Outcome Measure Relative risk (RR) of stroke by subtype based on cumulative average fish consumption or long-chain omega-3 PUFA intake, ascertained in 1986, 1990, and 1994. Results We documented 608 strokes during the 12-year follow-up period, including 377 ischemic, 106 hemorrhagic, and 125 unclassified strokes. Compared with men who consumed fish less than once per month, the multivariate RR of ischemic stroke was significantly lower among those who ate fish 1 to 3 times per month (RR, 0.57; 95% confidence interval [Cl], 0.35-0.95). However, a higher frequency of fish intake was not associated with further risk reduction; the RR was 0.54 (95% Cl, 0.31-0.94) for men who consumed fish 5 or more times per week. This lack of linearity was confirmed by spline analyses. By dichotomized fish intake, the multivariate RR for men who consumed fish at least once per month compared with those who ate fish less than once per month was 0.56 (95% Cl, 0.38-0.83) for ischemic stroke and 1.36 (95% Cl, 0.48-3.82) for hemorrhagic stroke. The inverse association between fish intake and risk of ischemic stroke was not materially modified by use of aspirin. No significant associations were found between fish or long-chain omega-3 PUFA intake and risk of hemorrhagic stroke. Conclusion Our findings suggest that eating fish once per month or more can reduce the risk of ischemic stroke in men.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	He, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 335 Huntington Ave, Boston, MA 02115 USA.	khe@hsph.harvard.edu	Merchant, Anwar/B-5233-2009		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BJERREGAARD P, 1988, INT J EPIDEMIOL, V17, P514, DOI 10.1093/ije/17.3.514; *CONS FOOD EC I, 1976, HDB 8 SER; De Caterina R, 1998, J LIPID RES, V39, P1062; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; DRISS F, 1984, THROMB RES, V36, P389, DOI 10.1016/0049-3848(84)90295-0; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; Greenland S, 1999, AM J EPIDEMIOL, V149, P1077; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; HARRIS WS, 1989, J LIPID RES, V30, P785; HIRAI A, 1980, LANCET, V2, P1132; HUI R, 1992, J HYPERTENS, V10, P1145, DOI 10.1097/00004872-199210000-00006; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; Kang JX, 2000, AM J CLIN NUTR, V71, p202S, DOI 10.1093/ajcn/71.1.202S; KELI SO, 1994, STROKE, V25, P328, DOI 10.1161/01.STR.25.2.328; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KRISTENSEN SD, 1989, J INTERN MED, V225, P141, DOI 10.1111/j.1365-2796.1989.tb01448.x; KROMANN N, 1980, ACTA MED SCAND, V208, P401; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MCKEIGUE P, 1994, LANCET, V343, P1445, DOI 10.1016/S0140-6736(94)92575-5; MEYDANI M, 1991, J NUTR, V121, P484, DOI 10.1093/jn/121.4.484; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; NESTEL PJ, 1990, ANNU REV NUTR, V10, P149, DOI 10.1146/annurev.nu.10.070190.001053; Orencia AJ, 1996, STROKE, V27, P204, DOI 10.1161/01.STR.27.2.204; PHILLIPSON BE, 1985, NEW ENGL J MED, V312, P1210, DOI 10.1056/NEJM198505093121902; RAPER NR, 1992, J AM COLL NUTR, V11, P304; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Roche HM, 2000, AM J CLIN NUTR, V71, p232S, DOI 10.1093/ajcn/71.1.232s; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; STEINBERG D, 1992, CIRCULATION, V85, P2338, DOI 10.1161/01.CIR.85.6.2337; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; *USDA, 1993, COMP FOODS RAW PROC; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Walker AE, 1981, STROKE S1, V12, P13; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; YAMORI Y, 1985, J NUTR SCI VITAMINOL, V31, P417, DOI 10.3177/jnsv.31.417; Zhang JJ, 1999, PREV MED, V28, P520, DOI 10.1006/pmed.1998.0472	50	238	243	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	2002	288	24					3130	3136		10.1001/jama.288.24.3130	http://dx.doi.org/10.1001/jama.288.24.3130			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628QQ	12495393	Bronze			2022-12-24	WOS:000180008200023
J	Srygley, RB; Thomas, ALR				Srygley, RB; Thomas, ALR			Unconventional lift-generating mechanisms in free-flying butterflies	NATURE			English	Article							WEIS-FOGH MECHANISM; INSECT FLIGHT; 3-DIMENSIONAL SEPARATION; VORTEX; FLOW; AIRFOILS; AERODYNAMICS; VORTICES; DYNAMICS; HAWKMOTH	Flying insects generate forces that are too large to be accounted for by conventional steady-state aerodynamics(1,2). To investigate these mechanisms of force generation, we trained red admiral butterflies, Vanessa atalanta, to fly freely to and from artificial flowers in a wind tunnel, and used high-resolution, smoke-wire flow visualizations to obtain qualitative, high-speed digital images of the air flow around their wings. The images show that free-flying butterflies use a variety of unconventional aerodynamic mechanisms to generate force: wake capture(3), two different types of leading-edge vortex(3-7), active and inactive upstrokes(8), in addition to the use of rotational mechanisms 3 and the Weis-Fogh 'clap-and-fling' mechanism(9-12). Free-flying butterflies often used different aerodynamic mechanisms in successive strokes. There seems to be no one 'key' to insect flight, instead insects rely on a wide array of aerodynamic mechanisms to take off, manoeuvre, maintain steady flight, and for landing.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Thomas, ALR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.							Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Delery JM, 2001, ANNU REV FLUID MECH, V33, P129, DOI 10.1146/annurev.fluid.33.1.129; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1995, BIOL FLUID DYNAMICS, V49, P109; GADELHAK M, 1986, AIAA J, V24, P713, DOI 10.2514/3.9337; GURSUL I, 1992, AIAA J, V30, P1117, DOI 10.2514/3.11034; HORNUNG H, 1984, Z FLUGWISS WELTRAUM, V8, P77; HUANG MK, 1982, AIAA J, V20, P292, DOI 10.2514/3.7913; Legendre R., 1956, RECH AERO, V54, P3; LIGHTHILL M, 1963, LAMINAR BOUNDARY LAY, V2, P72; LIGHTHILL MJ, 1973, J FLUID MECH, V60, P1, DOI 10.1017/S0022112073000017; MAXWORTHY T, 1979, J FLUID MECH, V93, P47, DOI 10.1017/S0022112079001774; MAXWORTHY T, 1981, ANNU REV FLUID MECH, V13, P329, DOI 10.1146/annurev.fl.13.010181.001553; Mourtos NJ, 1996, J APPL MECH-T ASME, V63, P543, DOI 10.1115/1.2788902; PERRY AE, 1987, ANNU REV FLUID MECH, V19, P125, DOI 10.1146/annurev.fluid.19.1.125; Poincar? H., 1882, CR HEBD ACAD SCI, V94, P416; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; Riddle TW, 1999, J FLUID ENG-T ASME, V121, P555, DOI 10.1115/1.2823504; ROSSOW VJ, 1978, J AIRCRAFT, V15, P618, DOI 10.2514/3.58416; ROSSOW VJ, 1992, J AIRCRAFT, V29, P847, DOI 10.2514/3.46255; ROSSOW VJ, 1994, J AIRCRAFT, V31, P146, DOI 10.2514/3.46467; SAFFMAN PG, 1977, STUD APPL MATH, V57, P107; Sane SP, 2002, J EXP BIOL, V205, P1087; SPEDDING GR, 1993, ADV COMP ENV PHYSL, V11; TOBAK M, 1982, ANNU REV FLUID MECH, V14, P61, DOI 10.1146/annurev.fl.14.010182.000425; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P317, DOI 10.1098/rstb.1997.0023; WEISFOGH T, 1973, J EXP BIOL, V59, P169; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Zbikowski R, 2002, PHILOS T ROY SOC A, V360, P273, DOI 10.1098/rsta. 2001.0930	30	260	282	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					660	664		10.1038/nature01223	http://dx.doi.org/10.1038/nature01223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478291				2022-12-24	WOS:000179751800043
J	Fitzgerald, DW; Behets, FMTF				Fitzgerald, DW; Behets, FMTF			Beyond folklore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREGNANCY											Dennie CC, 1962, HIST SYPHILIS; Farmer P., 1999, INFECT INEQUALITIES; FARMER P, 1992, COMP STUDIES HLTH SY; Fitzgerald D W, 1998, Int J Infect Dis, V2, P127, DOI 10.1016/S1201-9712(98)90113-8; FITZGERALD DW, IN PRESS AM J PUBLIC; HIRA SK, 1990, GENITOURIN MED, V66, P159; JENNISKENS F, 1995, INT J GYNECOL OBSTET, V48, pS121, DOI 10.1016/0020-7292(95)02326-8; Moore JE, 1933, MODERN TREATMENT SYP, DOI [10.1001/jama.1943.02840480071034, DOI 10.1001/JAMA.1943.02840480071034]; RADOLF JD, 1999, SEXUALLY TRANSMITTED, P1168; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0	10	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2791	2792		10.1001/jama.288.22.2791	http://dx.doi.org/10.1001/jama.288.22.2791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472303				2022-12-24	WOS:000179732600001
J	Connolly, MA; Heymann, DL				Connolly, MA; Heymann, DL			Deadly comrades: war and infectious diseases	LANCET			English	Article									WHO, Programme Communicable Dis Complex Emergencies, CH-1211 Geneva 27, Switzerland	World Health Organization	Connolly, MA (corresponding author), WHO, Programme Communicable Dis Complex Emergencies, CH-1211 Geneva 27, Switzerland.								0	34	34	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S23	S24		10.1016/S0140-6736(02)11807-1	http://dx.doi.org/10.1016/S0140-6736(02)11807-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504490				2022-12-24	WOS:000180064500011
J	Messaoudi, I; Guevara-Patino, JA; Dyall, R; LeMaoult, J; Nikolich-Zugich, J				Messaoudi, I; Guevara-Patino, JA; Dyall, R; LeMaoult, J; Nikolich-Zugich, J			Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense	SCIENCE			English	Article							HERPES-SIMPLEX-VIRUS; CLASS-I; CTL RESPONSE; RECOGNITION; INFECTION; SITE; SPECIFICITY; ADVANTAGE; SELECTION; MICE	Major histocompatibility complex (mhc)-encoded molecules govern immune responses by presenting antigenic peptides to T cells. The extensive polymorphism of genes encoding these molecules is believed to enhance immune defense by broadening the array of antigenic peptides available for T cell recognition, but direct evidence supporting the importance of this mechanism in combating pathogens is limited. Here we link mhc polymorphism-driven diversification of the cytotoxic T lymphocyte (CTL) repertoire to the generation of high-avidity, protective antiviral T cells and to superior antiviral defense. Thus, much of the beneficial effect of the mhc polymorphism in immune defense may be due to its critical influence on the properties of the selected CTL repertoire.	Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Memorial Sloan Kettering Cancer Center	Nikolich-Zugich, J (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.	nikolich@ohsu.edu	LeMaoult, Joel/E-9583-2011; Guevara, Jose/AAD-6707-2020	Nikolich-Zugich, Janko/0000-0001-5830-5323	NATIONAL CANCER INSTITUTE [R01CA086803] Funding Source: NIH RePORTER; NCI NIH HHS [CA-86803] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bertoni R, 1997, J CLIN INVEST, V100, P503, DOI 10.1172/JCI119559; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cose SC, 1997, EUR J IMMUNOL, V27, P2310, DOI 10.1002/eji.1830270927; COSE SC, 1995, J VIROL, V69, P5849, DOI 10.1128/JVI.69.9.5849-5852.1995; Dyall R, 1996, J EXP MED, V184, P253, DOI 10.1084/jem.184.1.253; Dyall R, 2000, J IMMUNOL, V164, P1695, DOI 10.4049/jimmunol.164.4.1695; Ehl S, 1997, EUR J IMMUNOL, V27, P3404, DOI 10.1002/eji.1830271240; FINK PJ, 1995, ADV IMMUNOL, V59, P99, DOI 10.1016/S0065-2776(08)60630-6; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gallimore A, 1998, J EXP MED, V187, P1647; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.iy.11.040193.002155; Goldsmith K, 1998, J EXP MED, V187, P341, DOI 10.1084/jem.187.3.341; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Malherbe L, 2000, IMMUNITY, V13, P771, DOI 10.1016/S1074-7613(00)00075-3; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; Messaoudi I, 2001, J IMMUNOL, V167, P836, DOI 10.4049/jimmunol.167.2.836; MOSKOPHIDIS D, 1994, J IMMUNOL, V152, P4976; NASH AA, 1993, SEMIN VIROL, V4, P181, DOI 10.1006/smvy.1993.1013; NATHENSON SG, 1986, ANNU REV IMMUNOL, V4, P471, DOI 10.1146/annurev.iy.04.040186.002351; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; POTTS WK, 1995, IMMUNOL REV, V143, P181, DOI 10.1111/j.1600-065X.1995.tb00675.x; ROUSE BT, 2000, HERPES S1, V8, pA2; SPEISER DE, 1992, J IMMUNOL, V149, P972; Turner SJ, 1998, MOL IMMUNOL, V35, P307, DOI 10.1016/S0161-5890(98)00051-0; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999	32	252	255	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1797	1800		10.1126/science.1076064	http://dx.doi.org/10.1126/science.1076064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459592				2022-12-24	WOS:000179494800048
J	Arseneault, L; Cannon, M; Poulton, R; Murray, R; Caspi, A; Moffitt, TE				Arseneault, L; Cannon, M; Poulton, R; Murray, R; Caspi, A; Moffitt, TE			Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study	BRITISH MEDICAL JOURNAL			English	Article									Kings Coll London, SGDP Res Ctr, London SE5 8AF, England; Kings Coll London, Div Psychol Med, London WC2R 2LS, England; Univ Otago, Dunedin Multidisciplinary Hlth & Dev Res Unit, Dunedin, New Zealand	University of London; King's College London; University of London; King's College London; University of Otago	Moffitt, TE (corresponding author), Kings Coll London, SGDP Res Ctr, London SE5 8AF, England.	t.moffitt@iop.kcl.ac.uk	Moffitt, Terrie E/D-5295-2011; caspi, avshalom/D-5294-2011; Arseneault, Louise/ABE-7205-2020; Young, Alexander/A-1523-2009; Cannon, Mary/D-8227-2012; caspi, avshalom/AAJ-5874-2020; murray, robin/F-8658-2012	Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; Young, Alexander/0000-0002-9367-9213; Cannon, Mary/0000-0002-0910-299X; caspi, avshalom/0000-0003-0082-4600; Arseneault, Louise/0000-0002-2938-2191; murray, robin/0000-0003-0829-0519	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049414, R29MH049414, R01MH045070] Funding Source: NIH RePORTER; NIMH NIH HHS [MH45070, R01 MH045070, R01 MH049414, MH49414] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Fergusson DM, 1997, ADDICTION, V92, P279; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Silva P., 1996, CHILD ADULT DUNEDIN; Strang J, 2000, BMJ-BRIT MED J, V320, P108, DOI 10.1136/bmj.320.7227.108	5	876	894	10	227	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2002	325	7374					1212	1213		10.1136/bmj.325.7374.1212	http://dx.doi.org/10.1136/bmj.325.7374.1212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	619YU	12446537	Green Published, Bronze			2022-12-24	WOS:000179506200020
J	Horng, T; Barton, GM; Flavell, RA; Medzhitov, R				Horng, T; Barton, GM; Flavell, RA; Medzhitov, R			The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors	NATURE			English	Article							INNATE IMMUNE-RESPONSE; NF-KAPPA-B; RECOGNITION; ACTIVATION; LIPOPROTEINS; ENDOTOXIN; PATHWAY; MICE; TLR4	Mammalian Toll-like receptors (TLRs) function as sensors of infection and induce the activation of innate and adaptive immune responses(1-3). Upon recognizing conserved pathogen-associated molecular products, TLRs activate host defence responses through their intracellular signalling domain, the Toll/interleukin-1 receptor (TIR) domain, and the downstream adaptor protein MyD88 (refs 1-3). Although members of the TLR and the interleukin-1 (IL-1) receptor families all signal through MyD88, the signalling pathways induced by individual receptors differ. TIRAP, an adaptor protein in the TLR signalling pathway, has been identified and shown to function downstream of TLR4 ( refs 4, 5). Here we report the generation of mice deficient in the Tirap gene. TIRAP-deficient mice respond normally to the TLR5, TLR7 and TLR9 ligands, as well as to IL-1 and IL-18, but have defects in cytokine production and in activation of the nuclear factor NF-kappaB and mitogen-activated protein kinases in response to lipopolysaccharide, a ligand for TLR4. In addition, TIRAP-deficient mice are also impaired in their responses to ligands for TLR2, TLR1 and TLR6. Thus, TIRAP is differentially involved in signalling by members of the TLR family and may account for specificity in the downstream signalling of individual TLRs.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.			Barton, Gregory/0000-0002-3793-0100				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459	20	642	703	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					329	333		10.1038/nature01180	http://dx.doi.org/10.1038/nature01180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447442				2022-12-24	WOS:000179340400045
J	Pasare, C; Medzhitov, R				Pasare, C; Medzhitov, R			Toll pathway-dependent blockade of CD4(+)CD25(+) T cell-mediated suppression by dendritic cells	SCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL SELF-TOLERANCE; IL-6-DEFICIENT MICE; ACTIVATION; RECEPTOR; DISEASE; IMMUNITY; INTERLEUKIN-6; RESISTANT; INDUCTION	Toll-like receptors (TLRs) control activation of adaptive immune responses by antigen-presenting cells (APCs). However, initiation of adaptive immune responses is also controlled by regulatory T cells (T-R cells), which act to prevent activation of autoreactive T cells. Here we describe a second mechanism of immune induction by TLRs,which is independent of effects on costimulation. Microbial induction of the Toll pathway blocked the suppressive effect of CD4(+)CD25(+) T-R cells, allowing activation of pathogen-specific adaptive immune responses. This block of suppressor activity was dependent in part on interleukin-6, which was induced by TLRs upon recognition of microbial products.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.							Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; JANEWAY CA, 1989, COLD SH Q B, V54, P1; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; KISHIMOTO T, 1992, J AUTOIMMUN, V5, P123, DOI 10.1016/0896-8411(92)90027-N; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Onizuka S, 1999, CANCER RES, V59, P3128; PASARE C, UNPUB; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rose NR, 1998, SEMIN IMMUNOL, V10, P5, DOI 10.1006/smim.1997.0100; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878	28	1688	1803	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1033	1036		10.1126/science.1078231	http://dx.doi.org/10.1126/science.1078231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12532024				2022-12-24	WOS:000180960000037
J	Wang, H; Yu, M; Ochani, M; Amella, CA; Tanovic, M; Susarla, S; Li, JH; Wang, HC; Yang, H; Ulloa, L; Al-Abed, Y; Czura, CJ; Tracey, KJ				Wang, H; Yu, M; Ochani, M; Amella, CA; Tanovic, M; Susarla, S; Li, JH; Wang, HC; Yang, H; Ulloa, L; Al-Abed, Y; Czura, CJ; Tracey, KJ			Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTOXIN LETHALITY; MICE; BUNGAROTOXIN; DEFICIENT; CACHECTIN; CLONING; CALCIUM; SHOCK	Excessive inflammation and tumour-necrosis factor (TNF) synthesis cause morbidity and mortality in diverse human diseases including endotoxaemia, sepsis, rheumatoid arthritis and inflammatory bowel disease(1-4). Highly conserved, endogenous mechanisms normally regulate the magnitude of innate immune responses and prevent excessive inflammation. The nervous system, through the vagus nerve, can inhibit significantly and rapidly the release of macrophage TNF, and attenuate systemic inflammatory responses(5-7). This physiological mechanism, termed the 'cholinergic anti- inflammatory pathway'(5) has major implications in immunology and in therapeutics; however, the identity of the essential macrophage acetylcholine-mediated (cholinergic) receptor that responds to vagus nerve signals was previously unknown. Here we report that the nicotinic acetylcholine receptor alpha7 subunit is required for acetylcholine inhibition of macrophage TNF release. Electrical stimulation of the vagus nerve inhibits TNF synthesis in wild-type mice, but fails to inhibit TNF synthesis in alpha7-deficient mice. Thus, the nicotinic acetylcholine receptor alpha7 subunit is essential for inhibiting cytokine synthesis by the cholinergic anti- inflammatory pathway.	N Shore Long Isl Jewish Res Inst, Lab Biomed Sci, Manhasset, NY 11030 USA; N Shore Long Isl Jewish Res Inst, Med Chem Lab, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Tracey, KJ (corresponding author), N Shore Long Isl Jewish Res Inst, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.		Wang, Haichao/K-6310-2012; Ulloa, Luis/AAE-8751-2019; Wang, Haichao/AAU-2237-2021; Susarla, Srinivas/P-1051-2019	Wang, Haichao/0000-0002-0211-9000; Ulloa, Luis/0000-0002-7702-7549; Wang, Haichao/0000-0002-0211-9000; Susarla, Srinivas/0000-0003-0155-8260; Tracey, Kevin J/0000-0003-1884-6314; Wang, Hong/0000-0003-4130-8741				Andersson L1992A, SCRIPTA BOT BELG, V1, P1; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Feng GP, 1998, J NEUROSCI, V18, P4166; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Kumins NH, 1996, SHOCK, V5, P385, DOI 10.1097/00024382-199605000-00012; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Leonard S, 2001, Nicotine Tob Res, V3, P203; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lindstrom J.M., 1995, HDB RECEPTORS CHANNE, P153; Marubio LM, 2000, EUR J PHARMACOL, V393, P113, DOI 10.1016/S0014-2999(00)00007-8; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; PENG X, 1994, MOL PHARMACOL, V45, P546; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shoop RD, 2000, J NEUROSCI, V20, P4021; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Steinlein O, 1998, BEHAV BRAIN RES, V95, P31, DOI 10.1016/S0166-4328(97)00207-6; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	27	2251	2521	14	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					384	388		10.1038/nature01339	http://dx.doi.org/10.1038/nature01339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12508119				2022-12-24	WOS:000180533000045
J	Genbacev, OD; Prakobphol, A; Foulk, RA; Krtolica, AR; Ilic, D; Singer, MS; Yang, ZQ; Kiessling, LL; Rosen, SD; Fisher, SJ				Genbacev, OD; Prakobphol, A; Foulk, RA; Krtolica, AR; Ilic, D; Singer, MS; Yang, ZQ; Kiessling, LL; Rosen, SD; Fisher, SJ			Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface	SCIENCE			English	Article							HIGH-ENDOTHELIAL VENULES; HUMAN CYTOTROPHOBLASTS; LYMPHOCYTES; INVASION; RECEPTORS; LIGAND; CELLS	Trophoblast adhesion to the uterine wall is the requisite first step of implantation and, subsequently, placentation. At the maternal-fetal interface, we investigated the expression of selectin adhesion systems that enable leukocyte capture from the bloodstream. On the maternal side, human uterine epithelial cells up-regulated selectin oligosaccharide-based ligands during the window of receptivity. On the fetal side, human trophoblasts expressed L-selectin. This ligand-receptor system was functional, because beads coated with the selectin ligand 6-sulfo sLe(x) bound to trophoblasts, and trophoblasts bound to ligand-expressing uterine luminal epithelium in tissue sections. These results suggest that trophoblast L-selectin mediates interactions with the uterus and that this adhesion mechanism may be critical to establishing human pregnancy.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Nevada Ctr Reprod Med, Reno, NV 89509 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fisher, SJ (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.		Kiessling, Laura L/A-4074-2008	Kiessling, Laura/0000-0001-6829-1500; ILIC, DUSKO/0000-0003-1647-0026; Rosen, Steven/0000-0002-6245-701X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042283] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE007244, R37DE007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023547] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64597] Funding Source: Medline; NICHD NIH HHS [U01 HD 42283] Funding Source: Medline; NIDCR NIH HHS [DE 07244] Funding Source: Medline; NIGMS NIH HHS [R37GM23547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Calatayud S, 1996, INT IMMUNOL, V8, P1637, DOI 10.1093/intimm/8.10.1637; Damsky CH, 1998, CURR OPIN CELL BIOL, V10, P660, DOI 10.1016/S0955-0674(98)80043-4; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Frenette PS, 1997, THROMB HAEMOSTASIS, V78, P60; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Giblin PA, 1997, J IMMUNOL, V159, P3498; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Kimber SJ, 2000, SEMIN CELL DEV BIOL, V11, P77, DOI 10.1006/scdb.2000.0154; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; NORWITZ ER, 1907, NEW ENGL J MED, V345, P1400; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	18	348	384	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					405	408		10.1126/science.1079546	http://dx.doi.org/10.1126/science.1079546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532021				2022-12-24	WOS:000180426800049
J	Su, C; Evans, D; Cole, RH; Kissinger, JC; Ajioka, JW; Sibley, LD				Su, C; Evans, D; Cole, RH; Kissinger, JC; Ajioka, JW; Sibley, LD			Recent expansion of Toxoplasma through enhanced oral transmission	SCIENCE			English	Article							INTERNAL TRANSCRIBED SPACER; GONDII STRAINS; 2 ALLELES; SEQUENCE; PLASMODIUM; ANTIGEN; IDENTIFICATION; PHYLOGENY; VIRULENCE; CLONING	The global predominance of three clonal Toxoplasma gondii lineages suggests that they are endowed with an exceptional trait responsible for their current parasitism of nearly all warm-blooded vertebrates. Genetic polymorphism analyses indicate that these clonal lineages emerged within the last 10,000 years after a single genetic cross. Comparison with ancient strains (similar to1 million years) suggests that the success of the clonal lineages resulted from the concurrent acquisition of direct oral infectivity. This key adaptation circumvented sexual recombination, simultaneously promoting transmission through successive hosts, hence leading to clonal expansion. Thus, changes in complex life cycles can occur rapidly and can profoundly influence pathogenicity.	Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	Washington University (WUSTL); University of Cambridge; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sibley, LD (corresponding author), Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@borcim.wustl.edu	Sibley, L. David/C-4616-2008; Su, Chunlei/M-1892-2013; Kissinger, Jessica C/E-9610-2010; Kissinger, Jessica/M-9920-2019	Su, Chunlei/0000-0001-8392-7108; Kissinger, Jessica C/0000-0002-6413-1101; Kissinger, Jessica/0000-0002-6413-1101				BULOW R, 1991, J IMMUNOL, V147, P3496; CAI J, 1992, BIOCHIM BIOPHYS ACTA, V1131, P317, DOI 10.1016/0167-4781(92)90032-U; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; DUBEY JP, 1980, AM J VET RES, V41, P427; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; GAGNON S, 1993, MOL BIOCHEM PARASIT, V60, P145, DOI 10.1016/0166-6851(93)90037-X; GAJADHAR AA, 1991, MOL BIOCHEM PARASIT, V45, P147, DOI 10.1016/0166-6851(91)90036-6; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hnida JA, 1999, J PARASITOL, V85, P873, DOI 10.2307/3285824; HOLE F, 1994, ORIGINS AGR, P373; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Israelski D M, 1993, Curr Clin Top Infect Dis, V13, P322; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; LEVINE N. D., 1988, PROTOZOAN PHYLUM API, VI; Levine ND., 1988, PROTOZOAN PHYLUM API; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Meisel R, 1996, MOL BIOCHEM PARASIT, V81, P259, DOI 10.1016/0166-6851(96)02719-3; Mugridge NB, 1999, INT J PARASITOL, V29, P1545, DOI 10.1016/S0020-7519(99)00150-2; Olivier C, 2001, INT J PARASITOL, V31, P1475, DOI 10.1016/S0020-7519(01)00283-1; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Remington JS, 2001, INFECT DIS FETUS NEW, P205; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; SERPELL J, 2000, DOMESTIC CAT; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	36	261	272	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					414	416		10.1126/science.1078035	http://dx.doi.org/10.1126/science.1078035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532022	Green Published			2022-12-24	WOS:000180426800052
J	Kirschke, DL; Jones, TF; Craig, AS; Chu, PS; Mayernick, GG; Patel, JA; Schaffner, W				Kirschke, DL; Jones, TF; Craig, AS; Chu, PS; Mayernick, GG; Patel, JA; Schaffner, W			Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; INFECTION; OUTBREAK; STERILIZATION	Background: Several outbreaks and pseudo-outbreaks of Pseudomonas aeruginosa and Serratia marcescens infections associated with bronchoscopy have been reported. We conducted an investigation of P. aeruginosa and S. marcescens isolates related to bronchoscopy at a community hospital. Methods: We reviewed the records of all bronchoscopic procedures at the community hospital from July to October 2001. Environmental samples were obtained. Pulsed-field gel electrophoresis (PFGE) was performed on isolates of P. aeruginosa. Results: From July 1 to October 31, 2001, 66 bronchoscopic procedures were performed in 60 patients, and 43 specimens were obtained for bacterial culture; 20 of the specimens (47 percent) were positive for P. aeruginosa. Six (30 percent) of the specimens that were positive for P. aeruginosa also yielded S. marcescens. All 20 P. aeruginosa isolates were associated with procedures performed with three of four new bronchoscopes from the same manufacturer. Contrary to manufacturing specifications, the biopsy-port caps on all four bronchoscopes were easily removable, and P. aeruginosa was cultured from the biopsy ports of the three implicated bronchoscopes. The PFGE patterns of P. aeruginosa isolates from the bronchoscopes, patients, and two environmental samples were indistinguishable. One patient was hospitalized with P. aeruginosa pneumonia 11 days after bronchoscopy. The manufacturer reported a design change instituted in 1997, and production problems may have resulted in the distribution of bronchoscopes that did not meet specifications. Conclusions: We documented contamination of bronchoscopes with P. aeruginosa and S. marcescens and possible infection of patients at a community hospital as a result of the inadequate disinfection of bronchoscopes because of a manufacturing defect.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; Tennessee Dept Hlth, Nashville, TN USA; Skyline Med Ctr, Nashville, TN USA	Vanderbilt University; Centers for Disease Control & Prevention - USA; Tennessee Department Health	Schaffner, W (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N,Rm A-1124, Nashville, TN 37232 USA.	william.schaffner@vanderbilt.edu						Alvarado CJ, 2000, AM J INFECT CONTROL, V28, P138; [Anonymous], MMWR MORB MORTAL WKL; *BIOR LAB, 1992, MOL AN SOFTW VERS 1; Blanc DS, 1997, INFECT CONT HOSP EP, V18, P134; BOND WW, 1998, DISINFECTION STERILI, P151; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DEAN AG, 2001, INFO 2000 VERSION 1; Favero M., 1991, DISINFECTION STERILI, P617; FEIGAL DW, 1999, FDA CDC PUBLIC HLTH; KOLMOS HJ, 1994, SCAND J INFECT DIS, V26, P653, DOI 10.3109/00365549409008632; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; Muscarella LF, 2000, INFECT CONT HOSP EP, V21, P628, DOI 10.1086/503241; Muscarella LF, 1996, INFECT CONT HOSP EP, V17, P183; Ostrowsky B., 2001, SEMIN INFECT CONTROL, V1, P267; OWINGS MF, 1996, VITAL HLTH STAT 13, V139; PRAKASH UBS, 1993, CHEST, V104, P552, DOI 10.1378/chest.104.2.552; Rutala WA, 1998, AM J INFECT CONTROL, V26, P393, DOI 10.1016/S0196-6553(98)70034-3; Rutala WA, 1999, INFECT CONT HOSP EP, V20, P302; Sammartino M T, 1982, J Hosp Infect, V3, P65, DOI 10.1016/0195-6701(82)90032-9; Seijo LM, 2001, NEW ENGL J MED, V344, P740, DOI 10.1056/NEJM200103083441007; SIEGMANIGRA Y, 1985, J HOSP INFECT, V6, P218; Sorin M, 2001, INFECT CONT HOSP EP, V22, P409, DOI 10.1086/501925; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; VANDENBROUCKEGRAULS CMJE, 1993, J HOSP INFECT, V23, P263, DOI 10.1016/0195-6701(93)90143-N; Weber DJ, 2001, INFECT CONT HOSP EP, V22, P403, DOI 10.1086/501924; WHEELER PW, 1989, J INFECT DIS, V159, P954, DOI 10.1093/infdis/159.5.954	28	94	101	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					214	220		10.1056/NEJMoa021791	http://dx.doi.org/10.1056/NEJMoa021791			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529461				2022-12-24	WOS:000180390600005
J	Friend, M; Vucenik, I; Miller, M				Friend, M; Vucenik, I; Miller, M			Platelet responsiveness to aspirin in patients with hyperlipidaemia	BRITISH MEDICAL JOURNAL			English	Article							RESISTANCE		Univ Maryland, Med Ctr, Div Cardiol, Baltimore, MD 21201 USA; Univ Maryland, Med Ctr, Dept Med & Res Technol & Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Miller, M (corresponding author), Univ Maryland, Med Ctr, Div Cardiol, Baltimore, MD 21201 USA.		Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061369] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL061369, HL 61369] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARVALHO AC, 1974, NEW ENGL J MED, V290, P434, DOI 10.1056/NEJM197402212900805; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; Kawasaki T, 2000, STROKE, V31, P591, DOI 10.1161/01.STR.31.3.591; SATHIROPAS P, 1988, THROMB RES, V51, P55, DOI 10.1016/0049-3848(88)90282-4; Weber AA, 1999, LANCET, V353, P900, DOI 10.1016/S0140-6736(99)00498-5	5	117	129	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					82	83		10.1136/bmj.326.7380.82	http://dx.doi.org/10.1136/bmj.326.7380.82			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521973	Green Published, Bronze			2022-12-24	WOS:000180426900017
J	Voulhoux, R; Bos, MP; Geurtsen, J; Mols, M; Tommassen, J				Voulhoux, R; Bos, MP; Geurtsen, J; Mols, M; Tommassen, J			Role of a highly conserved bacterial protein in outer membrane protein assembly	SCIENCE			English	Article							CHLOROPLASTIC ENVELOPE MEMBRANES; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; PHOSPHOLIPASE-A; GONORRHOEAE; ORIGIN	After transport across the cytoplasmic membrane, bacterial outer membrane proteins are assembled into the outer membrane. Meningococcal Omp85 is a highly conserved protein in Gram-negative bacteria, and its homolog Toc75 is a component of the chloroplast protein-import machinery. Omp85 appeared to be essential for viability, and unassembled forms of various outer membrane proteins accumulated upon Omp85 depletion. Immuno fluorescence microscopy revealed decreased surface exposure of outer membrane proteins, which was particularly apparent at the cell-division planes. Thus, Omp85 is likely to play a role in outer membrane protein assembly.	Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Tommassen, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.		Tommassen, Jan/I-1690-2016; Voulhoux, Rome/AAT-5333-2021	Tommassen, Jan/0000-0001-7633-4945; 				Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; BROK RGPM, 1994, J BACTERIOL, V176, P861, DOI 10.1128/jb.176.3.861-870.1994; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Jansen C, 2000, BBA-BIOMEMBRANES, V1464, P284, DOI 10.1016/S0005-2736(00)00155-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Manning DS, 1998, MICROB PATHOGENESIS, V25, P11, DOI 10.1006/mpat.1998.0206; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Martin D, 1997, J EXP MED, V185, P1173, DOI 10.1084/jem.185.7.1173; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Prinz T, 2000, FEMS MICROBIOL LETT, V183, P49, DOI 10.1111/j.1574-6968.2000.tb08932.x; Reumann S, 1999, TRENDS PLANT SCI, V4, P302, DOI 10.1016/S1360-1385(99)01449-1; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Thomas KL, 2001, INFECT IMMUN, V69, P4438, DOI 10.1128/IAI.69.7.4438-4446.2001; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	22	571	582	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					262	265		10.1126/science.1078973	http://dx.doi.org/10.1126/science.1078973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522254				2022-12-24	WOS:000180284000043
J	Chiu, SS; Lau, YL; Chan, KH; Wong, WHS; Peiris, JSM				Chiu, SS; Lau, YL; Chan, KH; Wong, WHS; Peiris, JSM			Influenza-related hospitalizations among children in Hong Kong	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISEASE; COST-EFFECTIVENESS; VIRUS INFECTION; YOUNG-CHILDREN; INFANTS; IMPACT; EPIDEMICS; DIAGNOSIS; VACCINE; ILLNESS	Background: It has been difficult to define the burden of influenza in children because of confounding by the cocirculation of respiratory syncytial virus (RSV). In Hong Kong, China, the influenza and RSV infection seasons sometimes do not overlap, thus providing an opportunity to estimate the rate of influenza-related hospitalization in a defined population, free from the effects of RSV. Methods: In a retrospective, population-based study, we estimated the influenza-associated excess rate of hospitalization among children 15 years old or younger in the Hong Kong Special Administrative Region from 1997 to 1999. Data from a single hospital with intensive use of virologic analyses for diagnosis were obtained to define and adjust for underestimation of the model. Results: Peaks of influenza and RSV infection activity were well separated in 1998 and 1999 but overlapped in 1997. The adjusted rates of excess hospitalization for acute respiratory disease that were attributable to influenza were 278.5 and 288.2 per 10,000 children less than 1 year of age in 1998 and 1999, respectively; 218.4 and 209.3 per 10,000 children 1 to less than 2 years of age; 125.6 and 77.3 per 10,000 children 2 to less than 5 years of age; 57.3 and 20.9 per 10,000 children 5 to less than 10 years of age; and 16.4 and 8.1 per 10,000 children 10 to 15 years of age. Conclusions: In the subtropics, influenza is an important cause of hospitalization among children, with rates exceeding those reported for temperate regions.	Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Peiris, JSM (corresponding author), Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Wong, Wilfred/Q-8751-2019; Chan, Kwok Hung/ABD-5399-2021; Chiu, Susan Shui Seng/C-4247-2009; Lau, Yu Lung/C-4322-2009	Chiu, Susan Shui Seng/0000-0002-3908-1974; Wong, Hing Sang Wilfred/0000-0001-8396-2368; Lau, Yu Lung/0000-0002-4780-0289				ADAMS PF, 1995, VITAL HLTH STAT, V10; [Anonymous], 2002, Wkly Epidemiol Rec, V77, P191; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chiu SS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e63; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; Drinka P, 1999, J AM GERIATR SOC, V47, P1363; Edwards KM, 2001, PEDIATRICS, V108, P1004, DOI 10.1542/peds.108.4.1004; Fitzner K. A., 1999, Hong Kong Medical Journal, V5, P87; Fitzner KA, 2001, HEALTH POLICY, V56, P215, DOI 10.1016/S0168-8510(00)00140-8; Glezen WP, 1999, JAMA-J AM MED ASSOC, V281, P944, DOI 10.1001/jama.281.10.944; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Glezen WP, 1997, PEDIATR INFECT DIS J, V16, P1065, DOI 10.1097/00006454-199711000-00012; *GOV HONG KONG SPE, INFL SURV; *HONG KONG GOV, 1993, HONG KONG COR REP; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; McIntosh K, 2000, NEW ENGL J MED, V342, P275, DOI 10.1056/NEJM200001273420409; Monto Arnold S., 1997, Journal of Infectious Diseases, V176, pS32, DOI 10.1086/514172; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2001, INFECT DIS CLIN N AM, V15, P123, DOI 10.1016/S0891-5520(05)70271-3; Poland GA, 1999, PEDIATRICS, V103, P1280, DOI 10.1542/peds.103.6.1280; SHORTRIDGE KF, 1995, LANCET, V346, P1210, DOI 10.1016/S0140-6736(95)92906-1; SHORTRIDGE KF, 1982, LANCET, V2, P812; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; SUGAYA N, 1992, J INFECT DIS, V165, P373, DOI 10.1093/infdis/165.2.373; Szucs TD, 1999, PHARMACOECONOMICS, V16, P27, DOI 10.2165/00019053-199916001-00004; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2000, N ENGL J MED, V342, P1752	32	225	241	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2097	2103		10.1056/NEJMoa020546	http://dx.doi.org/10.1056/NEJMoa020546			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501221	Bronze			2022-12-24	WOS:000180040900002
J	Cerullo, G; Polli, D; Lanzani, G; De Silvestri, S; Hashimoto, H; Cogdell, RJ				Cerullo, G; Polli, D; Lanzani, G; De Silvestri, S; Hashimoto, H; Cogdell, RJ			Photosynthetic light harvesting by carotenoids: Detection of an intermediate excited state	SCIENCE			English	Article							BETA-CAROTENE; ELECTRONIC EXCITATIONS; ENERGY-TRANSFER; 1B(U)(+); DEPENDENCE; ABSORPTION; LIFETIME; COMPLEX; FINITE	We present the first direct evidence of the presence of an intermediate singlet excited state (S-x) mediating the internal conversion from S-2 to S-1 in carotenoids. The S-2 to S-x transition is extremely fast and is completed within approximately 50 femtoseconds. These results require a reassessment of the energy transfer pathways from carotenoids to chlorophylls in the primary step of photosynthesis.	Politecn Milan, Dipartimento Fis, Natl Lab Ultrafast & Ultraintense Opt Sci, INFM, I-20133 Milan, Italy; Univ Glasgow, Div Biochem & Mol Biol, Glasgow, Lanark, Scotland	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Polytechnic University of Milan; University of Glasgow	Cerullo, G (corresponding author), Politecn Milan, Dipartimento Fis, Natl Lab Ultrafast & Ultraintense Opt Sci, INFM, Piazza L da Vinci 32, I-20133 Milan, Italy.	giulio.cerullo@fisi.polimi.it	Polli, Dario/B-4809-2011; Cerullo, Giulio/F-6534-2011	Polli, Dario/0000-0002-6960-5708; Cerullo, Giulio/0000-0002-9534-2702				Cerullo G, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.241104; Cerullo G, 1998, OPT LETT, V23, P1283, DOI 10.1364/OL.23.001283; Damjanovic A, 1999, PHYS REV E, V59, P3293, DOI 10.1103/PhysRevE.59.3293; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; ISLER O, 1971, CAROTENOIDS; KANDORI H, 1994, J AM CHEM SOC, V116, P2671, DOI 10.1021/ja00085a078; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; Macpherson AN, 1998, J PHYS CHEM A, V102, P5049, DOI 10.1021/jp980979z; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; PELLEGRIN E, 1991, PHYS REV LETT, V66, P2022, DOI 10.1103/PhysRevLett.66.2022; Ritz T, 2000, PHOTOSYNTH RES, V66, P125, DOI 10.1023/A:1010750332320; Sashima T, 2000, J PHYS CHEM B, V104, P5011, DOI 10.1021/jp994185b; Sashima T, 1999, CHEM PHYS LETT, V299, P187, DOI 10.1016/S0009-2614(98)01278-0; SHREVE AP, 1991, CHEM PHYS LETT, V178, P89, DOI 10.1016/0009-2614(91)85058-5; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; TAVAN P, 1986, J CHEM PHYS, V85, P6602, DOI 10.1063/1.451442; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; YOSHIZAWA M, 2001, PHYS REV B, V63; Zavelani-Rossi M, 2001, OPT LETT, V26, P1155, DOI 10.1364/OL.26.001155; Zhang JP, 2001, PHOTOCHEM PHOTOBIOL, V73, P219, DOI 10.1562/0031-8655(2001)073<0219:TAFTUS>2.0.CO;2; Zhang JP, 2000, CHEM PHYS LETT, V332, P351, DOI 10.1016/S0009-2614(00)01275-6	23	225	227	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2395	2398		10.1126/science.1074685	http://dx.doi.org/10.1126/science.1074685			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493917				2022-12-24	WOS:000179915900059
J	Kwong, PD; Doyle, ML; Casper, DJ; Cicala, C; Leavitt, SA; Majeed, S; Steenbeke, TD; Venturi, M; Chaiken, I; Fung, M; Katinger, H; Parren, PWLH; Robinson, J; Van Ryk, D; Wang, LP; Burton, DR; Freire, E; Wyatt, R; Sodroski, J; Hendrickson, WA; Arthos, J				Kwong, PD; Doyle, ML; Casper, DJ; Cicala, C; Leavitt, SA; Majeed, S; Steenbeke, TD; Venturi, M; Chaiken, I; Fung, M; Katinger, H; Parren, PWLH; Robinson, J; Van Ryk, D; Wang, LP; Burton, DR; Freire, E; Wyatt, R; Sodroski, J; Hendrickson, WA; Arthos, J			HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; HUMAN MONOCLONAL-ANTIBODY; TYPE-1 GP120; EFFICIENT NEUTRALIZATION; CELLS; RETROVIRUS; EPITOPES; COMPLEX; FUSION	The ability of human immunodeficiency virus (HIV-1) to persist and cause AIDS is dependent on its avoidance of antibody-mediated neutralization. The virus elicits abundant, envelope-directed antibodies that have little neutralization capacity(1). This lack of neutralization is paradoxical, given the functional conservation and exposure of receptor-binding sites on the gp120 envelope glycoprotein, which are larger than the typical antibody footprint(2) and should therefore be accessible for antibody binding. Because gp120-receptor interactions involve conformational reorganization(3), we measured the entropies of binding for 20 gp120-reactive antibodies. Here we show that recognition by receptor-binding-site antibodies induces conformational change. Correlation with neutralization potency and analysis of receptor-antibody thermodynamic cycles suggested a receptor-binding-site 'conformational masking' mechanism of neutralization escape. To understand how such an escape mechanism would be compatible with virus-receptor interactions, we tested a soluble dodecameric receptor molecule and found that it neutralized primary HIV-1 isolates with great potency, showing that simultaneous binding of viral envelope glycoproteins by multiple receptors creates sufficient avidity to compensate for such masking. Because this solution is available for cell-surface receptors but not for most antibodies, conformational masking enables HIV-1 to maintain receptor binding and simultaneously to resist neutralization.	NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; NIAID, NIH, Bethesda, MD 20892 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; GlaxosmithKline Pharmaceut, Dept Biol Struct, King Of Prussia, PA 19406 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Tanox Biosyst Inc, Cell Biol, Houston, TX 77025 USA; Univ Agr & Forestry, Inst Appl Microbiol, A-1190 Vienna, Austria; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70112 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Div AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Columbia University; Howard Hughes Medical Institute; GlaxoSmithKline; Johns Hopkins University; University of Pennsylvania; Scripps Research Institute; Scripps Research Institute; Tulane University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA.			Parren, Paul/0000-0002-4365-3859; Doyle, Michael/0000-0003-4569-6315	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000883, ZIAAI000883] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; Binley JM, 1998, AIDS RES HUM RETROV, V14, P191, DOI 10.1089/aid.1998.14.191; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Doyle ML, 2000, METHOD ENZYMOL, V323, P207; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; FUNG MSC, 1992, J VIROL, V66, P848, DOI 10.1128/JVI.66.2.848-856.1992; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Luque I, 1998, METHOD ENZYMOL, V295, P100; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; POSNER MR, 1991, J IMMUNOL, V146, P4325; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Salzwedel K, 2000, J VIROL, V74, P326, DOI 10.1128/JVI.74.1.326-333.2000; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhou JY, 1997, J VIROL, V71, P2512, DOI 10.1128/JVI.71.3.2512-2517.1997; Zhu P, 2001, J VIROL, V75, P6682, DOI 10.1128/JVI.75.14.6682-6686.2001	30	712	760	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					678	682		10.1038/nature01188	http://dx.doi.org/10.1038/nature01188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478295				2022-12-24	WOS:000179751800048
J	Bates, NR; Pequignet, AC; Johnson, RJ; Gruber, N				Bates, NR; Pequignet, AC; Johnson, RJ; Gruber, N			A short-term sink for atmospheric CO2 in subtropical mode water of the North Atlantic Ocean	NATURE			English	Article							INTERANNUAL VARIABILITY; TIME-SERIES; SEA; OSCILLATION; GYRE	Large-scale features of ocean circulation, such as deep water formation in the northern North Atlantic Ocean(1), are known to regulate the long-term physical uptake of CO2 from the atmosphere by moving CO2-laden surface waters into the deep ocean. But the importance of CO2 uptake into water masses that ventilate shallower ocean depths, such as subtropical mode waters(2) of the subtropical gyres, are poorly quantified. Here we report that, between 1988 and 2001, dissolved CO2 concentrations in subtropical mode waters of the North Atlantic have increased at a rate twice that expected from these waters keeping in equilibrium with increasing atmospheric CO2. This accounts for an extra similar to0.4-2.8 Pg C (1 Pg = 10(15) g) over this period (that is, about 0.03-0.24 Pg Cyr(-1)), equivalent to similar to3-10% of the current net annual ocean uptake of CO2 (ref. 3). We suggest that the lack of strong winter mixing events, to greater than 300 m in depth, in recent decades is responsible for this accumulation, which would otherwise disturb the mode water layer and liberate accumulated CO2 back to the atmosphere. However, future climate variability (which influences subtropical mode water formation(1,4-8)) and changes in the North Atlantic Oscillation(9) (leading to a return of deep winter mixing events) may reduce CO2 accumulation in subtropical mode waters. We therefore conclude that, although CO2 uptake by subtropical mode waters in the North Atlantic-and possibly elsewhere-does not always represent a long-term CO2 sink, the phenomenon is likely to contribute substantially to interannual variability in oceanic CO2 uptake(3).	Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda; Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Bates, NR (corresponding author), Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda.	nick@bbsr.edu	Pequignet, Christine/H-5618-2014; Gruber, Nicolas/B-7013-2009	Gruber, Nicolas/0000-0002-2085-2310				Alfultis MA, 2001, J PHYS OCEANOGR, V31, P2066, DOI 10.1175/1520-0485(2001)031<2066:AAICIT>2.0.CO;2; Bates NR, 1996, DEEP-SEA RES PT II, V43, P347, DOI 10.1016/0967-0645(95)00093-3; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; BEHRINGER DW, 1980, DEEP-SEA RES, V27, P225, DOI 10.1016/0198-0149(80)90014-X; Conte MH, 2001, DEEP-SEA RES PT II, V48, P1471, DOI 10.1016/S0967-0645(00)00150-8; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; GRAEDEL TE, 1988, APPL GEOCHEM, V3, P37; HANAWA K, 2001, INT GEOPHYSICS SERIE, V77, P378; Hazeleger W, 1998, J PHYS OCEANOGR, V28, P266, DOI 10.1175/1520-0485(1998)028<0266:MWVIAM>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jenkins WJ, 1982, J MAR RES, V40, P265; Jenkins WJ, 1998, J GEOPHYS RES-OCEANS, V103, P15817, DOI 10.1029/98JC00141; Joyce TM, 2000, J CLIMATE, V13, P2550, DOI 10.1175/1520-0442(2000)013<2550:TRBDVO>2.0.CO;2; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; KARL DM, IN PRESS DEEP SEA RE; Keeling C. D., 1993, GLOBAL CARBON CYCLE, P413; Klein B, 1996, DEEP-SEA RES PT I, V43, P1777, DOI 10.1016/S0967-0637(96)00069-6; LUYTEN JR, 1983, J PHYS OCEANOGR, V13, P292, DOI 10.1175/1520-0485(1983)013<0292:TVT>2.0.CO;2; Marsh R, 1996, J PHYS OCEANOGR, V26, P1059, DOI 10.1175/1520-0485(1996)026<1059:MWV>2.0.CO;2; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; SPALL MA, 1992, J PHYS OCEANOGR, V22, P564, DOI 10.1175/1520-0485(1992)022<0564:CSARIT>2.0.CO;2; SPEER K, 1992, J PHYS OCEANOGR, V22, P93, DOI 10.1175/1520-0485(1992)022<0093:ROWMFI>2.0.CO;2; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Talley LD, 1982, J MAR RES, V40, P757; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; Williams RG, 1995, J PHYS OCEANOGR, V25, P3089, DOI 10.1175/1520-0485(1995)025<3089:DSMLW>2.0.CO;2; WOODS JD, 1986, NATURE, V319, P574, DOI 10.1038/319574a0; WORTHINGTON LV, 1959, DEEP-SEA RES, V5, P297, DOI 10.1016/0146-6313(58)90026-1	30	85	86	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					489	493		10.1038/nature01253	http://dx.doi.org/10.1038/nature01253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12487116				2022-12-24	WOS:000179611600041
J	Feng, Q; Zhang, YJ; Hao, P; Wang, SY; Fu, G; Huang, YC; Li, Y; Zhu, JJ; Liu, YL; Hu, X; Jia, PX; Zhang, Y; Zhao, Q; Ying, K; Yu, SL; Tang, YS; Weng, QJ; Zhang, L; Lu, Y; Mu, J; Lu, YQ; Zhang, LS; Yu, Z; Fan, DL; Liu, XH; Lu, TT; Li, C; Wu, YR; Sun, TG; Lei, HY; Li, T; Hu, H; Guan, JP; Wu, M; Zhang, RQ; Zhou, B; Chen, ZH; Chen, L; Jin, ZQ; Wang, R; Yin, HF; Cai, Z; Ren, SX; Lv, G; Gu, WY; Zhu, GF; Tu, YF; Jia, J; Zhang, Y; Chen, J; Kang, H; Chen, XY; Shao, CY; Sun, Y; Hu, QP; Zhang, XL; Zhang, W; Wang, LJ; Ding, CW; Sheng, HH; Gu, JL; Chen, ST; Ni, L; Zhu, FH; Chen, W; Lan, LF; Lai, Y; Cheng, ZK; Gu, MH; Jiang, JM; Li, JY; Hong, GF; Xue, YB; Han, B				Feng, Q; Zhang, YJ; Hao, P; Wang, SY; Fu, G; Huang, YC; Li, Y; Zhu, JJ; Liu, YL; Hu, X; Jia, PX; Zhang, Y; Zhao, Q; Ying, K; Yu, SL; Tang, YS; Weng, QJ; Zhang, L; Lu, Y; Mu, J; Lu, YQ; Zhang, LS; Yu, Z; Fan, DL; Liu, XH; Lu, TT; Li, C; Wu, YR; Sun, TG; Lei, HY; Li, T; Hu, H; Guan, JP; Wu, M; Zhang, RQ; Zhou, B; Chen, ZH; Chen, L; Jin, ZQ; Wang, R; Yin, HF; Cai, Z; Ren, SX; Lv, G; Gu, WY; Zhu, GF; Tu, YF; Jia, J; Zhang, Y; Chen, J; Kang, H; Chen, XY; Shao, CY; Sun, Y; Hu, QP; Zhang, XL; Zhang, W; Wang, LJ; Ding, CW; Sheng, HH; Gu, JL; Chen, ST; Ni, L; Zhu, FH; Chen, W; Lan, LF; Lai, Y; Cheng, ZK; Gu, MH; Jiang, JM; Li, JY; Hong, GF; Xue, YB; Han, B			Sequence and analysis of rice chromosome 4	NATURE			English	Article							PLANT ARABIDOPSIS-THALIANA; GENOME SEQUENCE; DRAFT SEQUENCE; PHYSICAL MAP; GENETIC-MAP; EXPRESSION; PROJECT; CLONING; TOOL; DNA	Rice is the principal food for over half of the population of the world. With its genome size of 430 megabase pairs ( Mb), the cultivated rice species Oryza sativa is a model plant for genome research(1). Here we report the sequence analysis of chromosome 4 of O. sativa, one of the first two rice chromosomes to be sequenced completely(2). The finished sequence spans 34.6 Mb and represents 97.3% of the chromosome. In addition, we report the longest known sequence for a plant centromere, a completely sequenced contig of 1.16 Mb corresponding to the centromeric region of chromosome 4. We predict 4,658 protein coding genes and 70 transfer RNA genes. A total of 1,681 predicted genes match available unique rice expressed sequence tags. Transposable elements have a pronounced bias towards the euchromatic regions, indicating a close correlation of their distributions to genes along the chromosome. Comparative genome analysis between cultivated rice subspecies shows that there is an overall syntenic relationship between the chromosomes and divergence at the level of single-nucleotide polymorphisms and insertions and deletions. By contrast, there is little conservation in gene order between rice and Arabidopsis.	Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Gene Res, Shanghai 200233, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Yangzhou Univ, Yangzhou 225009, Jiangsu, Peoples R China; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Yangzhou University; University of Wisconsin System; University of Wisconsin Madison	Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Ctr Gene Res, 500 Caobao Rd, Shanghai 200233, Peoples R China.	bhan@ncgr.ac.cn	Yin, Haifeng/E-8787-2012; Jiang, Jiming/V-6060-2019; Jiang, Jiming/A-9614-2009; chen, zehua/H-1260-2011; Chen, Zehua/E-6356-2011	Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Lan, Lefu/0000-0002-5551-5496; Hao, Pei/0000-0002-1498-7059				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harushima Y, 1998, GENETICS, V148, P479; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; KNUTZON DS, 1995, PLANT PHYSIOL, V109, P999, DOI 10.1104/pp.109.3.999; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maugenest S, 1999, PLANT MOL BIOL, V39, P503, DOI 10.1023/A:1006131506193; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Messing J, 1998, P NATL ACAD SCI USA, V95, P2017, DOI 10.1073/pnas.95.5.2017; Oka H. I., 1991, Rice biotechnology., P55; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Saji S, 2001, GENOME, V44, P32, DOI 10.1139/gen-44-1-32; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhao Q, 2002, GENOME RES, V12, P817, DOI 10.1101/gr.48902	30	387	930	3	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					316	320		10.1038/nature01183	http://dx.doi.org/10.1038/nature01183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447439				2022-12-24	WOS:000179340400042
J	Charlebois, RL; Beiko, RG; Ragan, MA				Charlebois, RL; Beiko, RG; Ragan, MA			Branching out	NATURE			English	Editorial Material									Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Ottawa; University of Queensland	Charlebois, RL (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.		Ragan, Mark A/A-9825-2014	Ragan, Mark A/0000-0003-1672-7020				Clarke GDP, 2002, J BACTERIOL, V184, P2072, DOI 10.1128/JB.184.8.2072-2080.2002; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8	5	28	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					217	217		10.1038/421217a	http://dx.doi.org/10.1038/421217a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529621	Bronze			2022-12-24	WOS:000180397600026
J	Reichhardt, T				Reichhardt, T			NSF urged to take multidisciplinary tack on environment	NATURE			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102a	http://dx.doi.org/10.1038/421102a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520270	Bronze			2022-12-24	WOS:000180267200008
J	Fontaine, KR; Redden, DT; Wang, CX; Westfall, AO; Allison, DB				Fontaine, KR; Redden, DT; Wang, CX; Westfall, AO; Allison, DB			Years of life lost due to obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; WHITE; DISEASE; COHORT; HEALTH; MEN	Context Public health officials and organizations have disseminated health messages regarding the dangers of obesity, but these have not produced the desired effect. Objective To estimate the expected number of years of life lost (YLL) due to overweight and obesity across the life span of an adult. Design, Setting, and Subjects Data from the (1) US Life Tables (1999); (2) Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994); and (3) First National Health and Nutrition Epidemiologic Follow-up Study (NHANES I and II; 1971-1992) and NHANES II, Mortality Study (1976-1992) were used to derive YLL estimates for adults aged 18 to 85 years. Body mass index (BMI) integer-defined categories were used (ie, <17; 17 to <18; 18 to <19; 20 to <21; 21 to 45; or greater than or equal to45). A BMI of 24 was used as the reference category. Main Outcome Measure The difference between the number of years of life expected if an individual were obese vs not obese, which was designated YLL. Results Marked race and sex differences were observed in estimated YLL. Among whites, a J- or U-shaped association was found between overweight or obesity and YLL. The optimal BMI (associated with the least YLL or greatest longevity) is approximately 23 to 25 for whites and -23 to 30 for blacks. For any given degree of overweight, younger adults generally had greater YLL than did older adults. The maximum YLL for white men aged 20 to 30 years with a severe level of obesity (BMI >45) is 13 and is 8 for white women. For men, this could represent a 22% reduction in expected remaining life span. Among black men and black women older than 60 years, overweight and moderate obesity were generally not associated with an increased YLL and only severe obesity resulted in YLL. However, blacks at younger ages with severe levels of obesity had a maximum YLL of 20 for men and 5 for women. Conclusion Obesity appears to lessen life expectancy markedly, especially among younger adults.	Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Clin Nutr Res Ctr, Sect Stat Genet, Birmingham, AL 35294 USA; Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, 327 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@ms.soph.uab.edu	Kohn, Geoffrey P/A-9056-2009	Allison, David/0000-0003-3566-9399; Westfall, Andrew/0000-0002-0468-4695	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30DK56336] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison D. B., 2001, International textbook of obesity, P31, DOI 10.1002/0470846739.ch3; Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1997, AM J EPIDEMIOL, V146, P672; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; ANDRES R, 1985, PRINCIPLES GERIATRIC, P311; [Anonymous], 1994, VITAL HLTH STAT, V1, P1, DOI DOI 10.1136/BMJ.L42; Berman DM, 2001, J CLIN ENDOCR METAB, V86, P97, DOI 10.1210/jc.86.1.97; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1988, MMWR-MORBID MORTAL W, V37, P543; CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765; Cox C S, 1997, Vital Health Stat 1, P1; David H., 1978, THEORY COMPETING RIS; DRENICK EJ, 1980, JAMA-J AM MED ASSOC, V243, P443, DOI 10.1001/jama.243.5.443; Durazo-Arvizu R, 1997, J AM STAT ASSOC, V92, P1312, DOI 10.2307/2965401; Ezzati T M, 1992, Vital Health Stat 2, P1; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; FLEGAL KM, 1997, OBES RES, V5, pS93; Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Green L. W., 1999, HLTH PROMOTION PLANN; HEO M, IN PRESS STAT MED; JOHNSON JL, 1986, AM J EPIDEMIOL, V123, P209, DOI 10.1093/oxfordjournals.aje.a114230; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sanchez Ana M., 2000, Ethnicity and Disease, V10, P24; Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4	34	1533	1594	9	107	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					187	193		10.1001/jama.289.2.187	http://dx.doi.org/10.1001/jama.289.2.187			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517229				2022-12-24	WOS:000180226400029
J	Hoermann, R				Hoermann, R			Thyroid-hormone suppressive therapy in benign thyroid nodules - is it effective?	LANCET			English	Editorial Material							MULTINODULAR GOITERS; LEVOTHYROXINE; PREVALENCE		Klinikum Luedenscheid, Dept Gen Internal Med Gastroenterol & Endocrinol, D-58515 Luedenscheid, Germany		Hoermann, R (corresponding author), Klinikum Luedenscheid, Dept Gen Internal Med Gastroenterol & Endocrinol, D-58515 Luedenscheid, Germany.			Hoermann, Rudolf/0000-0002-1326-4270				BURGI H, 1990, ACTA ENDOCRINOL-COP, V123, P577, DOI 10.1530/acta.0.1230577; Castro MR, 2002, J CLIN ENDOCR METAB, V87, P4154, DOI 10.1210/jc.2001-011762; HAMPEL R, 1995, MED KLIN, V90, P324; KOPP P, 1994, J CLIN ENDOCR METAB, V79, P134, DOI 10.1210/jc.79.1.134; Krohn K, 2002, MOL GENET METAB, V75, P202, DOI 10.1006/mgme.2001.3290; Lima N, 1997, THYROID, V7, P691, DOI 10.1089/thy.1997.7.691; Quadbeck B, 2002, EXP CLIN ENDOCR DIAB, V110, P348, DOI 10.1055/s-2002-34992; STUDER H, 1995, ENDOCR REV, V16, P411, DOI 10.1210/er.16.4.411; Zelmanovitz F, 1998, J CLIN ENDOCR METAB, V83, P3881, DOI 10.1210/jc.83.11.3881	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1899	1900		10.1016/S0140-6736(02)11934-9	http://dx.doi.org/10.1016/S0140-6736(02)11934-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493251				2022-12-24	WOS:000179870200003
J	Janata, P; Birk, JL; Van Horn, JD; Leman, M; Tillmann, B; Bharucha, JJ				Janata, P; Birk, JL; Van Horn, JD; Leman, M; Tillmann, B; Bharucha, JJ			The cortical topography of tonal structures underlying Western music	SCIENCE			English	Article							PREFRONTAL CORTICES; MEMORY; PITCH; EXPECTANCY; CONNECTIONS; MECHANISMS; CHORDS; CORTEX; TIME; ERP	Western tonal music relies on a formal geometric structure that determines distance relationships within a harmonic or tonal space. In functional magnetic resonance imaging experiments, we identified an area in the rostromedial prefrontal cortex that tracks activation in tonal space. Different voxels in this area exhibited selectivity for different keys. Within the same set of consistently activated voxels, the topography of tonality selectivity rearranged itself across scanning sessions. The tonality structure was thus maintained as a dynamic topography in cortical areas known to be at a nexus of cognitive, affective, and mnemonic processing.	Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA; State Univ Ghent, Inst Psychoacoust & Electron Music, B-9000 Ghent, Belgium	Dartmouth College; Dartmouth College; Dartmouth College; Ghent University	Janata, P (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.			Birk, Jeffrey/0000-0002-1313-0993; Van Horn, John Darrell/0000-0003-1537-0816	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017778] Funding Source: NIH RePORTER; NINDS NIH HHS [P50 NS17778-18] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BESSON M, 1995, J EXP PSYCHOL HUMAN, V21, P1278, DOI 10.1037/0096-1523.21.6.1278; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BIGAND E, IN PRESS J EXP PSYCH; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; FRANCES R, 1958, PERCEPTION MUSIQUE; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gazzaniga M., 2000, NEW COGNITIVE NEUROS, P1047; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Huron D., 1993, PSYCHOMUSICOLOGY J R, V12, P154, DOI DOI 10.1037/H0094110; JANATA P, 1995, J COGNITIVE NEUROSCI, V7, P153, DOI 10.1162/jocn.1995.7.2.153; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; Leman M, 2000, MUSIC PERCEPT, V17, P481; Lerdahl F., 2001, TONAL PITCH SPACE; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Meyer L. B., 1956, EMOTION MEANING MUSI; ORAM N, 1995, PSYCHOL RES-PSYCH FO, V57, P103; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2001, BRAIN, V124, P928, DOI 10.1093/brain/124.5.928; SHEPARD RN, 1982, PSYCHOL REV, V89, P305, DOI 10.1037/0033-295X.89.4.305; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tramo M J, 1990, J Cogn Neurosci, V2, P195, DOI 10.1162/jocn.1990.2.3.195; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	30	252	257	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2167	2170		10.1126/science.1076262	http://dx.doi.org/10.1126/science.1076262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481131				2022-12-24	WOS:000179773700040
J	Ko, HW; Jiang, J; Edery, I				Ko, HW; Jiang, J; Edery, I			Role for Slimb in the degradation of Drosophila Period protein phosphorylated by Doubletime	NATURE			English	Article							CASEIN-KINASE-I; DOUBLE-TIME; CLOCK-GENE; CYCLIN-E; F-BOX; LIGHT; UBIQUITINATION; EXPRESSION; MUTATION	Protein phosphorylation has a key role in modulating the stabilities of circadian clock proteins in a manner specific to the time of day(1). A conserved feature of animal clocks is that Period (Per) proteins undergo daily rhythms in phosphorylation and levels(2,3), events that are crucial for normal clock progression(4-7). Casein kinase Iepsilon (CKIepsilon) has a prominent role in regulating the phosphorylation and abundance of Per proteins in animals(8). This was first shown in Drosophila with the characterization of Doubletime (Dbt), a homologue of vertebrate casein kinase Iepsilon(4,6). However, it is not clear how Dbt regulates the levels of Per. Here we show, using a cell culture system, that Dbt promotes the progressive phosphorylation of Per, leading to the rapid degradation of hyperphosphorylated isoforms by the ubiquitin-proteasome pathway. Slimb, an F-box/WD40-repeat protein functioning in the ubiquitin-proteasome pathway(9,10) interacts preferentially with phosphorylated Per and stimulates its degradation. Overexpression of slimb or expression in clock cells of a dominant-negative version of slimb disrupts normal rhythmic activity in flies. Our findings suggest that hyperphosphorylated Per is targeted to the proteasome by interactions with Slimb.	Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Adv Biotechnol & Med, Grad Program Physiol & Neurobiol, Piscataway, NJ 08854 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, 679 Hoes Lane, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu		KO, HYUK WAN/0000-0003-1753-1900	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061269] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Bae K, 2000, J NEUROSCI, V20, P1746; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bocca SN, 2001, BIOCHEM BIOPH RES CO, V286, P357, DOI 10.1006/bbrc.2001.5394; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Edery I, 1999, CHRONOBIOL INT, V16, P377, DOI 10.3109/07420529908998716; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Eide EJ, 2001, CHRONOBIOL INT, V18, P389, DOI 10.1081/CBI-100103963; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Sidote D, 1998, MOL CELL BIOL, V18, P2004, DOI 10.1128/MCB.18.4.2004; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301	30	258	261	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					673	678		10.1038/nature01272	http://dx.doi.org/10.1038/nature01272			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12442174				2022-12-24	WOS:000179751800047
J	Matter, N; Herrlich, P; Konig, H				Matter, N; Herrlich, P; Konig, H			Signal-dependent regulation of splicing via phosphorylation of Sam68	NATURE			English	Article							MESSENGER-RNA; CD44; KINASE; TRANSDUCTION; ACTIVATION; SELECTION; DOMAINS; BINDING; MITOSIS; VARIANT	Evolution of human organismal complexity from a relatively small number of genes(1,2-)only approximately twice that of worm or fly-is explained mainly by mechanisms generating multiple proteins from a single gene, the most prevalent of which is alternative pre-messenger-RNA splicing(1,3,4). Appropriate spatial and temporal generation of splice variants demands that alternative splicing be subject to extensive regulation, similar to transcriptional control. Activation by extracellular cues of several cellular signalling pathways can indeed regulate alternative splicing(5-8). Here we address the link between signal transduction and splice regulation. We show that the nuclear RNA-binding protein Sam68 is a new extracellular signal-regulated kinase (ERK) target. It binds exonic splice-regulatory elements of an alternatively spliced exon that is physiologically regulated by the Ras signalling pathway, namely exon v5 of CD44. Forced expression of Sam68 enhanced ERK-mediated inclusion of the v5-exon sequence in mRNA. This enhancement was impaired by mutation of ERK-phosphorylation sites in Sam68, whereas ERK phosphorylation of Sam68 stimulated splicing of the v5 exon in vitro. Finally, Ras-pathway-induced alternative splicing of the endogenous CD44-v5 exon was abolished by suppression of Sam68 expression. Our data define Sam68 as a prototype regulator of alternative splicing whose function depends on protein modification in response to extracellular cues.	Forschungszentrum Karlsruhe, Inst Toxicol & Genet, D-76021 Karlsruhe, Germany; Univ Karlsruhe, Inst Genet, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Konig, H (corresponding author), Forschungszentrum Karlsruhe, Inst Toxicol & Genet, Postfach 3640, D-76021 Karlsruhe, Germany.	harald.koenig@itg.fzk.de		Konig, Harald/0000-0002-0117-0939				ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; COOPER DL, 1995, NAT MED, V1, P635, DOI 10.1038/nm0795-635; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Konig H, 1998, EMBO J, V17, P2904, DOI 10.1093/emboj/17.10.2904; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Reddy TR, 2000, ONCOGENE, V19, P3570, DOI 10.1038/sj.onc.1203676; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Sherman L, 1996, CURR TOP MICROBIOL, V213, P249; Stoss O, 2001, J BIOL CHEM, V276, P8665, DOI 10.1074/jbc.M006851200; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593	26	355	366	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					691	695		10.1038/nature01153	http://dx.doi.org/10.1038/nature01153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478298				2022-12-24	WOS:000179751800051
J	Collins, S; Sadler, K				Collins, S; Sadler, K			Outpatient care for severely malnourished children in emergency relief programmes: a retrospective cohort study	LANCET			English	Article							SEVERE MALNUTRITION; MORTALITY	Background In emergency nutritional relief programmes, therapeutic feeding centres are the accepted intervention for the treatment of severely malnourished people. These centres often cannot treat all the people requiring care. Consequently, coverage of therapeutic feeding centre programmes can be low, reducing their effectiveness. We aimed to assess the effectiveness of outpatient treatment for severe malnutrition in an emergency relief programme. Methods We did a retrospective cohort study in an outpatient therapeutic feeding programme in Ethiopia from September, 2000, to January, 2001. We assessed clinical records for 170 children aged 6-120 months. The children had either marasmus, kwashiorkor, or marasmic kwashiorkor. Outcomes were mortality, default from programme, discharge from programme, rate of weight gain, and length of stay in programme. Findings 144 (85%) patients recovered, seven (4%) died, 11 (6%) were transferred, and eight (5%) defaulted. Median time to discharge was 42 days (IQR 28-56), days to death 14 (7-26), and days to default 14 (7-28). Median rate of weight gain was 3.16 g kg(-1) day(-1) (1.86-5.60). In patients who recovered, median rates of weight gain were 4.80 g kg(-1) day(-1) (2.95-8.07) for marasmic patients, 4.03 g kg(-1) day(-1) (2.68-4.29) for marasmic kwashiorkor patients, and 2.70 g kg(-1) day(-1) (0.00-4.76) for kwashiorkor patients. Interpretation Outpatient treatment exceeded internationally accepted minimum standards for recovery, default, and mortality rates. Time spent in the programme and rates of weight gain did not meet these standards. Outpatient care could provide a complementary treatment strategy to therapeutic feeding centres. Further research should compare the effectiveness of outpatient and centre-based treatment of severe malnutrition in emergency nutritional interventions.	Valid Int, London, England; Inst Child Hlth, Ctr Int Child Hlth, London, England; Concern Worldwide, Dublin, Ireland	University of London; University College London	Collins, S (corresponding author), 37 Squires Court,Binfield Rd, London SW4 6TD, England.							Ashworth A, 1997, HEALTH POLICY PLANN, V12, P115, DOI 10.1093/heapol/12.2.115; BEATON GH, 1982, AM J CLIN NUTR, V35, P864, DOI 10.1093/ajcn/35.4.864; BOELAERT M, 1995, NUTR GUIDELINES; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; de Waal A., 1989, FAMINE KILLS DARFUR; DEGOYET CV, 2000, MANAGEMENT NUTR EMER; GOLDEN MHN, 1993, LANCET, V342, P360, DOI 10.1016/0140-6736(93)91491-4; Gomez Federico, 1956, J Trop Pediatr (Lond), V2, P77; Khanum S, 1998, AM J CLIN NUTR, V67, P940, DOI 10.1093/ajcn/67.5.940; KHANUM S, 1994, LANCET, V344, P1728; *NAT CTR HLTH STAT, 1979, NCHS GROWTH CURV CHI; Prudhon C, 1997, EUR J CLIN NUTR, V51, P771, DOI 10.1038/sj.ejcn.1600483; *SPHER PROJ, 2000, PROJ TEAM SPHER PROJ; WATERLOW JC, 1993, PROTEIN ENERGY MALNU; *WHO UN HIGH COMM, 2000, MAN NUTR MAJ EM; *WORLD FOOD PROGR, 2000, FOOD NUTR HDB; World Health Organization, 1998, MAN SEV MALN MAN PHY	19	91	92	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1824	1830		10.1016/S0140-6736(02)11770-3	http://dx.doi.org/10.1016/S0140-6736(02)11770-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480359				2022-12-24	WOS:000179706100009
J	Kazmierczak, J; Kremer, B				Kazmierczak, J; Kremer, B			Palaeontology (Communication arising): Thermal alteration of the Earth's oldest fossils	NATURE			English	Article									Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Kazmierczak, J (corresponding author), Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland.		Kremer, Barbara/ABB-1201-2020	Kremer, Barbara/0000-0002-0464-1265				Aleksandrowski P, 2000, T ROY SOC EDIN-EARTH, V90, P127, DOI 10.1017/S0263593300007197; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Dalton R, 2002, NATURE, V417, P782, DOI 10.1038/417782a; HORODYSKI RJ, 1975, J SEDIMENT PETROL, V45, P894; KOMAREK J, 1986, Archiv fuer Hydrobiologie Supplement, V73, P157; KREMER B, 2001, EARLY PALAEOZOIC PAL, P36; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; TISSOT BP, 1987, AAPG BULL, V71, P1445; Wyzga B, 1987, GEOL SUDETICA, V22, P119	9	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					477	478		10.1038/420477b	http://dx.doi.org/10.1038/420477b			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466835				2022-12-24	WOS:000179611600037
J	White, F				White, F			Water: life force or instrument of war?	LANCET			English	Article									Aga Khan Univ, Karachi 74800, Pakistan	Aga Khan University	White, F (corresponding author), Aga Khan Univ, Stadium Rd,Box 3500, Karachi 74800, Pakistan.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S29	S30		10.1016/S0140-6736(02)11810-1	http://dx.doi.org/10.1016/S0140-6736(02)11810-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504493				2022-12-24	WOS:000180064500014
J	Conner, JK				Conner, JK			Genetic mechanisms of floral trait correlations in a natural population	NATURE			English	Article							DROSOPHILA-MELANOGASTER; WILD RADISH; SELECTION; CHARACTERS; EVOLUTION; ARCHITECTURE; COVARIANCES; LINKAGE; FITNESS	Genetic correlations among traits are important in evolution, as they can constrain evolutionary change or reflect past selection for combinations of traits(1,2). Constraints and integration depend on whether the correlations are caused by pleiotropy or linkage disequilibrium(3), but these genetic mechanisms underlying correlations remain largely unknown in natural populations(4). Quantitative trait locus (QTL) mapping studies do not adequately address the mechanisms of within-population genetic correlations because they rely on crosses between distinct species, inbred lines or selected lines (see ref. 5), and they cannot distinguish moderate linkage disequilibrium from pleiotropy because they commonly rely on only one or two episodes of recombination(6). Here I report that after nine generations of enforced random mating (nine episodes of recombination), correlations between six floral traits in wild radish plants are unchanged, showing that pleiotropy generates the correlations. There is no evidence for linkage disequilibrium despite previous correlational selection acting on one functionally integrated pair of traits(7). This study provides direct evidence of the genetic mechanisms underlying correlations between quantitative traits in a natural population and suggests that there may be constraints on the independent evolution of pairs of highly correlated traits.	Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; Michigan State Univ, Dept Plant Biol, Hickory Corners, MI 49060 USA	Michigan State University; Michigan State University	Conner, JK (corresponding author), Michigan State Univ, Kellogg Biol Stn, 3700 E Gull Lake Dr, Hickory Corners, MI 49060 USA.	conner@kbs.msu.edu	Conner, Jeffrey/F-3188-2011	Conner, Jeffrey/0000-0003-1613-5826				BULMER MG, 1974, GENET RES, V23, P281, DOI 10.1017/S0016672300014920; Bulmer MG, 1985, MATH THEORY QUANTITA; Clark A., 1987, GENETIC CONSTRAINTS, P25, DOI DOI 10.1007/978-3-642-72770-2_3; CONNER J, 1993, EVOLUTION, V47, P704, DOI 10.1111/j.1558-5646.1993.tb02128.x; Conner JK, 1997, INT J PLANT SCI, V158, pS108, DOI 10.1086/297511; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Deng HW, 1999, EVOLUTION, V53, P1592, DOI 10.1111/j.1558-5646.1999.tb05422.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; Futuyma DJ., 1998, EVOL BIOL; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Houle D, 2002, EVOLUTION, V56, P433; Kearsey MJ, 1998, HEREDITY, V80, P137, DOI 10.1046/j.1365-2540.1998.00500.x; LANDE R, 1984, GENET RES, V44, P309, DOI 10.1017/S0016672300026549; LANDE R, 1980, GENETICS, V94, P203; Lynch M., 1998, AM J HUM GENET; MAYNARDSMITH J, 1985, Q REV BIOL, V60, P265, DOI DOI 10.1086/414425); MitchellOlds T, 1996, EVOLUTION, V50, P1849, DOI 10.1111/j.1558-5646.1996.tb03571.x; Morgan MT, 2001, EVOLUTION, V55, P272, DOI 10.1111/j.0014-3820.2001.tb01292.x; Nuzhdin SV, 1999, GENETICS, V153, P1317; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; Roff DA, 1999, J EVOLUTION BIOL, V12, P361, DOI 10.1046/j.1420-9101.1999.00036.x; SAS Institute, 1999, SAS STAT US GUID VER; Shabalina SA, 1997, P NATL ACAD SCI USA, V94, P13034, DOI 10.1073/pnas.94.24.13034; Shaw FH, 1995, EVOLUTION, V49, P1260, DOI 10.1111/j.1558-5646.1995.tb04452.x; SHAW RG, 1991, EVOLUTION, V45, P143, DOI 10.1111/j.1558-5646.1991.tb05273.x; Snedecor GW, 1989, STAT METHODS; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; WILLIS JH, 1991, EVOLUTION, V45, P441, DOI 10.1111/j.1558-5646.1991.tb04418.x; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	30	139	142	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					407	410		10.1038/nature01105	http://dx.doi.org/10.1038/nature01105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459781				2022-12-24	WOS:000179494700037
J	Vittinghoff, E; Shlipak, MG; Varosy, PD; Furberg, CD; Ireland, CC; Khan, SS; Blumenthal, R; Barrett-Connor, E; Hulley, S				Vittinghoff, E; Shlipak, MG; Varosy, PD; Furberg, CD; Ireland, CC; Khan, SS; Blumenthal, R; Barrett-Connor, E; Hulley, S		Heart Estrogen Progestin Replaceme	Risk factors and secondary prevention in women with heart disease: The heart and estrogen/progestin replacement study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; ASSOCIATION TASK-FORCE; RENAL-INSUFFICIENCY; AMERICAN-COLLEGE; POTENTIAL IMPACT; ELDERLY-PATIENTS; SEX-DIFFERENCES; BETA-BLOCKERS; PREDICTORS	Background: Risk factors for coronary heart disease events have most commonly been evaluated in healthy men. Objective: To assess risk factors, event rates, and use of secondary prevention treatments in women with preexisting coronary disease. Design: A prospective cohort of clinical trial participants. Setting: 20 U.S. clinical centers. Participants: 2763 postmenopausal women with known coronary disease in the Heart and Estrogen/progestin Replacement Study (HERS). Measurements: Myocardial infarction or death from coronary heart disease. Results: On multivariable analysis, the researchers found 11 risk factors: 6 noted by history (nonwhite ethnicity, lack of exercise, treated diabetes, angina, congestive heart failure, and more than one previous myocardial infarction) and 5 that were measured (blood pressure, low-density lipoprotein cholesterol level, high-density lipoprotein cholesterol level, lipoprotein(a) level, and creatinine clearance). The annual rate of coronary events was 1.3% (95% Cl, 0.7% to 2.5%) in women with no risk factors and 8.7% (Cl, 7.1% to 10.8%) in women with five or more risk factors (a sixfold increase). At entry into HERS, 83% of participants were receiving aspirin or other antiplatelet agents, 33% were receiving beta-blockers, 18% were receiving angiotensin-converting enzyme inhibitors, and 53% were receiving lipid-lowering drugs. Women with more risk factors were less likely to be taking aspirin (P < 0.001) and lipid-lowering drugs (P = 0.006). Conclusions: Women with coronary disease are at high risk for myocardial infarction or death from coronary heart disease even in the absence of other risk factors, and their risk increases up to sixfold when many risk factors are present. Established drugs for secondary prevention, including. aspirin, beta-blockers, and lipid-lowering agents, are underused in these women, especially those at highest risk.	Univ Calif San Francisco, San Francisco, CA 94105 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wake Forest University; University of California System; University of California Los Angeles; Johns Hopkins University; University of California System; University of California San Diego	Vittinghoff, E (corresponding author), Univ Calif San Francisco, 74 New Montgomery,Suite 600, San Francisco, CA 94105 USA.		Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; Allen JK, 2001, AM J CARDIOL, V87, P1203, DOI 10.1016/S0002-9149(01)01496-5; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; CLARKE KW, 1994, BMJ-BRIT MED J, V309, P563, DOI 10.1136/bmj.309.6954.563; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Denke Margo A., 1999, American Journal of Medicine, V107, p48S; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; EPSTEIN SE, 1982, NEW ENGL J MED, V307, P1487, DOI 10.1056/NEJM198212093072404; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Giugliano RP, 1998, ARCH INTERN MED, V158, P1113, DOI 10.1001/archinte.158.10.1113; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HENNING H, 1979, CIRCULATION, V59, P1124, DOI 10.1161/01.CIR.59.6.1124; Herrington DM, 1998, AM HEART J, V136, P115, DOI 10.1016/S0002-8703(98)70191-7; Hulley S, 1999, JAMA-J AM MED ASSOC, V281, P796; HULLEY S, 1998, JAMA-J AM MED ASSOC, V280, P608; KANNEL WB, 1990, J HYPERTENS, V8, pS3; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; MANSON JE, 1996, PREVENTION MYOCARDIO; McCormick D, 1999, ARCH INTERN MED, V159, P561, DOI 10.1001/archinte.159.6.561; Mosca L, 1997, CIRCULATION, V96, P2468; MOSS AJ, 1977, AM J CARDIOL, V39, P635, DOI 10.1016/S0002-9149(77)80122-7; OROURKE RA, 1991, CIRCULATION, V84, pI177; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; Schrott HG, 1997, JAMA-J AM MED ASSOC, V277, P1281, DOI 10.1001/jama.277.16.1281; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Shlipak MG, 2000, JAMA-J AM MED ASSOC, V283, P1845, DOI 10.1001/jama.283.14.1845; Shlipak MG, 2001, LANCET, V357, P717, DOI 10.1016/S0140-6736(05)71473-2; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; SIEGEL D, 1988, ANN INTERN MED, V109, P213, DOI 10.7326/0003-4819-109-3-213; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 1974, J CHRONIC DIS, V27, P267	46	74	80	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					81	89		10.7326/0003-4819-138-2-200301210-00007	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529088				2022-12-24	WOS:000181018300001
J	Hayflick, SJ; Westaway, SK; Levinson, B; Zhou, B; Johnson, MA; Ching, KHL; Gitschier, J				Hayflick, SJ; Westaway, SK; Levinson, B; Zhou, B; Johnson, MA; Ching, KHL; Gitschier, J			Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE	Background: Hallervorden-Spatz syndrome is an autosomal recessive disorder characterized by dystonia, parkinsonism, and iron accumulation in the brain. Many patients with this disease have mutations in the gene encoding pantothenate kinase 2 (PANK2); these patients are said to have pantothenate kinase-associated neurodegeneration. In this study, we compared the clinical and radiographic features of patients with Hallervorden-Spatz syndrome with and without mutations in PANK2. Methods: One hundred twenty-three patients from 98 families with a diagnosis of Hallervorden-Spatz syndrome were classified on the basis of clinical assessment as having classic disease (characterized by early onset with rapid progression) or atypical disease (later onset with slow progression). Their genomic DNA was sequenced for PANK2 mutations. Results: All patients with classic Hallervorden-Spatz syndrome and one third of those with atypical disease had PANK2 mutations. Whereas almost all mutations in patients with atypical disease led to amino acid changes, those in patients with classic disease more often resulted in predicted protein truncation. Patients with atypical disease who had PANK2 mutations were more likely to have prominent speech-related and psychiatric symptoms than patients with classic disease or mutation-negative patients with atypical disease. In all patients with pantothenate kinase-associated neurodegeneration, whether classic or atypical, T(sub 2)-weighted magnetic resonance imaging (MRI) of the brain showed a specific pattern of hyperintensity within the hypointense medial globus pallidus. This pattern was not seen in any patients without mutations. Conclusions: PANK2 mutations are associated with all cases of classic Hallervorden-Spatz syndrome and one third of cases of atypical disease. A specific MRI pattern distinguishes patients with PANK2 mutations. Predicted levels of pantothenate kinase 2 protein correlate with the severity of disease.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Hayflick, SJ (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd,Mailcode L-103A, Portland, OR 97201 USA.				NEI NIH HHS [R01 EY012353] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ching KHL, 2002, NEUROLOGY, V58, P1673, DOI 10.1212/WNL.58.11.1673; COPPETO JR, 1990, NEUROLOGY, V40, P1359, DOI 10.1212/WNL.40.9.1359; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DOOLING EC, 1974, ARCH NEUROL-CHICAGO, V30, P70, DOI 10.1001/archneur.1974.00490310072012; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Guimaraes J, 1999, EUR J NEUROL, V6, P509, DOI 10.1046/j.1468-1331.1999.640509.x; Hallervorden J, 1922, Z GESAMTE NEUROL PSY, V79, P254, DOI 10.1007/BF02878455; HALLERVORDEN J, 1924, DTSCH Z NERVENHEILK, V81, P204; Halliday W, 1995, J NEUROL SCI, V134, P84, DOI 10.1016/0022-510X(95)00212-K; Hickman SJ, 2001, ACTA NEUROL SCAND, V103, P201, DOI 10.1034/j.1600-0404.2001.103003201.x; JANKOVIC J, 1985, NEUROLOGY, V35, P227, DOI 10.1212/WNL.35.2.227; LUCKENBACH MW, 1983, AM J OPHTHALMOL, V95, P369, DOI 10.1016/S0002-9394(14)78308-4; MORPHY MA, 1989, J CLIN PSYCHIAT, V50, P66; NARDOCCI N, 1994, MOVEMENT DISORD, V9, P369, DOI 10.1002/mds.870090322; ROTH AM, 1971, SURV OPHTHALMOL, V16, P24; SETHI KD, 1988, ANN NEUROL, V24, P692, DOI 10.1002/ana.410240519; SHEVELL M, 1992, NEUROLOGY, V42, P2214, DOI 10.1212/WNL.42.11.2214; SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029; SWISHER CN, 1972, T AM NEUROL ASSOC, V97, P212; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	20	464	491	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					33	40		10.1056/NEJMoa020817	http://dx.doi.org/10.1056/NEJMoa020817			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510040				2022-12-24	WOS:000180134400005
J	Zhu, M; Ahlberg, PE; Zhao, WJ; Jia, LT				Zhu, M; Ahlberg, PE; Zhao, WJ; Jia, LT			Palaeontology - First Devonian tetrapod from Asia	NATURE			English	Article							JAWS		Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Natural History Museum London	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.		Zhu, Min/E-8728-2012; min, zhu/AAL-6712-2021; Ahlberg, Per/E-8086-2013	Zhu, Min/0000-0002-4786-0898; Zhao, Wenjin/0000-0002-9649-2171; Ahlberg, Per/0000-0001-9054-2900				AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, NATURE, V368, P507, DOI 10.1038/368507a0; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; Campbell KSW, 1977, ALCHERINGA, V1, P369, DOI 10.1080/03115517708527771; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; Metcalfe Ian, 1998, P25; Milner A.R., 1993, P324; Pan J., 1987, CONTINENTAL DEVONIAN	10	39	47	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					760	761		10.1038/420760a	http://dx.doi.org/10.1038/420760a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490937				2022-12-24	WOS:000179897300044
J	Round, JEC; Deheragoda, M				Round, JEC; Deheragoda, M			Sex - can you get it right?	BRITISH MEDICAL JOURNAL			English	Article									Guys Hosp, Neonatal Intens Care Unit, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Round, JEC (corresponding author), Guys Hosp, Neonatal Intens Care Unit, London SE1 9RT, England.			Round, Jonathan/0000-0002-7404-2006				PORTER RH, 1984, PEDIATRICS, V74, P501	1	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1446	1447		10.1136/bmj.325.7378.1446	http://dx.doi.org/10.1136/bmj.325.7378.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493659	Green Published			2022-12-24	WOS:000180188600011
J	Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW				Rosenberg, NA; Pritchard, JK; Weber, JL; Cann, HM; Kidd, KK; Zhivotovsky, LA; Feldman, MW			Genetic structure of human populations	SCIENCE			English	Article							MULTILOCUS GENOTYPES; DIVERSITY; APPORTIONMENT; STRATIFICATION; PATTERNS; BIAS	We studied human population structure using genotypes at 377 autosomal microsatellite loci in 1056 individuals from 52 populations. Within-population differences among individuals account for 93 to 95% of genetic variation; differences among major groups constitute only 3 to 5%. Nevertheless, without using prior information about the origins of individuals, we identified six main genetic clusters, five of which correspond to major geographic regions, and subclusters that often correspond to individual populations. General agreement of genetic and predefined populations suggests that self-reported ancestry can facilitate assessments of epidemiological risks but does not obviate the need to use genetic information in genetic association studies.	Univ So Calif, Los Angeles, CA 90089 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Marshfield Med Res Fdn, Ctr Genet Med, Marshfield, WI 54449 USA; Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 117809, Russia; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Southern California; University of Chicago; Foundation Jean Dausset-CEPH; Yale University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Stanford University	Rosenberg, NA (corresponding author), Univ So Calif, 1042 W 36th Pl DRB 289, Los Angeles, CA 90089 USA.	noahr@usc.edu	Zhivotovsky, Lev A/A-1351-2012; Peng, Bo/A-6920-2009	Peng, Bo/0000-0001-8225-2284; Rosenberg, Noah/0000-0002-1829-8664	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28428] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brown RA, 2001, EVOL ANTHROPOL, V10, P34, DOI 10.1002/1520-6505(2001)10:1<34::AID-EVAN1011>3.0.CO;2-P; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cann HM, 2002, SCIENCE, V296, P261; DU R, 1996, ETHNIC GROUPS CHINA; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Haywood John, 1995, PENGUIN HIST ATLAS V; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin RC, 1972, EVOLUTIONARY BIOL, V6, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Risch Neil, 2002, GENOME BIO, V3, P1, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2001, GENETICS, V159, P699; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	26	1910	1983	3	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2381	2385		10.1126/science.1078311	http://dx.doi.org/10.1126/science.1078311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493913				2022-12-24	WOS:000179915900054
J	Hong, MK; Bero, LA				Hong, MK; Bero, LA			How the tobacco industry responded to an influential study of the health effects of secondhand smoke	BRITISH MEDICAL JOURNAL			English	Article							WILLIAMSON DOCUMENTS; PASSIVE SMOKING; LAWYER CONTROL; LUNG-CANCER; AUTHORSHIP; RISK		Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bero, LA (corresponding author), Univ Calif San Francisco, Dept Clin Pharm, Box 0613, San Francisco, CA 94143 USA.			Bero, Lisa/0000-0003-1893-6651	NCI NIH HHS [CA-87472, R01 CA087472] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; BARNES DE, 1995, JAMA-J AM MED ASSOC, V274, P248, DOI 10.1001/jama.274.3.248; BERO L, 1995, JAMA-J AM MED ASSOC, V274, P241, DOI 10.1001/jama.274.3.241; BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612; BERO LA, 1993, TOB CONTROL, V2, P103; BEROLA, 2001, TOBACCO CONTROL, V10, P329; Drope J, 2001, J EPIDEMIOL COMMUN H, V55, P588, DOI 10.1136/jech.55.8.588; GLATNZ S, 1996, CIGARETTE PAPERS; GREEN CR, 1991, ETS DIVISION WEEKLY; GREEN CR, 1991, CIAR; HANAUER P, 1995, JAMA-J AM MED ASSOC, V274, P234; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; *INT COMM MED J ED, 1993, JAMA-J AM MED ASSOC, V269, P2282; Lee P, 1994, LIMITATIONS STUDIES; LEE PN, 1995, INT ARCH OCC ENV HEA, V67, P287, DOI 10.1007/BF00385642; LEE PN, LIMITATIONS STUDIES; LEE PN, 1991, DRAFT PROPOSAL STUDY; LEE PN, 1993, PN LEE STAT COM 0815; LEE PN, 1994, IS ENV TOBACCO SMOKE; Malone RE, 2000, SOC STUD SCI, V30, P713, DOI 10.1177/030631200030005003; MARCOTULLIO RJ, 1991, INT ETS MANAGEMENT C; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; MORRIS P, 1991, LIFESTYLE QUESTIONNA; MORRIS P, 1991, PROPOSAL APPL RES ST; Muggli ME, 2001, AM J PUBLIC HEALTH, V91, P1419, DOI 10.2105/AJPH.91.9.1419; OSDENE TS, 1991, INVESTIGATION EXPOSU; PAGES R, 1991, JAPAN EXPOSURE ASSES; PAGES R, 1991, COMMUNICATION   0415; PAGES R, 1991, COMMUNICATION   1108; PROCTOR C, 1993, COMMUNICATION   0726; PROCTOR C, 1991, STUDY RESULTS JAPANE; PROCTOR C, 1991, QUESTIONNAIRE DEV JA; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; SADLER PA, 1993, COMMUNICATION   1005; Schotland MS, 2002, RISK ANAL, V22, P131, DOI 10.1111/0272-4332.t01-1-00011; Smith R, 1997, BRIT MED J, V314, P992, DOI 10.1136/bmj.314.7086.992; YANO E, 1992, CONFOUNDING FACTORS; YANO E, 1992, LACK VALIDITY MARRIA; 1981, BMJ, V283, P1464; 1981, BMJ, V283, P914	40	59	59	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1413	1416		10.1136/bmj.325.7377.1413	http://dx.doi.org/10.1136/bmj.325.7377.1413			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480862	Green Published, Green Submitted			2022-12-24	WOS:000179975000030
J	Galil, K; Lee, B; Strine, T; Carraher, C; Baughman, AL; Eaton, M; Montero, J; Seward, J				Galil, K; Lee, B; Strine, T; Carraher, C; Baughman, AL; Eaton, M; Montero, J; Seward, J			Outbreak of varicella at a day-care center despite vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	41st Interscience Conference on Antimicrobial Agents and Chemotherapy	DEC 16-20, 2001	CHICAGO, ILLINOIS				HEALTHY-CHILDREN; FOLLOW-UP; EFFICACY; POSTLICENSURE; ADOLESCENTS; LICENSURE	Background: In seven studies of the effectiveness of the varicella vaccine conducted since it was licensed, the effectiveness was 71 to 100 percent against disease of any severity and 95 to 100 percent against moderate and severe disease. We investigated an outbreak of varicella in a population of children with a high proportion of vaccinees who were attending a day-care center in a small community in New Hampshire. Methods: Using standardized questionnaires, we collected information about the children's medical and vaccination history from parents and health care providers. The analysis of the effectiveness of the vaccine and of risk factors for vaccine failure was restricted to children who were enrolled in the day-care center continuously during the outbreak and attended for one week or more and who were cared for in the building that represented the epicenter of the outbreak, since transmission was not documented in a second building. Results: Varicella developed in 25 of 88 children (28.4 percent) between December 1, 2000, and January 11, 2001. The index case occurred in a healthy child who had been vaccinated three years previously and who infected more than 50 percent of his classmates who had no history of varicella. The effectiveness of the vaccine was 44.0 percent (95 percent confidence interval, 6.9 to 66.3 percent) against disease of any severity and 86.0 percent (95 percent confidence interval, 38.7 to 96.8 percent) against moderate or severe disease. Children who had been vaccinated three years or more before the outbreak were at greater risk for vaccine failure than those who had been vaccinated more recently (relative risk, 2.6 [95 percent confidence interval, 1.3 to 5.3]). Conclusions: In this outbreak, vaccination provided poor protection against varicella, although there was good protection against moderate or severe disease. A longer interval since vaccination was associated with an increased risk of vaccine failure. Breakthrough infections in vaccinated, healthy persons can be as infectious as varicella in unvaccinated persons.	Ctr Dis Control & Prevent, Atlanta, GA USA; New Hampshire Dept Hlth & Human Serv, Concord, NH 03301 USA; Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA	Centers for Disease Control & Prevention - USA; Washington State University	Galil, K (corresponding author), 65 Hayden Ave, Lexington, MA 02421 USA.							[Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P637; ARBETER AM, 1986, PEDIATRICS, V78, P748; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; CLEMENTS DA, 1995, PEDIATR INFECT DIS J, V14, P874, DOI 10.1097/00006454-199510000-00011; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; FINE PEM, 1994, AM J EPIDEMIOL, V139, P77, DOI 10.1093/oxfordjournals.aje.a116937; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Galil Karin, 2001, Pediatric Research, V49, p150A; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOHNSON C, 1989, PEDIATRICS, V84, P418; JOHNSON CE, 1988, PEDIATRICS, V81, P512; Johnson CE, 1997, PEDIATRICS, V100, P761, DOI 10.1542/peds.100.5.761; KUTER BJ, 1991, VACCINE, V9, P643, DOI 10.1016/0264-410X(91)90189-D; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; Loparev VN, 2000, J CLIN MICROBIOL, V38, P3156, DOI 10.1128/JCM.38.9.3156-3160.2000; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rothstein EP, 1997, J INFECT DIS, V175, P444, DOI 10.1093/infdis/175.2.444; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201; WHITE CJ, 1991, PEDIATRICS, V87, P604	25	164	175	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1909	1915		10.1056/NEJMoa021662	http://dx.doi.org/10.1056/NEJMoa021662			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477940				2022-12-24	WOS:000179735800002
J	Sambrano, GR; Fraser, I; Han, HP; Ni, Y; O'Connell, T; Yan, Z; Stull, JT				Sambrano, GR; Fraser, I; Han, HP; Ni, Y; O'Connell, T; Yan, Z; Stull, JT			Navigating the signalling network in mouse cardiac myocytes	NATURE			English	Article							MYOCARDIAL-CONTRACTILITY; CELL-SIZE; PHOSPHOLAMBAN; MECHANISM; PATHWAYS; HEART	Cardiac myocytes have a complex network of signals that regulates their essential role in the rhythmic pumping of the heart. This network is an appealing model system in which to study the basic principles underlying cellular signalling mechanisms. Progress in this effort has come through the establishment of standardized myocyte isolation and culture procedures and characterization of important signalling responses.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; San Francisco Vet Adm Med Ctr, Dept Cardiol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Sambrano, GR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sambrano@cmp.ucsf.edu	O'Connell, Timothy/D-5048-2013; Fraser, Iain DC/L-4735-2017	Fraser, Iain DC/0000-0003-2272-3907; Yan, Zhen/0000-0002-4826-9813				Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; BENNDORF K, 1985, PFLUG ARCH EUR J PHY, V404, P190, DOI 10.1007/BF00585418; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Colan Steven D., 1997, Cardiology Clinics, V15, P355, DOI 10.1016/S0733-8651(05)70345-3; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Hagemann D, 2002, TRENDS CARDIOVAS MED, V12, P51, DOI 10.1016/S1050-1738(01)00145-1; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Koch WJ, 2000, ANNU REV PHYSIOL, V62, P237, DOI 10.1146/annurev.physiol.62.1.237; KRUPPENBACHER JP, 1993, NATURWISSENSCHAFTEN, V80, P132, DOI 10.1007/BF01131017; Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6; ROBISON GA, 1965, MOL PHARMACOL, V1, P168; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; SELLIN LC, 1994, PHARMACOL TOXICOL, V74, P305, DOI 10.1111/j.1600-0773.1994.tb01365.x; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Small KM, 2002, NEW ENGL J MED, V347, P1135, DOI 10.1056/NEJMoa020803; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Thum T, 2001, Cardiovasc Toxicol, V1, P61, DOI 10.1385/CT:1:1:61; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; XIAO RP, 2001, BETA ADRENERGIC SIGN; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	25	70	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					712	714		10.1038/nature01306	http://dx.doi.org/10.1038/nature01306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478303				2022-12-24	WOS:000179751800056
J	Ahumada, A; Slusarski, DC; Liu, XX; Moon, RT; Malbon, CC; Wang, HY				Ahumada, A; Slusarski, DC; Liu, XX; Moon, RT; Malbon, CC; Wang, HY			Signaling of rat Frizzled-2 through phosphodiesterase and cyclic GMP	SCIENCE			English	Article							BETA-CATENIN; FUNCTIONAL INTERACTION; TERATOCARCINOMA CELLS; WNT; HOMOLOG; PATHWAY; FAMILY	The Frizzled-2 receptor (Rfz2) from rat binds Wnt proteins and can signal by activating calcium release from intracellular stores. We show that wildtype Rfz2 and a chimeric receptor consisting of the extracellular and transmembrane portions of the beta(2)-adrenergic receptor with cytoplasmic domains of Rfz2 also signaled through modulation of cyclic guanosine 3',5'-monophosphate (cGMP). Activation of either receptor led to a decline in the intracellular concentration of cGMP, a process that was inhibited in cells treated with pertussis toxin, reduced by suppression of the expression of the heterotrimeric GTP-binding protein (G protein) transducin, and suppressed through inhibition of cGMP-specific phosphodiesterase (PDE) activity. Moreover, PDE inhibitors blocked Rfz2-induced calcium transients in zebrafish embryos. Thus, Frizzled-2 appears to couple to PDEs and calcium transients through G proteins.	SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; University of Iowa; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wang, HY (corresponding author), SUNY Stony Brook, Univ Med Ctr, Diabet & Metab Dis Res Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	wangh@pharm.sunysb.edu	Moon, Randall T/B-1743-2014; malbon, craig/ABF-3604-2020; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408	NIDDK NIH HHS [T32-DK07521] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007521] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHUMADA A, UNPUB; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Malbon CC, 2001, BIOCHEM BIOPH RES CO, V287, P589, DOI 10.1006/bbrc.2001.5630; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; RAPORT CJ, 1989, J BIOL CHEM, V264, P7122; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STRICKLAND S, 1981, CELL, V24, P277, DOI 10.1016/0092-8674(81)90313-5; Wang YS, 1996, J BIOL CHEM, V271, P4468; Weinberg ES, 1996, DEVELOPMENT, V122, P271; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	26	137	141	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					2006	2010		10.1126/science.1073776	http://dx.doi.org/10.1126/science.1073776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471263				2022-12-24	WOS:000179629200050
J	Shaw, MR; Zavaleta, ES; Chiariello, NR; Cleland, EE; Mooney, HA; Field, CB				Shaw, MR; Zavaleta, ES; Chiariello, NR; Cleland, EE; Mooney, HA; Field, CB			Grassland responses to global environmental changes suppressed by elevated CO2	SCIENCE			English	Article							PLANT-RESPONSES; CARBON; NITROGEN; ECOSYSTEM; CLIMATE; PRODUCTIVITY; ASSIMILATION; ENRICHMENT; BIOSPHERE; WHEAT	Simulated global changes, including warming, increased precipitation, and nitrogen deposition, alone and in concert, increased net primary production (NPP) in the third year of ecosystem-scale manipulations in a California annual grassland. Elevated carbon dioxide also increased NPP, but only as a single-factor treatment. Across all multifactor manipulations, elevated carbon dioxide suppressed root allocation, decreasing the positive effects of increased temperature, precipitation, and nitrogen deposition on NPP. The NPP responses to interacting global changes differed greatly from simple combinations of single-factor responses. These findings indicate the importance of a multifactor experimental approach to understanding ecosystem responses to global change.	Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Jasper Ridge Biol Preserve, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University; Stanford University	Shaw, MR (corresponding author), Nat Conservancy Calif, 201 Mission St,4th Floor, San Francisco, CA 94105 USA.	shaw@globalecology.stanford.edu						[Anonymous], 1996, CARBON DIOXIDE POPUL; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Diaz S, 1996, PLANT SOIL, V187, P309, DOI 10.1007/BF00017096; Drake B. G., 1996, CARBON DIOXIDE TERRE, P197; Easterling DR, 2000, J GEOPHYS RES-ATMOS, V105, P20101, DOI 10.1029/2000JD900166; Edwards NT, 1999, PLANT SOIL, V206, P85, DOI 10.1023/A:1004319109772; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FIELD CB, 2000, EARTH SYSTEMS PROCES, P297; Higgins PAT, 2002, GLOBAL CHANGE BIOL, V8, P841, DOI 10.1046/j.1365-2486.2002.00514.x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hungate BA, 2000, OECOLOGIA, V124, P589, DOI 10.1007/s004420000405; IDSO KE, 1994, AGR FOREST METEOROL, V69, P153, DOI 10.1016/0168-1923(94)90025-6; *INT PAN CLIM CHAN, 2001, WORK GROUP 1 3 ASS R; KARL TR, 1998, REGIONAL IMPACTS CLI, P412; Kimball BA, 1995, GLOB CHANGE BIOL, V1, P429, DOI 10.1111/j.1365-2486.1995.tb00041.x; KIMBALL BA, 1993, AGRON J, V85, P706, DOI 10.2134/agronj1993.00021962008500030035x; KIMBALL BA, 1983, AGRON J, V75, P779, DOI 10.2134/agronj1983.00021962007500050014x; Koch G.W., 1996, CARBON DIOXIDE TERRE, ppp 415, DOI DOI 10.1016/B978-012505295-5/50023-9; Koide RT, 1988, FUNCT ECOL, V2, P335, DOI 10.2307/2389406; Korner C, 1997, ACTA OECOL, V18, P165, DOI 10.1016/S1146-609X(97)80002-1; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; LUO Y, 1994, PLANT CELL ENVIRON, V17, P1195, DOI 10.1111/j.1365-3040.1994.tb02017.x; Luo YQ, 1996, OECOLOGIA, V108, P130, DOI 10.1007/BF00333224; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Mooney H.A., 1999, TERRESTRIAL BIOSPHER, P141; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volk M, 2000, OECOLOGIA, V125, P380, DOI 10.1007/s004420000454; ZAVALETA ES, 2001, THESIS STANFORD U	38	409	452	15	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1987	1990		10.1126/science.1075312	http://dx.doi.org/10.1126/science.1075312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471257				2022-12-24	WOS:000179629200044
J	Burrone, J; O'Byrne, M; Murthy, VN				Burrone, J; O'Byrne, M; Murthy, VN			Multiple forms of synaptic plasticity triggered by selective suppression of activity in individual neurons	NATURE			English	Article							GLUTAMATE RECEPTORS; NEUROMUSCULAR-JUNCTION; PRESYNAPTIC RELEASE; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; SILENT SYNAPSES; NMDA RECEPTOR; EXPRESSION; BLOCKADE; MEMBRANE	The rules by which neuronal activity causes long-term modification of synapses in the central nervous system are not fully understood. Whereas competitive or correlation-based rules result in local modification of synapses, homeostatic modifications allow neuron-wide changes in synaptic strength, promoting stability(1,2). Experimental investigations of these rules at central nervous system synapses have relied generally on manipulating activity in populations of neurons(1,3-6). Here, we investigated the effect of suppressing excitability in single neurons within a network of active hippocampal neurons by overexpressing an inward-rectifier potassium channel. Reducing activity in a neuron before synapse formation leads to a reduction in functional synaptic inputs to that neuron; no such reduction was observed when activity of all neurons was uniformly suppressed. In contrast, suppressing activity in a single neuron after synapses are established results in a homeostatic increase in synaptic input, which restores the activity of the neuron to control levels. Our results highlight the differences between global and selective suppression of activity, as well as those between early and late manipulation of activity.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Burrone, Juan/C-5654-2009	Burrone, Juan/0000-0003-1233-668X; Murthy, Venkatesh/0000-0003-2443-4252; O'Byrne, Michael/0000-0001-6023-1634				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Holt JR, 1999, J NEUROPHYSIOL, V81, P1881, DOI 10.1152/jn.1999.81.4.1881; Hubener M, 1999, NAT NEUROSCI, V2, P1043, DOI 10.1038/15964; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Johns DC, 1999, J NEUROSCI, V19, P1691; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	30	349	358	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 28	2002	420	6914					414	418		10.1038/nature01242	http://dx.doi.org/10.1038/nature01242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459783				2022-12-24	WOS:000179494700039
J	Krusell, L; Madsen, LH; Sato, S; Aubert, G; Genua, A; Szczyglowski, K; Duc, G; Kaneko, T; Tabata, S; de Bruijn, F; Pajuelo, E; Sandal, N; Stougaard, J				Krusell, L; Madsen, LH; Sato, S; Aubert, G; Genua, A; Szczyglowski, K; Duc, G; Kaneko, T; Tabata, S; de Bruijn, F; Pajuelo, E; Sandal, N; Stougaard, J			Shoot control of root development and nodulation is mediated by a receptor-like kinase	NATURE			English	Article							LOTUS-JAPONICUS; SYMBIOTIC MUTANTS; WILD-TYPE; CLAVATA1; ARABIDOPSIS; INFECTION; MERISTEM; GENES	In legumes, root nodule organogenesis is activated in response to morphogenic lipochitin oligosaccharides that are synthesized by bacteria, commonly known as rhizobia(1). Successful symbiotic interaction results in the formation of highly specialized organs called root nodules, which provide a unique environment for symbiotic nitrogen fixation. In wild-type plants the number of nodules is regulated by a signalling mechanism integrating environmental and developmental cues to arrest most rhizobial infections within the susceptible zone of the root(2-7). Furthermore, a feedback mechanism controls the temporal and spatial susceptibility to infection of the root system. This mechanism is referred to as autoregulation of nodulation, as earlier nodulation events inhibit nodulation of younger root tissues(3,4,8). Lotus japonicus plants homozygous for a mutation in the hypernodulation aberrant root (har1) locus escape this regulation and form an excessive number of nodules(9-11). Here we report the molecular cloning and expression analysis of the HAR1 gene and the pea orthologue, Pisum sativum, SYM29. HAR1 encodes a putative serine/threonine receptor kinase, which is required for shoot-controlled regulation of root growth, nodule number, and for nitrate sensitivity of symbiotic development.	Aarhus Univ, Dept Mol Biol, Gene Express Lab, DK-8000 Aarhus C, Denmark; Kazusa DNA Res Inst, Chiba 2920812, Japan; INRA, URGAP, F-21065 Dijon, France; Agr & Agri Food Canada, SPFRC, London, ON N5V 4T3, Canada; Lab Biol Mol Relat Plantes Microorganismes, F-31326 Castanet Tolosan, France	Aarhus University; Kazusa DNA Research Institute; INRAE; Agriculture & Agri Food Canada	Stougaard, J (corresponding author), Aarhus Univ, Dept Mol Biol, Gene Express Lab, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.		Sato, Shusei/A-3616-2015; Aubert, Gregoire/AAC-4035-2019; Han, Liqi/K-6127-2013	Sato, Shusei/0000-0002-0293-5366; Aubert, Gregoire/0000-0002-1867-5730; Stougaard, Jens/0000-0002-9312-2685; Genua, Aratz/0000-0003-0437-1119; pajuelo, Eloisa/0000-0002-1084-5301				CAETANOANOLLES G, 1991, ANNU REV MICROBIOL, V45, P345, DOI 10.1146/annurev.mi.45.100191.002021; Carroll B. J., 1990, Molecular biology of symbiotic nitrogen fixation., P159; CARROLL BJ, 1985, P NATL ACAD SCI USA, V82, P4162, DOI 10.1073/pnas.82.12.4162; Clark SE, 2001, NAT REV MOL CELL BIO, V2, P276, DOI 10.1038/35067079; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DELVES AC, 1986, PLANT PHYSIOL, V82, P588, DOI 10.1104/pp.82.2.588; HANDBERG K, 1992, PLANT J, V2, P487, DOI 10.1111/j.1365-313X.1992.00487.x; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Kawaguchi M, 2000, J PLANT RES, V113, P507, DOI 10.1007/PL00013961; KOSSLAK RM, 1984, PLANT PHYSIOL, V75, P125, DOI 10.1104/pp.75.1.125; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Nakamura Y, 2002, DNA RES, V9, P63, DOI 10.1093/dnares/9.2.63; NUTMAN PS, 1952, ANN BOT, V16, P81; Penmetsa RV, 1997, SCIENCE, V275, P527, DOI 10.1126/science.275.5299.527; PIERCE M, 1983, PLANT PHYSIOL, V73, P286, DOI 10.1104/pp.73.2.286; Sagan M, 1996, SYMBIOSIS, V20, P229; Sandal N, 2002, GENETICS, V161, P1673; Sato S, 2001, DNA RES, V8, P311, DOI 10.1093/dnares/8.6.311; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Sheng CX, 1997, PLANT PHYSIOL, V113, P825, DOI 10.1104/pp.113.3.825; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Spaink HP, 2000, ANNU REV MICROBIOL, V54, P257, DOI 10.1146/annurev.micro.54.1.257; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wopereis J, 2000, PLANT J, V23, P97, DOI 10.1046/j.1365-313x.2000.00799.x; Yamamoto E, 2000, BBA-GENE STRUCT EXPR, V1491, P333, DOI 10.1016/S0167-4781(00)00061-0	29	410	441	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 28	2002	420	6914					422	426		10.1038/nature01207	http://dx.doi.org/10.1038/nature01207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12442170				2022-12-24	WOS:000179494700041
J	Dundr, M; Hoffmann-Rohrer, U; Hu, QY; Grummt, I; Rothblum, LI; Phair, RD; Misteli, T				Dundr, M; Hoffmann-Rohrer, U; Hu, QY; Grummt, I; Rothblum, LI; Phair, RD; Misteli, T			A kinetic framework for a mammalian RNA polymerase in vivo	SCIENCE			English	Article							TRANSCRIPTION; COMPONENTS; PROMOTER	We have analyzed the kinetics of assembly and elongation of the mammalian RNA polymerase I complex on endogenous ribosomal genes in the nuclei of living cells with the use of in vivo microscopy. We show that components of the RNA polymerase I machinery are brought to ribosomal genes as distinct subunits and that assembly occurs via metastable intermediates. With the use of computational modeling of imaging data, we have determined the in vivo elongation time of the polymerase, and measurements of recruitment and incorporation frequencies show that incorporation of components into the assembling polymerase is inefficient. Our data provide a kinetic and mechanistic framework for the function of a mammalian RNA polymerase in living cells.	NCI, NIH, Bethesda, MD 20892 USA; German Canc Res Ctr, D-69120 Heidelberg, Germany; Weis Ctr Res, Danville, PA 17821 USA; BioInformat Serv, Rockville, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov						Aprikian P, 2001, MOL CELL BIOL, V21, P4847, DOI 10.1128/MCB.21.15.4847-4855.2001; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; CAVANAUGH AH, 2002, J BIOL CHEM; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Dundr M, 2000, J CELL BIOL, V150, P433, DOI 10.1083/jcb.150.3.433; DUNDR M, IN PRESS J STRUCT BI; DUNDR M, UNPUB; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; GRUMMT I, UNPUB; HAAF T, 1991, EXP CELL RES, V193, P78, DOI 10.1016/0014-4827(91)90540-B; Hannan RD, 1999, NUCLEIC ACIDS RES, V27, P3720, DOI 10.1093/nar/27.18.3720; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; MILLER OL, 1972, ACTA ENDOCRINOL-COP, P155; Panov KI, 2001, MOL CELL BIOL, V21, P2641, DOI 10.1128/MCB.21.8.2641-2649.2001; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Scheer U, 1997, CHROMOSOMA, V105, P470, DOI 10.1007/s004120050209; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; ZEEVI M, 1982, MOL CELL BIOL, V2, P517, DOI 10.1128/MCB.2.5.517	22	336	342	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1623	1626		10.1126/science.1076164	http://dx.doi.org/10.1126/science.1076164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446911				2022-12-24	WOS:000179361600050
J	Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA				Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA			Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; WOMENS INTERAGENCY HIV; INFECTED PATIENTS; NATURAL-HISTORY; VIRAL LOAD; SERUM-ALBUMIN; LYMPHOCYTE COUNTS; MORTALITY; AIDS	Background Low serum albumin concentration is associated with short-term survival in individuals with HIV-1. However, few investigators have assessed whether individuals with a low serum albumin concentration have delayed progression to AIDS, or survive in the long term. We aimed to assess the relation between markers of liver function and progression to AIDS and death in individuals with haemophilia infected with HIV-1 and hepatitis C virus. Methods We measured markers of liver function and took CD4 counts every 3 months in 111 patients registered at the Royal Free Hospital Haemophilia Centre, London, UK. HIV RNA concentrations were measured yearly and then every 3-6 months from 1996. We used Cox's regression models to assess the independent prognostic value of these markers for AIDS and death. Findings As a fixed covariate, albumin concentrations measured shortly after HIV-1 seroconversion were associated with risk of AIDS (relative hazard 0.91 [95% Cl 0.84-1.00], p=0.04) and death (0.89 [0.82-0.96], p=0.004) over a 15-year period. These findings were independent of the CD4 count and HIV-1 RNA concentration. As a time-updated covariate, after adjustment for CD4 count and HIV-1 RNA concentrations, albumin was not associated with progression to AIDS (0.96 [0.90-1.01], p=0.13), but was strongly associated with death (0.88 [0.84-0.93], p<0.0001) in the short term. Interpretation Low concentrations of albumin in individuals infected with HIV-1 could indicate a poor outlook and should therefore prompt concern at any stage of infection.	UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept Primary Care & Populat Sci, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept Virol, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Haemophilia Ctr, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Haemostasis Unit, London NW3 2PF, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Sabin, CA (corresponding author), UCL Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, Dept Primary Care & Populat Sci, Rowland Hill St, London NW3 2PF, England.	c.sabin@pcps.ucl.ac.uk	Phillips, Andrew N/B-4427-2008; Yee, Thynn Thynn/H-5862-2012; Sabin, Caroline/C-2464-2008; Emery, Vincent/G-8928-2013	Phillips, Andrew N/0000-0003-2384-4807; Sabin, Caroline/0000-0001-5173-2760; Emery, Vincent/0000-0001-5893-9756				Anastos K, 1999, AIDS, V13, P1717, DOI 10.1097/00002030-199909100-00016; BAUM MK, 1995, AIDS, V9, P1051, DOI 10.1097/00002030-199509000-00010; BIRD G, 1994, AIDS, V8, P911; BLATT SP, 1995, J INFECT DIS, V171, P847; Daar ES, 2001, J INFECT DIS, V183, P589, DOI 10.1086/318539; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; DORRUCCI M, 1995, J INFECT DIS, V172, P1503, DOI 10.1093/infdis/172.6.1503; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Feldman JG, 2000, AIDS, V14, P863, DOI 10.1097/00002030-200005050-00013; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Hoover DR, 1996, AM J EPIDEMIOL, V143, P943; JUSTICE AC, 1989, NEW ENGL J MED, V320, P1388, DOI 10.1056/NEJM198905253202106; KERNOFF PBA, 1985, BRIT J HAEMATOL, V60, P469, DOI 10.1111/j.1365-2141.1985.tb07444.x; Khan MH, 2000, HEPATOLOGY, V31, P513, DOI 10.1002/hep.510310236; Kim S, 2000, AIDS RES HUM RETROV, V16, P645, DOI 10.1089/088922200308873; Kvale D, 1999, AIDS, V13, P195, DOI 10.1097/00002030-199902040-00007; Landau A, 2001, AIDS, V15, P2149, DOI 10.1097/00002030-200111090-00010; LEE CA, 1989, BRIT J HAEMATOL, V73, P228, DOI 10.1111/j.1365-2141.1989.tb00257.x; Levy S, 1997, AIDS, V11, P1399; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Miller V, 2000, AIDS, V14, P2129, DOI 10.1097/00002030-200009290-00009; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; PHILLIPS A, 1989, LANCET, V2, P1434; PHILLIPS AN, 1993, AIDS, V7, P975, DOI 10.1097/00002030-199307000-00011; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Prins M, 2000, AIDS, V14, P1829, DOI 10.1097/00002030-200008180-00019; Sabin CA, 2000, J ACQ IMMUN DEF SYND, V23, P172; Sabin CA, 2000, AIDS, V14, P1001, DOI 10.1097/00002030-200005260-00012; SABIN CA, 1994, BRIT J HAEMATOL, V86, P366, DOI 10.1111/j.1365-2141.1994.tb04741.x; Yee TT, 2000, GUT, V47, P845, DOI 10.1136/gut.47.6.845; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	34	28	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 16	2002	360	9345					1546	1551		10.1016/S0140-6736(02)11519-4	http://dx.doi.org/10.1016/S0140-6736(02)11519-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443592				2022-12-24	WOS:000179292400010
J	Yamamoto, H; Esaki, M; Kanamori, T; Tamura, Y; Nishikawa, S; Endo, T				Yamamoto, H; Esaki, M; Kanamori, T; Tamura, Y; Nishikawa, S; Endo, T			Tim50 is a subunit of the TIM23 complex that links protein translocation across the outer and inner mitochondrial membranes	CELL			English	Article							INTERMEMBRANE-SPACE DOMAIN; IMPORT PATHWAY; PREPROTEIN TRANSLOCASE; TARGETING SEQUENCES; YEAST MITOCHONDRIA; CONTACT SITES; BINDING-SITE; PRESEQUENCE; RECEPTOR; CHANNEL	Based on the results of site-specific photocrosslinking of translocation intermediates, we have identified Tim50, a component of the yeast TIM23 import machinery, which mediates translocation of presequence-containing proteins across the mitochondrial inner membrane. Tim50 is anchored to the inner mitochondrial membrane, exposing the C-terminal domain to the intermembrane space. Tim50 interacts with the N-terminal intermembrane space domain of Tim23. Functional defects of Tim50 either by depletion of the protein or addition of anti-Tim50 antibodies block the protein translocation across the inner membrane. A translocation intermediate accumulated at the TOM complex is crosslinked to Tim50. We suggest that Tim50, in cooperation with Tim23, facilitates transfer of the translocating protein from the TOM complex to the TIM23 complex.	Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nippon Med Coll, Inst Gerontol, Dept Biochem & Cell Biol, Nakahara Ku, Kanagawa 2118533, Japan	Nagoya University; Nippon Medical School	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.		Esaki, Masatoshi/L-6591-2017; Tamura, Yasushi/H-8270-2017; Esaki, Masatoshi/ABS-6645-2022; Yasushi, TAMURA/I-7122-2014	Tamura, Yasushi/0000-0002-8462-0607; 				Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Arnold I, 1997, FEBS LETT, V411, P195, DOI 10.1016/S0014-5793(97)00691-1; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; Bomer U, 1997, J BIOL CHEM, V272, P30439, DOI 10.1074/jbc.272.48.30439; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Court DA, 1996, MOL CELL BIOL, V16, P4035; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Esaki M, 1999, P NATL ACAD SCI USA, V96, P11770, DOI 10.1073/pnas.96.21.11770; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; James P, 1996, GENETICS, V144, P1425; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rose MD., 1990, METHODS YEAST GENETI; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Sirrenberg C, 1997, J BIOL CHEM, V272, P29963, DOI 10.1074/jbc.272.47.29963; Tokatlidis K, 1996, NATURE, V384, P585, DOI 10.1038/384585a0; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726	35	189	193	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 15	2002	111	4					519	528		10.1016/S0092-8674(02)01053-X	http://dx.doi.org/10.1016/S0092-8674(02)01053-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437925	Bronze			2022-12-24	WOS:000179346900005
J	Park, SH; Zarrinpar, A; Lim, WA				Park, SH; Zarrinpar, A; Lim, WA			Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms	SCIENCE			English	Article							PDZ-DOMAIN PROTEIN; MUTATIONAL ANALYSIS; YEAST; STE5; ACTIVATION; ORGANIZATION; COMPLEXES; CASCADE; BINDING; SYSTEM	How scaffold proteins control information flow in signaling pathways is poorly understood: Do they simply tether components, or do they precisely orient and activate them? We found that the yeast mitogen-activated protein (MAP) kinase scaffold Ste5 is tolerant to major stereochemical perturbations; heterologous protein interactions could functionally replace native kinase recruitment interactions, indicating that simple tethering is largely sufficient for scaffold-mediated signaling. Moreover, by engineering a scaffold that tethers a unique kinase set, we could create a synthetic MAP kinase pathway with non-natural input-output properties. These findings demonstrate that scaffolds are highly flexible organizing factors that can facilitate pathway evolution and engineering.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CHOI KY, 1994, CELL, V78, P499; Elion EA, 2001, J CELL SCI, V114, P3967; FERRELL JE, 2002, SCI STKE; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Inouye C, 1997, GENETICS, V147, P479; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Park S.C., UNPUB; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; PRINTEN JA, 1994, GENETICS, V138, P609; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7	27	267	289	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1061	1064		10.1126/science.1076979	http://dx.doi.org/10.1126/science.1076979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12511654				2022-12-24	WOS:000180960000046
J	Kash, TL; Jenkins, A; Kelley, JC; Trudell, JR; Harrison, NL				Kash, TL; Jenkins, A; Kelley, JC; Trudell, JR; Harrison, NL			Coupling of agonist binding to channel gating in the GABA(A) receptor	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR; MUTATIONS; SUBUNIT; AFFINITY; SITE; PORE; M2	Neurotransmitters such as acetylcholine and GABA (gamma-aminobutyric acid) mediate rapid synaptic transmission by activating receptors belonging to the gene superfamily of ligand-gated ion channels (LGICs)(1). These channels are pentameric proteins that function as signal transducers, converting chemical messages into electrical signals(2). Neurotransmitters activate LGICs by interacting with a ligand-binding site(3-7), triggering a conformational change in the protein that results in the opening of an ion channel(8). This process, which is known as 'gating', occurs rapidly and reversibly, but the molecular rearrangements involved are not well understood(9). Here we show that optimal gating in the GABA(A) receptor, a member of the LGIC superfamily, is dependent on electrostatic interactions between the negatively charged Asp 57 and Asp 149 residues in extracellular loops 2 and 7, and the positively charged Lys 279 residue in the transmembrane 2-3 linker region of the alpha(1)-subunit. During gating, Asp 149 and Lys 279 seem to move closer to one another, providing a potential mechanism for the coupling of ligand binding to opening of the ion channel.	Cornell Univ, Weill Grad Sch Biomed Sci, Grad Program Neurosci, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Anesthesiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Stanford Univ, Dept Anesthesia, Stanford, CA 94305 USA; Stanford Univ, Beckman Program Mol & Genet Med, Stanford, CA 94305 USA	Cornell University; Cornell University; Cornell University; Stanford University; Stanford University	Harrison, NL (corresponding author), Cornell Univ, Weill Grad Sch Biomed Sci, Grad Program Neurosci, New York, NY 10021 USA.	neh2001@med.cornell.edu	Jenkins, Andrew/E-1180-2011; Kash, Thomas/G-9625-2013					Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/ng0501-46; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bertaccini E, 2002, PROTEIN ENG, V15, P443, DOI 10.1093/protein/15.6.443; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Croxen R, 1997, HUM MOL GENET, V6, P767, DOI 10.1093/hmg/6.5.767; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; Dougherty DA, 2001, NATURE, V411, P252, DOI 10.1038/35077192; Ebert B, 1997, MOL PHARMACOL, V52, P1150, DOI 10.1124/mol.52.6.1150; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Nishikawa K, 2002, NEUROPHARMACOLOGY, V42, P337, DOI 10.1016/S0028-3908(01)00189-7; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Sigel E, 1999, J NEUROCHEM, V73, P1758, DOI 10.1046/j.1471-4159.1999.731758.x; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SMITH GB, 1994, J BIOL CHEM, V269, P20380; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Trudell JR, 2002, BRIT J ANAESTH, V89, P32, DOI 10.1093/bja/aef157; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9	28	266	271	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					272	275		10.1038/nature01280	http://dx.doi.org/10.1038/nature01280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529644				2022-12-24	WOS:000180397600048
J	Kawai, H; Kanegae, T; Christensen, S; Kiyosue, T; Sato, Y; Imaizumi, T; Kadota, A; Wada, M				Kawai, H; Kanegae, T; Christensen, S; Kiyosue, T; Sato, Y; Imaizumi, T; Kadota, A; Wada, M			Responses of ferns to red light are mediated by an unconventional photoreceptor	NATURE			English	Article							ADIANTUM-CAPILLUS-VENERIS; ORIENTED CHLOROPLAST MOVEMENT; BLUE-LIGHT; ARABIDOPSIS NPH1; PHYTOCHROME; PHOTOTROPISM; PROTONEMATA; RELOCATION; PLANTS; NPL1	Efficient photosynthesis is essential for plant survival. To optimize photosynthesis, plants have developed several photo-responses. Stems bend towards a light source (phototropism), chloroplasts move to a place of appropriate light intensity (chloroplast photorelocation) and stomata open to absorb carbon dioxide. These responses are mediated by the blue-light receptors phototropin 1 (phot1) and phototropin 2 (phot2) in Arabidopsis (refs 1-5). In some ferns, phototropism and chloroplast photorelocation are controlled by red light as well as blue light(6). However, until now, the photoreceptor mediating these red-light responses has not been identified. The fern Adiantum capillus-veneris has an unconventional photoreceptor, phytochrome 3 (phy3), which is a chimaera of the red/far-red light receptor phytochrome and phototropin(7). We identify here a function of phy3 for red-light-induced phototropism and for red-light-induced chloroplast photorelocation, by using mutational analysis and complementation. Because phy3 greatly enhances the sensitivity to white light in orienting leaves and chloroplasts, and PHY3 homologues exist among various fern species, this chimaeric photoreceptor may have had a central role in the divergence and proliferation of fern species under low-light canopy conditions.	Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Aichi 4448585, Japan	Tokyo Metropolitan University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Wada, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan.		Sato, Yoshikatsu/I-6129-2014					Augustynowicz J, 1999, PLANT CELL ENVIRON, V22, P1239, DOI 10.1046/j.1365-3040.1999.00487.x; Bunning E., 1958, BER DEUT BOT GES, V71, P304; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; DAVIS BD, 1975, PLANT CELL PHYSIOL, V16, P537; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; KADOTA A, 1982, PHOTOCHEM PHOTOBIOL, V35, P533, DOI 10.1111/j.1751-1097.1982.tb02605.x; Kadota A, 1999, PLANT CELL PHYSIOL, V40, P238, DOI 10.1093/oxfordjournals.pcp.a029533; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 1996, PLANTA, V198, P488, DOI 10.1007/BF00620067; Kanegae T, 1998, MOL GEN GENET, V259, P345, DOI 10.1007/s004380050821; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; MILLER JH, 1974, AM J BOT, V61, P296, DOI 10.2307/2441609; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; NOZUE K, 2000, PLANT PHYSIOL, V122, P1457; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; TAYLOR TN, 1993, BIOL EVOLUTION FOSSI, P346; TIDWELL WD, 1994, J PLANT RES, V107, P417, DOI 10.1007/BF02344066; WADA M, 1994, J PLANT RES, V107, P181, DOI 10.1007/BF02346015; WADA M, 1989, ANNU REV PLANT PHYS, V40, P169; Willis K. J, 2002, EVOLUTION PLANTS, P130; YATSUHASHI H, 1990, PLANT SCI, V68, P87, DOI 10.1016/0168-9452(90)90156-I; YATSUHASHI H, 1993, J PHOTOCH PHOTOBIO B, V19, P25, DOI 10.1016/1011-1344(93)80089-R; YATSUHASHI H, 1985, PLANTA, V165, P43, DOI 10.1007/BF00392210	29	166	182	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					287	290		10.1038/nature01310	http://dx.doi.org/10.1038/nature01310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529647				2022-12-24	WOS:000180397600052
J	Watzman, H				Watzman, H			German researchers set to receive Israeli stem-cell shipment	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					199	199		10.1038/421199b	http://dx.doi.org/10.1038/421199b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529601	Bronze			2022-12-24	WOS:000180397600008
J	Bischoff, FZ; Hahn, S; Johnson, KL; Simpson, JL; Bianchi, DW; Lewis, DE; Weber, WD; Klinger, K; Elias, S; Jackson, LG; Evans, MI; Holzgreve, W; de la Cruz, F				Bischoff, FZ; Hahn, S; Johnson, KL; Simpson, JL; Bianchi, DW; Lewis, DE; Weber, WD; Klinger, K; Elias, S; Jackson, LG; Evans, MI; Holzgreve, W; de la Cruz, F			Intact fetal cells in maternal plasma: are they really there?	LANCET			English	Article							PRENATAL DETECTION; DOWNS-SYNDROME	Rare fetal cells can be recovered from maternal blood, which suggests that non-invasive prenatal diagnosis is possible. However, recovery and analysis of fetal cells from blood is complex, and sensitivity is low because of the rarity of these cells in the maternal circulation. An alternative strategy, which suggested that intact fetal cells can be found in maternal plasma by use of simple enrichment methods, has been reported. We aimed to replicate this technique. However, five independent laboratories were unable to identify any intact male cells from the plasma of 38 women known to be carrying male fetuses. Although apoptotic intact fetal cells could contribute to the detection of fetal DNA in maternal plasma, we believe that recovery of these cells is difficult and not clinically practical.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Basel, Dept Obstet & Gynecol, CH-4003 Basel, Switzerland; Tufts Univ, Sch Med, Dept Pediat Obstet & Gynecol, Div Genet, Boston, MA 02111 USA; Genzyme Genet, Framingham, MA USA; Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA; Med Coll Penn & Hahnemann Univ, Dept Obstet & Gynecol, Philadelphia, PA USA; NICHHD, Mental Retardat Res Branch, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; University of Basel; Tufts University; Sanofi-Aventis; Genzyme Corporation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Drexel University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bischoff, FZ (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 6550 Fannin St,Suite 885, Houston, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD043204, N01HD043201, N01HD043202, N01HD043203] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-4-3201, N01-HD-4-3202, N01-HD-4-3204, N01-HD-4-3203] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Choolani M, 2001, LANCET, V357, P958, DOI 10.1016/S0140-6736(05)71658-5; Pertl B, 1999, SEMIN PERINATOL, V23, P393, DOI 10.1016/S0146-0005(99)80005-6; Poon LLM, 2000, LANCET, V356, P1819, DOI 10.1016/S0140-6736(00)03237-2; van Wijk IJ, 2000, CLIN CHEM, V46, P729	5	29	44	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					139	140		10.1016/S0140-6736(03)12191-5	http://dx.doi.org/10.1016/S0140-6736(03)12191-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531583				2022-12-24	WOS:000180428000015
J	Smith, LK; Peake, MD; Botha, JL				Smith, LK; Peake, MD; Botha, JL			Recent changes in lung cancer incidence for south Asians: a population based register study	BRITISH MEDICAL JOURNAL			English	Article									Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England; Weston Pk Hosp, Trent Canc Registry, Sheffield S10 2SJ, S Yorkshire, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Weston Park Hospital	Smith, LK (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.		Smith, Lucy K/I-6300-2018; Smith, Lucy K/S-6593-2019	Smith, Lucy K/0000-0001-9470-0793; Smith, Lucy K/0000-0001-9470-0793				Bhopal RS, 1996, BRIT J CANCER, V74, pS22; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; Johnson M, 1999, BLACK MINORITY ETHNI; Winter H, 1999, BRIT J CANCER, V79, P645, DOI 10.1038/sj.bjc.6690102	4	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					81	82		10.1136/bmj.326.7380.81	http://dx.doi.org/10.1136/bmj.326.7380.81			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521972	Green Published, Bronze			2022-12-24	WOS:000180426900016
J	Abtahian, F; Guerriero, A; Sebzda, E; Lu, MM; Zhou, R; Mocsai, A; Myers, EE; Huang, B; Jackson, DG; Ferrari, VA; Tybulewicz, V; Lowell, CA; Lepore, JJ; Koretzky, GA; Kahn, ML				Abtahian, F; Guerriero, A; Sebzda, E; Lu, MM; Zhou, R; Mocsai, A; Myers, EE; Huang, B; Jackson, DG; Ferrari, VA; Tybulewicz, V; Lowell, CA; Lepore, JJ; Koretzky, GA; Kahn, ML			Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk	SCIENCE			English	Article							B-CELL DEVELOPMENT; ENDOTHELIAL-CELLS; MICE LACKING; ANGIOGENESIS; EXPRESSION; VIABILITY; RECEPTORS; COLLAGEN	Lymphatic vessels develop from specialized endothelial cells in preexisting blood vessels, but the molecular signals that regulate this separation are unknown. Here we identify a failure to separate emerging lymphatic vessels from blood vessels in mice lacking the hematopoietic signaling protein SLP-76 or Syk. Blood-lymphatic connections lead to embryonic hemorrhage and arteriovenous shunting. Expression of slp-76 could not be detected in endothelial cells, and blood-filled lymphatics also arose in wild-type mice reconstituted with SLP-76 deficient bone marrow. These studies reveal a hematopoietic signaling pathway required for separation of the two major vascular networks in mammals.	Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; John Radcliffe Hosp, MRC, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California San Francisco; University of Oxford; MRC National Institute for Medical Research; University of Pennsylvania	Koretzky, GA (corresponding author), Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Koretzky, Gary/AAU-5381-2021; Mocsai, Attila/B-2792-2008	Tybulewicz, Victor/0000-0003-2439-0798; Mocsai, Attila/0000-0002-0512-1157; Ferrari, Victor/0000-0001-8696-3243; , david/0000-0002-4133-9364	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB002473] Funding Source: NIH RePORTER; NIBIB NIH HHS [R21 EB002473, R21 EB002473-02] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ABTAHIAN F, UNPUB; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Braunwald E., 1997, HEART DIS; Carmeliet P, 2001, THROMB HAEMOSTASIS, V86, P289; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; SABIN F, 2001, AM J ANAT, V4, P367; Sauter B, 1998, J HISTOCHEM CYTOCHEM, V46, P165, DOI 10.1177/002215549804600205; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	25	312	330	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					247	251		10.1126/science.1079477	http://dx.doi.org/10.1126/science.1079477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522250	Green Accepted			2022-12-24	WOS:000180284000038
J	Strazzullo, P; Lacone, R; Lacoviello, L; Russo, O; Barba, G; Russo, P; D'Orazio, A; Barbato, A; Cappuccio, FP; Farinaro, E; Siani, A				Strazzullo, P; Lacone, R; Lacoviello, L; Russo, O; Barba, G; Russo, P; D'Orazio, A; Barbato, A; Cappuccio, FP; Farinaro, E; Siani, A			Genetic variation in the renin-angiotensin system and abdominal adiposity in men: The olivetti prospective heart study	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING-ENZYME GENE; HUMAN OBESITY GENES; INSERTION DELETION POLYMORPHISM; HUMAN ESSENTIAL-HYPERTENSION; CARDIOVASCULAR-RENAL RISK; BLOOD-PRESSURE; ACE GENE; INSULIN-RESISTANCE; TISSUE; ASSOCIATION	Background: The renin-angiotensin system is involved in adipocyte growth and differentiation and possibly in adipose tissue metabolism. Objective: To investigate the association of polymorphism in the angiotensin-converting enzyme (ACE) I/D gene, angiotensinogen M235T gene, and angiotensin II type 1 receptor A1166C gene with body mass index, body fat pattern, and obesity-associated hypertension. Design: Cross-sectional longitudinal study. Setting: The Olivetti factories in Marcianise and Pozzuoli, suburbs of Naples, Italy. Participants: 959 adult men, 25 to 75 years of age. Measurements: Renin-angiotensin system polymorphism, anthropometric indexes, blood pressure, and serum glucose and insulin levels. Results: No association was detected between angiotensinogen or angiotensin II type 1 receptor gene polymorphism and anthropometric indexes or blood pressure. For ACE I/D polymorphism, significant age-genotype interaction was detected on cross-sectional observation; the relation of body mass index, waist circumference, and diastolic blood pressure to age was significantly greater in persons with the DD genotype than in those with the ID or II genotype. Overweight and abdominal adiposity were more common in men with the DD genotype, particularly among older participants (51.1% vs. 36.5% and 33.1% vs. 22.0%, respectively). Odds ratios were 1.82 (95% Cl, 1.16 to 2.87) for overweight and 1.76 (Cl, 1.06 to 2.90) for abdominal adiposity. Among 314 untreated men first examined 20 years earlier, those with the DD genotype had greater age-adjusted weight gain (1.45 kg [Cl, 0.12 to 2.78 kg]) and change in diastolic blood pressure (2.83 mm Hg [Cl, 0.39 to 5.28 mm Hg]). The relative risk for overweight was 2.34 (Cl, 1.32 to 4.15) among participants with the DD genotype versus those with the ID or II genotype. Conclusions: The ACE I/D polymorphism was a significant predictor of overweight and abdominal adiposity in men. DD homozygosity was associated with larger increases in body weight and blood pressure in aging persons, as well as with higher incidence of overweight.	Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, I-80131 Naples, Italy; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; CNR, Inst Food Sci, Avellino, Italy; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England	University of Naples Federico II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); St Georges University London	Strazzullo, P (corresponding author), Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, Via S Pansini 5, I-80131 Naples, Italy.	strazzul@unina.it	Iacoviello, Licia/AGX-7071-2022; Barbato, Antonio/AAG-3313-2020; Siani, Alfonso/B-7925-2015; Russo, Paola/AAW-8308-2020; Cappuccio, Francesco Paolo/ABF-1094-2020; Iacoviello, Licia/K-4676-2016; Cappuccio, Francesco/D-3028-2009	Iacoviello, Licia/0000-0003-0514-5885; Cappuccio, Francesco Paolo/0000-0002-7842-5493; Iacoviello, Licia/0000-0003-0514-5885; IACONE, ROBERTO/0000-0003-3360-3855; Barbato, Antonio/0000-0002-4660-821X				Ailhaud G, 2000, INT J OBESITY, V24, pS33, DOI 10.1038/sj.ijo.0801501; Arner P, 2000, INT J OBESITY, V24, pS57, DOI 10.1038/sj.ijo.0801507; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; BOUCHARD C, 1993, ANNU REV NUTR, V13, P337, DOI 10.1146/annurev.nu.13.070193.002005; CAMPBELL DJ, 1995, J CARDIOVASC PHARM, V26, P426, DOI 10.1097/00005344-199509000-00013; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cooper R, 1998, J HYPERTENS, V16, P571, DOI 10.1097/00004872-199816050-00003; Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391; CRANDALL DL, 1994, DRUG DEVELOP RES, V32, P117, DOI 10.1002/ddr.430320208; DARIMONT C, 1994, ENDOCRINOLOGY, V135, P2030, DOI 10.1210/en.135.5.2030; EGAN BM, 1994, AM J HYPERTENS, V7, P886, DOI 10.1093/ajh/7.10.886; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Giacchetti G, 1999, INT J OBES RELAT S5, V23, pS71; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hennes MMI, 1996, HYPERTENSION, V28, P120, DOI 10.1161/01.HYP.28.1.120; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; Jones BH, 1997, AM J PHYSIOL-REG I, V273, pR236, DOI 10.1152/ajpregu.1997.273.1.R236; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; LICATA G, 1994, AM J HYPERTENS, V7, P314, DOI 10.1093/ajh/7.4.314; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RUSS AP, 1993, HUM MOL GENET, V2, P609, DOI 10.1093/hmg/2.5.609; Ryan AS, 2001, DIABETES CARE, V24, P1646, DOI 10.2337/diacare.24.9.1646; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; Strazzullo P, 2001, J HYPERTENS, V19, P399, DOI 10.1097/00004872-200103000-00007; Thomas GN, 2001, DIABETES CARE, V24, P356, DOI 10.2337/diacare.24.2.356; TIRET L, 1994, LANCET, V344, P910, DOI 10.1016/S0140-6736(94)92268-3; TIRET L, 1992, AM J HUM GENET, V51, P197; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Viitanen L, 2001, ATHEROSCLEROSIS, V157, P57, DOI 10.1016/S0021-9150(00)00705-X	47	140	143	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					17	23		10.7326/0003-4819-138-1-200301070-00007	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513040				2022-12-24	WOS:000180996200003
J	Cowen, JP; Giovannoni, SJ; Kenig, F; Johnson, HP; Butterfield, D; Rappe, MS; Hutnak, M; Lam, P				Cowen, JP; Giovannoni, SJ; Kenig, F; Johnson, HP; Butterfield, D; Rappe, MS; Hutnak, M; Lam, P			Fluids from aging ocean crust that support microbial life	SCIENCE			English	Article							HYDROTHERMAL SYSTEMS; RIDGE; FLANK	Little is known about the potential for life in the vast, low-temperature (<100&DEG;C) reservoir of fluids within mid-ocean ridge flank and ocean basin crust. Recently, an overpressured 300-meter-deep borehole was fitted with an experimental seal (CORK) delivering crustal fluids to the sea floor for discrete and large-volume sampling and characterization. Results demonstrate that the 65&DEG;C fluids from 3.5-million-year-old ocean crust support microbial growth. Ribosomal RNA gene sequence data indicate the presence of diverse Bacteria and Archaea, including gene clones of varying degrees of relatedness to known nitrate reducers (with ammonia production), thermophilic sulfate reducers, and thermophilic fermentative heterotrophs, all consistent with fluid chemistry.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Illinois, Chicago, IL 60607 USA; Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Hawaii System; Oregon State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cowen, JP (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA.		Kenig, Fabien/A-4961-2008; Butterfield, David/H-3815-2016; Lam, Phyllis/D-9574-2011	Butterfield, David/0000-0002-1595-9279; Lam, Phyllis/0000-0003-2067-171X; Kenig, Fabien/0000-0003-4868-5232				Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; BECKER K, 1999, EOS, V80, pF931; Butterfield DA, 2001, GEOCHIM COSMOCHIM AC, V65, P4141, DOI 10.1016/S0016-7037(01)00712-8; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Cowen JP, 1999, GEOPHYS RES LETT, V26, P3637, DOI 10.1029/1999GL002343; Davis E, 1999, EARTH PLANET SC LETT, V172, P141, DOI 10.1016/S0012-821X(99)00197-1; Davis E.E., 1997, P OCEAN DRILLING PRO, V168, P470; Davis EE, 1992, P OCEAN DRILL PROGRA, V139, P43, DOI DOI 10.2973/ODP.PROC.IR.139.103.1992; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; Ferdelman TG, 1997, GEOCHIM COSMOCHIM AC, V61, P3065, DOI 10.1016/S0016-7037(97)00158-0; Huber R, 1996, SYST APPL MICROBIOL, V19, P40, DOI 10.1016/S0723-2020(96)80007-5; KARL DM, 1980, SCIENCE, V207, P1345, DOI 10.1126/science.207.4437.1345; KENIG F, UNPUB; MARESCOTTI P, 2000, P OCEAN DRILL PROGRA, V168; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; SHOCK EL, 1992, ORIGINS LIFE EVOL B, V22, P67, DOI 10.1007/BF01808019; WARWICK B, 1991, STUDIES PLANT SCI, V1, P162; Wheat CG, 2000, GEOCHIM COSMOCHIM AC, V64, P629, DOI 10.1016/S0016-7037(99)00347-6	20	189	200	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					120	123		10.1126/science.1075653	http://dx.doi.org/10.1126/science.1075653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511653				2022-12-24	WOS:000180165800049
J	Nishida, M; MacKinnon, R				Nishida, M; MacKinnon, R			Structural basis of inward rectification: Cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 angstrom resolution	CELL			English	Article							K+-CHANNEL; POTASSIUM CHANNEL; BETA-GAMMA; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; MECHANISM; SUBUNIT; ACTIVATION; CELLS; BLOCK	Inward rectifier K+ channels govern the resting membrane voltage in many cells. Regulation of these ion channels via G protein-coupled receptor signaling underlies the control of heart rate and the actions of neurotransmitters in the central nervous system. We have determined the protein structure formed by the intracellular N- and C termini of the G protein-gated inward rectifier K+ channel GIRK1 at 1.8 Angstrom resolution. A cytoplasmic pore, conserved among inward rectifier K+ channels, extends the ion pathway to 60 Angstrom, nearly twice the length of a canonical transmembrane K+ channel. The cytoplasmic pore is lined by acidic and hydrophobic amino acids, creating a favorable environment for polyamines, which block the pore. These results explain in structural and chemical terms the basis of inward rectification, and they also have implications for G protein regulation of GIRK channels.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43949] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGEN ASV, 1953, J PHYSIOL-LONDON, V120, P449, DOI 10.1113/jphysiol.1953.sp004910; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo DL, 2000, J GEN PHYSIOL, V115, P799, DOI 10.1085/jgp.115.6.799; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	60	301	319	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					957	965		10.1016/S0092-8674(02)01227-8	http://dx.doi.org/10.1016/S0092-8674(02)01227-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507423	Bronze			2022-12-24	WOS:000180086000006
J	Wang, JD; Herman, C; Tipton, KA; Gross, CA; Weissman, JS				Wang, JD; Herman, C; Tipton, KA; Gross, CA; Weissman, JS			Directed evolution of substrate-optimized GroEL/S chaperonins	CELL			English	Article							GREEN FLUORESCENT PROTEIN; HEAT-SHOCK PROTEINS; FOLDING IN-VIVO; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; TRIGGER FACTOR; CENTRAL CAVITY; BINDING; COMPLEX	GroEL/S chaperonin ring complexes fold many unrelated proteins. To understand the basis and extent of the chaperonin substrate spectrum, we used rounds of selection and DNA shuffling to obtain GroEL/S variants that dramatically enhanced folding of a single substrate-green fluorescent protein (GFP). Changes in the substrate-optimized chaperonins increase the polarity of the folding cavity and alter the ATPase cycle. These findings reveal a surprising plasticity of GroEL/S, which can be exploited to aid folding of recombinant proteins. Our studies also reveal a conflict between specialization and generalization of chaperonins as increased GFP folding comes at the expense of the ability of GroEL/S to fold its natural substrates. This conflict and the nature of the ring structure may help explain the evolution of cellular chaperone systems.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol & Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Wang, Jue/GVU-0480-2022	Wang, Jue/0000-0003-1503-170X; Weissman, Jonathan/0000-0003-2445-670X	NIGMS NIH HHS [GM36278, GM55595] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036278, R37GM036278, R01GM055595] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang D, 2000, ANNU REV GENET, V34, P439, DOI 10.1146/annurev.genet.34.1.439; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chan HS, 1996, PROTEINS, V24, P345; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; deLeon P, 1997, MICROBIOL-SGM, V143, P3563, DOI 10.1099/00221287-143-11-3563; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Farinas ET, 2001, CURR OPIN BIOTECH, V12, P545, DOI 10.1016/S0958-1669(01)00261-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GULUKOTA K, 1994, P NATL ACAD SCI USA, V91, P9292, DOI 10.1073/pnas.91.20.9292; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HERMAN C, 1995, MOL MICROBIOL, V18, P247, DOI 10.1111/j.1365-2958.1995.mmi_18020247.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; KANEMORI M, 1994, J BACTERIOL, V176, P4235, DOI 10.1128/jb.176.14.4235-4242.1994; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KHODURSKY A, 2002, IN PRESS METHODS MOL; Kubota H, 1997, FEBS LETT, V402, P53, DOI 10.1016/S0014-5793(96)01501-3; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Leroux MR, 2001, ADV APPL MICROBIOL, V50, P219, DOI 10.1016/S0065-2164(01)50007-6; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; LUO GX, 1993, J BIOL CHEM, V268, P10246; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mogk A, 1997, EMBO J, V16, P4579, DOI 10.1093/emboj/16.15.4579; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TOBE T, 1984, MOL GEN GENET, V195, P10, DOI 10.1007/BF00332716; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulrich HD, 2002, CURR TOP MICROBIOL, V268, P137; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997	62	110	116	5	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					1027	1039		10.1016/S0092-8674(02)01198-4	http://dx.doi.org/10.1016/S0092-8674(02)01198-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507429	Bronze			2022-12-24	WOS:000180086000012
J	Grutzendler, J; Kasthuri, N; Gan, WB				Grutzendler, J; Kasthuri, N; Gan, WB			Long-term dendritic spine stability in the adult cortex	NATURE			English	Article							VISUAL-CORTEX; MACACA-NEMESTRINA; OCULAR DOMINANCE; STRIATE CORTEX; LIVING MICE; PLASTICITY; NEURONS; SYNAPTOGENESIS; FILOPODIA; SYNAPSES	The structural dynamics of synapses probably has a crucial role in the development and plasticity of the nervous system. In the mammalian brain, the vast majority of excitatory axo-dendritic synapses occur on dendritic specializations called 'spines'. However, little is known about their long-term changes in the intact developing or adult animal. To address this question we developed a transcranial two-photon imaging technique to follow identified spines of layer-5 pyramidal neurons in the primary visual cortex of living transgenic mice expressing yellow fluorescent protein. Here we show that filopodia-like dendritic protrusions, extending and retracting over hours, are abundant in young animals but virtually absent from the adult. In young mice, within the 'critical period' for visual cortex development, similar to73% of spines remain stable over a one-month interval; most changes are associated with spine elimination. In contrast, in adult mice, the overwhelming majority of spines (similar to96%) remain stable over the same interval with a half-life greater than 13 months. These results indicate that spines, initially plastic during development, become remarkably stable in the adult, providing a potential structural basis for long-term information storage.	NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst,Mol Neurobiol Program, New York, NY 10016 USA	New York University	Gan, WB (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Skirball Inst,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.		Grutzendler, Jaime/F-3691-2010					Antonini A, 1999, J NEUROSCI, V19, P4388; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BOOTHE RG, 1979, J COMP NEUROL, V186, P473, DOI 10.1002/cne.901860310; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; HUTTENLOCHER PR, 1987, HUM NEUROBIOL, V6, P1; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LUND JS, 1977, J COMP NEUROL, V176, P149, DOI 10.1002/cne.901760203; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; PURVES D, 1987, SCIENCE, V238, P1122, DOI 10.1126/science.3685967; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; RAKIC P, 1994, PROG BRAIN RES, V102, P227; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	29	865	884	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					812	816		10.1038/nature01276	http://dx.doi.org/10.1038/nature01276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490949				2022-12-24	WOS:000179897300056
J	Carroll, D; Ebrahim, S; Tilling, K; MacLeod, J; Smith, GD				Carroll, D; Ebrahim, S; Tilling, K; MacLeod, J; Smith, GD			Admissions for myocardial infarction and World Cup football: database survey	BRITISH MEDICAL JOURNAL			English	Article							EARTHQUAKE; DISEASE; STRESS; CIVILIANS; MORTALITY; TRIGGERS	Objectives To examine hospital admissions for a range of diagnoses on days surrounding England's 1998 World Cup football matches. Design Analysis of hospital admissions obtained from English hospital episode statistics. Setting England. Participants Population aged 15-64 years. Main outcome measures Ratio of number of admissions for acute myocardial infarction, stroke, deliberate self harm, and road traffic injuries on the day of and five days after England's World Cup matches, compared with admissions at die same time in previous and following years and in the month preceding the tournament. Results Risk of admission for acute myocardial infarction increased by 25% on 30 June 1998 (the day England lost to Argentina in a penalty shoot-out) and the following two days. No excess admissions occurred for other diagnoses or on the days of the other England matches. The effect was the same when only the two days after the match were treated as the exposed condition. Individual analyses of the day of and the two days after the Argentina match showed 55 extra admissions for myocardial infarctions compared with the number expected. Conclusion The increase in admissions suggests that myocardial infarction can be triggered by emotional upset, such as watching your football team lose an important match.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Bristol; University of Birmingham; University of Birmingham	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013; Tilling, Kate/AAY-1578-2021	Davey Smith, George/0000-0002-1407-8314; Tilling, Kate/0000-0002-1010-8926				BERGOVEC M, 1992, LANCET, V339, P303, DOI 10.1016/0140-6736(92)91370-N; BRODKIN J, 1998, GUARDIAN        0702, P3; Brunekreef B, 2002, EPIDEMIOLOGY, V13, P491, DOI 10.1097/00001648-200207000-00022; Harrison LK, 2000, BIOL PSYCHOL, V52, P113, DOI 10.1016/S0301-0511(99)00033-2; Heslop P, 2001, BRIT J HEALTH PSYCH, V6, P167, DOI 10.1348/135910701169133; KATSOUYANNI K, 1986, INT J EPIDEMIOL, V15, P326, DOI 10.1093/ije/15.3.326; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Kondo N I, 1995, J Cardiovasc Risk, V2, P499, DOI 10.1097/00043798-199512000-00003; LEAR J, 1996, AM J CARDIOL, V77, P1230; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; SUZUKI S, 1995, LANCET, V345, P981, DOI 10.1016/S0140-6736(95)90727-0; *TEL AUD RES INF S, 1999, UK TEL VID YB; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K; TRICHOPOULOS D, 1983, LANCET, V1, P441; WITTE DR, 2000, BRIT MED J, V321, P1332; Zanobetti A, 2002, EPIDEMIOLOGY, V13, P87, DOI 10.1097/00001648-200201000-00014; 2002, GUARDIAN        0620, P11	19	142	147	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1439	1442		10.1136/bmj.325.7378.1439	http://dx.doi.org/10.1136/bmj.325.7378.1439			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493655	Green Published, Green Accepted			2022-12-24	WOS:000180188600007
J	Ball, AM; Gillen, DL; Sherrard, D; Weiss, NS; Emerson, SS; Seliger, SL; Kestenbaum, BR; Stehman-Breen, C				Ball, AM; Gillen, DL; Sherrard, D; Weiss, NS; Emerson, SS; Seliger, SL; Kestenbaum, BR; Stehman-Breen, C			Risk of hip and renal fracture among dialysis transplant recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; KIDNEY-TRANSPLANTATION; INDUCED OSTEOPOROSIS; DISEASE; HYPERPARATHYROIDISM	Context Renal failure places people at particularly high risk of hip fracture. However, the possible differential impact of dialysis and renal transplantation on this risk is not well understood. Objective To determine if patients who receive kidney transplants are at greater risk of hip fracture compared with those who continue to undergo dialysis. Design, Setting, and Participants Cohort study of 101039 patients with end-stage renal disease placed on the renal transplant waiting list in the United States between January 1, 1990, and December 31, 1999. Main Outcome Measures I Hip fractures, identified from Medicare claims data. Results Among the patients included in this analysis, 971 hip fractures were observed during the follow-up period of 314767 person-years. The incidence rate of hip fracture in patients receiving dialysis was 2.9 per 1000 patients per year compared with 3.3 hip fractures per 1000 patients per year in those who had previously received a renal transplant. Initially, the relative risk (RR) of hip fracture associated with transplantation was 1.34-fold greater when compared with dialysis (adjusted RR, 1.34; 95 % confidence interval [CI], 1.12-1.61) but then decreased by 1 % per month (adjusted RR, 0.99; 95% Cl, 0.98-0.99) until the estimated risk became equal for dialysis and transplant recipients approximately 630 days after transplantation (adjusted RR, 1.00; 95 % Cl, 0.87-1-15). Among transplant recipients, risk of fracture was relatively higher in persons with a prolonged period of dialysis before transplantation. Conclusion The high risk of hi p fracture among dialysis patients is exceeded by that among renal, transplant patients during the first 1 to 3 years after transplantation.	Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, Seattle, WA 98108 USA; Univ Washington, Sch Med, Div Nephrol, Seattle, WA USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Stehman-Breen, C (corresponding author), Vet Affairs Pubet Sound Hlth Care Syst, Div Nephrol, 1660 S Columbian Way,Mailstop 111A, Seattle, WA 98108 USA.							Alem AM, 2000, KIDNEY INT, V58, P396, DOI 10.1046/j.1523-1755.2000.00178.x; ALMOND MK, 1994, NEPHRON, V66, P52, DOI 10.1159/000187765; Caglar M, 1999, ANN NUCL MED, V13, P141, DOI 10.1007/BF03164853; Canalis E, 1996, J CLIN ENDOCR METAB, V81, P3441, DOI 10.1210/jc.81.10.3441; Carlini RG, 2000, AM J KIDNEY DIS, V36, P160, DOI 10.1053/ajkd.2000.8289; Chevalley T, 1996, EUR J ENDOCRINOL, V134, P591, DOI 10.1530/eje.0.1340591; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; CUNDY T, 1983, Q J MED, V52, P67; Dalen N, 1973, Clin Nephrol, V1, P338; Epstein Sol, 1995, Current Opinion in Rheumatology, V7, P255, DOI 10.1097/00002281-199505000-00018; FISHER ES, 1990, AM J PUBLIC HEALTH, V80, P1487, DOI 10.2105/AJPH.80.12.1487; GROTZ WH, 1995, NEPHROL DIAL TRANSPL, V10, P2096; HORBER FF, 1994, J BONE MINER RES, V9, P1; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; KWAN JTC, 1992, MINER ELECTROL METAB, V18, P166; Manolagas SC, 1999, J BONE MINER RES, V14, P1061, DOI 10.1359/jbmr.1999.14.7.1061; *NIH, 1999, US REN DAT SYST USRD; PARFITT AM, 1982, MINER ELECTROL METAB, V8, P92; Pichette V, 1996, AM J KIDNEY DIS, V28, P105, DOI 10.1016/S0272-6386(96)90138-9; Ramsey-Goldman R, 1999, J BONE MINER RES, V14, P456, DOI 10.1359/jbmr.1999.14.3.456; RIGGS BL, 1992, NEW ENGL J MED, V327, P620; Stehman-Breen CO, 2000, KIDNEY INT, V58, P2200, DOI 10.1046/j.1523-1755.2000.00394.x; Stein MS, 1996, AM J KIDNEY DIS, V28, P515, DOI 10.1016/S0272-6386(96)90461-8; *US C, 1994, HIP FRACT OUTC PEOPL; Weisinger JR, 1999, TRANSPLANT P, V31, P3033, DOI 10.1016/S0041-1345(99)00658-2; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	26	298	305	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3014	3018		10.1001/jama.288.23.3014	http://dx.doi.org/10.1001/jama.288.23.3014			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479766	Bronze			2022-12-24	WOS:000179854200036
J	Graham, SM				Graham, SM			Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa	LANCET			English	Editorial Material							VIRUS-INFECTED CHILDREN; COTRIMOXAZOLE PROPHYLAXIS; TRIMETHOPRIM; RESISTANCE		Univ Malawi, Wellcome Trust Res Labs, Blantyre 3, Malawi; Univ Malawi, Coll Med, Dept Paediat, Blantyre 3, Malawi; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool	Graham, SM (corresponding author), Univ Malawi, Wellcome Trust Res Labs, POB 30096, Blantyre 3, Malawi.	sgraham@mlw.medcol.mw		Graham, Stephen/0000-0003-3525-2294				Abdel-Haq N, 1999, PEDIATR INFECT DIS J, V18, P647, DOI 10.1097/00006454-199907000-00017; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Chokephaibulkit K, 1999, PEDIATR INFECT DIS J, V18, P147, DOI 10.1097/00006454-199902000-00012; DOUNG T, 1999, BMJ-BRIT MED J, V319, P1227; Fisher RG, 2001, AIDS PATIENT CARE ST, V15, P263, DOI 10.1089/10872910152050784; GIBB DM, 1994, ARCH DIS CHILD, V70, P241, DOI 10.1136/adc.70.3.241; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Grimwade K, 2001, CURR OPIN INFECT DIS, V14, P507, DOI 10.1097/00001432-200110000-00002; Ikeogu MO, 1997, ARCH DIS CHILD, V76, P124, DOI 10.1136/adc.76.2.124; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; JohannLiang R, 1997, PEDIATR INFECT DIS J, V16, P1145, DOI 10.1097/00006454-199712000-00009; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; Ruffini DD, 2002, AIDS, V16, P105, DOI 10.1097/00002030-200201040-00013; SIMONDS RJ, 1993, JAMA-J AM MED ASSOC, V270, P470, DOI 10.1001/jama.270.4.470; *UNAIDS WHO, 2000, UNAIDS PROV WHO UNAI; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P202, DOI 10.1016/S0035-9203(02)90306-8; Zar HJ, 2000, PEDIATR INFECT DIS J, V19, P603, DOI 10.1097/00006454-200007000-00004	20	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1966	1968		10.1016/S0140-6736(02)11921-0	http://dx.doi.org/10.1016/S0140-6736(02)11921-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493279				2022-12-24	WOS:000179870200031
J	Kirwan, JF; Nightingale, JA; Bunce, C; Wormald, R				Kirwan, JF; Nightingale, JA; Bunce, C; Wormald, R			beta Blockers for glaucoma and excess risk of airways obstruction: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							TOPICAL TIMOLOL; PULMONARY		Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England; Royal Brompton Hosp, London SW3 6LY, England; Moorfields Eye Hosp, London EC1V 2PD, England	University of London; University College London; Royal Brompton Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Kirwan, JF (corresponding author), Inst Ophthalmol, Dept Epidemiol & Int Eye Hlth, London EC1V 9EL, England.			Nightingale, Julia/0000-0002-8978-2840; Bunce, Catey/0000-0002-0935-3713	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bateman DN, 2001, BRIT MED J, V323, P1401, DOI 10.1136/bmj.323.7326.1401; CHARAN NB, 1980, ARCH INTERN MED, V140, P843, DOI 10.1001/archinte.140.6.843; DIGGORY P, 1995, LANCET, V345, P1604, DOI 10.1016/S0140-6736(95)90116-7; Quigley HA, 1996, AM J OPHTHALMOL, V122, P355, DOI 10.1016/S0002-9394(14)72062-8; Stewart WC, 2001, J GLAUCOMA, V10, P227, DOI 10.1097/00061198-200106000-00015	5	20	22	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1396	1397		10.1136/bmj.325.7377.1396	http://dx.doi.org/10.1136/bmj.325.7377.1396			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480856	Green Published			2022-12-24	WOS:000179975000025
J	Rutz, HP				Rutz, HP			Effects of corticosteroid use on treatment of solid tumours	LANCET			English	Editorial Material							IONIZING-RADIATION; GENE-EXPRESSION; DEXAMETHASONE; CELLS; RESISTANCE; AGENTS; RADIORESISTANCE; APOPTOSIS; INVITRO		Paul Scherrer Inst, Dept Life Sci, Div Radiat Med, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Rutz, HP (corresponding author), Paul Scherrer Inst, Dept Life Sci, Div Radiat Med, CH-5232 Villigen, Switzerland.							AAPRO MS, 1991, RECENT RESULTS CANC, P91; AMBRUS JL, 1985, LANCET, V2, P148; BANSAL N, 1991, FASEB J, V5, P211, DOI 10.1096/fasebj.5.2.2004665; Biswas T, 1999, ONCOGENE, V18, P525, DOI 10.1038/sj.onc.1202320; BRADY ME, 1987, EUR J CLIN PHARMACOL, V32, P593, DOI 10.1007/BF02455994; BROCK WA, 1984, INT J RADIAT ONCOL, V10, P2113, DOI 10.1016/0360-3016(84)90210-4; DEVITA D, 1993, CANC PRINCIPLES PRAC; FREI E, 1965, BLOOD, V26, P624; Ioannidis JPA, 2000, J CLIN ONCOL, V18, P3409, DOI 10.1200/JCO.2000.18.19.3409; KARIN M, 1979, SCIENCE, V204, P176, DOI 10.1126/science.432639; Mariotta M, 1999, STRAHLENTHER ONKOL, V175, P392, DOI 10.1007/s000660050027; MILLAR BC, 1985, INT J RADIAT BIOL, V47, P539, DOI 10.1080/09553008514550771; Nauck M, 1997, AM J RESP CELL MOL, V16, P398, DOI 10.1165/ajrcmb.16.4.9115750; Naumann U, 1998, ONCOGENE, V17, P1567, DOI 10.1038/sj.onc.1202071; ORTH DN, 1992, WILLIAMS TXB ENDOCRI, P513; Pruschy M, 1997, BIOCHEM BIOPH RES CO, V241, P519, DOI 10.1006/bbrc.1997.7846; RENAN MJ, 1989, RADIAT RES, V120, P442, DOI 10.2307/3577795; ROILA F, 1995, NEW ENGL J MED, V332, P1; Roila F, 2000, NEW ENGL J MED, V342, P1554; Rutz HP, 1998, STRAHLENTHER ONKOL, V174, P71, DOI 10.1007/BF03038478; ZHAO JY, 1993, ENDOCRINOLOGY, V133, P521, DOI 10.1210/en.133.2.521	21	96	100	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1969	1970		10.1016/S0140-6736(02)11922-2	http://dx.doi.org/10.1016/S0140-6736(02)11922-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493280				2022-12-24	WOS:000179870200032
J	Di Blasi, Z; Kaptchuk, TJ; Weinman, J; Kleijnen, J				Di Blasi, Z; Kaptchuk, TJ; Weinman, J; Kleijnen, J			Informing participants of allocation to placebo at trial closure: postal survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIAL; CONSUMERS; CONSENT	Objectives To assess whether and how investigators of placebo controlled randomised trials inform participants of their treatment allocation at trial closure and to assess barriers to feedback. Design Postal survey With a semistructured questionnaire. Participants All investigators who published a placebo controlled randomised trial in 2000 in five leading medical journals, and a random sample of 120 trials listed in the national research register database. Main outcome measures Number of investigators who informed participants of their treatment allocation at trial closure, methods for delivering the information, and barriers to unmasking treatment. Results 45% of investigators informed either,all or most participants of their treatment allocation, and 55% did not inform any participant or only informed those who asked. The main reasons for not informing participants were that the investigators never considered this option (40%) or to avoid biasing results at study follow up (24%). Conclusion Further research is required to examine sensitive ways to communicate treatment information to trial participants.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Harvard Univ, Sch Med, Osher Inst, Boston, MA 02215 USA; Guys Kings & St Thomas Sch Med, Unit Psychol, London SE1 9RT, England; Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England	University of York - UK; Harvard University; Harvard Medical School; University of London; King's College London; University of York - UK	Di Blasi, Z (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	zdb1@york.ac.uk		Di Blasi, Zelda/0000-0001-8950-4958; Weinman, John Alfred/0000-0002-6786-0166				[Anonymous], 1986, HIST THEORY INFORM C; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; BERGMANN JF, 1994, CLIN TRIAL META-ANAL, V29, P41; Chalmers I, 2001, INT J EPIDEMIOL, V30, P1156, DOI 10.1093/ije/30.5.1156; Crow R., 1999, HEALTH TECHNOL ASSES, V3, P1, DOI [DOI 10.3310/HTA3030, DOI 10.3310/hta3030]; DAHAN R, 1986, BRIT MED J, V293, P363, DOI 10.1136/bmj.293.6543.363; *DEP HLTH, 2001, RES GOV FRAM HLTH SO; *DEP HLTH, 2001, RES GOVT FRAM HLTH S; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; FOX M, 2002, BRAIN SCAN STUDY SHO; Hanley B, 2001, BRIT MED J, V322, P519, DOI 10.1136/bmj.322.7285.519; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; Leuchter AF, 2002, AM J PSYCHIAT, V159, P122, DOI 10.1176/appi.ajp.159.1.122; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; *NHS CTR REV DISS, 2001, 4 U YORK NHS CTR REV; RABKIN JG, 1990, AM J PSYCHIAT, V147, P1622; Royle J, 2001, BRIT MED J, V323, P48; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; 2001, NATL RES REGISTER	20	27	27	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2002	325	7376					1329	1331		10.1136/bmj.325.7376.1329	http://dx.doi.org/10.1136/bmj.325.7376.1329			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468480	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000179817100017
J	Bidle, KD; Manganelli, M; Azam, F				Bidle, KD; Manganelli, M; Azam, F			Regulation of oceanic silicon and carbon preservation by temperature control on bacteria	SCIENCE			English	Article							BIOGENIC SILICA; SOUTHERN-OCEAN; ORGANIC-CARBON; WATER-COLUMN; MARINE DIATOMS; ROSS SEA; DISSOLUTION; CYCLE; AVAILABILITY; CONSUMPTION	We demonstrated in laboratory experiments that temperature control of marine bacteria action on diatoms strongly influences the coupling of biogenic silica and organic carbon preservation. Low temperature intensified the selective regeneration of organic matter by marine bacteria as the silicon: carbon preservation ratio gradually increased from similar to1 at 33degreesC to similar to6 at -1.8degreesC. Temperature control of bacteria-mediated selective preservation of silicon versus carbon should help to interpret and model the variable coupling of silicon and carbon sinking fluxes and the spatial patterns of opal accumulation in oceanic systems with different temperature regimes.	Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Bidle, KD (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.		Azam, Farooq/A-2306-2012; Manganelli, Maura/M-7103-2017	Manganelli, Maura/0000-0002-5650-8191				ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2001, LIMNOL OCEANOGR, V46, P1606, DOI 10.4319/lo.2001.46.7.1606; BIDLE KD, UNPUB; BRZEZINSKI MA, 1989, DEEP-SEA RES, V36, P1009, DOI 10.1016/0198-0149(89)90075-7; Brzezinski MA, 1998, MAR ECOL PROG SER, V167, P89, DOI 10.3354/meps167089; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; CHRISTIAN JR, 1995, LIMNOL OCEANOGR, V40, P1042, DOI 10.4319/lo.1995.40.6.1042; CHRISTIAN JR, 1993, ANTARCT J US, V28, P221; Christian JR, 1992, ANTARCT J US, V27, P170; DeMaster DJ, 2002, DEEP-SEA RES PT II, V49, P3155, DOI 10.1016/S0967-0645(02)00076-0; DEMASTER DJ, 1991, MAR CHEM, V35, P489, DOI 10.1016/S0304-4203(09)90039-1; DEMASTER DJ, 1992, OCEANOGRAPHY, V5, P146, DOI DOI 10.5670/OCEANOG.1992.03; Dugdale RC, 1998, NATURE, V391, P270, DOI 10.1038/34630; HANSON R B, 1981, Antarctic Journal of the United States, V16, P130; HODSON RE, 1981, MAR BIOL, V61, P89, DOI 10.1007/BF00386648; HURD DC, 1983, AM J SCI, V283, P1, DOI 10.2475/ajs.283.1.1; KAMATANI A, 1979, MAR BIOL, V55, P29, DOI 10.1007/BF00391714; KAMATANI A, 1982, MAR BIOL, V68, P91, DOI 10.1007/BF00393146; KARL DM, 1993, ANTARCTIC MICROBIOLO, V1, P1; LEWIN JC, 1961, GEOCHIM COSMOCHIM AC, V21, P182, DOI 10.1016/S0016-7037(61)80054-9; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; NELSON DM, 1982, GEOCHIM COSMOCHIM AC, V46, P491, DOI 10.1016/0016-7037(82)90153-3; Nelson DM, 2002, DEEP-SEA RES PT II, V49, P1645, DOI 10.1016/S0967-0645(02)00005-X; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson DM, 1996, J GEOPHYS RES-OCEANS, V101, P18519, DOI 10.1029/96JC01573; NELSON DM, 1991, MAR CHEM, V35, P461, DOI 10.1016/S0304-4203(09)90037-8; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; POMEROY LR, 1986, SCIENCE, V233, P359, DOI 10.1126/science.233.4761.359; Pondaven P, 2000, NATURE, V405, P168, DOI 10.1038/35012046; Ragueneau O, 2002, DEEP-SEA RES PT II, V49, P3127, DOI 10.1016/S0967-0645(02)00075-9; Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; TREGUER P, 1989, POLAR BIOL, V9, P397, DOI 10.1007/BF00442531	40	87	88	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1980	1984		10.1126/science.1076076	http://dx.doi.org/10.1126/science.1076076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471255				2022-12-24	WOS:000179629200042
J	Sala, E; Aburto-Oropeza, O; Paredes, G; Parra, I; Barrera, JC; Dayton, PK				Sala, E; Aburto-Oropeza, O; Paredes, G; Parra, I; Barrera, JC; Dayton, PK			A general model for designing networks of marine reserves	SCIENCE			English	Article							CONNECTIVITY; POPULATION; RETENTION	There is debate concerning the most effective conservation of marine biodiversity, especially regarding the appropriate location, size, and connectivity of marine reserves. We describe a means of establishing marine reserve networks by using optimization algorithms and multiple levels of information on biodiversity, ecological processes (spawning, recruitment, and larval connectivity), and socioeconomic factors in the Gulf of California. A network covering 40% of rocky reef habitat can fulfill many conservation goals while reducing social conflict. This quantitative approach provides a powerful tool for decision-makers tasked with siting marine reserves.	Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; Univ Autonoma Baja California, La Paz, Baja Calif Sur, Mexico; World Wildlife Fund, Gulf Calif Program, Hermosillo, Sonora, Mexico	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad Autonoma de Baja California	Sala, E (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	esala@ucsd.edu		Aburto-Oropeza, Octavio/0000-0002-8173-1432				AIRAME S, IN PRESS ECOL APPL; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Botsford LW, 2001, ECOL LETT, V4, P144; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; CARR MH, 1993, CAN J FISH AQUAT SCI, V50, P2019, DOI 10.1139/f93-226; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dayton PK, 2000, B MAR SCI, V66, P617; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; KINLAN BP, IN PRESS ECOLOGY; Lauck T, 1998, ECOL APPL, V8, pS72, DOI 10.1890/1051-0761(1998)8[S72:ITPPIF]2.0.CO;2; LESLIE H, IN PRESS ECOL APPL; Lockwood DR, 2002, THEOR POPUL BIOL, V61, P297, DOI 10.1006/tpbi.2002.1572; LUBCHENCO J, IN PRESS ECOL APPL; Malakoff D, 2002, SCIENCE, V296, P245, DOI 10.1126/science.296.5566.245; Mangel M, 2000, ECOL LETT, V3, P15, DOI 10.1046/j.1461-0248.2000.00104.x; Musick JA, 2000, FISHERIES, V25, P6, DOI 10.1577/1548-8446(2000)025<0006:MEADFS>2.0.CO;2; National Research Council, 2001, MAR PROT AR TOOLS SU; Ogden JC, 1997, SCIENCE, V278, P1414, DOI 10.1126/science.278.5342.1414; Palumbi SR, 2001, MARINE COMMUNITY ECOLOGY, P509; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson DR, 2001, P NATL ACAD SCI USA, V98, P5667, DOI 10.1073/pnas.091367798; SALA E, UNPUB; SALA E, IN PRESS B MAR SCI; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Ward TJ, 1999, ECOL APPL, V9, P691; Warner RR, 2000, B MAR SCI, V66, P821	29	303	315	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1991	1993		10.1126/science.1075284	http://dx.doi.org/10.1126/science.1075284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471258	Green Submitted			2022-12-24	WOS:000179629200045
J	Temple, R; Aldridge, V; Greenwood, R; Heyburn, P; Sampson, M; Stanley, K				Temple, R; Aldridge, V; Greenwood, R; Heyburn, P; Sampson, M; Stanley, K			Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; WOMEN		Norfolk & Norwich Hosp NHS Trust, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England; Norfolk & Norwich Hosp NHS Trust, E Anglia Ctr Fetal & Maternal Med, Norwich NR4 7UY, Norfolk, England		Temple, R (corresponding author), Norfolk & Norwich Hosp NHS Trust, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England.							Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; HANSON U, 1990, DIABETOLOGIA, V33, P100, DOI 10.1007/BF00401047; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Nielsen GL, 1997, ACTA DIABETOL, V34, P217, DOI 10.1007/s005920050077; ROSENN B, 1994, OBSTET GYNECOL, V84, P515	5	93	96	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2002	325	7375					1275	1276		10.1136/bmj.325.7375.1275	http://dx.doi.org/10.1136/bmj.325.7375.1275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623HB	12458245	Bronze, Green Published			2022-12-24	WOS:000179696300017
J	Bracey, MH; Hanson, MA; Masuda, KR; Stevens, RC; Cravatt, BF				Bracey, MH; Hanson, MA; Masuda, KR; Stevens, RC; Cravatt, BF			Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling	SCIENCE			English	Article							ACID AMIDE HYDROLASE; MOLECULAR CHARACTERIZATION; FAMILY	Cellular communication in the nervous system is mediated by chemical messengers that include amino acids, monoamines, peptide hormones, and lipids. An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids. Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase ( FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity. The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to soluble hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Stevens, RC (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu; cravatt@scripps.edu	Stevens, Raymond/K-7272-2015	Stevens, Raymond/0000-0002-4522-8725	NIDA NIH HHS [R01 DA013173-02] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013173] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boger DL, 2000, P NATL ACAD SCI USA, V97, P5044, DOI 10.1073/pnas.97.10.5044; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; GOMI K, 1991, GENE, V108, P91, DOI 10.1016/0378-1119(91)90491-S; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; Patricelli MP, 2001, BIOCHEMISTRY-US, V40, P6107, DOI 10.1021/bi002578r; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P9804, DOI 10.1021/bi990637z; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Sipe JC, 2002, P NATL ACAD SCI USA, V99, P8394, DOI 10.1073/pnas.082235799; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	26	417	447	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1793	1796		10.1126/science.1076535	http://dx.doi.org/10.1126/science.1076535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459591				2022-12-24	WOS:000179494800047
J	Dubertret, B; Skourides, P; Norris, DJ; Noireaux, V; Brivanlou, AH; Libchaber, A				Dubertret, B; Skourides, P; Norris, DJ; Noireaux, V; Brivanlou, AH; Libchaber, A			In vivo imaging of quantum dots encapsulated in phospholipid micelles	SCIENCE			English	Article							CDSE NANOCRYSTALS; PHASE-BEHAVIOR; MIXTURES; DNA	Fluorescent semiconductor nanocrystals (quantum dots) have the potential to revolutionize biological imaging, but their use has been limited by difficulties in obtaining nanocrystals that are biocompatible. To address this problem, we encapsulated individual nanocrystals in phospholipid block-copolymer micelles and demonstrated both in vitro and in vivo imaging. When conjugated to DNA, the nanocrystal-micelles acted as in vitro. fluorescent probes to hybridize to specific complementary sequences. Moreover, when injected into Xenopus embryos, the nanocrystal-micelles were stable, nontoxic (<5 x 10(9) nanocrystals per cell), cell autonomous, and slow to photobleach. Nanocrystal fluorescence could be followed to the tadpole stage, allowing lineage-tracing experiments in embryogenesis.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA; NEC Res Inst, Princeton, NJ 08540 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	Rockefeller University; Rockefeller University; NEC Corporation; University of Minnesota System; University of Minnesota Twin Cities	Dubertret, B (corresponding author), CNRS, UPRA0005, 10 Rue Vauquelin, F-75005 Paris, France.		Norris, David J/F-4022-2010	Norris, David J/0000-0002-3765-0678; noireaux, vincent/0000-0002-5213-273X; Skourides, Paris/0000-0003-3502-5729				Aldana J, 2001, J AM CHEM SOC, V123, P8844, DOI 10.1021/ja016424q; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Belsito S, 2000, BIOPHYS J, V78, P1420, DOI 10.1016/S0006-3495(00)76695-1; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Dahan M, 2001, OPT LETT, V26, P825, DOI 10.1364/OL.26.000825; Gerion D, 2002, J AM CHEM SOC, V124, P7070, DOI 10.1021/ja017822w; Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488; Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.; Goldman ER, 2002, ANAL CHEM, V74, P841, DOI 10.1021/ac010662m; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; HRISTOVA K, 1995, MACROMOLECULES, V28, P991, DOI 10.1021/ma00108a029; Johnsson M, 2001, J PHYS CHEM B, V105, P8420, DOI 10.1021/jp011088l; Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; LASIC DD, 1991, PERIOD BIOL, V93, P287; Leatherdale CA, 2002, J PHYS CHEM B, V106, P7619, DOI 10.1021/jp025698c; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; Mikulec F. V., 1999, THESIS MIT; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Parak WJ, 2002, ADV MATER, V14, P882, DOI 10.1002/1521-4095(20020618)14:12<882::AID-ADMA882>3.0.CO;2-Y; Pathak S, 2001, J AM CHEM SOC, V123, P4103, DOI 10.1021/ja0058334; Rosenthal SJ, 2002, J AM CHEM SOC, V124, P4586, DOI 10.1021/ja003486s; Torchilin VP, 2002, ADV DRUG DELIVER REV, V54, P235, DOI 10.1016/S0169-409X(02)00019-4; Winter JO, 2001, ADV MATER, V13, P1673, DOI 10.1002/1521-4095(200111)13:22<1673::AID-ADMA1673>3.0.CO;2-6	28	2661	2905	18	863	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1759	1762		10.1126/science.1077194	http://dx.doi.org/10.1126/science.1077194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459582				2022-12-24	WOS:000179494800036
J	Hochheimer, A; Zhou, S; Zheng, S; Holmes, MC; Tjian, R				Hochheimer, A; Zhou, S; Zheng, S; Holmes, MC; Tjian, R			TRF2 associates with DREF and directs promoter-selective gene expression in Drosophila	NATURE			English	Article							TBP-LIKE FACTOR; NUCLEOSOME REMODELING FACTOR; POLYMERASE-II TRANSCRIPTION; CELL NUCLEAR ANTIGEN; BINDING PROTEIN; MICE LACKING; C-ELEGANS; ISWI; SPERMIOGENESIS; ELEMENTS	Drosophila TATA-box-binding protein (TBP)-related factor 2 (TRF2) is a member of a family of TBP-related factors present in metazoan organisms. Recent evidence suggests that TRF2s are required for proper embryonic development and differentiation(1-5). However, true target promoters and the mechanisms by which TRF2 operates to control transcription remain elusive. Here we report the antibody affinity purification of a Drosophila TRF2-containing complex that contains components of the nucleosome remodelling factor (NURF) chromatin remodelling complex as well as the DNA replication-related element (DRE)-binding factor DREF. This latter finding led us to potential target genes containing TRF2-responsive promoters. We have used a combination of in vitro and in vivo assays to show that the DREF-containing TRF2 complex directs core promoter recognition of the proliferating cell nuclear antigen (PCNA) gene. We also identified additional TRF2-responsive target genes involved in DNA replication and cell proliferation. These data suggest that TRF2 functions as a core promoter-selectivity factor responsible for coordinating transcription of a subset of genes in Drosophila.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.	jmlim@uclink4.berkeley.edu						Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Coligan JKA, 1991, CURRENT PROTOCOLS IM; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; DYNLACHT BD, 1994, P NATL ACAD SCI USA, V91, P6359, DOI 10.1073/pnas.91.14.6359; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; GOODRICH LA, 1994, CURR OPIN CELL BIOL, V6, P403, DOI 10.1016/0955-0674(94)90033-7; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hirose F, 1996, J BIOL CHEM, V271, P3930; HIROSE F, 1993, J BIOL CHEM, V268, P2092; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Yamaguchi M, 1996, GENES CELLS, V1, P47, DOI 10.1046/j.1365-2443.1996.03003.x; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	29	170	177	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					439	445		10.1038/nature01167	http://dx.doi.org/10.1038/nature01167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459787				2022-12-24	WOS:000179494700045
J	Nishimura, R; Hayashi, M; Wu, GJ; Kouchi, H; Imaizumi-Anraku, H; Murakami, Y; Kawasaki, S; Akao, S; Ohmori, M; Nagasawa, M; Harada, K; Kawaguchi, M				Nishimura, R; Hayashi, M; Wu, GJ; Kouchi, H; Imaizumi-Anraku, H; Murakami, Y; Kawasaki, S; Akao, S; Ohmori, M; Nagasawa, M; Harada, K; Kawaguchi, M			HAR1 mediates systemic regulation of symbiotic organ development	NATURE			English	Article							SPLIT-ROOT SYSTEM; LOTUS-JAPONICUS; RECEPTOR KINASE; WILD-TYPE; LINKAGE MAP; NODULATION; MUTANT; SHOOT; CLAVATA1; SUPPRESSION	Symbiotic root nodules are beneficial to leguminous host plants; however, excessive nodulation damages the host because it interferes with the distribution of nutrients in the plant. To keep a steady balance, the nodulation programme is regulated systemically in leguminous hosts(1),(2). Leguminous mutants that have lost this ability display a hypernodulating phenotype. Through the use of reciprocal and self-grafting studies using Lotus japonicus hypernodulating mutants, har1 (also known as sym78)(3), we show that the shoot genotype is responsible for the negative regulation of nodule development. A map-based cloning strategy revealed that HAR1 encodes a protein with a relative molecular mass of 108, 000, which contains 21 leucine-rich repeats, a single transmembrane domain and serine/threonine kinase domains. The har1 mutant phenotype was rescued by transfection of the HAR1 gene. In a comparison of Arabidopsis receptor-like kinases, HAR1 showed the highest level of similarity with CLAVATA1 (CLV1)(4). CLV1 negatively regulates formation of the shoot and floral meristems through cell-cell communication involving the CLV3 peptide(5). Identification of hypernodulation genes thus indicates that genes in leguminous plants bearing a close resemblance to CLV1 regulate nodule development systemically, by means of organ-organ communication.	Niigata Univ, Fac Sci, Dept Environm Sci, Niigata 9502181, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1638902, Japan; Chiba Univ, Fac Hort, Chiba 2718510, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Niigata University; University of Tokyo; Chiba University; National Institute of Agrobiological Sciences - Japan; Japan Science & Technology Agency (JST)	Kawaguchi, M (corresponding author), Niigata Univ, Fac Sci, Dept Environm Sci, Niigata 9502181, Japan.	masayosi@env.sc.niigata-u.ac.jp	Han, Liqi/K-6127-2013	Kawaguchi, Masayoshi/0000-0002-1032-6261				AKAO S, 1992, SOIL SCI PLANT NUTR, V38, P183, DOI 10.1080/00380768.1992.10416966; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DELVES AC, 1986, PLANT PHYSIOL, V82, P588, DOI 10.1104/pp.82.2.588; DeYoung BJ, 2001, PLANT MOL BIOL, V46, P505, DOI 10.1023/A:1010672910703; Flemetakis E, 2000, MOL PLANT MICROBE IN, V13, P987, DOI 10.1094/MPMI.2000.13.9.987; GRESSHOFF PM, 1992, CURRENT TOPICS PLANT, P87; HAMAGUCHI H, 1992, SOIL SCI PLANT NUTR, V38, P771, DOI 10.1080/00380768.1992.10416710; Hayashi M, 2001, DNA RES, V8, P301, DOI 10.1093/dnares/8.6.301; Kawaguchi M, 2002, MOL PLANT MICROBE IN, V15, P17, DOI 10.1094/MPMI.2002.15.1.17; Kawaguchi M, 2001, MOL GENET GENOMICS, V266, P157, DOI 10.1007/s004380100540; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; KOSSLAK RM, 1984, PLANT PHYSIOL, V75, P125, DOI 10.1104/pp.75.1.125; Kouchi H, 1999, PLANT J, V18, P121, DOI 10.1046/j.1365-313X.1999.00432.x; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Nishimura R, 2002, PLANT CELL PHYSIOL, V43, P853, DOI 10.1093/pcp/pcf098; NUTMAN PS, 1952, ANN BOT-LONDON, V16, P79, DOI 10.1093/oxfordjournals.aob.a083304; OLSSON JE, 1989, PLANT PHYSIOL, V90, P1347, DOI 10.1104/pp.90.4.1347; Penmetsa RV, 1997, SCIENCE, V275, P527, DOI 10.1126/science.275.5299.527; PIERCE M, 1983, PLANT PHYSIOL, V73, P286, DOI 10.1104/pp.73.2.286; Sagan M, 1996, SYMBIOSIS, V20, P229; Schauser L, 1998, MOL GEN GENET, V259, P414, DOI 10.1007/s004380050831; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Sheng CX, 1997, PLANT PHYSIOL, V113, P825, DOI 10.1104/pp.113.3.825; Solaiman MZ, 2000, J PLANT RES, V113, P443, DOI 10.1007/PL00013953; Stiller J, 1997, J EXP BOT, V48, P1357, DOI 10.1093/jxb/48.7.1357; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; van Brussel AAN, 2002, MOL PLANT MICROBE IN, V15, P341, DOI 10.1094/MPMI.2002.15.4.341; Wopereis J, 2000, PLANT J, V23, P97, DOI 10.1046/j.1365-313x.2000.00799.x; Yamamoto E, 2000, BBA-GENE STRUCT EXPR, V1491, P333, DOI 10.1016/S0167-4781(00)00061-0; Yamanaka N, 2001, DNA RES, V8, P61, DOI 10.1093/dnares/8.2.61	30	392	421	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					426	429		10.1038/nature01231	http://dx.doi.org/10.1038/nature01231			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12442172				2022-12-24	WOS:000179494700042
J	Rutter, J				Rutter, J			PAS domains and metabolic status signaling	SCIENCE			English	Editorial Material							CLOCK; NPAS2		Univ Texas, SW Med Ctr, Houston, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Rutter, J (corresponding author), Univ Texas, SW Med Ctr, Houston, TX 75390 USA.							Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; DIOUMET EM, 2002, SCIENCE         1121; HARDY TA, 1993, J BIOL CHEM, V268, P23799; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; RUTTER J, 2001, THESIS U TEXAS SW ME; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999	11	5	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 22	2002	298	5598					1567	1568		10.1126/science.1080001	http://dx.doi.org/10.1126/science.1080001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446897				2022-12-24	WOS:000179361600036
J	Doye, A; Mettouchi, A; Bossis, G; Clement, R; Buisson-Touati, C; Flatau, G; Gagnoux, L; Piechaczyk, M; Boquet, P; Lemichez, E				Doye, A; Mettouchi, A; Bossis, G; Clement, R; Buisson-Touati, C; Flatau, G; Gagnoux, L; Piechaczyk, M; Boquet, P; Lemichez, E			CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion	CELL			English	Article							CYTOTOXIC NECROTIZING FACTOR-1; UROPATHOGENIC ESCHERICHIA-COLI; URINARY-TRACT INFECTIONS; ACTIN CYTOSKELETON; FACTOR TYPE-1; PROTEIN; TOXIN; DEAMIDATION; BINDING; DOMAIN	CNF1 toxin is a virulence factor produced by uropathogenic Escherichia coli. Upon cell binding and introduction into the cytosol, CNF1 deamidates glutamine 63 of RhoA (or 61 of Rac and Cdc42), rendering constitutively active these GTPases. Unexpectedly, we measured in bladder cells a transient CNF1-induced activation of Rho GTPases, maximal for Rac. Deactivation of Rac correlated with the increased susceptibility of its deamidated form to ubiquitin/proteasome-mediated degradation. Sensitivity to ubiquitylation could be generalized to other permanent-activated forms of Rac and to its sustained activation by Dbl. Degradation of the toxin-activated Rac allowed both host cell motility and efficient cell invasion by uropathogenic bacteria. CNF1 toxicity thus results from a restricted activation of Rho GTPases through hijacking the host cell proteasomal machinery.	Fac Med, INSERM, U452, IFR 50, F-06107 Nice, France; Fac Med, INSERM, U3825, IFR 50, F-06107 Nice, France; Ctr Antoine Lacassagne, CNRS, UMR 6543, IFR 72, F-06189 Nice, France; Inst Genet Mol, CNRS, UMR 5535, IFR 24, F-34293 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Lemichez, E (corresponding author), Fac Med, INSERM, U452, IFR 50, 28 Ave Valombrose, F-06107 Nice, France.		Gagnoux, Laurent/O-9954-2016; Bossis, Guillaume/C-7172-2012; PIECHACZYK, Marc/E-7896-2013; Lemichez, Emmanuel/G-3559-2013	PIECHACZYK, Marc/0000-0003-1367-2597; Lemichez, Emmanuel/0000-0001-9080-7761; bossis, guillaume/0000-0002-3349-8250; METTOUCHI, Amel/0000-0003-1453-6482				BLANCO J, 1992, RES MICROBIOL, V143, P869, DOI 10.1016/0923-2508(92)90074-X; BLUM G, 1995, FEMS MICROBIOL LETT, V126, P189, DOI 10.1016/0378-1097(95)00009-T; Bonacorsi SPP, 2000, INFECT IMMUN, V68, P2096, DOI 10.1128/IAI.68.4.2096-2101.2000; Boquet P, 1998, CURR OPIN MICROBIOL, V1, P66, DOI 10.1016/S1369-5274(98)80144-6; Boquet P, 2001, TOXICON, V39, P1673, DOI 10.1016/S0041-0101(01)00154-4; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; FALKOW S, 1987, REV INFECT DIS, V9, P450; Flatau G, 2000, BIOCHEM BIOPH RES CO, V267, P588, DOI 10.1006/bbrc.1999.1904; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horiguchi Y, 2001, TOXICON, V39, P1619, DOI 10.1016/S0041-0101(01)00149-0; Khan NA, 2002, J BIOL CHEM, V277, P15607, DOI 10.1074/jbc.M112224200; Landraud L, 2000, LETT APPL MICROBIOL, V30, P213, DOI 10.1046/j.1472-765x.2000.00698.x; Lemichez E, 1997, MOL MICROBIOL, V24, P1061, DOI 10.1046/j.1365-2958.1997.4151781.x; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Lerm M, 1999, J BIOL CHEM, V274, P28999, DOI 10.1074/jbc.274.41.28999; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Lockman HA, 2002, INFECT IMMUN, V70, P2708, DOI 10.1128/IAI.70.5.2708-2714.2002; LOW D, 1984, INFECT IMMUN, V43, P353, DOI 10.1128/IAI.43.1.353-358.1984; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Pei S, 2001, MOL MICROBIOL, V41, P1237, DOI 10.1046/j.1365-2958.2001.02596.x; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; SASAKAWA C, 1987, GENE, V56, P283; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000	36	219	220	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 15	2002	111	4					553	564		10.1016/S0092-8674(02)01132-7	http://dx.doi.org/10.1016/S0092-8674(02)01132-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437928	Bronze			2022-12-24	WOS:000179346900008
J	Fagarasan, S; Muramatsu, M; Suzuki, K; Nagaoka, H; Hiai, H; Honjo, T				Fagarasan, S; Muramatsu, M; Suzuki, K; Nagaoka, H; Hiai, H; Honjo, T			Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora	SCIENCE			English	Article							IMMUNE-SYSTEM; AID; HYPERMUTATION; DEFICIENCY; EXPRESSION; CELLS; MICE	Activation-induced cytidine deaminase (AID) plays an essential role in class switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes. We report here that deficiency in AID results in the development of hyperplasia of isolated lymphoid follicles (ILFs) associated with a 100-fold expansion of anaerobic. ora in the small intestine. Reduction of bacterial. ora by antibiotic treatment of AID(-/-) mice abolished ILF hyperplasia as well as the germinal center enlargement seen in secondary lymphoid tissues. Because an inability to switch to immunoglobulin A on its own does not lead to a similar phenotype, these results suggest that SHM of ILF B cells plays a critical role in regulating intestinal microflora.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan	Kyoto University; Kyoto University; RIKEN	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.		Muramatsu, Masamichi/C-4339-2015; Fagarasan, Sidonia/A-5258-2016; Honjo, Tasuku/N-4470-2016	Muramatsu, Masamichi/0000-0002-0153-3533; Fagarasan, Sidonia/0000-0003-2086-6402; 				BASTLEIN C, 1988, ENDOSCOPY, V20, P272, DOI 10.1055/s-2007-1018192; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Burt JR RW, 1999, TXB GASTROENTEROLOGY, P1995; Cebra J. J., 1994, HDB MUCOSAL IMMUNOLO, P151; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; FAGARASAN S, UNPUB; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Harriman GR, 1999, J IMMUNOL, V162, P2521; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; LeMaoult J, 1997, J IMMUNOL, V159, P3866; Levy Y, 1998, P NATL ACAD SCI USA, V95, P13135, DOI 10.1073/pnas.95.22.13135; METZGER D, COMMUNICATION; Moghaddami M, 1998, GASTROENTEROLOGY, V115, P1414, DOI 10.1016/S0016-5085(98)70020-4; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9	17	452	469	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1424	1427		10.1126/science.1077336	http://dx.doi.org/10.1126/science.1077336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434060				2022-12-24	WOS:000179223100053
J	Burkhart, CN				Burkhart, CN			Fomite transmission with head lice: a continuing controversy	LANCET			English	Editorial Material									Med Coll Ohio, Dept Microbiol & Immunol, Sylvania, OH 43560 USA		Burkhart, CN (corresponding author), Med Coll Ohio, Dept Microbiol & Immunol, Sylvania, OH 43560 USA.							BACOT AW, 1915, PARASITOLOGY, V9, P228; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; BURGESS IF, 2001, PESTICIDE OUTLOOK, V10, P109; Burkhart CN., 1999, J CLIN DERMATOL, V2, P15; Canyon DV, 2002, J INVEST DERMATOL, V119, P629, DOI 10.1046/j.1523-1747.2002.00540.x; CARTER DG, 1992, THESIS U CAMBRIDGE U; MAUDER JW, 1993, HLTH VISITOR, V66, P317; MEINKING TL, 1999, CURRENT PROBLEMS DER, P77; NOBLE ER, 1982, PARASITOLOGY BIOL AN, P339; Taplin D, 1988, PEDIAT DERMATOLOGY, V2, P1465	10	18	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					99	100		10.1016/S0140-6736(03)12243-X	http://dx.doi.org/10.1016/S0140-6736(03)12243-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531574				2022-12-24	WOS:000180428000006
J	Bose, A; Guilherme, A; Robida, SI; Nicoloro, SMC; Zhou, QL; Jiang, ZY; Pomerleau, DP; Czech, MP				Bose, A; Guilherme, A; Robida, SI; Nicoloro, SMC; Zhou, QL; Jiang, ZY; Pomerleau, DP; Czech, MP			Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c	NATURE			English	Article							3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; ACTIN-FILAMENTS; PHOSPHATIDYLINOSITOL 3-KINASE; MAMMALIAN-CELLS; IN-VIVO; GLUT4; TRANSLOCATION; MEMBRANE; VESICLES	Insulin stimulates glucose uptake in muscle and adipocytes by signalling the translocation of GLUT4 glucose transporters from intracellular membranes to the cell surface(1,2). The translocation of GLUT4 may involve signalling pathways that are both independent of and dependent on phosphatidylinositol-3-OH kinase (PI(3) K)(3-5). This translocation also requires the actin cytoskeleton(6-8), and the rapid movement of GLUT4 along linear tracks may be mediated by molecular motors(9). Here we report that the unconventional myosin Myo1c is present in GLUT4-containing vesicles purified from 3T3-L1 adipocytes. Myo1c, which contains a motor domain, three IQ motifs and a carboxy-terminal cargo domain, is highly expressed in primary and cultured adipocytes. Insulin enhances the localization of Myo1c with GLUT4 in cortical tubulovesicular structures associated with actin filaments, and this colocalization is insensitive to wortmannin. Insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane is augmented by the expression of wild-type Myo1c and inhibited by a dominant-negative cargo domain of Myo1c. A decrease in the expression of endogenous Myo1c mediated by small interfering RNAs inhibits insulin-stimulated uptake of 2-deoxyglucose. Thus, myosin Myo1c functions in a PI(3) K-independent insulin signalling pathway that controls the movement of intracellular GLUT4-containing vesicles to the plasma membrane.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.			Nicoloro, Sarah/0000-0002-8638-4556				BARYLKO B, 1992, P NATL ACAD SCI USA, V89, P490, DOI 10.1073/pnas.89.2.490; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Czech MP, 2000, NATURE, V407, P147, DOI 10.1038/35025183; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; DeOca GM, 1997, ARCH MED RES, V28, P321; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Emoto M, 2001, J BIOL CHEM, V276, P10677, DOI 10.1074/jbc.M010785200; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; JIANG ZY, UNPUB P NATL ACAD SC; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; LAURIE SM, 1993, J BIOL CHEM, V268, P19110; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; OKADA T, 1994, J BIOL CHEM, V269, P3568; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; REIZES O, 1994, P NATL ACAD SCI USA, V91, P6349, DOI 10.1073/pnas.91.14.6349; RUPPERT C, 1995, J CELL SCI, V108, P3775; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; Wu XF, 2000, CURR OPIN CELL BIOL, V12, P42, DOI 10.1016/S0955-0674(99)00055-1; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	30	202	207	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					821	824		10.1038/nature01246	http://dx.doi.org/10.1038/nature01246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490950				2022-12-24	WOS:000179897300058
J	Ray, JG; Meier, C; Vermeulen, MJ; Boss, S; Wyatt, PR; Cole, DEC				Ray, JG; Meier, C; Vermeulen, MJ; Boss, S; Wyatt, PR; Cole, DEC			Association of neural tube defects and folic acid food fortification in Canada	LANCET			English	Article							WOMEN	Many women do not receive folic acid supplements before conception. In response, most of Canada's cereal grain products were being fortified with folic acid by January, 1998, thereby providing an additional 0.1-0.2 mg per day of dietary folate to the Canadian population. We assessed the effect of supplementation on prevalence of open neural tube defects in the province of Ontario. Among 336 963 women who underwent maternal serum screening over 77 months, the prevalence of open neural tube defects declined from 1.13 per 1000 pregnancies before fortification to 0.58 per 1000 pregnancies thereafter (prevalence ratio 0.52, 95% Cl 0.40-0.67, p<0.0001). At a population level, folic acid food fortification is associated with a pronounced reduction in open neural tube defects.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Prehosp Care Programme, Toronto, ON, Canada; N York Gen Hosp, Genet Programme, Ontario Maternal Serum Screening Database Dept, Toronto, ON, Canada; MDS Serv, Toronto, ON, Canada; N York Gen Hosp, Dept Genet, Toronto, ON, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Paediat Genet, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University of Toronto	Ray, JG (corresponding author), 235A Medland St, Toronto, ON M6P 2N6, Canada.	Jray515445@aol.com						Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, DOI 10.1002/14651858.CD001056, 10.1002/14651858.CD001056]; Mathews F, 1998, BRIT J OBSTET GYNAEC, V105, P954, DOI 10.1111/j.1471-0528.1998.tb10257.x; Ray JG, 2002, EPIDEMIOLOGY, V13, P238, DOI 10.1097/00001648-200203000-00026	5	195	200	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2047	2048		10.1016/S0140-6736(02)11994-5	http://dx.doi.org/10.1016/S0140-6736(02)11994-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504403				2022-12-24	WOS:000179974200015
J	Garcia-Mira, MM; Sadqi, M; Fischer, N; Sanchez-Ruiz, JM; Munoz, V				Garcia-Mira, MM; Sadqi, M; Fischer, N; Sanchez-Ruiz, JM; Munoz, V			Experimental identification of downhill protein folding	SCIENCE			English	Article							KINETICS; BINDING; DYNAMICS; COMPLEX; DOMAIN	Theory predicts the existence of barrierless protein folding. Without barriers, folding should be noncooperative and the degree of native structure should be coupled to overall protein stability. We investigated the thermal unfolding of the peripheral subunit binding domain from Escherichia coli's 2-oxoglutarate dehydrogenase multienzyme complex (termed BBL) with a combination of spectroscopic techniques and calorimetry. Each technique probed a different feature of protein structure. BBL has a defined three-dimensional structure at low temperatures. However, each technique showed a distinct unfolding transition. Global analysis with a statistical mechanical model identified BBL as a downhill-folding protein. Because of BBL's biological function, we propose that downhill folders may be molecular rheostats, in which effects could be modulated by altering the distribution of an ensemble of structures.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Granada	Garcia-Mira, MM (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	vm48@umail.umd.edu	Fischer, Niels/ABA-5342-2021; Sanchez-Ruiz, Jose/H-2849-2015; Sadqi, Mourad/J-3180-2018; Garcia-Mira, Maria del Mar/E-2623-2018	Fischer, Niels/0000-0002-4609-4052; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Sadqi, Mourad/0000-0003-3553-3408; Garcia-Mira, Maria del Mar/0000-0003-0245-8093				ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chamberlain AK, 1998, BIOCHEMISTRY-US, V37, P1736, DOI 10.1021/bi972692i; Eaton WA, 1999, P NATL ACAD SCI USA, V96, P5897, DOI 10.1073/pnas.96.11.5897; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Freire E, 2000, P NATL ACAD SCI USA, V97, P11680, DOI 10.1073/pnas.97.22.11680; GARCIAMIRA MM, UNPUB; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hardin C, 1999, PROTEINS, V34, P281; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Leeson DT, 2000, P NATL ACAD SCI USA, V97, P2527, DOI 10.1073/pnas.040580397; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Munoz V, 2001, CURR OPIN STRUC BIOL, V11, P212, DOI 10.1016/S0959-440X(00)00192-5; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; PACKMAN LC, 1986, FEBS LETT, V206, P193, DOI 10.1016/0014-5793(86)80979-6; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; SADQI M, UNPUB; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Spector S, 1999, J MOL BIOL, V293, P763, DOI 10.1006/jmbi.1999.3189; Spector S, 1998, J MOL BIOL, V276, P479, DOI 10.1006/jmbi.1997.1522; Thirumalai D, 2002, ADV CHEM PHYS, V120, P35; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Young M, 1999, PROTEIN SCI, V8, P1752, DOI 10.1110/ps.8.9.1752	30	274	278	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2191	2195		10.1126/science.1077809	http://dx.doi.org/10.1126/science.1077809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481137				2022-12-24	WOS:000179773700048
J	Weis, CP; Intrepido, AJ; Miller, AK; Cowin, PG; Durno, MA; Gebhardt, JS; Bull, R				Weis, CP; Intrepido, AJ; Miller, AK; Cowin, PG; Durno, MA; Gebhardt, JS; Bull, R			Secondary aerosolization of viable Bacillus anthracis spores in a contaminated US Senate Office	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PCR	Context Bioterrorist attacks involving letters and mail-handling systems in Washington, DC, resulted in Bacillus anthracis (anthrax) spore contamination in the Hart Senate Office Building and other facilities in the US Capitol's vicinity. Objective To provide information about the nature and extent of indoor secondary aerosolization of B anthracis spores. Design Stationary and personal air samples, surface dust, and swab samples were collected under semiquiescent (minimal activities) and then simulated active office conditions to estimate secondary aerosolization of B anthracis spores. Nominal size characteristics, airborne concentrations, and surface contamination of a anthracis particles (colony-forming units) were evaluated. Results Viable B anthracis spores reaerosolized under semiquiescent conditions, with a marked increase in reaerosolization during simulated active office conditions. Increases were observed for B anthracis collected on open sheep blood agar plates (P<.001) and personal air monitors (P=.01) during active office conditions. More than 80% of the B anthracis particles collected on stationary monitors were within an alveolar respirable size range of 0.95 to 3.5 &mu;m. Conclusions Bacillus anthracis spores used in a recent terrorist incident reaerosolized under common office activities. These findings have important implications for appropriate respiratory protection, remediation, and reoccupancy of contaminated office environments.	US EPA, Natl Enforcement Invest Ctr, Denver Fed Ctr, Denver, CO 80225 USA; USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD USA; US PHS, Denver, CO USA; US EPA, Cleveland Off, Westlake, OH USA; Naval Med Res Ctr, Biol Def Directorate, Silver Spring, MD USA	United States Environmental Protection Agency; United States Public Health Service; United States Environmental Protection Agency; Naval Medical Research Center (NMRC)	Weis, CP (corresponding author), US EPA, Natl Enforcement Invest Ctr, Denver Fed Ctr, Bldg 53,POB 25227, Denver, CO 80225 USA.		Weis, Christopher/GWR-1351-2022					Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; BRACHMAN PS, 1966, BACTERIOL REV, V30, P646, DOI 10.1128/MMBR.30.3.646-659.1966; CHINN KS, 1996, REAEROSOLIZATION HAZ; DAVIDS DE, 1981, 321 DEF RES EST SUFF; DRUETT HA, 1953, J HYG-CAMBRIDGE, V51, P359, DOI 10.1017/S0022172400015795; FELLER W, 1950, INTRO PROBABILITY TH, P324; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Keim M, 1999, ANN EMERG MED, V34, P177, DOI 10.1016/S0196-0644(99)70227-1; Linn William S., 1993, Journal of Occupational Medicine and Toxicology, V2, P1; LINN WS, 1993, J CLEAN TECHNOL ENV, V3, P101; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Marple V.A., 1986, CASCADE IMPACTOR SAM, P79; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; PARKER JS, 2001, TERRORISM MAIL PROTE; PATRICK WC, 1999, RISK ASSESSMENT BIOL; Peters CJ, 2002, LANCET, V359, P710, DOI 10.1016/S0140-6736(02)07792-9; Resnick IG, 1990, EVALUATION NEED DETE; WATSON A, 1994, EPIDEMIOL INFECT, V113, P47	21	91	97	3	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2002	288	22					2853	2858		10.1001/jama.288.22.2853	http://dx.doi.org/10.1001/jama.288.22.2853			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623YM	12472327				2022-12-24	WOS:000179732600030
J	Galvao, J				Galvao, J			Access to antiretroviral drugs in Brazil	LANCET			English	Article								Since 1996, the Brazilian Ministry of Health has guaranteed free and universal access to antiretroviral treatment for people living with HIV/AIDS. Implementation of this policy has had political, financial, and logistical challenges. I have investigated the history and context of antiretroviral policy in Brazil, the logistics of the drugs' distribution, and the government's strategies for acquisition of the drugs. Many antiretrovirals used in Brazil are produced domestically; the remainder, including some of the most expensive drugs, are purchased from abroad. Although the Brazilian policy of antiretroviral distribution has had notable success, it remains threatened by the high cost of acquisition of drugs, which has led to disputes with international pharmaceutical companies over prices and patents. Whether or not the Brazilian model of guaranteeing access to antiretroviral treatment for people living with HIV/AIDS can be applied in other countries or regions, much can be learnt from the country's experience.	Univ Calif Berkeley, Sch Publ Hlth, Fogarty Int AIDS Training Programme, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Galvao, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Fogarty Int AIDS Training Programme, Berkeley, CA 94720 USA.			Galvao, Jane/0000-0003-1598-9125	FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; FIC NIH HHS [1-D43-TW00003] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Ashraf H, 2001, LANCET, V357, P2112, DOI 10.1016/S0140-6736(00)05244-2; BIEHL J, 1999, THESIS U CALIFORNIA; *BRAZ MIN HLTH, 2002, AIDS 2 REL IMPL AV D; *BRAZ MIN HLTH, 2001, MIN HLTH ANN COMP LI; *BRAZ MIN HLTH, 2002, NAT AIDS DRUG POL; *BRAZ MIN HLTH, 2001, WTO PAN CALLS BRAZ P; *BRAZ MIN HLTH, 1999, DIR CENTR TEST AC; *BRAZ MIN HLTH, 2002, B EP AIDS; *BRAZ MIN HLTH, 2000, SUS PRINC CONQ; DANIEL H, 1989, VIDA ANTES MORTE LIF; FALCAO D, 1997, FOLHA S PAULO, P1; Galvão Jane, 2002, Cad. Saúde Pública, V18, P213, DOI 10.1590/S0102-311X2002000100022; GALVAO JANE, 2000, AIDS NO BRASIL AGEND, P256; LIMA RM, 2000, ACAO ANTI AIDS, V43, P6; Lima RM, 2000, 13 INT AIDS C DURB S; PASSARELLI C, 2001, B ABIA, V46, P8; RICH JL, 2001, NY TIMES        0901, pB1; ROSENBERG T, 2001, NY TIMES MAGAZI 0126; *UN, 2001, ACC MED CONTEXT PAND; VELOSO V, 2000, 13 INT AIDS C DURB; *WORLD TRAD ORG, 2001, UR ROUND FIN ACT; World Trade Organization, 2001, DECL TRIPS AGR PUBL; 2001, OXFAM DRUG CO VS BRA	23	110	114	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1862	1865		10.1016/S0140-6736(02)11775-2	http://dx.doi.org/10.1016/S0140-6736(02)11775-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480377				2022-12-24	WOS:000179706100027
J	Okazaki, Y; Furuno, M; Kasukawa, T; Adachi, J; Bono, H; Kondo, S; Nikaido, I; Osato, N; Saito, R; Suzuki, H; Yamanaka, I; Kiyosawa, H; Yagi, K; Tomaru, Y; Hasegawa, Y; Nogami, A; Schonbach, C; Gojobori, T; Baldarelli, R; Hill, DP; Bult, C; Hume, DA; Quackenbush, J; Schriml, LM; Kanapin, A; Matsuda, H; Batalov, S; Beisel, KW; Blake, JA; Bradt, D; Brusic, V; Chothia, C; Corbani, LE; Cousins, S; Dalla, E; Dragani, TA; Fletcher, CF; Forrest, A; Frazer, KS; Gaasterland, T; Gariboldi, M; Gissi, C; Godzik, A; Gough, J; Grimmond, S; Gustincich, S; Hirokawa, N; Jackson, IJ; Jarvis, ED; Kanai, A; Kawaji, H; Kawasawa, Y; Kedzierski, RM; King, BL; Konagaya, A; Kurochkin, IV; Lee, Y; Lenhard, B; Lyons, PA; Maglott, DR; Maltais, L; Marchionni, L; McKenzie, L; Miki, H; Nagashima, T; Numata, K; Okido, T; Pavan, WJ; Pertea, G; Pesole, G; Petrovsky, N; Pillai, R; Pontius, JU; Qi, D; Ramachandran, S; Ravasi, T; Reed, JC; Reed, DJ; Reid, J; Ring, BZ; Ringwald, M; Sandelin, A; Schneider, C; Semple, CAM; Setou, M; Shimada, K; Sultana, R; Takenaka, Y; Taylor, MS; Teasdale, RD; Tomita, M; Verardo, R; Wagner, L; Wahlestedt, C; Wang, Y; Watanabe, Y; Wells, C; Wilming, LG; Wynshaw-Boris, A; Yanagisawa, M; Yang, I; Yang, L; Yuan, Z; Zavolan, M; Zhu, Y; Zimmer, A; Carninci, P; Hayatsu, N; Hirozane-Kishikawa, T; Konno, H; Nakamura, M; Sakazume, N; Sato, K; Shiraki, T; Waki, K; Kawai, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Miyazaki, A; Sakai, K; Sasaki, D; Shibata, K; Shinagawa, A; Yasunishi, A; Yoshino, M; Waterston, R; Lander, ES; Rogers, J; Birney, E; Hayashizaki, Y				Okazaki, Y; Furuno, M; Kasukawa, T; Adachi, J; Bono, H; Kondo, S; Nikaido, I; Osato, N; Saito, R; Suzuki, H; Yamanaka, I; Kiyosawa, H; Yagi, K; Tomaru, Y; Hasegawa, Y; Nogami, A; Schonbach, C; Gojobori, T; Baldarelli, R; Hill, DP; Bult, C; Hume, DA; Quackenbush, J; Schriml, LM; Kanapin, A; Matsuda, H; Batalov, S; Beisel, KW; Blake, JA; Bradt, D; Brusic, V; Chothia, C; Corbani, LE; Cousins, S; Dalla, E; Dragani, TA; Fletcher, CF; Forrest, A; Frazer, KS; Gaasterland, T; Gariboldi, M; Gissi, C; Godzik, A; Gough, J; Grimmond, S; Gustincich, S; Hirokawa, N; Jackson, IJ; Jarvis, ED; Kanai, A; Kawaji, H; Kawasawa, Y; Kedzierski, RM; King, BL; Konagaya, A; Kurochkin, IV; Lee, Y; Lenhard, B; Lyons, PA; Maglott, DR; Maltais, L; Marchionni, L; McKenzie, L; Miki, H; Nagashima, T; Numata, K; Okido, T; Pavan, WJ; Pertea, G; Pesole, G; Petrovsky, N; Pillai, R; Pontius, JU; Qi, D; Ramachandran, S; Ravasi, T; Reed, JC; Reed, DJ; Reid, J; Ring, BZ; Ringwald, M; Sandelin, A; Schneider, C; Semple, CAM; Setou, M; Shimada, K; Sultana, R; Takenaka, Y; Taylor, MS; Teasdale, RD; Tomita, M; Verardo, R; Wagner, L; Wahlestedt, C; Wang, Y; Watanabe, Y; Wells, C; Wilming, LG; Wynshaw-Boris, A; Yanagisawa, M; Yang, I; Yang, L; Yuan, Z; Zavolan, M; Zhu, Y; Zimmer, A; Carninci, P; Hayatsu, N; Hirozane-Kishikawa, T; Konno, H; Nakamura, M; Sakazume, N; Sato, K; Shiraki, T; Waki, K; Kawai, J; Aizawa, K; Arakawa, T; Fukuda, S; Hara, A; Hashizume, W; Imotani, K; Ishii, Y; Itoh, M; Kagawa, I; Miyazaki, A; Sakai, K; Sasaki, D; Shibata, K; Shinagawa, A; Yasunishi, A; Yoshino, M; Waterston, R; Lander, ES; Rogers, J; Birney, E; Hayashizaki, Y		FANTOM Consurtium; RIKEN Genome Exploration Res Grp	Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs	NATURE			English	Article							HUMAN GENOME; GENE; SEQUENCE; PROTEIN; RNA; CLASSIFICATION; IDENTIFICATION; CHROMOSOME-21; EVOLUTION; DISCOVERY	Only a small proportion of the mouse genome is transcribed into mature messenger RNA transcripts. There is an international collaborative effort to identify all full-length mRNA transcripts from the mouse, and to ensure that each is represented in a physical collection of clones. Here we report the manual annotation of 60,770 full-length mouse complementary DNA sequences. These are clustered into 33,409 'transcriptional units', contributing 90.1% of a newly established mouse transcriptome database. Of these transcriptional units, 4,258 are new protein-coding and 11,665 are new non-coding messages, indicating that non-coding RNA is a major component of the transcriptome. 41% of all transcriptional units showed evidence of alternative splicing. In protein-coding transcripts, 79% of splice variations altered the protein product. Whole-transcriptome analyses resulted in the identification of 2,431 sense-antisense pairs. The present work, completely supported by physical clones, provides the most comprehensive survey of a mammalian transcriptome so far, and is a valuable resource for functional genomics.	RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi KU, Yokohama, Kanagawa 2300045, Japan; Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; NTT Software Corp, Naka Ku, Kanagawa 2318554, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Div Genom Informat Resources Sci Biol Supramol Sy, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Bioinformat Grp, Biomed Knowledge Discovery Team, Kanagawa 2300045, Japan; Natl Inst Genet, DNA Data Bank Japan, Shizuoka 4118540, Japan; Natl Inst Genet, Ctr Informat Biol, Shizuoka 4118540, Japan; Jackson Lab, Mouse Genome Informat Grp, Bar Harbor, ME 04609 USA; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia; Inst Genom Res TIGR, Rockville, MD 20850 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; European Bioinformat Inst, Cambridge CB10 1SD, England; Osaka Univ, Grad Sch Informat Sci & Technol, Osaka 5608531, Japan; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Boys Town Natl Res Hosp, Omaha, NE 68131 USA; Labs Informat Technol, Singapore 119613, Singapore; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; LNCIB, Funct Genom, I-34012 Trieste, Italy; Ist Tumori Milano, I-20133 Milan, Italy; The Scripps Res Inst, Res Inst, La Jolla, CA 92037 USA; Univ Oregon, Zebrafish Int Resource Ctr, Eugene, OR 97403 USA; Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Univ Milan, I-20133 Milan, Italy; Burnham Inst, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Howard Hughes Med Inst, Dallas, TX 75390 USA; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Addenbrookes Hosp, Cambridge Inst Med Res, JDRF WT Diabet & Inflammat Lab, Cambridge CB2 2XY, England; NHGRI, NIH, Bethesda, MD 20892 USA; Canberra Hosp, Autoimmun Res Unit, Woden, ACT 2606, Australia; Appl Genom Inc, Sunnyvale, CA 94085 USA; Hirakata Ryoikuen, Osaka 5650874, Japan; Hyogo Med Univ, Inst Adv Med Sci, Nishinomiya, Hyogo 6638501, Japan; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02141 USA	RIKEN; Yokohama City University; Keio University; University of Tsukuba; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Jackson Laboratory; University of Queensland; University of Queensland; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; European Molecular Biology Laboratory (EMBL); Osaka University; Novartis; Boys Town National Research Hospital; MRC Laboratory Molecular Biology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Scripps Research Institute; University of Oregon; Rockefeller University; University of Milan; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; University of Tokyo; University of Edinburgh; Duke University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Australian National University; Canberra Hospital; Hyogo College of Medicine; University of Hyogo; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; University of Bonn; Washington University (WUSTL); Massachusetts Institute of Technology (MIT); Whitehead Institute	Hayashizaki, Y (corresponding author), RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Lab Genome Explorat Res Grp, Tsurumi KU, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yosihide@gsc.riken.go.jp	Petrovsky, Nikolai/P-1912-2017; Godzik, Adam/AAW-1467-2020; Kurochkin, Igor/Q-5646-2019; Teasdale, Rohan/AAD-6698-2019; Brusic, Vladimir/B-1478-2008; Kawai, Jun/A-6451-2016; Hayashizaki, Yoshihide/N-6590-2015; Kanapin, Alexander/E-7632-2013; Sandelin, Albin/G-2881-2011; Suzuki, Harukazu/N-9553-2015; Zimmer, Andreas/B-8357-2009; Teasdale, Rohan D/B-2538-2009; Godzik, Adam/A-7279-2009; Marchionni, Luigi/S-6774-2017; Yuan, Zheng/A-1344-2008; Carninci, Piero/K-1568-2014; Reid, James/G-2496-2010; Dragani, Tommaso A./K-4493-2016; Kawaji, Hideya/N-5116-2015; Konno, Hideaki/A-9191-2012; Grimmond, Sean M/J-5304-2016; Konno, Hideaki/N-4366-2014; Forrest, Alistair/A-6597-2008; Ravasi, Timothy/B-8777-2008; Dalla, Emiliano/AAH-3039-2020; Schönbach, Christian/B-1998-2009; Grimmond, Sean/K-3246-2019; Pesole, Graziano/K-5283-2019; King, Benjamin/AAI-1492-2019; Wells, Christine A/A-5071-2010; Nikaido, Itoshi/K-2058-2014; Itoh, Masayoshi/N-5363-2015; Schriml, Lynn/AFO-9472-2022; Yang, Ivana V/P-3059-2018; Bono, Hidemasa/AAF-3649-2020; Kanapin, Alexander A/Q-7590-2016; Pesole, Graziano/C-1408-2009; Jarvis, Erich D/A-2319-2008; Pesole, Graziano/E-9051-2014; Hume, David A/C-7695-2013; Zavolan, Mihaela/S-3888-2016; Konagaya, Akihiko/F-9302-2014; Kanai, Akio/C-4921-2014; Wahlestedt, Claes/A-7039-2009; Semple, Colin A M/A-5613-2009; Taylor, Martin S/C-3825-2009; Kasukawa, Takeya/N-5070-2015; Gariboldi, Manuela/K-4744-2016; Waki, Kazunori/T-6444-2019	Petrovsky, Nikolai/0000-0002-1580-5245; Godzik, Adam/0000-0002-2425-852X; Teasdale, Rohan/0000-0001-7455-5269; Brusic, Vladimir/0000-0003-0523-5266; Sandelin, Albin/0000-0002-7109-7378; Suzuki, Harukazu/0000-0002-8087-0836; Teasdale, Rohan D/0000-0001-7455-5269; Godzik, Adam/0000-0002-2425-852X; Marchionni, Luigi/0000-0002-7336-8071; Carninci, Piero/0000-0001-7202-7243; Dragani, Tommaso A./0000-0001-5915-4598; Kawaji, Hideya/0000-0002-0575-0308; Grimmond, Sean M/0000-0002-8102-7998; Konno, Hideaki/0000-0002-8470-4835; Forrest, Alistair/0000-0003-4543-1675; Dalla, Emiliano/0000-0002-4687-6011; Schönbach, Christian/0000-0002-0693-7617; Grimmond, Sean/0000-0002-8102-7998; Wells, Christine A/0000-0003-3133-3628; Nikaido, Itoshi/0000-0002-7261-2570; Itoh, Masayoshi/0000-0002-1772-318X; Yang, Ivana V/0000-0002-1018-489X; Bono, Hidemasa/0000-0003-4413-0651; Kanapin, Alexander A/0000-0001-9802-5297; Pesole, Graziano/0000-0003-3663-0859; Jarvis, Erich D/0000-0001-8931-5049; Pesole, Graziano/0000-0003-3663-0859; Kanai, Akio/0000-0002-6362-2419; Semple, Colin A M/0000-0003-1765-4118; Taylor, Martin S/0000-0001-7656-330X; Kasukawa, Takeya/0000-0001-5085-0802; Batalov, Sergey/0000-0002-0925-0554; Gustincich, Stefano/0000-0002-2749-2514; Gariboldi, Manuela/0000-0001-8406-165X; Zavolan, Mihaela/0000-0002-8832-2041; Birney, Ewan/0000-0001-8314-8497; Waki, Kazunori/0000-0001-7311-7208; Reid, James/0000-0001-6997-2850; King, Benjamin/0000-0001-6463-1336; Okazaki, Yasushi/0000-0003-3241-5502; Jackson, Ian/0000-0001-6526-0688; Osato, Naoki/0000-0002-7584-5388; Fukuda, Shiro/0000-0002-0065-662X; Wilming, Laurens/0000-0002-4154-7358; Lenhard, Boris/0000-0002-1114-1509; Ravasi, Timothy/0000-0002-9950-465X; Osato, Naoki/0000-0001-9716-6725; Quackenbush, John/0000-0002-2702-5879; Schriml, Lynn/0000-0001-8910-9851; Gissi, Carmela/0000-0002-2269-079X; Blake, Judith/0000-0001-8522-334X; Hume, David/0000-0002-2615-1478; Kurochkin, Igor V/0000-0002-6231-9004; Matsuda, Hideo/0000-0002-4701-3779	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000136, Z01HG000136] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2001, GENOME RES, V11, P1425; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2002, BIOTECHNIQUES, V33, P306, DOI 10.2144/02332st01; Carninci P, 2002, BIOTECHNIQUES, V32, P984, DOI 10.2144/02325bm01; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Daly MJ, 2002, CELL, V109, P283, DOI 10.1016/S0092-8674(02)00742-0; Dreyer SD, 1999, GENOMICS, V62, P119, DOI 10.1006/geno.1999.5981; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Hill DP, 2001, GENOMICS, V74, P121, DOI 10.1006/geno.2001.6513; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kawaji H, 2002, GENOME RES, V12, P367, DOI 10.1101/gr.193702; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Konno H, 2001, GENOME RES, V11, P281, DOI 10.1101/gr.GR-1457R; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Pesole G, 2000, BIOINFORMATICS, V16, P439, DOI 10.1093/bioinformatics/16.5.439; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Poirier GMC, 1999, J IMMUNOL, V163, P4960; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schweighoffer F, 2000, Pharmacogenomics, V1, P187, DOI 10.1517/14622416.1.2.187; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563	52	1277	1464	3	179	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					563	573		10.1038/nature01266	http://dx.doi.org/10.1038/nature01266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466851	hybrid, Green Published			2022-12-24	WOS:000179611600054
J	Altfeld, M; Allen, TM; Yu, XG; Johnston, MN; Agrawal, D; Korber, BT; Montefiori, DC; O'Connor, DH; Davis, BT; Lee, PK; Maier, EL; Harlow, J; Goulder, PJR; Brander, C; Rosenberg, ES; Walker, BD				Altfeld, M; Allen, TM; Yu, XG; Johnston, MN; Agrawal, D; Korber, BT; Montefiori, DC; O'Connor, DH; Davis, BT; Lee, PK; Maier, EL; Harlow, J; Goulder, PJR; Brander, C; Rosenberg, ES; Walker, BD			HIV-1 superinfection despite broad CD8(+) T-cell responses containing replication of the primary virus	NATURE			English	Article							ANTIRETROVIRAL THERAPY; IMMUNE-RESPONSES; VIREMIA; INFECTION; AIDS; DISCONTINUATION; LYMPHOCYTES; PREVENTION; CHALLENGE; MACAQUES	Early treatment of acute HIV-1 infection followed by treatment interruptions has shown promise for enhancing immune control of infection(1-3). A subsequent loss of control, however, allows the correlates of protective immunity to be assessed. Here we show that sudden breakthrough of plasma viraemia occurred after prolonged immune containment in an individual infected with HIV-1 at a time when 25 distinct CD8(+) T-cell epitopes in the viral proteins Gag, RT, Integrase, Env, Nef, Vpr, Vif and Rev were being targeted. Sequencing of the virus in plasma and cells showed that superinfection with a second clade-B virus was coincident with the loss of immune control. This sudden increase in viraemia was associated with a decline in half of the CD8(+) T-cell responses. The declining CD8(+) T-cell responses were coupled with sequence changes relative to the initial virus that resulted in impaired recognition. Our data show that HIV-1 superinfection can occur in the setting of a strong and broadly directed virus-specific CD8(+) T-cell response. The lack of cross-protective immunity for closely related HIV-1 strains, despite persistent recognition of multiple CD8 epitopes, has important implications for public health and vaccine development.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02129 USA; Harvard Univ, Sch Med, Div AIDS, Boston, MA 02129 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA; Nuffield Dept Med, Dept Pediat, Oxford OX3 7LJ, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Los Alamos National Laboratory; Duke University; University of Wisconsin System; University of Wisconsin Madison; University of Oxford	Walker, BD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Partners AIDS Res Ctr, Boston, MA 02129 USA.	bwalker@partners.org	Allen, Todd/F-5473-2011; Altfeld, Marcus/AAE-7306-2019	Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; o'connor, david/0000-0003-2139-470X; Brander, Christian/0000-0002-0548-5778; Korber, Bette/0000-0002-2026-5757				Allen TM, 2002, J VIROL, V76, P4108, DOI 10.1128/JVI.76.8.4108-4112.2002; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Altfeld MA, 2000, J VIROL, V74, P8541, DOI 10.1128/JVI.74.18.8541-8549.2000; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BRANDER C, 1999, HIV MOL DATABASE, pI1; DEL VM, 1991, CELL, V66, P1145; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Felsenstein J., 1989, PHYLIP PHYLOGENY INF; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; McCutchan FE, 2000, AIDS, V14, pS31; Montefiori DC, 2001, J VIROL, V75, P10200, DOI 10.1128/JVI.75.21.10200-10207.2001; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Yu XG, 2002, J VIROL, V76, P8690, DOI 10.1128/JVI.76.17.8690-8701.2002	27	256	268	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					434	439		10.1038/nature01200	http://dx.doi.org/10.1038/nature01200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459786				2022-12-24	WOS:000179494700044
J	Brown, P; Spalding, RE; ReVelle, DO; Tagliaferri, E; Worden, SP				Brown, P; Spalding, RE; ReVelle, DO; Tagliaferri, E; Worden, SP			The flux of small near-Earth objects colliding with the Earth	NATURE			English	Article							INFRASOUND; COLLISION; RADIATION; SATELLITE; IMPACTS; BOLIDES; ENTRY	Asteroids with diameters smaller than similar to50-100 m that collide with the Earth usually do not hit the ground as a single body; rather, they detonate in the atmosphere(1). These small objects can still cause considerable damage, such as occurred near Tunguska(2), Siberia, in 1908. The flux of small bodies is poorly constrained, however, in part because ground-based observational searches pursue strategies that lead them preferentially to find larger objects(3). ATunguska-class event - the energy of which we take to be equivalent to 10 megatons of TNT - was previously estimated to occur every 200 - 300 years, with the largest annual airburst calculated to be similar to20 kilotons (kton) TNT equivalent (ref. 4). Here we report satellite records of bolide detonations in the atmosphere over the past 8.5 years. We find that the flux of objects in the 1-10-m size range has the same power-law distribution as bodies with diameters > 50 m. From this we estimate that the Earth is hit on average annually by an object with similar to5 kton equivalent energy, and that Tunguska-like events occur about once every 1,000 years.	Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Sandia Natl Labs, Albuquerque, NM 87185 USA; ET Space Syst, Camarillo, CA 93012 USA; US Space Command, Directorate Operat, Peterson AFB, Colorado Springs, CO 80914 USA	Western University (University of Western Ontario); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; National Aeronautics & Space Administration (NASA)	Brown, P (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	pbrown@uwo.ca		Brown, Peter/0000-0001-6130-7039				Borovicka J, 1996, ICARUS, V121, P484, DOI 10.1006/icar.1996.0104; BOROVICKA J, UNPUB METEORIT PLANE; Britt DT, 2000, ICARUS, V146, P213, DOI 10.1006/icar.2000.6374; Brown P, 1996, METORIT PLANET SCI, V31, P502, DOI 10.1111/j.1945-5100.1996.tb02092.x; BROWN P, 2002, GEOPHYS RES LETT, V29, P1; Brown PG, 2002, METEORIT PLANET SCI, V37, P661, DOI 10.1111/j.1945-5100.2002.tb00846.x; Ceplecha Z, 1998, SPACE SCI REV, V84, P327, DOI 10.1023/A:1005069928850; Ceplecha Z, 1996, P SOC PHOTO-OPT INS, V2813, P46, DOI 10.1117/12.256072; Halliday I, 1996, METORIT PLANET SCI, V31, P185, DOI 10.1111/j.1945-5100.1996.tb02014.x; Harris AW, 1999, ICARUS, V142, P464, DOI 10.1006/icar.1999.6248; HARRIS AW, 2002, IN PRESS P AST COM M; Hills JG, 1998, PLANET SPACE SCI, V46, P219, DOI 10.1016/S0032-0633(97)00051-2; Levison HF, 2002, SCIENCE, V296, P2212, DOI 10.1126/science.1070226; MCCORD TB, 1995, J GEOPHYS RES-PLANET, V100, P3245, DOI 10.1029/94JE02802; Morbidelli A, 2002, ICARUS, V158, P329, DOI 10.1006/icar.2002.6887; MORRISON D, 1994, HAZARDS DUE COMETS A, P59; Nemtchinov IV, 1997, ICARUS, V130, P259, DOI 10.1006/icar.1997.5821; Rabinowitz D, 2000, NATURE, V403, P165, DOI 10.1038/35003128; ReVelle DO, 1998, P SOC PHOTO-OPT INS, V3434, P66, DOI 10.1117/12.331223; REVELLE DO, 1980, J GEOPHYS RES, V85, P1803, DOI 10.1029/JB085iB04p01803; Revelle DO, 1997, ANN NY ACAD SCI, V822, P284, DOI 10.1111/j.1749-6632.1997.tb48347.x; REVELLE DO, 2001, ESA, P483; REVELLE DO, 2001, EUROPEAN SPACE AGENC, P507; REVELLE DO, 2001, EUROPEAN SPACE AGENC, P513; Sekanina Z, 1998, PLANET SPACE SCI, V46, P191, DOI 10.1016/S0032-0633(96)00154-7; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; Stuart JS, 2001, SCIENCE, V294, P1691, DOI 10.1126/science.1065318; Tagliaferri E., 1998, HAZARDS DUE COMETS A, P199; Werner SC, 2002, ICARUS, V156, P287, DOI 10.1006/icar.2001.6789	29	308	316	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2002	420	6913					294	296		10.1038/nature01238	http://dx.doi.org/10.1038/nature01238			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447433				2022-12-24	WOS:000179340400035
J	Wang, A; Kurdistani, SK; Grunstein, M				Wang, A; Kurdistani, SK; Grunstein, M			Requirement of Hos2 histone deacetylase for gene activity in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REPRESSION; IN-VIVO; RPD3; ACETYLTRANSFERASE; ACETYLATION; COMPLEX; GENOME; UME6	Histone deacetylases, typified by class I Rpd3 in the yeast Saccharomyces cerevisiae, have historically been associated with gene repression. We now demonstrate that Hos2, another member of the class I family, binds to the coding regions of genes primarily during gene activation, when it specifically deacetylates the lysines in H3 and H4 histone tails. Moreover, Hos2 is preferentially associated with genes of high activity genome-wide. We also show that Hos2 and an associated factor, Set3, are necessary for efficient transcription. Therefore, our data indicate that, in contrast to other class I histone deacetylases, Hos2 is directly required for gene activation.	Univ Calif Los Angeles, UCLA Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Grunstein, M (corresponding author), Univ Calif Los Angeles, UCLA Sch Med, Dept Biol Chem, Boyer Hall, Los Angeles, CA 90095 USA.			Kurdistani, Siavash/0000-0003-3295-3511	NIGMS NIH HHS [GM23674] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023674, R37GM023674] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; TURI TG, 1992, J BIOL CHEM, V267, P2046; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang A. F., UNPUB; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; YARGER JG, 1984, MOL CELL BIOCHEM, V61, P173	20	203	209	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1412	1414		10.1126/science.1077790	http://dx.doi.org/10.1126/science.1077790			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434058				2022-12-24	WOS:000179223100049
J	Hung, J; Beilby, JP; Knuiman, MW; Divitini, M				Hung, J; Beilby, JP; Knuiman, MW; Divitini, M			Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; SERUM FOLATE; HOMOCYSTEINE; HEALTH; ATHEROSCLEROSIS; HOMOCYST(E)INE; DIET	Objective To test the hypothesis that the incidence of fatal coronary heart disease and cardiovascular disease in a general population is related to serum and red cell folate and vitamin B-12 concentrations. Design Cohort study with follow up of 29 years. Setting Busselton, Western Australia. Participants 1419 men and 1531 women aged 20 to 90 years, who were alive more than three years after their participation in the 1969 Busselton health survey. 2314 (78.4%) had no cardiovascular disease at the initial survey. Main outcome measures Hazard. ratios for fatal coronary heart disease and cardiovascular disease in men and women according to baseline concentrations of serum and red cell folate and serum vitamin B-12. Results 213 men and 159 women died from coronary heart disease, and 342 men and 302 women died from cardiovascular disease. Serum and red cell folate concentrations showed a moderate positive correlation (r=0.26, P<0.001) but other-wise serum and red cell folate and serum B-12 concentrations were not strongly correlated with each other or with other standard risk factors. After age and standard risk factors were adjusted for, there was no independent association between folate and B-12 concentrations and death from coronary heart disease or cardiovascular disease in the full cohort or the subcohort with no cardiovascular disease at baseline. The multivariate adjusted hazard ratio for death from cardiovascular disease in the lowest versus the highest category of red cell folate concentration was 1.05 (95% confidence interval 0.77 to 1.43) in men and 1.10 (0.81 to 1.51) in women. Conclusions These findings do not support the hypothesis that lower folate and B-12 concentrations increase the risk of fatal cardiovascular disease in a general population. The routine use of these vitamins for preventing cardiovascular disease should await evidence from clinical trials.	Univ Western Australia, Sir Charles Gairdner Hosp, Dept Cardiol, Nedlands, WA 6009, Australia; Univ Western Australia, Sir Charles Gairdner Hosp, Dept Med, Nedlands, WA 6009, Australia; QEII Med Ctr, PathCtr, Nedlands, WA 6009, Australia; Univ Western Australia, Dept Publ Hlth, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Hung, J (corresponding author), Univ Western Australia, Sir Charles Gairdner Hosp, Dept Cardiol, Nedlands, WA 6009, Australia.		Knuiman, Matthew W/I-5549-2013	Knuiman, Matthew/0000-0001-8874-2305; Beilby, John/0000-0002-4915-2254				BABIOR BM, 2001, WILLIAMS HEMATOLOGY, P425; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; ChasanTaber L, 1996, J AM COLL NUTR, V15, P136; Clarke R, 1998, J Cardiovasc Risk, V5, P249, DOI 10.1097/00043798-199808000-00007; CULLEN KJ, 1972, MED J AUSTRALIA, V2, P714, DOI 10.5694/j.1326-5377.1972.tb103506.x; Davis R. E., 1979, Proceedings of the Nutrition Society of Australia, V4, P45; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Ford ES, 1998, INT J EPIDEMIOL, V27, P592, DOI 10.1093/ije/27.4.592; Knuiman M W, 1996, J Cardiovasc Risk, V3, P447; KNUIMAN MW, 1995, AUST J PUBLIC HEALTH, V19, P375; Knuiman MW, 1998, AUST NZ J PUBL HEAL, V22, P747, DOI 10.1111/j.1467-842X.1998.tb01487.x; Knuiman MW, 1997, J EPIDEMIOL COMMUN H, V51, P515, DOI 10.1136/jech.51.5.515; Lonn E, 2001, J AM COLL CARDIOL, V38, P1795, DOI 10.1016/S0735-1097(01)01626-6; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; MILLBANK L, 1970, J CLIN PATHOL, V23, P54, DOI 10.1136/jcp.23.1.54; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; UBBINK JB, 1994, NUTR REV, V52, P383, DOI 10.1111/j.1753-4887.1994.tb01369.x; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; WELBORN TA, 1969, AM J EPIDEMIOL, V89, P521, DOI 10.1093/oxfordjournals.aje.a120965	23	39	40	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					131	134		10.1136/bmj.326.7381.131	http://dx.doi.org/10.1136/bmj.326.7381.131			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531843	Bronze, Green Published			2022-12-24	WOS:000180575900022
J	Reilly, SM; White, TD				Reilly, SM; White, TD			Hypaxial motor patterns and the function of epipubic bones in primitive mammals	SCIENCE			English	Article							LOCOMOTION; MUSCLES; WALKING	Since the first description of epipubic bones in 1698, their functions and those of the associated abdominal muscles of monotremes and marsupial mammals have remained unresolved. We show that each epipubic bone is part of a kinetic linkage extending from the femur, by way of the pectineus muscle, to the epipubic bone, through the pyramidalis and rectus abdominis muscles on one side of the abdomen, and through the contralateral external and internal oblique muscles to the vertebrae and ribs of the opposite side. This muscle series is activated synchronously as the femur and contralateral forelimb are retracted during the stance phase in locomotion. The epipubic bone acts as a lever that is retracted ( depressed) to stiffen the trunk between the diagonal limbs that support the body during each step. This cross-couplet kinetic linkage and the stiffening function of the epipubic bone appear to be the primitive conditions for mammals.	Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA	University System of Ohio; Ohio University; State University of New York (SUNY) System; Buffalo State College	Reilly, SM (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	reilly@ohiou.edu						Bennett WO, 2001, J EXP BIOL, V204, P1979; CARRIER D, 1990, J EXP BIOL, V152, P453; CARRIER DR, 1993, J EXP BIOL, V180, P75; Fife MM, 2001, J EXP BIOL, V204, P2371; FOURIE S, 1963, NATURE, V198, P201, DOI 10.1038/198201a0; Gambaryan P.P., 1974, MAMMALS RUN ANATOMIC; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; JENKINS FA, 1970, EVOLUTION, V24, P230, DOI 10.1111/j.1558-5646.1970.tb01756.x; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; OWEN R, 1943, P ZOOL SOC LOND 1843, P148; Reilly SM, 1998, BRAIN BEHAV EVOLUT, V52, P126, DOI 10.1159/000006557; Ritter D, 1996, J EXP BIOL, V199, P2499; Tyson, 1698, PHIL T R SOC, V239, P105, DOI [10.1098/rstl.1698.0023, DOI 10.1098/RSTL.1698.0023]; VAUGHN PETER PAUL, 1956, JOUR ELISHA MITCHELL SCI SOC, V72, P243; WHITE TD, 1989, J THEOR BIOL, V139, P343, DOI 10.1016/S0022-5193(89)80213-9; WHITE TD, 1990, J MAMMAL, V71, P79, DOI 10.2307/1381321	17	25	27	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					400	402		10.1126/science.1074905	http://dx.doi.org/10.1126/science.1074905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532019				2022-12-24	WOS:000180426800047
J	Mahadevia, PJ; Fleisher, LA; Fric, KD; Eng, J; Goodman, SN; Powe, NR				Mahadevia, PJ; Fleisher, LA; Fric, KD; Eng, J; Goodman, SN; Powe, NR			Lung, cancer screening with helical computed tomography in older adult smokers - A decision and cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKING CESSATION; ACTION PROJECT; SURVIVAL; ASPIRATION; SURGERY; UTILITY; PROGRAM; SCANNER; STATES; BIOPSY	Context Encouraged by direct-to-consumer marketing, smokers and-their physicians are contemplating lung cancer screening with a promising but unproven imaging procedure, helical computed tomography (CT). Objective To estimate the potential benefits, harms, and cost-effectiveness of lung cancer screening with helical CT in various efficacy scenarios. Design, Setting, and Population Using a computer-simulated model, we compared annual helical CT screening to no screening for hypothetical cohorts of 100000 current, quitting, and former heavy smokers, aged 60 years, of whom 55% were men. We simulated efficacy by changing the clinical stage distribution of lung cancers so that the screened group would have fewer advanced-stage cancers and more localized-stage cancers than the nonscreened group (ie, a stage shift). Our model incorporated known biases in screening programs such as lead time, length, and overdiagnosis bias. Main Outcome Measures We measured the benefits of screening by comparing the absolute and relative difference in lung cancer-specific deaths. We measured harms by the number of false-positive invasive tests or surgeries per 100000 and incremental cost-effectiveness in US dollars per quality-adjusted life-year (QALY) gained. Results Over a 20-year period, assuming a 50% stage shift, the current heavy smoker cohort had 553 fewer lung cancer deaths (13% lung cancer-specific mortality reduction) and 1186 false-positive invasive procedures per 100000 persons. The incremental cost-effectiveness for current smokers was $116300 per QALY gained. For quitting and former smokers, the incremental cost-effectiveness was $558600 and $2322700 per QALY gained, respectively. Other than the degree of stage shift, the most influentia parameters were adherence to screening, degree of length or overdiagnosis bias in the first year of screening, quality of life of persons with screen-detected localized lung cancers, cost of helical CT, and anxiety about indeterminate nodule diagnoses. In 1-way sensitivity analyses, none of these parameters was sufficient to make screening highly cost-effective for any of the cohorts. In multiway sensitivity analyses, a program screening current smokers was $42 500 per QALY gained if extremely favorable estimates were used for all of the influential parameters simultaneously. Conclusion Even if efficacy is eventually proven, screening must overcome multiple additional barriers to be highly cost-effective. Given the current uncertainty of benefits, the harms from invasive testing, and the high costs associated with screening, direct-to-consumer marketing of helical CT is not advisable.	Johns Hopkins Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; MEDTAP Int, Bethesda, MD 20814 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Mahadevia, PJ (corresponding author), MEDTAP Int, 7101 Wisconsin Ave, Bethesda, MD 20814 USA.		Lee A, Fleisher/Q-9894-2019	Goodman, Steven/0000-0002-3872-5723; Frick, Kevin/0000-0002-0178-5319				*AM MED ASS, 1998, 1998 NAT PHYS FREE S; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; BRICE J, 2000, DIAGN IMAGING SAN FR, V22, P44; Burns DM, 2000, CANCER, V89, P2506, DOI 10.1002/1097-0142(20001201)89:11+<2506::AID-CNCR33>3.3.CO;2-#; Celik M, 1998, EUR J CARDIO-THORAC, V14, P113, DOI 10.1016/S1010-7940(98)00167-5; DECAMP MM, 1995, J AM COLL SURGEONS, V181, P113; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; EDDY DM, 1990, ANN INTERN MED, V112, P73, DOI 10.7326/0003-4819-112-1-73; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Fry WA, 1999, CANCER, V86, P1867, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9; Grannis FW, 2002, CHEST, V121, P1388, DOI 10.1378/chest.121.5.1388; Gurley MB, 1998, RADIOLOGY, V209, P717, DOI 10.1148/radiology.209.3.9844664; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 2000, RADIOL CLIN N AM, V38, P487, DOI 10.1016/S0033-8389(05)70179-2; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hillner BE, 1996, SEMIN ONCOL, V23, P25; HULKA BS, 1986, J OCCUP ENVIRON MED, V28, P687, DOI 10.1097/00043764-198608000-00030; Jaklitsch MT, 1996, CHEST, V110, P751, DOI 10.1378/chest.110.3.751; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; KOLATA G, 2001, NY TIMES        0720, pA1; KUBIK A, 1990, INT J CANCER, V45, P26, DOI 10.1002/ijc.2910450107; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; LERNER BH, 2002, NY TIMES        0305, pD6; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; MELAMED MR, 1987, SURG CLIN N AM, V67, P909; *NAT ALL CAR AM AS, 2001, CAR US FIND NAT SURV; *NAT CANC I, 2001, DEVC PROB DEV DYING; *NAT CANC I, 2001, SURV EP END RES SEER; *NAT CANC I AM CAN, 2001, EARL LUNG CANC SCREE; Palmisano WA, 2000, CANCER RES, V60, P5954; Patz EF, 2000, NEW ENGL J MED, V343, P1627, DOI 10.1056/NEJM200011303432208; Patz EF, 2000, CHEST, V117, P1568, DOI 10.1378/chest.117.6.1568; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; SAGEL SS, 1978, ANN THORAC SURG, V26, P399, DOI 10.1016/S0003-4975(10)62917-7; SHAH SS, 1992, RESPIRATION, V59, P243; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; *THOMS HEALTHC, 2001, RED BOOK DRUG TOP 20; TOCKMAN MS, 1986, CHEST S, V89, P324; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; *TREEAG INC, 2002, DAT PRO COMP PROGR V; Trippoli S, 2001, PHARMACOECONOMICS, V19, P855, DOI 10.2165/00019053-200119080-00007; WALTER SD, 1992, CANCER CAUSE CONTROL, V3, P115, DOI 10.1007/BF00051651; 2000, ONCOL NEWS INT, V9, P1	50	248	252	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					313	322		10.1001/jama.289.3.313	http://dx.doi.org/10.1001/jama.289.3.313			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525232	Bronze			2022-12-24	WOS:000180345100026
J	Nikolaev, AY; Li, MY; Puskas, N; Qin, J; Gu, W				Nikolaev, AY; Li, MY; Puskas, N; Qin, J; Gu, W			Parc: A cytoplasmic anchor for p53	CELL			English	Article							WILD-TYPE P53; NUCLEAR EXPORT SIGNAL; TUMOR-SUPPRESSOR P53; RING-FINGER DOMAIN; COLORECTAL ADENOCARCINOMA; MDM2-MEDIATED DEGRADATION; DNA-DAMAGE; PROTEIN; MDM2; UBIQUITINATION	Nuclear localization of p53 is essential for its tumor suppressor function. Here, we have identified Parc, a Parkin-like ubiquitin ligase, as a cytoplasmic anchor protein in p53-associated protein complexes. Parc directly interacts and forms a similar to1 MDa complex with p53 in the cytoplasm of unstressed cells. In the absence of stress, inactivation of Parc induces nuclear localization of endogenous p53 and activates p53-dependent apoptosis. Overexpression of Parc promotes cytoplasmic sequestration of ectopic p53. Furthermore, abnormal cytoplasmic localization of p53 was observed in a number of neuroblastoma cell lines; RNAi-mediated reduction of endogenous Parc significantly sensitizes these neuroblastoma cells in the DNA damage response. These results reveal that Parc is a critical regulator in controlling p53 subcellular localization and subsequent function.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.			Nikolaev, Anatoly/0000-0003-2818-5839				BOSARI S, 1995, AM J PATHOL, V147, P790; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elela Sherif Abou, 1997, Cancer Letters, V117, P23; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; GANNON JV, 1991, NATURE, V349, P802; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Metcalfe S, 1999, ONCOGENE, V18, P2351, DOI 10.1038/sj.onc.1202559; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	47	308	325	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					29	40		10.1016/S0092-8674(02)01255-2	http://dx.doi.org/10.1016/S0092-8674(02)01255-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526791	Bronze			2022-12-24	WOS:000181191500004
J	Check, E				Check, E			Biologists seek blueprint for international stem-cell effort	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102b	http://dx.doi.org/10.1038/421102b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520271	Bronze			2022-12-24	WOS:000180267200009
J	Mukamal, KJ; Conigrave, KM; Mittleman, MA; Camargo, CAJ; Stampfer, MJ; Willett, WC; Rimm, EB				Mukamal, KJ; Conigrave, KM; Mittleman, MA; Camargo, CAJ; Stampfer, MJ; Willett, WC; Rimm, EB			Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; REGULAR DRINKERS; CONTROLLED TRIAL; BRITISH MEN; CONSUMPTION; RISK; WINE; BEER; MORTALITY	BACKGROUND: Although moderate drinking confers a decreased risk of myocardial infarction, the roles of the drinking pattern and type of beverage remain unclear. METHODS: We studied the association of alcohol consumption with the risk of myocardial infarction among 38,077 male health professionals who were free of cardiovascular disease and cancer at base line. We assessed the consumption of beer, red wine, white wine, and liquor individually every four years using validated food-frequency questionnaires. We documented cases of nonfatal myocardial infarction and fatal coronary heart disease from 1986 to 1998. RESULTS: During 12 years of follow-up, there were 1418 cases of myocardial infarction. As compared with men who consumed alcohol less than once per week, men who consumed alcohol three to four or five to seven days per week had decreased risks of myocardial infarction (multivariate relative risk, 0.68 [95 percent confidence interval, 0.55 to 0.84] and 0.63 [95 percent confidence interval, 0.54 to 0.74], respectively). The risk was similar among men who consumed less than 10 g of alcohol per drinking day and those who consumed 30 g or more. No single type of beverage conferred additional benefit, nor did consumption with meals. A 12.5-g increase in daily alcohol consumption over a four-year follow-up period was associated with a relative risk of myocardial infarction of 0.78 (95 percent confidence interval, 0.62 to 0.99). CONCLUSIONS: Among men, consumption of alcohol at least three to four days per week was inversely associated with the risk of myocardial infarction. Neither the type of beverage nor the proportion consumed with meals substantially altered this association. Men who increased their alcohol consumption by a moderate amount during follow-up had a decreased risk of myocardial infarction.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Sydney; University of Sydney; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY-303, Boston, MA 02215 USA.		Camargo, Carlos A./C-2145-2008; Mukamal, Kenneth/GVR-7978-2022	Camargo, Carlos A./0000-0002-5071-7654; Mittleman, Murray/0000-0001-9788-7274; Conigrave, Katherine/0000-0002-6428-1441	NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA11181, AA00299] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABE H, 1994, CIRCULATION, V89, P2626, DOI 10.1161/01.CIR.89.6.2626; *AM CANC SOC, 2002, ALC CANC; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; [Department of Agriculture US Department of Health and Human Services], 2000, HOM GARD B, V232; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; GABH Rose, 1982, WHO MONOGRAPH SERIES; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GOLDBERG RJ, 1994, CIRCULATION, V89, P651, DOI 10.1161/01.CIR.89.2.651; GRUCHOW HW, 1982, ATHEROSCLEROSIS, V43, P393, DOI 10.1016/0021-9150(82)90038-7; JACKSON R, 1992, AM J EPIDEMIOL, V136, P819, DOI 10.1093/aje/136.7.819; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; MIKHAILIDIS DP, 1990, ALCOHOL, V7, P171, DOI 10.1016/0741-8329(90)90080-V; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; *NUTR DAT LAB, 1999, USDA NUTR DAT STAND; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Rehm J, 2001, AM J EPIDEMIOL, V153, P64, DOI 10.1093/aje/153.1.64; RENAUD SC, 1992, AM J CLIN NUTR, V55, P1012, DOI 10.1093/ajcn/55.5.1012; Rimm E, 2001, EPIDEMIOLOGY, V12, P380, DOI 10.1097/00001648-200107000-00006; Rimm EB, 1996, AM J EPIDEMIOL, V143, P1094; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Sesso HD, 2000, ARCH INTERN MED, V160, P2605, DOI 10.1001/archinte.160.17.2605; SHAPER AG, 1988, LANCET, V2, P1267; SHAPER AG, 1987, BMJ-BRIT MED J, V294, P733, DOI 10.1136/bmj.294.6574.733; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TASKINEN MR, 1985, METABOLISM, V34, P112, DOI 10.1016/0026-0495(85)90118-0; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59; Wannamethee SG, 2002, HEART, V87, P32, DOI 10.1136/heart.87.1.32; Wouters S, 2000, AM J EPIDEMIOL, V151, P1189, DOI 10.1093/oxfordjournals.aje.a010169	37	566	590	0	52	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					109	118		10.1056/NEJMoa022095	http://dx.doi.org/10.1056/NEJMoa022095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519921				2022-12-24	WOS:000180263900003
J	Nakano, H; Hibino, T; Oji, T; Hara, Y; Amemiya, S				Nakano, H; Hibino, T; Oji, T; Hara, Y; Amemiya, S			Larval stages of a living sea lily (stalked crinoid echinoderm)	NATURE			English	Article							RADIATION	The embryos and larvae of stalked crinoids, which are considered the most basal group of extant echinoderms(1,2), have not previously been described. In contrast, much is known about the development of the more accessible stalkless crinoids (feather stars)(3), which are phylogenetically derived from stalked forms(4). Here we describe the development of a sea lily from fertilization to larval settlement. There are two successive larval stages: the first is a non-feeding auricularia stage with partly longitudinal ciliary bands (similar to the auricularia and bipinnaria larvae of holothurian and asteroid echinoderms, respectively); the second is a doliolaria larva with circumferential ciliary bands (similar to the earliest larval stage of stalkless crinoids). We suggest that a dipleurula-type larva is primitive for echinoderms and is the starting point for the evolution of additional larval forms within the phylum. From a wider evolutionary viewpoint, the demonstration that the most basal kind of echinoderm larva is a dipleurula is consistent with Garstang's auricularia theory(5) for the phylogenetic origin of the chordate neural tube.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Amemiya, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bldg FSB-501,5-1-5 Kashiwanoha, Chiba 2778562, Japan.		拓, 日比野/D-8115-2013; Oji, Tatsuo/A-1840-2009	拓, 日比野/0000-0002-4789-7375; Oji, Tatsuo/0000-0002-1034-1111				Foote M, 1999, PALEOBIOLOGY, V25, P1, DOI 10.1666/0094-8373(1999)25[1:MDITER]2.0.CO;2; GARSTANG W, 1894, ZOOL ANT, V17, P122; Gee C. H. R., COMMUNICATION; HENDLER G, 1991, REPRODUCTION MARINE, V6, P355; Holland N. D, 1991, REPROD MARINE INVERT, V4, P247; Hyman L.H., 1955, INVERTEBRATES, V4; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; LACALLI TC, 1986, J EMBRYOL EXP MORPH, V96, P303; Metschnikoff E, 1881, ZOOL ANZ, V4, p[139, 153]; Nielsen C., 1995, ANIMAL EVOLUTION; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Smiley S., 1991, P663; Strathmann R., 1974, Thalassia Jugosl, V10, P321	13	86	89	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					158	160		10.1038/nature01236	http://dx.doi.org/10.1038/nature01236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520300				2022-12-24	WOS:000180267200038
J	Shingo, T; Gregg, C; Enwere, E; Fujikawa, H; Hassam, R; Geary, C; Cross, JC; Weiss, S				Shingo, T; Gregg, C; Enwere, E; Fujikawa, H; Hassam, R; Geary, C; Cross, JC; Weiss, S			Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin	SCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN FOREBRAIN; MATERNAL-BEHAVIOR; NULL MUTATION; INSECT BRAIN; RECEPTOR; MOUSE; MECHANISMS; RAT	Neurogenesis occurs in the olfactory system of the adult brain throughout life, in both invertebrates and vertebrates, but its physiological regulation is not understood. We show that the production of neuronal progenitors is stimulated in the forebrain subventricular zone of female mice during pregnancy and that this effect is mediated by the hormone prolactin. The progenitors then migrate to produce new olfactory interneurons, a process likely to be important for maternal behavior, because olfactory discrimination is critical for recognition and rearing of offspring. Neurogenesis occurs even in females that mate with sterile males. These findings imply that forebrain olfactory neurogenesis may contribute to adaptive behaviors in mating and pregnancy.	Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Weiss, S (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada.	weiss@ucalgary.ca	Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BARKLEY MS, 1978, BIOL REPROD, V19, P291, DOI 10.1095/biolreprod19.2.291; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Bridges RS, 2001, ENDOCRINOLOGY, V142, P730, DOI 10.1210/en.142.2.730; CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0; Cayre M, 2002, COMP BIOCHEM PHYS B, V132, P1, DOI 10.1016/S1096-4959(01)00525-5; DIAZRUIZ C, 1993, NEUROSCI LETT, V164, P44, DOI 10.1016/0304-3940(93)90853-D; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Exton MS, 2001, PSYCHONEUROENDOCRINO, V26, P287, DOI 10.1016/S0306-4530(00)00053-6; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Harzsch S, 1999, J NEUROSCI, V19, P3472; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hull KL, 1998, COMP BIOCHEM PHYS C, V119, P389, DOI 10.1016/S0742-8413(98)00010-3; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Kruger THC, 2002, NEUROSCI BIOBEHAV R, V26, P31, DOI 10.1016/S0149-7634(01)00036-7; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Neville MC, 2001, PEDIATR CLIN N AM, V48, P35, DOI 10.1016/S0031-3955(05)70284-4; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roky R, 1996, NEUROENDOCRINOLOGY, V63, P422, DOI 10.1159/000127067; Schmidt M, 1997, BRAIN RES, V762, P131, DOI 10.1016/S0006-8993(97)00376-4; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001	43	522	543	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					117	120		10.1126/science.1076647	http://dx.doi.org/10.1126/science.1076647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511652				2022-12-24	WOS:000180165800048
J	Shin, BS; Maag, D; Roll-Mecak, A; Arefin, MS; Burley, SK; Lorsch, JR; Dever, TE				Shin, BS; Maag, D; Roll-Mecak, A; Arefin, MS; Burley, SK; Lorsch, JR; Dever, TE			Uncoupling of initiation factor eIF5B/IF2 GTPase and translational activities by mutations that lower ribosome affinity	CELL			English	Article							ELONGATION-FACTOR G; TRANSFER-RNA; LATE EVENTS; FACTOR IF2; BINDING; HYDROLYSIS; VISUALIZATION; MECHANISM; SUBUNITS; SWITCH	Translation initiation factor eIF5B/IF2 is a GTPase that promotes ribosomal subunit joining. We show that eIF5B mutations in Switch I, an element conserved in all GTP binding domains, impair GTP hydrolysis and general translation but not eIF5B subunit joining function. Intragenic suppressors of the Switch I mutation restore general translation, but not eIF5B GTPase activity. These suppressor mutations reduce the ribosome affinity of eIF5B and increase AUG skipping/leaky scanning. The uncoupling of translation and eIF5B GTPase activity suggests a regulatory rather than mechanical function for eIF5B GTP hydrolysis in translation initiation. The translational defect suggests eIF5B stabilizes Met-tRNAi(Met) binding and that GTP hydrolysis by eIF5B is a checkpoint monitoring 80S ribosome assembly in the final step of translation initiation.	NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Dever, TE (corresponding author), NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@box-t.nih.gov	Dever, Thomas/GSE-0966-2022	Lorsch, Jon/0000-0002-4521-4999; Roll-Mecak, Antonina/0000-0003-2621-7307; Dever, Thomas/0000-0001-7120-9678; Burley, Stephen K./0000-0002-2487-9713	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061262, R01GM062128] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62128, GM61262] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Choi SK, 2000, MOL CELL BIOL, V20, P7183, DOI 10.1128/MCB.20.19.7183-7191.2000; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LaTeana A, 1996, J MOL BIOL, V256, P667; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	33	96	98	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					1015	1025		10.1016/S0092-8674(02)01171-6	http://dx.doi.org/10.1016/S0092-8674(02)01171-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507428	Bronze			2022-12-24	WOS:000180086000011
J	Unhavaithaya, Y; Shin, TH; Miliaras, N; Lee, J; Oyama, T; Mello, CC				Unhavaithaya, Y; Shin, TH; Miliaras, N; Lee, J; Oyama, T; Mello, CC			MEP-1 and a homolog of the NURD complex component Mi-2 act together to maintain germline-soma distinctions in C-elegans	CELL			English	Article							ZYGOTIC GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; POLYCOMB GROUP; HISTONE DEACETYLASE; RNA INTERFERENCE; MATERNAL CONTROL; PROTEIN; LINE; PIE-1; MES-3	A rapid cascade of regulatory events defines the developmental fates of embryonic cells. However, once established, these developmental fates and the underlying transcriptional programs can be remarkably stable. Here, we describe two proteins, MEP-1 and LET-418/Mi-2, required for maintenance of somatic differentiation in C. elegans. In animals lacking MEP-1 and LET-418, germline-specific genes become derepressed in somatic cells, and Polycomb group (PcG) and SET domain-related proteins promote this ectopic expression. MEP-1 and LET-418 interact in vivo with the germline-protein PIE-1. Our findings support a model in which PIE-1 inhibits MEP-1 and associated factors to maintain the pluripotency of germ cells, while at later times MEP-1 and LET-418 remodel chromatin to establish new stage- or cell-type-specific differentiation potential.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Baylor College of Medicine	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu		/0000-0001-7230-1767	NICHD NIH HHS [HD33769, HD36247] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033769, R01HD036247] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Belfiore M, 2002, RNA, V8, P725, DOI 10.1017/S1355838202028595; BOWERMAN B, 1993, CELL, V74, P443, DOI 10.1016/0092-8674(93)80046-H; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; DEMBURG AF, 2002, CELL, V111, P159; EPSTEIN RJ, 1988, CYTOMETRY, V9, P349, DOI 10.1002/cyto.990090412; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Garvin C, 1998, GENETICS, V148, P167; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Holdeman R, 1998, DEVELOPMENT, V125, P2457; James P, 1996, GENETICS, V144, P1425; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kelly WG, 2002, DEVELOPMENT, V129, P479; Korf I, 1998, DEVELOPMENT, V125, P2469; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; Lukacsovich T, 2001, GENETICS, V157, P727; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; PAULSEN JE, 1995, GENETICS, V141, P1383; Pirrotta V, 2002, CELL, V110, P661, DOI 10.1016/S0092-8674(02)00967-4; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1996, NUCLEIC ACIDS RES, V24, P2119, DOI 10.1093/nar/24.11.2119; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Van Doren M, 1998, CURR BIOL, V8, P243; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xu L, 2001, GENETICS, V159, P1019; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	44	148	178	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					991	1002		10.1016/S0092-8674(02)01202-3	http://dx.doi.org/10.1016/S0092-8674(02)01202-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507426	Bronze			2022-12-24	WOS:000180086000009
J	Lin, JM; Kilman, VL; Keegan, K; Paddock, B; Emery-Le, M; Rosbash, M; Allada, R				Lin, JM; Kilman, VL; Keegan, K; Paddock, B; Emery-Le, M; Rosbash, M; Allada, R			A role for casein kinase 2 alpha in the Drosophila circadian clock	NATURE			English	Article							NERVOUS-SYSTEM; DOUBLE-TIME; DNA-DAMAGE; PROTEIN; GENE; PERIOD; CK2; MELANOGASTER; RHYTHMS; NEUROPEPTIDE	Circadian clocks drive rhythmic behaviour in animals and are regulated by transcriptional feedback loops(1,2). For example, the Drosophila proteins Clock (Clk) and Cycle (Cyc) activate transcription of period (per) and timeless (tim). Per and Tim then associate, translocate to the nucleus, and repress the activity of Clk and Cyc. However, post-translational modifications are also critical to proper timing. Per and Timundergo rhythmic changes in phosphorylation(1), and evidence supports roles for two kinases in this process: Doubletime (Dbt) phosphorylates Per(3,4), whereas Shaggy (Sgg) phosphorylates Tim(5). Yet Sgg and Dbt often require a phosphoserine in their target site(6,7), and analysis of Per phosphorylation in dbt mutants(3,8) suggests a role for other kinases. Here we show that the catalytic subunit of Drosophila casein kinase 2 (CK2alpha) is expressed predominantly in the cytoplasm of key circadian pacemaker neurons. CK2alpha mutant flies show lengthened circadian period, decreased CK2 activity, and delayed nuclear entry of Per. These effects are probably direct, as CK2alpha specifically phosphorylates Per in vitro. We propose that CK2 is an evolutionary link between the divergent circadian systems of animals, plants and fungi.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Dept Pathol, Evanston, IL 60208 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	Northwestern University; Northwestern University; Brandeis University; Howard Hughes Medical Institute	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.							Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chen B, 1998, GENETICS, V149, P157; DAHMUS GK, 1984, J BIOL CHEM, V259, P9001; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; GOUELI BS, 1995, ANAL BIOCHEM, V225, P10, DOI 10.1006/abio.1995.1100; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Kaneko M, 1997, J NEUROSCI, V17, P6745; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Niefind K, 1998, EMBO J, V17, P2451, DOI 10.1093/emboj/17.9.2451; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RENN SC, 2000, CELL, V101, P113; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Suri V, 2000, J NEUROSCI, V20, P7547; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	29	293	300	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					816	820		10.1038/nature01235	http://dx.doi.org/10.1038/nature01235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12447397				2022-12-24	WOS:000179897300057
J	Reader, JS; Joyce, GF				Reader, JS; Joyce, GF			A ribozyme composed of only two different nucleotides	NATURE			English	Article							RNA; CYTIDINE; DNA	RNA molecules are thought to have been prominent in the early history of life on Earth because of their ability both to encode genetic information and to exhibit catalytic function(1). The modern genetic alphabet relies on two sets of complementary base pairs to store genetic information. However, owing to the chemical instability of cytosine, which readily deaminates to uracil(2), a primitive genetic system composed of the bases A, U, G and C may have been difficult to establish. It has been suggested that the first genetic material instead contained only a single base-pairing unit(3-7). Here we show that binary informational macromolecules, containing only two different nucleotide sub-units, can act as catalysts. In vitro evolution was used to obtain ligase ribozymes composed of only 2,6-diaminopurine and uracil nucleotides, which catalyse the template-directed joining of two RNA molecules, one bearing a 5'-triphosphate and the other a 3'-hydroxyl. The active conformation of the fastest isolated ribozyme had a catalytic rate that was about 36,000-fold faster than the uncatalysed rate of reaction. This ribozyme is specific for the formation of biologically relevant 3',5'-phosphodiester linkages.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Joyce, GF (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gjoyce@scripps.edu						Atkins J.F, 1999, RNA WORLD; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Joyce GF, 1997, SCIENCE, V276, P1658, DOI 10.1126/science.276.5319.1658; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; McGinness KE, 2002, CHEM BIOL, V9, P585, DOI 10.1016/S1074-5521(02)00136-9; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; ORO J, 1961, NATURE, V191, P1193, DOI 10.1038/1911193a0; Plaxco KW, 1998, CURR OPIN STRUC BIOL, V8, P80, DOI 10.1016/S0959-440X(98)80013-4; Rich A., 1962, HORIZONS BIOCH, P103; Rogers J, 1999, NATURE, V402, P323, DOI 10.1038/46335; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; SANCHEZ RA, 1968, J MOL BIOL, V38, P121, DOI 10.1016/0022-2836(68)90132-0; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; WACHTERSHAUSER G, 1988, P NATL ACAD SCI USA, V85, P1134, DOI 10.1073/pnas.85.4.1134; ZUBAY G, 1991, CHEMTRACTS, V2, P439	19	69	75	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					841	844		10.1038/nature01185	http://dx.doi.org/10.1038/nature01185			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490955				2022-12-24	WOS:000179897300063
J	Starai, VJ; Celic, I; Cole, RN; Boeke, JD; Escalante-Semerena, JC				Starai, VJ; Celic, I; Cole, RN; Boeke, JD; Escalante-Semerena, JC			Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM LT2; LIFE-SPAN; SIR2; GENE	Acetyl-coenzyme A (CoA) synthetase (Acs) is an enzyme central to metabolism in prokaryotes and eukaryotes. Acs synthesizes acetyl CoA from acetate, adenosine triphosphate, and CoA through an acetyl-adenosine monophosphate (AMP) intermediate. Immunoblotting and mass spectrometry analysis showed that Salmonella enterica Acs enzyme activity is posttranslationally regulated by acetylation of lysine-609. Acetylation blocks synthesis of the adenylate intermediate but does not affect the thioester-forming activity of the enzyme. Activation of the acetylated enzyme requires the nicotinamide adenine dinucleotide-dependent protein deacetylase activity of the CobB Sir2 protein from S. enterica. We propose that acetylation modulates the activity of all the AMP-forming family of enzymes, including nonribosomal peptide synthetases, luciferase, and aryl- and acyl-CoA synthetases. These findings extend our knowledge of the roles of Sir2 proteins in gene silencing, chromosome stability, and cell aging and imply that lysine acetylation is a common regulatory mechanism in eukaryotes and prokaryotes.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; Johns Hopkins University	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	escalante@bact.wisc.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062385, R01GM062203] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10-RR14702] Funding Source: Medline; NIGMS NIH HHS [GM62203, GM62385, R01 GM062203] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; BERG P, 1956, J BIOL CHEM, V222, P991; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; LEE Y, 1981, BIOCHEMISTRY-US, V20, P1253, DOI 10.1021/bi00508a031; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; STARAI VJ, IN PRESS GENETICS; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang AW, 1996, J BACTERIOL, V178, P7016, DOI 10.1128/jb.178.23.7016-7019.1996	15	445	468	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2390	2392		10.1126/science.1077650	http://dx.doi.org/10.1126/science.1077650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493915				2022-12-24	WOS:000179915900057
J	Zhu, J; Nathan, C; Jin, WW; Sim, D; Ashcroft, GS; Wahl, SM; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Wright, CD; Ding, AH				Zhu, J; Nathan, C; Jin, WW; Sim, D; Ashcroft, GS; Wahl, SM; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Wright, CD; Ding, AH			Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair	CELL			English	Article							LEUKOCYTE PROTEASE INHIBITOR; SECRETORY LEUKOPROTEASE INHIBITOR; PROTEINASE-INHIBITOR; HUMAN-NEUTROPHILS; EPITHELIN/GRANULIN PRECURSOR; BACTERIAL LIPOPOLYSACCHARIDE; GRANULIN/EPITHELIN PRECURSOR; 2-HYBRID SYSTEM; GENE-EXPRESSION; GROWTH-FACTORS	Increased leukocyte elastase activity in mice lacking secretory leukocyte protease inhibitor (SLPI) leads to impaired wound healing due to enhanced activity of TGFbeta and perhaps additional mechanisms. Proepithelin (PEPI), an epithelial growth factor, can be converted to epithelins (EPIs) in vivo by unknown mechanisms with unknown consequences. We found that PEPI and EPIs exert opposing activities. EPIs inhibit the growth of epithelial cells but induce them to secrete the neutrophil attractant IL-8, while PEPI blocks neutrophil activation by tumor necrosis factor, preventing release of oxidants and proteases. SLPI and PEPI form complexes, preventing elastase from converting PEPI to EPIs. Supplying PEPI corrects the wound-healing defect in SLPI null mice. Thus, SLPI/elastase act via PEPI/EPIs to operate a switch at the interface between innate immunity and wound healing.	Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Program Pharmacol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Program Immunol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Program Mol Biol, Weill Grad Sch Med Sci, New York, NY 10021 USA; NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Cornell University; Cornell University; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Memorial Sloan Kettering Cancer Center; Amgen	Ding, AH (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA.			Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIAID NIH HHS [AI46382] Funding Source: Medline; NIGMS NIH HHS [GM61710] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000691, Z01DE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE T, 1991, J CLIN INVEST, V87, P2207, DOI 10.1172/JCI115255; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Avrova AO, 1999, MOL PLANT MICROBE IN, V12, P1114, DOI 10.1094/MPMI.1999.12.12.1114; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BELCOURT DR, 1993, J BIOL CHEM, V268, P9230; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; CARP H, 1980, EXP LUNG RES, V1, P225, DOI 10.3109/01902148009065462; CAUGHEY GH, 1994, AM J RESP CRIT CARE, V150, P138; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COUTO MA, 1992, INFECT IMMUN, V60, P3065, DOI 10.1128/IAI.60.8.3065-3071.1992; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; FUORTES M, 1993, J CELL BIOL, V120, P777, DOI 10.1083/jcb.120.3.777; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Grobmyer SR, 2000, CRIT CARE MED, V28, P1276, DOI 10.1097/00003246-200005000-00003; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; He ZH, 1999, CANCER RES, V59, P3222; HELMIG R, 1995, EUR J OBSTET GYN R B, V59, P95, DOI 10.1016/0028-2243(94)02023-8; Hong SJ, 1999, PROTEIN EXPRES PURIF, V16, P340; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; HUNT TK, 1990, J TRAUMA, V30, P122; Hutchison D C, 1987, Eur J Respir Dis Suppl, V153, P78; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; KRAMPS JA, 1983, SCAND J CLIN LAB INV, V43, P427; LEE CH, 1993, AM REV RESPIR DIS, V147, P710, DOI 10.1164/ajrccm/147.3.710; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; MELLET P, 1995, BIOCHEMISTRY-US, V34, P2645, DOI 10.1021/bi00008a031; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; OHLSSON K, 1995, J ANDROL, V16, P64; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; RAPPOLEE DA, 1988, CURR OPIN IMMUNOL, V1, P47, DOI 10.1016/0952-7915(88)90050-7; Rehault S, 1999, J BIOL CHEM, V274, P13810, DOI 10.1074/jbc.274.20.13810; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SOMORIN O, 1979, J BIOCHEM-TOKYO, V85, P157, DOI 10.1093/oxfordjournals.jbchem.a132305; Song XY, 1999, J EXP MED, V190, P535, DOI 10.1084/jem.190.4.535; Sparro G, 1997, PROTEIN EXPRES PURIF, V10, P169, DOI 10.1006/prep.1997.0726; Taggart AV, 2000, HEALTH SOC CARE COMM, V8, P1, DOI 10.1046/j.1365-2524.2000.00227.x; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON RC, 1986, P NATL ACAD SCI USA, V83, P6692, DOI 10.1073/pnas.83.18.6692; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; Wahl SM, 1997, AM J PATHOL, V150, P1275; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108; Xu SQ, 1998, J BIOL CHEM, V273, P20078, DOI 10.1074/jbc.273.32.20078; YING QL, 1994, BIOCHEMISTRY-US, V33, P5445, DOI 10.1021/bi00184a013; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 1999, BBA-MOL CELL RES, V1451, P219, DOI 10.1016/S0167-4889(99)00111-1; Zhu JW, 1997, P NATL ACAD SCI USA, V94, P13063, DOI 10.1073/pnas.94.24.13063; Zitnik RJ, 1997, BIOCHEM BIOPH RES CO, V232, P687, DOI 10.1006/bbrc.1997.6358	70	502	530	5	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					867	878		10.1016/S0092-8674(02)01141-8	http://dx.doi.org/10.1016/S0092-8674(02)01141-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526812	Bronze			2022-12-24	WOS:000179862600012
J	Lambert, GW; Reid, C; Kaye, DM; Jennings, GL; Esler, MD				Lambert, GW; Reid, C; Kaye, DM; Jennings, GL; Esler, MD			Effect of sunlight and season on serotonin turnover in the brain	LANCET			English	Article							AFFECTIVE-DISORDER; LIGHT THERAPY	Alterations in monoaminergic neurotransmission in the brain are thought to underlie seasonal variations in mood, behaviour, and affective disorders. We took blood samples from internal jugular veins in 101 healthy men, to assess the relation between concentration of serotonin metabolite in these samples and weather conditions and season. We showed that turnover of serotonin by the brain was lowest in winter (p=0-013). Moreover, the rate of production of serotonin by the brain was directly related to the prevailing duration of bright sunlight (r=0.294, p=0.010), and rose rapidly with increased luminosity. Our findings are further evidence for the notion that changes in release of serotonin by the brain underlie mood seasonality and seasonal affective disorder.	Baker Heart Res Inst, Human Neurotransmitter Lab, Melbourne, Vic 8008, Australia; Baker Heart Res Inst, Alfred & Baker Med Unit, Melbourne, Vic 8008, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute	Lambert, GW (corresponding author), Baker Heart Res Inst, Human Neurotransmitter Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	gavin.lambert@baker.edu.au	Lambert, Gavin W/E-7384-2010; Kaye, David/AAF-1202-2021; Jennings, Garry/B-3914-2009; Reid, Christopher M/AAP-8135-2021; Lambert, Gavin/Q-4869-2017	Lambert, Gavin W/0000-0003-0315-645X; Lambert, Gavin/0000-0003-0315-645X; Kaye, David/0000-0003-4058-0372; Reid, Christopher/0000-0001-9173-3944; Jennings, Garry/0000-0002-7865-5483				CARLSSON A, 1980, ACTA PSYCHIAT SCAND, V61, P75, DOI 10.1111/acps.1980.61.s280.75; Lam RW, 1996, ARCH GEN PSYCHIAT, V53, P41; LAMBERT GW, 1995, LIFE SCI, V57, P255, DOI 10.1016/0024-3205(95)00269-C; RUDORFER MV, 1993, PSYCHIAT RES, V46, P19, DOI 10.1016/0165-1781(93)90004-Z; TORK I, 1990, ANN NY ACAD SCI, V600, P9	5	335	345	5	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1840	1842		10.1016/S0140-6736(02)11737-5	http://dx.doi.org/10.1016/S0140-6736(02)11737-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	623MB	12480364				2022-12-24	WOS:000179706100014
J	Greenbaum, DC; Baruch, A; Grainger, M; Bozdech, Z; Medzihradszky, KF; Engel, J; DeRisi, J; Holder, AA; Bogyo, M				Greenbaum, DC; Baruch, A; Grainger, M; Bozdech, Z; Medzihradszky, KF; Engel, J; DeRisi, J; Holder, AA; Bogyo, M			A role for the protease falcipain 1 in host cell invasion by the human malaria parasite	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; PROTEINASE; ERYTHROCYTE; HEMOGLOBINASE; MEROZOITES; EXPRESSION; INHIBITORS; SEQUENCE	Cysteine proteases of Plasmodium falciparum are required for survival of the malaria parasite, yet their specific cellular functions remain unclear. We used a chemical proteomic screen with a small-molecule probe to characterize the predominant cysteine proteases throughout the parasite life cycle. Only one protease, falcipain 1, was active during the invasive merozoite stage. Falcipain 1-specific inhibitors, identified by screening of chemical libraries, blocked parasite invasion of host erythrocytes, yet had no effect on normal parasite processes such as hemoglobin degradation. These results demonstrate a specific role for falcipain 1 in host cell invasion and establish a potential new target for antimalarial therapeutics.	Univ Calif San Francisco, Dept Biochem & Biophys, Vet Affairs Med Ctr, San Francisco, CA 94043 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94043 USA; Natl Inst Med Res, Div Parasitol, London NW7 1AA, England	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; MRC National Institute for Medical Research	Greenbaum, DC (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Vet Affairs Med Ctr, 513 Parnassus Ave, San Francisco, CA 94043 USA.		Holder, Anthony A/A-7554-2013; Bozdech, Zbynek/A-2205-2011	Holder, Anthony A/0000-0002-8490-6058; Bozdech, Zbynek/0000-0002-9830-8446; Bogyo, Matthew/0000-0003-3753-4412	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; BANNISTER LH, 1986, CELL TISSUE RES, V245, P281, DOI 10.1007/BF00213933; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Chitnis CE, 2000, PARASITOL TODAY, V16, P411, DOI 10.1016/S0169-4758(00)01756-7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, CHEM BIOL, V9, P1085, DOI 10.1016/S1074-5521(02)00238-7; GREENBAUM DC, UNPUB; Hanspal M, 2002, MOL BIOCHEM PARASIT, V122, P227, DOI 10.1016/S0166-6851(02)00104-4; MAYER R, 1991, J MED CHEM, V34, P3029, DOI 10.1021/jm00114a011; McKerrow JH, 1999, BIOORGAN MED CHEM, V7, P639, DOI 10.1016/S0968-0896(99)00008-5; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Raphael P, 2000, MOL BIOCHEM PARASIT, V110, P259, DOI 10.1016/S0166-6851(00)00283-8; ROSENTHAL PJ, 1992, MOL BIOCHEM PARASIT, V51, P143, DOI 10.1016/0166-6851(92)90209-3; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; ROSENTHAL PJ, 1993, J CLIN INVEST, V91, P1052, DOI 10.1172/JCI116262; SALAS F, 1995, INFECT IMMUN, V63, P2120, DOI 10.1128/IAI.63.6.2120-2125.1995; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481	24	236	256	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2002	2006		10.1126/science.1077426	http://dx.doi.org/10.1126/science.1077426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471262				2022-12-24	WOS:000179629200049
J	Schwalbe, N; Harrington, P				Schwalbe, N; Harrington, P			HIV and tuberculosis in the former Soviet Union	LANCET			English	Article									Open Soc Inst, New York, NY 10019 USA		Schwalbe, N (corresponding author), Open Soc Inst, 400 W 59th St, New York, NY 10019 USA.							*DEP SOC MED, 1999, PROGR SOC INF DIS SO; *INT HARM RED DEV, 2001, DRUGS AIDS HARM RED; RUHL C, 2002, EC CONSEQUENCES HIV; SHRESTHA L, 2002, HIV AIDS CENTRAL ASI; Stem V., 1998, SIN FUTURE IMPRISONM; VINOKUR A, 2001, 510 WORLD BANK; *WHO, 2002, GLOB PLAN STOP TB	7	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S19	S20		10.1016/S0140-6736(02)11805-8	http://dx.doi.org/10.1016/S0140-6736(02)11805-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504488				2022-12-24	WOS:000180064500009
J	Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J				Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J			Time to act: global apathy towards HIV/AIDS is a crime against humanity	LANCET			English	Editorial Material									Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; Fdn Huesped, Buenos Aires, DF, Argentina; Makerere Univ, Fac Med, Kampala, Uganda; Univ Amsterdam, Acad Med Ctr, IATEC, NL-1105 AZ Amsterdam, Netherlands; TN DR MGR Med Univ, Dept Expt Med, Chennai, India; Univ British Columbia, Fac Med, Vancouver, BC, Canada; Ist Super Sanita, HIV AIDS Clin Res, I-00161 Rome, Italy; McGill Univ, AIDS Ctr, AIDS Res Lab, Lady Davis Inst Med Res, Montreal, PQ, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Makerere University; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Istituto Superiore di Sanita (ISS); Lady Davis Institute; McGill University	Montaner, J (corresponding author), Univ British Columbia, St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada.		Montaner, Julio/K-7621-2012; VELLA, STEFANO/ABI-3368-2020; Hogg, Robert S/B-2783-2012; VELLA, STEFANO/V-8440-2019; Vella, Stefano/GZM-0519-2022	Hogg, Robert S/0000-0003-3463-5488; VELLA, STEFANO/0000-0003-2347-5984; 				BUMILLER E, 2002, LA DAILY NEWS   0826; CHANG GG, 2002, CHINA BRIEF, V2; Luo RF, 2002, JAMA-J AM MED ASSOC, V288, P1649, DOI 10.1001/jama.288.13.1649; MERCER M, 2002, GAINESVILLE SUN 0430; Ramasundaram S, 2002, BRIT MED J, V324, P182, DOI 10.1136/bmj.324.7331.182; Sleigh A, 1998, LANCET, V351, P1449, DOI 10.1016/S0140-6736(05)78866-8; Weber AE, 1999, AIDS, V13, P2481, DOI 10.1097/00002030-199912030-00024; 2002, BLOBE MAIL      1022, pA20	8	34	35	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1710	1711		10.1016/S0140-6736(02)11722-3	http://dx.doi.org/10.1016/S0140-6736(02)11722-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480418				2022-12-24	WOS:000179636800002
J	Bass, RB; Strop, P; Barclay, M; Rees, DC				Bass, RB; Strop, P; Barclay, M; Rees, DC			Crystal structure of Escherichia coli MscS, a voltage-modulated and mechanosensitive channel	SCIENCE			English	Article							POTASSIUM CHANNEL; ION-CHANNEL; CYTOPLASMIC MEMBRANE; ACTIVATED CHANNELS; GATING MECHANISM; PATCH-CLAMP; PROTEIN; MOVEMENT; SENSOR; TRANSDUCTION	The mechanosensitive channel of small conductance (MscS) responds both to stretching of the cell membrane and to membrane depolarization. The crystal structure at 3.9 angstroms resolution demonstrates that Escherichia coli MscS folds as a membrane-spanning heptamer with a large cytoplasmic region. Each subunit contains three transmembrane helices (TM1, -2, and -3), with the TM3 helices lining the pore, while TM1 and TM2, with membrane-embedded arginines, are likely candidates for the tension and voltage sensors. The transmembrane pore, apparently captured in an open state, connects to a large chamber, formed within the cytoplasmic region, that connects to the cytoplasm through openings that may function as molecular filters. Although MscS is likely to be structurally distinct from other ion channels, similarities in gating mechanisms suggest common structural elements.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BERRIER C, 1989, FEBS LETT, V259, P27, DOI 10.1016/0014-5793(89)81486-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; CUI C, 1995, J MEMBRANE BIOL, V144, P31; Cui C, 1996, J MEMBRANE BIOL, V150, P143, DOI 10.1007/s002329900039; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kloda Anna, 2002, Archaea, V1, P35, DOI 10.1155/2002/419261; Kong YF, 2002, P NATL ACAD SCI USA, V99, P5999, DOI 10.1073/pnas.092051099; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; MARTINAC B, 1987, P NATL ACAD SCI USA, V84, P2297, DOI 10.1073/pnas.84.8.2297; McLaggan D, 2002, MOL MICROBIOL, V43, P521, DOI 10.1046/j.1365-2958.2002.02764.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Rees DC, 2000, J BIOL CHEM, V275, P713, DOI 10.1074/jbc.275.2.713; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SHAPOVALOV G, UNPUB; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STROP P, IN PRESS ADV PROT CH, V63; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	55	479	503	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1582	1587		10.1126/science.1077945	http://dx.doi.org/10.1126/science.1077945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446901				2022-12-24	WOS:000179361600039
J	Bodenheimer, T; Lorig, K; Holman, H; Grumbach, K				Bodenheimer, T; Lorig, K; Holman, H; Grumbach, K			Patient self-management of chronic disease in primary care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; HEALTH-STATUS; RHEUMATOID-ARTHRITIS; EDUCATION-PROGRAM; OLDER-ADULTS; OSTEOARTHRITIS; ADHERENCE; PEOPLE; PARTNERSHIP	Patients with chronic conditions make day-to-day, decisions about-self-manage-their illnesses. This reality introduces a new chronic disease paradigm: the patient-professional partnership, involving collaborative care and self-management education. Self-management education complements traditional patient education in supporting patients to live the best possible quality of life with their chronic condition. Whereas traditional patient education offers information and technical skills, self-management education teaches problem-solving skills. A central concept in self-management is self-efficacy-confidence to carry out a behavior necessary to reach a desired goal. Self-efficacy is enhanced when patients succeed in solving patient-identified problems. Evidence from controlled clinical trials suggests that (1) programs teaching self-management skills are more effective than information-only patient education in improving clinical outcomes; (2) in some circumstances, self-management education improves outcomes and can reduce costs for arthritis and probably for adult asthma patients; and (3) in initial studies, a self-management education program bringing together patients with a variety of chronic conditions may improve outcomes and reduce costs. Self-management education for chronic illness may soon become an integral part of high-quality primary care.	Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; Stanford University	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Ward 83,1001 Potrero Ave, San Francisco, CA 94110 USA.	tbodie@earthlink.net	Young, Alexander/A-1523-2009; Grumbach, Kevin/L-9222-2016	Young, Alexander/0000-0002-9367-9213; 				Anderson RM, 2000, DIABETES EDUCATOR, V26, P597, DOI 10.1177/014572170002600405; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; ANDERSON RM, 1996, PRACTICAL PSYCHOL DI; ARNOLD MS, 1995, DIABETES EDUCATOR, V21, P308, DOI 10.1177/014572179502100408; Bailey WC, 1999, ARCH INTERN MED, V159, P2422, DOI 10.1001/archinte.159.20.2422; Bandura A, 1997, SELF EFFICACY EXERCI; Barlow JH, 1996, PATIENT EDUC COUNS, V27, P257, DOI 10.1016/0738-3991(95)00844-6; Barlow JH, 2000, HEALTH EDUC RES, V15, P665, DOI 10.1093/her/15.6.665; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Brus H, 1999, PATIENT EDUC COUNS, V36, P57, DOI 10.1016/S0738-3991(98)00087-1; CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204; Corbin J. M., 1988, UNENDING WORK CARE M; Cote J, 2000, Can Respir J, V7, P395; D'Zurilla T. J, 1986, PROBLEM SOLVING THER; *DEP HLTH, 2002, HLTH IN WEB SIT; Edworthy SM, 1999, J RHEUMATOL, V26, P1793; Elasy TA, 2001, PATIENT EDUC COUNS, V43, P121, DOI 10.1016/S0738-3991(00)00150-6; Fries JF, 1997, J RHEUMATOL, V24, P1378; Funnell M M, 1991, Diabetes Educ, V17, P37, DOI 10.1177/014572179101700108; Funnell MM, 2000, JAMA-J AM MED ASSOC, V284, P1709, DOI 10.1001/jama.284.13.1709; Gallefoss F, 1999, AM J RESP CRIT CARE, V159, P812, DOI 10.1164/ajrccm.159.3.9804047; GIBSON PG, 2001, LTD INFORMATION ONLY; GIBSON PG, 2001, SELF MANAGEMENT ED R; Glasgow RE, 1999, DIABETES CARE, V22, P2090, DOI 10.2337/diacare.22.12.2090; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 1997, PATIENT EDUC COUNS, V32, P175, DOI 10.1016/S0738-3991(97)00039-6; Glasgow RE, 1996, DIABETES EDUCATOR, V22, P573, DOI 10.1177/014572179602200605; Gotler RS, 2000, MED CARE, V38, P1200, DOI 10.1097/00005650-200012000-00007; Groessl EJ, 2000, AM J COMMUN PSYCHOL, V28, P455, DOI 10.1023/A:1005184414241; Hammond A, 2001, RHEUMATOLOGY, V40, P1044, DOI 10.1093/rheumatology/40.9.1044; Helliwell PS, 1999, RHEUMATOLOGY, V38, P303, DOI 10.1093/rheumatology/38.4.303; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Hopman-Rock M, 2000, J RHEUMATOL, V27, P1947; *I FUT, 2000, HLTH HLTH CAR 2010; Kauppinen R, 2001, RESP MED, V95, P56, DOI 10.1053/rmed.2000.0971; Keefe FJ, 1999, ARTHRIT CARE RES, V12, P101, DOI 10.1002/1529-0131(199904)12:2<101::AID-ART5>3.0.CO;2-9; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Levy ML, 2000, RESP MED, V94, P900, DOI 10.1053/rmed.2000.0861; Lindroth Y, 1997, ARTHRIT CARE RES, V10, P325, DOI 10.1002/art.1790100507; Lorig K., 1994, LIVING HLTH LIFE CHR; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Mazzuca SA, 1997, ARTHRITIS RHEUM-US, V40, P1466, DOI 10.1002/art.1780400815; *MICH DIAB TRAIN C, 2002, WEB SIT; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Parker JC, 1995, ARTHRITIS RHEUM, V38, P1807, DOI 10.1002/art.1780381214; Riemsma RP, 1997, ARTHRIT CARE RES, V10, P238, DOI 10.1002/art.1790100405; Simeoni E, 1995, ARTHRIT CARE RES, V8, P102, DOI 10.1002/art.1790080208; *STANDF PAT ED RES, 2002, WEB SIT; *STANF PAT ED RES, 1997, CHRON DIS SELF MAN L; TAAL E, 1993, PATIENT EDUC COUNS, V20, P177, DOI 10.1016/0738-3991(93)90131-F; Van der Palen J, 1998, RESP MED, V92, P668, DOI 10.1016/S0954-6111(98)90516-9; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; 2001, DIABETES ED, V27, P899	55	2120	2169	9	320	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2002	288	19					2469	2475		10.1001/jama.288.19.2469	http://dx.doi.org/10.1001/jama.288.19.2469			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	616FB	12435261				2022-12-24	WOS:000179292300031
J	Randolph, WM; Goodwin, JS; Mahnken, JD; Freeman, JL				Randolph, WM; Goodwin, JS; Mahnken, JD; Freeman, JL			Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis	ANNALS OF INTERNAL MEDICINE			English	Article							SCREENING MAMMOGRAPHY; COMORBIDITY INDEX; ELDERLY-WOMEN; OLDER; HEALTH; MORTALITY; SURVIVAL; EFFICACY; COSTS	Background: There is little consensus about recommending mammography for women 75 years of age and older. These women have mammography less frequently and are more likely to receive a diagnosis of advanced breast cancer. Objective: To examine the relationship between use of screening mammography and size and stage of cancer at diagnosis in older women. Design: Retrospective cohort study. Setting: Tumor registries in the Surveillance, Epidemiology, and End Results (SEER) program. Patients: 12 038 women who were Medicare beneficiaries, were at least 69 years of age, resided in a SEER area, and received a new diagnosis of breast cancer in 1995 through 1996. Measurements: Screening mammograms obtained in the 2 years before breast cancer diagnosis (none, one, or at least two) and stage and size of tumor at diagnosis. Results: older women ( :75 years of age) had larger tumors at diagnosis and were less likely to have undergone screening mammography than younger women (69 to 74 years of age). The association between increased mammography use and smaller tumor size and stage was significantly greater in older women than in younger women (P = 0.010 for stage; P = 0.001 for size). The percentage of regular mammography users who received a diagnosis of high-stage disease (28% vs. 26%; P > 0.2) and the mean size of the tumors (15.0 mm vs. 15.1 mm; P > 0.2) did not significantly differ between younger and older women, respectively. These findings remained constant after controlling for factors that might contribute to biases. Conclusion: Mammography in older women is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis.	Univ Texas, Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Freeman, JL (corresponding author), Univ Texas, Med Branch, Sealy Ctr Aging, 301 Univ Blvd, Galveston, TX 77555 USA.				NCI NIH HHS [CA72076] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072076] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG HEALTHC RES QU, 2002, SCREEN BREAST CANC R; *AM GER SOC, 2002, BREAST CANC SCREEN O; American Cancer Society, 2002, CANC FACTS FIG 2002; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Blustein J, 1998, J AM GERIATR SOC, V46, P941, DOI 10.1111/j.1532-5415.1998.tb02746.x; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BREEN N, 1994, AM J PUBLIC HEALTH, V84, P62, DOI 10.2105/AJPH.84.1.62; Burns RB, 1996, J AM GERIATR SOC, V44, P922, DOI 10.1111/j.1532-5415.1996.tb01861.x; Caplan L S, 1996, Public Health Rev, V24, P193; CHAMBERLAIN J, 1988, LANCET, V2, P411; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen H H, 1995, J Med Screen, V2, P10; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Draper N.R., 1998, WILEY SERIES PROBABI, V326; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; FRISELL J, 1991, BREAST CANCER RES TR, V18, P49, DOI 10.1007/BF01975443; GOODWIN JS, 1986, J AM GERIATR SOC, V34, P20, DOI 10.1111/j.1532-5415.1986.tb06335.x; HALABI S, 1993, CANCER DETECT PREV, V17, P359; Hedegaard HB, 1996, AM J PREV MED, V12, P51, DOI 10.1016/S0749-3797(18)30370-2; Hillner BE, 1996, BREAST CANCER RES TR, V40, P75, DOI 10.1007/BF01806004; *HLTH CAR FIN ADM, 2002, DAT US REF GUID; HOLMES FF, 1981, J AM GERIATR SOC, V29, P55, DOI 10.1111/j.1532-5415.1981.tb01227.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KATTLOVE H, 1995, JAMA-J AM MED ASSOC, V273, P142, DOI 10.1001/jama.273.2.142; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; MANDELBLATT JS, 1992, ANN INTERN MED, V116, P722, DOI 10.7326/0003-4819-116-9-722; May DS, 1998, ANN EPIDEMIOL, V8, P439, DOI 10.1016/S1047-2797(98)00010-6; McCarthy EP, 2000, J AM GERIATR SOC, V48, P1226, DOI 10.1111/j.1532-5415.2000.tb02595.x; Morrison AS, 1992, SCREENING CHRONIC DI; Parker J, 1998, AM J PREV MED, V15, P198, DOI 10.1016/S0749-3797(98)00045-2; POTOSKY AL, 1993, MED CARE, V31, P732; REIS L, 1999, SEER CANC STAT REV 1; REYNOLDS T, 1994, J NATL CANCER I, V86, P168, DOI 10.1093/jnci/86.3.168; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; SAS Institute, 1999, SAS STAT US GUID VER; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Smith-Bindman R, 2000, AM J MED, V108, P112, DOI 10.1016/S0002-9343(99)00406-4; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Tabar L, 1999, Swiss Surg, V5, P199, DOI 10.1024/1023-9332.5.5.199; *US DEP HHS, 2000, DHHS PUB; YANCIK R, 1989, CANCER, V63, P976, DOI 10.1002/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A; 1995, MMWR MORB MORTAL WKL, V44, P777	46	78	80	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2002	137	10					783	790		10.7326/0003-4819-137-10-200211190-00006	http://dx.doi.org/10.7326/0003-4819-137-10-200211190-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	616VE	12435214				2022-12-24	WOS:000179323400001
J	Andersen, AMN; Vastrup, P; Wohlfahrt, J; Andersen, PK; Olsen, J; Melbye, M				Andersen, AMN; Vastrup, P; Wohlfahrt, J; Andersen, PK; Olsen, J; Melbye, M			Fever in pregnancy and risk of fetal death: a cohort study	LANCET			English	Article							NEURAL-TUBE DEFECTS; MATERNAL HYPERTHERMIA; SPONTANEOUS-ABORTION; TERATOGENIC AGENT; INFREQUENT CAUSE; ABNORMALITIES; POPULATION; EXPOSURE; EMBRYOS; UPDATE	Background Hyperthermia acts as a teratogen in some animals where it can induce resorption of the fetus and fetal death. Fever during pregnancy, especially in the period of embryogenesis, is also suspected as being a risk factor for fetal death in human beings. We did a large cohort study in Denmark to investigate this possibility. Methods We interviewed 24 040 women who were recruited in the first half of pregnancy to the Danish National Birth Cohort Study, and obtained information on the number of fever incidents during the first 16 weeks of pregnancy. For each fever episode, the highest measured body temperature, duration of incident, and gestational age were recorded. Outcomes of pregnancies were identified through linkage with the Civil Registration System and the National Discharge Registry. Cox's regression with time-dependent variables was used to estimate the relative risk of fetal death, taking delayed entry into account. Findings 1145 pregnancies resulted in a miscarriage or stillbirth (4.8%). During the first 16 pregnancy weeks 18.5% of the women experienced at least one episode of fever. However, we found no association between fever in pregnancy and fetal death before or after adjustment for known risk factors of fetal death (relative risk 0.95 [95% Cl 0.80-1.13]). This finding was consistent irrespective of measured maximum temperature, duration and number of fever incidents, or the gestational time of the fever incident, and was observed for fetal death in all three trimesters of pregnancy. Interpretation We found no evidence that fever in the first 16 weeks of pregnancy is associated with the risk of fetal death in clinically recognised pregnancies.	Statens Serum Inst, Danish Epidemiol Sci ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Univ Aarhus, Danish Epidemiol Sci Ctr, Inst Epidemiol & Social Med, Aarhus, Denmark; Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Aarhus University; Statens Serum Institut; Aarhus University; University of Copenhagen	Andersen, AMN (corresponding author), Univ Copenhagen, Dept Social Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.		Nybo Andersen, Anne-Marie/AAA-1997-2022; Andersen, Anne-Marie Nybo/E-4993-2013	Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Andersen, Anne-Marie Nybo/0000-0002-4296-8488; melbye, mads/0000-0001-8264-6785				ANDERSEN AK, 2000, THESIS U COPENHAGEN; BUXTON D, 1986, VET REC, V118, P510, DOI 10.1136/vr.118.18.510; Chambers CD, 1998, TERATOLOGY, V58, P251, DOI 10.1002/(SICI)1096-9926(199812)58:6<251::AID-TERA6>3.0.CO;2-L; CLARREN SK, 1979, J PEDIATR-US, V95, P81, DOI 10.1016/S0022-3476(79)80092-X; COCKROFT DL, 1978, TERATOLOGY, V17, P277, DOI 10.1002/tera.1420170306; EDWARDS MJ, 1995, REPROD TOXICOL, V9, P411, DOI 10.1016/0890-6238(95)00043-A; EDWARDS MJ, 1969, TERATOLOGY, V2, P313, DOI 10.1002/tera.1420020406; FAOAGALI JL, 1985, NEW ZEAL MED J, V98, P64; Farrow A, 1996, INT J EPIDEMIOL, V25, P797, DOI 10.1093/ije/25.4.797; GERMAIN MA, 1985, TERATOLOGY, V31, P265, DOI 10.1002/tera.1420310212; Graham JM, 1998, TERATOLOGY, V58, P209, DOI 10.1002/(SICI)1096-9926(199811)58:5<209::AID-TERA8>3.0.CO;2-Q; Hills, 1993, STAT MODELS EPIDEMIO; KLINE J, 1985, AM J EPIDEMIOL, V121, P832, DOI 10.1093/oxfordjournals.aje.a114054; LITTLE BB, 1991, AM J PERINAT, V8, P185, DOI 10.1055/s-2007-999373; LYNBERG MC, 1994, AM J EPIDEMIOL, V140, P244, DOI 10.1093/oxfordjournals.aje.a117243; MILLER P, 1978, LANCET, V1, P519; MILUNSKY A, 1992, JAMA-J AM MED ASSOC, V268, P882, DOI 10.1001/jama.268.7.882; NILSEN NO, 1984, TERATOLOGY, V30, P237, DOI 10.1002/tera.1420300211; Peterka M, 1996, REPROD TOXICOL, V10, P327, DOI 10.1016/0890-6238(96)00062-7; POSWILLO D, 1974, ANN ROY COLL SURG, V55, P171; *PUBL HLTH LAB SER, 1990, PROSPECTIVE STUDY HU, P1166; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; SASAKI J, 1995, TERATOLOGY, V51, P233, DOI 10.1002/tera.1420510407; Shaw GM, 1998, TERATOLOGY, V57, P1; SHIOTA K, 1982, AM J MED GENET, V12, P281, DOI 10.1002/ajmg.1320120306; Simpson JL, 1996, HUM REPROD, V11, P668, DOI 10.1093/HUMREP/11.3.668; Simpson JL, 1996, HUM REPROD, V11, P2058; TIKKANEN J, 1991, EUR J EPIDEMIOL, V7, P628; WARKANY J, 1986, TERATOLOGY, V33, P365, DOI 10.1002/tera.1420330316; 1996, SAS STAT SOFTWARE CH, P807	30	44	47	1	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 16	2002	360	9345					1552	1556		10.1016/S0140-6736(02)11518-2	http://dx.doi.org/10.1016/S0140-6736(02)11518-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443593				2022-12-24	WOS:000179292400011
J	Currie, CR; Wong, B; Stuart, AE; Schultz, TR; Rehner, SA; Mueller, UG; Sung, GH; Spatafora, JW; Straus, NA				Currie, CR; Wong, B; Stuart, AE; Schultz, TR; Rehner, SA; Mueller, UG; Sung, GH; Spatafora, JW; Straus, NA			Ancient tripartite coevolution in the attine ant-microbe symbiosis	SCIENCE			English	Article							FUNGUS-GROWING ANTS; LEAF-CUTTING ANTS; HYMENOPTERA; AGRICULTURE; FORMICIDAE; MUTUALISM; PHYLOGENY; BACTERIA	The symbiosis between fungus-growing ants and the fungi they cultivate for food has been shaped by 50 million years of coevolution. Phylogenetic analyses indicate that this long coevolutionary history includes a third symbiont lineage: specialized microfungal parasites of the ants fungus gardens. At ancient levels, the phylogenies of the three symbionts are perfectly congruent, revealing that the ant-microbe symbiosis is the product of tripartite coevolution between the farming ants, their cultivars, and the garden parasites. At recent phylogenetic levels, coevolution has been punctuated by occasional host-switching by the parasite, thus intensifying continuous coadaptation between symbionts in a tripartite arms race.	Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Texas, Austin, TX 78712 USA; Smithsonian Inst, Natl Museum Nat Hist, MRC 188, Washington, DC 20013 USA; ARS, Insect Biocontrol Lab, USDA, Beltsville, MD 20705 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	University of Kansas; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Toronto; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Oregon State University	Currie, CR (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.							Ahmadjian V., 1987, SYMBIOSIS INTRO BIOL; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Boucher Douglas H., 1985, BIOL MUTUALISM ECOLO; Castle A, 1998, APPL ENVIRON MICROB, V64, P133; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; CURRIE CR, IN PRESS OIKOS; FUTUYMA DJ, 1983, COEVOLUTION; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; Margulis L., 1991, SYMBIOSISOURCE EVO; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; QUINLAN RJ, 1977, ECOL ENTOMOL, V2, P161, DOI 10.1111/j.1365-2311.1977.tb00877.x; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Smith J. M., 1995, MAJOR TRANSITIONS EV; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466	23	273	291	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					386	388		10.1126/science.1078155	http://dx.doi.org/10.1126/science.1078155			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532015				2022-12-24	WOS:000180426800043
J	Phelps, CJ; Koike, C; Vaught, TD; Boone, J; Wells, KD; Chen, SH; Ball, S; Specht, SM; Polejaeva, IA; Monahan, JA; Jobst, PM; Sharma, SB; Lamborn, AE; Garst, AS; Moore, M; Demetris, AJ; Rudert, WA; Bottino, R; Bertera, S; Trucco, M; Starzl, TE; Dai, YF; Ayares, DL				Phelps, CJ; Koike, C; Vaught, TD; Boone, J; Wells, KD; Chen, SH; Ball, S; Specht, SM; Polejaeva, IA; Monahan, JA; Jobst, PM; Sharma, SB; Lamborn, AE; Garst, AS; Moore, M; Demetris, AJ; Rudert, WA; Bottino, R; Bertera, S; Trucco, M; Starzl, TE; Dai, YF; Ayares, DL			Production of alpha 1,3-galactosyltransferase-deficient pigs	SCIENCE			English	Article							CLOSTRIDIUM-DIFFICILE; TOXIN-A; XENOTRANSPLANTATION; GAL-ALPHA-1-3GAL-BETA-1-4GLCNAC-R; EXPRESSION; EPITOPES; CELLS; MOUSE	The enzyme alpha1,3-galactosyltransferase (alpha1,3GT or GGTA1) synthesizes alpha1,3-galactose (alpha1,3Gal) epitopes (Galbeta1,3Galbeta1,4GlcNac-R), which are the major xenoantigens causing hyperacute rejection in pig-to-human xenotransplantation. Complete removal of alpha1,3Gal from pig organs is the critical step toward the success of xenotransplantation. We reported earlier the targeted disruption of one allele of the alpha1,3GT gene in cloned pigs. A selection procedure based on bacterial toxin was used to select for cells in which the second allele of the gene was knocked out. Sequencing analysis demonstrated that knockout of the second allele of the alpha1,3GT gene was caused by T-to-G single point mutation at the second base of exon 9, which resulted in inactivation of the alpha1,3GT protein. Four healthy alpha1,3GT double-knockout female piglets were produced by three consecutive rounds of cloning. The piglets carrying point mutation in the alpha1,3GT gene hold significant value, as they would allow production of alpha1,3Gal-deficient pigs free of antibiotic-resistance genes and thus have the potential to make safer product for human use.	PPL Therapeut Inc, Blacksburg, VA 24060 USA; PPL Therapeut Ltd, Roslin EH25 9PP, Midlothian, Scotland; Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; Childrens Hosp, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dai, YF (corresponding author), PPL Therapeut Inc, 1700 Kraft Dr, Blacksburg, VA 24060 USA.		Polejaeva, Irina/G-4881-2012	Polejaeva, Irina/0000-0002-0858-5889; Yang, Haiyuan/0000-0001-5253-0079; Bertera, Suzanne/0000-0002-9228-4279; Dai, Yifan/0000-0003-2872-8442	NIADDK NIH HHS [R01 AM007772] Funding Source: Medline; NIDDK NIH HHS [DK29961, R01 AM007772, R01 DK029961-19] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CLARK GF, 1987, ARCH BIOCHEM BIOPHYS, V257, P217, DOI 10.1016/0003-9861(87)90561-3; COOPER DKC, 1993, LANCET, V342, P682, DOI 10.1016/0140-6736(93)91791-J; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Drake JW, 1998, GENETICS, V148, P1667; GALILI U, 1988, J BIOL CHEM, V263, P17755; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; GOOD AH, 1992, TRANSPL P, V24, P559; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; Koike C, 2002, J BIOL CHEM, V277, P10114, DOI 10.1074/jbc.M110527200; KUSHNARYOV VM, 1990, CYTOBIOS, V64, P181; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Logan JS, 2000, CURR OPIN IMMUNOL, V12, P563, DOI 10.1016/S0952-7915(00)00139-4; MOHAN R, 2001, PROTEIN, V44, P428; Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4; Tanemura M, 2000, TRANSPLANTATION, V69, P187, DOI 10.1097/00007890-200001150-00034; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004	17	820	917	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					411	414		10.1126/science.1078942	http://dx.doi.org/10.1126/science.1078942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12493821	Green Accepted			2022-12-24	WOS:000180426800051
J	Doebeli, M; Dieckmann, U				Doebeli, M; Dieckmann, U			Speciation along environmental gradients	NATURE			English	Article							SYMPATRIC SPECIATION; DIVERGENCE; COMPETITION; RADIATION; ORIGIN; MORPHS	Traditional discussions of speciation are based on geographical patterns of species ranges(1,2). In allopatric speciation, long-term geographical isolation generates reproductively isolated and spatially segregated descendant species(1,3). In the absence of geographical barriers, diversification is hindered by gene flow(1,3,4). Yet a growing body of phylogenetic and experimental data suggests that closely related species often occur in sympatry or have adjacent ranges in regions over which environmental changes are gradual and do not prevent gene flow(5-14). Theory has identified a variety of evolutionary processes that can result in speciation under sympatric conditions(15-25), with some recent advances concentrating on the phenomenon of evolutionary branching(18,23-25). Here we establish a link between geographical patterns and ecological processes of speciation by studying evolutionary branching in spatially structured populations. We show that along an environmental gradient, evolutionary branching can occur much more easily than in non-spatial models. This facilitation is most pronounced for gradients of intermediate slope. Moreover, spatial evolutionary branching readily generates patterns of spatial segregation and abutment between the emerging species. Our results highlight the importance of local processes of adaptive divergence for geographical patterns of speciation, and caution against pitfalls of inferring past speciation processes from present biogeographical patterns.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada; Int Inst Appl Syst Anal, Adapt Dynam Network, A-2361 Laxenburg, Austria	University of British Columbia; University of British Columbia; International Institute for Applied Systems Analysis (IIASA)	Doebeli, M (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	doebeli@zoology.ubc.ca	Doebeli, Michael/D-5391-2012; Dieckmann, Ulf/E-1424-2011	Dieckmann, Ulf/0000-0001-7089-0393				Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Endler J.A., 1977, Monographs in Population Biology, pi; Feder JL, 1998, ENDLESS FORMS, P130; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Johannesson K, 1995, EVOLUTION, V49, P1180, DOI 10.1111/j.1558-5646.1995.tb04445.x; Kawecki TJ, 1997, EVOLUTION, V51, P1751, DOI 10.1111/j.1558-5646.1997.tb05099.x; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; KNOX EB, 1995, P NATL ACAD SCI USA, V92, P10349, DOI 10.1073/pnas.92.22.10349; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; MIZERA F, IN PRESS EVOL ECOL R; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SLATKIN M, 1978, J THEOR BIOL, V70, P213, DOI 10.1016/0022-5193(78)90348-X; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Doorn GS, 2001, P ROY SOC B-BIOL SCI, V268, P2155, DOI 10.1098/rspb.2001.1780; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	30	517	532	2	229	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					259	264		10.1038/nature01274	http://dx.doi.org/10.1038/nature01274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529641	Green Submitted			2022-12-24	WOS:000180397600045
J	Hu, M; Li, PW; Li, MY; Li, WY; Yao, TT; Wu, JW; Gu, W; Cohen, RE; Shi, YG				Hu, M; Li, PW; Li, MY; Li, WY; Yao, TT; Wu, JW; Gu, W; Cohen, RE; Shi, YG			Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde	CELL			English	Article							ACTIVE-SITE; P53; PROTEASE; PATHWAY; ISOPEPTIDASE; DEGRADATION; SPECIFICITY; MECHANISMS; DIVERSITY; ALIGNMENT	The ubiquitin-specific processing protease (UBP) family of deubiquitinating enzymes plays an essential role in numerous cellular processes. HAUSP, a representative UBP, specifically deubiquitinates and hence stabilizes the tumor suppressor protein p53. Here, we report the crystal structures of the 40 kDa catalytic core domain of HAUSP in isolation and in complex with ubiquitin aldehyde. These studies reveal that the UBP deubiquitinating enzymes exhibit a conserved three-domain architecture, comprising Fingers, Palm, and Thumb. The leaving ubiquitin moiety is specifically coordinated by the Fingers, with its C terminus placed in the active site between the Palm and the Thumb. Binding by ubiquitin aldehyde induces a drastic conformational change in the active site that realigns the catalytic triad residues for catalysis.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Princeton University; Columbia University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X				Baek KH, 2001, BLOOD, V98, P636, DOI 10.1182/blood.V98.3.636; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Chung JY, 2002, J CELL SCI, V115, P679; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; DUNTEN RL, 1989, J BIOL CHEM, V264, P16739; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Gilchrist CA, 2000, BBA-PROTEIN STRUCT M, V1481, P297, DOI 10.1016/S0167-4838(00)00134-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Schwartz AL, 1999, ANNU REV MED, V50, P57; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu JW, 2001, J BIOL CHEM, V276, P20688, DOI 10.1074/jbc.M100174200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200	53	474	501	1	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					1041	1054		10.1016/S0092-8674(02)01199-6	http://dx.doi.org/10.1016/S0092-8674(02)01199-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507430	Bronze			2022-12-24	WOS:000180086000013
J	Phornphutkul, C; Introne, WJ; Perry, MB; Bernardini, I; Murphey, MD; Fitzpatrick, DL; Anderson, PD; Huizing, M; Anikster, Y; Gerber, LH; Gahl, WA				Phornphutkul, C; Introne, WJ; Perry, MB; Bernardini, I; Murphey, MD; Fitzpatrick, DL; Anderson, PD; Huizing, M; Anikster, Y; Gerber, LH; Gahl, WA			Natural history of alkaptonuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOMOGENTISIC ACID; MUTATIONS; IDENTIFICATION; DIOXYGENASE; OCHRONOSIS; INHIBITION; SLOVAKIA; GENE; NTBC	Background: Alkaptonuria, caused by mutations in the HGO gene and a deficiency of homogentisate 1,2-dioxygenase, results in an accumulation of homogentisic acid (HGA), ochronosis, and destruction of connective tissue. There is no effective therapy for this disorder, although nitisinone inhibits the enzyme that produces HGA. We performed a study to delineate the natural history of alkaptonuria. Methods: We evaluated 58 patients with alkaptonuria (age range, 4 to 80 years), using clinical, radiographic, biochemical, and molecular methods. A radiographic scoring system was devised to assess the severity of spinal and joint damage. Two patients were treated with nitisinone for 10 and 9 days, respectively. Results: Life-table analyses showed that joint replacement was performed at a mean age of 55 years and that renal stones developed at 64 years, cardiac-valve involvement at 54 years, and coronary-artery calcification at 59 years. Linear regression analysis indicated that the radiographic score for the severity of disease began increasing after the age of 30 years, with a more rapid increase in men than in women. Twenty-three new HGO mutations were identified. In a 51-year-old woman, urinary HGA excretion fell from 2.9 to 0.13 g per day after a 10-day course of nitisinone (7 days at a dose of 0.7 mg per day and 3 days at 2.8 mg per day). In a 59-year-old woman, urinary HGA fell from 6.4 g to 1.7 g per day after nine days of treatment with nitisinone (0.7 mg per day). Plasma tyrosine levels in these patients rose from approximately 1.1 mg per deciliter (60 micromol per liter) in both to approximately 12.8 mg per deciliter (700 micromol per liter) and 23.6 mg per deciliter (1300 micromol per liter), respectively, with no clinical signs or symptoms. Conclusions: The reported data on the natural history of alkaptonuria provide a basis for the evaluation of long-term therapies. Although nitisinone can reduce HGA production in humans with homogentisate 1,2-dioxygenase deficiency, the long-term safety and efficacy of this treatment require further evaluation.	NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, Bethesda, MD 20892 USA; Natl Inst Hlth Clin Ctr, Dept Rehabil Med, Bethesda, MD USA; Armed Forces Inst Pathol, Dept Radiol Pathol, Washington, DC 20306 USA; Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); United States Department of Defense; University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA	Gahl, WA (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1851,Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Huizing, Marjan/AAR-8860-2020	Gerber, Lynn/0000-0001-7525-680X				Anikster Y, 1998, AM J HUM GENET, V63, P920, DOI 10.1086/302027; BAHN AK, 1972, BASIC MED STATISTICS, P154; Baumann E, 1891, Z PHYSL CHEM, V15, P228; Boedeker C., 1859, Z RATION MED, V7, P130; de Bernabe DBV, 1999, AM J HUM GENET, V64, P1316, DOI 10.1086/302376; de Bernabe DBV, 1998, AM J HUM GENET, V62, P776, DOI 10.1086/301805; Deutsch JC, 1996, J CHROMATOGR B, V677, P147, DOI 10.1016/0378-4347(95)00442-4; ELLIS MK, 1995, TOXICOL APPL PHARM, V133, P12, DOI 10.1006/taap.1995.1121; FernandezCanon JM, 1996, NAT GENET, V14, P19, DOI 10.1038/ng0996-19; Garrod AE, 1908, LANCET, V2, P73; Garrod AE, 1902, LANCET, V2, P1616; de Jorge EG, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.7.e40; Hall MG, 2001, BRIT J CLIN PHARMACO, V52, P169, DOI 10.1046/j.0306-5251.2001.01421.x; Introne WJ, 2002, MOL GENET METAB, V77, P136, DOI 10.1016/S1096-7192(02)00121-X; KHAN MA, 1984, SPONDYLARTHROPATHIES, P69; LADU BN, 1958, J BIOL CHEM, V230, P251; LADU BN, 2002, CONNECTIVE TISSUE IT, P809; LADU BN, 2001, METABOLIC MOL BASES, V2, P2109; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; LUSTBERG TJ, 1971, CLIN CHIM ACTA, V35, P325, DOI 10.1016/0009-8981(71)90202-6; MACRAE IF, 1969, ANN RHEUM DIS, V28, P584, DOI 10.1136/ard.28.6.584; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; MOLL JMH, 1971, ANN RHEUM DIS, V30, P381, DOI 10.1136/ard.30.4.381; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P55; NEUBAUER O, 1909, DTSCH ARCH KLIN MED, V95, P211; OBRIEN WM, 1963, AM J MED, V34, P813, DOI 10.1016/0002-9343(63)90089-5; Porfirio B, 2000, J MED GENET, V37, P309, DOI 10.1136/jmg.37.4.309; Rodriguez JM, 2000, HUM MOL GENET, V9, P2341, DOI 10.1093/oxfordjournals.hmg.a018927; Sambrook JFE, 1989, MOL CLONING LAB MANU; Schober P., 1937, MUNCH MED WOCHENSCHR, V84, P336; SCHULZ A, 1993, FEBS LETT, V318, P162, DOI 10.1016/0014-5793(93)80013-K; Srsen S, 2002, MOL GENET METAB, V75, P353, DOI 10.1016/S1096-7192(02)00002-1; STENN FF, 1977, SCIENCE, V197, P566, DOI 10.1126/science.327549; Suzuki Y, 1999, J HUM GENET, V44, P79, DOI 10.1007/s100380050114; WARE JE, 1981, AM J PUBLIC HEALTH, V71, P620, DOI 10.2105/AJPH.71.6.620; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WOLFF JA, 1989, PEDIATR RES, V26, P140, DOI 10.1203/00006450-198908000-00015; Zatkova A, 2000, AM J HUM GENET, V67, P1333	38	362	379	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 26	2002	347	26					2111	2121		10.1056/NEJMoa021736	http://dx.doi.org/10.1056/NEJMoa021736			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629FZ	12501223				2022-12-24	WOS:000180040900004
J	Moberg, L; Johansson, H; Lukinius, A; Berne, C; Foss, A; Kallen, R; Ostraat, O; Salmela, K; Tibell, A; Tufveson, G; Elgue, G; Ekdahl, KN; Korsgren, O; Nilsson, B				Moberg, L; Johansson, H; Lukinius, A; Berne, C; Foss, A; Kallen, R; Ostraat, O; Salmela, K; Tibell, A; Tufveson, G; Elgue, G; Ekdahl, KN; Korsgren, O; Nilsson, B			Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation	LANCET			English	Article							COMPLEMENT ACTIVATION; ENDOCRINE PANCREAS; HUMAN BLOOD; COAGULATION; BIOMATERIAL; EXPRESSION; INHIBITION; RECEPTOR; MODEL; RNA	Background Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal thrombosis remains a possible complication. The thrombotic reaction may explain why graft loss occurs and islets from more than one donor are needed, since contact between human islets and ABO-compatible blood in vitro triggers a thrombotic reaction that damages the islets. We investigated the possible mechanism and treatment of such thrombotic reactions. Methods Coagulation activation and islet damage were monitored in four patients undergoing clinical islet transplantation according to a modified Edmonton protocol. Expression of tissue factor (TF) in the islet preparations was investigated by immunohistochemistry, immunoprecipitation, electron microscopy, and RT-PCR. To assess TF activity in purified islets, human islets were mixed with non-anticoagulated ABO-compatible blood in tubing loops coated with heparin. Findings Coagulation activation and subsequent release of insulin were found consistently after clinical islet transplantation, even in the absence of signs of intraportal thrombosis. The endocrine, but not the exocrine, cells of the pancreas were found to synthesise and secrete active TF. The clotting reaction triggered by pancreatic islets in vitro could be abrogated by blocking the active site of TF with specific antibodies or site-inactivated factor Vlla, a candidate drug for inhibition of TF activity in vivo. Interpretation Blockade of TF represents a new therapeutic approach that might increase the success of islet transplantation in patients with type 1 diabetes, in terms of both the risk of intraportal thrombosis and the need for islets from more than one donor.	Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, Div Pathol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, Div Med, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Surg Sci, Div Transplantat Surg, S-75185 Uppsala, Sweden; Dept Transplantat Surg, Oslo, Norway; Malmo Univ Hosp, Dept Nephrol & Transplantat, Malmo, Sweden; Skejby Hosp, Dept Urol, Aarhus, Denmark; Univ Helsinki, Surg Hosp, Div Transplantat, Helsinki, Finland; Dept Transplantat Surg, Stockholm, Sweden; Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Lund University; Skane University Hospital; Aarhus University; University of Helsinki; Linnaeus University; University of Kalmar	Nilsson, B (corresponding author), Univ Uppsala Hosp, Rudbeck Lab, Div Clin Immunol, Dept Radiol Oncol & Clin Immunol, S-75185 Uppsala, Sweden.		Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012	Nilsson, Bo/0000-0003-0057-2730; Korsgren, Olle/0000-0002-8524-9547				Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Colman RW, 1996, BLOOD, V87, P2089; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Ekdahl KN, 1997, ARTHRITIS RHEUM, V40, P2178, DOI 10.1002/art.1780401212; EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x; Froberg MK, 1997, HUM PATHOL, V28, P1295, DOI 10.1016/S0046-8177(97)90204-5; Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309; Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7; LUKINIUS A, 1992, DEV BIOL, V153, P376, DOI 10.1016/0012-1606(92)90122-W; Lukinius A, 2001, DIABETES, V50, P962, DOI 10.2337/diabetes.50.5.962; Luther T, 1996, AM J PATHOL, V149, P101; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; PARKER RC, 1957, NY ACAD SCI, V5, P303; Pazzagli M, 1999, CLIN APPL THROMB-HEM, V5, P228, DOI 10.1177/107602969900500404; Peppelenbosch MP, 2001, TRENDS CARDIOVAS MED, V11, P335, DOI 10.1016/S1050-1738(01)00137-2; POTGENS AJG, 1994, THROMB HAEMOSTASIS, V71, P208; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027; VANSUYLICHEM PTR, 1995, CELL TRANSPLANT, V4, P609, DOI 10.1016/0963-6897(95)00026-7; WILDGOOSE P, 1990, BIOCHEMISTRY-US, V29, P3413, DOI 10.1021/bi00465a039; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	30	434	444	1	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2039	2045		10.1016/S0140-6736(02)12020-4	http://dx.doi.org/10.1016/S0140-6736(02)12020-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504401				2022-12-24	WOS:000179974200013
J	Bosanac, I; Alattia, JR; Mal, TK; Chan, J; Talarico, S; Tong, FK; Tong, KI; Yoshikawa, F; Furuichi, T; Iwai, M; Michikawa, T; Mikoshiba, K; Ikura, M				Bosanac, I; Alattia, JR; Mal, TK; Chan, J; Talarico, S; Tong, FK; Tong, KI; Yoshikawa, F; Furuichi, T; Iwai, M; Michikawa, T; Mikoshiba, K; Ikura, M			Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand	NATURE			English	Article							DOMAIN; SITE; RECOGNITION; EFFICIENT	In a variety of cells, the Ca2+ signalling process is mediated by the endoplasmic-reticulum-membrane-associated Ca2+ release channel, inositol 1,4,5-trisphosphate (InsP(3)) receptor (InsP(3)R)(1). Being ubiquitous and present in organisms ranging from humans to Caenorhabditis elegans, InsP(3)R has a vital role in the control of cellular and physiological processes as diverse as cell division, cell proliferation, apoptosis, fertilization, development, (b)ehaviour, memory and learning(2). Mouse type I InsP(3)R (InsP(3)R1), found in high abundance in cerebellar Purkinje cells, is a polypeptide with three major functionally distinct regions: the amino-terminal InsP(3)-binding region, the central modulatory region and the carboxy-terminal channel region (2). Here we present a 2.2-Angstrom crystal structure of the InsP(3)-binding core of mouse InsP(3)R1 in complex with InsP(3). The asymmetric, boomerang-like structure consists of an N-terminal beta-trefoil domain and a C-terminal alpha-helical domain containing an 'armadillo repeat'-like fold. The cleft formed by the two domains exposes a cluster of arginine and lysine residues that coordinate the three phosphoryl groups of InsP(3). Putative Ca2+-binding sites are identified in two separate locations within the InsP(3)-binding core.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan; Univ Toronto, Ontario Canc Inst, Div Mol & Struct Biol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; RIKEN, Inst Brain Res, Lab Dev Neurobiol & Mol Neurogenesis, Wako, Saitama 3510198, Japan; JST, ICORP, Calcium Oscillat Project, Tokyo 1080071, Japan	University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; RIKEN; Japan Science & Technology Agency (JST)	Ikura, M (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Tokyo 1088639, Japan.		Mal, Tapas K/A-9453-2011; Furuichi, Teiichi/B-5086-2014; Mikoshiba, Katsuhiko/N-7943-2015	Mal, Tapas K/0000-0002-0625-2095; Furuichi, Teiichi/0000-0002-9676-1888; 				Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hotoda H, 1999, BIOCHEMISTRY-US, V38, P9234, DOI 10.1021/bi990114r; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Jiang QX, 2002, EMBO J, V21, P3575, DOI 10.1093/emboj/cdf380; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOZIKOWSKI AP, 1993, J AM CHEM SOC, V115, P4429, DOI 10.1021/ja00064a002; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; OVERDUIN M, 2001, MOL INTERVENTIONS, V1, P151; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; Sienaert I, 2002, BIOCHEM J, V365, P269, DOI 10.1042/BJ20020144; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wilcox RA, 1998, TRENDS PHARMACOL SCI, V19, P467, DOI 10.1016/S0165-6147(98)01260-7; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, BIOCHEM BIOPH RES CO, V257, P792, DOI 10.1006/bbrc.1999.0498	30	261	267	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					696	700		10.1038/nature01268	http://dx.doi.org/10.1038/nature01268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12442173				2022-12-24	WOS:000179751800052
J	Abbott, A				Abbott, A			Talkin' about regeneration	NATURE			English	Article																			0	0	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					456	457		10.1038/420456b	http://dx.doi.org/10.1038/420456b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466810	Bronze			2022-12-24	WOS:000179611600013
J	Phillips, MR; Yang, GH; Zhang, YP; Wang, LJ; Ji, HY; Zhou, MG				Phillips, MR; Yang, GH; Zhang, YP; Wang, LJ; Ji, HY; Zhou, MG			Risk factors for suicide in China: a national case-control psychological autopsy study	LANCET			English	Article								Background Suicide is the fifth most important cause of death in China, but the reasons for the high rate and unique pattern of characteristics of those who kill themselves are unknown. Methods We pretested, and then administered a comprehensive interview to family members and close associates of 519 people who committed suicide and of 536 people who died from other injuries (controls) randomly selected from 23 geographically representative sites in China. Findings After adjustment for sex, age, location of residence, and research site, eight significant predictors of suicide remained in the final unconditional logistic regression model. In order of importance they were: high depression symptom score, previous suicide attempt, acute stress at time of death, low quality of life, high chronic stress, severe interpersonal conflict in the 2 days before death, a blood relative with previous suicidal behaviour, and a friend or associate with previous suicidal behaviour. Suicide risk increased substantially with exposure to multiple risk factors: none of the 265 deceased people who were exposed to one or fewer of the eight risk factors died by suicide, but 30% (90/299) with two or three risk factors, 85% (320/377) with four or five risk factors, and 96% (109/114) with six or more risk factors died by suicide. Interpretation Despite substantial differences between characteristics of people who commit suicide in China and the west, risk factors for suicide do not differ greatly. Suicide prevention programmes that concentrate on a single risk factor are unlikely to reduce suicide rates substantially; preventive efforts should focus on individuals exposed to multiple risk factors.	Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China; Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Phillips, MR (corresponding author), Beijing Hui Long Guan Hosp, Beijing Suicide Res & Prevent Ctr, Beijing 100096, Peoples R China.		Zhang, Xiao/V-9027-2017; Phillips, Michael Robert/AAE-7585-2021; Zhou, Maigeng/HCH-7703-2022	Zhang, Xiao/0000-0002-2932-5875; Phillips, Michael Robert/0000-0002-5973-2439; 				American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; [Anonymous], 2008, INT HDB SUICIDE ATTE; [Anonymous], 1999, WORLD HLTH REPORT 19; Appleby L, 1999, BRIT J PSYCHIAT, V175, P168, DOI 10.1192/bjp.175.2.168; Beautrais AL, 2001, PSYCHOL MED, V31, P837; BRENT DA, 1989, SUICIDE LIFE-THREAT, V19, P43; Cavanagh JTO, 1999, PSYCHOL MED, V29, P1141, DOI 10.1017/S0033291799001038; *CHIN SOC PSYCH, 2000, CHIN CLASS MENT DIS; CLARK D. C., 1992, ASSESSMENT PREDICTIO, P144; Cooper JE, 1996, MENTAL DISORDERS CHI; First M. B., 2014, SCID 5 105 STRUCTURE; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GURURAJ G, 2001, NAT I MENTAL HLTH NE, V43; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hawton K, 1998, J AFFECT DISORDERS, V50, P269; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; LI SR, 1998, CHIN J PSYCHIAT, V31, P80; Li X, 2001, CHIN J EPIDEMIOL, V22, P281; Lonnqvist J. K., 2000, INT HDB SUICIDE ATTE, P107, DOI [DOI 10.1002/9780470698976.CH7, 10.1002/9780470698976.ch7]; Ma C, 1999, CHIN MENT HLTH J, V13, P110; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Moscicki EK, 1997, PSYCHIAT CLIN N AM, V20, P499, DOI 10.1016/S0193-953X(05)70327-0; Nagelkerle N, 1991, BIOMETRIKA, V78, P791; Parker G, 2001, AM J PSYCHIAT, V158, P857, DOI 10.1176/appi.ajp.158.987.857; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x; United Nations, 1996, PREV SUIC GUID FORM; Vijayakumar L, 1999, ACTA PSYCHIAT SCAND, V99, P407, DOI 10.1111/j.1600-0447.1999.tb00985.x; *WHO, 2001, WORKSH SUIC PREV CHI; Yang GH., 1991, EXPLORING ADULT MORT; Zhang B, 2000, SHANGHAI J PREV MED, V12, P282; Zhang W.X., 1998, CHINESE J PSYCHIAT, V31, P69; Zhao M., 2000, SHANGHAI PSYCHIATRIC, V12, P222, DOI [10.3969/j.issn.1002-0829.2000.04.015, DOI 10.3969/J.ISSN.1002-0829.2000.04.015]	34	561	687	3	77	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1728	1736		10.1016/S0140-6736(02)11681-3	http://dx.doi.org/10.1016/S0140-6736(02)11681-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622FU	12480425				2022-12-24	WOS:000179636800009
J	Tao, YZ; Farsetta, DL; Nibert, ML; Harrison, SC				Tao, YZ; Farsetta, DL; Nibert, ML; Harrison, SC			RNA synthesis in a cage - Structural studies of reovirus polymerase lambda 3	CELL			English	Article							CRYSTAL-STRUCTURE; DNA-POLYMERASE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; ELONGATION COMPLEX; INITIATION; MICROSCOPY; PARTICLES; MECHANISM; HELICASE	The reovirus polymerase and those of other dsRNA viruses function within the confines of a protein capsid to transcribe the tightly packed dsRNA genome segments. The crystal structure of the reovirus polymerase, lambda3, determined at 2.5 Angstrom resolution, shows a fingers-palm-thumb core, similar to those of other viral polymerases, surrounded by major N- and C-terminal elaborations, which create a cage-like structure, with four channels leading to the catalytic site. This "caged" polymerase has allowed us to visualize the results of several rounds of RNA polymerization directly in the crystals. A 5' cap binding site on the surface of lambda3 suggests a template retention mechanism by which attachment of the 5' end of the plus-sense strand facilitates insertion of the 3' end of the minus-sense strand into the template channel.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Univ Wisconsin, Inst Mol Virol, Mol & Cellular Biol Program, Madison, WI 53706 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School	Harrison, SC (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	harrison@crystal.harvard.edu			NATIONAL CANCER INSTITUTE [R37CA013202, R01CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039533, R01AI047904] Funding Source: NIH RePORTER; NCI NIH HHS [CA13202] Funding Source: Medline; NIAID NIH HHS [AI-47904, AI-39533] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Ahola T, 2000, J VIROL, V74, P8803, DOI 10.1128/JVI.74.19.8803-8811.2000; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisaillon M, 1997, J BIOL CHEM, V272, P18298, DOI 10.1074/jbc.272.29.18298; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; BRUENN JA, 1991, NUCLEIC ACIDS RES, V19, P217, DOI 10.1093/nar/19.2.217; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Farsetta DL, 2000, J BIOL CHEM, V275, P39693, DOI 10.1074/jbc.M004562200; GILLIES S, 1971, SCIENCE, V174, P694, DOI 10.1126/science.174.4010.694; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hakansson K, 1998, P NATL ACAD SCI USA, V95, P1505, DOI 10.1073/pnas.95.4.1505; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nibert ML., 2001, FIELDS VIROLOGY, P1679; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; SKEHEL JJ, 1969, VIROLOGY, V39, P822, DOI 10.1016/0042-6822(69)90019-1; STARNES MC, 1993, VIROLOGY, V193, P356, DOI 10.1006/viro.1993.1132; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328	48	265	278	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					733	745		10.1016/S0092-8674(02)01110-8	http://dx.doi.org/10.1016/S0092-8674(02)01110-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464184	Bronze			2022-12-24	WOS:000179594500014
J	Zammit, S; Allebeck, P; Andreasson, S; Lundberg, I; Lewis, G				Zammit, S; Allebeck, P; Andreasson, S; Lundberg, I; Lewis, G			Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study	BRITISH MEDICAL JOURNAL			English	Article							DOPAMINE	Objectives An association between use of cannabis in adolescence and subsequent risk of schizophrenia was previously reported in a follow up of Swedish conscripts. Arguments were raised that this association may be due to use of drugs other than cannabis and that personality traits may have confounded results. We performed a further analysis of this cohort to address these uncertainties while extending the follow up period to identify additional cases. Design Historical cohort study. Setting 1969-70 survey of Swedish conscripts (> 97% of the country's male population aged 18-20). Participants 50 087 subjects: data were available on self reported use of cannabis and other drugs, and on several social and psychological characteristics. Main outcome measures Admissions to hospital for ICD-8/9 schizophrenia and other psychoses, as determined by record linkage. Results Cannabis was associated with an increased risk of developing schizophrenia in a dose dependent fashion both for subjects who had ever used cannabis (adjusted odds ratio for linear trend of increasing frequency 1.2, 95% confidence interval 1.1 to 1.4, P < 0.001), mid for subjects who had used only cannabis and no other drugs (adjusted odds ratio for linear trend 1.3, 1.1 to 1.5, P < 0.015). The adjusted odds ratio for using cannabis > 50 times was 6.7 (2.1 to 21.7) in the cannabis only group. Similar results were obtained when analysis was restricted to subjects developing schizophrenia after five years after conscription, to exclude prodromal cases. Conclusions Cannabis use is associated with an increased risk of developing schizophrenia, consistent with a causal relation. This association is not explained by use of other psychoactive drugs or personality traits relating to social integration.	Univ Wales Coll Med, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales; Univ Gothenburg, Dept Social Med, Gothenburg, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; Univ Bristol, Div Psychiat, Bristol, Avon, England	Cardiff University; University of Gothenburg; Karolinska Institutet; University of Bristol	Zammit, S (corresponding author), Univ Wales Coll Med, Dept Psychol Med, Cardiff CF14 4XN, S Glam, Wales.		Young, Alexander/A-1523-2009; Lewis, Glyn/E-9944-2012	Young, Alexander/0000-0002-9367-9213; Lewis, Glyn/0000-0001-5205-8245; Zammit, Stanley/0000-0002-2647-9211				ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; ANDREASSON S, 1989, ACTA PSYCHIAT SCAND, V79, P505, DOI 10.1111/j.1600-0447.1989.tb10296.x; Andreasson S, 1990, MISUSE ALCOHOL CANNA; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; David AS, 1997, PSYCHOL MED, V27, P1311, DOI 10.1017/S0033291797005680; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; GEDDES JR, 1995, PSYCHOL MED, V25, P859, DOI 10.1017/S003329170003511X; Greenland S, 1998, MODERN EPIDEMIOLOGY, P231; Hall W, 2000, AUST NZ J PSYCHIAT, V34, P26, DOI 10.1046/j.1440-1614.2000.00685.x; Hall W., 1994, HLTH PSYCHOL CONSEQU; JABLENSKY A, 1986, SCHIZOPHRENIA BULL, V12, P52, DOI 10.1093/schbul/12.1.52; Johns A, 2001, BRIT J PSYCHIAT, V178, P116, DOI 10.1192/bjp.178.2.116; JOHNSON BA, 1988, LANCET, V1, P592; Johnstone EC, 1998, COMPANION PSYCHIAT S, P369; Kristjansson E, 1987, NORD PSYKIATR TIDSSK, V41, P229, DOI DOI 10.3109/08039488709103182; Lewis G, 2000, BRIT J PSYCHIAT, V177, P416, DOI 10.1192/bjp.177.5.416; LEWIS G, 1992, LANCET, V340, P137, DOI 10.1016/0140-6736(92)93213-7; Malmberg A, 1998, BRIT J PSYCHIAT, V172, P308, DOI 10.1192/bjp.172.4.308; NEGRETE JC, 1989, BRIT J ADDICT, V84, P349; Otto U, 1980, Acta Psychiatr Scand Suppl, V282, P1; SINGLETON N, 2001, PSYCHIAT MORBIDITY A; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; THOMAS HUW, 1993, BRIT J PSYCHIAT, V163, P141, DOI 10.1192/bjp.163.2.141; World Health Organization, 1974, GLOSS MENT DIS GUID; ZAMMIT S, IN PRESS INVESTIGATI; ZAMMIT S, IN PRESS PATERNAL AG	26	544	559	4	70	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2002	325	7374					1199	1201		10.1136/bmj.325.7374.1199	http://dx.doi.org/10.1136/bmj.325.7374.1199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	619YU	12446534	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000179506200017
J	Hori, S; Nomura, T; Sakaguchi, S				Hori, S; Nomura, T; Sakaguchi, S			Control of regulatory T cell development by the transcription factor Foxp3	SCIENCE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; AUTOIMMUNE-DISEASE; SCURFY MOUSE; ENTEROPATHY; HOMEOSTASIS; INDUCTION; CD25(+); MUTANT	Regulatory T cells engage in the maintenance of immunological self-tolerance by actively suppressing self-reactive lymphocytes. Little is known, however, about the molecular mechanism of their development. Here we show that Foxp3, which encodes a transcription factor that is genetically defective in an autoimmune and inflammatory syndrome in humans and mice, is specifically expressed in naturally arising CD4(+) regulatory T cells. Furthermore, retroviral gene transfer of Foxp3 converts naive T cells toward a regulatory T cell phenotype similar to that of naturally occurring CD4(+) regulatory T cells. Thus, Foxp3 is a key regulatory gene for the development of regulatory T cells.	Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	RIKEN; Kyoto University	Sakaguchi, S (corresponding author), Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan.		Sakaguchi, Shimon/C-9535-2009; Hori, Shohei/O-6163-2019	Hori, Shohei/0000-0001-8770-4593				Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark LB, 1999, J IMMUNOL, V162, P2546; Coutinho A, 2001, IMMUNOL REV, V182, P89, DOI 10.1034/j.1600-065X.2001.1820107.x; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hori S., UNPUB; Itoh M, 1999, J IMMUNOL, V162, P5317; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Van Parijs L, 1998, SCIENCE, V280, P243; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zahorsky-Reeves JL, 2001, EUR J IMMUNOL, V31, P196, DOI 10.1002/1521-4141(200101)31:1<196::AID-IMMU196>3.0.CO;2-9	31	6218	6849	6	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1057	1061		10.1126/science.1079490	http://dx.doi.org/10.1126/science.1079490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12522256				2022-12-24	WOS:000180960000045
J	Liu, JG; Daily, GC; Ehrlich, PR; Luck, GW				Liu, JG; Daily, GC; Ehrlich, PR; Luck, GW			Effects of household dynamics on resource consumption and biodiversity	NATURE			English	Article							HUMAN-POPULATION; ENERGY USE; HOTSPOTS	Human population size and growth rate are often considered important drivers of biodiversity loss(1-6), whereas household dynamics are usually neglected. Aggregate demographic statistics may mask substantial changes in the size and number of households, and their effects on biodiversity. Household dynamics influence per capita consumption(7,8) and thus biodiversity through, for example, consumption of wood for fuel(9), habitat alteration for home building and associated activities(10-12), and greenhouse gas emissions(13). Here we report that growth in household numbers globally, and particularly in countries with biodiversity hotspots (areas rich in endemic species and threatened by human activities 14), was more rapid than aggregate population growth between 1985 and 2000. Even when population size declined, the number of households increased substantially. Had the average household size (that is, the number of occupants) remained static, there would have been 155 million fewer households in hotspot countries in 2000. Reduction in average household size alone will add a projected 233 million additional households to hotspot countries during the period 2000-15. Rapid increase in household numbers, often manifested as urban sprawl, and resultant higher per capita resource consumption in smaller households(15-19) pose serious challenges to biodiversity conservation.	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA	Michigan State University; Stanford University	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	jliu@panda.msu.edu	Liu, Jianguo/G-5211-2015; feng, tingting/A-9545-2012	Liu, Jianguo/0000-0001-6344-0087; Luck, Gary/0000-0002-7266-5568				An L, 2001, ECOL MODEL, V140, P31, DOI 10.1016/S0304-3800(01)00267-8; BONGAARTS J, 2001, END FERTILITY TRANSI; Cincotta R. P., 2000, NATURES PLACE HUMAN; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Daily G. C., 1997, Nature's services: societal dependence on natural ecosystems., P113; Dompka V, 1996, HUMAN POPULATION BIO; Durrenberger G, 2001, INT J ENVIRON POLLUT, V15, P159, DOI 10.1504/IJEP.2001.000599; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; GARDNEROUTLAW T, 1999, FOREST FUTURES POPUL; HOLDREN JP, 1974, AM SCI, V62, P282; IRONMONGER DS, 1995, ENERG ECON, V17, P301, DOI 10.1016/0140-9883(95)00032-P; KAUL S, 1992, ENERGY, V17, P405, DOI 10.1016/0360-5442(92)90114-F; Kinsella K., 2001, AGEING WORLD, DOI [10.1037/e407472005-001, DOI 10.1037/E407472005-001]; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Kluza DA, 2000, ANIM CONSERV, V3, P15, DOI 10.1017/S1367943000000706; Lenzen M, 2001, ECOL ECON, V37, P229, DOI 10.1016/S0921-8009(00)00275-5; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; MacKellar FL, 1995, POPUL DEV REV, V21, P849, DOI 10.2307/2137777; MICHAEL RT, 1980, DEMOGRAPHY, V17, P39, DOI 10.2307/2060962; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NILON CH, 1995, LANDSCAPE URBAN PLAN, V32, P81, DOI 10.1016/0169-2046(94)00192-6; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Rutledge DT, 2001, CONSERV BIOL, V15, P475, DOI 10.1046/j.1523-1739.2001.015002475.x; SANDIFORD P, 1990, J TROP MED HYG, V93, P383; THOMPSON WC, 1989, LAW HUMAN BEHAV, V13, P185, DOI 10.1007/BF01055923; *UN CTR HUMAN SETT, 2001, CIT GLOB WORLD GLOB; Wilson E.O., 1988, P3; YOUSIF HM, 1995, INT J SUST DEV WORLD, V2, P54, DOI 10.1080/13504509509469889	28	422	456	4	192	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 30	2003	421	6922					530	533		10.1038/nature01359	http://dx.doi.org/10.1038/nature01359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640DB	12540852				2022-12-24	WOS:000180670600044
J	Mack, T				Mack, T			A different view of smallpox and vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESPONSES		Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Southern California	Mack, T (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA.							*ADV COMM IMM PRAC, 2002, SUMM OCT 2002 ACIP S; Alibek K, 1999, BIOHAZARD CHILLING T; *ANDR AIR FORC BAS, 2001, DARK WINT BIOT EX; ARITA I, 1970, AM J PUBLIC HEALTH N, V60, P1960, DOI 10.2105/AJPH.60.10.1960; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BROAD WJ, 2002, NY TIMES A      0615, P1; *BUR LAB STAT, 2002, 2000 NAT IND SPEC OC; COWLEY G, 2002, NEWSWEEK        1014; DERUGY V, 2002, 434 CAT I, P1; DIXON C.W, 1962, SMALLPOX; DOWNIE AW, 1965, B WORLD HEALTH ORGAN, V33, P615; DOWNIE AW, 1961, B WORLD HEALTH ORGAN, V25, P49; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; HEINER GG, 1971, AM J EPIDEMIOL, V94, P435, DOI 10.1093/oxfordjournals.aje.a121340; IRONS JV, 1953, AM J PUBLIC HEALTH, V43, P25, DOI 10.2105/AJPH.43.1.25; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; KEMPE CH, 1960, PEDIATRICS, V26, P176; KEMPE CH, 1961, B WORLD HEALTH ORGAN, V25, P41; LANE JM, 1970, J AMER MED ASSOC, V212, P441, DOI 10.1001/jama.212.3.441; Lane JM, 1972, SMALLPOX YUGOSLAVIA; MACK TM, 1970, J INFECT DIS, V122, P479, DOI 10.1093/infdis/122.6.479; MACK TM, 1972, J INFECT DIS, V125, P161, DOI 10.1093/infdis/125.2.161; MACK TM, 1972, AM J EPIDEMIOL, V95, P169, DOI 10.1093/oxfordjournals.aje.a121382; MARENNIKOVA SS, 1962, B WORLD HEALTH ORGAN, V27, P325; MAYHEW CJ, 1970, APPL MICROBIOL, V20, P313, DOI 10.1128/AEM.20.3.313-316.1970; MEIKLEJOHN G, 1961, B WORLD HEALTH ORGAN, V25, P63; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Palmquist Emil E., 1947, CANADIAN JOUR PUBL HEALTH, V38, P213; Rao AR, 1972, SMALLPOX; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; THOMAS DB, 1972, AM J EPIDEMIOL, V95, P178, DOI 10.1093/oxfordjournals.aje.a121383; THOMAS DB, 1971, AM J EPIDEMIOL, V93, P361, DOI 10.1093/oxfordjournals.aje.a121269; WEINSTEIN I, 1947, AM J PUBLIC HEALTH, V37, P1376	35	41	42	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					460	463		10.1056/NEJMsb022994	http://dx.doi.org/10.1056/NEJMsb022994			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496354				2022-12-24	WOS:000180643800014
J	Gawande, AA; Studdert, DM; Orav, EJ; Brennan, TA; Zinner, MJ				Gawande, AA; Studdert, DM; Orav, EJ; Brennan, TA; Zinner, MJ			Risk factors for retained instruments and sponges after surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAABDOMINAL SURGERY; SURGICAL SPONGE; CLAIMS	Background: Risk factors for medical errors remain poorly understood. We performed a case-control study of retained foreign bodies in surgical patients in order to identify risk factors for this type of error. Methods: We reviewed the medical records associated with all claims or incident reports of a retained surgical sponge or instrument filed between 1985 and 2001 with a large malpractice insurer representing one third of the physicians in Massachusetts. For each case, we identified an average of four randomly selected controls who underwent the same type of operation during the same six-month period. Results: Our study included 54 patients with a total of 61 retained foreign bodies (of which 69 percent were sponges and 31 percent instruments) and 235 control patients. Thirty-seven of the patients with retained foreign bodies (69 percent) required reoperation, and one died. Patients with retained foreign bodies were more likely than controls to have had emergency surgery (33 percent vs. 7 percent, P<0.001) or an unexpected change in surgical procedure (34 percent vs. 9 percent, P<0.001). Patients with retained foreign bodies also had a higher mean body-mass index and were less likely to have had counts of sponges and instruments performed. In multivariate analysis, factors associated with a significantly increased risk of retention of a foreign body were emergency surgery (risk ratio, 8.8 [95 percent confidence interval, 2.4 to 31.9]), unplanned change in the operation (risk ratio, 4.1 [95 percent confidence interval, 1.4 to 12.4]), and body-mass index (risk ratio for each one-unit increment, 1.1 [95 percent confidence interval, 1.0 to 1.2]). Conclusions: The risk of retention of a foreign body after surgery significantly increases in emergencies, with unplanned changes in procedure, and with higher body-mass index. Case -control analysis of medical-malpractice claims may identify and quantify risk factors for specific types of errors.	Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, AA (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Gawande, Atul/0000-0002-1824-9176	AHRQ HHS [KO2HS11285, U18HS11886] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS011886, K02HS011285] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Cheney FW, 1999, ANESTHESIOLOGY, V91, P552, DOI 10.1097/00000542-199908000-00030; CLARK C, 2002, SAN DIEGO UNION 0223, pB1; *DEP HHS, 1980, DHHS PUBL; Gibbs VC, 2001, MAKING HLTH CARE SAF, P255; Gonzalez-Ojeda A, 1999, HEPATO-GASTROENTEROL, V46, P808; HYSLOP JW, 1982, SOUTH MED J, V75, P657, DOI 10.1097/00007611-198206000-00006; Jason R S, 1979, J Natl Med Assoc, V71, P501; Kaiser CW, 1996, ANN SURG, V224, P79, DOI 10.1097/00000658-199607000-00012; KOHN LT, 1999, ERR HUMAN BUILDING S; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; MALERNEE J, 2001, ST PETERSBURG T 0724, P3; Pierson MA., 1995, ALEXANDERS CARE PATI, P19; POPOVIC JR, 2001, ADV DATA VITAL HLTH, V319; RAPPAPORT W, 1990, ARCH SURG-CHICAGO, V125, P405; SMITH C, 2001, SEATTLE POSTINT 1208, pB1; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002	16	580	595	0	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					229	235		10.1056/NEJMsa021721	http://dx.doi.org/10.1056/NEJMsa021721			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529464	Bronze			2022-12-24	WOS:000180390600008
J	Knaut, H; Werz, C; Geisler, R; Nusslein-Volhard, C				Knaut, H; Werz, C; Geisler, R; Nusslein-Volhard, C		Tubingen 2000 Screen Consortium	A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor	NATURE			English	Article							HIV-1 ENTRY; PROTEIN; CHEMOTAXIS; ACTIVATION; AKT/PKB; RNA	Germ cells preserve an individual's genetic information and transmit it to the next generation. Early in development germ cells are set aside and undergo a specialized developmental programme, a hallmark of which is the migration from their site of origin to the future gonad(1). In Drosophila, several factors have been identified that control germ-cell migration to their target tissues(2-4); however, the germ-cell chemoattractant or its receptor have remained unknown. Here we apply genetics and in vivo imaging to show that odysseus, a zebrafish homologue of the G-protein-coupled chemokine receptor Cxcr4, is required specifically in germ cells for their chemotaxis. odysseus mutant germ cells are able to activate the migratory programme, but fail to undergo directed migration towards their target tissue, resulting in randomly dispersed germ cells. SDF-1, the presumptive cognate ligand for Cxcr4, shows a similar loss-of-function phenotype and can recruit germ cells to ectopic sites in the embryo, thus identifying a vertebrate ligand-receptor pair guiding migratory germ cells at all stages of migration towards their target.	Max Planck Inst Entwicklungsbiol, Abt Genet 3, D-72076 Tubingen, Germany	Max Planck Society	Knaut, H (corresponding author), Max Planck Inst Entwicklungsbiol, Abt Genet 3, Spemannstr 35, D-72076 Tubingen, Germany.		Geisler, Robert/K-6201-2013	Geisler, Robert/0000-0002-3909-8311; Dahm, Ralf/0000-0001-5203-8578; Knaut, Holger/0000-0002-8399-8720; Maderspacher, Florian/0000-0003-4324-8455				Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; TACHMINTZIS J, 1994, BIOCONTROL SCI TECHN, V4, P591, DOI 10.1080/09583159409355372; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Weidinger G, 2002, DEVELOPMENT, V129, P25; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	24	328	339	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					279	282		10.1038/nature01338	http://dx.doi.org/10.1038/nature01338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12508118				2022-12-24	WOS:000180397600050
J	Benner, SA				Benner, SA			Act natural	NATURE			English	Editorial Material									Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Benner, SA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.							BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; Gee H, 2001, NATURE, V409, P1079; WOODWARD R B, 1968, Pure and Applied Chemistry, V17, P519, DOI 10.1351/pac196817030519	3	67	73	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					118	118		10.1038/421118a	http://dx.doi.org/10.1038/421118a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520282				2022-12-24	WOS:000180267200020
J	Maas, R; Ventura, R; Kretzschmar, C; Aydin, A; Schuchert, A				Maas, R; Ventura, R; Kretzschmar, C; Aydin, A; Schuchert, A			Syncope, driving recommendations, and clinical reality: survey of patients	BRITISH MEDICAL JOURNAL			English	Article									Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Cardiol, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg	Maas, R (corresponding author), Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, Martinistr 52, D-20246 Hamburg, Germany.							Brignole M, 2001, EUR HEART J, V22, P1256, DOI 10.1053/euhj.2001.2739; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; Olshansky B., 1998, SYNCOPE MECH MANAGEM; Petch MC, 1998, EUR HEART J, V19, P1165; SHELDON R, 1995, AM J CARDIOL, V75, P955, DOI 10.1016/S0002-9149(99)80699-7	5	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					21	21		10.1136/bmj.326.7379.21	http://dx.doi.org/10.1136/bmj.326.7379.21			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511456	Green Published, Bronze			2022-12-24	WOS:000180302000020
J	Call, ME; Pyrdol, J; Wiedmann, M; Wucherpfennig, KW				Call, ME; Pyrdol, J; Wiedmann, M; Wucherpfennig, KW			The organizing principle in the formation of the T cell receptor-CD3 complex	CELL			English	Article							ANTIGEN RECEPTOR; SURFACE EXPRESSION; TCR/CD3 COMPLEX; MULTIVALENT STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEIN; CD3-GAMMA CHAIN; CD3 COMPLEX; IN-VITRO; ASSOCIATION	The T cell receptor (TCR) serves a critical function in the immune system and represents one of the most complex receptor structures. A striking feature is the presence of nine highly conserved, potentially charged residues in the transmembrane helices. Previous models have attempted to explain assembly based on pairwise interactions of these residues. Using a novel method for the isolation of intact radiolabeled protein complexes, we demonstrate that one basic and two acidic transmembrane residues are required for the assembly of each of the three signaling dimers with the TCR. This remarkable three-helix arrangement applies to all three assembly steps and represents the organizing principle for the formation of this intricate receptor structure.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Program Immunol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.			Call, Matthew/0000-0001-5846-6469	NIAID NIH HHS [AI45757, P01 AI045757] Funding Source: Medline; NINDS NIH HHS [R01 NS039096, NS39096] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039096] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; BIJLMAKERS MJE, 1993, EUR J IMMUNOL, V23, P1305, DOI 10.1002/eji.1830230618; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BLUMBERG RS, 1990, P NATL ACAD SCI USA, V87, P7220, DOI 10.1073/pnas.87.18.7220; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BUFERNE M, 1992, J IMMUNOL, V148, P657; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Exley M, 1991, Semin Immunol, V3, P283; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GEISLER C, 1992, J IMMUNOL, V148, P2437; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; JACOBS RR, 1997, INT J OCCUP ENV HL S, V3, P3; KEARSE KP, 1995, IMMUNITY, V2, P391; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	34	307	324	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					967	979		10.1016/S0092-8674(02)01194-7	http://dx.doi.org/10.1016/S0092-8674(02)01194-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507424	Bronze, Green Accepted			2022-12-24	WOS:000180086000007
J	Schubert, WD; Urbanke, C; Ziehm, T; Beier, V; Machner, MP; Domann, E; Wehland, J; Chakraborty, T; Heinz, DW				Schubert, WD; Urbanke, C; Ziehm, T; Beier, V; Machner, MP; Domann, E; Wehland, J; Chakraborty, T; Heinz, DW			Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin	CELL			English	Article							LEUCINE-RICH REPEAT; CELL-ADHESION; SURFACE-PROTEINS; ENTRY; RECOGNITION; REFINEMENT; EXPRESSION; CATENINS; DOMAIN; SRTA	Listeria monocytogenes, a food-borne bacterial pathogen, enters mammalian cells by inducing its own phagocytosis. The listerial protein internalin (InIA) mediates bacterial adhesion and invasion of epithelial cells in the human intestine through specific interaction with its host cell receptor E-cadherin. We present the crystal structures of the functional domain of InIA alone and in a complex with the extracellular, N-terminal domain of human E-cadherin (hEC1). The leucine rich repeat (LRR) domain of InIA surrounds and specifically recognizes hEC1. Individual interactions were probed by mutagenesis and analytical ultracentrifugation. These include Pro16 of hEC1, a major determinant for human susceptibility to L. monocytogenes infection that is essential for intermolecular recognition. Our studies reveal the structural basis for host tropism of this bacterium and the molecular deception L. monocytogenes employs to exploit the E-cadherin system.	German Res Ctr Biotechnol, Dept Biol Struct, D-38124 Braunschweig, Germany; German Res Ctr Biotechnol, Dept Cell Biol, D-38124 Braunschweig, Germany; Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany; Univ Giessen, Inst Med Microbiol, D-35385 Giessen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Justus Liebig University Giessen	Heinz, DW (corresponding author), German Res Ctr Biotechnol, Dept Biol Struct, Mascheroder Weg 1, D-38124 Braunschweig, Germany.	dih@gbf.de	Machner, Matthias/G-2758-2015; Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X; Machner, Matthias/0000-0002-6971-7451				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Daniels JJD, 2000, FEMS MICROBIOL LETT, V190, P323, DOI 10.1016/S0378-1097(00)00356-6; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; DRAMSI S, 1993, MOL MICROBIOL, V9, P931, DOI 10.1111/j.1365-2958.1993.tb01223.x; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galan JE, 2000, CELL, V103, P363, DOI 10.1016/S0092-8674(00)00127-6; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Glaser P, 2001, SCIENCE, V294, P849; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HARTMAN AB, 1990, J BACTERIOL, V172, P1905, DOI 10.1128/jb.172.4.1905-1915.1990; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn RA, 2002, TRENDS BIOCHEM SCI, V27, P308, DOI 10.1016/S0968-0004(02)02108-4; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 2000, J APPL CRYSTALLOGR, V33, P990; Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Lecuit M, 2000, P NATL ACAD SCI USA, V97, P10008, DOI 10.1073/pnas.97.18.10008; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Machner MP, 2001, J BIOL CHEM, V276, P40096, DOI 10.1074/jbc.M104279200; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5; Schlech WF, 2000, CLIN INFECT DIS, V31, P770, DOI 10.1086/314008; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X	57	222	246	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					825	836		10.1016/S0092-8674(02)01136-4	http://dx.doi.org/10.1016/S0092-8674(02)01136-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526809	Bronze			2022-12-24	WOS:000179862600009
J	Jayaraman, KS				Jayaraman, KS			Syngenta ready to drop plans for Indian rice venture	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					596	596		10.1038/420596b	http://dx.doi.org/10.1038/420596b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478254	Bronze			2022-12-24	WOS:000179751800010
J	Cheung, CY; Poon, LLM; Lau, AS; Luk, W; Lau, YL; Shortridge, KF; Gordon, S; Guan, Y; Peiris, JSM				Cheung, CY; Poon, LLM; Lau, AS; Luk, W; Lau, YL; Shortridge, KF; Gordon, S; Guan, Y; Peiris, JSM			Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?	LANCET			English	Article							HUMAN INFECTION; EXPRESSION; TRANSCRIPTION; PATHOGENESIS; INHIBITION; RESPONSES; POULTRY; BLOOD; LUNG	Background In 1997, the first documented instance of human respiratory disease and death associated with a purely avian H5N1 influenza virus resulted in an overall case-fatality rate of 33%. The biological basis for the severity of human H5N1 disease has remained unclear. We tested the hypothesis that virus-induced cytokine dysregulation has a role. Methods We used cDNA arrays and quantitative RT-PCR to, compare the profile of cytokine gene expression induced by viruses A/HK/486/97 and A/HK/483/97 (both H5N1/97) with that of human H3N2 and H1N1 viruses in human primary monocyte-derived macrophages in vitro. Secretion of tumour necrosis factor alpha (TNF alpha) from macrophages infected with the viruses was compared by ELISA. By use of naturally occurring viral reassortants and recombinant viruses generated by reverse genetic techniques, we investigated the viral genes associated with the TNF-alpha response. Findings The H5N1/97 viruses induced much higher gene transcription of proinflammatory cytokines than did H3N2 or H1N1 viruses, particularly TNF alpha. and interferon beta. The concentration of TNF-alpha. protein in culture supernatants of macrophages infected with these viruses was similar to that induced by stimulation with Escherichia coli lipopolysaccharide. The non-structural (NS) gene-segment of H5N1/97 viruses contributed to the increase in TNF alpha induced by the virus. Interpretation The H5N1/97 viruses are potent inducers of proinflammatory cytokines in macrophages, the most notable being TNF alpha. This characteristic may contribute to the unusual severity of human H5N1 disease.	Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Hong Kong; University of Hong Kong; University of Oxford	Peiris, JSM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China.	malik@hkucc.hku.hk	Cheung, Chung Yan/C-4233-2009; Poon, Leo/AAP-6887-2020; Lau, Yu Lung/C-4322-2009; Poon, Leo Lit Man/C-4382-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Poon, Leo Lit Man/0000-0002-9101-7953; Guan, Yi/0000-0001-6057-9243; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				Aggarwal B., 2001, CYTOKINE REFERENCE C, V1, P413; Blaschke V, 2000, J IMMUNOL METHODS, V246, P79, DOI 10.1016/S0022-1759(00)00304-5; Cauthen AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000; Ciesielski CJ, 2002, EUR J IMMUNOL, V32, P2037, DOI 10.1002/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO;2-I; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; DEHOUX MS, 1994, AM J RESP CRIT CARE, V150, P710, DOI 10.1164/ajrccm.150.3.8087341; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; GORDON S, 1997, LUNG MACROPHAGES DEN, P3; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Headley AS, 1997, CHEST, V111, P1306, DOI 10.1378/chest.111.5.1306; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P10096, DOI 10.1073/pnas.152327499; Liu EM, 2001, PEDIATR RES, V50, P184, DOI 10.1203/00006450-200108000-00004; Matikainen S, 2000, VIROLOGY, V276, P138, DOI 10.1006/viro.2000.0542; MONTANER LJ, 1996, WEIRS HDB EXPT IMMUN, V4, P1; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Webby RJ, 2001, PHILOS T R SOC B, V356, P1817, DOI 10.1098/rstb.2001.0997; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	30	693	750	1	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1831	1837		10.1016/S0140-6736(02)11772-7	http://dx.doi.org/10.1016/S0140-6736(02)11772-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480361				2022-12-24	WOS:000179706100011
J	Lardner, B; bin Lakim, M				Lardner, B; bin Lakim, M			Tree-hole frogs exploit resonance effects	NATURE			English	Article							CALL DURATION; GRAY; ACOUSTICS; BURROW; CHOICE		Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA; Sabah Pk, Res & Educ Div, Kota Kinabalu 88806, Sabah, Malaysia	Field Museum of Natural History (Chicago)	Lardner, B (corresponding author), Field Museum Nat Hist, Div Amphibians & Reptiles, Chicago, IL 60605 USA.							BAILEY WJ, 1981, J NAT HIST, V15, P693, DOI 10.1080/00222938100770491; Bailey WJ, 2001, J EXP BIOL, V204, P2827; BENNETCLARK HC, 1987, J EXP BIOL, V128, P383; Daws A. G., 1996, Bioacoustics, V7, P81; Gerhardt H.C., 2002, ACOUSTIC COMMUNICATI; Gerhardt HC, 1996, BEHAV ECOL, V7, P7, DOI 10.1093/beheco/7.1.7; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; KLUMP GM, 1987, NATURE, V326, P286, DOI 10.1038/326286a0; Penna M, 1996, ANIM BEHAV, V51, P255, DOI 10.1006/anbe.1996.0026; PROZESKYSCHULZE L, 1975, NATURE, V255, P142, DOI 10.1038/255142a0; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Wells Kentwood D., 2001, P45	12	73	75	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					475	475		10.1038/420475a	http://dx.doi.org/10.1038/420475a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466831	Bronze			2022-12-24	WOS:000179611600033
J	Wade, CM; Kulbokas, EJ; Kirby, AW; Zody, MC; Mullikin, JC; Lander, ES; Lindblad-Toh, K; Daly, MJ				Wade, CM; Kulbokas, EJ; Kirby, AW; Zody, MC; Mullikin, JC; Lander, ES; Lindblad-Toh, K; Daly, MJ			The mosaic structure of variation in the laboratory mouse genome	NATURE			English	Article							GENETIC-VARIATION; INBRED STRAINS; MICE; DNA	Most inbred laboratory mouse strains are known to have originated from a mixed but limited founder population in a few laboratories(1,2). However, the effect of this breeding history on patterns of genetic variation among these strains and the implications for their use are not well understood. Here we present an analysis of the fine structure of variation in the mouse genome, using single nucleotide polymorphisms (SNPs). When the recently assembled genome sequence from the C57BL/6J strain(3) is aligned with sample sequence from other strains, we observe long segments of either extremely high (similar to40 SNPs per 10 kb) or extremely low (similar to0.5 SNPs per 10 kb) polymorphism rates. In all strain-to-strain comparisons examined, only one-third of the genome falls into long regions (averaging >1 Mb) of a high SNP rate, consistent with estimated divergence rates between Mus musculus domesticus and either M. m. musculus or M. m. castaneus. These data suggest that the genomes of these inbred strains are mosaics with the vast majority of segments derived from domesticus and musculus sources. These observations have important implications for the design and interpretation of positional cloning experiments.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA; Univ Queensland, Sch Vet Sci, St Lucia, Qld 4067, Australia; Sanger Ctr, Hinxton CB10 1RQ, Cambs, England	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Queensland; Wellcome Trust Sanger Institute	Lindblad-Toh, K (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02139 USA.		Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Wade, Claire/0000-0003-3413-4771				Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Prager EM, 1998, GENETICS, V150, P835; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schalkwyk LC, 1999, GENOME RES, V9, P878, DOI 10.1101/gr.9.9.878; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; YONEKAWA H, 1980, JPN J GENET, V55, P289, DOI 10.1266/jjg.55.289	18	370	381	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					574	578		10.1038/nature01252	http://dx.doi.org/10.1038/nature01252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466852	Bronze			2022-12-24	WOS:000179611600055
J	Barbera, JA; Macintyre, AG				Barbera, JA; Macintyre, AG			The reality of the modern bioterrorism response	LANCET			English	Article									George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC 20052 USA	George Washington University	Barbera, JA (corresponding author), George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC 20052 USA.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S33	S34		10.1016/S0140-6736(02)11812-5	http://dx.doi.org/10.1016/S0140-6736(02)11812-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504495	Bronze			2022-12-24	WOS:000180064500016
J	MacKie, RM; Bray, CA; Hole, DJ				MacKie, RM; Bray, CA; Hole, DJ			Observational study of type of surgical training and outcome of definitive surgery for primary malignant melanoma	BRITISH MEDICAL JOURNAL			English	Article							SURVIVAL; MARGINS		Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow	MacKie, RM (corresponding author), Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland.		Kelly, Caroline/AAZ-4146-2021	Kelly, Caroline/0000-0002-5330-7888				BALCH CM, 1993, ANN SURG, V218, P262, DOI 10.1097/00000658-199309000-00005; COX DR, 1972, J R STAT SOC B, V34, P187; MacKie RM, 1997, BRIT MED J, V315, P1117, DOI 10.1136/bmj.315.7116.1117; SAINSBURY R, 1995, LANCET, V345, P1265, DOI 10.1016/S0140-6736(95)90924-9; VERONESI U, 1988, NEW ENGL J MED, V318, P1159, DOI 10.1056/NEJM198805053181804	5	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 30	2002	325	7375					1276	1277		10.1136/bmj.325.7375.1276	http://dx.doi.org/10.1136/bmj.325.7375.1276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623HB	12458246	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000179696300018
J	Bezerra, JA; Tiao, G; Ryckman, FC; Alonso, M; Sabla, GE; Shneider, B; Sokol, RJ; Aronow, BJ				Bezerra, JA; Tiao, G; Ryckman, FC; Alonso, M; Sabla, GE; Shneider, B; Sokol, RJ; Aronow, BJ			Genetic induction of proinflammatory immunity in children with billary atresia	LANCET			English	Article							EXTRAHEPATIC BILIARY ATRESIA; BILE-DUCTS; T-CELLS; EXPRESSION; LIVER; INTERLEUKIN-8; OSTEOPONTIN; DISEASE; GAMMA	Background Biliary atresia is the commonest cause of pathological jaundice in infants and the leading indication for liver transplantation in children worldwide. The cause and pathogenesis remain largely unknown. Because of clinical heterogeneity and experimental difficulties in addressing molecular mechanisms underlying multifactorial disorders in human beings, we searched for genomic signatures of biliary atresia in affected infants. Methods We generated pools of biotinylated cRNA from livers of 14 infants with biliary atresia and six with neonatal intrahepatic cholestasis (diseased controls) and hybridised the cRNA against oligonucleotide-based gene chips. Immunohistochemistry and reverse transcriptase (RT)-PCR were used to assess the specificity of the findings and functional commitment of lymphocytes in affected livers. Findings Data filtering, to identify genes that are differentially expressed, and cluster analysis revealed a predominant and coordinated activation of immunity/inflammation genes within the livers of infants with biliary atresia. Most of the genes showed differential lymphocyte function, with activation of osteopontin, a regulator of cell-mediated (T-helper 1 [Th-1]) immunity in T-helper lymphocytes, and suppression of immunoglobulin genes in early stages of disease. These findings were associated with production of interferon gamma in 65% of infants with biliary atresia and no diseased control. However, histologically similar inflammatory infiltrates were present in livers of both groups, implying differential activation states of similar cell types. Interpretation Livers of infants with biliary atresia have a coordinated activation of genes involved in lymphocyte differentiation. Among these genes, the overexpression of osteopontin and interferon gamma points to a potential role of Th-1-like cytokines in disease pathogenesis.	Childrens Hosp, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Div Surg, Cincinnati, OH 45229 USA; Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Cincinnati, OH USA; Mt Sinai Sch Med, Div Pediat Gastroenterol & Hepatol, New York, NY USA; Univ Colorado, Hlth Sci Ctr, Pediat Liver Ctr, Sect Pediat Gastroenterol Hepatol & Nutr, Denver, CO USA; Childrens Hosp, Denver, CO 80218 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado	Bezerra, JA (corresponding author), Childrens Hosp, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.		Aronow, Bruce J/F-8438-2012					Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Ahmed AFKU, 2001, J PATHOL, V193, P383; Balistreri WF, 1996, HEPATOLOGY, V23, P1682, DOI 10.1002/hep.510230652; Bezerra JA, 1999, P NATL ACAD SCI USA, V96, P15143, DOI 10.1073/pnas.96.26.15143; Broome U, 1997, J HEPATOL, V26, P857, DOI 10.1016/S0168-8278(97)80253-X; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Davenport M, 2001, J PEDIATR SURG, V36, P1017, DOI 10.1053/jpsu.2001.24730; Delhanty PJD, 2001, AM J PHYSIOL-ENDOC M, V280, pE287, DOI 10.1152/ajpendo.2001.280.2.E287; Eystathioy T, 2000, J AUTOIMMUN, V14, P179, DOI 10.1006/jaut.1999.0359; Fukushi M, 1999, FEBS LETT, V442, P83, DOI 10.1016/S0014-5793(98)01631-7; Hu HM, 1998, J IMMUNOL, V160, P2334; Kameda H, 1998, ANN RHEUM DIS, V57, P366, DOI 10.1136/ard.57.6.366; Kelley-Loughnane N, 2002, HEPATOLOGY, V35, P525, DOI 10.1053/jhep.2002.31351; Lamireau T, 1999, J HEPATOL, V31, P248, DOI 10.1016/S0168-8278(99)80221-9; Marchant A, 1999, J IMMUNOL, V163, P2249; Mazziotti MV, 1999, HEPATOLOGY, V30, P372, DOI 10.1002/hep.510300223; Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; OHYA T, 1995, J PEDIATR SURG, V30, P515, DOI 10.1016/0022-3468(95)90120-5; Oxelius VA, 1999, SCAND J IMMUNOL, V50, P440, DOI 10.1046/j.1365-3083.1999.00618.x; Oxelius VA, 1998, INT ARCH ALLERGY IMM, V115, P215, DOI 10.1159/000023903; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Prescott SL, 1997, INT ARCH ALLERGY IMM, V113, P75, DOI 10.1159/000237512; Ramm GA, 1998, AM J PATHOL, V153, P527, DOI 10.1016/S0002-9440(10)65595-2; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; TAKAISHI K, 1993, MOL CELL BIOL, V13, P72, DOI 10.1128/MCB.13.1.72; Urushihara N, 2000, J PEDIATR SURG, V35, P446, DOI 10.1016/S0022-3468(00)90211-2; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009	30	144	155	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 23	2002	360	9346					1653	1659		10.1016/S0140-6736(02)11603-5	http://dx.doi.org/10.1016/S0140-6736(02)11603-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618AE	12457789				2022-12-24	WOS:000179393900011
J	Delaunay, A; Pflieger, D; Barrault, MB; Vinh, J; Toledano, MB				Delaunay, A; Pflieger, D; Barrault, MB; Vinh, J; Toledano, MB			A thiol peroxidase is an H2O2 receptor and redox-transducer in gene activation	CELL			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS-RESPONSE; TRANSCRIPTION FACTOR; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; THIOREDOXIN; YAP1; REDUCTASE; CATALYSIS; PROTEINS	The Yap1 transcription factor regulates hydroperoxide homeostasis in S. cerevisiae. Yap1 is activated by oxidation when hydroperoxide levels increase. We show that Yap1 is not directly oxidized by hydroperoxide. We identified the glutathione peroxidase (GPX)-like enzyme Gpx3 as a second component of the pathway, serving the role of sensor and transducer of the hydroperoxide signal to Yap1. When oxidized by H2O2, Gpx3 Cys36 bridges Yap1 Cys598 by a disulfide bond. This intermolecular disulfide bond is then resolved into a Yap1 intramolecular disulfide bond, the activated form of the regulator. Thioredoxin turns off the pathway by reducing both sensor and regulator. These data reveal a redox-signaling function for a GPx-like enzyme and elucidate a eukaryotic hydroperoxide-sensing mechanism. Gpx3 is thus a hydroperoxide receptor and redox-transducer.	CEA Saclay, Lab Stress Oxydants & Canc, SBGM, DBJC, F-91191 Gif Sur Yvette, France; Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, Lab Neurobiol & Divers Cellulaire, F-75231 Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Toledano, MB (corresponding author), CEA Saclay, Lab Stress Oxydants & Canc, SBGM, DBJC, F-91191 Gif Sur Yvette, France.	toledano@jonas.saclay.cea.fr	Delaunay-moisan, Agnes/GRX-7749-2022; Vinh, Joelle/K-1347-2015	Delaunay-moisan, Agnes/0000-0003-3105-221X; Vinh, Joelle/0000-0001-7184-2668				Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godeas C, 1997, BIOL REPROD, V57, P1502, DOI 10.1095/biolreprod57.6.1502; Gonzalez-Flecha B, 2000, ANN NY ACAD SCI, V899, P69; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Izawa S, 1999, J BIOL CHEM, V274, P28459, DOI 10.1074/jbc.274.40.28459; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kuge S, 1998, GENES CELLS, V3, P521, DOI 10.1046/j.1365-2443.1998.00209.x; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Maiorino M, 1999, BIOFACTORS, V10, P251, DOI 10.1002/biof.5520100224; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SIKORSKI RS, 1989, GENETICS, V122, P19; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Ursini F, 1997, BIOMED ENVIRON SCI, V10, P327; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; WU AL, 1993, J BIOL CHEM, V268, P18850; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	31	666	695	2	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2002	111	4					471	481		10.1016/S0092-8674(02)01048-6	http://dx.doi.org/10.1016/S0092-8674(02)01048-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437921	Bronze			2022-12-24	WOS:000179346900001
J	O'Kelly, I; Butler, MH; Zilberberg, N; Goldstein, SAN				O'Kelly, I; Butler, MH; Zilberberg, N; Goldstein, SAN			Forward transport: 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals	CELL			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; 2 PORE DOMAINS; POTASSIUM LEAK CHANNELS; INVARIANT CHAIN; PROTEIN-KINASE; K+ CHANNEL; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; 14-3-3-PROTEINS; TRAFFICKING	Proteins with dibasic retention motifs are subject to retrograde transport to endoplasmic reticulum (ER) by COPI-coated vesicles. As forward transport requires escape from ER retention, general release mechanisms have been expected. Here, KCNK3 potassium channels are shown to bear two cytoplasmic trafficking motifs: an N-terminal dibasic site that binds P-COP to hold channels in ER and a C-terminal "release" site that binds the ubiquitous intracellular regulator 14-3-3beta on a nonclassical motif in a phosphorylation-dependent fashion to suppress P-COP binding and allow forward transport. The strategy appears to be common. The major histocompatibility antigen class II-associated invariant chain lip35 exhibits dibasic retention, carries a release motif, and shows mutually exclusive binding of P-COP and 14-3-3beta on adjacent N-terminal sites. Other retained proteins are demonstrated to carry functional 14-3-3beta release motifs.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, New Haven, CT 06536 USA	Yale University; Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St, New Haven, CT 06536 USA.		Zilberberg, Noam/F-2005-2012; Goldstein, Steven A./E-9817-2015	Zilberberg, Noam/0000-0002-7848-2391; Goldstein, Steven A./0000-0001-5207-5061				Anderson HA, 1999, J IMMUNOL, V163, P5435; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Campbell JK, 1997, BIOCHEMISTRY-US, V36, P15363, DOI 10.1021/bi9708085; Craparo A, 1997, J BIOL CHEM, V272, P11663; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; GELPERIN D, 1995, P NATL ACAD SCI USA, V92, P11539, DOI 10.1073/pnas.92.25.11539; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Kim YM, 1999, HEALTH COMMUN, V11, P1, DOI 10.1207/s15327027hc1101_1; Kindler CH, 1999, ANESTHESIOLOGY, V90, P1092, DOI 10.1097/00000542-199904000-00024; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kuwana T, 1998, P NATL ACAD SCI USA, V95, P1056, DOI 10.1073/pnas.95.3.1056; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; McGehee DS, 1999, ANN NY ACAD SCI, V868, P565, DOI 10.1111/j.1749-6632.1999.tb11330.x; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NIGAM SK, 1989, J BIOL CHEM, V264, P16927; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; PALLAS DC, 1994, SCIENCE, V265, P535, DOI 10.1126/science.8036498; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schroder-Kohne S, 1998, J CELL SCI, V111, P3459; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; TOKER A, 1990, EUR J BIOCHEM, V191, P421, DOI 10.1111/j.1432-1033.1990.tb19138.x; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	56	237	241	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 15	2002	111	4					577	588		10.1016/S0092-8674(02)01040-1	http://dx.doi.org/10.1016/S0092-8674(02)01040-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437930	Bronze			2022-12-24	WOS:000179346900010
J	Levy, JA				Levy, JA			Is HIV superinfection worrisome?	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; AIDS PATIENT; INFECTION; INDIVIDUALS; COINFECTION; TYPE-1; WOMEN		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Barker E, 1996, J GEN VIROL, V77, P2953, DOI 10.1099/0022-1317-77-12-2953; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; EVANS LA, 1988, LANCET, V2, P1389; FULTZ PN, 1987, J VIROL, V61, P4026, DOI 10.1128/JVI.61.12.4026-4029.1987; Goulder PJR, 2002, NEW ENGL J MED, V347, P756, DOI 10.1056/NEJMe020091; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kampinga GA, 1997, VIROLOGY, V227, P63, DOI 10.1006/viro.1996.8318; Levy JA, 2001, LANCET, V357, P223, DOI 10.1016/S0140-6736(00)03601-1; Levy JA, 1998, HIV PATHOGENESIS AID; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; RAYFIELD M, 1988, J INFECT DIS, V158, P1170, DOI 10.1093/infdis/158.6.1170; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Stranford SA, 2001, P NATL ACAD SCI USA, V98, P597, DOI 10.1073/pnas.021550598; Takehisa J, 1997, J ACQ IMMUN DEF SYND, V14, P81, DOI 10.1097/00042560-199701010-00015; 2002, REUTERS         0904	18	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					98	99		10.1016/S0140-6736(03)12242-8	http://dx.doi.org/10.1016/S0140-6736(03)12242-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531573				2022-12-24	WOS:000180428000005
J	Tuomisto, H; Ruokolainen, K; Yli-Halla, M				Tuomisto, H; Ruokolainen, K; Yli-Halla, M			Dispersal, environment, and floristic variation of western Amazonian forests	SCIENCE			English	Article							RAIN-FOREST; PATTERNS; BASIN; DIVERSITY; ECOLOGY; HISTORY	The distribution of plant species, the species compositions of different sites, and the factors that affect them in tropical rain forests are not well understood. The main hypotheses are that species composition is either (i) uniform over large areas, (ii) random but spatially autocorrelated because of dispersal limitation, or (iii) patchy and environmentally determined. Here we test these hypotheses, using a large data set from western Amazonia. The uniformity hypothesis gains no support, but the other hypotheses do. Environmental determinism explains a larger proportion of the variation in floristic differences between sites than does dispersal limitation; together, these processes explain 70 to 75% of the variation. Consequently, it is important that management planning for conservation and resource use take into account both habitat heterogeneity and biogeographic differences.	Univ Turku, Dept Biol, FIN-20014 Turku, Finland; MTT Agrifood Res Finland, FIN-31600 Jokioinen, Finland	University of Turku; Natural Resources Institute Finland (Luke)	Tuomisto, H (corresponding author), Univ Turku, Dept Biol, FIN-20014 Turku, Finland.	hantuo@utu.fi	Ruokolainen, Kalle/G-3141-2013; Yli-Halla, Markku/B-5567-2015; Tuomisto, Hanna/G-6483-2012	Ruokolainen, Kalle/0000-0002-7494-9417; Tuomisto, Hanna/0000-0003-1640-490X				BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Botschek J, 1996, GEODERMA, V72, P119, DOI 10.1016/0016-7061(96)00026-2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Condit R, 1996, TRENDS ECOL EVOL, V11, P4, DOI 10.1016/0169-5347(96)81054-8; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; RASANEN M, 1992, GEOL MAG, V129, P293, DOI 10.1017/S0016756800019233; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 2002, SCIENCE, V297; SANCHEZ PA, 1974, SOIL SCI SOC AM J, V38, P117, DOI 10.2136/sssaj1974.03615995003800010036x; Terborgh J, 1998, J TROP ECOL, V14, P645, DOI 10.1017/S0266467498000455; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tuomisto H, 1996, J BIOGEOGR, V23, P283, DOI 10.1046/j.1365-2699.1996.00044.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; TUOMISTO H, IN PRESS ECOL APPL; Vormisto J, 2000, ECOGRAPHY, V23, P349, DOI 10.1034/j.1600-0587.2000.d01-1644.x; Whitfield J, 2002, NATURE, V417, P480, DOI 10.1038/417480a; WHITTAKER RH, 1977, THEOR POPUL BIOL, V12, P117, DOI 10.1016/0040-5809(77)90039-9	29	724	783	10	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					241	244		10.1126/science.1078037	http://dx.doi.org/10.1126/science.1078037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522248				2022-12-24	WOS:000180284000036
J	Holzenberger, M; Dupont, J; Ducos, B; Leneuve, P; Geloen, A; Even, PC; Cervera, P; Le Bouc, Y				Holzenberger, M; Dupont, J; Ducos, B; Leneuve, P; Geloen, A; Even, PC; Cervera, P; Le Bouc, Y			IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice	NATURE			English	Article							INSULIN-RECEPTOR; GROWTH-HORMONE; DWARF MICE; LONGEVITY; GENE; MUTATIONS; EXTENSION; CANCER; TISSUE	Studies in invertebrates have led to the identification of a number of genes that regulate lifespan, some of which encode components of the insulin or insulin-like signalling pathways(1-3). Examples include the related tyrosine kinase receptors InR (Drosophila melanogaster) and DAF-2 (Caenorhabditis elegans) that are homologues of the mammalian insulin-like growth factor type 1 receptor (IGF-1R). To investigate whether IGF-1R also controls longevity in mammals, we inactivated the IGF-1R gene in mice (Igf1r). Here, using heterozygous knockout mice because null mutants are not viable, we report that Igf1r (+/-) mice live on average 26% longer than their wild-type littermates (P < 0.02). Female Igf1r (+/-) mice live 33% longer than wild-type females (P < 0.001), whereas the equivalent male mice show an increase in lifespan of 16%, which is not statistically significant. Long-lived Igf1r (+/-) mice do not develop dwarfism, their energy metabolism is normal, and their nutrient uptake, physical activity, fertility and reproduction are unaffected. The Igf1r (+/-) mice display greater resistance to oxidative stress, a known determinant of ageing. These results indicate that the IGF-1 receptor may be a central regulator of mammalian lifespan.	INSERM, U515, F-75571 Paris 12, France; Hop St Antoine, Serv Anat & Cytol Pathol, F-75571 Paris 12, France; INRA, F-37380 Nouzilly, France; Inst Natl Sci Appl, INSERM, U352, F-69621 Villeurbanne, France; INA PG, INRA, F-75231 Paris 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; INRAE	Holzenberger, M (corresponding author), INSERM, U515, F-75571 Paris 12, France.	holzenberger@st-antoine.inserm.fr	Holzenberger, Martin/N-9732-2018; GELOEN, Alain/D-6725-2011	GELOEN, Alain/0000-0001-7921-1254; Even, Patrick/0000-0001-5733-3023; Holzenberger, Martin/0000-0003-4869-725X; Ducos, Bertrand/0000-0002-5322-1339				Bartke A, 2001, TRENDS ENDOCRIN MET, V12, P233, DOI 10.1016/S1043-2760(01)00426-X; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gems D, 2001, CURR OPIN GENET DEV, V11, P287, DOI 10.1016/S0959-437X(00)00192-1; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Holzenberger M, 2001, ENDOCRINOLOGY, V142, P4469, DOI 10.1210/en.142.10.4469; Holzenberger M, 2000, ENDOCRINOLOGY, V141, P2557, DOI 10.1210/en.141.7.2557; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hunter WS, 1999, PHYSIOL BEHAV, V67, P433, DOI 10.1016/S0031-9384(99)00098-0; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sun JT, 1999, MOL CELL BIOL, V19, P216; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tissenbaum HA, 1998, GENETICS, V148, P703; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	30	1512	1573	3	187	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					182	187		10.1038/nature01298	http://dx.doi.org/10.1038/nature01298			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12483226	Green Submitted			2022-12-24	WOS:000180267200045
J	Taylor, MS; Hellberg, ME				Taylor, MS; Hellberg, ME			Genetic evidence for local retention of pelagic larvae in a Caribbean reef fish	SCIENCE			English	Article							SEXUAL SELECTION; POPULATION; CONNECTIVITY; RECRUITMENT; VARIANCE	The pelagic larvae of many marine organisms can potentially disperse across hundreds of kilometers, but whether oceanographic or behavioral mechanisms can constrain dispersal over periods sufficient for the evolution of genetic differentiation remains unclear. Here, we concurrently examine larval duration and genetic population differentiation in a cleaner goby, Elacatinus evelynae, a member of the most species-rich genus of Caribbean reef fishes. Despite evidence for extended pelagic duration (21 days), populations of E. evelynae show strong genetic differentiation: among color forms (1.36 to 3.04% divergent at mitochondrial cytochrome b) and among island populations within color forms (Phi(ST) up to 70%). These results suggest that marine populations can remain demographically closed for thousands of generations despite extended larval duration, and that recognition cues such as color may promote speciation when geographic barriers are transient or weak.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Taylor, MS (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.		Gilbert, Marcus TP/A-8936-2013; 平山, 幸恵 Ｓ/G-9307-2012	Gilbert, Marcus TP/0000-0002-5805-7195; 				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BOHLKE JE, 1968, P ACAD NAT SCI PHILA, V120, P45; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Burton R.S., 1982, ESTUARINE COMP, P537, DOI [10.1016/b978-0-12-404070-0.50038-7., DOI 10.1016/B978-0-12-404070-0.50038-7]; Colin P., 1975, COLIN; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; EXCOFFIER L, 1992, GENETICS, V131, P479; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Leis J.M., 1991, P183; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; Nelson J.S., 2016, FISHES WORLD, V5th ed., DOI [https://doi.org/10.1002/9781119174844.fmatter, DOI 10.1002/9781119174844.FMATTER, 10.1002/9781119174844]; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Palumbi SR, 1998, ENDLESS FORMS, P271; Riginos C, 2001, P ROY SOC B-BIOL SCI, V268, P1931, DOI 10.1098/rspb.2001.1748; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Warner RR, 1997, CORAL REEFS, V16, pS115, DOI 10.1007/s003380050247	23	433	441	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					107	109		10.1126/science.1079365	http://dx.doi.org/10.1126/science.1079365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511651				2022-12-24	WOS:000180165800044
J	Imamura, H; Takayama, T; Sugawara, Y; Kokudo, N; Aoki, T; Kaneko, J; Matsuyama, Y; Sano, K; Maema, A; Makuuchi, M				Imamura, H; Takayama, T; Sugawara, Y; Kokudo, N; Aoki, T; Kaneko, J; Matsuyama, Y; Sano, K; Maema, A; Makuuchi, M			Pringle's manoeuvre in living donors	LANCET			English	Article							TRANSPLANTATION	The safety of the donor is paramount in living donor liver transplantation. The most important risk to the donor during hepatectomy is bleeding, and the inflow occlusion technique (Pringle's manoeuvre) has been reported to decrease bleeding without inducing liver injury in liver surgery. However, most transplant centres are doing donor hepatectomies without this technique for fear that it would result in ischaemic injury to the graft. We have done 46 living donor hepatectomies with Pringle's manoeuvre without any negative outcome on the quality of the graft. Surgeons should not hesitate to apply this technique in living donor hepatectomy.	Univ Tokyo, Grad Sch Med, Div Hepatobillary Pancreat Surg & Artificial Orga, Dept Surg,Bunkyo Ku, Tokyo 1130033, Japan; Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan	University of Tokyo; Kyoto University	Makuuchi, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Hepatobillary Pancreat Surg & Artificial Orga, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makuuchi-tky@umin.ac.jp	Sano, Keiji/ABI-6150-2020; 幕内, 雅敏 m/A-2140-2012					Arai M, 2000, HEPATOLOGY, V32, P297, DOI 10.1053/jhep.2000.8896; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Strong RW, 2000, LIVER TRANSPLANT, V6, P250, DOI 10.1016/S1527-6465(00)80024-6; Surman OS, 2002, NEW ENGL J MED, V346, P1038, DOI 10.1056/NEJM200204043461402; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629	5	82	83	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2049	2050		10.1016/S0140-6736(02)11995-7	http://dx.doi.org/10.1016/S0140-6736(02)11995-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504404				2022-12-24	WOS:000179974200016
J	Vera, A; Moledina, S; Gunson, B; Hubscher, S; Mirza, D; Olliff, S; Neuberger, J				Vera, A; Moledina, S; Gunson, B; Hubscher, S; Mirza, D; Olliff, S; Neuberger, J			Risk factors for recurrence of primary sclerosing cholangitis of liver allograft	LANCET			English	Article								Primary sclerosing cholangitis (PSC) is a disease of unknown cause that effects the biliary tree and is closely associated with inflammatory bowel disease. We did a retrospective analysis of the risk factors associated with recurrence of PSC in an allograft after liver transplantation. Recurrence of disease, assessed by liver histology or imaging the biliary tree, occurred in 56 of 152 patients (37%) at a median of 36 months (range 1.4-120 months). Multivariate analysis showed that being male (relative risk 1.2, 95% CI 0.73-2.15) and an intact colon before transplantation (8.7, 1.19-64.48) were associated with recurrence. These observations could help elucidate the pathogenesis of the disease.	Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Neuberger, J (corresponding author), Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England.	J.M.Neuberger@bham.ac.uk	Neuberger, James/ABG-3010-2020	Gunson, Bridget/0000-0001-6149-9915				Cullen S, 2001, BEST PRACT RES CL GA, V15, P577, DOI 10.1053/bega.2001.0206; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; HARRISON RF, 1994, HEPATOLOGY, V20, P356, DOI 10.1002/hep.1840200214; Sheng R, 1996, AM J ROENTGENOL, V166, P1109, DOI 10.2214/ajr.166.5.8615253; Zein C O, 2001, Semin Gastrointest Dis, V12, P103	5	139	140	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2002	360	9349					1943	1944		10.1016/S0140-6736(02)11861-7	http://dx.doi.org/10.1016/S0140-6736(02)11861-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493264				2022-12-24	WOS:000179870200016
J	Check, E				Check, E			All mutants great and small	NATURE			English	Article																			0	1	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					457	457		10.1038/420457a	http://dx.doi.org/10.1038/420457a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466811				2022-12-24	WOS:000179611600014
J	Churchill, GC; Okada, Y; Thomas, JM; Genazzani, AA; Patel, S; Galione, A				Churchill, GC; Okada, Y; Thomas, JM; Genazzani, AA; Patel, S; Galione, A			NAADP mobilizes Ca(2+) from reserve granules, lysosome-related organelles, in sea urchin eggs	CELL			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PANCREATIC ACINAR-CELLS; INTRACELLULAR CALCIUM; INOSITOL TRISPHOSPHATE; RELEASE; STORES; THAPSIGARGIN; COORDINATION; INACTIVATION	Nicotinic acid adenine dinucleotide phosphate (NAADP) mobilizes Call in many cells and species. Unlike other Ca(2+)-mobilizing messengers, NAADP mobilizes Ca(2+) from an unknown store that is not the endoplasmic reticulum, the store traditionally associated with messenger-mediated Ca(2+) signaling. Here, we demonstrate the presence of a Ca(2+) store in sea urchin eggs mobilized by NAADP that is dependent on a proton gradient maintained by an ATP-dependent vacuolar-type proton pump. Moreover, we provide pharmacological and biochemical evidence that this Ca(2+) store is the reserve granule, the functional equivalent of a lysosome in the sea urchin egg. These findings represent an unsuspected mechanism for messenger-mediated Ca(2+) release from lysosome-related organelles.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; UCL, Dept Physiol, London WC1E 6BT, England	University of Oxford; University of Cambridge; University of London; University College London	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	grant.churchill@pharm.ox.ac.uk	Galione, Antony/E-5884-2011; Genazzani, Armando/AAI-8280-2020; Patel, Sandip/O-9591-2015	Galione, Antony/0000-0002-4132-7646; Genazzani, Armando/0000-0003-1923-7430; Patel, Sandip/0000-0001-7247-2013				Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; ARMANT DR, 1986, DEV BIOL, V113, P342, DOI 10.1016/0012-1606(86)90169-7; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; CLAPPER DL, 1985, J BIOL CHEM, V260, P3947; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Docampo R, 1999, PARASITOL TODAY, V15, P443, DOI 10.1016/S0169-4758(99)01531-8; Galione A, 2000, BIOL CELL, V92, P197, DOI 10.1016/S0248-4900(00)01070-4; GALIONE A, 2000, CYCLIC ADP RIBOSE CA; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gonzalez A, 1997, PFLUG ARCH EUR J PHY, V434, P609, DOI 10.1007/s004240050443; GUSE AH, 1994, BIOCHEM J, V301, P83, DOI 10.1042/bj3010083; Haller T, 1996, CELL CALCIUM, V19, P157, DOI 10.1016/S0143-4160(96)90084-6; JADOT M, 1984, BIOCHEM J, V219, P965, DOI 10.1042/bj2190965; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Lee HC, 1997, J BIOL CHEM, V272, P4172, DOI 10.1074/jbc.272.7.4172; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; McNeil PL, 2000, J CELL SCI, V113, P1891; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Patel S, 2000, BIOCHEM J, V352, P725, DOI 10.1042/0264-6021:3520725; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; ROONEY EK, 1992, P NATL ACAD SCI USA, V89, P8025, DOI 10.1073/pnas.89.17.8025; SCHUEL H, 1975, DEV BIOL, V46, P404, DOI 10.1016/0012-1606(75)90116-5; SUGAYA E, 1978, SCIENCE, V202, P1195, DOI 10.1126/science.725594; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; WILLIAMS J, 1967, BIOCHEMISTRY ANIMAL, V2, P341; Yagodin S, 1999, CELL CALCIUM, V25, P429, DOI 10.1054/ceca.1999.0043	34	380	386	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					703	708		10.1016/S0092-8674(02)01082-6	http://dx.doi.org/10.1016/S0092-8674(02)01082-6			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464181	Bronze			2022-12-24	WOS:000179594500011
J	Patton, GC; Coffey, C; Carlin, JB; Degenhardt, L; Lynskey, M; Hall, W				Patton, GC; Coffey, C; Carlin, JB; Degenhardt, L; Lynskey, M; Hall, W			Cannabis use and mental health in young people: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-USE; COMMUNITY; ABUSE	Objective To determine whether cannabis use in adolescence predisposes to higher rates of depression and anxiety in young adulthood. Design Seven wave cohort study over six years. Setting 44 schools in the Australian state of Victoria. Participants A statewide secondary school sample of 1601 students aged 14-15 followed for seven years. Main outcome measure Interview measure of depression and anxiety (revised clinical interview schedule) at wave 7. Results Some 60% of participants had used cannabis by the age of 20; 7% were daily users at that point. Daily use in young women was associated with an over fivefold increase in the odds of reporting a state of depression and anxiety after adjustment for intercurrent use of other substances (odds ratio 5.6, 95% confidence interval 2.6 to 12). Weekly or more frequent cannabis use in teenagers predicted an approximately twofold increase in risk for later depression and anxiety (1.9, 1.1 to 3.3) after adjustment for potential baseline confounders. In contrast, depression and anxiety in teenagers predicted neither later weekly nor daily cannabis use. Conclusions Frequent cannabis use in teenage girls predicts later depression and anxiety, with daily users carrying the highest risk. Given recent increasing levels of cannabis use, measures to reduce frequent and heavy recreational use seem warranted.	Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Clin Epidemiol & Biostat Unit, Parkville, Vic, Australia; Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Univ Queensland, Inst Mol Biosci, Off Publ Policy & Eth, Brisbane, Qld 4072, Australia	Murdoch Children's Research Institute; Murdoch Children's Research Institute; University of New South Wales Sydney; Washington University (WUSTL); University of Queensland	Patton, GC (corresponding author), Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia.	gpatton@cryptic.rch.unimelb.edu.au	Degenhardt, Louisa J/D-4515-2012; Ribeiro, Ana Cristina/HHN-7466-2022; Carlin, John/AAG-4332-2020; Hall, Wayne D/A-3283-2008; Lynskey, michael T/B-9179-2016; Lynskey, Michael T/A-3181-2008; Carlin, John B/B-3492-2012; Patton, George C/B-5246-2013	Degenhardt, Louisa J/0000-0002-8513-2218; Ribeiro, Ana Cristina/0000-0002-0493-8376; Carlin, John/0000-0002-2694-9463; Hall, Wayne D/0000-0003-1984-0096; Carlin, John B/0000-0002-2694-9463; Patton, George C/0000-0001-5039-8326				Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Bebbington PE, 1998, PSYCHOL MED, V28, P9, DOI 10.1017/S0033291797006077; Bovasso GB, 2001, AM J PSYCHIAT, V158, P2033, DOI 10.1176/appi.ajp.158.12.2033; Degenhardt L, 2001, ADDICTION, V96, P1603, DOI 10.1046/j.1360-0443.2001.961116037.x; Fergusson DM, 1997, ADDICTION, V92, P279; Green BE, 2000, J HEALTH SOC BEHAV, V41, P40, DOI 10.2307/2676359; Hall W, 1998, DRUG ALCOHOL REV, V17, P433, DOI 10.1080/09595239800187271; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lewis G., 1992, MANUAL CIS R; LINSZEN DH, 1994, ARCH GEN PSYCHIAT, V51, P273; McGee R, 2000, ADDICTION, V95, P491, DOI 10.1046/j.1360-0443.2000.9544912.x; MOFFITT TE, 1988, AUST NZ J CRIMINOL, V21, P227, DOI 10.1177/000486588802100405; PAPERNY DM, 1990, J PEDIATR-US, V116, P456, DOI 10.1016/S0022-3476(05)82844-6; PATON S, 1977, J GENET PSYCHOL, V131, P267, DOI 10.1080/00221325.1977.10533299; RAMSAY M, 1977, DRUG USED DECLARED 1; Reilly D, 1998, ADDICTION, V93, P837, DOI 10.1046/j.1360-0443.1998.9368375.x; Rey JM, 2002, BRIT J PSYCHIAT, V180, P216, DOI 10.1192/bjp.180.3.216; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 2002, J COMPUT GRAPH STAT, V11, P437, DOI 10.1198/106186002760180608; Smart RG, 2000, ADDICT BEHAV, V25, P455, DOI 10.1016/S0306-4603(99)00013-1; Strang J, 2000, BMJ-BRIT MED J, V320, P108, DOI 10.1136/bmj.320.7227.108; Thomas H, 1996, DRUG ALCOHOL DEPEN, V42, P201, DOI 10.1016/S0376-8716(96)01277-X; Troisi A, 1998, ADDICTION, V93, P487, DOI 10.1046/j.1360-0443.1998.9344874.x	23	598	616	3	104	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 23	2002	325	7374					1195	1198		10.1136/bmj.325.7374.1195	http://dx.doi.org/10.1136/bmj.325.7374.1195			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	619YU	12446533	Green Published, Bronze			2022-12-24	WOS:000179506200016
J	Ayanian, JZ; Landrum, MB; Guadagnoli, E; Gaccione, P				Ayanian, JZ; Landrum, MB; Guadagnoli, E; Gaccione, P			Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; RIGHT HEART CATHETERIZATION; MEDICARE PATIENTS; PROPENSITY SCORE; CARDIOLOGISTS; GENERALIST; QUALITY; OUTCOMES; ASSOCIATION; MANAGEMENT	Background: The outcome after myocardial infarction may be influenced by the type of physician providing ambulatory care. Methods: We studied 35,520 patients 65 years of age or older who were hospitalized for myocardial infarction in seven states during 1994 and 1995 and who survived for at least three months after discharge. From Medicare claims, we identified ambulatory visits to cardiologists, internists, and family practitioners. Using propensity scores to adjust for demographic, clinical, and hospital characteristics, we analyzed treatment and mortality at two years among patients matched according to their estimated propensity to receive care from a cardiologist within three months after discharge. Results: As compared with patients who saw only an internist or a family practitioner in the three months after discharge, patients who saw a cardiologist were younger, were more likely to be white, were more likely to be male, had fewer coexisting conditions, and were more likely to have undergone invasive cardiac procedures while hospitalized (P<0.01 for all comparisons). Patients who saw a cardiologist were more likely to undergo cardiac procedures and rehabilitation after discharge. Patients who saw a cardiologist had a lower two-year mortality rate than matched patients who saw only an internist or a family practitioner (14.6 percent vs. 18.3 percent, P<0.001). Patients who saw both a cardiologist and an internist or a family practitioner had a lower mortality rate than matched patients who saw only a cardiologist (11.1 percent vs. 12.1 percent, P=0.02). Conclusions: Ambulatory visits to cardiologists were associated with greater use of cardiac procedures and decreased mortality after myocardial infarction. Concurrent care by an internist or a family practitioner was associated with a further reduction in mortality.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Gen Med & Primary Care, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.				AHRQ HHS [R01 HS09718, R01 HS08071] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009718, R01HS008071] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM MED ASS, 1997, PHYS CURR PROC TERM; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; Ayanian JZ, 2000, AM J MED, V108, P259, DOI 10.1016/S0002-9343(99)00455-6; Ayanian JZ, 2002, ARCH INTERN MED, V162, P1013, DOI 10.1001/archinte.162.9.1013; Baldwin LM, 2002, MED CARE, V40, P82; Casale PN, 1998, J AM COLL CARDIOL, V32, P885, DOI 10.1016/S0735-1097(98)00325-8; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; Frances CD, 2000, HEALTH SERV RES, V35, P1093; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; Hardarson T, 2001, J INTERN MED, V249, P495, DOI 10.1046/j.1365-2796.2001.00834.x; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; LANDRUM MB, 2001, HLTH SERV OUTCOMES R, V2, P221, DOI DOI 10.1023/A:1020367111374; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Majumdar SR, 2001, J GEN INTERN MED, V16, P351, DOI 10.1046/j.1525-1497.2001.016006351.x; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Nash IS, 1999, AM J CARDIOL, V83, P650, DOI 10.1016/S0002-9149(98)00961-8; Nash IS, 1997, J AM COLL CARDIOL, V29, P475, DOI 10.1016/S0735-1097(96)00528-1; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; Polanczyk CA, 2001, JAMA-J AM MED ASSOC, V286, P309, DOI 10.1001/jama.286.3.309; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Seddon ME, 2001, AM J MED, V111, P24, DOI 10.1016/S0002-9343(01)00741-0; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; Willison DJ, 1998, ARCH INTERN MED, V158, P1778, DOI 10.1001/archinte.158.16.1778	34	163	164	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2002	347	21					1678	1686		10.1056/NEJMsa020080	http://dx.doi.org/10.1056/NEJMsa020080			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BL	12444183	Bronze			2022-12-24	WOS:000179339900007
J	Eckardt, LH; Naumann, K; Pankau, WM; Rein, M; Schweitzer, M; Windhab, N; von Kiedrowski, G				Eckardt, LH; Naumann, K; Pankau, WM; Rein, M; Schweitzer, M; Windhab, N; von Kiedrowski, G			DNA nanotechnology: Chemical copying of connectivity	NATURE			English	Editorial Material							LIGATION		Ruhr Univ Bochum, Lehrstuhl Bioorgan Chem, D-44780 Bochum, Germany	Ruhr University Bochum	Eckardt, LH (corresponding author), Ruhr Univ Bochum, Lehrstuhl Bioorgan Chem, D-44780 Bochum, Germany.	kiedro@ernie.orch.ruhr-uni-bochum.de		Naumann, Kai/0000-0003-2151-1048				CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cochran JR, 2000, CHEM BIOL, V7, P683, DOI 10.1016/S1074-5521(00)00019-3; Dawson PE, 1997, J AM CHEM SOC, V119, P4325, DOI 10.1021/ja962656r; DORENBECK A, IN PRESS ANGEW CHEM; Li ZY, 2002, J AM CHEM SOC, V124, P746, DOI 10.1021/ja017319j; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; Raddatz S, 2002, NUCLEIC ACIDS RES, V30, P4793, DOI 10.1093/nar/gkf594; Scheffler M, 1999, ANGEW CHEM INT EDIT, V38, P3312; Stetsenko DA, 2000, J ORG CHEM, V65, P4900, DOI 10.1021/jo000214z; van Aalten DMF, 1999, P NATL ACAD SCI USA, V96, P11809, DOI 10.1073/pnas.96.21.11809	10	132	136	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2002	420	6913					286	286		10.1038/420286a	http://dx.doi.org/10.1038/420286a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447432	Bronze			2022-12-24	WOS:000179340400033
J	Yamamoto, M; Sato, S; Hemmi, H; Sanjo, H; Uematsu, S; Kaisho, T; Hoshino, K; Takeuchi, O; Kobayashi, M; Fujita, T; Takeda, K; Akira, S				Yamamoto, M; Sato, S; Hemmi, H; Sanjo, H; Uematsu, S; Kaisho, T; Hoshino, K; Takeuchi, O; Kobayashi, M; Fujita, T; Takeda, K; Akira, S			Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; SIGNALING PATHWAY; TOLL; RECOGNITION; ENDOTOXIN; CELLS	Signal transduction through Toll-like receptors ( TLRs) originates from their intracellular Toll/interleukin-1 receptor (TIR) domain, which binds to MyD88, a common adaptor protein containing a TIR domain(1-4). Although cytokine production is completely abolished in MyD88-deficient mice, some responses to lipopolysaccharide (LPS), including the induction of interferon-inducible genes and the maturation of dendritic cells, are still observed(5-7). Another adaptor, TIRAP ( also known as Mal), has been cloned as a molecule that specifically associates with TLR4 and thus may be responsible for the MyD88-independent response(8,9). Here we report that LPS-induced splenocyte proliferation and cytokine production are abolished in mice lacking TIRAP. As in MyD88-deficient mice, LPS activation of the nuclear factor NF-kappaB and mitogen-activated protein kinases is induced with delayed kinetics in TIRAP-deficient mice(5). Expression of interferon-inducible genes and the maturation of dendritic cells is observed in these mice; they also show defective response to TLR2 ligands, but not to stimuli that activate TLR3, TLR7 or TLR9. In contrast to previous suggestions, our results show that TIRAP is not specific to TLR4 signalling and does not participate in the MyD88-independent pathway. Instead, TIRAP has a crucial role in the MyD88-dependent signalling pathway shared by TLR2 and TLR4.	Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan; RIKEN, Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan; Tokyo Metropolitan Inst Med Sci, Dept Tumor Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan	Osaka University; Japan Science & Technology Agency (JST); RIKEN; Tokyo Metropolitan Institute of Medical Science	Akira, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Host Def, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Hoshino, Katsuaki/AAE-2830-2022; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/D-6007-2011; Kaisho, Tsuneyasu/B-4130-2012; Takeuchi, Osamu/AAG-9359-2019; Takeda, Kiyoshi/C-9331-2009; Hoshino, Katsuaki/L-9162-2014	Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Hoshino, Katsuaki/0000-0003-0493-4815; Sato, Shintaro/0000-0001-5156-3354				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; IMER JL, 2001, TRENDS CELL BIOL, V11, P304; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Neill LAJ, 2002, TRENDS IMMUNOL, V23, P296, DOI 10.1016/S1471-4906(02)02222-6; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774	19	755	829	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					324	329		10.1038/nature01182	http://dx.doi.org/10.1038/nature01182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447441				2022-12-24	WOS:000179340400044
J	Crowther, C; Henderson-Smart, D				Crowther, C; Henderson-Smart, D			Prenatal phenobarbital before very-preterm birth and neurodevelopmental outcome	LANCET			English	Editorial Material							HEMORRHAGE; NEWBORN; INFANTS		Univ Adelaide, Dept Obstet & Gynaecol, Maternal Perinatal Clin Trials Unit, Adelaide, SA 5001, Australia; Univ Sydney, Neonatal Med Royal Prince Alfred Hosp, NSW Ctr Perinatal Serv Res, Sydney, NSW 2006, Australia	University of Adelaide; University of Sydney	Crowther, C (corresponding author), Univ Adelaide, Dept Obstet & Gynaecol, Maternal Perinatal Clin Trials Unit, Adelaide, SA 5001, Australia.							CROWLEY P, 2002, COCHRANE LIB; Doyle L, 1996, LANCET, V348, P975, DOI 10.1016/S0140-6736(05)64922-7; Early Supported Discharge Trialists, 2002, COCHRANE LIB; GODDARDFINEGOLD J, 1987, PEDIATRICS, V79, P901; Shankaran S, 1997, NEW ENGL J MED, V337, P466, DOI 10.1056/NEJM199708143370705; Shankaran S, 2002, AM J OBSTET GYNECOL, V187, P171, DOI 10.1067/mob.2002.122445; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; WIMBERLEY PD, 1982, ACTA PAEDIATR SCAND, V71, P537, DOI 10.1111/j.1651-2227.1982.tb09471.x; 2002, COCHRANE LIB, V3	9	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 16	2002	360	9345					1529	1530		10.1016/S0140-6736(02)11578-9	http://dx.doi.org/10.1016/S0140-6736(02)11578-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443587				2022-12-24	WOS:000179292400005
J	Eogan, MA; Geary, MP; O'Connell, MP; Keane, DP				Eogan, MA; Geary, MP; O'Connell, MP; Keane, DP			Effect of fetal sex on labour and delivery: retrospective review	BRITISH MEDICAL JOURNAL			English	Article							GENDER		Natl Matern Hosp, Dublin 2, Ireland	National Maternity Hospital, Dublin	Eogan, MA (corresponding author), Natl Matern Hosp, Holles St, Dublin 2, Ireland.							Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3; Hindmarsh PC, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000020600.45753.78; Makhseed M, 1998, INT J GYNECOL OBSTET, V63, P55, DOI 10.1016/S0020-7292(98)00078-2; ODRISCOLL K, 1993, ACTIVE MANAGEMENT LA; SPINILLO A, 1994, AM J OBSTET GYNECOL, V171, P1273, DOI 10.1016/0002-9378(94)90146-5	5	40	42	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					137	137		10.1136/bmj.326.7381.137	http://dx.doi.org/10.1136/bmj.326.7381.137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531846	Green Published, Bronze			2022-12-24	WOS:000180575900025
J	Crotty, S; Kersh, EN; Cannons, J; Schwartzberg, PL; Ahmed, R				Crotty, S; Kersh, EN; Cannons, J; Schwartzberg, PL; Ahmed, R			SAP is required for generating long-term humoral immunity	NATURE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-CELLS; VIRAL-INFECTION; ENCODING GENE; PLASMA-CELLS; BONE-MARROW; B-CELLS; MUTATIONS; MEMORY	Long-lived plasma cells and memory B cells are the primary cellular components of long-term humoral immunity and as such are vitally important for the protection afforded by most vaccines. The SAP gene has been identified as the genetic locus responsible for X-linked lymphoproliferative disease, a fatal immunodeficiency(1-4). Mutations in SAP have also been identified in some cases of severe common variable immunodeficiency disease(5,6). The underlying cellular basis of this genetic disorder remains unclear. We have used a SAP knockout mouse model system to explore the role of SAP in immune responses. Here we report that mice lacking expression of SAP generate strong acute IgG antibody responses after viral infection, but show a near complete absence of virus-specific long-lived plasma cells and memory B cells, despite the presence of virus-specific memory CD4(+) T cells. Adoptive transfer experiments show that SAP-deficient B cells are normal and the defect is in CD4(+) T cells. Thus, SAP has a crucial role in CD4(+) T-cell function: it is essential for late B-cell help and the development of long-term humoral immunity but is not required for early B-cell help and class switching.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.		Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Morra M, 2001, BLOOD, V98, P1321, DOI 10.1182/blood.V98.5.1321; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nistala K, 2001, CLIN EXP IMMUNOL, V126, P126, DOI 10.1046/j.1365-2249.2001.01599.x; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Sumegi J, 2000, BLOOD, V96, P3118; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	30	335	348	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					282	287		10.1038/nature01318	http://dx.doi.org/10.1038/nature01318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529646				2022-12-24	WOS:000180397600051
J	Jiang, XJ; Kim, HE; Shu, HJ; Zhao, YM; Zhang, HC; Kofron, J; Donnelly, J; Burns, D; Ng, SC; Rosenberg, S; Wang, XD				Jiang, XJ; Kim, HE; Shu, HJ; Zhao, YM; Zhang, HC; Kofron, J; Donnelly, J; Burns, D; Ng, SC; Rosenberg, S; Wang, XD			Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway	SCIENCE			English	Article							ACIDIC NUCLEAR-PROTEIN; CYTOCHROME-C; ACTIVATION; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; BINDING; FAMILY; GENE; RICH	A small molecule, alpha-(trichloromethyl)-4-pyridineethanol (PETCM), was identified by high-throughput screening as an activator of caspase-3 in extracts of a panel of cancer cells. PETCM was used in combination with biochemical fractionation to identify a pathway that regulates mitochondria-initiated caspase activation. This pathway consists of tumor suppressor putative HLA-DR associated proteins (PHAP) and oncoprotein prothymosin-alpha (ProT). PHAP proteins promoted caspase-9 activation after apoptosome formation, whereas ProT negatively regulated caspase-9 activation by inhibiting apoptosome formation. PETCM relieved ProT inhibition and allowed apoptosome formation at a physiological concentration of deoxyadenosine triphosphate. Elimination of ProT expression by RNA interference sensitized cells to ultraviolet irradiation induced apoptosis and negated the requirement of PETCM for caspase activation. Thus, this chemical-biological combinatory approach has revealed the regulatory roles of oncoprotein ProT and tumor suppressor PHAP in apoptosis.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Abbott Labs, Abbott Pk, IL 60064 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Abbott Laboratories	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu	Kim, Hyun-Eui/GOV-5988-2022	Kim, Hyun-Eui/0000-0003-1495-1993; Wang, Xiaodong/0000-0001-9885-356X	NIGMS NIH HHS [GMRO1-57158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brody JR, 1999, J BIOL CHEM, V274, P20053, DOI 10.1074/jbc.274.29.20053; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; DOSIL M, 1993, EXP CELL RES, V204, P94, DOI 10.1006/excr.1993.1013; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Magdalena C, 2000, BRIT J CANCER, V82, P584, DOI 10.1054/bjoc.1999.0968; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Mutai H, 2000, BIOCHEM BIOPH RES CO, V274, P427, DOI 10.1006/bbrc.2000.3133; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rodriguez P, 1998, BIOCHEM J, V331, P753, DOI 10.1042/bj3310753; SBURLATI AR, 1991, P NATL ACAD SCI USA, V88, P253, DOI 10.1073/pnas.88.1.253; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SMITH MR, 1993, BLOOD, V82, P1127; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang XD, 2001, GENE DEV, V15, P2922; Wu CG, 1997, BRIT J CANCER, V76, P1199, DOI 10.1038/bjc.1997.533; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhu LJ, 1997, BIOCHEM MOL BIOL INT, V42, P927; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	41	330	351	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					223	226		10.1126/science.1076807	http://dx.doi.org/10.1126/science.1076807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522243				2022-12-24	WOS:000180284000030
J	Keller, G; Zimmer, G; Mall, G; Ritz, E; Amann, K				Keller, G; Zimmer, G; Mall, G; Ritz, E; Amann, K			Nephron number in patients with primary hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; BLOOD-PRESSURE; ADULT HYPERTENSION; SIZE; KIDNEY; TRANSPLANTATION; GLOMERULI	BACKGROUND: A diminished number of nephrons has been proposed as one of the factors contributing to the development of primary hypertension. METHODS: To test this hypothesis, we used a three-dimensional stereologic method to compare the number and volume of glomeruli in 10 middle-aged white patients (age range, 35 to 59 years) with a history of primary hypertension or left ventricular hypertrophy (or both) and renal arteriolar lesions with the number and volume in 10 normotensive subjects matched for sex, age, height, and weight. All 20 subjects had died in accidents. RESULTS: Patients with hypertension had significantly fewer glomeruli per kidney than matched normotensive controls (median, 702,379 vs. 1,429,200). Patients with hypertension also had a significantly greater glomerular volume than did the controls (median, 6.50x10(sup -3) mm(sup 3) vs. 2.79x10(sup -3) mm(sup 3); P<0.001) but very few obsolescent glomeruli. CONCLUSIONS: The data support the hypothesis that the number of nephrons is reduced in white patients with primary hypertension.	Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany; Heidelberg Univ, Dept Forens Med, D-6900 Heidelberg, Germany; Heidelberg Univ, Dept Internal Med, D-6900 Heidelberg, Germany; City Hosp Darmstadt, Dept Pathol, Darmstadt, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Klinikum Darmstadt	Amann, K (corresponding author), Univ Erlangen Nurnberg, Dept Pathol, Krankenhausstr 8-10, D-91054 Erlangen, Germany.	kerstin.amann@patho.imed.uni-erlangen.de						BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bertram J. F., 2001, Journal of the American Society of Nephrology, V12, p724A; BIANCHI G, 1974, CLIN SCI MOL MED, V47, P435, DOI 10.1042/cs0470435; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; CURTIS JJ, 1983, NEW ENGL J MED, V309, P1009, DOI 10.1056/NEJM198310273091702; DAHL LK, 1974, CIRC RES, V34, P94, DOI 10.1161/01.RES.34.1.94; Fassi A, 1998, J AM SOC NEPHROL, V9, P1399; GENNSER G, 1988, BMJ-BRIT MED J, V296, P1498, DOI 10.1136/bmj.296.6635.1498; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Gurnani Anuradha, 2000, Journal of the American Society of Nephrology, V11, p390A; HAKIM RM, 1984, KIDNEY INT, V25, P930, DOI 10.1038/ki.1984.112; MCLACHLAN MSF, 1977, J PATHOL, V121, P65, DOI 10.1002/path.1711210202; Merlet-Benichou C, 1999, LAB INVEST, V79, P515; MERLETBENICHOU C, 1993, M S-MED SCI, V9, P777, DOI 10.4267/10608/2991; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Pesce CM, 1994, J NEPHROL, P355; RETTIG R, 1990, AM J PHYSIOL, V258, pF606, DOI 10.1152/ajprenal.1990.258.3.F606; SCHMIDT K, 1992, J AM SOC NEPHROL, V3, P229; SKOV K, 1994, J HYPERTENS, V12, P1373; Spencer J, 2001, AM J KIDNEY DIS, V37, P915, DOI 10.1016/S0272-6386(05)80006-X; STRANDGAARD S, 1986, BRIT MED J, V292, P1041, DOI 10.1136/bmj.292.6527.1041; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Yiu V, 1999, AM J KIDNEY DIS, V33, P253, DOI 10.1016/S0272-6386(99)70297-0	26	763	790	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					101	108		10.1056/NEJMoa020549	http://dx.doi.org/10.1056/NEJMoa020549			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519920				2022-12-24	WOS:000180263900002
J	Nakazaki, T; Okumoto, Y; Horibata, A; Yamahira, S; Teraishi, M; Nishida, H; Inoue, H; Tanisaka, T				Nakazaki, T; Okumoto, Y; Horibata, A; Yamahira, S; Teraishi, M; Nishida, H; Inoue, H; Tanisaka, T			Mobilization of a transposon in the rice genome	NATURE			English	Article							INVERTED-REPEAT ELEMENTS; ORYZA-SATIVA L.; RETROTRANSPOSONS; IDENTIFICATION; PROTEIN; GENES	Rice (Oryza sativa L.) is an important crop worldwide and, with the availability of the draft sequence(1,2), a useful model for analysing the genome structure of grasses(3),(4). To practice efficient rice breeding through genetic engineering techniques, it is important to identify the economically important genes in this crop. The use of mobile transposons as gene tags in intact plants is a powerful tool for functional analysis because transposon insertions often inactivate genes(5). Here we identify an active rice transposon named miniature Ping (mPing) through analysis of the mutability of a slender mutation of the glume(6)-the seed structure that encloses and determines the shape of the grain. The mPing transposon is inserted in the slender glume (slg) mutant allele but not in the wild-type allele. Search of the O. sativa variety Nipponbare genome identified 34 sequences with high nucleotide similarity to mPing, indicating that mPing constitutes a family of transposon elements. Excision of mPing from slg plants results in reversion to a wild-type phenotype. The mobility of the transposon mPing in intact rice plants represents a useful alternative tool for the functional analysis of rice genes.	Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan; Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496433, Japan	Kyoto University; Kindai University (Kinki University)	Tanisaka, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan.		Teraishi, Masayoshi/D-8602-2018; Teraishi, Masayoshi/AAC-1055-2021	Teraishi, Masayoshi/0000-0002-6768-8052; Teraishi, Masayoshi/0000-0002-6768-8052				BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Cartinhour SW, 1997, PLANT MOL BIOL, V35, P241, DOI 10.1023/A:1005797203035; Delseny M, 2001, PLANT PHYSIOL BIOCH, V39, P323, DOI 10.1016/S0981-9428(01)01245-1; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Hirochika H, 1999, MOLECULAR BIOLOGY OF RICE, P43; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jurka J, 2001, P NATL ACAD SCI USA, V98, P12315, DOI 10.1073/pnas.231490598; Kumar A, 2001, TRENDS PLANT SCI, V6, P127, DOI 10.1016/S1360-1385(00)01860-4; KUNZE R, 1997, ADV BOT RES, V27, P321; Maes T, 1999, TRENDS PLANT SCI, V4, P90, DOI 10.1016/S1360-1385(99)01375-8; Nakazaki T, 1998, BREEDING SCI, V48, P371; STEPHEN A, 2002, SCIENCE, V296, P92; Teraishi M, 1999, MOL GEN GENET, V261, P487, DOI 10.1007/s004380050992; Teraishi M, 2001, GENOME, V44, P1, DOI 10.1139/gen-44-1-1; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	21	183	211	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					170	172		10.1038/nature01219	http://dx.doi.org/10.1038/nature01219			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520304				2022-12-24	WOS:000180267200042
J	Strand, A; Asami, T; Alonso, J; Ecker, JR; Chory, J				Strand, A; Asami, T; Alonso, J; Ecker, JR; Chory, J			Chloroplast to nucleus communication triggered by accumulation of Mg-protoporphyrinIX	NATURE			English	Article							TETRAPYRROLE BIOSYNTHESIS; CHLOROPHYLL PRECURSORS; SIGNAL-TRANSDUCTION; LIGHT INDUCTION; EXPRESSION; SEEDLINGS; BINDING; GENES; INVOLVEMENT; MUTANTS	Plant cells coordinately regulate the expression of nuclear and plastid genes that encode components of the photosynthetic apparatus. Nuclear genes that regulate chloroplast development and chloroplast gene expression provide part of this coordinate control. There is evidence that information also flows in the opposite direction, from chloroplasts to the nucleus(1),(2). Until now, at least three different signalling pathways have been identified that originate in the plastid and control nuclear gene expression(3,4) but the molecular nature of these signals has remained unknown. Here we show that the tetrapyrrole intermediate Mg-protoporphyrin (Mg-ProtoIX) acts as a signalling molecule in one of the signalling pathways between the chloroplast and nucleus. Accumulation of Mg-ProtoIX is both necessary and sufficient to regulate the expression of many nuclear genes encoding chloroplastic proteins associated with photosynthesis.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; RIKEN, Plant Funct Lab, Wako, Saitama 3510198, Japan	Salk Institute; Howard Hughes Medical Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	Chory@salk.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Strand, Åsa/C-5093-2012	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; 				ANDERSON SL, 1994, PLANT J, V6, P457, DOI 10.1046/j.1365-313X.1994.6040457.x; BURGESS DG, 1987, PLANTA, V170, P520, DOI 10.1007/BF00402986; CRAWFORD MS, 1983, PLANT PHYSIOL, V71, P303, DOI 10.1104/pp.71.2.303; DAMM B, 1991, PLANT TISSUE CULTURE; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Ghassemian M, 2001, TRENDS PLANT SCI, V6, P448, DOI 10.1016/S1360-1385(01)02092-1; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Jarvis P, 2001, CURR BIOL, V11, pR307, DOI 10.1016/S0960-9822(01)00171-3; JOHANNINGMEIER U, 1984, J BIOL CHEM, V259, P3541; KITTSTEINER U, 1991, PHYSIOL PLANTARUM, V81, P190, DOI 10.1111/j.1399-3054.1991.tb02128.x; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; Kropat J, 2000, PLANT J, V24, P523, DOI 10.1046/j.1365-313x.2000.00898.x; La Rocca N, 2001, PLANTA, V213, P101, DOI 10.1007/s004250000477; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; MAYFIELD SP, 1984, EUR J BIOCHEM, V144, P79, DOI 10.1111/j.1432-1033.1984.tb08433.x; MAYFIELD SP, 1986, PLANTA, V169, P23, DOI 10.1007/BF01369771; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; SATO R, 1991, PLANT PHYSIOL, V96, P432, DOI 10.1104/pp.96.2.432; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; TERZAGI WB, 1995, ANNU REV PLANT PHYS, V40, P211	26	429	462	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					79	83		10.1038/nature01204	http://dx.doi.org/10.1038/nature01204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511958				2022-12-24	WOS:000180165500041
J	Morris, RM; Rappe, MS; Connon, SA; Vergin, KL; Siebold, WA; Carlson, CA; Giovannoni, SJ				Morris, RM; Rappe, MS; Connon, SA; Vergin, KL; Siebold, WA; Carlson, CA; Giovannoni, SJ			SAR11 clade dominates ocean surface bacterioplankton communities	NATURE			English	Article							16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; LABELED OLIGONUCLEOTIDE PROBES; PLANKTONIC BACTERIA; SARGASSO SEA; IDENTIFICATION; ACCESSIBILITY; SENSITIVITY; DIVERSITY; INCREASE	The most abundant class of bacterial ribosomal RNA genes detected in seawater DNA by gene cloning belongs to SAR11-an alpha-proteobacterial clade(1). Other than indications of their prevalence in seawater, little is known about these organisms. Here we report quantitative measurements of the cellular abundance of the SAR11 clade in northwestern Sargasso Sea waters to 3,000 m and in Oregon coastal surface waters. On average, the SAR11 clade accounts for a third of the cells present in surface waters and nearly a fifth of the cells present in the mesopelagic zone. In some regions, members of the SAR11 clade represent as much as 50% of the total surface microbial community and 25% of the subeuphotic microbial community. By extrapolation, we estimate that globally there are 2.4 x 10(28) SAR11 cells in the oceans, half of which are located in the euphotic zone. Although the biogeochemical role of the SAR11 clade remains uncertain, these data support the conclusion that this microbial group is among the most successful organisms on Earth.	Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Oregon State University; University of California System; University of California Santa Barbara	Giovannoni, SJ (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.		Connon, Stephanie A/K-1959-2012; Morris, Robert/C-5188-2012	VERGIN, KEVIN/0000-0002-8972-2813				AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; BUCK KR, 1996, AQUAT MICROB ECOL, V10, P238; Carlson CA, 1996, DEEP-SEA RES PT II, V43, P491, DOI 10.1016/0967-0645(95)00101-8; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Frischer ME, 1996, CAN J MICROBIOL, V42, P1061, DOI 10.1139/m96-136; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; FUHRMAN JA, 1989, MAR ECOL PROG SER, V57, P207, DOI 10.3354/meps057207; Fuhrman Jed. A., 1998, Aquatic Ecology, V32, P3, DOI 10.1023/A:1009974817127; Giovannoni S., 2000, P47; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; HICKS RE, 1992, APPL ENVIRON MICROB, V58, P2158, DOI 10.1128/AEM.58.7.2158-2163.1992; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; LEE SH, 1993, MAR ECOL PROG SER, V101, P193, DOI 10.3354/meps101193; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P661, DOI 10.1128/AEM.68.2.661-667.2002; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Schonhuber W, 1997, APPL ENVIRON MICROB, V63, P3268; SIERACKI ME, 1985, APPL ENVIRON MICROB, V49, P799, DOI 10.1128/AEM.49.4.799-810.1985; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wintzingerode Friedrich V., 1997, FEMS Microbiology Reviews, V21, P213	27	789	810	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					806	810		10.1038/nature01240	http://dx.doi.org/10.1038/nature01240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490947				2022-12-24	WOS:000179897300054
J	Habicht, KS; Gade, M; Thamdrup, B; Berg, P; Canfield, DE				Habicht, KS; Gade, M; Thamdrup, B; Berg, P; Canfield, DE			Calibration of sulfate levels in the Archean Ocean	SCIENCE			English	Article							SULFUR CYCLE; ISOTOPE; ATMOSPHERE; REDUCTION; WATER; MODEL	The size of the marine sulfate reservoir has grown through Earth's history, reflecting the accumulation of oxygen into the atmosphere. Sulfur isotope fractionation experiments on marine and freshwater sulfate reducers, together with the isotope record, imply that oceanic Archean sulfate concentrations were <200 mu M, which is less than one-hundredth of present marine sulfate levels and one-fifth of what was previously thought. Such low sulfate concentrations were maintained by volcanic outgassing of SO2 gas, and severely suppressed sulfate reduction rates allowed for a carbon cycle dominated by methanogenesis.	Univ So Denmark, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Southern Denmark; University of Southern Denmark; University of Virginia	Canfield, DE (corresponding author), Univ So Denmark, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.		Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016	Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077				Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Cypionka H., 1995, BIOTECH HAN, V8, P151; de Hoog JCM, 2001, EARTH PLANET SC LETT, V189, P237, DOI 10.1016/S0012-821X(01)00355-7; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Holland H.D., 1984, CHEM EVOLUTION ATMOS; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; INGVORSEN K, 1984, ARCH MICROBIOL, V139, P61, DOI 10.1007/BF00692713; INGVORSEN K, 1984, APPL ENVIRON MICROB, V27, P1029; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; Kakegawa T, 1999, PRECAMBRIAN RES, V96, P209, DOI 10.1016/S0301-9268(99)00006-6; Kakegawa T, 2000, GEOCHEM J, V34, P121, DOI 10.2343/geochemj.34.121; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; MARTENS CS, 1980, GEOCHIM COSMOCHIM AC, V44, P471, DOI 10.1016/0016-7037(80)90045-9; Middelburg JJ, 1997, DEEP-SEA RES PT I, V44, P327, DOI 10.1016/S0967-0637(96)00101-X; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; REEBURGH WS, 1976, EARTH PLANET SC LETT, V28, P337, DOI 10.1016/0012-821X(76)90195-3; Roychoudhury AN, 1998, APPL GEOCHEM, V13, P269, DOI 10.1016/S0883-2927(97)00064-4; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; STOIBER RE, 1987, J VOLCANOL GEOTH RES, V33, P1, DOI 10.1016/0377-0273(87)90051-5; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	26	569	595	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2372	2374		10.1126/science.1078265	http://dx.doi.org/10.1126/science.1078265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493910				2022-12-24	WOS:000179915900051
J	Lu, JR; Bassel-Duby, R; Hawkins, A; Chang, P; Valdez, R; Wu, H; Gan, L; Shelton, JM; Richardson, JA; Olson, EN				Lu, JR; Bassel-Duby, R; Hawkins, A; Chang, P; Valdez, R; Wu, H; Gan, L; Shelton, JM; Richardson, JA; Olson, EN			Control of facial muscle development by MyoR and capsulin	SCIENCE			English	Article							HELIX TRANSCRIPTION FACTOR; CRANIAL PARAXIAL MESODERM; SKELETAL-MUSCLE; GENE; MYF-5; MESENCHYME; EXPRESSION; UPSTREAM; KIDNEY; CELLS	Members of the MyoD family of basic helix-loop-helix (bHLH) transcription factors control the formation of all skeletal muscles in vertebrates, but little is known of the molecules or mechanisms that confer unique identities to different types of skeletal muscles. MyoR and capsulin are related bHLH transcription factors expressed in specific facial muscle precursors. We show that specific facial muscles are missing in mice lacking both MyoR and capsulin, reflecting the absence of MyoD family gene expression and ablation of the corresponding myogenic lineages. These findings identify MyoR and capsulin as unique transcription factors for the development of specific head muscles.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Rochester, Ctr Aging & Dev Biol, Rochester, NY 14642 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Rochester	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eolson@hamon.swmed.edu	Lu, Jianrong/F-5240-2013	Lu, Jianrong/0000-0002-4969-6040				Brohmann H, 2000, DEVELOPMENT, V127, P437; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chen JCJ, 2001, DEV DYNAM, V221, P274, DOI 10.1002/dvdy.1138; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Hacker A, 1998, DEVELOPMENT, V125, P3461; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hidai H, 1998, MECH DEVELOP, V73, P33, DOI 10.1016/S0925-4773(98)00031-8; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Lu J., UNPUB; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; OTT MO, 1991, DEVELOPMENT, V111, P1097; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rawls A, 1997, CELL, V89, P5, DOI 10.1016/S0092-8674(00)80175-0; Rawls A, 1998, DEVELOPMENT, V125, P2349; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397	24	153	162	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2378	2381		10.1126/science.1078273	http://dx.doi.org/10.1126/science.1078273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493912				2022-12-24	WOS:000179915900053
J	Smaglik, P				Smaglik, P			Turning oil into science - Norway	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916		S			A13	+		10.1038/420a13a	http://dx.doi.org/10.1038/420a13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625LG	12501121	Bronze			2022-12-24	WOS:000179817500003
J	Dehaene-Lambertz, G; Dehaene, S; Hertz-Pannier, L				Dehaene-Lambertz, G; Dehaene, S; Hertz-Pannier, L			Functional neuroimaging of speech perception in infants	SCIENCE			English	Article							CORTICAL REPRESENTATION; BRAIN; LANGUAGE; ACTIVATION; DISCRIMINATION; ACQUISITION; RETRIEVAL; MEMORY; CORTEX; HUMANS	Human infants begin to acquire their native language in the first months of life. To determine which brain regions support language processing at this young age, we measured with functional magnetic resonance imaging the brain activity evoked by normal and reversed speech in awake and sleeping 3-month-old infants. Left-lateralized brain regions similar to those of adults, including the superior temporal and angular gyri, were already active in infants. Additional activation in right prefrontal cortex was seen only in awake infants processing normal speech. Thus, precursors of adult cortical language areas are already active in infants, well before the onset of speech production.	CNRS, Lab Sci Cognit & Psycholinguist, F-75270 Paris 06, France; Ecole Hautes Etud Sci Sociales, F-75270 Paris, France; CEA, Unite Neuroanat Fonct, Serv Hosp Frederic Joliot, F-91401 Orsay, France; Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Radiol Pediat, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Dehaene-Lambertz, G (corresponding author), CNRS, Lab Sci Cognit & Psycholinguist, 54 Blvd Raspail, F-75270 Paris 06, France.		Dehaene, Ghislaine/O-3633-2017	Dehaene, Ghislaine/0000-0003-2221-9081; Hertz-Pannier, Lucie/0000-0003-4952-7009				Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; Anderson AW, 2001, MAGN RESON IMAGING, V19, P1, DOI 10.1016/S0730-725X(00)00231-9; BERTONCINI J, 1989, BRAIN LANG, V37, P591, DOI 10.1016/0093-934X(89)90113-2; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Born AP, 2000, NEUROPEDIATRICS, V31, P24, DOI 10.1055/s-2000-15402; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; Dehaene-Lambertz G, 1998, LANG SPEECH, V41, P21, DOI 10.1177/002383099804100102; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; DEHAENELAMBERTZ G, 1994, NATURE, V370, P292, DOI 10.1038/370292a0; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Elman JL, 1996, RETHINKING INNATENES; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Krause BJ, 1999, BRAIN, V122, P255, DOI 10.1093/brain/122.2.255; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Moore RJ, 2001, HUM BRAIN MAPP, V12, P94, DOI 10.1002/1097-0193(200102)12:2<94::AID-HBM1006>3.0.CO;2-E; Morita T, 2000, NEUROSCI RES, V38, P63, DOI 10.1016/S0168-0102(00)00146-2; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; PINKER S, 1994, LANGUAGE INSTINCT MI; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Vaissiere J., 1983, PROSODY MODELS MEASU, P53, DOI DOI 10.1007/978-3-642-69103-4_5; WADA JA, 1975, ARCH NEUROL-CHICAGO, V32, P239, DOI 10.1001/archneur.1975.00490460055007	27	666	682	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2013	2015		10.1126/science.1077066	http://dx.doi.org/10.1126/science.1077066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471265				2022-12-24	WOS:000179629200052
J	Stathopoulos, A; Van Drenth, M; Erives, A; Markstein, M; Levine, M				Stathopoulos, A; Van Drenth, M; Erives, A; Markstein, M; Levine, M			Whole-genome analysis of dorsal-ventral patterning in the Drosophila embryo	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-SHAPE CHANGES; TRANSCRIPTION FACTOR; MORPHOGEN GRADIENTS; GASTRULATION GENE; COLUMN IDENTITY; EXPRESSION; MESODERM; POLARITY; TISSUE	The maternal Dorsal regulatory gradient initiates the differentiation of several tissues in the early Drosophila embryo. Whole-genome microarray assays identified as many as 40 new Dorsal target genes, which encode a broad spectrum of cell signaling proteins and transcription factors. Evidence is presented that a tissue-specific form of the NF-Y transcription complex is essential for the activation of gene expression in the mesoderm. Tissue-specific enhancers were identified for new Dorsal target genes, and bioinformatics methods identified conserved cis-regulatory elements for coordinately regulated genes that respond to similar thresholds of the Dorsal gradient. The new Dorsal target genes and enhancers represent one of the most extensive gene networks known for any developmental process.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, Berkeley, CA 94720 USA; Auilix Biopharma Inc, Berkeley, CA 94710 USA; Univ Chicago, Comm Dev Biol, Cummings Life Sci Ctr, Chicago, IL 60637 USA	University of California System; University of California Berkeley; University of Chicago	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, 401 Barker Hall, Berkeley, CA 94720 USA.			Markstein, Michele/0000-0003-2635-8118; Levine, Michael/0000-0001-7629-0081; Erives, Albert/0000-0001-7107-5518	NIGMS NIH HHS [GM46638, GM20352] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046638, R01GM046638] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; BODMER R, 1990, DEVELOPMENT, V110, P661; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Casal J, 1996, P NATL ACAD SCI USA, V93, P10327, DOI 10.1073/pnas.93.19.10327; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; COUREY AJ, 1995, BBA-GENE STRUCT EXPR, V1261, P1, DOI 10.1016/0167-4781(94)00234-T; Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9; DOYLE HJ, 1989, GENE DEV, V3, P1518, DOI 10.1101/gad.3.10.1518; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Frank LH, 1996, DEVELOPMENT, V122, P1343; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; IP YT, 1991, CELL, V64, P439; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Kasai Y, 1998, GENE EXPRESSION, V7, P171; KIROV N, 1994, MOL CELL BIOL, V14, P713, DOI 10.1128/MCB.14.1.713; Kosman D, 1997, DEVELOPMENT, V124, P1343; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LEPTIN M, 1994, DEVELOPMENT, V120, P853; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Morisato D, 2001, DEVELOPMENT, V128, P2309; Morize P, 1998, DEVELOPMENT, V125, P589; NATZLE JE, 1984, DEV BIOL, V104, P187, DOI 10.1016/0012-1606(84)90047-2; Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; ROTH S, 1994, CURR BIOL, V4, P755, DOI 10.1016/S0960-9822(00)00170-6; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Rusch J, 1997, DEVELOPMENT, V124, P303; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; Shao XP, 2002, P NATL ACAD SCI USA, V99, P113, DOI 10.1073/pnas.012584599; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Stathopoulos A, 2002, DEVELOPMENT, V129, P3411; Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STJOHNSTON D, 1992, CELL, V68, P201; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; SZYMANSKI P, 1995, EMBO J, V14, P2229, DOI 10.1002/j.1460-2075.1995.tb07217.x; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; WINICK J, 1993, DEVELOPMENT, V119, P1055	66	229	245	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					687	701		10.1016/S0092-8674(02)01087-5	http://dx.doi.org/10.1016/S0092-8674(02)01087-5			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464180	Bronze, Green Published			2022-12-24	WOS:000179594500010
J	Hillis, JM; Ernst, MO; Banks, MS; Landy, MS				Hillis, JM; Ernst, MO; Banks, MS; Landy, MS			Combining sensory information: Mandatory fusion within, but not between, senses	SCIENCE			English	Article							CUE COMBINATION; TEXTURE; SLANT; SHAPE	Humans use multiple sources of sensory information to estimate environmental properties. For example, the eyes and hands both provide relevant information about an object's shape. The eyes estimate shape using binocular disparity, perspective projection, etc. The hands supply haptic shape information by means of tactile and proprioceptive cues. Combining information across cues can improve estimation of object properties but may come at a cost: loss of single-cue information. We report that single-cue information is indeed lost when cues from within the same sensory modality (disparity and texture gradients in vision) are combined, but not when different modalities (vision and haptics) are combined.	Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	University of California System; University of California Berkeley; Max Planck Society; University of California System; University of California Berkeley; New York University; New York University	Hillis, JM (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	jmhillis@CATTELL.psych.upenn.edu		Landy, Michael/0000-0002-2079-4552; Ernst, Marc/0000-0003-4197-8569	NEI NIH HHS [EY12851, EY08266] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008266, R01EY012851] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; BACKUS BT, 2002, ADV NEURAL INFORMA 7, V14, pCH1; Brenner E, 1999, VISION RES, V39, P975, DOI 10.1016/S0042-6989(98)00162-X; Clark J.J., 1990, DATA FUSION SENSORY; DEBERG M, 2002, COMPUTATIONAL GEOMET; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; JOHNSTON EB, 1994, VISION RES, V34, P2259, DOI 10.1016/0042-6989(94)90106-6; Jordan M. I, 1997, SELF ORG COMPUTATION, P117, DOI DOI 10.1016/S0166-4115(97)80006-4; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Landy MS, 2001, J OPT SOC AM A, V18, P2307, DOI 10.1364/JOSAA.18.002307; RICHARDS W, 1979, SENS PROCESS, V3, P207	12	310	315	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1627	1630		10.1126/science.1075396	http://dx.doi.org/10.1126/science.1075396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446912				2022-12-24	WOS:000179361600051
J	Parisi, M; Nuttall, R; Naiman, D; Bouffard, G; Malley, J; Andrews, J; Eastman, S; Oliver, B				Parisi, M; Nuttall, R; Naiman, D; Bouffard, G; Malley, J; Andrews, J; Eastman, S; Oliver, B			Paucity of genes on the Drosophila X chromosome showing male-biased expression	SCIENCE			English	Article							MELANOGASTER; SPERMATOGENESIS; EVOLUTION; SEX	Sex chromosomes are primary determinants of sexual dimorphism in many organisms. These chromosomes are thought to arise via the divergence of an ancestral autosome pair and are almost certainly influenced by differing selection in mates and females. Exploring how sex chromosomes differ from autosomes is highly amenable to genomic analysis. We examined global gene expression in Drosophila melanogaster and report a dramatic underrepresentation of X-chromosome genes showing high relative expression in mates. Using comparative genomics, we find that these same X-chromosome genes are exceptionally poorly conserved in the mosquito Anopheles gambiae. These data indicate that the X chromosome is a disfavored location for genes selectively expressed in males.	NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; Incyte Genom, Palo Alto, CA 94304 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA; NHGRI, Natl Inst Hlth Intramural Sequencing Ctr, NIH, US Dept HHS, Gaithersburg, MD 20877 USA; NIH, Ctr Informat Technol, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Incyte; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Oliver, B (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA.		Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081	NIDDK NIH HHS [Z01 DK015600-10] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kelly WG, 2002, DEVELOPMENT, V129, P479; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Oliver B, 2002, INT REV CYTOL, V219, P1; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	20	403	412	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					697	700		10.1126/science.1079190	http://dx.doi.org/10.1126/science.1079190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12511656	Green Accepted			2022-12-24	WOS:000180687700044
J	Ben-Yehuda, S; Rudner, DZ; Losick, R				Ben-Yehuda, S; Rudner, DZ; Losick, R			RacA, a bacterial protein that anchors chromosomes to the cell poles	SCIENCE			English	Article							BACILLUS-SUBTILIS SPOIIIE; DIVISION SEPTUM; DNA SEGREGATION; SITE; LOCALIZATION; DIVIVA; SPORULATION; SELECTION	Eukaryotic chromosomes are anchored to a spindle apparatus during mitosis, but no such structure is known during chromosome segregation in bacteria. When sister chromosomes are segregated during sporulation in Bacillus subtilis, the replication origin regions migrate to opposite poles of the cell. If and how origin regions are fastened at the poles has not been determined. Here we describe a developmental protein, RacA, that acts as a bridge between the origin region and the cell poles. We propose that RacA assembles into an adhesive patch at a centromere-like element near the origin, causing chromosomes to stick at the poles.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.				NIGMS NIH HHS [GM18568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Graumann PL, 2001, J BACTERIOL, V183, P4052, DOI 10.1128/JB.183.13.4052-4060.2001; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lindow JC, 2002, MOL MICROBIOL, V46, P997, DOI 10.1046/j.1365-2958.2002.03235.x; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; RYTER A, 1966, ANN I PASTEUR PARIS, V110, P305; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2002, EMBO J, V21, P4001, DOI 10.1093/emboj/cdf393	23	254	262	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 24	2003	299	5606					532	536		10.1126/science.1079914	http://dx.doi.org/10.1126/science.1079914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638EZ	12493822				2022-12-24	WOS:000180559800039
J	Fitzgerald, DW; Behets, FMT				Fitzgerald, DW; Behets, FMT			Women's health and human rights in HIV prevention research	LANCET			English	Editorial Material									Cornell Univ, Coll Med, Div Int Med & Infect Dis, New York, NY 10021 USA; Univ N Carolina, Sch Publ Hlth, Dept Med, Chapel Hill, NC USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fitzgerald, DW (corresponding author), Cornell Univ, Coll Med, Div Int Med & Infect Dis, New York, NY 10021 USA.							Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6; COELHO HLL, 1993, LANCET, V341, P1261, DOI 10.1016/0140-6736(93)91157-H; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; PIOT P, PREFACE REPORT GLOBA; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954	5	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					68	69		10.1016/S0140-6736(03)12166-6	http://dx.doi.org/10.1016/S0140-6736(03)12166-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517474				2022-12-24	WOS:000180191600028
J	Yedid, G; Bell, G				Yedid, G; Bell, G			Macroevolution simulated with autonomously replicating computer programs	NATURE			English	Article							EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; POPULATIONS; ADAPTATION; DIVERGENCE; COMPLEXITY; RESISTANCE; DROSOPHILA; SELECTION; BACTERIA	The process of adaptation occurs on two timescales. In the short term, natural selection merely sorts the variation already present in a population, whereas in the longer term genotypes quite different from any that were initially present evolve through the cumulation of new mutations. The first process is described by the mathematical theory of population genetics. However, this theory begins by defining a fixed set of genotypes and cannot provide a satisfactory analysis of the second process because it does not permit any genuinely new type to arise. The evolutionary outcome of selection acting on novel variation arising over long periods is therefore difficult to predict. The classical problem of this kind is whether 'replaying the tape of life' would invariably lead to the familiar organisms of the modern biota(1,2). Here we study the long-term behaviour of populations of autonomously replicating computer programs and find that the same type, introduced into the same simple environment, evolves on any given occasion along a unique trajectory towards one of many well-adapted end points.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	McGill University; Michigan State University	Bell, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.							ADAMI C, 1995, PHYSICA D, V80, P154, DOI 10.1016/0167-2789(95)90073-X; Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; Bull JJ, 1997, GENETICS, V147, P1497; COHAN FM, 1986, GENETICS, V114, P145; DYKHUIZEN D, 1981, EVOLUTION, V35, P581, DOI 10.1111/j.1558-5646.1981.tb04919.x; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Gerrish P, 2001, NATURE, V413, P299, DOI 10.1038/35095046; Gould S.J, 1989, WONDERFUL LIFE BURGE; Hartley B.S., 1984, MICROORGANISMS MODEL, P23; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; JOHNSON PA, 1995, P ROY SOC B-BIOL SCI, V259, P125, DOI 10.1098/rspb.1995.0019; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; KRAMER FR, 1974, J MOL BIOL, V89, P719, DOI 10.1016/0022-2836(74)90047-3; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Nakatsu CH, 1998, J BACTERIOL, V180, P4325, DOI 10.1128/JB.180.17.4325-4331.1998; Ray T.S., 1991, SANTA FE I STUDIES S, VXI, P371; SPIEGELMAN S, 1971, Quarterly Reviews of Biophysics, V4, P213; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Travisano M, 1997, GENETICS, V146, P471; Wahl LM, 2000, GENETICS, V156, P1437; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Yedid G, 2001, AM NAT, V157, P465, DOI 10.1086/319928; YIN J, 1993, J BACTERIOL, V175, P1272, DOI 10.1128/JB.175.5.1272-1277.1993	26	53	54	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					810	812		10.1038/nature01151	http://dx.doi.org/10.1038/nature01151			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490948				2022-12-24	WOS:000179897300055
J	Macho, B; Brancorsini, S; Fimia, GM; Setou, M; Hirokawa, N; Sassone-Corsi, P				Macho, B; Brancorsini, S; Fimia, GM; Setou, M; Hirokawa, N; Sassone-Corsi, P			CREM-dependent transcription in male germ cells controlled by a kinesin	SCIENCE			English	Article							NUCLEAR EXPORT; LEPTOMYCIN-B; PROTEIN; CRM1; TRANSPORT; SIGNAL; ACTIVATION; INHIBITION; RECEPTOR; BINDING	ACT is a LIM-only protein expressed exclusively in round spermatids, where it cooperates with transcriptional activator CREM in regulating various postmeiotic genes. Targeted inactivation of CREM leads to a complete block of mouse spermiogenesis. We sought to identify the regulatory steps controlling the functional interplay between CREM and ACT. We found that ACT selectively associates with KIF17b, a kinesin highly expressed in male germ cells. The ACT-KIF17b interaction is restricted to specific stages of spermatogenesis and directly determines the intracellular localization of ACT. Sensitivity to leptomycin B indicates that KIF17b can be actively exported from the nucleus through the Crm1 receptor. Thus, a kinesin directly controls the activity of a transcriptional coactivator by a tight regulation of its intracellular localization.	Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France; Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Tokyo	Sassone-Corsi, P (corresponding author), Inst Genet & Biol Mol & Cellulaire, BP 10142, F-67404 Strasbourg, France.	paolosc@gbmc.u-strasbg.fr	Brancorsini, Stefano/L-8770-2015; Sassone-Corsi, Paolo/H-6182-2011; Fimia, Gian Maria/K-3232-2016	Brancorsini, Stefano/0000-0002-8410-7248; Fimia, Gian Maria/0000-0003-4438-3325				Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PARVINEN M, 1993, METHODS TOXICOLOGY A, V3, P142; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	24	90	103	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2388	2390		10.1126/science.1077265	http://dx.doi.org/10.1126/science.1077265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493914				2022-12-24	WOS:000179915900056
J	Fieggen, G; Peter, J; Millar, A; Rode, H				Fieggen, G; Peter, J; Millar, A; Rode, H			Conjoined spinal cords in pygopagus twins	LANCET			English	Editorial Material									Red Cross War Mem Childrens Hosp, Dept Neurosurg & Paediat Surg, Cape Town, South Africa		Fieggen, G (corresponding author), Red Cross War Mem Childrens Hosp, Dept Neurosurg & Paediat Surg, Cape Town, South Africa.		Fieggen, Anthony Graham/AAT-6510-2021	Fieggen, Anthony Graham/0000-0001-6541-8377					0	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1934	1934		10.1016/S0140-6736(02)11916-7	http://dx.doi.org/10.1016/S0140-6736(02)11916-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493260				2022-12-24	WOS:000179870200012
J	Di Bisceglie, AM				Di Bisceglie, AM			An error rationalised is still a mistake	LANCET			English	Editorial Material									St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO 63110 USA	Saint Louis University	Di Bisceglie, AM (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, 3635 Vista Ave, St Louis, MO 63110 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 23	2002	360	9346					1688	1688		10.1016/S0140-6736(02)11609-6	http://dx.doi.org/10.1016/S0140-6736(02)11609-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618AE	12457806				2022-12-24	WOS:000179393900028
J	Harvey, CF; Swartz, CH; Badruzzaman, ABM; Keon-Blute, N; Yu, W; Ali, MA; Jay, J; Beckie, R; Niedan, V; Brabander, D; Oates, PM; Ashfaque, KN; Islam, S; Hemond, HF; Ahmed, MF				Harvey, CF; Swartz, CH; Badruzzaman, ABM; Keon-Blute, N; Yu, W; Ali, MA; Jay, J; Beckie, R; Niedan, V; Brabander, D; Oates, PM; Ashfaque, KN; Islam, S; Hemond, HF; Ahmed, MF			Arsenic mobility and groundwater extraction in Bangladesh	SCIENCE			English	Article							CARBON	High levels of arsenic in well water are causing widespread poisoning in Bangladesh. In a typical aquifer in southern Bangladesh, chemical data imply that arsenic mobilization is associated with recent inflow of carbon. High concentrations of radiocarbon-young methane indicate that young carbon has driven recent biogeochemical processes, and irrigation pumping is sufficient to have drawn water to the depth where dissolved arsenic is at a maximum. The results of field injection of molasses, nitrate, and low-arsenic water show that organic carbon or its degradation products may quickly mobilize arsenic, oxidants may lower arsenic concentrations, and sorption of arsenic is limited by saturation of aquifer materials.	MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 01239 USA; Bangladesh Univ Engn & Technol, Dhaka 1000, Bangladesh; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z1, Canada; Univ Cincinnati, Dept Civil & Environm Engn, Cincinnati, OH 45221 USA	Massachusetts Institute of Technology (MIT); Bangladesh University of Engineering & Technology (BUET); University of British Columbia; University System of Ohio; University of Cincinnati	Harvey, CF (corresponding author), MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 01239 USA.		harvey, charles F/A-8601-2012	harvey, charles F/0000-0002-7759-4447; Brabander, Daniel/0000-0002-2967-3087; Beckie, Roger/0000-0001-6152-4420	NIEHS NIH HHS [P30ES02109] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Appelo CAJ, 2002, ENVIRON SCI TECHNOL, V36, P3096, DOI 10.1021/es010130n; Chowdhury TR, 1999, NATURE, V401, P545, DOI 10.1038/44056; Das D., 1995, P INT C ARS GROUNDW; Goodbred SL, 1999, GEOLOGY, V27, P559, DOI 10.1130/0091-7613(1999)027<0559:HAMSBF>2.3.CO;2; Harvey CF, 2002, SCIENCE, V296; HARVEY CF, 2001, ENV SCI, V8, P491; Keon NE, 2001, ENVIRON SCI TECHNOL, V35, P2778, DOI 10.1021/es001511o; Khan FH, 1991, GEOLOGY BANGLADESH; Kinniburgh D., 2001, ARSENIC CONTAMINATIO; McArthur JM, 2001, WATER RESOUR RES, V37, P109, DOI 10.1029/2000WR900270; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Nordstrom DK, 2000, MINOR ELEMENTS 2000: PROCESSING AND ENVIRONMENTAL ASPECTS OF AS, SB, SE, TE, AND BI, P21; Senn DB, 2002, SCIENCE, V296, P2373, DOI 10.1126/science.1072402; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; YAPP CJ, 1986, GEOCHIM COSMOCHIM AC, V50, P1213, DOI 10.1016/0016-7037(86)90404-7; YU WH, IN PRESS WATER RESOU	18	933	968	20	455	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1602	1606		10.1126/science.1076978	http://dx.doi.org/10.1126/science.1076978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446905				2022-12-24	WOS:000179361600044
J	Yang, MY; Bowmaker, M; Reyes, A; Vergani, L; Angeli, P; Gringeri, E; Jacobs, HT; Holt, IJ				Yang, MY; Bowmaker, M; Reyes, A; Vergani, L; Angeli, P; Gringeri, E; Jacobs, HT; Holt, IJ			Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication	CELL			English	Article							SEQUENCE; ORGANIZATION; INITIATION; GENOME	Recently, we presented evidence for conventional, strand-coupled replication of mammalian mitochondrial DNA (Holt et al., 2000). Partially single-stranded replication intermediates detected in the same DNA preparations were assumed to derive from the previously described, strand-asymmetric mode of mitochondrial DNA replication. Here, we show that bona fide replication intermediates from highly purified mitochondria are essentially duplex throughout their length, but contain widespread regions of RNA:DNA hybrid, as a result of the incorporation of ribonucleotides on the light strand which are subsequently converted to DNA. Ribonucleotide-rich regions can be degraded to generate partially single-stranded molecules by RNase H treatment in vitro or during DNA extraction from crude mitochondria. Mammalian mitochondrial DNA replication thus proceeds mainly, or exclusively, by a strand-coupled mechanism.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Univ Padua, Dept Neurol Sci & Psychiat, I-35128 Padua, Italy; Univ Padua, Dept Clin & Expt Med, I-35128 Padua, Italy; Univ Padua, Dept Surg & Gastroenterol Sci, I-35128 Padua, Italy; Univ Tampere, Tampere Univ Hosp, FIN-33014 Tampere, Finland; Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Padua; University of Padua; University of Padua; Tampere University; Tampere University Hospital; Tampere University; University of Glasgow	Holt, IJ (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.		Jacobs, Howard T/G-2434-2011; GRINGERI, ENRICO/AAB-9315-2019; Yang, Mingyao/AAX-9927-2020; Angeli, Paolo/A-9759-2015; Gringeri, Enrico/K-4199-2018	GRINGERI, ENRICO/0000-0002-3459-7306; Yang, Mingyao/0000-0001-6508-2738; holt, ian/0000-0001-5468-0193; Jacobs, Howard/0000-0003-1895-6003	MRC [MC_U105663140] Funding Source: UKRI; Medical Research Council [MC_U105663140] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BLAIR DG, 1972, P NATL ACAD SCI USA, V69, P2518, DOI 10.1073/pnas.69.9.2518; BOGENHAGEN D, 1977, CELL, V12, P471; BRENNICKE A, 1981, PLASMID, V6, P332; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; DEFRANCESCO L, 1981, NUCLEIC ACIDS RES, V9, P6017, DOI 10.1093/nar/9.22.6017; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GILLUM AM, 1978, P NATL ACAD SCI USA, V75, P735; GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; INSELBURG J, 1974, P NATL ACAD SCI USA, V71, P2256, DOI 10.1073/pnas.71.6.2256; Kornberg A., 1992, DNA REPLICATION; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SPADARI S, 1974, J BIOL CHEM, V249, P5809; ten Asbroek ALMA, 2002, EUR J BIOCHEM, V269, P583, DOI 10.1046/j.0014-2956.2001.02686.x	19	203	209	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 15	2002	111	4					495	505		10.1016/S0092-8674(02)01075-9	http://dx.doi.org/10.1016/S0092-8674(02)01075-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437923	Bronze			2022-12-24	WOS:000179346900003
J	Schifano, F; Oyefeso, A; Webb, L; Pollard, M; Corkery, J; Ghodse, AH				Schifano, F; Oyefeso, A; Webb, L; Pollard, M; Corkery, J; Ghodse, AH			Review of deaths related to taking ecstasy, England and Wales, 1997-2000	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England	St Georges University London	Schifano, F (corresponding author), St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England.		Webb, Lucy/AAA-3078-2022	Webb, Lucy/0000-0003-2580-3654; Corkery, John Martin/0000-0002-3849-817X				*EUR MON CTR DRUG, 2001, ANN REP STAT DRUGS P; GHODSE AH, 2002, 9 NPSAD EUR CTR ADD; Giroud C, 1997, Praxis (Bern 1994), V86, P510; Gore SM, 1999, LANCET, V354, P1265, DOI 10.1016/S0140-6736(99)02729-4; Schifano F, 2000, NEUROPSYCHOBIOLOGY, V42, P25, DOI 10.1159/000026667	5	41	42	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					80	81		10.1136/bmj.326.7380.80	http://dx.doi.org/10.1136/bmj.326.7380.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521971	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000180426900015
J	Levin-Zaidman, S; Englander, J; Shimoni, E; Sharma, AK; Minton, KW; Minsky, A				Levin-Zaidman, S; Englander, J; Shimoni, E; Sharma, AK; Minton, KW; Minsky, A			Ringlike structure of the Deinococcus radiodurans genome: A key to radioresistance?	SCIENCE			English	Article							IONIZING-RADIATION; CELL-DIVISION; DNA; RESISTANT; REPAIR; RECOMBINATION; FRAGMENTS; MODEL	The bacterium Deinococcus radiodurans survives ionizing irradiation and other DNA-damaging assaults at doses that are lethal to all other organisms. How D. radiodurans accurately reconstructs its genome from hundreds of radiation-generated fragments in the absence of an intact template is unknown. Here we show that the D. radiodurans genome assumes an unusual toroidal morphology that may contribute to its radioresistance. We propose that, because of restricted diffusion within the tightly packed and laterally ordered DNA toroids, radiation-generated free DNA ends are held together, which may facilitate template-independent yet error-free joining of DNA breaks.	Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA	Minsky, A (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.							Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; CHOU FI, 1990, J BACTERIOL, V172, P2029, DOI 10.1128/jb.172.4.2029-2035.1990; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; DALY MJ, 1995, SCIENCE, V270, P1318, DOI 10.1126/science.270.5240.1318; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; Jary D, 1999, BIOCHEMISTRY-US, V38, P3223, DOI 10.1021/bi982770h; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; MA CL, 1994, BIOPHYS J, V67, P1678, DOI 10.1016/S0006-3495(94)80641-1; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Minton KW, 1996, MUTAT RES-DNA REPAIR, V363, P1, DOI 10.1016/0921-8777(95)00014-3; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514; MURRAY RGE, 1983, CAN J MICROBIOL, V29, P1412, DOI 10.1139/m83-217; NORRIS V, 1995, J MOL BIOL, V253, P739, DOI 10.1006/jmbi.1995.0587; RAU DC, 1992, BIOPHYS J, V61, P260, DOI 10.1016/S0006-3495(92)81832-5; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z	22	186	210	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					254	256		10.1126/science.1077865	http://dx.doi.org/10.1126/science.1077865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522252				2022-12-24	WOS:000180284000040
J	Peeters, A; Barendregt, JJ; Willekens, F; Mackenbach, JP; Al Mamun, A; Bonneux, L				Peeters, A; Barendregt, JJ; Willekens, F; Mackenbach, JP; Al Mamun, A; Bonneux, L		Netherlands Epidemiology Demograph	Obesity in adulthood and its consequences for, life expectancy: A life-table analysis	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; WEIGHT CHANGE; DIABETES-MELLITUS; RISK-FACTORS; FOLLOW-UP; MORTALITY; HEALTH; ASSOCIATION; OVERWEIGHT	Background: Overweight and obesity in adulthood are linked to an increased risk for death and disease. Their potential effect on life expectancy and premature death has not yet been described. Objective: To analyze reductions in life expectancy and increases in premature death associated with overweight and obesity at 40 years of age. Design: Prospective cohort study. Setting: The Framingham Heart Study with follow-up from 1948 to 1990. Participants: 3457 Framingham Heart Study participants who were 30 to 49 years of age at baseline. Measurements: Mortality rates specific for age and body mass index group (normal weight, overweight, or obese at baseline) were derived within sex and smoking status strata. Life expectancy and the probability of death before 70 years of age were analyzed by using life tables. Results: Large decreases in life expectancy were associated with overweight and obesity. Forty-year-old female nonsmokers lost 3.3 years and 40-year-old male nonsmokers lost 3.1 years of life expectancy because of overweight. Forty-year-old female nonsmokers lost 7.1 years and 40-year-old male nonsmokers lost 5.8 years because of obesity. Obese female smokers lost 7.2 years and obese male smokers lost 6.7 years of life expectancy compared with normal-weight, smokers. Obese female smokers lost 13.3 years and obese male smokers lost 13.7 years compared with normal-weight nonsmokers. Body mass index at ages 30 to 49 years predicted mortality after ages 50 to 69 years, even after adjustment for body mass index at age 50 to 69 years. Conclusions: Obesity and overweight in adulthood are associated with large decreases in life expectancy and increases in early mortality. These decreases are similar to those seen with smoking. Obesity in adulthood is. a powerful predictor of death at older ages. Because of the increasing prevalence of obesity, more efficient prevention and treatment should become high priorities in public health.	Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Univ Groningen, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	Peeters, A (corresponding author), Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	peeters@mgz.fgg.eur.nl	Mamun, Abdullah/HHM-9898-2022; PEETERS, ANNA/B-3663-2013; Peeters, Anna/M-8284-2019; Barendregt, Jan J/F-6895-2010; Mamun, Abdullah A/A-4673-2011	PEETERS, ANNA/0000-0003-4340-9132; Peeters, Anna/0000-0003-4340-9132; Mamun, Abdullah A/0000-0002-1535-8086; Kunst, Anton/0000-0002-3313-5273				ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1989, US DEC LIF TABL 1989, V2; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; EFRON B, 1993, INTRO BOOTSTRAP, P184; Garrison RJ, 1996, CURR OPIN LIPIDOL, V7, P199, DOI 10.1097/00041433-199608000-00005; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Magarey AM, 2001, MED J AUSTRALIA, V174, P561, DOI 10.5694/j.1326-5377.2001.tb143435.x; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Peeters A, 2002, EUR HEART J, V23, P458, DOI 10.1053/euhj.2001.2838; PEKKANEN J, 1993, CARDIOLOGY, V82, P181, DOI 10.1159/000175867; PETERS ETJ, 1995, INT J OBESITY, V19, P862; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; ROGERS RG, 1991, SOC SCI MED, V32, P1151, DOI 10.1016/0277-9536(91)90092-Q; ROTHMAN K, 1998, MODERN EPIDEMIOLOGY, P422; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; SHURTLEFF D, 1971, FRAMINGHAM STUDY EPI; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Visscher TLS, 2000, AM J EPIDEMIOL, V151, P660, DOI 10.1093/oxfordjournals.aje.a010260; Wannamethee SG, 1999, HEART, V81, P374, DOI 10.1136/hrt.81.4.374; Wannamethee SG, 2001, INT J EPIDEMIOL, V30, P777, DOI 10.1093/ije/30.4.777; *WHO, 1998, REP WHO CONS OB 3 5	35	893	923	3	79	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					24	32		10.7326/0003-4819-138-1-200301070-00008	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513041	Green Published			2022-12-24	WOS:000180996200004
J	Klaholz, BP; Pape, T; Zavialov, AV; Myasnikov, AG; Orlova, EV; Vestergaard, B; Ehrenberg, M; van Heel, M				Klaholz, BP; Pape, T; Zavialov, AV; Myasnikov, AG; Orlova, EV; Vestergaard, B; Ehrenberg, M; van Heel, M			Structure of the Escherichia coli ribosomal termination complex with release factor 2	NATURE			English	Article							TRANSFER-RNA HYDROLYSIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; FACTOR RF3; TRANSLATION; ERF1; RESOLUTION; BINDING; ERRORS; SITE	Termination of protein synthesis(1) occurs when the messenger RNA presents a stop codon in the ribosomal aminoacyl (A) site. Class I release factor proteins (RF1 or RF2) are believed to recognize stop codons via tripeptide motifs(2), leading to release of the completed polypeptide chain from its covalent attachment to transfer RNA in the ribosomal peptidyl (P) site. Class I RFs possess a conserved GGQ amino-acid motif that is thought to be involved directly in protein-transfer-RNA bond hydrolysis(3,4). Crystal structures of bacterial and eukaryotic class I RFs have been determined(5,6), but the mechanism of stop codon recognition and peptidyl-tRNA hydrolysis remains unclear. Here we present the structure of the Escherichia coli ribosome in a post-termination complex with RF2, obtained by single-particle cryo-electron microscopy (cryo-EM). Fitting the known 70S and RF2 structures into the electron density map reveals that RF2 adopts a different conformation on the ribosome when compared with the crystal structure of the isolated protein. The amino-terminal helical domain of RF2 contacts the factor-binding site of the ribosome, the 'SPF' loop of the protein is situated close to the mRNA, and the GGQ-containing domain of RF2 interacts with the peptidyl-transferase centre (PTC). By connecting the ribosomal decoding centre with the PTC, RF2 functionally mimics a tRNA molecule in the A site. Translational termination in eukaryotes is likely to be based on a similar mechanism.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus, Denmark	Imperial College London; Uppsala University; Aarhus University	van Heel, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.		Orlova, Elena/CAF-8290-2022; Myasnikov, Alexander/T-4654-2018	Orlova, Elena/0000-0003-3371-415X; Vestergaard, Bente/0000-0001-8011-6414; Pape, Tillmann/0000-0002-0612-3568; Zavialov, Andrey/0000-0001-6420-0368				Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; HARAUZ G, 1986, OPTIK, V73, P146; Inagaki Y, 2002, NUCLEIC ACIDS RES, V30, P532, DOI 10.1093/nar/30.2.532; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KASTNER B, 1990, J MOL BIOL, V212, P241, DOI 10.1016/0022-2836(90)90120-B; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Tin OF, 2000, BIOCHIMIE, V82, P765, DOI 10.1016/S0300-9084(00)01149-4; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Xu WB, 2002, J BACTERIOL, V184, P1200, DOI 10.1128/jb.184.4.1200-1203.2002; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZAVIALOV AV, IN PRESS MOL CELL	29	166	170	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					90	94		10.1038/nature01225	http://dx.doi.org/10.1038/nature01225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511961				2022-12-24	WOS:000180165500044
J	Taylor, WR; Lin, K				Taylor, WR; Lin, K			Protein knots - A tangled problem	NATURE			English	Editorial Material									Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Taylor, WR (corresponding author), Natl Inst Med Res, Div Math Biol, Mill Hill, London NW7 1AA, England.							MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; TAYLOR WR, IN PRESS COMP BIOL C	4	87	88	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					25	25		10.1038/421025a	http://dx.doi.org/10.1038/421025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511935	Bronze			2022-12-24	WOS:000180165500019
J	Mokdad, AH; Ford, ES; Bowman, BA; Dietz, WH; Vinicor, F; Bales, VS; Marks, JS				Mokdad, AH; Ford, ES; Bowman, BA; Dietz, WH; Vinicor, F; Bales, VS; Marks, JS			Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WEIGHT-LOSS; LIFE-STYLE; US ADULTS; OVERWEIGHT; GLUCOSE	Context Obesity and diabetes are increasing in the United States. Objective To estimate the prevalence of obesity and diabetes among US adults in 2001. Design, Setting, and Participants Random-digit telephone survey of 195 005 adults aged 18 years or older residing in all states participating in the Behavioral Risk Factor Surveillance System in 2001. Main Outcome Measures Body mass index,based on self-reported weight and height and self-reported diabetes., Results In 2001 the prevalence of obesity (BMI greater than or equal to30) was 20.9% vs 19.8% in 2000, an increase of 5.6%. The prevalence of diabetes increased to 7.9% vs 7.3% in 2000, an increase of 8.2%. The prevalence of BMI of 40 or higher in 2001 was 2.3%. Overweight and obesity were significantly associated with diabetes, high blood pressure, high cholesterol, asthma, arthritis, and poor health status. Compared with adults with normal weight, adults with a BMI of 40 or higher had an odds ratio (OR) of 7.37 (95% confidence interval [CI], 6.39-8.50) for diagnosed diabetes, 6.38 (95% Cl, 5.67-7.17) for high blood pressure, 1.88 (95% CI,1.67-2.13) for high cholesterol levels, 2.72 (95% CI, 2.38-3.12) for asthma, 4.41 (95% CI, 3.91-4.97),for arthritis, and 4.19 (95% CI, 3.68-4.76) for fair or poor health. Conclusions Increases in obesity and diabetes among US adults continue in both sexes, all ages, all races, all educational levels, and all smoking levels. Obesity is strongly associated with several major health risk factors.	CDCP, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; CDCP, Off Director, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mokdad, AH (corresponding author), CDCP, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy NE,Mailstop K66, Atlanta, GA 30341 USA.	ahm1@cdc.gov	Adiels, Martin/C-9278-2011					ADAY LA, 1989, DESIGNING CONDUCTING, P79; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *CDCP, 2000, NAT DIAB FACT SHEET; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON DE, 1998, P SECT SURV METH AM; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Ray NF, 1998, DIABETES CARE, V21, P296; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *SAS I INC, 2001, SAS SYST VERS 8; SHAH BV, 2000, SUDAAN USERS MANUAL; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Will JC, 2002, AM J PUBLIC HEALTH, V92, P1245, DOI 10.2105/AJPH.92.8.1245	23	2980	3043	10	459	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					76	79		10.1001/jama.289.1.76	http://dx.doi.org/10.1001/jama.289.1.76			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503980				2022-12-24	WOS:000180136600029
J	Beall, EL; Manak, JR; Zhou, S; Bell, M; Lipsick, JS; Botchan, MR				Beall, EL; Manak, JR; Zhou, S; Bell, M; Lipsick, JS; Botchan, MR			Role for a Drosophila Myb-containing protein complex in site-specific DNA replication	NATURE			English	Article							CHORION GENE AMPLIFICATION; ORIGIN RECOGNITION COMPLEX; BINDING DOMAIN; IDENTIFICATION; ELEMENT; CELLS	There is considerable interest in the developmental, temporal and tissue-specific patterns of DNA replication in metazoans(1,2). Site-specific DNA replication at the chorion loci in Drosophila follicle cells leads to extensive gene amplification, and the organization of the cis-acting DNA elements that regulate this process may provide a model for how such regulation is achieved(3). Two elements important for amplification of the third chromosome chorion gene cluster, ACE3 and Ori-beta, are directly bound by Orc(4-6) (origin recognition complex), and two-dimensional gel analysis has revealed that the primary origin used is Ori-beta (refs 7-9). Here we show that the Drosophila homologue of the Myb (Myeloblastosis) oncoprotein family is tightly associated with four additional proteins, and that the complex binds site-specifically to these regulatory DNA elements. Drosophila Myb is required in trans for gene amplification, showing that a Myb protein is directly involved in DNA replication. A Drosophila Myb binding site, as well as the binding site for another Myb complex member (p120), is necessary in cis for replication of reporter transgenes. Chromatin immunoprecipitation experiments localize both proteins to the chorion loci in vivo. These data provide evidence that specific protein complexes bound to replication enhancer elements work together with the general replication machinery for site-specific origin utilization during replication.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University; Stanford University	Botchan, MR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Manak, John/0000-0002-6562-7694				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BOSCH T, 1995, OPT REV, V2, P289, DOI 10.1007/s10043-995-0289-2; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; DELIDAKIS C, 1989, EMBO J, V8, P891, DOI 10.1002/j.1460-2075.1989.tb03450.x; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Fitzpatrick CA, 2002, DEVELOPMENT, V129, P4497; Ganter B, 1999, ADV CANCER RES, V76, P21, DOI 10.1016/S0065-230X(08)60773-3; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; GOSSEN M, 1995, SCIENCE, V270, P1674, DOI 10.1126/science.270.5242.1674; Harlow E., 1989, ANTIBODIES LAB MANUA; HECK MMS, 1990, J CELL BIOL, V110, P903, DOI 10.1083/jcb.110.4.903; Lu L, 2001, GENE DEV, V15, P134, DOI 10.1101/gad.822101; Manak JR, 2002, P NATL ACAD SCI USA, V99, P7438, DOI 10.1073/pnas.122231599; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; ORRWEAVER TL, 1991, BIOESSAYS, V13, P97, DOI 10.1002/bies.950130302; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; RIO DC, 1988, P NATL ACAD SCI USA, V85, P8929, DOI 10.1073/pnas.85.23.8929; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; STOBERGRASSER U, 1992, ONCOGENE, V7, P589; Suzanne M, 2001, DEV BIOL, V237, P282, DOI 10.1006/dbio.2001.0384; Voitenleitner C, 2002, J VIROL, V76, P3440, DOI 10.1128/JVI.76.7.3440-3451.2002	26	184	188	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					833	837		10.1038/nature01228	http://dx.doi.org/10.1038/nature01228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490953				2022-12-24	WOS:000179897300061
J	Di Tanna, GL; Rosano, A; Mastroiacovo, P				Di Tanna, GL; Rosano, A; Mastroiacovo, P			Prevalence of gastroschisis at birth: retrospective study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL-WALL DEFECTS; ENGLAND		Int Ctr Birth Defects, I-00195 Rome, Italy; Italian Inst Social Med, I-00196 Rome, Italy		Mastroiacovo, P (corresponding author), Int Ctr Birth Defects, I-00195 Rome, Italy.		rosano, Aldo/T-7180-2019; Di Tanna, Gian Luca/AAF-2352-2019; Rosano, Aldo/G-6525-2012	Di Tanna, Gian Luca/0000-0002-5470-3567; Rosano, Aldo/0000-0002-5453-2294				Barisic I, 2001, ULTRASOUND OBST GYN, V18, P309, DOI 10.1046/j.0960-7692.2001.00534.x; Nichols C R, 1997, J Matern Fetal Med, V6, P225; Rankin J, 1999, PRENATAL DIAG, V19, P662, DOI 10.1002/(SICI)1097-0223(199907)19:7<662::AID-PD607>3.0.CO;2-C; Tan KH, 1996, BRIT MED J, V313, P903; TORFS CP, 1994, TERATOLOGY, V50, P44, DOI 10.1002/tera.1420500107	5	47	52	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1389	1390		10.1136/bmj.325.7377.1389	http://dx.doi.org/10.1136/bmj.325.7377.1389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480852	Green Published			2022-12-24	WOS:000179975000021
J	Stephens, DW; McLinn, CM; Stevens, JR				Stephens, DW; McLinn, CM; Stevens, JR			Discounting and reciprocity in an iterated prisoner's dilemma	SCIENCE			English	Article							TIT-FOR-TAT; COOPERATION; GAME; EVOLUTION; CHOICE; MODELS; DELAYS	The Iterated Prisoner's Dilemma (IPD) is a central paradigm in the study of animal cooperation. According to the IPD framework, repeated play ( repetition) and reciprocity combine to maintain a cooperative equilibrium. However, experimental studies with animals suggest that cooperative behavior in IPDs is unstable, and some have suggested that strong preferences for immediate benefits (that is, temporal discounting) might explain the fragility of cooperative equilibria. We studied the effects of discounting and strategic reciprocity on cooperation in captive blue jays. Our results demonstrate an interaction between discounting and reciprocity. Blue jays show high stable levels of cooperation in treatments with reduced discounting when their opponent reciprocates, but their levels of cooperation decline in all other treatment combinations. This suggests that stable cooperation requires both reduced discounting and reciprocity, and it offers an explanation of earlier failures to find cooperation in controlled payoff games.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Stephens, DW (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.		Stevens, Jeffrey R/C-4619-2011	Stevens, Jeffrey R/0000-0003-2375-1360; Stephens, David/0000-0003-3720-5248				AINSLIE GW, 1974, J EXP ANAL BEHAV, V21, P485, DOI 10.1901/jeab.1974.21-485; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Dugatkin L.A., 1997, COOPERATION ANIMALS; DUGATKIN LA, 1992, TRENDS ECOL EVOL, V7, P202, DOI 10.1016/0169-5347(92)90074-L; FLOOD M, 1983, BEHAV SCI, V28, P65, DOI 10.1002/bs.3830280108; GARDNER RM, 1984, PSYCHOL REP, V55, P687, DOI 10.2466/pr0.1984.55.3.687; GODIN JGJ, 1995, P ROY SOC B-BIOL SCI, V259, P193, DOI 10.1098/rspb.1995.0028; GREEN L, 1995, J EXP ANAL BEHAV, V64, P1, DOI 10.1901/jeab.1995.64-1; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Heinrich B., 1989, RAVENS WINTER; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; MAZUR JE, 1984, J EXP PSYCHOL ANIM B, V10, P426, DOI 10.1037/0097-7403.10.4.426; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Pusey Anne E., 1997, P254; RACHLIN H, 1972, J EXP ANAL BEHAV, V17, P15, DOI 10.1901/jeab.1972.17-15; Silverstein A, 1998, J BEHAV DECIS MAKING, V11, P123, DOI 10.1002/(SICI)1099-0771(199806)11:2<123::AID-BDM283>3.3.CO;2-X; STEPHENS DW, 1995, J THEOR BIOL, V176, P457, DOI 10.1006/jtbi.1995.0213; Stephens DW, 1997, ANIM BEHAV, V53, P113, DOI 10.1006/anbe.1996.0283; Stephens DW, 2000, J THEOR BIOL, V205, P1, DOI 10.1006/jtbi.2000.2041; Weitzman ML, 2001, AM ECON REV, V91, P260, DOI 10.1257/aer.91.1.260	24	138	144	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2216	2218		10.1126/science.1078498	http://dx.doi.org/10.1126/science.1078498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624RA	12481142	Green Submitted			2022-12-24	WOS:000179773700056
J	Segura, TL; Toon, OB; Colaprete, A; Zahnle, K				Segura, TL; Toon, OB; Colaprete, A; Zahnle, K			Environmental effects of large impacts on Mars	SCIENCE			English	Article							CLIMATE	The martian valley networks formed near the end of the period of heavy bombardment of the inner solar system, about 3.5 billion years ago. The largest impacts produced global blankets of very hot ejecta, ranging in thickness from meters to hundreds of meters. Our simulations indicated that the ejecta warmed the surface, keeping it above the freezing point of water for periods ranging from decades to millennia, depending on impactor size, and caused shallow subsurface or polar ice to evaporate or melt. Large impacts also injected steam into the atmosphere from the craters or from water innate to the impactors. From all sources, a typical 100-, 200-, or 250-kilometers asteroid injected about 2, 9, or 16 meters, respectively, of precipitable water into the atmosphere, which eventually rained out at a rate of about 2 meters per year. The rains from a large impact formed rivers and contributed to recharging aquifers.	Univ Colorado, Program Atmospher & Ocean Sci, Atmospher & Space Phys Lab, Boulder, CO 80309 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Segura, TL (corresponding author), NASA, Ames Res Ctr, MS 245-3, Moffett Field, CA 94035 USA.							Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Carr M.H, 1996, WATER MARS; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; Christensen PR, 1998, SCIENCE, V279, P1692, DOI 10.1126/science.279.5357.1692; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; COLAPRETE A, IN PRESS J GEOPHYS R; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; FREY HV, 2002, GEOPHYS RES LETT, V29; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; Hartmann W. K., 2000, ORIGIN EARTH MOON, P493; JAKOSKY BM, 1983, ICARUS, V55, P1, DOI 10.1016/0019-1035(83)90046-5; KASTING JF, 1991, ICARUS, V91, P1; LEOVY CB, UNPUB; Lodders K., 1998, PLANETARY SCI COMPAN; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; MALIN MC, 1986, GEOPHYS RES LETT, V13, P444, DOI 10.1029/GL013i005p00444; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Sleep NH, 1998, J GEOPHYS RES-PLANET, V103, P28529, DOI 10.1029/98JE01809; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Tanaka K. L., 1992, MARS, P345; ZAHNLE K, 1990, GEOCHIM COSMOCHIM AC, V54, P2577, DOI 10.1016/0016-7037(90)90243-E; Zahnle K. J., 1990, GEOL SOC AM SPEC PAP, V247, P271, DOI DOI 10.1130/SPE247-P271	25	216	220	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1977	1980		10.1126/science.1073586	http://dx.doi.org/10.1126/science.1073586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471254				2022-12-24	WOS:000179629200041
J	Pichichero, ME; Cernichiari, E; Lopreiato, J; Treanor, J				Pichichero, ME; Cernichiari, E; Lopreiato, J; Treanor, J			Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study	LANCET			English	Article							METHYLMERCURY EXPOSURE; VACCINATION; SEYCHELLES; HAIR	Background Thiomersal is a preservative containing small amounts of ethylmercury that is used in routine vaccines for infants and children. The effect of vaccines containing thiomersal on concentrations of mercury in infants' blood has not been extensively assessed, and the metabolism of ethylmercury in infants is unknown. We aimed to measure concentrations of mercury in blood, urine, and stools of infants who received such vaccines. Methods 40 full-term infants aged 6 months and younger were given vaccines that contained thiomersal (diptheria-tetanus-acellular pertussis vaccine, hepatitis B vaccine, and in some children Haemophilus influenzae type B vaccine). 21 control infants received thiomersal-free vaccines. We obtained samples of blood, urine, and stools 3-28 days after vaccination. Total mercury (organic and inorganic) in the samples was measured by cold vapour atomic absorption. Findings Mean mercury doses in infants exposed to thiomersal were 45.6 mug (range 37.5-62.5) for 2-month-olds and 111.3 mug (range 87.5-175.0) for 6-month-olds. Blood mercury in thiomersal-exposed 2-month-olds ranged from less than 3.75 to 20.55 nmol/L (parts per billion); in 6-month-olds all values were lower than 7.50 nmol/L. Only one of 15 blood samples from controls contained quantifiable mercury. Concentrations of mercury were low in urine after vaccination but were high in stools of thiomersal-exposed 2-month-olds (mean 82 ng/g dry weight) and in 6-month-olds (mean 58 ng/g dry weight). Estimated blood half-life of ethylmercury was 7 days (95% CI 4-10 days). Interpretation Administration of vaccines containing thiomersal does not seem to raise blood concentrations of mercury above safe values in infants. Ethylmercury seems to be eliminated from blood rapidly via the stools after parenteral administration of thiomersal in vaccines.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Rochester, NY 14642 USA; Natl Naval Med Res Inst, Bethesda, MD USA	University of Rochester; University of Rochester; University of Rochester; Naval Medical Research Center (NMRC)	Pichichero, ME (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	michael_pichichero@urmc.rochester.edu	Pichichero, Michael E/AID-7886-2022		ACF HHS [1 AF-45248] Funding Source: Medline	ACF HHS		Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; AXTON JH, 1972, POSTGRAD MED J, V561, P417; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Clements CJ, 2000, LANCET, V355, P1279, DOI 10.1016/S0140-6736(05)74714-0; COX NH, 1988, CONTACT DERMATITIS, V18, P229, DOI 10.1111/j.1600-0536.1988.tb02809.x; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; FAGAN DG, 1977, ARCH DIS CHILD, V52, P962, DOI 10.1136/adc.52.12.962; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Lowell J A, 1996, Liver Transpl Surg, V2, P475, DOI 10.1002/lt.500020612; MATHESON DS, 1980, J PEDIATR-US, V97, P153, DOI 10.1016/S0022-3476(80)80159-4; National Academy of Sciences, 2000, TOX EFF METH; NIELSEN JB, 1994, ARCH TOXICOL, V68, P317, DOI 10.1007/s002040050075; Pfab R, 1996, J TOXICOL-CLIN TOXIC, V34, P453, DOI 10.3109/15563659609013818; Shenker BJ, 1998, ENVIRON RES, V77, P149, DOI 10.1006/enrs.1997.3816; Stajich GV, 2000, J PEDIATR-US, V136, P679, DOI 10.1067/mpd.2000.105133; YESS NJ, 1993, J AOAC INT, V76, P36; [No title captured]	20	157	170	0	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1737	1741		10.1016/S0140-6736(02)11682-5	http://dx.doi.org/10.1016/S0140-6736(02)11682-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480426				2022-12-24	WOS:000179636800010
J	Mehta, RL; Pascual, MT; Soroko, S; Chertow, GM				Mehta, RL; Pascual, MT; Soroko, S; Chertow, GM		PICARD Study Grp	Diuretics, mortality, and nonrecovery of renal function in acute renal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE TUBULAR-NECROSIS; RANDOMIZED TRIAL; CARDIAC-SURGERY; FAILURE; FUROSEMIDE; DIALYSIS; MANNITOL; DYSFUNCTION; MANAGEMENT; DOPAMINE	Context Acute renal failure is associated with high mortality and morbidity. Diuretic agents continue to be used in this setting despite a lack of evidence supporting their benefit. Objective To determine whether the use of diuretics is associated with adverse or favorable outcomes in critically ill patients with acute renal failure. Design Cohort study conducted from October 1989 to September 1995. Patients and Setting A total of 552 patients with acute renal failure in intensive care units at 4 academic medical centers affiliated with the University of California. Patients were categorized by the use of diuretics on the day of nephrology consultation and, in companion analyses, by diuretic use at any time during the first week following consultation. Main Outcome Measures All-cause hospital mortality, nonrecovery of renal function, and the combined outcome of death or nonrecovery. Results Diuretics were used in 326 patients (59%) at the time of nephrology consultation. Patients treated with diuretics on or before the day of consultation were older and more likely to have a history of congestive heart failure, nephrotoxic (rather than ischemic or multifactorial) origin of acute renal failure, acute respiratory failure, and lower serum urea nitrogen concentrations. With adjustment for relevant covariates and propensity scores, diuretic use Was associated with a significant increase in the risk of death or nonrecovery of renal function (odds ratio, 1.77; 95% confidence interval, 1.14-2.76). The risk was magnified (odds ratio, 3.12; 95% confidence interval, 1.73-5.62) when patients who died within the first week following consultation were excluded. The increased risk was borne largely by patients who were relatively unresponsive, to diuretics. Conclusions The use of diuretics in critically ill patients with acute renal failure was associated with an increased risk of death and nonrecovery of renal function. Although observational data prohibit causal inference, it is unlikely that diuretics afford any material benefit in this clinical setting. In the absence of compelling contradictory data from a randomized, blinded clinical trial, the widespread use of diuretics in critically ill patients with acute renal failure should be discouraged.	Univ Calif San Diego, Med Ctr, Div Nephrol, San Diego, CA 92103 USA; Univ Calif San Francisco, Mt Zion Med Ctr, Div Nephrol, San Francisco, CA 94120 USA; Moffitt Long Hosp, Div Nephrol, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion	Chertow, GM (corresponding author), Univ Calif San Francisco, Dept Med Res, UCSF Laurel Hts,Suite 430,3333 Calif St, San Francisco, CA 94118 USA.		Mehta, Ravindra/ACD-4769-2022	Mehta, Ravindra/0000-0002-0908-2968; Chertow, Glenn/0000-0002-7599-0534; NOIRI, Eisei/0000-0002-9515-7582	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053412] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK53412-0] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RJ, 1977, NEW ENGL J MED, V296, P1134, DOI 10.1056/NEJM197705192962002; Bates DW, 2001, CLIN INFECT DIS, V32, P686, DOI 10.1086/319211; Bellomo R, 2000, LANCET, V356, P2139; Bellomo R, 1998, KIDNEY INT, V53, pS106; BROWN CB, 1981, CLIN NEPHROL, V15, P90; BROWN RS, 1979, CRIT CARE MED, V7, P63, DOI 10.1097/00003246-197902000-00007; BULLOCK ML, 1985, AM J KIDNEY DIS, V5, P97, DOI 10.1016/S0272-6386(85)80003-2; Cantarovich F, 1996, RENAL FAILURE, V18, P585, DOI 10.3109/08860229609047681; CHANG RWS, 1988, CRIT CARE MED, V16, P34, DOI 10.1097/00003246-198801000-00007; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 1998, J AM SOC NEPHROL, V9, P692; DAVIDMAN M, 1991, ARCH INTERN MED, V151, P1809, DOI 10.1001/archinte.151.9.1809; DIAMOND JR, 1982, ARCH INTERN MED, V142, P1882, DOI 10.1001/archinte.142.10.1882; Gerlach AT, 2000, PHARMACOTHERAPY, V20, P540, DOI 10.1592/phco.20.6.540.35154; GUBERN JM, 1988, SURGERY, V103, P39; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kellum, 1997, Crit Care, V1, P53, DOI 10.1186/cc103; Kellum JA, 1997, BLOOD PURIFICAT, V15, P319, DOI 10.1159/000170350; Klahr S, 1998, NEW ENGL J MED, V338, P671, DOI 10.1056/NEJM199803053381007; KLEINKNECHT D, 1976, NEPHRON, V17, P51, DOI 10.1159/000180710; Lassnigg A, 2000, J AM SOC NEPHROL, V11, P97, DOI 10.1681/ASN.V11197; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Lewis J, 2000, AM J KIDNEY DIS, V36, P767, DOI 10.1053/ajkd.2000.17659; Liano F, 1998, SEMIN NEPHROL, V18, P541; LIANO F, 1993, NEPHRON, V63, P21, DOI 10.1159/000187139; McCarthy JT, 1996, MAYO CLIN PROC, V71, P117, DOI 10.4065/71.2.117; Mehta RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014692.19351.52; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; MEHTA RL, IN PRESS AM J MED; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Shilliday IR, 1997, NEPHROL DIAL TRANSPL, V12, P2592, DOI 10.1093/ndt/12.12.2592; Sladen R N, 2000, Anesthesiol Clin North Am, V18, P739, DOI 10.1016/S0889-8537(05)70192-9; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; Venkataram R, 2001, CONTRIB NEPHROL, V132, P158; Visweswaran P, 1997, J AM SOC NEPHROL, V8, P1028; WEINSTEIN JM, 1992, NEPHRON, V62, P413, DOI 10.1159/000187090; Wilson W C, 2001, Anesthesiol Clin North Am, V19, P841	39	387	404	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2002	288	20					2547	2553		10.1001/jama.288.20.2547	http://dx.doi.org/10.1001/jama.288.20.2547			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618AL	12444861	Bronze			2022-12-24	WOS:000179394500021
J	Raymond, J; Zhaxybayeva, O; Gogarten, JP; Gerdes, SY; Blankenship, RE				Raymond, J; Zhaxybayeva, O; Gogarten, JP; Gerdes, SY; Blankenship, RE			Whole-genome analysis of photosynthetic prokaryotes	SCIENCE			English	Article							HORIZONTAL GENE-TRANSFER; EARLY EVOLUTION; SEQUENCE; DATABASE	The process of photosynthesis has had profound global-scale effects on Earth; however, its origin and evolution remain enigmatic. Here we report a whole-genome comparison of representatives from all. five groups of photosynthetic prokaryotes and show that horizontal gene transfer has been pivotal in their evolution. Excluding a small number of orthologs that show congruent phylogenies, the genomes of these organisms represent mosaics of genes with very different evolutionary histories. We have also analyzed a subset of "photosynthesisspecific" genes that were elucidated through a differential genome comparison. Our results explain incoherencies in previous data-limited phylogenetic analyses of phototrophic bacteria and indicate that the core components of photosynthesis have been subject to lateral transfer.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; Integrated Genom, Chicago, IL 60612 USA	Arizona State University; Arizona State University-Tempe; University of Connecticut	Blankenship, RE (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.		Zhaxybayeva, Olga/A-9665-2009	Zhaxybayeva, Olga/0000-0002-1809-3909; Gogarten, Johann Peter/0000-0001-6459-6518				[Anonymous], 2002, PHOTOSYNTHETICA; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Baymann D, 2001, BBA-BIOENERGETICS, V1507, P291, DOI 10.1016/S0005-2728(01)00209-2; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Gogarten JP, 1999, CURR OPIN GENET DEV, V9, P630, DOI 10.1016/S0959-437X(99)00029-5; Gupta RS, 1999, MOL MICROBIOL, V32, P893, DOI 10.1046/j.1365-2958.1999.01417.x; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OYAIZU H, 1987, SYST APPL MICROBIOL, V9, P47, DOI 10.1016/S0723-2020(87)80055-3; RAYMOND J, UNPUB; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; VERMAAS WFJ, 1994, PHOTOSYNTH RES, V41, P285, DOI 10.1007/BF02184169; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Xiong J, 2002, ANNU REV PLANT BIOL, V53, P503, DOI 10.1146/annurev.arplant.53.100301.135212; Zhaxybayeva O, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-4	24	195	215	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 22	2002	298	5598					1616	1620		10.1126/science.1075558	http://dx.doi.org/10.1126/science.1075558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446909				2022-12-24	WOS:000179361600048
J	Zhou, ZH; Clarke, JA; Zhang, FC				Zhou, ZH; Clarke, JA; Zhang, FC			Archaeoraptor's better half	NATURE			English	Editorial Material									Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, Sect Vertebrate Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Zhou, ZH (corresponding author), Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.		/B-4978-2011	/0000-0003-2218-2637				Dalton R, 2000, NATURE, V403, P689, DOI 10.1038/35001723; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; Sloan C.P., 1999, NATL GEOGR, V196, P98; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhang M.M., 2001, JEHOL BIOTA; ZHOU Z, 2001, CHINESE SCI BULL, V46, P371; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	7	31	35	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					285	285		10.1038/420285a	http://dx.doi.org/10.1038/420285a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447431				2022-12-24	WOS:000179340400032
J	Heinrich, MC; Corless, CL; Duensing, A; McGreevey, L; Chen, CJ; Joseph, N; Singer, S; Griffith, DJ; Haley, A; Town, A; Demetri, GD; Fletcher, CDM; Fletcher, JA				Heinrich, MC; Corless, CL; Duensing, A; McGreevey, L; Chen, CJ; Joseph, N; Singer, S; Griffith, DJ; Haley, A; Town, A; Demetri, GD; Fletcher, CDM; Fletcher, JA			PDGFRA activating mutations in gastrointestinal stromal tumors	SCIENCE			English	Article							C-KIT; CELLS; GENE; IDENTIFICATION; FLT3	Most gastrointestinal stromal tumors (GISTS) have activating mutations in the KIT receptor tyrosine kinase, and most patients with GISTS respond well to Gleevec, which inhibits KIT kinase activity. Here we show that similar to35% (14 of 40) of GISTS lacking KIT mutations have intragenic activation mutations in the related receptor tyrosine kinase, plate let-derived growth factor receptor alpha (PDGFRA). Tumors expressing KIT or PDGFRA oncoproteins were indistinguishable with respect to activation of downstream signaling intermediates and cytogenetic changes associated with tumor progression. Thus, KIT and PDGFRA mutations appear to be alternative and mutually exclusive oncogenic mechanisms in GISTs.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Pathol, Portland, OR 97201 USA; Portland VA Med Ctr, Portland, OR 97201 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Heinrich, MC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	heinrich@ohsu.edu; jfletcher@partners.org	Heinrich, Michael/AAC-6745-2019; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Heinrich, Michael/0000-0003-3790-0478; Singer, Samuel/0000-0001-9713-8230; Duensing, Anette/0000-0002-0168-4067				Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Heinrich MC, 2002, HUM PATHOL, V33, P484, DOI 10.1053/hupa.2002.124124; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Lokker NA, 2002, CANCER RES, V62, P3729; Longley BJ, 2001, LEUKEMIA RES, V25, P571, DOI 10.1016/S0145-2126(01)00028-5; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Rubin BP, 2001, CANCER RES, V61, P8118; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Sun L, 2000, J MED CHEM, V43, P2655, DOI 10.1021/jm9906116; Taniguchi M, 1999, CANCER RES, V59, P4297; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434	17	1754	1947	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					708	710		10.1126/science.1079666	http://dx.doi.org/10.1126/science.1079666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12522257				2022-12-24	WOS:000180687700047
J	Davis, P; Lay-Yee, R; Scott, A; Briant, R; Schug, S				Davis, P; Lay-Yee, R; Scott, A; Briant, R; Schug, S			Acknowledgement of "no fault" medical injury: review of patients' hospital records in New Zealand	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Div Community Hlth, Auckland 1, New Zealand; Univ Auckland, Dept Stat, Auckland 1, New Zealand; Univ Western Australia, Dept Anaesthesia, Perth, WA 6009, Australia	University of Otago; University of Auckland; University of Auckland; University of Western Australia	Davis, P (corresponding author), Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, POB 4345, Christchurch, New Zealand.		Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315				Blendon RJ, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.3.233; Davis P, 2001, 3 MIN HLTH; Gostin L, 2000, JAMA-J AM MED ASSOC, V283, P1742, DOI 10.1001/jama.283.13.1742; Miller R, 1993, MARYLAND LAW REV, V52, P1070; National Audit Office, 2001, HANDL CLIN NEGL CLAI	5	17	19	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					79	80		10.1136/bmj.326.7380.79	http://dx.doi.org/10.1136/bmj.326.7380.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521970	Green Published, Bronze			2022-12-24	WOS:000180426900014
J	Hemmi, JM; Zeil, J				Hemmi, JM; Zeil, J			Robust judgement of inter-object distance by an arthropod	NATURE			English	Article							UCA LACTEA ANNULIPES; FIDDLER-CRABS; RESOLUTION; OCYPODIDAE; HORIZON; MODELS; WORLD; EYES	Animals use several strategies for depth vision, reflecting the constraints imposed by body size, the structure of the visual system and the visual geometry of the environment(1). Arthropods in particular have restricted depth perception, because they are small and possess closely set, low-resolution compound eyes. Yet, here we show that fiddler crabs defending their burrows from conspecifics can judge how close other crabs are to their burrow. When confronted with small dummy crabs, the burrow owners assess the dummy's position and motion relative to their burrow and not relative to themselves-in other words, by using an allocentric rather than an egocentric frame of reference. Irrespective of their own distance from the dummy, the likelihood that the crabs rush back to defend their burrow increases strongly as the dummy approaches the burrow. In addition, the mean dummy-burrow distance at which the crabs respond is constant and independent of the dummy's direction of approach. We propose that to solve this sophisticated task of relative distance judgement, the crabs combine visual information on dummy position and direction with information on burrow location acquired during path integration(2). In doing so, the crabs, like humans(3), make clever use of the visual geometry of their environment.	Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia	Australian National University	Hemmi, JM (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, POB 475, Canberra, ACT 2601, Australia.		Hemmi, Jan M/B-6458-2008; Zeil, Jochen/C-9223-2009	Hemmi, Jan M/0000-0003-4629-9362; 				Collett T.S., 1982, P111; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; HYATT GW, 1978, BEHAVIOUR, V65, P182, DOI 10.1163/156853978X00602; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; LAND M, 1995, J COMP PHYSIOL A, V177, P81, DOI 10.1007/BF00243400; MONTAGUE CL, 1980, CONTRIB MAR SCI, V23, P25; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; SCHALL R, 1991, BIOMETRIKA, V78, P719; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659; Zeil J, 2002, CRUSTACEAN EXPERIMENTAL SYSTEMS IN NEUROBIOLOGY, P227; Zeil J, 1998, J COMP PHYSIOL A, V183, P367, DOI 10.1007/s003590050263; ZEIL J, 1986, J COMP PHYSIOL A, V159, P801, DOI 10.1007/BF00603733; Zeil J, 1996, J EXP BIOL, V199, P1569	14	43	45	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					160	163		10.1038/nature01247	http://dx.doi.org/10.1038/nature01247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520301				2022-12-24	WOS:000180267200039
J	Redfield, MM; Jacobsen, SJ; Burnett, JC; Mahoney, DW; Bailey, KR; Rodeheffer, RJ				Redfield, MM; Jacobsen, SJ; Burnett, JC; Mahoney, DW; Bailey, KR; Rodeheffer, RJ			Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; DOPPLER-ECHOCARDIOGRAPHY; EJECTION FRACTION; NATRIURETIC PEPTIDE; FILLING PRESSURE; POPULATION; AGE; PREVALENCE; UTILITY	Context Approximately half of patients with overt congestive heart failure (CHF) have diastolic dysfunction without reduced ejection fraction (EF). Yet, the prevalence of diastolic dysfunction and its relation to systolic dysfunction and CHF in the community remain undefined. Objectives To determine the prevalence of CHF and preclinical diastolic dysfunction and systolic dysfunction in the community and determine if diastolic dysfunction is predictive of all-cause mortality. Design, Setting, Participants Cross-sectional survey of 2042 randomly selected residents of Olmsted County, Minnesota, aged 45 years or older from June 1997 through September 2000. Main Outcome Measures Doppler echocardiographic assessment of systolic and diastolic function. Presence of CHF diagnosis by review of medical records with designation as validated CHF if Framingham criteria are satisfied. Subjects without a CHF diagnosis but with diastolic or systolic dysfunction were considered as having either preclinical diastolic or preclinical systolic dysfunction. Results The prevalence of validated, CHF was 2.2% (95% confidence interval [CI], 1.6%-2.8%) with 44% having an EF higher than 50%. Overall, 20.8% (95% CI, 19.0%-22.7%) of the population had mild diastolic dysfunction, 6.6% (95% CI, 5.5%7.8%) had moderate diastolic dysfunction, and 0.7% (95% CI, 0.3%-1.1%) had severe diastolic dysfunction with 5.6% (95% CI, 4.5%-6.7%) of the population having moderate or severe diastolic dysfunction with normal EF. The prevalence of any systolic dysfunction (EF less than or equal to50%) was 6.0% (95% CI, 5.0%-7.1%) with moderate or severe systolic dysfunction (EF less than or equal to40.%) being present in 2.0% (95% CI, 1.4%-2.5%). CHF was much more common among those with systolic or diastolic dysfunction than in those with normal ventricular function. However, even among those with moderate or severe diastolic or systolic dysfunction, less than half had recognized CHF. In multivariate analysis, controlling for age, sex, and EF, mild diastolic dysfunction (hazard ratio, 8.31 [95% CI, 3.00-23.1], P<.001) and moderate or severe diastolic dysfunction (hazard ratio, 10.17 [95% CI, 3.28-31.0], P<.001) were predictive of all-cause mortality. Conclusions In the community, systolic dysfunction is frequently present in individuals without recognized CHF. Furthermore, diastolic dysfunction as rigorously defined by comprehensive Doppler techniques is common, often not accompanied by recognized CHF, and associated with marked increases in all-cause mortality.	Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Clin Epidemiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Guggenheim 9,200 1st St SW, Rochester, MN 55905 USA.		omidvari, elham/Q-6686-2016	Jacobsen, Steven/0000-0002-8174-8533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 55502] Funding Source: Medline; NIAMS NIH HHS [AR 30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Devereux RB, 2001, AM HEART J, V141, P439, DOI 10.1067/mhj.2001.113223; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; Gandhi SK, 2000, PHYSIOL REV, V344, P17; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hart CYT, 2001, CIRCULATION, V104, P215, DOI 10.1161/01.CIR.104.2.215; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Hurrell DG, 1997, J AM COLL CARDIOL, V30, P459, DOI 10.1016/S0735-1097(97)00184-8; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; KLEIN AL, 1994, MAYO CLIN PROC, V69, P212, DOI 10.1016/S0025-6196(12)61059-3; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Lloyd-Jones D M, 2001, Curr Cardiol Rep, V3, P184, DOI 10.1007/s11886-001-0021-1; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; MURRAY JA, 1968, CIRCULATION, V37, P800, DOI 10.1161/01.CIR.37.5.800; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Ommen SR, 2000, CIRCULATION, V102, P1788; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SHUB C, 1994, MAYO CLIN PROC, V69, P205, DOI 10.1016/S0025-6196(12)61058-1; SOBUE T, 1995, J AM COLL CARDIOL, V25, P91, DOI 10.1016/0735-1097(94)00347-S; STARLING MR, 1981, CIRCULATION, V63, P1075, DOI 10.1161/01.CIR.63.5.1075; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; Yamamoto K, 1997, J AM COLL CARDIOL, V30, P1819, DOI 10.1016/S0735-1097(97)00390-2; Yamamoto K, 2000, J CARD FAIL, V6, P194, DOI 10.1054/jcaf.2000.9676; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	41	2234	2328	1	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					194	202		10.1001/jama.289.2.194	http://dx.doi.org/10.1001/jama.289.2.194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517230	Bronze			2022-12-24	WOS:000180226400030
J	Lundin, J; Lundin, M; Isola, J; Joensuu, H				Lundin, J; Lundin, M; Isola, J; Joensuu, H			A web-based system for individualised survival estimation in breast cancer	BRITISH MEDICAL JOURNAL			English	Article									Univ Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland; Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; Tampere Univ Hosp, FIN-33014 Tampere, Finland; Univ Helsinki, Mol Canc Biol Res Programme, FIN-00290 Helsinki, Finland	University of Helsinki; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Lundin, J (corresponding author), Univ Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland.		Lundin, Johan/I-1843-2018; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Joensuu, Heikki/0000-0003-0281-2507				Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; *IH, 2000, J NATL CANC I MONOGR, V30, P5; Kattan M, 2002, J CLIN ONCOL, V20, P885, DOI 10.1200/JCO.2002.20.4.885; Lundin J, 2001, J CLIN ONCOL, V19, P28, DOI 10.1200/JCO.2001.19.1.28	4	26	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					29	29		10.1136/bmj.326.7379.29	http://dx.doi.org/10.1136/bmj.326.7379.29			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511459	Green Published, Bronze			2022-12-24	WOS:000180302000023
J	Buck, SW; Sandmeier, JJ; Smith, JS				Buck, SW; Sandmeier, JJ; Smith, JS			RNA polymerase I propagates unidirectional spreading of rDNA silent chromatin	CELL			English	Article							TRANSCRIPTION FACTOR UAF; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL DNA; PROTEIN SIR2; YEAST RDNA; LIFE-SPAN; SWITCH; GENE; HETEROCHROMATIN; DEACETYLASE	The ribosomal DNA (rDNA) tandem array in Saccharomyces cerevisiae induces transcriptional silencing of RNA polymerase II-transcribed genes. This SIR2-dependent form of repression (rDNA silencing) also functions to limit rDNA recombination and is involved in life span control. In this report, we demonstrate that rDNA silencing spreads into the centromere-proximal unique sequence located downstream of RNA polymerase I (Pol I) transcription, but fails to enter the upstream telomere-proximal sequences. The spreading of silencing correlates with SIR2-dependent histone H3 and H4 deacetylation and can be extended by SIR2 overexpression. Surprisingly, rDNA silencing required transcription by RNA polymerase I and the direction of spreading was controlled by the direction of Pol I transcription.	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Smith, JS (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Box 80073,Jordan Hall, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061692] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Brachmann CB, 1998, YEAST, V14, P115; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Cioci F, 2002, J MOL BIOL, V322, P41, DOI 10.1016/S0022-2836(02)00749-0; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MUSTERS W, 1989, NUCLEIC ACIDS RES, V17, P9661, DOI 10.1093/nar/17.23.9661; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Reeder RH, 1999, MOL CELL BIOL, V19, P7369; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Thon G, 2000, GENETICS, V155, P551; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; Vu L, 1999, P NATL ACAD SCI USA, V96, P4390, DOI 10.1073/pnas.96.8.4390; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	41	70	71	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					1003	1014		10.1016/S0092-8674(02)01193-5	http://dx.doi.org/10.1016/S0092-8674(02)01193-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507427	Bronze			2022-12-24	WOS:000180086000010
J	Jansens, A; van Duijn, E; Braakman, I				Jansens, A; van Duijn, E; Braakman, I			Coordinated nonvectorial folding in a newly synthesized multidomain protein	SCIENCE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; DISULFIDE BOND FORMATION; LDL RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; NMR STRUCTURE; BIOSYNTHESIS; CONCATEMER; ISOMERASE; PATHWAY; DOMAINS	The low-density lipoprotein receptor (LDL-R) is a typical example of a multidomain protein, for which in vivo folding is assumed to occur vectorially from the amino terminus to the carboxyl terminus. Using a pulse-chase approach in intact cells, we found instead that newly synthesized LDL-R molecules folded by way of "collapsed" intermediates that contained non-native disulfide bonds between distant cysteines. The most amino-terminal domain acquired its native conformation late in folding instead of during synthesis. Thus, productive LDL-R folding in a cell is not vectorial but is mostly posttranslational, and involves transient long-range non-native disulfide bonds that are isomerized into native short-range cysteine pairs.	Univ Utrecht, Dept Bioorgan Chem 1, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Braakman, I (corresponding author), Univ Utrecht, Dept Bioorgan Chem 1, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@chem.uu.nl	Jansens, A./L-4409-2015	Braakman, Ineke/0000-0003-1592-4364				BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BIERI S, 1995, FEBS LETT, V371, P341, DOI 10.1016/0014-5793(95)00939-7; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; EWBANK JJ, 1993, BIOCHEMISTRY-US, V32, P3677, DOI 10.1021/bi00065a022; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679	26	136	138	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2401	2403		10.1126/science.1078376	http://dx.doi.org/10.1126/science.1078376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493918	Green Submitted			2022-12-24	WOS:000179915900061
J	Kaech, SM; Hemby, S; Kersh, E; Ahmed, R				Kaech, SM; Hemby, S; Kersh, E; Ahmed, R			Molecular and functional profiling of memory CD8 T cell differentiation	CELL			English	Article							VIRAL-INFECTION; CYTOKINE PRODUCTION; EFFECTOR FUNCTION; GENE-EXPRESSION; IN-VIVO; ACTIVATION; NAIVE; LYMPHOCYTES; GENERATION; IMMUNITY	How and when memory T cells form during an immune response are long-standing questions. To better understand memory CD8 T cell development, a time course of gene expression and functional changes in antigen-specific T cells during viral infection was evaluated. The expression of many genes continued to change after viral clearance in accordance with changes in CD8 T cell functional properties. Even though memory cell precursors were present at the peak of the immune response, these cells did not display hallmark functional traits of memory T cells. However, these cells gradually acquired the memory cell qualities of self-renewal and rapid recall to antigen suggesting the model that antigen-specific CD8 T cells progressively differentiate into memory cells following viral infection.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.			Hemby, Scott/0000-0002-6987-1133	NIAID NIH HHS [AI30048] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030048, R01AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1987, J VIROL, V61, P3920, DOI 10.1128/JVI.61.12.3920-3929.1987; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Chao CC, 1997, J IMMUNOL, V159, P1686; Chow S, 2001, CYTOMETRY, V46, P72, DOI 10.1002/cyto.1067; Deeths MJ, 1999, J IMMUNOL, V163, P102; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; HATHCOCK K, 2003, IN PRESS J IMMUNOL; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JOHNSON ED, 1975, J EXP MED, V141, P866; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oehen S, 1998, J IMMUNOL, V161, P5338; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; VOLKERT M, 1974, J EXP MED, V139, P1329, DOI 10.1084/jem.139.5.1329; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	42	738	752	2	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					837	851		10.1016/S0092-8674(02)01139-X	http://dx.doi.org/10.1016/S0092-8674(02)01139-X			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526810	Bronze			2022-12-24	WOS:000179862600010
J	Li, J; Ning, YH; Hedley, W; Saunders, B; Chen, YS; Tindill, N; Hannay, T; Subramaniam, S				Li, J; Ning, YH; Hedley, W; Saunders, B; Chen, YS; Tindill, N; Hannay, T; Subramaniam, S			The Molecule Pages database	NATURE			English	Article								The Alliance for Cellular Signaling (AfCS)-Nature Molecule Pages will be a comprehensive database of key facts about more than 3,000 proteins involved in cell signalling. Each entry will be created by invited experts and be peer-reviewed. Alongside the large-scale experiments being conducted by the AfCS scientists, the wealth of information contained in this database offers the potential of accelerating the pace of discovery in signal transduction research.	Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA; Nat Publishing Grp, London N1 9XW, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Subramaniam, S (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Califano, Andrea/F-7239-2012	Hannay, Timo/0000-0002-5941-3390					0	50	52	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					716	717		10.1038/nature01307	http://dx.doi.org/10.1038/nature01307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478304	Bronze			2022-12-24	WOS:000179751800057
J	Sambrano, GR; Chandy, G; Choi, S; Decamp, D; Hsueh, R; Lin, KM; Mock, D; O'Rourke, N; Roach, T; Shu, HJ; Sinkovits, B; Verghese, M; Bourne, H				Sambrano, GR; Chandy, G; Choi, S; Decamp, D; Hsueh, R; Lin, KM; Mock, D; O'Rourke, N; Roach, T; Shu, HJ; Sinkovits, B; Verghese, M; Bourne, H			Unravelling the signal-transduction network in B lymphocytes	NATURE			English	Article							LYMPHOMA-CELLS; WEHI-231; ACTIVATION; CHEMOKINES; EXPRESSION	The Alliance for Cellular Signaling has chosen the mouse B lymphocyte as a model system to understand basic principles that govern cellular signalling. Progress to that end has focused initially on establishing a reproducible experimental cell system and characterizing essential signalling responses. Although unravelling this complex network will take years, findings revealed in the interim will prove immensely useful to the scientific community at large.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; San Francisco Vet Adm Med Ctr, Dept Rheumatol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; Stanford University; California Institute of Technology; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Sambrano, GR (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	sambrano@cmp.ucsf.edu						BENHAMOU LE, 1990, EUR J IMMUNOL, V20, P1405, DOI 10.1002/eji.1830200630; Bishop GA, 2001, CURR OPIN IMMUNOL, V13, P278, DOI 10.1016/S0952-7915(00)00216-8; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Hasler P, 2001, FASEB J, V15, P2085, DOI 10.1096/fj.00-0860rev; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; IANNONE MA, 1989, J BIOL CHEM, V264, P20177; JAKWAY JP, 1986, J IMMUNOL, V137, P2225; Klaus G G, 1997, Int Rev Immunol, V15, P5, DOI 10.3109/08830189709068169; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560, DOI 10.1128/MCB.13.9.5560; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Nisimoto Y, 2002, EUR J BIOCHEM, V269, P2622, DOI 10.1046/j.1432-1033.2002.02939.x; Reif K, 2000, J IMMUNOL, V164, P4720, DOI 10.4049/jimmunol.164.9.4720; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; SCOTT DW, 1986, J EXP MED, V164, P156, DOI 10.1084/jem.164.1.156; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tarakhovsky A, 1997, RES IMMUNOL, V148, P457, DOI 10.1016/S0923-2494(97)82670-3	22	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					708	710		10.1038/nature01305	http://dx.doi.org/10.1038/nature01305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478302				2022-12-24	WOS:000179751800055
J	Movassaghi, M; Jacobsen, EN				Movassaghi, M; Jacobsen, EN			The simplest "enzyme"	SCIENCE			English	Editorial Material									Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Movassaghi, M (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.							Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D; Danishefsky SJ, 1996, J AM CHEM SOC, V118, P2843, DOI 10.1021/ja952692a; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; EDER U, 1971, Patent No. 2014857; Hajos Z.G., 1971, [No title captured], Patent No. [2102623, DE 2102623]; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378	11	233	234	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1904	1905		10.1126/science.1076547	http://dx.doi.org/10.1126/science.1076547			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471240				2022-12-24	WOS:000179629200027
J	Bhatia, R; Thorne-Lyman, AL				Bhatia, R; Thorne-Lyman, AL			Food shortages and nutrition in North Korea	LANCET			English	Article							FAMINE		World Food Programme, I-00148 Rome, Italy		Bhatia, R (corresponding author), World Food Programme, Via CG Viola 68,Parco Medici, I-00148 Rome, Italy.							Natsios A., 2001, GREAT N KOREAN FAMIN; Noland M, 2001, ECON DEV CULT CHANGE, V49, P741, DOI 10.1086/452523; YOUNG H, 1995, DISASTERS, V19, P94, DOI 10.1111/j.1467-7717.1995.tb00361.x	3	13	13	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S27	S28		10.1016/S0140-6736(02)11809-5	http://dx.doi.org/10.1016/S0140-6736(02)11809-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504492				2022-12-24	WOS:000180064500013
J	Kehrer, M; Goelz, R; Krageloh-Mann, I; Schoning, M				Kehrer, M; Goelz, R; Krageloh-Mann, I; Schoning, M			Measurement of volume of cerebral blood flow in healthy preterm and term neonates with ultrasound	LANCET			English	Article							COLOR DUPLEX MEASUREMENT; REPRODUCIBILITY; ADULTS	Changes in cerebral blood flow are important in the pathogenesis of ischaemic brain damage, but standard methods cannot measure volume of cerebral blood flow quantitatively in neonates. We used colour duplex sonography of the extracranial cerebral arteries to measure volume of global cerebral blood flow in 67 healthy preterm and term neonates. Volume of cerebral blood flow increased between the postmenstrual ages of 34 weeks (median 33 mL/min [range 23-43]) and 42 weeks (85 mL/min [57-104]). However, intersession and interobserver variability was quite large. This non-invasive method will allow quantitative bedside monitoring of global brain perfusion in preterm and term neonates with pathological disorders, and could also be used to monitor effects of neuroprotective measures.	Univ Tubingen, Childrens Hosp, Dept Child Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Childrens Hosp, Dept Neonatol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL	Schoning, M (corresponding author), Univ Tubingen, Childrens Hosp, Dept Child Neurol, D-72076 Tubingen, Germany.		Schoening, Martin/H-7559-2012					ALTMAN DI, 1988, ANN NEUROL, V24, P218, DOI 10.1002/ana.410240208; MATTHEW E, 1993, J CEREBR BLOOD F MET, V13, P748, DOI 10.1038/jcbfm.1993.95; Scheel P, 2000, STROKE, V31, P147, DOI 10.1161/01.STR.31.1.147; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P827, DOI 10.1097/00004647-199609000-00007; Schoning M, 1996, J CEREBR BLOOD F MET, V16, P523, DOI 10.1097/00004647-199605000-00020	5	34	40	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1749	1750		10.1016/S0140-6736(02)11720-X	http://dx.doi.org/10.1016/S0140-6736(02)11720-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480431				2022-12-24	WOS:000179636800015
J	Mayer, L; Quinn, T; Wadsley, J; Stadel, J				Mayer, L; Quinn, T; Wadsley, J; Stadel, J			Formation of giant planets by fragmentation of protoplanetary disks	SCIENCE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; PROTOSTELLAR DISKS; INSTABILITIES; RESOLUTION; MIGRATION; ACCRETION; LIFETIMES; EVOLUTION; OBJECTS; GROWTH	The evolution of gravitationally unstable protoplanetary gaseous disks has been studied with the use of three-dimensional smoothed particle hydrodynamics simulations with unprecedented resolution. We have considered disks with initial masses and temperature profiles consistent with those inferred for the protosolar nebula and for other protoplanetary disks. We show that long-lasting, self-gravitating protoplanets arise after a few disk orbital periods if cooling is efficient enough to maintain the temperature close to 50 K. The resulting bodies have masses and orbital eccentricities similar to those of detected extrasolar planets.	Univ Washington, Dept Astron, Seattle, WA 98195 USA; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Univ Victoria, Dept Phys & Astron, Victoria, BC V8W 3PG, Canada	University of Washington; University of Washington Seattle; McMaster University; University of Victoria	Mayer, L (corresponding author), Univ Zurich, Inst Theoret Phys, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lucio@physik.nizh.ch; trq@astro.washington.edu		Quinn, Thomas/0000-0001-5510-2803; Stadel, Joachim Gerhard/0000-0001-7565-8622				Bally J, 1998, ASTRON J, V116, P854, DOI 10.1086/300469; BALSARA DS, 1995, J COMPUT PHYS, V121, P357, DOI 10.1016/S0021-9991(95)90221-X; Bate MR, 1997, MON NOT R ASTRON SOC, V288, P1060, DOI 10.1093/mnras/288.4.1060; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; Boss AP, 2002, ICARUS, V156, P291, DOI 10.1006/icar.2002.6816; Boss AP, 1998, ANNU REV EARTH PL SC, V26, P53, DOI 10.1146/annurev.earth.26.1.53; Boss AP, 1998, ASTROPHYS J, V503, P923, DOI 10.1086/306036; Boss AP, 2001, ASTROPHYS J, V563, P367, DOI 10.1086/323694; Briceno C, 2001, SCIENCE, V291, P93, DOI 10.1126/science.291.5501.93; Bryden G, 1999, ASTROPHYS J, V514, P344, DOI 10.1086/306917; D'Alessio P, 2001, ASTROPHYS J, V553, P321, DOI 10.1086/320655; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Guillot T, 1999, SCIENCE, V286, P72, DOI 10.1126/science.286.5437.72; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; LAUGHLIN G, 1994, ASTROPHYS J, V436, P335, DOI 10.1086/174909; LIN DNC, 1986, ASTROPHYS J, V309, P846, DOI 10.1086/164653; Lissauer JJ, 2001, NATURE, V409, P23, DOI 10.1038/35051182; Luhman KL, 2002, ASTROPHYS J, V566, P1132, DOI 10.1086/338338; Marcy GW, 1998, ANNU REV ASTRON ASTR, V36, P57, DOI 10.1146/annurev.astro.36.1.57; Marcy GW, 2000, PUBL ASTRON SOC PAC, V112, P137, DOI 10.1086/316516; Nelson AF, 1998, ASTROPHYS J, V502, P342, DOI 10.1086/305869; Nelson AF, 2000, ASTROPHYS J, V529, P357, DOI 10.1086/308238; Nelson RP, 2000, MON NOT R ASTRON SOC, V318, P18, DOI 10.1046/j.1365-8711.2000.03605.x; Pickett BK, 2000, ASTROPHYS J, V529, P1034, DOI 10.1086/308301; Pickett BK, 2000, ASTROPHYS J, V540, pL95, DOI 10.1086/312884; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Stadel J, 2002, SPRINGER INT SER ENG, V657, P501; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; Terquem C, 2002, MON NOT R ASTRON SOC, V332, pL39, DOI 10.1046/j.1365-8711.2002.05493.x; Thommes EW, 2002, ASTRON J, V123, P2862, DOI 10.1086/339975; Throop HB, 2001, SCIENCE, V292, P1686, DOI 10.1126/science.1059093; WEIDENSCHILLING SJ, 1977, ASTROPHYS SPACE SCI, V51, P153, DOI 10.1007/BF00642464	32	229	230	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1756	1759		10.1126/science.1077635	http://dx.doi.org/10.1126/science.1077635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459581	Green Submitted			2022-12-24	WOS:000179494800035
J	Das, G; Talukdar, P; Matile, S				Das, G; Talukdar, P; Matile, S			Fluorometric detection of enzyme activity with synthetic supramolecular pores	SCIENCE			English	Article							CHANNELS; SENSORS	The reversible blockage of synthetic pores formed by rigid-rod beta barrels, either by substrates or products, was used to sense a variety of enzymatic reactions in high-throughput format with "naked-eye" fluorescent detection. Improvement of sensor sensitivity beyond three orders of magnitude by straightforward internal mutations underscores the functional plasticity of rigid-rod beta barrels. Such detectors of enzyme activity with the aforementioned characteristics are needed in areas as diverse as proteomics and environmentally benign organic synthesis.	Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland	University of Geneva	Matile, S (corresponding author), Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland.		Talukdar, Pinaki/B-5966-2011; Matile, Stefan/AFL-7826-2022; Das, Gopal/AAW-4611-2020	Talukdar, Pinaki/0000-0003-3951-4335; Matile, Stefan/0000-0002-8537-8349; Das, Gopal/0000-0003-0043-1372				Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Cheley S, 2002, CHEM BIOL, V9, P829, DOI 10.1016/S1074-5521(02)00172-2; CZARNIK AW, 1994, ACCOUNTS CHEM RES, V27, P302, DOI 10.1021/ar00046a003; Das G, 2002, CHEMBIOCHEM, V3, P1089, DOI 10.1002/1439-7633(20021104)3:11<1089::AID-CBIC1089>3.0.CO;2-V; Das G, 2002, P NATL ACAD SCI USA, V99, P5183, DOI 10.1073/pnas.022547899; Gokel GW, 2001, CHEM SOC REV, V30, P274, DOI 10.1039/b008667n; Kirkovits GJ, 2000, ADV SUPR CH, V7, P1; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Matile S, 2001, CHEM SOC REV, V30, P158, DOI 10.1039/b008101i; PALCIC MM, 1994, METHOD ENZYMOL, V230, P300; Scrimin P, 1999, CURR OPIN CHEM BIOL, V3, P730, DOI 10.1016/S1367-5931(99)90031-5; Snowden TS, 1999, CURR OPIN CHEM BIOL, V3, P740, DOI 10.1016/S1367-5931(99)00034-4; Wahler D, 2001, CURR OPIN CHEM BIOL, V5, P152, DOI 10.1016/S1367-5931(00)00184-8; WHITESIDES GM, 1995, ACCOUNTS CHEM RES, V28, P37, DOI 10.1021/ar00049a006; Wymer N, 2000, CURR OPIN CHEM BIOL, V4, P110, DOI 10.1016/S1367-5931(99)00061-7	16	162	163	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 22	2002	298	5598					1600	1602		10.1126/science.1077353	http://dx.doi.org/10.1126/science.1077353			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446904				2022-12-24	WOS:000179361600043
J	Zhang, L; Conejo-Garcia, JR; Katsaros, D; Gimotty, PA; Massobrio, M; Regnani, G; Makrigiannakis, A; Gray, H; Schlienger, K; Liebman, MN; Rubin, SC; Coukos, G				Zhang, L; Conejo-Garcia, JR; Katsaros, D; Gimotty, PA; Massobrio, M; Regnani, G; Makrigiannakis, A; Gray, H; Schlienger, K; Liebman, MN; Rubin, SC; Coukos, G			Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ENDOTHELIAL GROWTH-FACTOR; CHEMOKINE RECEPTOR EXPRESSION; RECOMBINANT INTERLEUKIN-2; PROGNOSTIC-SIGNIFICANCE; PATIENT SURVIVAL; INTERFERON-GAMMA; CARCINOMA CELLS; DENDRITIC CELLS; INHIBITION	Background: Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical outcome has not been established. Methods: We performed immunohistochemical analysis of 186 frozen specimens from advanced-stage ovarian carcinomas to assess the distribution of tumor-infiltrating T cells and conducted outcome analyses. Molecular analyses were performed in some tumors by real-time polymerase chain reaction. Results: CD3+ tumor-infiltrating T cells were detected within tumor-cell islets (intratumoral T cells) in 102 of the 186 tumors (54.8 percent); they were undetectable in 72 tumors (38.7 percent); the remaining 12 tumors (6.5 percent) could not be evaluated. There were significant differences in the distributions of progression-free survival and overall survival according to the presence or absence of intratumoral T cells (P<0.001 for both comparisons). The five-year overall survival rate was 38.0 percent among patients whose tumors contained T cells and 4.5 percent among patients whose tumors contained no T cells in islets. Significant differences in the distributions of progression-free survival and overall survival according to the presence or absence of intratumoral T cells (P<0.001 for both comparisons) were also seen among 74 patients with a complete clinical response after debulking and platinum-based chemotherapy: the five-year overall survival rate was 73.9 percent among patients whose tumors contained T cells and 11.9 percent among patients whose tumors contained no T cells in islets. The presence of intratumoral T cells independently correlated with delayed recurrence or delayed death in multivariate analysis and was associated with increased expression of interferon-(gamma), interleukin-2, and lymphocyte-attracting chemokines within the tumor. The absence of intratumoral T cells was associated with increased levels of vascular endothelial growth factor. Conclusions: The presence of intratumoral T cells correlates with improved clinical outcome in advanced ovarian carcinoma.	Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Turin, Dept Obstet & Gynecol, Turin, Italy; Univ Heraklion, Dept Obstet & Gynecol, Iraklion, Greece	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Turin	Coukos, G (corresponding author), Univ Penn, Ctr Res Reprod & Womens Hlth, 1355 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Conejo-Garcia, Jose R/V-1897-2019; Coukos, George/ABG-7389-2020; Gimotty, Phyllis/GWZ-4136-2022; Rubin, Stephen/U-8535-2019; Zhang, Lin/K-8478-2012; Liebman, Michael/A-8556-2009	Conejo-Garcia, Jose R/0000-0001-6431-4074; Gimotty, Phyllis/0000-0002-3850-9799; Rubin, Stephen/0000-0003-3688-5333; Liebman, Michael/0000-0002-8626-8432; Makrigiannakis, Antonis/0000-0002-8475-1500; Coukos, George/0000-0001-8813-7367	NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER; NCI NIH HHS [CA-83638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berek JS, 1999, GYNECOL ONCOL, V75, P10, DOI 10.1006/gyno.1999.5532; Chen CA, 1999, GYNECOL ONCOL, V74, P235, DOI 10.1006/gyno.1999.5418; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dadmarz R D, 1996, Cancer J Sci Am, V2, P263; Favero J, 1998, BIOCHEM PHARMACOL, V56, P1539, DOI 10.1016/S0006-2952(98)00213-5; Freedman R S, 1996, Cancer Treat Res, V82, P115; Freedman RS, 2000, CLIN CANCER RES, V6, P2268; Fujita K, 1995, CLIN CANCER RES, V1, P501; HALAPI E, 1993, CANCER IMMUNOL IMMUN, V36, P191, DOI 10.1007/BF01741091; Halpern AC, 1997, SEMIN ONCOL, V24, pS2; Hartenbach EM, 1997, CANCER LETT, V121, P169, DOI 10.1016/S0304-3835(97)00350-9; Hayashi K, 1999, GYNECOL ONCOL, V74, P86, DOI 10.1006/gyno.1999.5430; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Jemal A, 2002, CA-CANCER J CLIN, V52, P119; Jemal A, 2002, CA-CANCER J CLIN, V52, P181; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Katsaros D, 2001, EUR J CANCER, V37, P478, DOI 10.1016/S0959-8049(00)00423-8; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; KOOI S, 1993, LYMPHOKINE CYTOK RES, V12, P429; Loercher AE, 1999, J IMMUNOL, V163, P6251; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z; Naito Y, 1998, CANCER RES, V58, P3491; Nakano O, 2001, CANCER RES, V61, P5132; Nakashima M, 1999, NAT MED, V5, P938, DOI 10.1038/11383; Negus RPM, 1997, AM J PATHOL, V150, P1723; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Ozols RF, 2000, SEMIN ONCOL, V27, P47; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Pertl U, 2001, J IMMUNOL, V166, P6944, DOI 10.4049/jimmunol.166.11.6944; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Rubin SC, 1999, OBSTET GYNECOL, V93, P21, DOI 10.1016/S0029-7844(98)00334-2; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Santin AD, 2000, OBSTET GYNECOL, V96, P422, DOI 10.1016/S0029-7844(00)00916-9; Santin AD, 2001, GYNECOL OBSTET INVES, V51, P254, DOI 10.1159/000058060; SAS INSTITUTE, 2000, SAS STAT US GUID VER; SCHLIENGER K, IN PRESS CLIN CANC R; Schumacher K, 2001, CANCER RES, V61, P3932; Shen GH, 2000, BRIT J CANCER, V83, P196; *SPSS, 1997, SPSS ADV STAT VERS 7; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; Sun H, 2001, J IMMUNOTHER, V24, P138, DOI 10.1097/00002371-200103000-00008; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; VESALAINEN S, 1994, EUR J CANCER, V30A, P1797, DOI 10.1016/0959-8049(94)E0159-2; Windbichler GH, 2000, BRIT J CANCER, V82, P1138; Woo EY, 2001, CANCER RES, V61, P4766	50	2431	2519	4	111	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					203	213		10.1056/NEJMoa020177	http://dx.doi.org/10.1056/NEJMoa020177			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529460	Bronze			2022-12-24	WOS:000180390600004
J	Lucas, RJ; Hattar, S; Takao, M; Berson, DM; Foster, RG; Yau, KW				Lucas, RJ; Hattar, S; Takao, M; Berson, DM; Foster, RG; Yau, KW			Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice	SCIENCE			English	Article							GANGLION-CELLS; OLIVARY	In the mammalian retina, a small subset of retinal ganglion cells (RGCs) are intrinsically photosensitive, express the opsin-like protein melanopsin, and project to brain nuclei involved in non image-forming visual functions such as pupillary light re ex and circadian photoentrainment. We report that in mice with the melanopsin gene ablated, RGCs retrograde-labeled from the suprachiasmatic nuclei were no longer intrinsically photosensitive, although their number, morphology, and projections were unchanged. These animals showed a pupillary light re ex indistinguishable from that of the wild type at low irradiances, but at high irradiances the re ex was incomplete, a pattern that suggests that the melanopsin-associated system and the classical rod/cone system are complementary in function.	Univ London Imperial Coll Sci Technol & Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fac Med, London W6 8RF, England; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Imperial College London; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Brown University	Lucas, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fac Med, Charing Cross Campus,St Dunstans Rd, London W6 8RF, England.	r.j.lucas@ic.ac.uk; kwyau@mail.jhmi.edu	Hattar, Samer/W-6927-2019	FOSTER, RUSSELL/0000-0001-6055-2067; Lucas, Robert/0000-0002-1088-8029	NEI NIH HHS [R37 EY006837, R01 EY014596, R01 EY006837-16A1, R37 EY006837-14, R01 EY006837, R37 EY006837-15, R37 EY006837-13, R01 EY014596-01, R37 EY006837-15S1] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837, R01EY014596] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4	12	612	631	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					245	247		10.1126/science.1077293	http://dx.doi.org/10.1126/science.1077293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522249				2022-12-24	WOS:000180284000037
J	Queller, DC; Ponte, E; Bozzaro, S; Strassmann, JE				Queller, DC; Ponte, E; Bozzaro, S; Strassmann, JE			Single-gene greenbeard effects in the social amoeba Dictyostelium discoideum	SCIENCE			English	Article							CELL-ADHESION	Selection can favor reproductive altruism if an altruism allele aids copies of itself by helping relatives. The alternative "greenbeard" mechanism, in which an allele directly recognizes and aids copies of itself in others, is generally thought to be too complex for a single gene to carry out. The csA gene in Dictyostelium discoideum acts as a single-gene greenbeard. When wild-type cells are mixed with csA-knockout cells, the wild type is more altruistic, but is also able preferentially to direct the benefits to other wild-type cells. Both properties derive directly from homophilic cell adhesion of the protein encoded by csA.	Rice Univ, Dept Ecol & Evolut, Houston, TX 77251 USA; Univ Turin, Osped S Luigi, Dept Clin & Biol Sci, I-10043 Orbassano, Italy	Rice University; University of Turin	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolut, POB 1892, Houston, TX 77251 USA.			bozzaro, salvatore/0000-0001-6323-6190; Strassmann, Joan/0000-0003-0638-8440				Alexander R. D., 1979, DARWINISM HUMAN AFFA; Bozzaro S, 1995, EXPERIENTIA, V51, P1175, DOI 10.1007/BF01944735; Dawkins R, 1976, SELFISH GENE; FORTUNATO A, IN PRESS MOL ECOL; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAIG D, 1996, BEHAV ECOLOGY EVOLUT, P284; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kessin RH., 2001, DICTYOSTELIUM EVOLUT, V38; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Maree AFM, 1999, J THEOR BIOL, V199, P297, DOI 10.1006/jtbi.1999.0958; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087	18	202	207	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					105	106		10.1126/science.1077742	http://dx.doi.org/10.1126/science.1077742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511650				2022-12-24	WOS:000180165800043
J	Sutton, MA; Schmidt, EF; Choi, KH; Schad, CA; Whisler, K; Simmons, D; Karanian, DA; Monteggia, LM; Neve, RL; Self, DW				Sutton, MA; Schmidt, EF; Choi, KH; Schad, CA; Whisler, K; Simmons, D; Karanian, DA; Monteggia, LM; Neve, RL; Self, DW			Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour	NATURE			English	Article							AMPHETAMINE ADMINISTRATION ALTERS; RAT NUCLEUS-ACCUMBENS; IN-VIVO; GLUTAMATE TRANSMISSION; PREFRONTAL CORTEX; EXPRESSION; NEURONS; SENSITIZATION; SENSITIVITY; RESPONSES	Cocaine addiction is thought to involve persistent neurobiological changes that facilitate relapse to drug use despite efforts to abstain. But the propensity for relapse may be reduced by extinction training-a form of inhibitory learning that progressively reduces cocaine-seeking behaviour in the absence of cocaine reward(1). Here we show that extinction training during withdrawal from chronic cocaine self-administration induces experience-dependent increases in the GluR1 and GluR2/3 subunits of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) glutamate receptors in the nucleus accumbens shell, a brain region that is critically involved in cocaine reward(2-5). Increases in the GluR1 subunit are positively associated with the level of extinction achieved during training, suggesting that GluR1 may promote extinction of cocaine seeking. Indeed, viral-mediated overexpression of both GluR1 and GluR2 in nucleus accumbens shell neurons facilitates extinction of cocaine- but not sucrose-seeking responses. A single extinction training session, when conducted during GluR subunit overexpression, attenuates stress-induced relapse to cocaine seeking even after GluR overexpression declines. Our findings indicate that extinction-induced plasticity in AMPA receptors may facilitate control over cocaine seeking by restoring glutamatergic tone in the nucleus accumbens, and may reduce the propensity for relapse under stressful situations in prolonged abstinence.	Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA; Yale Univ, Sch Med, Div Mol Psychiat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; Harvard University	Self, DW (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA.		Schmidt, Eric F./AAE-8723-2019; Sutton, Michael/C-6264-2011; Jansen, Heiko T./A-5770-2008	Schmidt, Eric F./0000-0002-7869-0270; Jansen, Heiko T./0000-0003-0178-396X; Sutton, Michael/0000-0002-0692-6459				Bell K, 2000, NEUROPSYCHOPHARMACOL, V23, P335, DOI 10.1016/S0893-133X(00)00100-7; BOUTON ME, 1991, CLIN PSYCHOL REV, V11, P123, DOI 10.1016/0272-7358(91)90091-8; CARLEZON WA, 1995, PSYCHOPHARMACOLOGY, V122, P194, DOI 10.1007/BF02246095; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Fabbricatore A. T., 1998, Society for Neuroscience Abstracts, V24, P1736; Guitart X, 2000, NEUROPSYCHOPHARMACOL, V23, P539, DOI 10.1016/S0893-133X(00)00142-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Keys AS, 1998, SYNAPSE, V30, P393, DOI 10.1002/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H; London ED, 1999, CRIT REV NEUROBIOL, V13, P227, DOI 10.1615/CritRevNeurobiol.v13.i3.10; Lu WX, 1997, SYNAPSE, V26, P269, DOI 10.1002/(SICI)1098-2396(199707)26:3<269::AID-SYN8>3.0.CO;2-5; Lu WX, 1999, SYNAPSE, V32, P119, DOI 10.1002/(SICI)1098-2396(199905)32:2<119::AID-SYN5>3.0.CO;2-F; MCLENNAN H, 1980, NEUROSCI LETT, V18, P313, DOI 10.1016/0304-3940(80)90303-1; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Robbins SJ, 1997, ADDICT BEHAV, V22, P157, DOI 10.1016/S0306-4603(96)00007-X; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; Schmidt EF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-07-j0003.2001; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1992, SYNAPSE, V11, P184, DOI 10.1002/syn.890110303; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; ZITO KA, 1985, PHARMACOL BIOCHEM BE, V23, P1029, DOI 10.1016/0091-3057(85)90110-8	30	266	272	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					70	75		10.1038/nature01249	http://dx.doi.org/10.1038/nature01249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511956				2022-12-24	WOS:000180165500039
J	Chochinov, HM; Hack, T; Hassard, T; Kristjanson, LJ; McClement, S; Harlos, M				Chochinov, HM; Hack, T; Hassard, T; Kristjanson, LJ; McClement, S; Harlos, M			Dignity in the terminally ill: a cross-sectional, cohort study	LANCET			English	Article							PHYSICIAN-ASSISTED SUICIDE; CANCER-PATIENTS; EUTHANASIA; EXPERIENCES; DEPRESSION; ATTITUDES; ILLNESS; OREGON; DEATH; LIFE	Background Considerations of dignity are often raised in reference to the care of dying patients. However, little research that addresses this issue has been done. Our aim was to identify the extent to which dying patients perceive they are able to maintain a sense of dignity, and to ascertain how demographic and disease-specific variables relate to the issue of dignity in these individuals. Methods We did a cross-sectional study of a cohort of terminally ill patients with cancer, who had a life expectancy of less than 6 months. We enrolled 213 patients from two palliative care units in Winnipeg, Canada, and asked them to rate their sense of dignity. Our main outcome measures included: a 7-point sense of dignity item; the symptom distress scale; the McGill pain questionnaire; the index of independence in activities of daily living (IADL); a quality of life scale; a brief battery of self-report measures, including screening for desire for death, anxiety, hopelessness, and will to live; burden to others; and requirement for social support. Findings 16 of 213 patients (7.5%; 95% Cl 4-11) indicated that loss of dignity was a great concern. These patients were far more than likely than the rest of the cohort to report psychological distress and symptom distress, heightened dependency needs, and loss of will to live. Interpretation Loss of dignity is closely associated with certain types of distress often seen among the terminally ill. Preservation of dignity should be an overall aim of treatment and care in patients who are nearing death.	Univ Manitoba, Dept Psychiat, Winnipeg, MB R3E 3N4, Canada; Univ Manitoba, Fac Nursing, Winnipeg, MB R3E 3N4, Canada; CancerCare Manitoba, Winnipeg, MB, Canada; St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; Edith Cowan Univ, Perth, WA, Australia	University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; University of Manitoba; Children's Hospital Research Institute of Manitoba; Edith Cowan University	Chochinov, HM (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB R3E 3N4, Canada.	chochin@cc.UManitoba.CA	Hack, Thomas/C-5174-2012; McClement, Susan E/H-7031-2016	Hack, Thomas/0000-0002-6913-8732; McClement, Susan E/0000-0002-9537-9900; Chochinov, Harvey/0000-0003-2656-4704				Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BRORSSON B, 1984, SCAND J REHABIL MED, V16, P125; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; CRAIG TJ, 1974, AM J PSYCHIAT, V131, P1323; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; GRAHAM KY, 1987, CANCER NURS, V10, P338; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; LEVINE PM, 1978, CANCER, V42, P1385, DOI 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0; MADAN TN, 1992, SOC SCI MED, V35, P425, DOI 10.1016/0277-9536(92)90335-N; McCorkle R, 1978, Cancer Nurs, V1, P373; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; NOYES R, 1990, PSYCHOSOMATICS, V31, P321, DOI 10.1016/S0033-3182(90)72170-6; Pannuti F, 1993, World Health Forum, V14, P172; Pullman D, 1996, Health Law J, V4, P197; Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454	29	246	257	3	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2026	2030		10.1016/S0140-6736(02)12022-8	http://dx.doi.org/10.1016/S0140-6736(02)12022-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504398				2022-12-24	WOS:000179974200010
J	Thunberg, U; Tobin, G; Johnson, A; Soderberg, O; Padyukov, L; Hultdin, M; Klareskog, L; Enblad, G; Sundstrom, C; Roos, G; Rosenquist, R				Thunberg, U; Tobin, G; Johnson, A; Soderberg, O; Padyukov, L; Hultdin, M; Klareskog, L; Enblad, G; Sundstrom, C; Roos, G; Rosenquist, R			Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia	LANCET			English	Article							CD38 EXPRESSION; ATP RECEPTOR; LEUKEMIA; P2X(7); CELLS	Background The P2X7 receptor is a ligand-gated cation channel that mediates ATP-induced apoptotic death in haemopoietic and chronic lymphocytic leukaemia (CLL) cells. We aimed to investigate the clinical effect of a single nucleotide polymorphism in the P2X7 receptor gene (1513A-->C) and correlate findings with the immunoglobulin heavy chain variable (V-H) gene mutation status, a prognostic marker in CLL. Methods We investigated tumour DNA in 170 patients with CLL using PCR-RFLP analysis with Hhal restriction enzyme cleavage to screen for the polymorphism in the P2X7 receptor gene. The V gene mutation status was assessed in 165 patients by PCR amplification and nucleotide sequencing. We correlated the findings of the P2X7 receptor genotype with the V-H gene mutation data and overall survival and screened for the P2X7 receptor polymorphism in 200 healthy controls. Findings Of the 170 patients, 35 (21%) were heterozygous and one (1%) homozygous for the 1513C allele; whereas 134 (79%) had the 1513A/A genotype of the P2X7 receptor gene. Overall survival was significantly longer for patients with CLL heterozygous for the 1513C allele than those with the 1513A/A genotype. Median survival for heterozygous patients was 104 months (range 33-467) and 72 months (1-190) for homozygous patients (p=0.009). Of the 165 patients with CLL in whom we assessed the V-H gene mutation status, the V-H genes were mutated in 71 (43%) patients and unmutated in 94; 18 (25%) of the 71 patients with mutated genes had 1513C allele compared with 17 (18%) of 94 who had unmutated genes. In patients with mutated V-H genes, those with CLL who were 1513C positive had 53 months' longer median survival than did those with the 1513A/A genotype (151 vs 98 months, p=0.011). Interpretation The P2X7 polymorphism could affect clinical outcome in CLL, especially in patients with mutated V-H genes. Studies are necessary to elucidate the biological role of the P2X7 polymorphism in CLL in vivo.	Univ Uppsala, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Oncol, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Radiol, S-75185 Uppsala, Sweden; Univ Uppsala, Dept Clin Immunol, S-75185 Uppsala, Sweden; Karolinska Inst, Ctr Mol Med, Dept Med, Rheumatol Unit, Stockholm, Sweden; Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet; Umea University	Rosenquist, R (corresponding author), Univ Uppsala, Dept Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden.		Söderberg, Ola/O-5130-2017; Padyukov, Leonid/A-4890-2009	Söderberg, Ola/0000-0003-2883-1925; Padyukov, Leonid/0000-0003-2950-5670; Rosenquist, Richard/0000-0002-0211-8788; Klareskog, Lars/0000-0001-9601-6186				Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Bange J, 2002, CANCER RES, V62, P840; Baricordi OR, 1996, BLOOD, V87, P682, DOI 10.1182/blood.V87.2.682.bloodjournal872682; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Jaffe ES, 2001, WHO CLASSIFICATION T; Krajinovic M, 2002, LANCET, V359, P1033, DOI 10.1016/S0140-6736(02)08065-0; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li AH, 1999, EUR J HAEMATOL, V63, P211; MATUTES E, 1994, LEUKEMIA, V8, P1640; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Thunberg U, 2001, BLOOD, V97, P1892, DOI 10.1182/blood.V97.6.1892; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wiley JS, 1998, AM J PHYSIOL-CELL PH, V275, pC1224, DOI 10.1152/ajpcell.1998.275.5.C1224	24	78	80	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1935	1939		10.1016/S0140-6736(02)11917-9	http://dx.doi.org/10.1016/S0140-6736(02)11917-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493261				2022-12-24	WOS:000179870200013
J	Colegrave, N				Colegrave, N			Sex releases the speed limit on evolution	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; RECOMBINATION; SELECTION; ADAPTATION	Explaining the evolutionary maintenance of sex remains a key problem in evolutionary biology(1-3). One potential benefit of sex is that it may allow a more rapid adaptive response when environmental conditions change, by increasing the efficiency with which selection can fix beneficial mutations(4-7). Here I show that sex can increase the rate of adaptation in the facultatively sexual single-celled chlorophyte Chlamydomonas reinhardtii, but that the benefits of sex depend crucially on the size of the population that is adapting: sex has a marked effect in large populations but little effect in small populations. Several mechanisms have been proposed to explain the benefits of sex in a novel environment, including stochastic effects in small populations, clonal interference and epistasis between beneficial alleles. These results indicate that clonal interference is important in this system.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Colegrave, N (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Colegrave, Nick/F-3916-2010					Bell G., 1982, MASTERPIECE NATURE; Burt A, 2000, EVOLUTION, V54, P337; Colegrave N, 2002, EVOLUTION, V56, P14; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Fisher R., 2005, TEACHING CHILDREN TH; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goho S, 2000, P ROY SOC B-BIOL SCI, V267, P123, DOI 10.1098/rspb.2000.0976; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Maynard Smith J., 1978, EVOLUTION SEX; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; West SA, 1999, J EVOLUTION BIOL, V12, P1003	15	185	189	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					664	666		10.1038/nature01191	http://dx.doi.org/10.1038/nature01191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478292	Green Published			2022-12-24	WOS:000179751800044
J	Sagata, N				Sagata, N			Untangling checkpoints	SCIENCE			English	Editorial Material							DNA-DAMAGE; REPLICATION CHECKPOINT; CDC25; CHK1; PATHWAY; ATR		Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan	Kyushu University	Sagata, N (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan.							Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Eckstein J., 1997, BIOCHIM BIOPHYS ACTA, V1332, P53; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Liu QH, 2000, GENE DEV, V14, P1448; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Walworth NC, 2001, CURR OPIN GENET DEV, V11, P78, DOI 10.1016/S0959-437X(00)00160-X; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	15	15	16	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1905	+		10.1126/science.1079225	http://dx.doi.org/10.1126/science.1079225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471241				2022-12-24	WOS:000179629200028
J	Hopkins, DR; Withers, PC				Hopkins, DR; Withers, PC			Sudan's war and eradication of dracunculiasis	LANCET			English	Article									Carter Ctr, Programme Support Hlth Programmes, Atlanta, GA 30307 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Hopkins, DR (corresponding author), Carter Ctr, Programme Support Hlth Programmes, 1 Copenhill,453 Freedom Pkwy, Atlanta, GA 30307 USA.							FISCHER I, 2000, NY TIMES        0211; HOPKINS DR, IN PRESS AM J TROP M; *US CDC, 2001, MMWR-MORBID MORTAL W, V50, P269	3	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S21	S22		10.1016/S0140-6736(02)11806-X	http://dx.doi.org/10.1016/S0140-6736(02)11806-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504489				2022-12-24	WOS:000180064500010
J	Birgens, H				Birgens, H			Clinical errors	LANCET			English	Editorial Material									Univ Copenhagen, Herlev Hosp, Dept Haematol L, DK-2730 Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Birgens, H (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Haematol L, DK-2730 Herlev, Denmark.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1775	1775		10.1016/S0140-6736(02)11670-9	http://dx.doi.org/10.1016/S0140-6736(02)11670-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480444				2022-12-24	WOS:000179636800028
J	Fromm, RE; Weltge, A; Varon, J				Fromm, RE; Weltge, A; Varon, J			Public use of automatic defibrillators: a bolt from the blue	LANCET			English	Editorial Material									Univ Texas, Hlth Sci Ctr, Dept Emergency Med, Houston, TX 77225 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Fromm, RE (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Emergency Med, Houston, TX 77225 USA.		Varon, Joseph/R-5198-2019; Varon, Joseph/T-9481-2019	Varon, Joseph/0000-0002-7622-9974				[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P123; Becker LB, 1991, AM J EMERG MED, V20, P335; Bigger JT, 2002, NEW ENGL J MED, V346, P931, DOI 10.1056/NEJMe020011; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; CUMMINS RO, 1984, ANN EMERG MED, V13, P798, DOI 10.1016/S0196-0644(84)80441-2; DIACK AW, 1979, MED INSTRUM, V13, P78; Fromm RE, 1997, RESUSCITATION, V33, P219, DOI 10.1016/S0300-9572(96)01036-2; WALTERS G, 1994, RESUSCITATION, V27, P39, DOI 10.1016/0300-9572(94)90020-5; 2000, CIRCULATION S1, V102, P60	9	0	0	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1712	1712		10.1016/S0140-6736(02)11724-7	http://dx.doi.org/10.1016/S0140-6736(02)11724-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480420				2022-12-24	WOS:000179636800004
J	Leonard, JA; Wayne, RK; Wheeler, J; Valadez, R; Guillen, S; Vila, C				Leonard, JA; Wayne, RK; Wheeler, J; Valadez, R; Guillen, S; Vila, C			Ancient DNA evidence for Old World origin of New World dogs	SCIENCE			English	Article							WOLF; EVOLUTION	Mitochondrial DNA sequences isolated from ancient dog remains from Latin America and Alaska showed that native American dogs originated from multiple Old World lineages of dogs that accompanied late Pleistocene humans across the Bering Strait. One clade of dog sequences was unique to the New World, which is consistent with a period of geographic isolation. This unique clade was absent from a large sample of modern dogs, which implies that European colonists systematically discouraged the breeding of native American dogs.	Univ Calif Los Angeles, Dept Organism Biol Ecol & Evolut, Los Angeles, CA 90095 USA; CONOPA, Coordinadora Invest & Desarrollo Camelidos, Lima 19, Peru; Univ Nacl Autonoma Mexico, Inst Invest Antropol, Lab Paleozool, Mexico City 04510, DF, Mexico; Bioanthropol Fdn Peru, Ctr Mallqui, Lima 11, Peru; Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden	University of California System; University of California Los Angeles; Universidad Nacional Autonoma de Mexico; Uppsala University	Leonard, JA (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Systemat Biol, Genet Program, 3001 Connecticut Ave NW, Washington, DC 20008 USA.	Leonard.Jennifer@NMNH.SI.edu	Vila, Carles/H-4893-2013; Leonard, Jennifer/A-7894-2010	Vila, Carles/0000-0002-4206-5246; wheeler, jane/0000-0001-9020-0660; Leonard, Jennifer/0000-0003-0291-7819				Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; CLUTTONBROCK J, 1994, J ZOOL, V233, P19, DOI 10.1111/j.1469-7998.1994.tb05259.x; DAYAN T, 1994, J ARCHAEOL SCI, V21, P633, DOI 10.1006/jasc.1994.1062; Derevanko A.P., 1998, PALAEOLITHIC SIBERIA, P5; Fiedel SJ, 2000, J ARCHAEOL RES, V8, P39, DOI 10.1023/A:1009400309773; Gamble C.S., 1999, PALAEOLITHIC SOC EUR; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; GRAYSON DK, 1988, ANTR PAP AM MUS NAT, V66; Koop B.F., 2000, DOGS TIME ARCHAEOLOG, P271; MOREY DF, 1994, AM SCI, V82, P336; NOBIS G, 1979, UMSCHAU, V79, P610; Olsen S, 1985, ORIGINS DOMESTIC DOG; Randi E, 2002, CONSERV GENET, V3, P31; Schwartz Marion, 1997, HIST DOGS EARLY AM; Scott J.P., 1965, DOG BEHAV GENETIC BA; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; VALADEZ AZOA R., 2000, BAR INT SERIES, V889, P193; VALADEZ R, 2002, ASOC MEXI MED VET ES, V13, P6; VALADEZ R., 1999, HIST XOLOITZCUINTLE; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vila C, 1999, CONSERV BIOL, V13, P195, DOI 10.1046/j.1523-1739.1999.97425.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; WAYNE RK, 1987, SYST ZOOL, V36, P339, DOI 10.2307/2413399; Zarr J., 1999, BIOSTATISTICAL ANAL	27	297	321	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1613	1616		10.1126/science.1076980	http://dx.doi.org/10.1126/science.1076980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446908	Green Published			2022-12-24	WOS:000179361600047
J	Redman, RS; Sheehan, KB; Stout, RG; Rodriguez, RJ; Henson, JM				Redman, RS; Sheehan, KB; Stout, RG; Rodriguez, RJ; Henson, JM			Thermotolerance generated by plant/fungal symbiosis	SCIENCE			English	Article									US Geol Survey, WFRC, Seattle, WA 98115 USA; Univ Washington, Dept Bot, Seattle, WA 98195 USA; Montana State Univ, Dept Plant Sci, Bozeman, MT 59717 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; Montana State Univ, Thermal Biol Inst, Bozeman, MT 59717 USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Rodriguez, RJ (corresponding author), US Geol Survey, WFRC, 6505 NE 65th St, Seattle, WA 98115 USA.							Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Lewis D.H., 1985, P29; Petrini O., 1986, MICROBIOLOGY PHYLLOS, P175; Redman RS, 1999, PLANT PHYSIOL, V119, P795, DOI 10.1104/pp.119.2.795; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Redman RS, 1999, APPL ENVIRON MICROB, V65, P5193; SIVANESAN A, 1987, MYCOL PAP, V158, P104; Smallwood MF, 1999, PLANT RESPONSES ENV; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	9	450	524	5	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 22	2002	298	5598					1581	1581		10.1126/science.1072191	http://dx.doi.org/10.1126/science.1072191			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446900	Green Submitted			2022-12-24	WOS:000179361600038
J	Friedman, ND; Kaye, KS; Stout, JE; McGarry, SA; Trivette, SL; Briggs, JP; Lamm, W; Clark, C; MacFarquhar, J; Walton, AL; Reller, LB; Sexton, DJ				Friedman, ND; Kaye, KS; Stout, JE; McGarry, SA; Trivette, SL; Briggs, JP; Lamm, W; Clark, C; MacFarquhar, J; Walton, AL; Reller, LB; Sexton, DJ			Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections	ANNALS OF INTERNAL MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; RESISTANT ENTEROCOCCUS-FAECIUM; METHICILLIN RESISTANCE; NOSOCOMIAL INFECTIONS; CLINICAL-SIGNIFICANCE; RISK-FACTORS; COLONIZATION; IMPACT; SURVEILLANCE; FACILITIES	Background: Bloodstream infections occurring in persons residing in the community, regardless of whether those persons have been receiving health care in an outpatient facility, have traditionally been categorized as community-acquired infections. Objective: To develop a new classification scheme for bloodstream infections that distinguishes among community-acquired, health care-associated, and nosocomial infections. Design: Prospective observational study. Setting: one academic medical center and two community hospitals. Patients: All adult patients admitted to the hospital with bloodstream infection. Measurements: Demographic characteristics, living arrangements before hospitalization, comorbid medical conditions, factors predisposing to bloodstream infection, date of hospitalization, dates and number of positive blood cultures, results of microbiological susceptibility testing, dates of hospital discharge or death, and mortality rates at 3 to 6 months of follow-up. Results: 504 patients with bloodstream infections were enrolled; 143 (28%) had community-acquired bloodstream infections, 186 (37%) had health care-associated bloodstream infections, and 175 (35%) had nosocomial bloodstream infections. Of the 186 patients with health care-associated bloodstream infection, 29 resided in a nursing home, 64 were receiving home health care, 78 were receiving intravenous or intravascular therapy at home or in a clinic, and 117 had been hospitalized in the 90 days before their bloodstream infection. Cancer was more common in patients with health care-associated or nosocomial bloodstream infection than in patients with community-acquired bloodstream infection. Intravascular devices were the most common source of health care-associated and nosocomial infections, and Staphylococcus aureus was the most frequent pathogen in these types of infections. Methicillin-resistant S. aureus occurred with similar frequency in the groups with health care-associated infection (52%) and nosocomial infection (61%) but was uncommon in the group with community-acquired bloodstream infection (14%) (P = 0.001). Mortality rate at follow-up was greater in patients with health care-associated infection (29% versus 16%; P = 0.019) or nosocomial infection (37% versus 16%; P < 0.001) than in patients with community-acquired infection. Conclusions: Health care-associated bloodstream infections are similar to nosocomial infections in terms of frequency of various comorbid conditions, source of infection, pathogens and their susceptibility patterns, and mortality rate at follow-up. A separate category for health care-associated bloodstream infections is justified, and this new category will have obvious implications for choices about empirical therapy and infection-control surveillance.	Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27710 USA; Durham Reg Hosp, Durham, NC USA; Nash Gen Hosp, Rocky Mount, NC USA	Duke University	Sexton, DJ (corresponding author), Duke Univ, Med Ctr, Div Infect Dis, Box 3605, Durham, NC 27710 USA.		Kaye, Keith/AAF-1048-2019	Stout, Jason/0000-0002-6698-8176; Sexton, Daniel J/0000-0001-9604-5948				Baden LR, 2001, CLIN INFECT DIS, V33, P1654, DOI 10.1086/323762; Beltrami EL, 2000, AM J INFECT CONTROL, V28, P282, DOI 10.1067/mic.2000.106276; BROWN RB, 1994, AM J INFECT CONTROL, V22, P149, DOI 10.1016/0196-6553(94)90003-5; Darouiche RO, 1996, CLIN INFECT DIS, V23, P260, DOI 10.1093/clinids/23.2.260; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GRAHAM DR, 1991, AM J MED, V91, pS95, DOI 10.1016/0002-9343(91)90351-W; GRAHAM DR, 2000, 4 DEC INT C NOS HEAL; Henning KJ, 1996, PEDIATR INFECT DIS J, V15, P848, DOI 10.1097/00006454-199610000-00004; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MCGOWAN JE, 1989, ANTIMICROB AGENTS CH, V33, P1855, DOI 10.1128/AAC.33.11.1855; Morin CA, 2001, J INFECT DIS, V184, P1029, DOI 10.1086/323459; *NAT COM CLIN LAB, 2001, M100S11 NCCLS; Padiglione AA, 2001, INFECT CONT HOSP EP, V22, P576, DOI 10.1086/501955; Richard P, 2001, CLIN INFECT DIS, V32, P162, DOI 10.1086/317551; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Senthilkumar A, 2001, CLIN INFECT DIS, V33, P1412, DOI 10.1086/322656; Smith PW, 2000, AM J INFECT CONTROL, V28, P8, DOI 10.1016/S0196-6553(00)90005-1; Steinberg JP, 1996, CLIN INFECT DIS, V23, P255, DOI 10.1093/clinids/23.2.255; Stevenson KB, 2000, INFECT CONT HOSP EP, V21, P200, DOI 10.1086/501744; Warren DK, 2001, CLIN INFECT DIS, V33, P1329, DOI 10.1086/322483; Warshawsky B, 2000, INFECT CONT HOSP EP, V21, P724, DOI 10.1086/501718; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; Weinstein RA, 2001, NEW ENGL J MED, V344, P1544, DOI 10.1056/NEJM200105173442009; 2001, SOCIAL SECURITY DEAT	27	1201	1230	0	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2002	137	10					791	797		10.7326/0003-4819-137-10-200211190-00007	http://dx.doi.org/10.7326/0003-4819-137-10-200211190-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616VE	12435215				2022-12-24	WOS:000179323400002
J	Chatterjee, M; Osborne, J; Bestetti, G; Chang, Y; Moore, PS				Chatterjee, M; Osborne, J; Bestetti, G; Chang, Y; Moore, PS			Viral IL-6-induced cell proliferation and immune evasion of interferon activity	SCIENCE			English	Article							HUMAN-HERPESVIRUS-8 ENCODES; CYTOKINE; EXPRESSION; GP130; IL-6; INTERLEUKIN-6; GROWTH; ALPHA; TRANSCRIPTION; HOMOLOGS	Lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus are autocrine dependent on virus-derived interleukin-6 (IL-6), but not on cellular IL-6. During viral infection, host cells induce the antiviral factor interferon (IFN) to up-regulate p21, initiate cell cycle arrest, and inhibit virus replication. Viral IL-6, however, blocks IFN signaling. A viral transcriptional program exists in which only the viral IL-6 gene is directly activated by IFN-alpha, allowing the virus to modify its cellular environment by sensing and responding to levels of intracellular IFN signaling. The human cytokine cannot mimic this effect because IFN-alpha down-regulates the IL-6 receptor, gp80. Viral IL-6 bypasses the gp80 regulatory checkpoint by binding directly to the gp130 transducer molecule, resulting in tumor cell autocrine dependence on the viral cytokine for proliferation and survival.	Univ Pittsburgh, Inst Canc, Mol Virol Program, Hillman Canc Ctr 1 8, Pittsburgh, PA 15213 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Chang, Y (corresponding author), Univ Pittsburgh, Inst Canc, Mol Virol Program, Hillman Canc Ctr 1 8, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yc70@pitt.edu; psm9@pitt.edu	Chang, Yuan/F-4146-2011; Moore, Patrick S./F-3960-2011; Moore, Patrick/GVR-8294-2022	Chang, Yuan/0000-0003-1125-4041; Moore, Patrick S./0000-0002-8132-858X; 	NATIONAL CANCER INSTITUTE [P01CA087661, R01CA076586] Funding Source: NIH RePORTER; NCI NIH HHS [CA76586, CA87661] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Chang J, 2000, VIROLOGY, V266, P17, DOI 10.1006/viro.1999.0077; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Hideshima T, 2000, CLIN CANCER RES, V6, P1180; Jones KD, 1999, BLOOD, V94, P2871; MEURS E, 1988, EMBO J, V7, P1689, DOI 10.1002/j.1460-2075.1988.tb02997.x; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Moore PS, 1998, TRENDS GENET, V14, P144, DOI 10.1016/S0168-9525(98)01408-5; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; Mullberg J, 2000, J IMMUNOL, V164, P4672, DOI 10.4049/jimmunol.164.9.4672; Neipel F, 1997, J VIROL, V71, P839, DOI 10.1128/JVI.71.1.839-842.1997; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Osborne J, 1999, HUM IMMUNOL, V60, P921, DOI 10.1016/S0198-8859(99)00083-X; Parravicini C, 1997, AM J PATHOL, V151, P1517; PELSCZAR MJ, 1972, MICROBIOLOGY, P5; REICH N, 1988, J VIROL, V62, P114, DOI 10.1128/JVI.62.1.114-119.1988; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sangfelt O, 1997, ONCOGENE, V14, P415, DOI 10.1038/sj.onc.1200832; SCHWABE M, 1994, J CLIN INVEST, V94, P2317, DOI 10.1172/JCI117596; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Teruya-Feldstein J, 1998, LAB INVEST, V78, P1637	27	168	181	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2002	298	5597					1432	1435		10.1126/science.1074883	http://dx.doi.org/10.1126/science.1074883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434062				2022-12-24	WOS:000179223100055
J	Cohen, I; Navarro, V; Clemenceau, S; Baulac, M; Miles, R				Cohen, I; Navarro, V; Clemenceau, S; Baulac, M; Miles, R			On the origin of interictal activity in human temporal lobe epilepsy in vitro	SCIENCE			English	Article							BURST DISCHARGE; DENTATE GYRUS; HIPPOCAMPUS; NEURONS; SLICES; REGION; RATS	The origin and mechanisms of human interictal epileptic discharges remain unclear. Here, we describe a spontaneous, rhythmic activity initiated in the subiculum of slices from patients with temporal lobe epilepsy. Synchronous events were similar to interictal discharges of patient electroencephalograms. They were suppressed by antagonists of either glutamatergic or gamma-aminobutyric acid (GABA)-ergic signaling. The network of neurons discharging during population events comprises both subicular interneurons and a subgroup of pyramidal cells. In these pyramidal cells, GABAergic synaptic events reversed at depolarized potentials. Depolarizing GABAergic responses in neurons downstream to the sclerotic CA1 region contribute to human interictal activity.	Univ Paris 06, CHU Pitie Salpetriere, EMI 0224, F-75013 Paris, France; Hop La Pitie Salpetriere APHP, CNRS, UPR 640, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Miles, R (corresponding author), Univ Paris 06, CHU Pitie Salpetriere, EMI 0224, F-75013 Paris, France.	rmiles@biomedicale.univ-paris5.fr	Navarro, Vincent/G-1534-2013	Cohen, Ivan/0000-0001-6046-5289; Navarro, Vincent/0000-0003-0077-8114; Miles, Richard/0000-0001-7303-0233	NIMH NIH HHS [MH54671] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; COHEN I, UNPUB; Colder BW, 1996, J NEUROPHYSIOL, V75, P2496, DOI 10.1152/jn.1996.75.6.2496; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DICHTER M, 1969, J NEUROPHYSIOL, V32, P649, DOI 10.1152/jn.1969.32.5.649; ENGEL J, 1994, CURR OPIN NEUROL, V7, P140, DOI 10.1097/00019052-199404000-00010; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Greene JRT, 1997, J COMP NEUROL, V380, P395, DOI 10.1002/(SICI)1096-9861(19970414)380:3<395::AID-CNE8>3.0.CO;2-Y; Kohling R, 1998, BRAIN, V121, P1073, DOI 10.1093/brain/121.6.1073; Lehericy S, 1997, NEURORADIOLOGY, V39, P788, DOI 10.1007/s002340050507; Lewis D V, 1999, Curr Opin Neurol, V12, P197, DOI 10.1097/00019052-199904000-00011; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; Patrylo PR, 1998, J NEUROPHYSIOL, V79, P418, DOI 10.1152/jn.1998.79.1.418; PRINCE DA, 1967, ARCH NEUROL-CHICAGO, V16, P194, DOI 10.1001/archneur.1967.00470200082007; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Salin P, 1995, J NEUROSCI, V15, P8234; SCHWARTZKROIN PA, 1983, ANN NEUROL, V13, P249, DOI 10.1002/ana.410130305; SCHWARTZKROIN PA, 1986, EPILEPSIA, V27, P523, DOI 10.1111/j.1528-1157.1986.tb03578.x; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; Sutula T, 1998, J COMP NEUROL, V390, P578, DOI 10.1002/(SICI)1096-9861(19980126)390:4<578::AID-CNE9>3.0.CO;2-Y; Vale C, 2000, J NEUROSCI, V20, P1912; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442	24	683	698	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2002	298	5597					1418	1421		10.1126/science.1076510	http://dx.doi.org/10.1126/science.1076510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434059				2022-12-24	WOS:000179223100051
J	Manfrini, M; Innocenti, M; Ceruso, M; Mercuri, M				Manfrini, M; Innocenti, M; Ceruso, M; Mercuri, M			Original biological reconstruction of the hip in a 4-year-old girl	LANCET			English	Article							BONE	We resected the proximal femur in a 4-year-old child who had Ewing's sarcoma. We reconstructed her hip by an autotransplant of the ipsilateral proximal fibula with its vascular supply, inserted inside a massive bone allograft, and fixed to the residual femur by a plate. Serial postoperative imaging showed the progressive hypertrophy of the transplanted fibula, whose head displayed impressive tridimensional growth inside the acetabulum. 4 years after surgery, hip motility is 100degrees in flexion, 10degrees in extension, and 30degrees in abduction, and the patient's limb is weight bearing.	Ist Ortoped Rizzoli, Dept Musculo Skeletal Oncol, I-40136 Bologna, Italy; Ctr Traumatol Ortoped, Unit REconstruct Microsurg, Florence, Italy	IRCCS Istituto Ortopedico Rizzoli	Manfrini, M (corresponding author), Ist Ortoped Rizzoli, Dept Musculo Skeletal Oncol, Via Pupulli 1, I-40136 Bologna, Italy.			MANFRINI, MARCO/0000-0003-2961-0171				Bacci G, 2000, J CLIN ONCOL, V18, P4, DOI 10.1200/JCO.2000.18.1.4; Innocenti M, 1998, J RECONSTR MICROSURG, V14, P137, DOI 10.1055/s-2007-1000157; Manfrini M, 1999, CLIN ORTHOP RELAT R, P111; MERCURI M, 1991, CLIN ORTHOP RELAT R, P156; Restrepo J., 1980, INT J MICROSUG, V2, P49	5	53	55	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					140	142		10.1016/S0140-6736(03)12192-7	http://dx.doi.org/10.1016/S0140-6736(03)12192-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531584				2022-12-24	WOS:000180428000016
J	Cai, Y; Yu, FW; Lin, SP; Chia, W; Yang, XH				Cai, Y; Yu, FW; Lin, SP; Chia, W; Yang, XH			Apical complex genes control mitotic spindle geometry and relative size of daughter cells in Drosophila neuroblast and pl asymmetric divisions	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; ZINC-FINGER PROTEINS; C-ELEGANS EMBRYOS; PROSPERO GENE; 2 DISTINCT; G-ALPHA; LOCALIZATION; POLARITY; BAZOOKA; ORIENTATION	Drosophila neuroblast asymmetric divisions generate two daughters of unequal size and fate. A complex of apically localized molecules mediates basal localization of cell fate determinants and apicobasal orientation of the mitotic spindle, but how daughter cell size is controlled remains unclear. Here we show that mitotic spindle geometry and unequal daughter cell size are controlled by two parallel pathways (Bazooka/DaPKC and Pins/Galphai) within the apical complex. While the localized activity of either pathway alone is sufficient to mediate the generation of an asymmetric mitotic spindle and unequal size neuroblast daughters, loss of both pathways results in symmetric divisions. In sensory organ precursors, Bazooka/DaPKC and Pins/Galphai localize to opposite sides of the cortex and function in opposition to generate a symmetric spindle.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Inst Mol & Cell Biol, Singapore 117609, Singapore	University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chia, W (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Hosp Campus,4th Floor New Hunts House, London SE1 1UL, England.	william.chia@kcl.ac.uk; mcbyangn@imcb.nus.edu.sg	Cai, Yu/R-7737-2019	Cai, Yu/0000-0003-2044-3290; Yu, Fengwei/0000-0003-0268-199X				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Ashraf SI, 1999, EMBO J, V18, P6426, DOI 10.1093/emboj/18.22.6426; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; HEUER JG, 1995, DEVELOPMENT, V121, P3861; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; SPANA EP, 1995, DEVELOPMENT, V121, P3187; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002	41	113	116	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 10	2003	112	1					51	62		10.1016/S0092-8674(02)01170-4	http://dx.doi.org/10.1016/S0092-8674(02)01170-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526793	Bronze			2022-12-24	WOS:000181191500006
J	Fotiadis, D; Liang, Y; Filipek, S; Saperstein, DA; Engel, A; Palczewski, K				Fotiadis, D; Liang, Y; Filipek, S; Saperstein, DA; Engel, A; Palczewski, K			Atomic-force microscopy: Rhodopsin dimers in native disc membranes	NATURE			English	Article									Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Basel; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.	palczews@u.washington.edu	Filipek, Slawomir/A-2985-2008	Filipek, Slawomir/0000-0003-3147-3858				Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Papermaster DS, 2002, INVEST OPHTH VIS SCI, V43, P1300; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7	6	620	637	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					127	128		10.1038/421127a	http://dx.doi.org/10.1038/421127a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520290				2022-12-24	WOS:000180267200027
J	Woodman, CBJ; Collins, S; Rollason, TP; Winter, H; Bailey, A; Yates, M; Young, LS				Woodman, CBJ; Collins, S; Rollason, TP; Winter, H; Bailey, A; Yates, M; Young, LS			Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia	LANCET			English	Article							NATURAL-HISTORY; RISK-FACTORS; CANCER; ADENOCARCINOMA; GRADE; PREVALENCE; EXPRESSION; INFECTION; CARCINOMA; HPV-18	Background Human papillomavirus type 18 (HPV-18) is the second most frequent of the HPV types detected when squamous-cell cancer is diagnosed and the type most strongly associated with adenocarcinoma of the cervix. However, in cross-sectional studies, HPV-18 is rarely detected at the time of diagnosis of high-grade cervical intraepithelial neoplasia (CIN). We used a longitudinal study design to describe the occurrence of cytological abnormality after incident HPV-18 and HPV-16 infections. Methods The analysis was based on 1075 women aged 15-19 years, who had normal cytology and were negative for HPV at recruitment from a single family-planning clinic, and who had further follow-up. The women reattended every 6 months, and samples were taken for cytological and virological examination. Findings The relative risk of a cytological diagnosis of borderline nuclear abnormality after exposure to HPV-18 was 2.06 (95% CI 1.24-3.43) and that after exposure to HPV-16 was 1.99 (1.32-3.01). The relative risks of mild dyskaryosis were 3.11 (1.86-5.18) and 4.76 (3.15-7.18), and the relative risks of moderate or severe dyskaryosis were 0.80 (0.24-2.65) and 2.85 (1.36-5.97). Time to acquisition of cytological abnormality was unrelated to the infecting type (p=0.88). Interpretation Our findings do not support the long-held view that the reason why HPV-18 infection is under-represented at the time of diagnosis of high-grade CIN is because HPV-18-associated disease rapidly progresses through the preinvasive stages of neoplasia. We suggest that the cytological changes detected after HPV-18 infection might understate the severity of underlying disease. This feature could compromise the effectiveness of screening programmes in reducing the frequency of HPV-18-associated cancers.	Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England; Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham, W Midlands, England; Univ Birmingham, Dept Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Cent Manchester Healthcare Trust, Dept Clin Virol, Manchester, Lancs, England	University of Manchester; Birmingham Women's Hospital; University of Birmingham; Cancer Research UK; University of Birmingham	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.	ciaran.woodman@cce.man.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298				BARNES W, 1990, GYNECOL ONCOL, V38, P343, DOI 10.1016/0090-8258(90)90070-2; BERGERON C, 1992, AM J SURG PATHOL, V16, P641, DOI 10.1097/00000478-199207000-00002; BJERSING L, 1991, ANTICANCER RES, V11, P123; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Collett D, 1994, MODELLING SURVIVAL D; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; GENEST DR, 1993, HUM PATHOL, V24, P730, DOI 10.1016/0046-8177(93)90009-6; HECHT JL, 1995, INT J CANCER, V60, P369, DOI 10.1002/ijc.2910600317; Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; JARMULOWICZ MR, 1989, BRIT J OBSTET GYNAEC, V96, P1061, DOI 10.1111/j.1471-0528.1989.tb03381.x; Kalantari M, 1997, HUM PATHOL, V28, P899, DOI 10.1016/S0046-8177(97)90004-6; KURMAN RJ, 1988, AM J OBSTET GYNECOL, V159, P293, DOI 10.1016/S0002-9378(88)80070-X; McLachlin CM, 1997, HUM PATHOL, V28, P1226, DOI 10.1016/S0046-8177(97)90194-5; MCLACHLIN CM, 1994, AM J PATHOL, V144, P141; MITCHELL H, 1995, BRIT J CANCER, V71, P894, DOI 10.1038/bjc.1995.172; Nindl I, 1999, J CLIN PATHOL, V52, P17, DOI 10.1136/jcp.52.1.17; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Riethdorf S, 2000, VIRCHOWS ARCH, V437, P491, DOI 10.1007/s004280000277; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Schwartz SM, 2001, J CLIN ONCOL, V19, P1906, DOI 10.1200/JCO.2001.19.7.1906; Steenbergen RDM, 1998, J VIROL, V72, P749, DOI 10.1128/JVI.72.1.749-757.1998; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; UNGER ER, 1995, J INFECT DIS, V172, P1184, DOI 10.1093/infdis/172.5.1184; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U; WALKER J, 1989, OBSTET GYNECOL, V74, P781; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	30	56	57	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					40	43		10.1016/S0140-6736(03)12120-4	http://dx.doi.org/10.1016/S0140-6736(03)12120-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517465				2022-12-24	WOS:000180191600019
J	Cobb, LA; Fahrenbruch, CE; Olsufka, M; Copass, MK				Cobb, LA; Fahrenbruch, CE; Olsufka, M; Copass, MK			Changing incidence,of out-of-hospital ventricular fibrillation. 1980-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; UNITED-STATES; TRENDS; ARREST; DELAY; RESUSCITATION	Context Recent reports from 2 European cities and an earlier observation from Seattle, Wash, suggest that the number of patients treated for out-of-hospital ventricular fibrillation (VF) has declined. Objective To analyze the incidence of cardiac arrest and to examine relationships among incidence, sex, race, age, and first identified cardiac rhythm in Seattle. Design, Setting, and Patients Population-based study of all cardiac arrest cases with presumed cardiac etiology who received advanced life support from Seattle Fire Department emergency medical services during specified periods between 1979 and 2000 . United States Census data for Seattle in 1980, 1990, and 2000 were used to determine incidence rates for treated cardiac arrest with adjustments for age and sex. Main Outcome Measures Changes in incidence of cardiac arrest and initial recorded cardiac rhythm. Results The adjusted annual incidence of cardiac arrest with VF as the first identified rhythm decreased by about 56% from 1980 to 2000 (from 0.85 to 0.38 per 1000; relative risk [RR], 0.44; 95% confidence/interval [CI], 0.37-0.53). Similar reductions occurred in blacks (54%; RR, 0.45; 95% Cl, 0.26-0.79) and whites (53%; RR, 0.47; 95% Cl, 0.38-0.58) and was most evident in men (57%; RR, 0.43; 95% Cl, 0.35-0.53), in whom the baseline incidence was relatively high. When all treated arrests with presumed cardiac etiology were considered, that incidence decreased by 43% (RR, 0.58; 95 % Cl, 0.49-0.67) in men but negligibly in women, for whom a relatively low incidence of VF also declined but was offset by more cases with asystole or pulseless electrical activity. Conclusion We observed a major decline in the incidence of out-of-hospital VF and in all cases of treated cardiac arrest presumably due to heart disease in Seattle. These changes likely reflect the national decline in coronary heart disease mortality.	Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Med, Seattle, WA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cobb, LA (corresponding author), Univ Washington, Harborview Med Ctr, Box 359748,325 9th Ave, Seattle, WA 98104 USA.							Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; COBB LA, 1992, CIRCULATION, V85, P98; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Cooper R, 2000, CIRCULATION, V102, P3137; Every NR, 1997, AM HEART J, V134, P1129, DOI 10.1016/S0002-8703(97)70035-8; Fox JP, 1970, EPIDEMIOLOGY MAN DIS; GILLUM RF, 1994, J AM COLL CARDIOL, V23, P1273, DOI 10.1016/0735-1097(94)90367-0; Goldberg RJ, 1999, ARCH INTERN MED, V159, P2141, DOI 10.1001/archinte.159.18.2141; Herlitz J, 2000, EUR HEART J, V21, P1251, DOI 10.1053/euhj.2000.2150; HO MT, 1989, ANN EMERG MED, V18, P727, DOI 10.1016/S0196-0644(89)80004-6; Iribarren C, 1998, AM J CARDIOL, V82, P50, DOI 10.1016/S0002-9149(98)00240-9; Kuisma M, 2001, LANCET, V358, P473, DOI 10.1016/S0140-6736(01)05634-3; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; Kurkciyan I, 2001, RESUSCITATION, V51, P27, DOI 10.1016/S0300-9572(01)00381-1; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; SILFVAST T, 1991, J INTERN MED, V229, P331, DOI 10.1111/j.1365-2796.1991.tb00355.x; *SPSS INC, 2001, SPSS VERS 11 0 COMP; *US BUR CENS, 1990, 1990 CENS TRANSP PLA; *US BUR CENS, 1984, 1980 CENS POP SUBJ R; *US BUR CENS, 2000, CENS 2000 SUMM FIL 1, pCH8; US Census Bureau, 2001, QUEST ANSW CENS 2000; WEAVER WD, 1987, J AM COLL CARDIOL, V10, P1259, DOI 10.1016/S0735-1097(87)80128-6; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	24	469	500	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	2002	288	23					3008	3013		10.1001/jama.288.23.3008	http://dx.doi.org/10.1001/jama.288.23.3008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CG	12479765	Bronze			2022-12-24	WOS:000179854200035
J	Okajima, T; Irvine, KD				Okajima, T; Irvine, KD			Regulation of notch signaling by O-linked fucose	CELL			English	Article							WING FORMATION; DROSOPHILA; FRINGE; DORSAL; MODULES; DELTA; CELLS; GLYCOSYLTRANSFERASE; TRANSDUCTION; FUCOSYLATION	Notch and its ligands are modified by a protein O-fucosyltransferase (OFUT1) that attaches fucose to a Serine or Threonine within EGF domains. By using RNAi to decrease Ofut1 expression in Drosophila, we demonstrate that O-linked fucose is positively required for Notch signaling, including both Fringe-dependent and Fringe-independent processes. The requirement for Ofut1 is cell autonomous, in the signal-receiving cell, and upstream of Notch activation. The transcription of Ofut1 is developmentally regulated, and surprisingly, overexpression of Ofut1 inhibits Notch signaling. Together, these results indicate that OFUT1 is a core component of the Notch pathway, which is required for the activation of Notch by its ligands, and whose regulation may contribute to the pattern of Notch activation during development.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.		Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	NIGMS NIH HHS [R01-GM54594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kao YH, 1999, BIOCHEMISTRY-US, V38, P7097, DOI 10.1021/bi990234z; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	34	307	315	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					893	904		10.1016/S0092-8674(02)01114-5	http://dx.doi.org/10.1016/S0092-8674(02)01114-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526814	Bronze			2022-12-24	WOS:000179862600014
J	Chelur, DS; Ernstrom, GG; Goodman, MB; Yao, CA; Chen, L; O'Hagan, R; Chalfie, M				Chelur, DS; Ernstrom, GG; Goodman, MB; Yao, CA; Chen, L; O'Hagan, R; Chalfie, M			The mechanosensory protein MEC-6 is a subunit of the C-elegans touch-cell degenerin channel	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; MEMBER; FAMILY; PARAOXONASE; UNC-8	Mechanosensory transduction in touch receptor neurons is believed to be mediated by DEG/ENaC (degenerin/epithelial Na+ channel) proteins in nematodes and mammals(1). In the nematode Caenorhabditis elegans, gain-of-function mutations in the degenerin genes mec-4 and mec-10 (denoted mec-4(d) and mec-10(d), respectively) cause degeneration of the touch cells(2,3). This phenotype is completely suppressed by mutation in a third gene, mec-6 (refs 3, 4), that is needed for touch sensitivity. This last gene is also required for the function of other degenerins(4-8). Here we show that mec-6 encodes a single-pass membrane-spanning protein with limited similarity to paraoxonases, which are implicated in human coronary heart disease(9). This gene is expressed in muscle cells and in many neurons, including the six touch receptor neurons. MEC-6 increases amiloride-sensitive Na+ currents produced by MEC-4(d)/MEC-10(d) by similar to30-fold, and functions synergistically with MEC-2 (a stomatin-like protein(10) that regulates MEC-4(d)/MEC-10(d) channel activity(11)) to increase the currents by 200-fold. MEC-6 physically interacts with all three channel proteins. In vivo, MEC-6 colocalizes with MEC-4, and is required for punctate MEC-4 expression along touch-neuron processes. We propose that MEC-6 is a part of the degenerin channel complex that may mediate mechanotransduction in touch cells.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Columbia University; Stanford University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu	O'Hagan, Robert/AAE-9789-2020; Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NIGMS NIH HHS [R37 GM030997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ERNSTROM GG, IN PRESS ANN REV GEN; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; SHREFFLER W, 1995, GENETICS, V139, P1261; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7	26	122	138	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					669	673		10.1038/nature01205	http://dx.doi.org/10.1038/nature01205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478294				2022-12-24	WOS:000179751800046
J	Levine, JD; Funes, P; Dowse, HB; Hall, JC				Levine, JD; Funes, P; Dowse, HB; Hall, JC			Resetting the circadian clock by social experience in Drosophila melanogaster	SCIENCE			English	Article							MUTANT DROSOPHILA; COURTSHIP; OLFACTION; RHYTHMS; ENTRAINMENT; SYSTEM	Circadian clocks are influenced by social interactions in a variety of species, but little is known about the sensory mechanisms underlying these effects. We investigated whether social cues could reset circadian rhythms in Drosophila melanogaster by addressing two questions: Is there a social influence on circadian timing? If so, then how is that influence communicated? The experiments show that in a social context Drosophila transmit and receive cues that influence circadian time and that these cues are likely olfactory.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Icosyst Corp, Cambridge, MA 02138 USA; Univ Maine, Dept Math & Stat, Orono, ME 04469 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA	Brandeis University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Hall, JC (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.				NIGMS NIH HHS [GM-33205] Funding Source: Medline; NINDS NIH HHS [NS-44232] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; AVERHOFF WW, 1974, BEHAV GENET, V4, P207, DOI 10.1007/BF01074155; Batschelet E, 1981, CIRCULAR STAT BIOL; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; Hall JC, 1998, ADV GENET, V38, P135, DOI 10.1016/S0065-2660(08)60143-1; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; KAVALIERS M, 1980, BIOL BULL, V158, P69, DOI 10.2307/1540759; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEVINE JH, UNPUB; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; LILLY M, 1990, GENETICS, V124, P293; Moore-Ede MC., 1982, CLOCKS TIME US; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Mrosovsky N, 1996, BIOL REV, V71, P343, DOI 10.1111/j.1469-185X.1996.tb01278.x; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Saunders DS, 1982, INSECT CLOCKS; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135	25	179	179	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					2010	2012		10.1126/science.1076008	http://dx.doi.org/10.1126/science.1076008			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471264				2022-12-24	WOS:000179629200051
J	Sampson, B; Fagerhol, MK; Sunderkotter, C; Golden, BE; Richmond, P; Klein, N; Kovar, IZ; Beattie, JH; Wolska-Kusnierz, B; Saito, Y; Roth, J				Sampson, B; Fagerhol, MK; Sunderkotter, C; Golden, BE; Richmond, P; Klein, N; Kovar, IZ; Beattie, JH; Wolska-Kusnierz, B; Saito, Y; Roth, J			Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism	LANCET			English	Article							CALCIUM-BINDING PROTEINS; MYELOID DIFFERENTIATION; IMMUNE-RESPONSE; S100 PROTEIN; CALPROTECTIN; CELLS; PLASMA; FAMILY; MRP14; NEUTROPHILS	Background Calprotectin (complex of S100A8 and S100A9) is the major calcium and zinc-binding protein of phagocytes. We report a new syndrome with recurrent infections, inflammation, and hyperzincaemia associated with excessively high plasma concentrations of calprotectin. Methods We measured calprotectin in plasma and protein fractions by ELISA assay and zinc by atomic absorption spectrometry. Plasma proteins were fractionated by size exclusion chromatography and electrophoresis. Mass spectra of purified proteins were determined by MALDI-TOFMS. Findings We assessed five patients, two of whom are related. All patients had much the same biochemical findings of hyperzincaemia (77-200 mumol/L, reference range 11-18 mumol/L) and raised plasma calprotectin concentrations (1.4-6.5 g/L, reference range <1 mg/L). All patients presented with recurrent infections, hepatosplenomegaly, anaemia, and evidence of systemic inflammation. Three patients had cutaneous inflammation and three presented in infancy with severe growth failure. Size exclusion chromatography showed that zinc and calprotectin were associated in a broad fraction with molecular weight range 100-300 kDa. Analysis by electrophoresis and mass spectrometry showed that the patients' protein contained normal S100A8 and S100A9 subunits. Interpretation Dysregulation of zinc metabolism associated with accumulation in plasma of S100A8 and S100A9 defines a new disease, which encompasses a pathological role for dysregulation of two members of the large S100 protein family.	Charing Cross Hosp, Dept Clin Chem, London W6 8RF, England; Ullevaal Univ Hosp, Dept Immunol & Transfus Med, Oslo, Norway; Univ Munster, Dept Dermatol, D-4400 Munster, Germany; Univ Munster, Inst Expt Dermatol, D-4400 Munster, Germany; Univ Aberdeen, Dept Child Hlth, Aberdeen, Scotland; Inst Child Hlth, Immunobiol Unit, London, England; Chelsea & Westminster Hosp, Dept Paediat, London, England; Rowett Res Inst, Aberdeen, Scotland; Childrens Mem Hlth Inst, Dept Immunol, Warsaw, Poland; Tokyo Womens Med Univ, Dept Paediat, Tokyo, Japan	Imperial College London; University of Oslo; University of Munster; University of Munster; University of Aberdeen; University of London; University College London; Imperial College London; University of Aberdeen; Children's Memorial Health Institute; Tokyo Women's Medical University	Sampson, B (corresponding author), Charing Cross Hosp, Dept Clin Chem, London W6 8RF, England.		Richmond, Peter C/G-3379-2012	Richmond, Peter C/0000-0001-7562-7228; Wolska-Kusnierz, Beata/0000-0003-4863-4443; Fagerhol, Magne Kristoffer/0000-0002-5103-6981; Klein, Nigel/0000-0003-3925-9258; Sunderkotter, Cord/0000-0002-2929-145X				BRANDTZAEG P, 1987, AM J CLIN PATHOL, V87, P700, DOI 10.1093/ajcp/87.6.700; CHANDRA RK, 1984, JAMA-J AM MED ASSOC, V252, P1443, DOI 10.1001/jama.252.11.1443; Clohessy PA, 1996, J LEUKOCYTE BIOL, V60, P674, DOI 10.1002/jlb.60.5.674; DANKS DM, 1985, CLIN ENDOCRINOL META, V14, P591, DOI 10.1016/S0300-595X(85)80008-6; EVERSOLE LR, 1992, ARCH ORAL BIOL, V37, P963, DOI 10.1016/0003-9969(92)90068-J; FAILLA ML, 1982, J LAB CLIN MED, V100, P943; HAMBIDGE KM, 1985, J PEDIATR-US, V106, P450, DOI 10.1016/S0022-3476(85)80677-6; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Johne B., 1997, Molecular Pathology, V50, P113, DOI 10.1136/mp.50.3.113; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; LAGASSE E, 1988, MOL CELL BIOL, V8, P2402, DOI 10.1128/MCB.8.6.2402; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Mikami M, 1998, MICROBIOL IMMUNOL, V42, P211, DOI 10.1111/j.1348-0421.1998.tb02273.x; MYERS MA, 1984, J CLIN PATHOL, V37, P862, DOI 10.1136/jcp.37.8.862; Neves I, 1998, CLIN EXP IMMUNOL, V111, P264; Newton RA, 1998, J IMMUNOL, V160, P1427; PRASAD AS, 1978, JAMA-J AM MED ASSOC, V240, P2166, DOI 10.1001/jama.240.20.2166; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICHMOND P, 1999, ARCH DIS CHILD, V80, pA67; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; ROTH J, 1993, BLOOD, V82, P1875; Saito Y, 2002, J PEDIATR-US, V140, P267, DOI 10.1067/mpd.2002.121699; Sampson B, 1997, PEDIATR RES, V42, P219, DOI 10.1203/00006450-199708000-00015; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; SMITH JC, 1983, SCIENCE, V193, P496; Sohnle PG, 1997, REV MED MICROBIOL, V8, P217; Sorg C, 1992, Behring Inst Mitt, P126; Srikrishna G, 2001, J IMMUNOL, V166, P4678, DOI 10.4049/jimmunol.166.7.4678; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Unoshima M, 2001, J LAB CLIN MED, V137, P28, DOI 10.1067/mlc.2001.111514; Vogl T, 1999, J AM SOC MASS SPECTR, V10, P1124; YUI S, 1995, J LEUKOCYTE BIOL, V58, P307, DOI 10.1002/jlb.58.3.307	32	93	97	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1742	1745		10.1016/S0140-6736(02)11683-7	http://dx.doi.org/10.1016/S0140-6736(02)11683-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480428				2022-12-24	WOS:000179636800012
J	Percy, KE; Awmack, CS; Lindroth, RL; Kubiske, ME; Kopper, BJ; Isebrands, JG; Pregitzer, KS; Hendrey, GR; Dickson, RE; Zak, DR; Oksanen, E; Sober, J; Harrington, R; Karnosky, DF				Percy, KE; Awmack, CS; Lindroth, RL; Kubiske, ME; Kopper, BJ; Isebrands, JG; Pregitzer, KS; Hendrey, GR; Dickson, RE; Zak, DR; Oksanen, E; Sober, J; Harrington, R; Karnosky, DF			Altered performance of forest pests under atmospheres enriched by CO2 and O-3	NATURE			English	Article							CARBON-DIOXIDE; ASPEN; MANAGEMENT; RESPONSES; SYSTEMS; GROWTH	Human activity causes increasing background concentrations of the greenhouse gases CO2 and O-3(1). Increased levels of CO2 can be found in all terrestrial ecosystems(2). Damaging O-3 concentrations currently occur over 29% of the world's temperate and subpolar forests but are predicted to affect fully 60% by 2100 (ref. 3). Although individual effects of CO2 and O-3 on vegetation have been widely investigated, very little is known about their interaction, and long-term studies on mature trees and higher trophic levels are extremely rare(4). Here we present evidence from the most widely distributed North American tree species(5), Populus tremuloides, showing that CO2 and O-3, singly and in combination, affected productivity, physical and chemical leaf defences and, because of changes in plant quality, insect and disease populations. Our data show that feedbacks to plant growth from changes induced by CO2 and O-3 in plant quality and pest performance are likely. Assessments of global change effects on forest ecosystems must therefore consider the interacting effects of CO2 and O-3 on plant performance, as well as the implications of increased pest activity.	Canadian Forest Serv, Atlantic Forestry Ctr, Nat Resources Canada, Fredericton, NB E3B 5P7, Canada; Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; US Forest Serv, N Cent Res Stn, Rhinelander, WI 54501 USA; Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; Brookhaven Natl Lab, Upton, NY 11973 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Univ Kuopio, Dept Ecol & Environm Sci, FIN-70211 Kuopio, Finland; Rothamsted Res, Plant & Invertebrate Ecol Div, Harpenden AL5 2JQ, Herts, England	Natural Resources Canada; Canadian Forest Service; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); United States Forest Service; Michigan Technological University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Michigan System; University of Michigan; University of Eastern Finland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Percy, KE (corresponding author), Canadian Forest Serv, Atlantic Forestry Ctr, Nat Resources Canada, Fredericton, NB E3B 5P7, Canada.		Lindroth, Richard L/A-8538-2009; Zak, Donald R/C-6004-2012	Lindroth, Richard L/0000-0003-4587-7255; Oksanen, Elina/0000-0002-1866-736X; Zak, Donald/0000-0002-9730-7337				Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; BARNOLA JM, 1995, TELLUS B, V47, P264, DOI 10.1034/j.1600-0889.47.issue1.22.x; Ciais P, 2000, ECOL APPL, V10, P1574, DOI 10.1890/1051-0761(2000)010[1574:RBCFAI]2.0.CO;2; David AJ, 2001, FOREST CHRON, V77, P525, DOI 10.5558/tfc77525-3; Davis C., 1997, FIELD GUIDE TREE DIS; Dickson RE, 1998, CAN J FOREST RES, V28, P1706, DOI 10.1139/cjfr-28-11-1706; DICKSON RE, 2000, NC214 USDA FOR SERV; Eigenbrode S.D., 1996, PLANT CUTICLES AN IN, P201; Finlayson-Pitts B., 1999, CHEM UPPER LOWER ATM; Fitzgerald T.D., 1995, TENT CATERPILLARS; Fowler D, 1999, WATER AIR SOIL POLL, V116, P5, DOI 10.1023/A:1005249231882; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; HOLLOWAY PJ, 1969, J SCI FOOD AGR, V20, P124, DOI 10.1002/jsfa.2740200214; IPCC, 2001, 3 ASSESSMENT REPORT; *IPCC SECR INT PAN, 2001, IPCC CLIM CHANG 2001; Isebrands JG, 2001, ENVIRON POLLUT, V115, P359, DOI 10.1016/S0269-7491(01)00227-5; Jeffree C. E, 1996, PLANT CUTICLES INTEG, P33; Karnosky DF, 2002, GLOBAL CHANGE BIOL, V8, P329, DOI 10.1046/j.1354-1013.2002.00479.x; Karnosky DF, 1999, WATER AIR SOIL POLL, V116, P311, DOI 10.1023/A:1005276824459; Lindroth RL, 1996, RECENT ADV PHYTOCHEM, V30, P25; LINDROTH RL, 1993, ECOLOGY, V74, P763, DOI 10.2307/1940804; Martineau R., 1984, INSECTS HARMFUL FORE; McLaughlin S, 1999, WATER AIR SOIL POLL, V116, P151, DOI 10.1023/A:1005215112743; MENDGEN K, 1996, PLANT CUTICLES, P175; Parry D, 2001, ECOL ENTOMOL, V26, P281, DOI 10.1046/j.1365-2311.2001.00319.x; Perala D.A., 1990, SILVICS N AM HARDWOO, P555; Percy KE, 1994, AIR POLLUTANTS LEAF, V36, P67; Tuskan GA, 2001, FOREST CHRON, V77, P259, DOI 10.5558/tfc77259-2; *USDA FOR SERV, 2001, APH; ZILLER WG, 1974, CANADIAN FORESTRY SE, V1329	30	219	245	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 28	2002	420	6914					403	407		10.1038/nature01028	http://dx.doi.org/10.1038/nature01028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459738	Green Published			2022-12-24	WOS:000179494700036
J	Park, Y; Kelley, RL; Oh, H; Kuroda, MI; Meller, VH				Park, Y; Kelley, RL; Oh, H; Kuroda, MI; Meller, VH			Extent of chromatin spreading determined by roX RNA recruitment of MSL proteins	SCIENCE			English	Article							DOSAGE COMPENSATION COMPLEX; X-CHROMOSOME; HISTONE H3; ENTRY SITE; LYSINE 9; DROSOPHILA; GENES	The untranslated roX1 and roX2 RNAs are components of the Drosophila male-specific lethal (MSL) complex, which modifies histones to up-regulate transcription of the male X chromosome. roX genes are normally located on the X chromosome, and roX transgenes can misdirect the dosage compensation machinery to spread locally on other chromosomes. Here we de. ne MSL protein abundance as a determinant of whether the MSL complex will spread in cis from an autosomal roX transgene. The number of expressed roX genes in a nucleus was inversely correlated with spreading from roX transgenes. We suggest a model in which MSL proteins assemble into active complexes by binding nascent roX transcripts. When MSL protein/roX RNA ratios are high, assembly will be efficient, and complexes may be completed while still tethered to the DNA template. We propose that this local production of MSL complexes determines the extent of spreading into flanking chromatin.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Tufts Univ, Dept Biol, Medford, MA 02155 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Tufts University	Kuroda, MI (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, R01GM058427, R01GM045744] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58427, GM45744] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BELOTE JM, 1980, NATURE, V285, P573, DOI 10.1038/285573a0; Bhadra U, 1999, GENETICS, V152, P249; Chang KA, 1998, GENETICS, V150, P699; Choi KW, 1996, P NATL ACAD SCI USA, V93, P5737, DOI 10.1073/pnas.93.12.5737; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; Henry RA, 2001, J BIOL CHEM, V276, P31953, DOI 10.1074/jbc.M103008200; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Netter S, 1998, GENETICS, V149, P257; Park Y, 2001, SCIENCE, V293, P1083, DOI 10.1126/science.1063073; Park Y. I., UNPUB; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7	21	103	103	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 22	2002	298	5598					1620	1623		10.1126/science.1076686	http://dx.doi.org/10.1126/science.1076686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446910				2022-12-24	WOS:000179361600049
J	Ashrafi, K; Chang, FY; Watts, JL; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G				Ashrafi, K; Chang, FY; Watts, JL; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G			Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes	NATURE			English	Article							LIFE-SPAN; LONGEVITY; GENETICS; MUTATION; DAF-16; FOOD	Regulation of body fat storage involves signalling between centres that regulate feeding in the brain and sites of fat storage and use in the body(1,2). Here we describe an assay for analysing fat storage and mobilization in living Caenorhabditis elegans. By using RNA-mediated interference (RNAi)(3,4) to disrupt the expression of each of the 16,757 worm genes, we have systematically screened the C. elegans genome for genes necessary for normal fat storage. We identify 305 gene inactivations that cause reduced body fat and 112 gene inactivations that cause increased fat storage. Analysis of the fat-reducing gene inactivations in insulin, serotonin and tubby signalling mutants of C. elegans, which have increased body fat, identifies a core set of fat regulatory genes as well as pathway-specific fat regulators. Many of the newly identified worm fat regulatory genes have mammalian homologues, some of which are known to function in fat regulation. Other C. elegans fat regulatory genes that are conserved across animal phylogeny, but have not previously been implicated in fat storage, may point to ancient and universal features of fat storage regulation, and identify targets for treating obesity and its associated diseases.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Cambridge, Wellcome Canc Res UK Inst, Cambridge CB2 1QR, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington State University; University of Cambridge	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Watts, Jennifer/AAC-7425-2020	Ahringer, Julie/0000-0002-7074-4051; Fraser, Andrew/0000-0001-9939-6014; Watts, Jennifer/0000-0003-4349-0639	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Brockmann GA, 2002, TRENDS GENET, V18, P367, DOI 10.1016/S0168-9525(02)02703-8; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GOODMAN R, 1997, CHILD PSYCHOL PSYCHI, V2, P15; GREENSPAN P, 1985, J LIPID RES, V26, P781; Johnstone I.J., 1999, C ELEGANS PRACTICAL, P201; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Riddle DL, 1997, C ELEGANS, P739; ROLLAND V, 1995, J BIOL CHEM, V270, P1102, DOI 10.1074/jbc.270.3.1102; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; YAMASAKI H, 1984, MECHANISMS TUMOR PRO, V4, P1	29	762	835	5	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					268	272		10.1038/nature01279	http://dx.doi.org/10.1038/nature01279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529643				2022-12-24	WOS:000180397600047
J	Thompson, WW; Shay, DK; Weintraub, E; Brammer, L; Cox, N; Anderson, LJ; Fukuda, K				Thompson, WW; Shay, DK; Weintraub, E; Brammer, L; Cox, N; Anderson, LJ; Fukuda, K			Mortality associated with influenza and respiratory syncytial virus in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELDERLY PERSONS; PROTECTIVE EFFICACY; US CHILDREN; VACCINE; INFECTION; YOUNG; OLDER; DISEASE; DEATHS; IMPACT	Context Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality. Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation. Objective To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype. Design, Setting, and Population Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths. Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons. Main Outcome Measures Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes. Results Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category). For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1). Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36155 (11055) and 11321 (668) underlying respiratory and circulatory deaths, and 51203 (15081) and 17358 (1086) all-cause deaths. For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older, Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year. On average, influenza was associated with 3 times as many deaths as RSV. Conclusions Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons. Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,MS E61, Atlanta, GA 30333 USA.	wct2@cdc.gov	Markofski, Melissa M/Q-6372-2016	Markofski, Melissa M/0000-0003-0214-4246; Shay, David/0000-0001-9619-4820; Fukuda, Keiji/0000-0002-9598-9565				ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 1992, MAN INT STAT CLASS D; Barker WH, 1998, ARCH INTERN MED, V158, P645, DOI 10.1001/archinte.158.6.645; BISNO AL, 1971, AM J MED SCI, V261, P251, DOI 10.1097/00000441-197105000-00004; Brammer T L, 2000, MMWR CDC Surveill Summ, V49, P13; Bridges Carolyn B, 2002, MMWR Recomm Rep, V51, P1; *CDCP, 1999, DHHS PUBL; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1091; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Douglas R G Jr, 1976, Hosp Pract, V11, P43; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; FALSEY AR, 1995, J AM GERIATR SOC, V43, P30, DOI 10.1111/j.1532-5415.1995.tb06238.x; Falsey AR, 1999, J MED VIROL, V59, P221, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;221::AID-JMV16&gt;3.0.CO;2-H; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Farr W, 1985, VITAL STAT MEMORIAL; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; HETZEL AM, 1997, HIST ORG VITAL SAT S; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Katz JM, 2000, VACCINE, V18, P2177, DOI 10.1016/S0264-410X(00)00022-0; Longini IM, 2000, VACCINE, V18, P1902, DOI 10.1016/S0264-410X(99)00419-3; *NAT CTR HLTH STAT, 1999, VIT STAT MORT DAT MU; Nichol KL, 1996, GERONTOLOGY, V42, P274, DOI 10.1159/000213803; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; TREANOR JJ, 1992, ANN INTERN MED, V117, P625, DOI 10.7326/0003-4819-117-8-625; *US BUR CENS, 1990, INT EST POP AG SEX R; Walsh EE, 1999, AM J RESP CRIT CARE, V160, P791, DOI 10.1164/ajrccm.160.3.9901004; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	46	2749	2914	7	457	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					179	186		10.1001/jama.289.2.179	http://dx.doi.org/10.1001/jama.289.2.179			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517228	Bronze			2022-12-24	WOS:000180226400028
J	van Schaik, CP; Ancrenaz, M; Borgen, G; Galdikas, B; Knott, CD; Singleton, I; Suzuki, A; Utami, SS; Merrill, M				van Schaik, CP; Ancrenaz, M; Borgen, G; Galdikas, B; Knott, CD; Singleton, I; Suzuki, A; Utami, SS; Merrill, M			Orangutan cultures and the evolution of material culture	SCIENCE			English	Article							TOOL USE; CHIMPANZEES; PRIMATES; BEHAVIOR	Geographic variation in some aspects of chimpanzee behavior has been interpreted as evidence for culture. Here we document similar geographic variation in orangutan behaviors. Moreover, as expected under a cultural interpretation, we find a correlation between geographic distance and cultural difference, a correlation between the abundance of opportunities for social learning and the size of the local cultural repertoire, and no effect of habitat on the content of culture. Hence, great-ape cultures exist, and may have done so for at least 14 million years.	Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA; Kinabatangan Orang Utan Conservat Project, Sandakan 90734, Sabah, Malaysia; Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; Orangutan Fdn Int, Los Angeles, CA 90049 USA; Harvard Univ, Dept Anthropol, Peabody Museum, Cambridge, MA 02138 USA; Sumatran Orangutan Conservat Programme, Medan 20000, Indonesia; Kyoto Univ, Primate Inst, Inuyama, Aichi 484, Japan; Univ Nas, Fak Biol, Jakarta 12520, Indonesia; Univ Utrecht, Dept Behav Biol, NL-3508 TB Utrecht, Netherlands	Duke University; Simon Fraser University; Harvard University; Kyoto University; Universitas Nasional Pionir Perubahan; Utrecht University	van Schaik, CP (corresponding author), Duke Univ, Dept Biol Anthropol & Anat, POB 90383, Durham, NC 27708 USA.		Merrill, Michelle Yvonne/D-7807-2014	Merrill, Michelle Yvonne/0000-0002-7337-7533; utami, sri/0000-0002-5138-242X				BOESCH C, 1994, J HUM EVOL, V26, P325, DOI 10.1006/jhev.1994.1020; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Curio E., 1988, P75; de Waal FBM, 1999, NATURE, V399, P635, DOI 10.1038/21310; FOX EA, IN PRESS AM J PHYS A; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; GALEF BG, IN PRESS BIOL ANIMAL; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hudson J. C., 1972, NW U STUDIES GEOGRAP; Keesing F. M, 1958, CULTURAL ANTHR SCI C; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; MANTEL N, 1967, CANCER RES, V27, P209; McGrew WC, 1997, INT J PRIMATOL, V18, P353, DOI 10.1023/A:1026382316131; Myowa-Yamakoshi M, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P349; Nishida T., 1987, P462; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; STOINSKI T, IN PRESS COMP PSYCHO; SUGIYAMA Y, 1981, Primates, V22, P435, DOI 10.1007/BF02381236; Sugiyama Y., 1968, Primates, V9, P225, DOI 10.1007/BF01730972; Tomasello M., 1999, CULTURAL ORIGINS HUM; Tuttle RH, 2001, CURR ANTHROPOL, V42, P407, DOI 10.1086/320476; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; VANSCHAIK CP, IN PRESS BIOL ANIMAL; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2000, COGNITIVE SCI, V24, P477	29	614	632	6	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					102	105		10.1126/science.1078004	http://dx.doi.org/10.1126/science.1078004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	631JZ	12511649				2022-12-24	WOS:000180165800042
J	Gu, ZL; Steinmetz, LM; Gu, X; Scharfe, C; Davis, RW; Li, WH				Gu, ZL; Steinmetz, LM; Gu, X; Scharfe, C; Davis, RW; Li, WH			Role of duplicate genes in genetic robustness against null mutations	NATURE			English	Article							REDUNDANCY; GENOME; YEAST; EVOLUTION	Deleting a gene in an organism often has little phenotypic effect(1-5), owing to two mechanisms of compensation(4-10). The first is the existence of duplicate genes: that is, the loss of function in one copy can be compensated by the other copy or copies. The second mechanism of compensation stems from alternative metabolic pathways, regulatory networks, and so on. The relative importance of the two mechanisms has not been investigated except for a limited study, which suggested that the role of duplicate genes in compensation is negligible(10). The availability of fitness data for a nearly complete set of single-gene-deletion mutants of the Saccharomyces cerevisiae genome(11) has enabled us to carry out a genome-wide evaluation of the role of duplicate genes in genetic robustness against null mutations. Here we show that there is a significantly higher probability of functional compensation for a duplicate gene than for a singleton, a high correlation between the frequency of compensation and the sequence similarity of two duplicates, and a higher probability of a severe fitness effect when the duplicate copy that is more highly expressed is deleted. We estimate that in S. cerevisiae at least a quarter of those gene deletions that have no phenotype are compensated by duplicate genes.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; Iowa State Univ, Dept Zool, Ames, IA 50011 USA; Iowa State Univ, Dept Genet, Ames, IA 50011 USA	University of Chicago; Stanford University; Stanford University; Iowa State University; Iowa State University	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.			Li, Wen-Hsiung/0000-0003-1086-1456; Steinmetz, Lars/0000-0002-3962-2865				Brookfield John, 1992, Current Biology, V2, P553, DOI 10.1016/0960-9822(92)90036-A; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson TJ, 1998, TRENDS GENET, V14, P46, DOI 10.1016/S0168-9525(97)01367-X; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang CQ, 2000, TEXT CHEM COLOR AM D, V32, P43	22	645	661	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					63	66		10.1038/nature01198	http://dx.doi.org/10.1038/nature01198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511954				2022-12-24	WOS:000180165500037
J	Parrish, AG				Parrish, AG			Country gardens	LANCET			English	Editorial Material											Parrish, AG (corresponding author), POB 244, ZA-5256 Gonuble, South Africa.								0	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2059	2060		10.1016/S0140-6736(02)11996-9	http://dx.doi.org/10.1016/S0140-6736(02)11996-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504416				2022-12-24	WOS:000179974200027
J	Winfree, AT				Winfree, AT			On emerging coherence	SCIENCE			English	Editorial Material									Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Arizona								BASAR E, 1980, EEG BRAIN DYNAMICS, P176; Dano S, 1999, NATURE, V402, P320, DOI 10.1038/46329; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kuramoto Y, 1984, CHEM OSCILLATIONS WA; STROGATZ SH, UNPUB; TYSON J, 1978, J THEOR BIOL, V73, P723, DOI 10.1016/0022-5193(78)90133-9; Vanag VK, 2001, SCIENCE, V294, P835, DOI 10.1126/science.1064167; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; WINFREE AT, 1966, PROGRESS REPORT; WINFREE AT, 2001, GEOMETRY BIOL TIME, P119	13	54	54	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2336	2337		10.1126/science.1072560	http://dx.doi.org/10.1126/science.1072560			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493899				2022-12-24	WOS:000179915900038
J	Bernasconi, NL; Traggiai, E; Lanzavecchia, A				Bernasconi, NL; Traggiai, E; Lanzavecchia, A			Maintenance of serological memory by polyclonal activation of human memory B cells	SCIENCE			English	Article							PLASMA-CELLS; IMMUNOLOGICAL MEMORY; HUMORAL IMMUNITY; BONE-MARROW; ANTIGEN; DIFFERENTIATION; LYMPHOCYTES	Production of antibodies can last for a lifetime, through mechanisms that remain poorly understood. Here, we show that human memory B lymphocytes proliferate and differentiate into plasma cells in response to polyclonal stimuli, such as bystander T cell help and CpG DNA. Furthermore, plasma cells secreting antibodies to recall antigens are produced in vivo at levels proportional to the frequency of specific memory B cells, even several years after antigenic stimulation. Although antigen boosting leads to a transient increase in specific antibody levels, ongoing polyclonal activation of memory B cells offers a means to maintain serological memory for a human lifetime.	Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Inst Biomed Res, Via Vela 6, CH-6500 Bellinzona, Switzerland.	lanzavecchia@irb.unisi.ch	traggiai, elisabetta/A-2316-2009					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BERNASCONI NL, UNPUB; CELADA F, 1967, J EXP MED, V125, P199, DOI 10.1084/jem.125.2.199; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; LANZAVECCHIA A, 1983, EUR J IMMUNOL, V13, P820, DOI 10.1002/eji.1830131008; Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2002, CURR OPIN IMMUNOL, V14, P517, DOI 10.1016/S0952-7915(02)00356-4; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Uhr J W, 1968, Adv Immunol, V8, P81, DOI 10.1016/S0065-2776(08)60465-4; Zinkernagel RM, 2002, CURR OPIN IMMUNOL, V14, P523, DOI 10.1016/S0952-7915(02)00367-9	28	1005	1062	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2199	2202		10.1126/science.1076071	http://dx.doi.org/10.1126/science.1076071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481138				2022-12-24	WOS:000179773700050
J	Shaye, DD; Greenwald, I				Shaye, DD; Greenwald, I			Endocytosis-mediated downregulation of LIN-12/Notch upon Ras activation in Caenorhabditis elegans	NATURE			English	Article							CELL FATE DECISIONS; C-ELEGANS; NEGATIVE REGULATOR; RECEPTOR; EXPRESSION; DROSOPHILA; NOTCH; DELTA; GENE; INDUCTION	The coordination of signals from different pathways is important for cell fate specification during animal development. Here, we define a novel mode of crosstalk between the epidermal growth factor receptor/Ras/mitogen-activated protein kinase cascade and the LIN-12/Notch pathway during Caenorhabditis elegans vulval development. Six vulval precursor cells (VPCs) are initially equivalent but adopt different fates as a result of an inductive signal mediated by the Ras pathway and a lateral signal mediated by the LIN-12/Notch pathway(1). One consequence of activating Ras is a reduction of LIN-12 protein in P6.p (ref. 2), the VPC believed to be the source of the lateral signal. Here we identify a 'downregulation targeting signal' (DTS) in the LIN-12 intracellular domain, which encompasses a di-leucine-containing endocytic sorting motif. The DTS seems to be required for internalization of LIN-12, and on Ras activation it might mediate altered endocytic routing of LIN-12, leading to downregulation. We also show that if LIN-12 is stabilized in P6.p, lateral signalling is compromised, indicating that LIN-12 downregulation is important in the appropriate specification of cell fates in vivo.	Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Greenwald, I (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.		Shaye, Daniel/AAY-5351-2020	Shaye, Daniel/0000-0002-3962-6903				Ambros V, 1999, DEVELOPMENT, V126, P1947; Burdine RD, 1998, DEVELOPMENT, V125, P1083; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Ehrlich M, 2001, J CELL SCI, V114, P1777; Fares H, 2001, GENETICS, V159, P133; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FITZGERALD K, 1993, DEVELOPMENT, V119, P1019; Grant B, 1997, DEVELOPMENT, V124, P637; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Greenwald Iva, 1997, Cold Spring Harbor Monograph Series, V33, P519; HEITZLER P, 1993, DEVELOPMENT, V117, P1113; Heitzler P, 1996, DEVELOPMENT, V122, P161; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Levitan D, 1998, DEVELOPMENT, V125, P3101; Mello C, 1995, CAENORHABDITIS ELEGA, P451; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; WILKINSON HA, 1995, GENETICS, V141, P513	30	113	117	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					686	690		10.1038/nature01234	http://dx.doi.org/10.1038/nature01234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478297				2022-12-24	WOS:000179751800050
J	Iyasu, S; Randall, LL; Welty, TK; Hsia, J; Kinney, HC; Mandell, F; McClain, M; Randall, B; Habbe, D; Wilson, H; Willinger, M				Iyasu, S; Randall, LL; Welty, TK; Hsia, J; Kinney, HC; Mandell, F; McClain, M; Randall, B; Habbe, D; Wilson, H; Willinger, M			Risk factors for sudden infant death syndrome among Northern Plains Indians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONFIDENTIAL INQUIRY; RANDOMIZED-TRIAL; ALCOHOL; STILLBIRTHS; ENVIRONMENT; PREGNANCY; OUTCOMES; SMOKING; GROWTH	Context Sudden infant death syndrome (SIDS) is a leading cause of postneonatal mortality among American Indians, a group whose infant death rate is consistently above the US national average. Objective To determine Prenatal and postnatal risk factors for SIDS among American Indians. Design, Setting, and Participants Population-based case-control study of 33 SIDS infants and 66 matched living controls among American Indians in South Dakota, North Dakota, Nebraska, and Iowa enrolled from December 1992 to November 1996 and investigated using standardized parental interview, medical record abstraction', autopsy protocol, and infant death review. Main Outcome Measures Association of SIDS with maternal socioeconomic and behavioral factors, health care utilization, and infant care practices. Results The proportions of case and control infants who were usually placed prone to sleep (15.2% and 13.6%, respectively), who shared a bed with parents (59.4% and 55.4%), or whose mothers smoked during pregnancy (69.7% and 54.6%) were similar. However, mothers of 72.7% of case infants and 45.5% of control infants engaged in binge drinking during pregnancy. Conditional logistic regression revealed significant associations between SIDS and 2 or more layers of clothing on the infant (adjusted odds ratio [aOR], 6.2; 95% confidence interval [CI], 1.4-26.5), any visits by a public health nurse (aOR, 0.2; 95% Cl, 0.1-0.8), periconceptional maternal alcohol use (aOR, 6.2; 95% Cl, 1.6-23.3), and maternal first-trimester binge drinking (aOR, 8.2; 95% Cl, 1.9-35.3). Conclusions Public health nurse visits, maternal alcohol use during the periconceptional period and first trimester, and layers of clothing are important risk factors for SIDS among Northern Plains Indians. Strengthening public health nurse visiting programs and programs to reduce alcohol consumption among women of childbearing age could potentially reduce the high rate of SIDS.	Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Aberdeen Area Indian Hlth Serv, Rapid City, SD USA; Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts SIDS Ctr, Boston, MA USA; LCM Pathologists PC, Sioux Falls, SD USA; Clin Lab Black Hills, Rapid City, SD USA; Providence Mem Hosp, Dept Pathol, El Paso, TX USA; NICHHD, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Iyasu, S (corresponding author), US FDA, Div Pediat, Off Counter Terrorism & Pediat Drug Dev, Ctr Drug Evaluat & Res, 5A-33,HFD-960,5600 Fishers Ln, Rockville, MD 20857 USA.	IyasuS@cder.fda.gov		Randall, Leslie L/0000-0002-4960-9541				Alm B, 1999, ARCH DIS CHILD, V81, P107, DOI 10.1136/adc.81.2.107; Blair PS, 1996, BRIT MED J, V313, P195, DOI 10.1136/bmj.313.7051.195; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; Braveman P, 1996, J Am Board Fam Pract, V9, P254; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; Bull LBH, 1999, AM J PREV MED, V16, P240; DAY NL, 1989, PEDIATRICS, V84, P536; DREWS CD, 1990, INT J EPIDEMIOL, V19, P405, DOI 10.1093/ije/19.2.405; ERNHART CB, 1985, ALCOHOL CLIN EXP RES, V9, P447, DOI 10.1111/j.1530-0277.1985.tb05581.x; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; GIBBONS LE, 1993, AM J EPIDEMIOL, V137, P654, DOI 10.1093/oxfordjournals.aje.a116723; GILBERT R, 1992, ARCH DIS CHILD, V67, P171, DOI 10.1136/adc.67.2.171; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; *IND HLTH SERV, 1998, REG DIFF IND HLTH 19; *IND HLTH SERV, REG DIFF IND HLTH DE; Indian Health Service, 2000, REG DIFF IND HLTH 19; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; Kleinman J C, 1990, MMWR CDC Surveill Summ, V39, P31; MacDonald CB, 1999, INT J PEDIATR OTORHI, V47, P23, DOI 10.1016/S0165-5876(98)90152-5; MACDORMAN MF, 2002, INFANT MORTALITY STA; Mathews TJ, 2002, NATL VITAL STAT REPO; OLDS DL, 1986, PEDIATRICS, V77, P16; OLDS DL, 1986, PEDIATRICS, V78, P65; PONSONBY AL, 1992, BRIT MED J, V304, P277, DOI 10.1136/bmj.304.6822.277; Randall L L, 2001, Am Indian Alsk Native Ment Health Res, V10, P1; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; SCRAGG R, 1993, BMJ-BRIT MED J, V307, P1312, DOI 10.1136/bmj.307.6915.1312; Shaw GM, 1999, J PEDIATR-US, V134, P298, DOI 10.1016/S0022-3476(99)70453-1; Williams SM, 1996, INT J EPIDEMIOL, V25, P366, DOI 10.1093/ije/25.2.366; WILLINGER M, 1991, Pediatric Pathology, V11, P677	30	132	135	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2717	2723		10.1001/jama.288.21.2717	http://dx.doi.org/10.1001/jama.288.21.2717			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460095	Bronze			2022-12-24	WOS:000179549800031
J	Ferraro, PJ; Kiss, A				Ferraro, PJ; Kiss, A			Ecology - Direct payments to conserve biodiversity	SCIENCE			English	Editorial Material							INTEGRATED CONSERVATION		Georgia State Univ, Andrew Young Sch Policy Studies, Dept Econ, Atlanta, GA 30303 USA; World Bank, Environm & Social Dev Unit, Washington, DC 20433 USA	University System of Georgia; Georgia State University; The World Bank	Ferraro, PJ (corresponding author), Georgia State Univ, Andrew Young Sch Policy Studies, Dept Econ, Atlanta, GA 30303 USA.	pferraro@gsu.edu; akiss@worldbank.org	Ferraro, Paul J/B-4435-2014	Ferraro, Paul J/0000-0002-4777-5108				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 2002, CONSERVATION PRACTIC; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barrett CB, 1998, LAND ECON, V74, P449, DOI 10.2307/3146878; CONRAD JC, 2001, ENV POLICY WORKING P; Ferraro P. J., 2001, Resources (Washington), P17; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Ferraro PJ, 2001, CONSERV BIOL, V15, P990, DOI 10.1046/j.1523-1739.2001.015004990.x; GICHOHI H, 2002, 16 ANN M SOC CONS BI; Gullison RE, 2000, NATURE, V404, P923, DOI 10.1038/35010151; HARDNER J, 2002, SCI AM           MAY, P89; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; KISS A, IN PRESS GETTING BIO; Myers N, 2001, PERVERSE SUBSIDIES; *NAT CONS WASH, 2002, 2001 ANN REP; *ORG EC COOP DEV, 1997, ENV EFF AGR LAND DIV; ORTIZ E, 2002, 16 ANN M SOC CONS BI; ORTIZ E, COMMUNICATION; Peters J, 1998, J AGR ENVIRON ETHIC, V11, P17, DOI 10.1023/A:1007796628731; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Rice It, 2002, 16 ANN M SOC CONS BI; ROE D, 2001, SERIES INT I ENV DEV, V8; Salafsky N, 1999, EVALUATING LINKAGES; *SOC CONS BIOL, 2002, 16 ANN M SOC CONS BI; TEWARI DD, 1996, UNASYLVA, V187, P26; *USDA, 2001, FY 2001 BUDG SUMM; [No title captured]	27	562	583	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1718	1719		10.1126/science.1078104	http://dx.doi.org/10.1126/science.1078104			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459569				2022-12-24	WOS:000179494800020
J	Bloch, JI; Boyer, DM				Bloch, JI; Boyer, DM			Grasping primate origins	SCIENCE			English	Article							FUNCTIONAL-MORPHOLOGY; TUPAIIDS MAMMALIA; SUBSTRATE USE; CARPOLESTIDAE; PLESIADAPIFORMES; ADAPTATIONS; SCANDENTIA; MARSUPIALS; DIAGNOSIS; EVOLUTION	The evolutionary history that led to Eocene-and-later primates of modern aspect (Euprimates) has been uncertain. We describe a skeleton of Paleocene plesiadapiform Carpolestes simpsoni that includes most of the skull and many postcranial bones. Phylogenetic analyses indicate that Carpolestidae are closely related to Euprimates. C. simpsoni had long fingers and an opposable hallux with a nail. It lacked orbital convergence and an ankle specialized for leaping. We infer that the ancestor of Euprimates was primitively an arboreal grasper adapted for terminal branch feeding rather than a specialized leaper or visually directed predator.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bloch, JI (corresponding author), Univ Michigan, Museum Paleontol, 1109 Geddes Rd, Ann Arbor, MI 48109 USA.	carpo@umich.edu	Self, Casey J/B-6871-2011	Boyer, Douglas/0000-0002-8697-2999; Bloch, Jonathan/0000-0003-1484-6931				BEARD KC, 1993, MAMMAL PHYLOGENY : PLACENTALS, P129; BEARD KC, 1995, ANN CARNEGIE MUS, V64, P1; BEARD KC, 1991, ORIGINES BIPEDIE CHE, P63; BIKNEVICIUS AR, 1986, AM J PHYS ANTHROPOL, V71, P157, DOI 10.1002/ajpa.1330710204; Bloch J, 2001, U MICHIGAN PAPERS PA, V33, P185; Bloch JI, 2001, T GEOBIOL, V18, P95; Bloch JI, 2002, J VERTEBR PALEONTOL, V22, P366, DOI 10.1671/0272-4634(2002)022[0366:NPPFTC]2.0.CO;2; Bloch JI, 2001, AM J PHYS ANTHROPOL, V116, P184, DOI 10.1002/ajpa.1114; Bloch JI, 2001, J VERTEBR PALEONTOL, V21, P119, DOI 10.1671/0272-4634(2001)021[0119:SAOPCM]2.0.CO;2; Bloch Jonathan I., 1998, Contributions from the Museum of Paleontology University of Michigan, V30, P131; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bowen GJ, 2002, J SEDIMENT RES, V72, P46, DOI 10.1306/061901720046; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; CARTMILL M, 1992, EVOL ANTHROPOL, V6, P111; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; DASHZEVEG D, 1977, Acta Palaeontologica Polonica, V22, P119; Fox Richard C., 1993, Journal of Vertebrate Paleontology, V13, P516; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; GINGERICH PD, 1975, NATURE, V253, P111, DOI 10.1038/253111a0; GINGERICH PD, 1987, CONTRIB MUS PALEONTO, V27, P265; GINGERICH PD, 2000, EARLY PALEOGENE WARM, P57; Gunnell GF., 1989, U MICH PAP PALEONT, V27, P1; Hamrick MW, 2001, J HUM EVOL, V40, P339, DOI 10.1006/jhev.2001.0467; HOFFSTETTER R, 1977, B MEM SOC ANTHRO PAR, V4, P327, DOI 10.3406/bmsap.1977.1886; KAY RF, 1992, AM J PHYS ANTHROPOL, V89, P477, DOI 10.1002/ajpa.1330890409; KRAUSE DW, 1991, J HUM EVOL, V21, P177, DOI 10.1016/0047-2484(91)90060-9; Lemelin P, 1999, J ZOOL, V247, P165, DOI 10.1017/S0952836999002046; MAAS MC, 1988, PALEOBIOLOGY, V14, P410, DOI 10.1017/S0094837300012148; MCKENNA MC, 1966, FOLIA PRIMATOL, V4, P1, DOI 10.1159/000155041; McKenna MC, 1997, CLASSIFICATION MAMMA; RASMUSSEN DT, 1990, AM J PRIMATOL, V22, P263, DOI 10.1002/ajp.1350220406; ROSE K D, 1975, Bulletin of the Museum of Comparative Zoology, V147, P1; RUNESTAD JA, 1995, AM J PHYS ANTHROPOL, V98, P101, DOI 10.1002/ajpa.1330980202; RUSSELL DONALD E., 1964, MEM MUS NAT HIST NATUR NOW SER SER C SCI TERRE, V13, P1; Sargis EJ, 2002, J MORPHOL, V254, P149, DOI 10.1002/jmor.10025; Sargis EJ, 2001, J ZOOL, V253, P473, DOI 10.1017/S0952836901000437; Sargis EJ, 2001, J ZOOL, V253, P485, DOI 10.1017/S0952836901000449; Silcox M.T., 2001, THESIS J HOPKINS U; Silcox MT, 2001, J VERTEBR PALEONTOL, V21, P132, DOI 10.1671/0272-4634(2001)021[0132:NSOERM]2.0.CO;2; Stafford BJ, 1998, J MORPHOL, V235, P135, DOI 10.1002/(SICI)1097-4687(199802)235:2<135::AID-JMOR4>3.0.CO;2-8; SUSSMAN RW, 1978, SCIENCE, V200, P731, DOI 10.1126/science.200.4343.731; SUSSMAN RW, 1991, AM J PRIMATOL, V23, P209, DOI 10.1002/ajp.1350230402; Szalay F. S., 1969, Bulletin of the American Museum of Natural History, V140, P195; Szalay F.S., 1980, P133; Szalay Frederick S., 1993, P187; SZALAY FS, 1980, FOLIA PRIMATOL, V34, P1, DOI 10.1159/000155946; SZALAY FS, 1987, YEARB PHYS ANTHROPOL, V30, P75; SZALAY FS, 1975, FOLIA PRIMATOL, V23, P158, DOI 10.1159/000155669; SZALAY FS, 1968, EVOLUTION, V22, P19, DOI 10.1111/j.1558-5646.1968.tb03445.x; SZALAY FS, 1988, J HUM EVOL, V17, P1, DOI 10.1016/0047-2484(88)90047-4; SZALAY FS, 1975, APPROACHES PRIMATE P, P136; Wible John R., 1993, P111; WIBLE JR, 1987, J HUM EVOL, V16, P1, DOI 10.1016/0047-2484(87)90058-3	53	171	183	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1606	1610		10.1126/science.1078249	http://dx.doi.org/10.1126/science.1078249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446906				2022-12-24	WOS:000179361600045
J	Sasaki, T; Matsumoto, T; Yamamoto, K; Sakata, K; Baba, T; Katayose, Y; Wu, JZ; Niimura, Y; Cheng, ZK; Nagamura, Y; Antonio, BA; Kanamori, H; Hosokawa, S; Masukawa, M; Arikawa, K; Chiden, Y; Hayashi, M; Okamoto, M; Ando, T; Aoki, H; Arita, K; Hamada, M; Harada, C; Hijishita, S; Honda, M; Ichikawa, Y; Idonuma, A; Iijima, M; Ikeno, M; Ito, S; Ito, T; Ito, Y; Ito, Y; Iwabuchi, A; Kamiya, K; Karasawa, W; Katagiri, S; Kikuta, A; Kobayashi, N; Kono, I; Machita, K; Maehara, T; Mizuno, H; Mizubayashi, T; Mukai, Y; Nagasaki, H; Nakashima, M; Nakama, Y; Nakamichi, Y; Nakamura, M; Namiki, N; Negishi, M; Ohta, I; Ono, N; Saji, S; Sakai, K; Shibata, M; Shimokawa, T; Shomura, A; Song, JY; Takazaki, Y; Terasawa, K; Tsuji, K; Waki, K; Yamagata, H; Yamane, H; Yoshiki, S; Yoshihara, R; Yukawa, K; Zhong, HS; Iwama, H; Endo, T; Ito, H; Hahn, JH; Kim, HI; Eun, MY; Yano, M; Jiang, JM; Gojohori, T				Sasaki, T; Matsumoto, T; Yamamoto, K; Sakata, K; Baba, T; Katayose, Y; Wu, JZ; Niimura, Y; Cheng, ZK; Nagamura, Y; Antonio, BA; Kanamori, H; Hosokawa, S; Masukawa, M; Arikawa, K; Chiden, Y; Hayashi, M; Okamoto, M; Ando, T; Aoki, H; Arita, K; Hamada, M; Harada, C; Hijishita, S; Honda, M; Ichikawa, Y; Idonuma, A; Iijima, M; Ikeno, M; Ito, S; Ito, T; Ito, Y; Ito, Y; Iwabuchi, A; Kamiya, K; Karasawa, W; Katagiri, S; Kikuta, A; Kobayashi, N; Kono, I; Machita, K; Maehara, T; Mizuno, H; Mizubayashi, T; Mukai, Y; Nagasaki, H; Nakashima, M; Nakama, Y; Nakamichi, Y; Nakamura, M; Namiki, N; Negishi, M; Ohta, I; Ono, N; Saji, S; Sakai, K; Shibata, M; Shimokawa, T; Shomura, A; Song, JY; Takazaki, Y; Terasawa, K; Tsuji, K; Waki, K; Yamagata, H; Yamane, H; Yoshiki, S; Yoshihara, R; Yukawa, K; Zhong, HS; Iwama, H; Endo, T; Ito, H; Hahn, JH; Kim, HI; Eun, MY; Yano, M; Jiang, JM; Gojohori, T			The genome sequence and structure of rice chromosome 1	NATURE			English	Article							TRANSFER-RNA GENES; ARABIDOPSIS-THALIANA; DRAFT SEQUENCE; DNA; EVOLUTION; MAP	The rice species Oryza sativa is considered to be a model plant because of its small genome size, extensive genetic map, relative ease of transformation and synteny with other cereal crops(1-4). Here we report the essentially complete sequence of chromosome 1, the longest chromosome in the rice genome. We summarize characteristics of the chromosome structure and the biological insight gained from the sequence. The analysis of 43.3 megabases (Mb) of non-overlapping sequence reveals 6,756 protein coding genes, of which 3,161 show homology to proteins of Arabidopsis thaliana, another model plant. About 30% ( 2,073) of the genes have been functionally categorized. Rice chromosome 1 is (G + C)-rich, especially in its coding regions, and is characterized by several gene families that are dispersed or arranged in tandem repeats. Comparison with a draft sequence(5) indicates the importance of a high-quality finished sequence.	Natl Inst Agrobiol Sci, Rice Genome Res Program, Tsukuba, Ibaraki 3058602, Japan; Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3058602, Japan; Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Tokyo Med & Dent Univ, Dept Bioinformat, Bunkyo Ku, Tokyo 1138510, Japan; Natl Inst Agr Sci & Technol, Rice Genome Sequencing Project, RDA, Suwon 441707, South Korea	National Institute of Agrobiological Sciences - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Wisconsin System; University of Wisconsin Madison; Tokyo Medical & Dental University (TMDU); Rural Development Administration (RDA)	Sasaki, T (corresponding author), Natl Inst Agrobiol Sci, Rice Genome Res Program, 1-2 Kannondai 2 Chome, Tsukuba, Ibaraki 3058602, Japan.	tsasaki@nias.affrc.go.jp	Arikawa, Koji/M-4771-2018; Jiang, Jiming/V-6060-2019; Ito, Hidetaka/Y-2865-2018; Jiang, Jiming/A-9614-2009; Yano, Masahiro/AAC-5441-2019; Waki, Kazunori/T-6444-2019	Arikawa, Koji/0000-0002-9508-2429; Jiang, Jiming/0000-0002-6435-6140; Jiang, Jiming/0000-0002-6435-6140; Yano, Masahiro/0000-0003-1510-4622; Waki, Kazunori/0000-0001-7311-7208; Tsugane, Mika/0000-0002-7991-5224; Mizuno, Hiroshi/0000-0002-4110-4717				Baba T., 2000, Bulletin of the National Institute of Agrobiological Resources, P41; Barakat A, 1997, P NATL ACAD SCI USA, V94, P6857, DOI 10.1073/pnas.94.13.6857; Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Harushima Y, 1998, GENETICS, V148, P479; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; Sakata K, 2002, NUCLEIC ACIDS RES, V30, P98, DOI 10.1093/nar/30.1.98; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yamamoto K, 1997, PLANT MOL BIOL, V35, P135, DOI 10.1023/A:1005735322577; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	21	423	1068	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					312	316		10.1038/nature01184	http://dx.doi.org/10.1038/nature01184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447438	hybrid			2022-12-24	WOS:000179340400041
J	Blendon, RJ; DesRoches, CM; Benson, JM; Herrmann, MJ; Taylor-Clark, K; Weldon, KJ				Blendon, RJ; DesRoches, CM; Benson, JM; Herrmann, MJ; Taylor-Clark, K; Weldon, KJ			The public and the smallpox threat	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIOTERRORISM	BACKGROUND: The potential for a bioterrorist attack involving smallpox has led to a debate about what national precautions should be taken. What is unclear is the public's knowledge of smallpox and views about precautions. METHODS: We conducted a national survey of 1006 adults selected by means of random-digit dialing. Respondents were asked about their knowledge of and beliefs about the smallpox virus and the vaccine, their possible reactions to a bioterrorist attack involving smallpox, and a number of proposed state emergency powers. RESULTS: The majority of the respondents have a number of beliefs about smallpox and smallpox vaccination that are false. The majority believe that there is an effective treatment for smallpox, that there have been cases of smallpox in the past five years, and that there is not enough smallpox vaccine to vaccinate everyone in the United States. Thirty percent believe that vaccination earlier in their lives would protect them from the disease. The majority of respondents said they wanted to be vaccinated; however, only 21 percent would want to be vaccinated if physicians declined vaccination. There was strong support among the respondents for several proposed state emergency powers. CONCLUSIONS: Our results suggest the need for public education about smallpox. These data also point to the importance of a discussion in the medical community about the advisability of vaccination of individual physicians at this time.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Int Commun Res, Media, PA USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.		DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X; Weldon, Kathleen/0000-0001-5884-6947				ALTMAN LK, 2002, NY TIMES        1012, P20; *AM ASS PUBL OP RE, 2000, STAND DEF FIN DISP C; Annas GJ, 2002, NEW ENGL J MED, V346, P1337, DOI 10.1056/NEJM200204253461722; [Anonymous], 2002, SMALLP FACT SHEET SM; Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BLENDON RJ, 2002, MEDSCAPE GEN MED, V4; *CDCP, 2002, SMALLP VACC VACC MET; *CDCP, 2002, MOD STAT EM HLTH POW; Cohen J, 2001, SCIENCE, V294, P985, DOI 10.1126/science.294.5544.985; Fauci AS, 2002, NEW ENGL J MED, V346, P1319, DOI 10.1056/NEJM200204253461711; FLAHERTY T, 2002, AMA ANSWERS NEEDED W; Gostin LO, 2002, JAMA-J AM MED ASSOC, V288, P622, DOI 10.1001/jama.288.5.622; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; MILLER J, 2002, NY TIMES        1203, pA18; Miller Judith, 2002, NEW YORK TIMES  1112, pA1; O'Toole T, 2002, CLIN INFECT DIS, V34, P972, DOI 10.1086/339909; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500; STIMSON JA, 1995, AM POLIT SCI REV, V89, P543, DOI 10.2307/2082973; STOLBERG SG, 2002, NY TIMES        1128, pA22; TANNER L, 2002, 434 CAT I; WLEZIEN C, 1995, AM POLIT SCI REV, V89, P981; 2002, NY TIMES        1214, pA14	26	62	66	1	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 30	2003	348	5					426	432		10.1056/NEJMsa023184	http://dx.doi.org/10.1056/NEJMsa023184			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639RU	12496352				2022-12-24	WOS:000180643800009
J	Zhuo, Y; Zhou, TG; Rao, HY; Wang, JJ; Meng, M; Chen, M; Zhou, C; Chen, L				Zhuo, Y; Zhou, TG; Rao, HY; Wang, JJ; Meng, M; Chen, M; Zhou, C; Chen, L			Contributions of the visual ventral pathway to long-range apparent motion	SCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; TOPOLOGICAL-STRUCTURE; PERCEPTION; BRAIN; RECOGNITION; ACTIVATION; VARIABLES; VISION; COLOR; NAME	Objects displaced intermittently across the visual field will nonetheless give an illusion of continuous motion [called apparent motion (AM)] under many common conditions. It is believed that form perception is of minor importance in determining AM, and that AM is mediated by motion-sensitive areas in the where pathway of the cortex. However, form and motion typically interact in specific ways when natural objects move through the environment. We used functional magnetic resonance imaging to measure cortical activation to long-range AM, compared to short-range AM and flicker, while we varied stability of structural differences between forms. Long-range AM activated the anterior-temporal lobe in the visual ventral pathway, and the response varied according to the form stability. The results suggest that long-range AM is associated with neural systems for form perception.	Chinese Acad Sci, Inst Biophys, Grad Sch, Key Lab Cognit Sci, Beijing 100101, Peoples R China; Beijing Hosp, Beijing 100730, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chinese Academy of Sciences, CAS; Beijing Hospital	Chen, L (corresponding author), Chinese Acad Sci, Inst Biophys, Grad Sch, Key Lab Cognit Sci, 15 Datun Rd, Beijing 100101, Peoples R China.		Wang, Danny JJ/O-2482-2018; Rao, Hengyi/A-7064-2009; Rao, Hengyi/K-5152-2019; Rao, Hengyi/AAQ-4919-2020; Meng, Ming/A-5829-2008	Wang, Danny JJ/0000-0002-0840-7062; Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 				ANSTIS S, 1986, SENSORY PROCESS PERC, V1, P16; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; CHEN L, 1985, PERCEPTION, V14, P197, DOI 10.1068/p140197; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; CHEN L, 1990, PERCEPT PSYCHOPHYS, V47, P47, DOI 10.3758/BF03208163; Chen L, 2001, VIS COGN, V8, P287, DOI 10.1080/13506280143000016; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; KOLERS PA, 1971, J EXP PSYCHOL, V87, P99, DOI 10.1037/h0030156; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Moore CJ, 1999, BRAIN, V122, P943, DOI 10.1093/brain/122.5.943; Mummery CJ, 1996, P ROY SOC B-BIOL SCI, V263, P989, DOI 10.1098/rspb.1996.0146; PALMER P, 1999, VISION SCI; PETERSIK JT, 1989, PSYCHOL BULL, V106, P107, DOI 10.1037/0033-2909.106.1.107; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; PRAZDNY K, 1986, PERCEPTION, V15, P37, DOI 10.1068/p150037; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Todd JT, 1998, PERCEPTION, V27, P273, DOI 10.1068/p270273; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P263; Wang JJ, 1999, HUM BRAIN MAPP, V8, P170, DOI 10.1002/(SICI)1097-0193(1999)8:4<170::AID-HBM2>3.3.CO;2-N; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068	33	84	92	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					417	420		10.1126/science.1077091	http://dx.doi.org/10.1126/science.1077091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	635YB	12532023				2022-12-24	WOS:000180426800053
J	Madeley, CR				Madeley, CR			Diagnosing smallpox in possible bioterrorist attack	LANCET			English	Editorial Material							VIRUS					dickmadeley@aol.com						ANDERSON T, 1951, LANCET, V260, P1248; Biel SS, 2001, J CLIN VIROL, V22, P1, DOI 10.1016/S1386-6532(01)00151-2; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Calisher CH, 2000, VIRAL IMMUNOL, V13, P411, DOI 10.1089/vim.2000.13.411; *CDCP, 2002, EV PAT SMALLP VERS 1; Elliott RM, 2001, SYMP SOC GEN MICROBI, V60, P53, DOI 10.1017/CBO9780511754883.004; GELDERBLOM HR, 2001, BIOFORUM INT, V5, P64; Nakano JH, 1989, DIAGNOSTIC PROCEDURE, P453; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2002, TIMES           1203, P21	10	23	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					97	98		10.1016/S0140-6736(03)12241-6	http://dx.doi.org/10.1016/S0140-6736(03)12241-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531572				2022-12-24	WOS:000180428000004
J	Bisley, JW; Goldberg, ME				Bisley, JW; Goldberg, ME			Neuronal activity in the lateral intraparietal area and spatial attention	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SELECTIVE VISUAL-ATTENTION; MOTOR INTENTION ACTIVITY; SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; MONKEY; MACAQUES; ENHANCEMENT; RESPONSES; PLAN	Although the parietal cortex has been implicated in the neural processes underlying visual attention, the nature of its contribution is not well understood. We tracked attention in the monkey and correlated the activity of neurons in the lateral intraparietal area (LIP) with the monkey's attentional performance. The ensemble activity in LIP across the entire visual field describes the spatial and temporal dynamics of a monkey's attention. Activity subtending a single location in the visual. field describes the attentional priority at that area but does not predict that the monkey will actually attend to or make an eye movement to that location.	New York State Psychiat Inst & Hosp, Ctr Neurobiol & Behav, Mahoney Keck Ctr Mind & Brain, Unit 87, New York, NY 10032 USA; NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20007 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Keck Ctr Cognit & Plast,Dept Neurol, Mahoney Ctr Mind & Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Keck Ctr Cognit & Plast,Dept Psychiat, Mahoney Ctr Mind & Brain, New York, NY 10032 USA	New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University; Columbia University; Columbia University	Bisley, JW (corresponding author), New York State Psychiat Inst & Hosp, Ctr Neurobiol & Behav, Mahoney Keck Ctr Mind & Brain, Unit 87, Room 5-06,1051 Riverside Dr, New York, NY 10032 USA.			Bisley, James/0000-0002-2841-0306				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; Basso MA, 1998, J NEUROSCI, V18, P7519; BOWMAN EM, 1993, J NEUROPHYSIOL, V70, P431, DOI 10.1152/jn.1993.70.1.431; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; PLATT ML, 1997, J NEUROPHYSIOL, V78, P157; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1994, J NEUROPHYSIOL, V72, P1020, DOI 10.1152/jn.1994.72.2.1020; Witte EA, 1996, BEHAV BRAIN RES, V82, P103, DOI 10.1016/S0166-4328(97)81113-8; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yantis S, 1996, J EXP PSYCHOL HUMAN, V22, P1505, DOI 10.1037/0096-1523.22.6.1505; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	43	617	624	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					81	86		10.1126/science.1077395	http://dx.doi.org/10.1126/science.1077395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	631JZ	12511644				2022-12-24	WOS:000180165800036
J	Walther, DJ; Peter, JU; Bashammakh, S; Hortnagl, H; Voits, M; Fink, H; Bader, M				Walther, DJ; Peter, JU; Bashammakh, S; Hortnagl, H; Voits, M; Fink, H; Bader, M			Synthesis of serotonin by a second tryptophan hydroxylase isoform	SCIENCE			English	Article									Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, Charite, Fac Med, Inst Pharmacol & Toxicol, D-10117 Berlin, Germany; Free Univ Berlin, Sch Vet Med, Inst Pharmacol & Toxicol, D-14195 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Walther, DJ (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.		Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164				Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Humble M, 2001, BIOL PSYCHIAT, V49, P360, DOI 10.1016/S0006-3223(00)00956-2; KUHN DM, 1980, ARCH BIOCHEM BIOPHYS, V199, P355, DOI 10.1016/0003-9861(80)90291-X; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1	5	1128	1205	6	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					76	76		10.1126/science.1078197	http://dx.doi.org/10.1126/science.1078197			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511643				2022-12-24	WOS:000180165800034
J	Naimi, TS; Brewer, RD; Mokdad, A; Denny, C; Serdula, MK; Marks, JS				Naimi, TS; Brewer, RD; Mokdad, A; Denny, C; Serdula, MK; Marks, JS			Binge drinking among US adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK FACTOR SURVEILLANCE; REPORTED ALCOHOL-USE; HARVARD-SCHOOL; CONSUMPTION; ENFORCEMENT; VALIDITY; TRENDS; PERIOD; SALES; DEATH	Context Binge drinking (consuming greater than or equal to5 alcoholic drinks on 1 occasion) generally results in acute impairment and has numerous adverse health consequences. Reports indicate that binge drinking may be increasing in the United States. Objectives To quantify episodes of binge drinking among US adults in 1993-2001, to characterize adults who engage in binge drinking, and to describe state and regional differences in binge drinking. Design, Setting, and Participants The Behavioral Risk Factor Surveillance System, a random-digit telephone survey of adults aged 18 years or older that is conducted annually in all states. The sample size ranged from 102263 in 1993 to 212 510 in 2001. Main Outcome Measures Binge-drinking prevalence, episodes, and episodes per person per year. Results Between 1993 and 2001, the total number of binge-drinking episodes among US adults increased from approximately 1.2 billion to 1.5 billion; during this time, binge-drinking episodes per person per year increased by 17% (from 6.3 to 7.4, P for trend = .03). Between 1995 and 2001, binge-drinking episodes per person per year increased by 35% (P for trend = .005). Men accounted for 81% of binge-drinking episodes in the study years. Although rates of binge-drinking episodes were highest among those aged 18 to 25 years, 69% of binge-drinking episodes during the study period occurred among those aged 26 years or older. Overall, 47% of binge-drinking episodes occurred among otherwise moderate (ie, non-heavy) drinkers, and 73% of all binge drinkers were moderate drinkers. Binge drinkers were 14 times more likely to drive while impaired by alcohol compared with non-binge drinkers. There were substantial state and regional differences in per capita binge-drinking episodes. Conclusions Binge drinking is common among most strata of US adults, including among those aged 26 years or older. Per capita binge-drinking episodes have increased, particularly since 1995. Binge drinking is strongly associated with alcohol-impaired driving. Effective interventions to prevent the mortality and morbidity associated with binge drinking should be widely adopted, including screening patients for alcohol abuse in accordance with national guidelines.	Ctr Dis Control & Prevent, Alcohol Team, Analyt Methods Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Behav Surveillance Branch, Div Adult & Community Hlth, Atlanta, GA USA; Ctr Dis Control & Prevent, Chron Dis Nutr Branch, Div Nutr & Phys Act, Atlanta, GA USA; Ctr Dis Control & Prevent, Off Director, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Alcohol Team, Emerging Invest Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Naimi, TS (corresponding author), CDC, Alcohol Team, MS K-67,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	tbn7@cdc.gov		Naimi, Timothy/0000-0001-9849-4413				*ALC EP PROGR, 2000, ALC POL US HIGHL 50; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P173; Center for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P1064; Center on Alcohol Marketing and Youth, 2002, OV YOUTH TARG ALC AD; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P273; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; CHALOUPKA FJ, 1993, J LEGAL STUD, V22, P161, DOI 10.1086/468161; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; Chikritzhs TN, 2001, MED J AUSTRALIA, V174, P281, DOI 10.5694/j.1326-5377.2001.tb143269.x; Coffield AB, 2001, AM J PREV MED, V21, P1, DOI 10.1016/S0749-3797(01)00308-7; Cook PJ, 2002, HEALTH AFFAIR, V21, P120, DOI 10.1377/hlthaff.21.2.120; *FED TRAD COMM, 2002, SELF REG ALC IND; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Floyd RL, 1999, AM J PREV MED, V17, P101, DOI 10.1016/S0749-3797(99)00059-8; Gentry E M, 1985, Am J Prev Med, V1, P9; Gladstone J, 1996, REPROD TOXICOL, V10, P3, DOI 10.1016/0890-6238(95)02024-1; Gmel G, 2001, ADDICTION, V96, P273, DOI 10.1046/j.1360-0443.2001.96227311.x; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; Holder HD, 2000, JAMA-J AM MED ASSOC, V284, P2341, DOI 10.1001/jama.284.18.2341; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; Jacobs EA, 2001, PEDIATRICS, V108, P185, DOI 10.1542/peds.108.1.185; Jacobson Joseph L, 1994, Alcohol Health Res World, V18, P30; LENDER ME, 1987, DRINKING AM; Liu S, 1997, JAMA-J AM MED ASSOC, V277, P122, DOI 10.1001/jama.277.2.122; Maier SE, 1997, ALCOHOL CLIN EXP RES, V21, P1418; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; MCKNIGHT AJ, 1994, ACCIDENT ANAL PREV, V26, P79, DOI 10.1016/0001-4575(94)90070-1; MIDANIK LT, 1988, BRIT J ADDICT, V83, P1019; MORSE J, 2002, TIME, V159, P56; Nelson DE, 2002, JAMA-J AM MED ASSOC, V287, P2659, DOI 10.1001/jama.287.20.2659; Nelson DE, 2001, SOZ PRAVENTIV MED, V46, pS3; *PARTN PREV, 2002, ALC HLTH RISK US MEA; RAE S, 1991, DRINK DRINKERS DRINK; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Rogers JD, 1999, J STUD ALCOHOL, V60, P732, DOI 10.15288/jsa.1999.60.732; SAFFER H, 1987, J LEGAL STUD, V16, P351, DOI 10.1086/467834; Shah BV, 1997, SUDAAN USERS MANUAL; SHULTZ JM, 1991, PUBLIC HEALTH REP, V106, P443; SMITH PF, 1990, AM J PUBLIC HEALTH, V80, P309, DOI 10.2105/AJPH.80.3.309; Stout EM, 2000, J STUD ALCOHOL, V61, P402, DOI 10.15288/jsa.2000.61.402; *SUBST AB MENT HLT, 2002, NAT HOUS DRUG AB SUM; U. S. Department of Health and Human Services, 2000, HLTH PEOPL 2010, V1; *US DEP HLTH HUM S, 2000, HOM GARD B, V232; US Department of Health and Human Services, 2000, SAYING IT CLEARL; *US PREV SERV TASK, 1996, SCREEN PROBL DRINK G, P567; WAGENAAR AC, 1995, PUBLIC HEALTH REP, V110, P419; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; Wechsler H, 1998, J STUD ALCOHOL, V59, P122, DOI 10.15288/jsa.1998.59.122; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Wechsler H, 1998, J AM COLL HEALTH, V47, P57, DOI 10.1080/07448489809595621; World Health Organization, 2000, INT GUID MON ALC CON	53	723	742	0	80	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					70	75		10.1001/jama.289.1.70	http://dx.doi.org/10.1001/jama.289.1.70			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630XL	12503979				2022-12-24	WOS:000180136600028
J	Smith, G				Smith, G			Scared to death?	BRITISH MEDICAL JOURNAL			English	Article									Pomona Coll, Dept Econ, Claremont, CA 91711 USA	Claremont Colleges; Pomona College	Smith, G (corresponding author), Pomona Coll, Dept Econ, Claremont, CA 91711 USA.			Smith, Gary/0000-0002-5173-2741				Glaser JH, 2002, BRIT MED J, V324, P1098, DOI 10.1136/bmj.324.7345.1098; PHILLIPS DP, 1988, LANCET, V2, P728; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Phillips DP, 2001, BRIT MED J, V323, P1443, DOI 10.1136/bmj.323.7327.1443; PHILLIPS DP, 1993, LANCET, V342, P1142, DOI 10.1016/0140-6736(93)92124-C	5	9	9	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2002	325	7378					1442	1443		10.1136/bmj.325.7378.1442	http://dx.doi.org/10.1136/bmj.325.7378.1442			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631VX	12493656	Green Published			2022-12-24	WOS:000180188600008
J	Dillin, A; Hsu, AL; Arantes-Oliveira, NA; Lehrer-Graiwer, J; Hsin, H; Fraser, AG; Kamath, RS; Ahringer, J; Kenyon, C				Dillin, A; Hsu, AL; Arantes-Oliveira, NA; Lehrer-Graiwer, J; Hsin, H; Fraser, AG; Kamath, RS; Ahringer, J; Kenyon, C			Rates of behavior and aging specified by mitochondrial function during development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; RNA INTERFERENCE; EXTENDS LIFE; GENE; LONGEVITY; NEMATODE; MUTANTS	To explore the role of mitochondrial activity in the aging process, we have lowered the activity of the electron transport chain and adenosine 5'-triphosphate (ATP) synthase with RNA interference (RNAi) in Caenorhabditis elegans. These perturbations reduced body size and behavioral rates and extended adult life-span. Restoring messenger RNA to near-normal levels during adulthood did not elevate ATP levels and did not correct any of these phenotypes. Conversely, inhibiting respiratory-chain components during adulthood only did not reset behavioral rates and did not affect life-span. Thus, the developing animal appears to contain a regulatory system that monitors mitochondrial activity early in life and, in response, establishes rates of respiration, behavior, and aging that persist during adulthood.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England	University of California System; University of California San Francisco; University of Cambridge	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu	Hsu, Ao-Lin Allen/AAX-1856-2020	Hsu, Ao-Lin/0000-0002-2864-3134; Fraser, Andrew/0000-0001-9939-6014; Kenyon, Cynthia/0000-0003-3446-2636; Hsin, Honor/0000-0002-0510-7494; Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Braeckman BP, 1999, CURR BIOL, V9, P493, DOI 10.1016/S0960-9822(99)80216-4; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DILLIN A, UNPUB; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; SLATER EC, 1983, TRENDS BIOCHEM SCI, V8, P239, DOI 10.1016/0968-0004(83)90348-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; WONG A, 1995, GENETICS, V139, P1247	22	746	784	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2398	2401		10.1126/science.1077780	http://dx.doi.org/10.1126/science.1077780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12471266				2022-12-24	WOS:000179915900060
J	Blagoveshchenskaya, AD; Thomas, L; Feliciangeli, SF; Hung, CH; Thomas, G				Blagoveshchenskaya, AD; Thomas, L; Feliciangeli, SF; Hung, CH; Thomas, G			HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway	CELL			English	Article							RIBOSYLATION FACTOR 6; PLASMA-MEMBRANE; CELL-SURFACE; COMPLEX; TRAFFICKING; MOLECULES; PROTEINS; BINDING; PHOSPHORYLATION; ACTIVATION	The HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the trans-Golgi network (TGN) enables HIV-1 to escape immune surveillance. However, the cellular pathway used by Nef to downregulate MHC-I is unknown. Here, we show that Nef and PACS-1 combine to usurp the ARF6 endocytic pathway by a PI3K-dependent process and downregulate cell surface MHC-I to the TGN. This mechanism requires the hierarchical actions of three Nef motifs-the acidic cluster (EEEE65)-E-62, the SH3 domain binding site (PXXP75)-P-72, and M-20-in controlling PACS-1-dependent sorting to the TGN, ARF6 activation, and sequestering internalized MHC-I to the TGN, respectively. These data provide new insights into the cellular basis of HIV-1 immunoevasion.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Thomas, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	thomasg@ohsu.edu	Feliciangeli, Sylvain/Q-1292-2016	Feliciangeli, Sylvain/0000-0003-3358-3719	NIAID NIH HHS [AI8585, AI49793, R01 AI049793] Funding Source: Medline; NIDDK NIH HHS [DK37274] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P27896, DOI 10.1074/jbc.273.43.27896; Capps GG, 2000, MOL IMMUNOL, V37, P59, DOI 10.1016/S0161-5890(00)00019-5; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Chang AH, 2001, EUR J IMMUNOL, V31, P2382, DOI 10.1002/1521-4141(200108)31:8<2382::AID-IMMU2382>3.0.CO;2-K; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hitt M M, 1997, Adv Pharmacol, V40, P137, DOI 10.1016/S1054-3589(08)60140-4; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Marsh M, 2000, TRAFFIC, V1, P525, DOI 10.1034/j.1600-0854.2000.010701.x; Matafora V, 2001, J CELL SCI, V114, P4509; Munch J, 2001, J VIROL, V75, P10532, DOI 10.1128/JVI.75.21.10532-10536.2001; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Peters PJ, 2001, TRAFFIC, V2, P885, DOI 10.1034/j.1600-0854.2001.21204.x; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Schibeci SD, 2000, AIDS, V14, P1701, DOI 10.1097/00002030-200008180-00003; Swann SA, 2001, VIROLOGY, V282, P267, DOI 10.1006/viro.2000.0816; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	49	231	239	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					853	866		10.1016/S0092-8674(02)01162-5	http://dx.doi.org/10.1016/S0092-8674(02)01162-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526811	Bronze			2022-12-24	WOS:000179862600011
J	Knapp, AK; Fay, PA; Blair, JM; Collins, SL; Smith, MD; Carlisle, JD; Harper, CW; Danner, BT; Lett, MS; McCarron, JK				Knapp, AK; Fay, PA; Blair, JM; Collins, SL; Smith, MD; Carlisle, JD; Harper, CW; Danner, BT; Lett, MS; McCarron, JK			Rainfall variability, carbon cycling, and plant species diversity in a mesic grassland	SCIENCE			English	Article							CLIMATE VARIABILITY; EXTREMES; FIRE	Ecosystem responses to increased variability in rainfall, a prediction of general circulation models, were assessed in native grassland by reducing storm frequency and increasing rainfall quantity per storm during a 4-year experiment. More extreme rainfall patterns, without concurrent changes in total rainfall quantity, increased temporal variability in soil moisture and plant species diversity. However, carbon cycling processes such as soil CO2 flux, CO2 uptake by the dominant grasses, and aboveground net primary productivity (ANPP) were reduced, and ANPP was more responsive to soil moisture variability than to mean soil water content. Our results show that projected increases in rainfall variability can rapidly alter key carbon cycling processes and plant community composition, independent of changes in total precipitation.	Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Natl Sci Fdn, Ecol Studies Program, Arlington, VA 22230 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	Kansas State University; National Science Foundation (NSF); National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Knapp, AK (corresponding author), Kansas State Univ, Div Biol, Manhattan, KS 66506 USA.	aknapp@ksu.edu	Smith, Melinda D/J-8987-2014; Blair, John M/I-4082-2014; Knapp, Alan K/A-2931-2008; Fay, Philip A./I-1853-2012; Collins, Scott L/P-7742-2014; Noojipady, Praveen/B-2511-2010	Blair, John M/0000-0003-0072-0721; Fay, Philip A./0000-0002-8291-6316; Collins, Scott L/0000-0002-0193-2892; 				Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Gates D.M., 1993, CLIMATE CHANGE ITS B; GORDON HB, 1992, CLIM DYNAM, V8, P83, DOI 10.1007/BF00209165; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SYNT; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Johnson LC, 2001, ECOLOGY, V82, P3377, DOI 10.1890/0012-9658(2001)082[3377:FAGRBP]2.0.CO;2; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Knapp A.K., 1998, GRASSLAND DYNAMICS L, V1st; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 1998, ECOL APPL, V8, P760, DOI 10.2307/2641264; KNAPP AK, 1993, ECOLOGY, V74, P549, DOI 10.2307/1939315; Koch G, 1996, CARBON DIOXIDE TERRE; Ludwig J. A., 1988, STAT ECOLOGY; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; MEARNS LO, 1990, J GEOPHYS RES-ATMOS, V95, P20469, DOI 10.1029/JD095iD12p20469; Mearns LO, 1997, CLIMATIC CHANGE, V35, P367, DOI 10.1023/A:1005358130291; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Plummer N, 1999, CLIMATIC CHANGE, V42, P183, DOI 10.1023/A:1005472418209; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; RIND D, 1989, CLIMATIC CHANGE, V14, P5, DOI 10.1007/BF00140173; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; SCHIMEL DS, 1991, ECOLOGY, V72, P672, DOI 10.2307/2937207; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257	27	818	913	47	687	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2202	2205		10.1126/science.1076347	http://dx.doi.org/10.1126/science.1076347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481139				2022-12-24	WOS:000179773700051
J	Stensmyr, MC; Urru, I; Collu, I; Celander, M; Hansson, BS; Angioy, AM				Stensmyr, MC; Urru, I; Collu, I; Celander, M; Hansson, BS; Angioy, AM			Rotting smell of dead-horse arum florets - These blooms chemically fool flies into pollinating them.	NATURE			English	Article							DECEPTION; MIMICRY		Swedish Univ Agr Sci, Dept Crop Sci, S-23053 Alnarp, Sweden; Univ Cagliari, Dept Expt Biol, I-4500 Monserrato, Italy	Swedish University of Agricultural Sciences; University of Cagliari	Stensmyr, MC (corresponding author), Swedish Univ Agr Sci, Dept Crop Sci, POB 44, S-23053 Alnarp, Sweden.		Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212; Celander, Malin/0000-0002-4350-751X				ARN H, 1975, Z NATURFORSCH C, V30, P722; BROWN MH, 1982, MEAT MICROBIOLOGY; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; Fridlender Alain, 2000, Webbia, V55, P7; Kite Geoffrey C., 2000, Kew Bulletin, V55, P237, DOI 10.2307/4117785; Linnaeus C., 1745, C LINNAEI OLANDSKA G; Rosello JA, 1997, ACTA BOT BARC, V44, P169; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Schiestl FP, 1999, NATURE, V399, P421, DOI 10.1038/20829; Schiestl FP, 2000, J COMP PHYSIOL A, V186, P567, DOI 10.1007/s003590000112	10	157	159	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					625	626		10.1038/420625a	http://dx.doi.org/10.1038/420625a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478279				2022-12-24	WOS:000179751800031
J	Chen, LC; Thurston, G				Chen, LC; Thurston, G			World Trade Center cough	LANCET			English	Article									NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	New York University	Chen, LC (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.		Cjem, Lung-Chi/H-5030-2012	Chen, Lung Chi/0000-0003-1154-2107	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))			0	35	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S37	S38		10.1016/S0140-6736(02)11814-9	http://dx.doi.org/10.1016/S0140-6736(02)11814-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504497				2022-12-24	WOS:000180064500018
J	Murray, VSG; Bailey, MR; Spratt, BG				Murray, VSG; Bailey, MR; Spratt, BG			Depleted uranium: a new battlefield hazard	LANCET			English	Article									Guys & St Thomas Hosp NHS Trust, Chem Incident Response Serv, London SE14 5ER, England; Natl Radiol Protect Board, Dose Assessments Dept, Chilton, England; St Marys Hosp, Imperial Coll, Dept Infect Dis Epidemiol, London, England	Imperial College London	Murray, VSG (corresponding author), Guys & St Thomas Hosp NHS Trust, Chem Incident Response Serv, London SE14 5ER, England.		Spratt, Brian G/A-1676-2009					*ROYAL SOC, 2001, HLTH HAZ DEPL UR M 1; Royal Society, 2002, HLTH HAZ DEPL UR M 2; World Health Organization, 2001, DEPL UR SOURC EXP HL, P273	3	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S31	S32		10.1016/S0140-6736(02)11811-3	http://dx.doi.org/10.1016/S0140-6736(02)11811-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504494				2022-12-24	WOS:000180064500015
J	Holmberg, SD; Moorman, AC; Williamson, JM; Tong, TC; Ward, DJ; Wood, KC; Greenberg, AE; Janssen, RS				Holmberg, SD; Moorman, AC; Williamson, JM; Tong, TC; Ward, DJ; Wood, KC; Greenberg, AE; Janssen, RS		HOPS Investigators	Protease inhibitors and cardiovascular outcomes in patients with HIV-1	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; CORONARY-ARTERY DISEASE	Protease inhibitors for treatment of HIV-1 have been linked with increased risk of hyperlipidaemia and hyperglycaemia. In a cohort of 5672 outpatients with HIV-1 seen at nine US HIV clinics between January, 1993, and January, 2002, the frequency of myocardial infarctions increased after the introduction of protease inhibitors in 1996 (test for trend, p=0.0125). We noted that 19 of 3247 patients taking, but only two of 2425 who did not take, protease inhibitors had a myocardial infarction (odds ratio 7.1, 95% CI 1.6-44.3; Cox proportional hazards model-adjusted for smoking, sex, age, diabetes, hyperlipidaemia, and hypertension-hazard ratio 6.5, 0.9-47.8). Our findings suggest that, although infrequent, use of protease inhibitors is associated with increased risk of myocardial infarction in patients with HIV-1.	Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; Dupont Circle Phys Grp, Washington, DC USA; Cerner Corp, McLean, VA USA	Centers for Disease Control & Prevention - USA	Holmberg, SD (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.			Moorman, Anne/0000-0003-2411-2798				BARBARO G, 2002, 14 INT C AIDS BARC J; BOZZETTE SA, 2002, 9 C RETR OPP INF SEA; Henry K, 1998, LANCET, V351, P1328, DOI 10.1016/S0140-6736(05)79053-X; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Passalaris JD, 2000, CLIN INFECT DIS, V31, P787	5	362	380	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1747	1748		10.1016/S0140-6736(02)11672-2	http://dx.doi.org/10.1016/S0140-6736(02)11672-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480430				2022-12-24	WOS:000179636800014
J	Gallo, RC; Montagnier, L				Gallo, RC; Montagnier, L			Historical essay - Enhanced Prospects for the future	SCIENCE			English	Editorial Material							HIV-1; INHIBITION		Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; World Fdn AIDS Res & Prevent, F-75015 Paris, France	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gallo, RC (corresponding author), Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA.							Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Davis C, 2001, J HUMAN VIROL, V4, P113; Fouts T, 2002, P NATL ACAD SCI USA, V99, P11842, DOI 10.1073/pnas.182412199; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Heredia A, 2000, J ACQ IMMUN DEF SYND, V25, P246, DOI 10.1097/00126334-200011010-00006; Khanna KV, 2002, J CLIN INVEST, V109, P205; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; Moore JP, 1999, NAT MED, V5, P142, DOI 10.1038/5502; Palani A, 2002, J MED CHEM, V45, P3143, DOI 10.1021/jm0200815	9	14	19	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1730	1731		10.1126/science.1079864	http://dx.doi.org/10.1126/science.1079864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459577				2022-12-24	WOS:000179494800029
J	Olson, JW; Maier, RJ				Olson, JW; Maier, RJ			Molecular hydrogen as an energy source for Helicobacter pylori	SCIENCE			English	Article							TRANSIT-TIME; EXPRESSION; GENE; HINDGUT	The gastric pathogen Helicobacter pylori is known to be able to use molecular hydrogen as a respiratory substrate when grown in the laboratory. We found that hydrogen is available in the gastric mucosa of mice and that its use greatly increased the stomach colonization by H. pylori. Hydrogenase activity in H. pylori is constitutive but increased fivefold upon incubation with hydrogen. Hydrogen concentrations measured in the stomachs of live mice were found to be 10 to 50 times as high as the H. pylori affinity for hydrogen. A hydrogenase mutant strain is much less efficient in its colonization of mice. Therefore, hydrogen present in animals as a consequence of normal colonic. ora is an energy-yielding substrate that can facilitate the maintenance of a pathogenic bacterium.	Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.							BLACK LK, 1994, J BACTERIOL, V176, P7102, DOI 10.1128/JB.176.22.7102-7106.1994; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; BOND JH, 1975, J LAB CLIN MED, V85, P546; BROWN NJ, 1987, GUT, V28, P849, DOI 10.1136/gut.28.7.849; COLBEAU A, 1992, J BACTERIOL, V174, P4258, DOI 10.1128/JB.174.13.4258-4264.1992; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Ebert A, 1997, APPL ENVIRON MICROB, V63, P4039, DOI 10.1128/AEM.63.10.4039-4046.1997; KUENEN G, 1999, BIOL PROKARYOTES, pCH10; Lemke T, 2001, APPL ENVIRON MICROB, V67, P4657, DOI 10.1128/AEM.67.10.4657-4661.2001; Lenz O, 1997, J BACTERIOL, V179, P1655, DOI 10.1128/jb.179.5.1655-1663.1997; LEVITT MD, 1969, NEW ENGL J MED, V281, P122, DOI 10.1056/NEJM196907172810303; Maier RJ, 1996, FEMS MICROBIOL LETT, V141, P71; MCCRAE RE, 1978, BIOCHEM BIOPH RES CO, V80, P384, DOI 10.1016/0006-291X(78)90688-5; REYNOLDS DJ, 1994, MICROBIOL-UK, V140, P2649, DOI 10.1099/00221287-140-10-2649; Salyers A, 2002, BACTERIAL PATHOGENES; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; WOLIN MJ, 1994, ACETOGENESIS, pCH13; ZUKOWSKI MM, 1983, P NATL ACAD SCI-BIOL, V80, P1101, DOI 10.1073/pnas.80.4.1101; [No title captured]	19	229	247	4	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1788	1790		10.1126/science.1077123	http://dx.doi.org/10.1126/science.1077123			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459589				2022-12-24	WOS:000179494800045
J	Takano, J; Noguchi, K; Yasumori, M; Kobayashi, M; Gajdos, Z; Miwa, K; Hayashi, H; Yoneyama, T; Fujiwara, T				Takano, J; Noguchi, K; Yasumori, M; Kobayashi, M; Gajdos, Z; Miwa, K; Hayashi, H; Yoneyama, T; Fujiwara, T			Arabidopsis boron transporter for xylem loading	NATURE			English	Article							MEDIATED GENE-TRANSFER; SACCHAROMYCES-CEREVISIAE; BORIC-ACID; THALIANA MUTANT; PLANTS; TRANSLOCATION; PERMEABILITY; EXPRESSION; SUNFLOWER; MEMBRANE	Boron deficiency hampers the productivity of 132 crops in more than 80 countries(1). Boron is essential in higher plants primarily for maintaining the integrity of cell walls(2-4) and is also beneficial and might be essential in animals(5) and in yeast(6). Understanding the molecular mechanism(s) of boron transport is crucial for alleviating boron deficiency. Here we describe the molecular identification of boron transporters in biological systems. The Arabidopsis thaliana mutant bor1-1 is sensitive to boron deficiency(7,8). Uptake studies indicated that xylem loading is the key step for boron accumulation in shoots with a low external boron supply and that the bor1-1 mutant is defective in this process. Positional cloning identified BOR1 as a membrane protein with homology to bicarbonate transporters in animals. Moreover, a fusion protein of BOR1 and green fluorescent protein (GFP) localized to the plasma membrane in transformed cells. The promoter of BOR1 drove GFP expression in root pericycle cells. When expressed in yeast, BOR1 decreased boron concentrations in cells. We show here that BOR1 is an efflux-type boron transporter for xylem loading and is essential for protecting shoots from boron deficiency.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Fujiwara, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	MIWA, Kyoko/D-4220-2009; Khan, Raza/D-2130-2011; Noguchi, Kyotaro/B-4137-2013; FUJIWARA, Toru/A-4119-2011; Takano, Junpei/A-5255-2012	Khan, Raza/0000-0003-4622-8177; Takano, Junpei/0000-0002-7474-3101; Miwa, Kyoko/0000-0001-7328-3628				Alper SL, 2002, J NEPHROL, V15, pS41; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bennett A, 1999, J NUTR, V129, P2236, DOI 10.1093/jn/129.12.2236; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Dannel F, 1998, J PLANT PHYSIOL, V153, P615, DOI 10.1016/S0176-1617(98)80212-5; Dannel F, 2000, AUST J PLANT PHYSIOL, V27, P397; Dannel F, 2002, PLANT BIOLOGY, V4, P193, DOI 10.1055/s-2002-25730; DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Dordas C, 2001, BIOL TRACE ELEM RES, V81, P127, DOI 10.1385/BTER:81:2:127; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Gaymard F, 1998, CELL, V94, P647, DOI 10.1016/S0092-8674(00)81606-2; JEFFERSON RA, 1987, EMBO J, V6, P3901; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Nielsen FH, 2000, NUTRITION, V16, P512, DOI 10.1016/S0899-9007(00)00324-5; Noguchi K, 2000, J PLANT PHYSIOL, V156, P751, DOI 10.1016/S0176-1617(00)80242-4; Noguchi K, 1997, PLANT PHYSIOL, V115, P901, DOI 10.1104/pp.115.3.901; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; RAVEN JA, 1980, NEW PHYTOL, V84, P231, DOI 10.1111/j.1469-8137.1980.tb04424.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Soleimani M, 2002, J NEPHROL, V15, pS32; Stangoulis JCR, 2001, PLANTA, V213, P142, DOI 10.1007/s004250000484; Takano J, 2001, SOIL SCI PLANT NUTR, V47, P345, DOI 10.1080/00380768.2001.10408398; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yasumori M., 1999, Plant nutrition - molecular biology and genetics. Proceedings of the Sixth International Symposium on Genetics and Molecular Biology of Plant Nutrition, Elsinore, Denmark, 17-21 August 1998., P269; Zhao RM, 2001, AM J PHYSIOL-CELL PH, V281, pC33, DOI 10.1152/ajpcell.2001.281.1.C33	30	451	479	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2002	420	6913					337	340		10.1038/nature01139	http://dx.doi.org/10.1038/nature01139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447444				2022-12-24	WOS:000179340400047
J	Geissler, A; Chacinska, A; Truscott, KN; Wiedemann, N; Brandner, K; Sickmann, A; Meyer, HE; Meisinger, C; Pfanner, N; Rehling, P				Geissler, A; Chacinska, A; Truscott, KN; Wiedemann, N; Brandner, K; Sickmann, A; Meyer, HE; Meisinger, C; Pfanner, N; Rehling, P			The mitochondrial presequence translocase: An essential role of Tim50 in directing preproteins to the import channel	CELL			English	Article							PROTEIN IMPORT; INNER-MEMBRANE; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; SORTING SIGNAL; MATRIX HSP70; RECEPTORS; INTERACTS; COMPLEX; TIM23	Mitochondrial proteins with N-terminal targeting signals are transported across the inner membrane via the presequence translocase, which consists of membrane-integrated channel proteins and the matrix Hsp70 import motor. It has not been known how pre-proteins are directed to the import channel. We have identified the essential protein Tim50, which exposes its major domain to the intermembrane space. Tim50 interacts with preproteins in transit and directs them to the channel protein Tim23. Inactivation of Tim50 strongly inhibits the import of preproteins with a classical matrix-targeting signal, while preproteins carrying an additional inner membrane-sorting signal do not strictly depend on Tim50. Thus, Tim50 is crucial for guiding the precursors of matrix proteins to their insertion site in the inner membrane.	Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; Fak Biol, D-79104 Freiburg, Germany; Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	University of Freiburg; Ruhr University Bochum	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Sickmann, Albert/A-1010-2011; Truscott, Kaye/D-3362-2012; Pfanner, Nikolaus/AAV-7878-2021; Meisinger, Chris/J-1110-2014	Sickmann, Albert/0000-0002-2388-5265; Meisinger, Chris/0000-0002-8326-3548; Truscott, Kaye/0000-0002-5352-9835; Chacinska, Agnieszka/0000-0002-2832-2568; Wiedemann, Nils/0000-0001-8305-6728				Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; BLOM J, 1995, EUR J BIOCHEM, V232, P309, DOI 10.1111/j.1432-1033.1995.tb20813.x; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; GARTNER F, 1995, EMBO J, V14, P6043, DOI 10.1002/j.1460-2075.1995.tb00293.x; GARTNER F, 1995, J BIOL CHEM, V270, P3788; Geissler A, 2000, MOL BIOL CELL, V11, P3977, DOI 10.1091/mbc.11.11.3977; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; KUBRICH M, 1994, FEBS LETT, V349, P222, DOI 10.1016/0014-5793(94)00670-9; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ryan KR, 1998, MOL CELL BIOL, V18, P178, DOI 10.1128/MCB.18.1.178; RYAN KR, 1993, J BIOL CHEM, V268, P23743; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; Sickman A, 2002, J CHROMATOGR B, V771, P167, DOI 10.1016/S1570-0232(01)00626-2; Siniossoglou S, 2000, J BIOL CHEM, V275, P19352, DOI 10.1074/jbc.M001314200; SOLLNER T, 1991, METHOD CELL BIOL, V34, P345; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119	30	202	208	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2002	111	4					507	518		10.1016/S0092-8674(02)01073-5	http://dx.doi.org/10.1016/S0092-8674(02)01073-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437924	Bronze			2022-12-24	WOS:000179346900004
J	Patterson, RL; van Rossum, DB; Ford, DL; Hurt, KJ; Bae, SS; Suh, PG; Kurosaki, T; Snyder, SH; Gill, DL				Patterson, RL; van Rossum, DB; Ford, DL; Hurt, KJ; Bae, SS; Suh, PG; Kurosaki, T; Snyder, SH; Gill, DL			Phospholipase C-gamma is required for agonist-induced Ca2+ entry	CELL			English	Article							NECROTIC CELL-DEATH; TYROSINE PHOSPHORYLATION; STORE DEPLETION; TRPC3 CHANNELS; CALCIUM-ENTRY; RECEPTOR; PROTEIN; ACTIVATION; C-GAMMA-1; MECHANISM	We report here that PLC-gamma isoforms are required for agonist-induced Ca2+ entry (ACE). Overexpressed wild-type PLC-gamma1 or a lipase-inactive mutant PLC-gamma1 each augmented ACE in PC12 cells, while a deletion mutant lacking the region containing the SH3 domain of PLC-gamma1 was ineffective. RNA interference to deplete either PLC-gamma1 or PLC-gamma2 in PC12 and A7r5 cells inhibited ACE. In DT40 B lymphocytes expressing only PLC-gamma2, overexpressed muscarinic M5 receptors (M5R) activated ACE. Using DT40 PLC-gamma2 knockout cells, M5R stimulation of ER Ca2+ store release was unaffected, but ACE was abolished. Normal ACE was restored by transient expression of PLC-gamma2 or a lipase-inactive PLC-gamma2 mutant. The results indicate a lipase-independent role of PLC-gamma in the physiological agonist-induced activation of Ca2+ entry.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Pohang Univ Sci & Technol, Dept Life Sci, Kyungbuk 790784, South Korea; Kansai Med Univ, Dept Mol Genet, Moriguchi, Osaka 5708506, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Pohang University of Science & Technology (POSTECH); Kansai Medical University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Hurt, K. Joseph/J-8266-2019; Suh, Pann-Ghill/F-3610-2010; Kurosaki, Tomohiro/D-1306-2009	Hurt, K. Joseph/0000-0001-6906-350X; Kurosaki, Tomohiro/0000-0002-6352-304X; van Rossum, Damian/0000-0003-1011-2586	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL55426] Funding Source: Medline; NIDA NIH HHS [DA-00074] Funding Source: Medline; NIH HHS [NH65090] Funding Source: Medline; NIMH NIH HHS [MH-18501] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BREDT DS, 1989, BIOCHEM BIOPH RES CO, V159, P976, DOI 10.1016/0006-291X(89)92204-3; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FASOLATO C, 1993, J BIOL CHEM, V268, P20737; Fernando KC, 1997, BIOCHEM J, V328, P463; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Kim MJ, 2000, BIOCHEMISTRY-US, V39, P8674, DOI 10.1021/bi992558t; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kurosaki T, 2000, IMMUNOL REV, V176, P19; LIAO CF, 1989, J BIOL CHEM, V264, P7328; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; MONTELL C, 2001, PHYSL PHYLOGENY FUNC; NIKODIJEVIC B, 1994, CELL MOL NEUROBIOL, V14, P27, DOI 10.1007/BF02088587; Onofri F, 2000, J BIOL CHEM, V275, P29857, DOI 10.1074/jbc.M006018200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Puceat M, 1996, BIOCHEM J, V318, P723, DOI 10.1042/bj3180723; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 2001, J CELL SCI, V114, P2223; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; UFRETVINCENTY CA, 1995, J BIOL CHEM, V270, P26790, DOI 10.1074/jbc.270.45.26790; van de Water B, 1999, CHEM RES TOXICOL, V12, P943, DOI 10.1021/tx990054q; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; Venema VJ, 1998, BIOCHEM BIOPH RES CO, V246, P70, DOI 10.1006/bbrc.1998.8574; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	59	158	168	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2002	111	4					529	541		10.1016/S0092-8674(02)01045-0	http://dx.doi.org/10.1016/S0092-8674(02)01045-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437926	Bronze			2022-12-24	WOS:000179346900006
J	Du, XLL; Key, CR; Osborne, C; Mahnken, JD; Goodwin, JS				Du, XLL; Key, CR; Osborne, C; Mahnken, JD; Goodwin, JS			Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer	ANNALS OF INTERNAL MEDICINE			English	Article							OLDER WOMEN; CLINICAL GUIDELINES; CONSERVING SURGERY; RADIATION-THERAPY; LINKED MEDICARE; NATIONAL SURVEY; AGE; CARCINOMA; CARE; DETERMINANTS	Background: Although the efficacy of adjuvant chemotherapy in prolonging survival for women with breast cancer has been well documented, limited population-based information is available on the actual use of chemotherapy. Objective: To examine the relationship between age and chemotherapy use. Design: Cohort study. Setting: New Mexico. Patients: 5101 women 20 years of age or older receiving a diagnosis of stage 1, stage 11, or stage IIIA breast cancer from 1991 through 1997. Measurements: Pattern of chemotherapy use by age; logistic regression analysis to generate the odds and probabilities of receiving chemotherapy; and sensitivity analysis to estimate potential effects of unmeasured confounders. Results: Overall, 29% of women received chemotherapy. The rate of chemotherapy use for women with stage I, stage II, or stage IIIA breast cancer was 11%, 47%, and 68%, respectively. Across all tumor stages, the use of chemotherapy decreased substantially with increasing age (P < 0.001). overall, 66% of women younger than 45 years of age received chemotherapy compared with 44% of women between 50 and 54 years of age, 31% of women between 55 and 59 years of age, and 18% of women between 60 and 64 years of age. The decreasing pattern of chemotherapy use with age continued after adjustment for prognostic factors and was relatively insensitive to changes in unmeasured factors. Conclusions: There is considerable discrepancy between the 1990 National Institutes of Health Consensus Conference recommendations for chemotherapy administration in women with breast cancer and the actual use of chemotherapy in the community. The decrease in use with age may relate to the decreasing efficacy of chemotherapy with age, as reported in clinical trials. Outcomes studies should address whether the recommendations are overly aggressive or whether practicing oncologists are too conservative in their use of chemotherapy.	Univ Texas, Dept Internal Med, Med Branch, Galveston, TX 77555 USA; Univ New Mexico, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico	Du, XLL (corresponding author), Univ Texas, Dept Internal Med, Med Branch, 3-134 Jennie Sealy Hosp, Galveston, TX 77555 USA.	xdu@utmb.edu			NATIONAL CANCER INSTITUTE [R01CA090626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090626-02S1, R01 CA090626, R01 CA090626-03, R01 CA090626-04, R01-CA90626, R01-CA871773, R01 CA090626-02, R01 CA090626-01, R01 CA090626-03S1] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1985, JAMA-J AM MED ASSOC, V254, P3461; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1992, Lancet, V339, P1; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Carlson RW, 2000, ONCOLOGY-NY, V14, P33; CHRISTMAN K, 1992, JAMA-J AM MED ASSOC, V268, P57, DOI 10.1001/jama.268.1.57; CHU J, 1987, J GERONTOL, V42, P185, DOI 10.1093/geronj/42.2.185; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Du XL, 2001, CANCER-AM CANCER SOC, V92, P730, DOI 10.1002/1097-0142(20010815)92:4<730::AID-CNCR1376>3.0.CO;2-P; Du XL, 2001, J CLIN ONCOL, V19, P1455, DOI 10.1200/JCO.2001.19.5.1455; Du XL, 1999, J GERONTOL A-BIOL, V54, pM474, DOI 10.1093/gerona/54.9.M474; Du XLL, 2002, J CLIN ONCOL, V20, P4636, DOI 10.1200/JCO.2002.05.088; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Field MJ., 1992, GUIDELINES CLIN PRAC; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Fisher B, 1999, CA-CANCER J CLIN, V49, P159, DOI 10.3322/canjclin.49.3.159; FISHER B, 1998, LANCET, V352, P930; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; GOODWIN JS, 1988, ARCH INTERN MED, V148, P2258, DOI 10.1001/archinte.148.10.2258; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; GREENLAND S, 1998, EPIDEMIOLOGY, P343; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; HOSMER DW, 2000, WILEY PS TX, P1; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; MANN BA, 1988, JAMA-J AM MED ASSOC, V259, P3413; MUSS HB, 1994, CANCER, V74, P2165, DOI 10.1002/1097-0142(19941001)74:7+<2165::AID-CNCR2820741727>3.0.CO;2-6; MUSS HB, 1995, SEMIN ONCOL, V22, P14; National Cancer Institute, 1994, NIH PUBLICATION; NERENZ DR, 1986, HEALTH SERV RES, V20, P961; *NEW MEX TUM REG, 2002, NEW MEX TUM REG; OSTEEN RT, 1994, J AM COLL SURGEONS, V178, P213; POTOSKY AL, 1993, MED CARE, V31, P732; RIES LA, 1997, NIH PUBLICAITON; RIES LAG, 1997, NIH PUBLICATION; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; *STEER COMM CLIN P, 1998, CAN MED ASSOC J S, V158, pS52; *STEER COMM CLIN P, 1998, CAN MED ASSOC J S, V158, pS43; WETLE T, 1987, JAMA-J AM MED ASSOC, V258, P516, DOI 10.1001/jama.1987.03400040114035; WILSON RE, 1984, SURG GYNECOL OBSTET, V159, P309; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; [No title captured]	46	81	82	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					90	97		10.7326/0003-4819-138-2-200301210-00009	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529090	Green Accepted			2022-12-24	WOS:000181018300002
J	Bonifati, V; Rizzu, P; van Baren, MJ; Schaap, O; Breedveld, GJ; Krieger, E; Dekker, MCJ; Squitieri, F; Ibanez, P; Joosse, M; van Dongen, JW; Vanacore, N; van Swieten, JC; Brice, A; Meco, G; van Duijn, CM; Oostra, BA; Heutink, P				Bonifati, V; Rizzu, P; van Baren, MJ; Schaap, O; Breedveld, GJ; Krieger, E; Dekker, MCJ; Squitieri, F; Ibanez, P; Joosse, M; van Dongen, JW; Vanacore, N; van Swieten, JC; Brice, A; Meco, G; van Duijn, CM; Oostra, BA; Heutink, P			Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism	SCIENCE			English	Article							ALPHA; LOCALIZATION; PROTEIN; STRESS	The DJ-1 gene encodes a ubiquitous, highly conserved protein. Here, we show that DJ-1 mutations are associated with PARK7, a monogenic form of human parkinsonism. The function of the DJ-1 protein remains unknown, but evidence suggests its involvement in the oxidative stress response. Our findings indicate that loss of DJ-1 function leads to neurodegeneration. Elucidating the physiological role of DJ-1 protein may promote understanding of the mechanisms of brain neuronal maintenance and pathogenesis of Parkinson's disease.	Erasmus MC, Dept Epidemiol & Biostat, Dept Clin Genet, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy; Univ Med Ctr Nijmegen, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; IRCCS INM Neuromed, Neurogenet Unit, I-86077 Pozzilli, Italy; Hop La Pitie Salpetriere, INSERM, U289, F-75013 Paris, France; Natl Inst Hlth, Epidemiol & Biostat Lab, I-00161 Rome, Italy; Erasmus MC, Dept Neurol, NL-3015 GD Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Sapienza University Rome; Radboud University Nijmegen; IRCCS Neuromed; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Istituto Superiore di Sanita (ISS); Erasmus University Rotterdam; Erasmus MC	Bonifati, V (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, Dept Clin Genet, Genet Epidemiol Unit, POB 1738, NL-3000 DR Rotterdam, Netherlands.	bonifati@kgen.fgg.eur.nl; heutink@kgen.fgg.eur.nl	brice, alexis/AAE-8275-2019; Squitieri, Ferdinando/N-1852-2019; Brice, Alexis/A-2170-2009; Longo, Kenneth A/A-5631-2010	brice, alexis/0000-0002-0941-3990; Squitieri, Ferdinando/0000-0002-7397-1727; van Swieten, John/0000-0001-6278-6844; Van Duijn, Cornelia/0000-0002-2374-9204; Heutink, Peter/0000-0001-5218-1737				Bonifati V, 2002, ANN NEUROL, V51, P253, DOI 10.1002/ana.10106; de Nobel H, 2001, YEAST, V18, P1413, DOI 10.1002/yea.793; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Giasson BI, 2002, FREE RADICAL BIO MED, V32, P1264, DOI 10.1016/S0891-5849(02)00804-3; Hashimoto M, 2002, J BIOL CHEM, V277, P11465, DOI 10.1074/jbc.M111428200; Hod Y, 1999, J CELL BIOCHEM, V72, P435, DOI 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.0.CO;2-H; Hyun DH, 2002, J BIOL CHEM, V277, P28572, DOI 10.1074/jbc.M200666200; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Van Duijn CM, 2001, AM J HUM GENET, V69, P505; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V	20	2009	2098	6	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					256	259		10.1126/science.1077209	http://dx.doi.org/10.1126/science.1077209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12446870				2022-12-24	WOS:000180284000041
J	Jiang, N; Bao, ZR; Zhang, XY; Hirochika, H; Eddy, SR; McCouch, SR; Wessler, SR				Jiang, N; Bao, ZR; Zhang, XY; Hirochika, H; Eddy, SR; McCouch, SR; Wessler, SR			An active DNA transposon family in rice	NATURE			English	Article							ELEMENTS; MAIZE; INSERTION; HEARTBREAKER; SEQUENCES; REVEALS	The publication of draft sequences for the two subspecies of Oryza sativa (rice), japonica (cv. Nipponbare) and indica (cv. 93-11)(1,2), provides a unique opportunity to study the dynamics of transposable elements in this important crop plant. Here we report the use of these sequences in a computational approach to identify the first active DNA transposons from rice and the first active miniature inverted-repeat transposable element (MITE) from any organism. A sequence classified as a Tourist-like MITE of 430 base pairs, called miniature Ping (mPing), was present in about 70 copies in Nipponbare and in about 14 copies in 93-11. These mPing elements, which are all nearly identical, transpose actively in an indica cell-culture line. Database searches identified a family of related transposase-encoding elements (called Pong), which also transpose actively in the same cells. Virtually all new insertions of mPing and Pong elements were into low-copy regions of the rice genome. Since the domestication of rice mPing MITEs have been amplified preferentially in cultivars adapted to environmental extremes-a situation that is reminiscent of the genomic shock theory for transposon activation(3).	Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 305, Japan; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); National Institute of Agrobiological Sciences - Japan; Cornell University	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.		Jiang, Ning/G-6546-2012	Eddy, Sean/0000-0001-6676-4706				Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Burr B, 2002, PLANT CELL, V14, P521, DOI 10.1105/tpc.140310; Casa AM, 2000, P NATL ACAD SCI USA, V97, P10083, DOI 10.1073/pnas.97.18.10083; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gautam R. K., 2014, RICE GENET NEWSL, V19, P136; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kushibuchi K., 1997, SCI RICE PLANT, V3, P837; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; MORISHIMA H, 1981, JPN J BREED, V31, P402; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; Tarchini R, 2000, PLANT CELL, V12, P381, DOI 10.1105/tpc.12.3.381; Ting Y., 1957, ACTA AGRON SIN, V8, P243; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; UENO K, 1988, Bulletin of the Institute for Agricultural Research Tohoku University, V39, P43; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; WANG ZY, 1992, THEOR APPL GENET, V83, P565, DOI 10.1007/BF00226900; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	30	333	365	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					163	167		10.1038/nature01214	http://dx.doi.org/10.1038/nature01214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520302				2022-12-24	WOS:000180267200040
J	Kramer, KL; Barnette, JE; Yost, HJ				Kramer, KL; Barnette, JE; Yost, HJ			PKC gamma regulates syndecan-2 inside-out signaling during Xenopus left-right development	CELL			English	Article							PROTEIN-KINASE-C; LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; MUTANT MICE; IN-VIVO; PHOSPHORYLATION; DOMAIN; EXPRESSION; GENE; PROTEOGLYCAN	The transmembrane proteoglycan syndecan-2 cell nonautonomously regulates left-right (LR) development in migrating mesoderm by an unknown mechanism, leading to LR asymmetric gene expression and LR orientation of the heart and gut. Here, we demonstrate that protein kinase C gamma (PKCgamma) mediates phosphorylation of the cytoplasmic domain of syndecan-2 in right, but not left, animal cap ectodermal cells. Notably, both phosphorylation states of syndecan-2 are obligatory for normal LR development, with PKCgamma-dependent phosphorylated syndecan-2 in right ectodermal cells and nonphosphorylated syndecan-2 in left cells. The ectodermal cells contact migrating mesodermal cells during early gastrulation, concurrent with the transmission of LR information. This precedes the appearance of monocilia and is one of the earliest steps of LR development. These results demonstrate that PKCgamma regulates the cytoplasmic phosphorylation of syndecan-2 and, consequently, syndecan-2-mediated inside-out signaling to adjacent cells.	Univ Utah, Huntsman Canc Inst, Ctr Children, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Yost, HJ (corresponding author), Univ Utah, Huntsman Canc Inst, Ctr Children, Dept Oncol Sci, 2000 Circle Hope, Salt Lake City, UT 84112 USA.							ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; BAUER DV, 1994, DEVELOPMENT, V120, P1179; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; FREISEWINKEL I, 1991, FEBS LETT, V280, P262, DOI 10.1016/0014-5793(91)80307-O; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; MARYNEN P, 1989, J BIOL CHEM, V264, P7017; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; OTTE AP, 1991, SCIENCE, V251, P570, DOI 10.1126/science.1990433; Pauken CM, 2000, DEV BIOL, V223, P411, DOI 10.1006/dbio.2000.9763; Prasthofer T, 1995, BIOCHEM MOL BIOL INT, V36, P793; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; Teel AL, 1996, MECH DEVELOP, V59, P115, DOI 10.1016/0925-4773(96)00584-9; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Ward KW, 1998, REPROD TOXICOL, V12, P525, DOI 10.1016/S0890-6238(98)00032-X; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; YOST HJ, 1995, CELL, V82, P689, DOI 10.1016/0092-8674(95)90464-6; YOST HJ, 1992, NATURE, V357, P158, DOI 10.1038/357158a0; YOST HJ, 1991, CIBA F SYMP, V162, P165	41	86	87	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					981	990		10.1016/S0092-8674(02)01200-X	http://dx.doi.org/10.1016/S0092-8674(02)01200-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507425	Bronze			2022-12-24	WOS:000180086000008
J	Picard, F; Gehin, M; Annicotte, JS; Rocchi, S; Champy, MF; O'Malley, BW; Chambon, P; Auwerx, J				Picard, F; Gehin, M; Annicotte, JS; Rocchi, S; Champy, MF; O'Malley, BW; Chambon, P; Auwerx, J			SRC-1 and TIF2 control energy balance between white and brown adipose tissues	CELL			English	Article							ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEAR RECEPTORS; MESSENGER-RNA; LIGAND; MOUSE; ALPHA	We have explored the effects of two members of the p160 coregulator family on energy homeostasis. TIF2-/- mice are protected against obesity and display enhanced adaptive thermogenesis, whereas SRC-1-/- mice are prone to obesity due to reduced energy expenditure. In white adipose tissue, lack of TIF2 decreases PPARgamma activity and reduces fat accumulation, whereas in brown adipose tissue it facilitates the interaction between SRC-1 and PGC-1alpha, which induces PGC-1alpha's thermogenic activity. Interestingly, a high-fat diet increases the TIF2/SRC-1 expression ratio, which may contribute to weight gain. These results reveal that the relative level of TIF2/SRC-1 can modulate energy metabolism.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Inst Clin Souris Genopole Strasbourg, F-67404 Illkirch Graffenstaden, France; Baylor Coll Med, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine	Auwerx, J (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.		Auwerx, Johan/ABE-9307-2021; Rocchi, Stephane/O-4152-2016; Annicotte, Jean-Sébastien/H-4641-2018	Rocchi, Stephane/0000-0002-0943-1304; Annicotte, Jean-Sébastien/0000-0002-2109-4849; Auwerx, Johan/0000-0002-5065-5393	NIDDK NIH HHS [1-P01-DK59820-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Arvaniti K, 1998, ENDOCRINOLOGY, V139, P4000, DOI 10.1210/en.139.9.4000; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; Choi DS, 1997, DEVELOPMENT, V124, P1745; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Glass CK, 2000, GENE DEV, V14, P121; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GUEZENNEC CY, 1988, EUR J APPL PHYSIOL O, V57, P114, DOI 10.1007/BF00691249; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; LARSEN ML, 1993, CURR OPIN LIPIDOL, V4, P34, DOI 10.1097/00041433-199302000-00007; Lefebvre AM, 1997, ARTERIOSCL THROM VAS, V17, P1756, DOI 10.1161/01.ATV.17.9.1756; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MARETTE A, 1991, AM J PHYSIOL, V261, pE204, DOI 10.1152/ajpendo.1991.261.2.E204; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Reginato MJ, 1998, J BIOL CHEM, V273, P32679, DOI 10.1074/jbc.273.49.32679; Richard D, 2002, INT J OBESITY, V26, P344, DOI 10.1038/sj.ijo.0801873; RICHARD D, 1992, AM J PHYSIOL, V262, pR921, DOI 10.1152/ajpregu.1992.262.5.R921; RICQUIER D, 1979, FEBS LETT, V101, P35, DOI 10.1016/0014-5793(79)81289-2; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shao G, 2000, MOL ENDOCRINOL, V14, P1198, DOI 10.1210/me.14.8.1198; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trayhurn P, 1996, BIOCHEM SOC T, V24, P565, DOI 10.1042/bst0240565; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Weiss RE, 2002, ENDOCRINOLOGY, V143, P1554, DOI 10.1210/en.143.4.1554; Xu JJ, 1998, ELECTROCHEM SOLID ST, V1, P1, DOI 10.1149/1.1390615; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829	50	351	367	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					931	941		10.1016/S0092-8674(02)01169-8	http://dx.doi.org/10.1016/S0092-8674(02)01169-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507421	Bronze			2022-12-24	WOS:000180086000004
J	Wolpert, L; Szathmary, E				Wolpert, L; Szathmary, E			Multicellularity: Evolution and the egg	NATURE			English	Editorial Material									UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1014 Budapest, Hungary; Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary	University of London; University College London; Eotvos Lorand University	Wolpert, L (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.		Szathmary, Eors/AAS-1202-2021; Szathmáry, Eörs/A-5007-2011	Szathmary, Eors/0000-0001-5227-2997; 				BONNER JT, 2002, 1 SIGNALS EVOLUTION; HAMMERSTEIN P, IN PRESS DAHL WORKSH, V90; Kaiser D, 2001, ANNU REV GENET, V35, P103, DOI 10.1146/annurev.genet.35.102401.090145; Kerszberg M, 1998, J THEOR BIOL, V193, P535, DOI 10.1006/jtbi.1998.0714; Smith J. M., 1995, MAJOR TRANSITIONS EV	5	59	59	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					745	745		10.1038/420745a	http://dx.doi.org/10.1038/420745a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490925	Bronze			2022-12-24	WOS:000179897300033
J	Myat, MM; Andrew, DJ				Myat, MM; Andrew, DJ			Epithelial tube morphology is determined by the polarized growth and delivery of apical membrane	CELL			English	Article							DROSOPHILA SALIVARY-GLAND; GENE-EXPRESSION; NUCLEAR MIGRATION; HAIRY; PROTEIN; CELL; MORPHOGENESIS; SEGMENTATION; CRUMBS; MELANOGASTER	Formation of tubes of the correct size and shape is essential for viability of most organisms, yet little is understood of the mechanisms controlling tube morphology. We identified a new allele of hairy in a mutagenesis screen and showed that hairy mutations cause branching and bulging of the normally unbranched salivary tube, in part through prolonged expression of huckebein (hkb). HKB controls polarized cell shape change and apical membrane growth during salivary cell invagination via two downstream target genes, crumbs (crb), a determinant of the apical membrane, and klarsicht (klar), which mediates microtubule-dependent organelle transport. In invaginating salivary cells, crb and klar mediate growth and delivery of apical membrane, respectively, thus regulating the size and shape of the salivary tube.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Andrew, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.				NIDCR NIH HHS [R01DE13899] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013899] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5; Andrew DJ, 1997, DEVELOPMENT, V124, P181; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bowes RC, 1999, J CELL PHYSIOL, V180, P81, DOI 10.1002/(SICI)1097-4652(199907)180:1<81::AID-JCP9>3.0.CO;2-J; Bradley PL, 2001, BIOESSAYS, V23, P901, DOI 10.1002/bies.1131; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; CARROLL SB, 1988, GENE DEV, V2, P883, DOI 10.1101/gad.2.7.883; CARROLL SB, 1986, NATURE, V323, P278, DOI 10.1038/323278a0; Clark IE, 1997, DEVELOPMENT, V124, P461; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; GINIGER E, 1993, DEVELOPMENT, V117, P431; Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250; Henderson KD, 2000, DEV BIOL, V217, P362, DOI 10.1006/dbio.1999.9560; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HOOPER KL, 1989, DEVELOPMENT, V107, P489; HOWARD K, 1986, CELL, V44, P949, DOI 10.1016/0092-8674(86)90018-8; INGHAM PW, 1985, GENETICS, V111, P463; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; LEHMANN R, 1994, DROSOPHILA MELANOGAS, P755; Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Myat MM, 2000, DEVELOPMENT, V127, P679; Myat MM, 2000, DEVELOPMENT, V127, P4217; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; ORENIC TV, 1993, DEVELOPMENT, V118, P9; PARKHURST SM, 1990, CELL, V63, P1179, DOI 10.1016/0092-8674(90)90414-A; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; REUTER R, 1990, DEVELOPMENT, V110, P1031; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	41	101	101	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					879	891		10.1016/S0092-8674(02)01140-6	http://dx.doi.org/10.1016/S0092-8674(02)01140-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526813	Bronze			2022-12-24	WOS:000179862600013
J	van de Put, W				van de Put, W			Addressing mental health in Afghanistan	LANCET			English	Article									HealthNet Int, NL-1062 GL Amsterdam, Netherlands		van de Put, W (corresponding author), HealthNet Int, Maassluisstr 258, NL-1062 GL Amsterdam, Netherlands.								0	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S41	S42		10.1016/S0140-6736(02)11816-2	http://dx.doi.org/10.1016/S0140-6736(02)11816-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	629TG	12504499				2022-12-24	WOS:000180064500020
J	Gabbiani, F; Krapp, HG; Koch, C; Laurent, G				Gabbiani, F; Krapp, HG; Koch, C; Laurent, G			Multiplicative computation in a visual neuron sensitive to looming	NATURE			English	Article							SIGNALING IMPENDING COLLISION; OBJECT APPROACH; WIDE-FIELD; MOTION; ORGANIZATION; THRESHOLD; VARIABLES; CIRCUIT; LOCUST	Multiplicative operations are important in sensory processing(1-5), but their biophysical implementation remains largely unknown(5-10). We investigated an identified neuron ( the lobula giant movement detector, LGMD, of locusts) whose output firing rate in response to looming visual stimuli has been described by two models, one of which involves a multiplication. In this model, the LGMD multiplies postsynaptically two inputs ( one excitatory, one inhibitory) that converge onto its dendritic tree(11,12); in the other model, inhibition is presynaptic to the LGMD(13,14). By using selective activation and inactivation of pre- and postsynaptic inhibition, we show that postsynaptic inhibition has a predominant role, suggesting that multiplication is implemented within the neuron itself. Our pharmacological experiments and measurements of firing rate versus membrane potential also reveal that sodium channels act both to advance the response of the LGMD in time and to map membrane potential to firing rate in a nearly exponential manner. These results are consistent with an implementation of multiplication based on dendritic subtraction of two converging inputs encoded logarithmically, followed by exponentiation through active membrane conductances.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	California Institute of Technology; Baylor College of Medicine; University of Cambridge	Gabbiani, F (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.		Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gabbiani F, 2001, J NEUROSCI, V21, P314, DOI 10.1523/JNEUROSCI.21-01-00314.2001; GALANT AR, 1987, NONLINEAR STAT MODEL; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; KOCH C, 1995, J COMPUT NEUROSCI, V2, P63, DOI 10.1007/BF00962708; Koch C., 1998, BIOPHYSICS COMPUTATI; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mead C.A., 1989, ANALOG VLSI NEURAL S; OSHEA M, 1975, NATURE, V254, P53, DOI 10.1038/254053a0; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; RAUH JJ, 1990, TRENDS PHARMACOL SCI, V11, P325, DOI 10.1016/0165-6147(90)90236-2; REICHARDT W, 1957, Z NATURFORSCH PT B, V12, P448, DOI 10.1515/znb-1957-0707; Rind FC, 1998, J COMP NEUROL, V395, P405; Rind FC, 1996, J NEUROPHYSIOL, V75, P967, DOI 10.1152/jn.1996.75.3.967; Rind FC, 1996, J NEUROPHYSIOL, V75, P986, DOI 10.1152/jn.1996.75.3.986; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; ROBERTSON RM, 1993, NATURWISSENSCHAFTEN, V80, P176, DOI 10.1007/BF01226378; Rowell C.H.F., 1974, P87; ROWELL CHF, 1977, J EXP BIOL, V68, P157; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329; Wicklein M, 2000, J COMP NEUROL, V424, P356; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; Zanker JM, 1999, BIOL CYBERN, V80, P109, DOI 10.1007/s004220050509	30	269	270	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					320	324		10.1038/nature01190	http://dx.doi.org/10.1038/nature01190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447440				2022-12-24	WOS:000179340400043
J	Chen, WY; Colditz, GA; Rosner, B; Hankinson, SE; Hunter, DJ; Manson, JE; Stampfer, MJ; Willett, WC; Speizer, FE				Chen, WY; Colditz, GA; Rosner, B; Hankinson, SE; Hunter, DJ; Manson, JE; Stampfer, MJ; Willett, WC; Speizer, FE			Use of postmenopausal hormones, alcohol, and risk for invasive breast cancer	ANNALS OF INTERNAL MEDICINE			English	Article							REPLACEMENT THERAPY; BEVERAGE CONSUMPTION; MEASUREMENT ERROR; WOMEN; ESTROGENS	Background: Physiologic evidence suggests that use of alcohol increases the risk for breast cancer through a hormonal mechanism, but the relationship among breast cancer, alcohol, and postmenopausal hormones (PMH) remains unclear. Objective: To examine the relation between concurrent use of alcohol and PMH and invasive breast cancer. Design: Prospective cohort study Setting: Nurses' Health Study. Participants: 44187 postmenopausal women. Measurements: Self-reported data on PMH use and breast cancer obtained from biennial questionnaires completed from 1980 to 1994 and average alcohol consumption in 1980, 1984, 1986, and 1990. Results: 1722 women developed invasive breast cancer. Risk for breast cancer was elevated in women who currently used PMH for 5 or more years and did not drink alcohol (relative risk, 1.32 [95% CI, 1.05 to 1.66]) and those who never used PMH but drank 20 or more g (1.5 to 2 drinks) of alcohol daily (relative risk, 1.28 [Cl, 0.97 to 1.69]). Current users of PMH for 5 or more years who consumed 20 or more g of alcohol daily had a relative risk for breast cancer nearly twice (1.99 [Cl, 1.42 to 2.79]) that of non-drinking nonusers of PMH. A hypothetical postmenopausal woman whose lifetime risk for breast cancer is 4% could increase her risk to 8% with 5 or more years of current PMH use and consumption of more than one alcoholic drink daily. Conclusions: Both alcohol consumption and PMH use were associated with an increased incidence of breast cancer. Women who are currently taking PMH may want to consider the added risks of regular alcohol consumption.	Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Chen, WY (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [5-R25-CA577011-08, CA40356] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; Dawson D A, 1995, J Subst Abuse, V7, P331, DOI 10.1016/0899-3289(95)90026-8; Flanders W D, 1990, Epidemiology, V1, P239, DOI 10.1097/00001648-199005000-00010; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GAPSTUR SM, 1992, AM J EPIDEMIOL, V136, P1221, DOI 10.1093/oxfordjournals.aje.a116430; Ginsburg ES, 1996, JAMA-J AM MED ASSOC, V276, P1747, DOI 10.1001/jama.276.21.1747; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HARVEY EB, 1987, J NATL CANCER I, V78, P657; LONGNECKER MP, 1995, CANCER EPIDEM BIOMAR, V4, P721; LONGNECKER MP, 1994, CANCER CAUSE CONTROL, V5, P73, DOI 10.1007/BF01830729; MIDANIK LT, 1994, AM J PUBLIC HEALTH, V84, P1218, DOI 10.2105/AJPH.84.8.1218; NEWCOMB PA, 1995, AM J EPIDEMIOL, V142, P788, DOI 10.1093/oxfordjournals.aje.a117717; PAGANINIHILL A, 1983, LANCET, V2, P626; Pike MC, 1998, AM J EPIDEMIOL, V147, P718; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; Rockhill B, 2000, AM J EPIDEMIOL, V151, P404; ROSENBERG L, 1990, AM J EPIDEMIOL, V131, P6, DOI 10.1093/oxfordjournals.aje.a115486; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; Rosner BA, 1996, STAT MED, V15, P293, DOI 10.1002/(SICI)1097-0258(19960215)15:3<293::AID-SIM166>3.0.CO;2-E; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; *USDA, 1997, USDA NUTR DAT STAND; WILLIAMS GD, 1992, BRIT J ADDICT, V87, P643; WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525	28	67	68	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 19	2002	137	10					798	804		10.7326/0003-4819-137-10-200211190-00008	http://dx.doi.org/10.7326/0003-4819-137-10-200211190-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616VE	12435216				2022-12-24	WOS:000179323400003
J	Warhurst, DC; Craig, JC; Adagu, IS				Warhurst, DC; Craig, JC; Adagu, IS			Lysosomes and drug resistance in malaria	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; CHLOROQUINE RESISTANCE; MOLECULAR MARKER		Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco	Warhurst, DC (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.		warhurst, david c/C-3428-2013					Bray PG, 1996, MOL PHARMACOL, V50, P1559; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1970, SCIENCE, V169, P289, DOI 10.1126/science.169.3942.289; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; KIRSCH GE, 1995, BIOPHYS J, V68, P1804, DOI 10.1016/S0006-3495(95)80357-7; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; MARTINEY JA, 1991, J EXP MED, V173, P961; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Warhurst DC, 2001, NEW ENGL J MED, V344, P299, DOI 10.1056/NEJM200101253440411; WARHURST DC, 2002, COST B9 M ANT CHEM L; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; ZHANG H, 2002, J BIOL CHEM     0925	18	52	52	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 16	2002	360	9345					1527	1529		10.1016/S0140-6736(02)11577-7	http://dx.doi.org/10.1016/S0140-6736(02)11577-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443586				2022-12-24	WOS:000179292400004
J	Lahann, J; Mitragotri, S; Tran, TN; Kaido, H; Sundaram, J; Choi, IS; Hoffer, S; Somorjai, GA; Langer, R				Lahann, J; Mitragotri, S; Tran, TN; Kaido, H; Sundaram, J; Choi, IS; Hoffer, S; Somorjai, GA; Langer, R			A reversibly switching surface	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SUM-FREQUENCY GENERATION; IN-SITU STRUCTURE; GOLD ELECTRODES; ACTIVE CONTROL; NUCLEIC-ACIDS; FORCE-FIELD; CONTACT; SPECTROSCOPY; INTERFACE		MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Chem, Div Mat Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Langer, R (corresponding author), MIT, Dept Chem Engn, 45 Carleton St, Cambridge, MA 02139 USA.	rlanger@mit.edu	Lahann, Joerg/J-7663-2013; CHOI, INSUNG S./C-1592-2011					ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Abbott S, 1999, LANGMUIR, V15, P8923, DOI 10.1021/la990558o; ABRAHAM MH, 1984, J CHEM SOC FARAD T 1, V80, P153, DOI 10.1039/f19848000153; ANDERSON MR, 1994, LANGMUIR, V10, P1638, DOI 10.1021/la00018a002; Aydogan N, 1999, LANGMUIR, V15, P722, DOI 10.1021/la9807208; Baldelli S, 1999, J PHYS CHEM B, V103, P8920, DOI 10.1021/jp991649x; Byloos M, 2001, J PHYS CHEM B, V105, P5900, DOI 10.1021/jp003066p; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; CHEN YL, 1991, J PHYS CHEM-US, V95, P10736, DOI 10.1021/j100179a041; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crevoisier GB, 1999, SCIENCE, V285, P1246, DOI 10.1126/science.285.5431.1246; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; EVERETT WR, 1995, ANAL CHIM ACTA, V307, P253, DOI 10.1016/0003-2670(95)00004-J; FINKLEA HO, 1987, LANGMUIR, V3, P409, DOI 10.1021/la00075a024; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; HAUTMAN J, 1989, J CHEM PHYS, V91, P4994, DOI 10.1063/1.457621; HINES MA, 1995, LANGMUIR, V11, P493, DOI 10.1021/la00002a022; IANNELLI A, 1994, J ELECTROANAL CHEM, V376, P49, DOI 10.1016/0022-0728(94)03463-X; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; LAIBINIS PE, 1995, J PHYS CHEM-US, V99, P7663, DOI 10.1021/j100019a054; Li TW, 1998, J PHYS CHEM B, V102, P2935, DOI 10.1021/jp980049f; NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2; ONG TH, 1993, LANGMUIR, V9, P1836, DOI 10.1021/la00031a035; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; Schoenfisch MH, 1999, LANGMUIR, V15, P509, DOI 10.1021/la9811618; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Shimazu K, 2002, J AM CHEM SOC, V124, P652, DOI 10.1021/ja004091b; STOLE SM, 1990, LANGMUIR, V6, P1199, DOI 10.1021/la00096a029; TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013; WILSON MD, 1988, J AM CHEM SOC, V110, P8718, DOI 10.1021/ja00234a035; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Zamborini FP, 1998, LANGMUIR, V14, P3279, DOI 10.1021/la971121o	34	968	1010	13	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					371	374		10.1126/science.1078933	http://dx.doi.org/10.1126/science.1078933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532011				2022-12-24	WOS:000180426800038
J	Lee, JY; Yoo, BC; Rojas, MR; Gomez-Ospina, N; Staehelin, LA; Lucas, WJ				Lee, JY; Yoo, BC; Rojas, MR; Gomez-Ospina, N; Staehelin, LA; Lucas, WJ			Selective trafficking of non-cell-autonomous proteins mediated by NtNCAPP1	SCIENCE			English	Article							TOBACCO MOSAIC-VIRUS; TO-CELL; MOVEMENT PROTEIN; MESSENGER-RNA; PLASMODESMATA; TRANSPORT; IDENTIFICATION; NUCLEAR; PHLOEM; LEAFY	In plants, cell-to-cell communication is mediated by plasmodesmata and involves the trafficking of non cell-autonomous proteins (NCAPs). A component in this pathway, Nicotiana tabacum NON-CELL-AUTONOMOUS PATHWAY PROTEIN1 (NtNCAPP1), was affinity purified and cloned. Protein overlay assays and in vivo studies showed that NtNCAPP1 is located on the endoplasmic reticulum at the cell periphery and displays specificity in its interaction with NCAPs. Deletion of the NtNCAPP1 amino-terminal transmembrane domain produced a dominant-negative mutant that blocked the trafficking of specific NCAPs. Transgenic tobacco plants expressing this mutant form of NtNCAPP1 and plants in which the NtNCAPP1 gene was silenced were compromised in their ability to regulate leaf and oral development. These results support a model in which NCAP delivery to plasmodesmata is both selective and regulated.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA; Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder	Lucas, WJ (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.			Gomez-Ospina, Natalia/0000-0002-6740-1154; Lee, Jung-Youn/0000-0003-4604-7974; Staehelin, Andrew/0000-0002-0611-4346; Lee, Jinkee/0000-0001-5590-0549	NIGMS NIH HHS [GM18639] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahearn KP, 2001, PLANT CELL PHYSIOL, V42, P1130, DOI 10.1093/pcp/pce143; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; Citovsky V, 1999, PHILOS T ROY SOC B, V354, P637, DOI 10.1098/rstb.1999.0415; DING BA, 1995, VIROLOGY, V207, P345, DOI 10.1006/viro.1995.1093; FUJIWARA T, 1993, PLANT CELL, V5, P1783, DOI 10.1105/tpc.5.12.1783; Haywood V, 2002, PLANT CELL, V14, pS303, DOI 10.1105/tpc.000778; Kragler F, 2000, EMBO J, V19, P2856, DOI 10.1093/emboj/19.12.2856; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; Li QB, 2001, MOL PLANT MICROBE IN, V14, P378, DOI 10.1094/MPMI.2001.14.3.378; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; ROBARDS AW, 1990, ANNU REV PLANT PHYS, V41, P369, DOI 10.1146/annurev.pp.41.060190.002101; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; TURNER A, 1994, J CELL SCI, V107, P3351; WAIGMANN E, 1994, P NATL ACAD SCI USA, V91, P1433, DOI 10.1073/pnas.91.4.1433; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; WU X, 2002, GENE DEV, V6, P151; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	21	127	136	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					392	396		10.1126/science.1077813	http://dx.doi.org/10.1126/science.1077813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532017				2022-12-24	WOS:000180426800045
J	Visser, K; Thunell, R; Stott, L				Visser, K; Thunell, R; Stott, L			Magnitude and timing of temperature change in the Indo-Pacific warm pool during deglaciation	NATURE			English	Article							CLIMATE-CHANGE; TROPICAL PACIFIC; NORTH-ATLANTIC; OCEAN; ANTARCTICA; WATERS; CO2	Ocean-atmosphere interactions in the tropical Pacific region have a strong influence on global heat and water vapour transport and thus constitute an important component of the climate system(1,2). Changes in sea surface temperatures and convection in the tropical Indo-Pacific region are thought to be responsible for the interannual to decadal climate variability observed in extratropical regions(1,3), but the role of the tropics in climate changes on millennial and orbital timescales is less clear. Here we analyse oxygen isotopes and Mg/Ca ratios of foraminiferal shells from the Makassar strait in the heart of the Indo-Pacific warm pool, to obtain synchronous estimates of sea surface temperatures and ice volume. We find that sea surface temperatures increased by 3.5-4.0 degreesC during the last two glacial-interglacial transitions, synchronous with the global increase in atmospheric CO2 and Antarctic warming, but the temperature increase occurred 2,000-3,000 years before the Northern Hemisphere ice sheets melted. Our observations suggest that the tropical Pacific region plays an important role in driving glacial-interglacial cycles, possibly through a system similar to how El Nino/Southern Oscillation regulates the poleward flux of heat and water vapour.	Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Southern California	Thunell, R (corresponding author), Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA.			Ackerman, Kate/0000-0003-3925-721X				Bacastow RB, 1996, GLOBAL BIOGEOCHEM CY, V10, P319, DOI 10.1029/96GB00039; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BOYLE EA, 1995, PALEOCEANOGRAPHY, V10, P881, DOI 10.1029/95PA01625; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Broecker WS, 1997, GLOBAL BIOGEOCHEM CY, V11, P589, DOI 10.1029/97GB02267; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; CLIMAP Climate: Long-Range Investigation Mapping and Prediction Project Members, 1981, GEOL SOC AM MAP CHAR, V36, P1; DEKENS PS, 2002, GEOCHEM GEOPHYS GEOS, V3; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; GUILDERSON T, 2000, GEOCHEM GEOPHYS GEOS, V1; Guilderson TP, 2001, MAR GEOL, V172, P75, DOI 10.1016/S0025-3227(00)00115-8; HASTENRATH S, 1982, J PHYS OCEANOGR, V12, P922, DOI 10.1175/1520-0485(1982)012<0922:OMHTIT>2.0.CO;2; HASTINGS D, 2001, EOS, V82; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; MARTENS R., 1987, SPORT PSYCHOL, V1, P29, DOI [10.1123/tsp.1.1.29, DOI 10.1123/TSP.1.1.29]; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P135, DOI 10.1029/1999PA000415; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0	31	280	332	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					152	155		10.1038/nature01297	http://dx.doi.org/10.1038/nature01297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520298				2022-12-24	WOS:000180267200036
J	Hypponen, E; Smith, GD; Power, C				Hypponen, E; Smith, GD; Power, C			Parental diabetes and birth weight of offspring: intergenerational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSOCIATION		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	University of London; University College London; University of Bristol	Hypponen, E (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	e.hypponen@ich.ucl.ac.uk	Davey Smith, George/A-7407-2013; Hypponen, Elina/B-2596-2014	Davey Smith, George/0000-0002-1407-8314; Hypponen, Elina/0000-0003-3670-9399	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Butler N.R., 1963, PERINATAL MORTALITY; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Pennison EH, 2001, AM J OBSTET GYNECOL, V184, P1118, DOI 10.1067/mob.2001.114918; Tynelius P, 2001, AM J EPIDEMIOL, V153, pS47	5	67	68	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2003	326	7379					19	20		10.1136/bmj.326.7379.19	http://dx.doi.org/10.1136/bmj.326.7379.19			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511454	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000180302000018
J	Trachtenberg, JT; Chen, BE; Knott, GW; Feng, GP; Sanes, JR; Welker, E; Svoboda, K				Trachtenberg, JT; Chen, BE; Knott, GW; Feng, GP; Sanes, JR; Welker, E; Svoboda, K			Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex	NATURE			English	Article							RAT BARREL CORTEX; PRIMARY SOMATOSENSORY CORTEX; DENDRITIC SPINES; VISUAL-CORTEX; FUNCTIONAL REORGANIZATION; PYRAMIDAL CELLS; IN-VIVO; SYNAPSES; MEMORY; CA1	Do new synapses form in the adult cortex to support experience-dependent plasticity? To address this question, we repeatedly imaged individual pyramidal neurons in the mouse barrel cortex over periods of weeks. We found that, although dendritic structure is stable, some spines appear and disappear. Spine lifetimes vary greatly: stable spines, about 50% of the population, persist for at least a month, whereas the remainder are present for a few days or less. Serial-section electron microscopy of imaged dendritic segments revealed retrospectively that spine sprouting and retraction are associated with synapse formation and elimination. Experience-dependent plasticity of cortical receptive fields was accompanied by increased synapse turnover. Our measurements suggest that sensory experience drives the formation and elimination of synapses and that these changes might underlie adaptive remodelling of neural circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Washington University (WUSTL)	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.		Feng, Guoping/Y-2827-2019	Knott, Graham W/0000-0002-2956-9052				ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Glazewski S, 1998, EUR J NEUROSCI, V10, P2107, DOI 10.1046/j.1460-9568.1998.00222.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HUTTENLOCHER PR, 1982, NEUROSCI LETT, V33, P247, DOI 10.1016/0304-3940(82)90379-2; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KIM HG, 1993, J NEUROSCI, V13, P5301, DOI 10.1523/JNEUROSCI.13-12-05301.1993; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ramon y Cajal S, 1893, ARCH ANAT PHYSL, P319; SANDISON DR, 1994, 3 DIMENSIONAL CONFOC, P29; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tanzi E., 1893, RIV SPER FRENIAT MED, V19, P419; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	43	1397	1421	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					788	794		10.1038/nature01273	http://dx.doi.org/10.1038/nature01273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490942				2022-12-24	WOS:000179897300049
J	Melillo, JM; Steudler, PA; Aber, JD; Newkirk, K; Lux, H; Bowles, FP; Catricala, C; Magill, A; Ahrens, T; Morrisseau, S				Melillo, JM; Steudler, PA; Aber, JD; Newkirk, K; Lux, H; Bowles, FP; Catricala, C; Magill, A; Ahrens, T; Morrisseau, S			Soil warming and carbon-cycle feedbacks to the climate system	SCIENCE			English	Article							TRACE GAS FLUXES; ORGANIC-CARBON; AVAILABILITY; TEMPERATURE; RESPIRATION; NITROGEN; FORESTS; PRAIRIE	In a decade-long soil warming experiment in a mid-latitude hardwood forest, we documented changes in soil carbon and nitrogen cycling in order to investigate the consequences of these changes for the climate system. Here we show that whereas soil warming accelerates soil organic matter decay and carbon dioxide fluxes to the atmosphere, this response is small and short-lived for a mid-latitude forest, because of the limited size of the labile soil carbon pool. We also show that warming increases the availability of mineral nitrogen to plants. Because plant growth in many mid-latitude forests is nitrogen-limited, warming has the potential to indirectly stimulate enough carbon storage in plants to at least compensate for the carbon losses from soils. Our results challenge assumptions made in some climate models that lead to projections of large long-term releases of soil carbon in response to warming of forest ecosystems.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; Res Designs, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole; University System Of New Hampshire; University of New Hampshire	Melillo, JM (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.							Bergh J, 1999, FOREST ECOL MANAG, V119, P51, DOI 10.1016/S0378-1127(98)00509-X; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; FRIEDLINGSTEIN P, IN PRESS TELLUS; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Grace J, 2000, NATURE, V404, P819, DOI 10.1038/35009170; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Merriam J, 1996, SOIL SCI SOC AM J, V60, P1050, DOI 10.2136/sssaj1996.03615995006000040013x; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; Rustad L, 2001, NATURE, V413, P578, DOI 10.1038/35098162; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Woodwell GM, 1995, BIOTIC FEEDBACKS GLO, P3	17	931	1157	29	733	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2173	2176		10.1126/science.1074153	http://dx.doi.org/10.1126/science.1074153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481133				2022-12-24	WOS:000179773700042
J	Lambert, JD; Nagy, LM				Lambert, JD; Nagy, LM			Asymmetric inheritance of centrosomally localized mRNAs during embryonic cleavages	NATURE			English	Article							C-ELEGANS EMBRYOS; ILYANASSA-OBSOLETA; ASCIDIAN EMBRYO; MESSENGER-RNA; PIE-1 PROTEIN; DROSOPHILA; SPECIFICATION; CELLS; GENE; CENTRIOLES	During development, different cell fates are generated by cell-cell interactions or by the asymmetric distribution of patterning molecules. Asymmetric inheritance is known to occur either through directed transport along actin microfilaments into one daughter cell(1,2) or through capture of determinants by a region of the cortex inherited by one daughter(3-5). Here we report a third mechanism of asymmetric inheritance in a mollusc embryo. Different messenger RNAs associate with centrosomes in different cells and are subsequently distributed asymmetrically during division. The segregated mRNAs are diffusely distributed in the cytoplasm and then localize, in a microtubule-dependent manner, to the pericentriolar matrix. During division, they dissociate from the core mitotic centrosome and move by means of actin filaments to the presumptive animal daughter cell cortex. In experimental cells with two interphase centrosomes, mRNAs accumulate on the correct centrosome, indicating that differences between centrosomes control mRNA targeting. Blocking the accumulation of mRNAs on the centrosome shows that this event is required for subsequent cortical localization. These events produce a complex pattern of mRNA localization, in which different messages distinguish groups of cells with the same birth order rank and similar developmental potentials.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Nagy, LM (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.			Lambert, J. David/0000-0002-7005-0244				Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Boyd L, 1996, DEVELOPMENT, V122, P3075; CLEMENT AC, 1962, J EXP ZOOL, V149, P193, DOI 10.1002/jez.1401490304; CLEMENT AC, 1976, AM ZOOL, V16, P447; CLEMENT AC, 1952, J EXP ZOOL, V132, P427; Conklin Edwin G., 1902, Journal of the Academy of Natural Sciences of Philadelphia Ser 2, V12; Crampton HE, 1896, ROUXS ARCH ENTW MECH, V3, P1; Goto S, 1997, DEV GENES EVOL, V207, P194, DOI 10.1007/s004270050107; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Lambert JD, 2001, DEVELOPMENT, V128, P45; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Nishikata T, 1999, DEV BIOL, V209, P72, DOI 10.1006/dbio.1999.9244; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Render J, 1997, DEV BIOL, V189, P301, DOI 10.1006/dbio.1997.8654; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Sweet HC, 1998, DEVELOPMENT, V125, P4033; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wilson EB, 1904, J EXP ZOOL, V1, P197, DOI 10.1002/jez.1400010202; Wu XY, 1999, P NATL ACAD SCI USA, V96, P1397, DOI 10.1073/pnas.96.4.1397; Yoshida S, 1996, DEVELOPMENT, V122, P2005	28	170	178	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					682	686		10.1038/nature01241	http://dx.doi.org/10.1038/nature01241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478296				2022-12-24	WOS:000179751800049
J	Wacker, M; Linton, D; Hitchen, PG; Nita-Lazar, M; Haslam, SM; North, SJ; Panico, M; Morris, HR; Dell, A; Wren, BW; Aebi, M				Wacker, M; Linton, D; Hitchen, PG; Nita-Lazar, M; Haslam, SM; North, SJ; Panico, M; Morris, HR; Dell, A; Wren, BW; Aebi, M			N-linked glycosylation in Campylobacter jejuni and its functional transfer into E-coli	SCIENCE			English	Article							PROTEIN GLYCOSYLATION; GLYCOPROTEIN; PILIN	N-linked protein glycosylation is the most abundant posttranslation modification of secretory proteins in eukaryotes. A wide range of functions are attributed to glycan structures covalently linked to asparagine residues within the asparagine-X-serine/threonine consensus sequence (Asn-Xaa-Ser/Thr). We found an N-linked glycosylation system in the bacterium Campylobacter jejuni and demonstrate that a functional N-linked glycosylation pathway could be transferred into Escherichia coli. Although the bacterial N-glycan differs structurally from its eukaryotic counterparts, the cloning of a universal N-linked glycosylation cassette in E. coli opens up the possibility of engineering permutations of recombinant glycan structures for research and industrial applications.	Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, CH-8092 Zurich, Switzerland; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; M SCAN Mass Spectrometry Res & Training Ctr, Ascot SL5 7PZ, Berks, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Aebi, M (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, CH-8092 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	nita-lazar, m/V-4259-2019; Mihai, Nita-Lazar/Q-2206-2016	Mihai, Nita-Lazar/0000-0002-5099-1311; Linton, Dennis/0000-0002-4717-5428				BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DOOLITTLE WF, 1999, TRENDS CELL BIOL, V9, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; ERICKSON PR, 1993, J BIOL CHEM, V268, P23780; Fry BN, 1998, MICROBIOL-SGM, V144, P2049, DOI 10.1099/00221287-144-8-2049; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Karaoglu D, 2001, BIOCHEMISTRY-US, V40, P12193, DOI 10.1021/bi0111911; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOTYCZKA P, UNPUB; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Schaffer C, 2001, PROTEOMICS, V1, P248; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Teng-umnuay P, 1998, J BIOL CHEM, V273, P18242, DOI 10.1074/jbc.273.29.18242; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	21	581	647	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1790	1793		10.1126/science.298.5599.1790	http://dx.doi.org/10.1126/science.298.5599.1790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459590				2022-12-24	WOS:000179494800046
J	Bogdanovich, S; Krag, TOB; Barton, ER; Morris, LD; Whittemore, LA; Ahima, RS; Khurana, TS				Bogdanovich, S; Krag, TOB; Barton, ER; Morris, LD; Whittemore, LA; Ahima, RS; Khurana, TS			Functional improvement of dystrophic muscle by myostatin blockade	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX MOUSE; MICE; GENE; EXPRESSION; PHENOTYPE; TRANSGENE; MYOPATHY; PROTEIN	Mice(1,2) and cattle(3) with mutations in the myostatin (GDF8) gene show a marked increase in body weight and muscle mass, indicating that this new member of the TGF-beta superfamily is a negative regulator of skeletal muscle growth. Inhibition of the myostatin gene product is predicted to increase muscle mass and improve the disease phenotype in a variety of primary and secondary myopathies. We tested the ability of inhibition of myostatin in vivo to ameliorate the dystrophic phenotype in the mdx mouse model of Duchenne muscular dystrophy (DMD)(4-8). Blockade of endogenous myostatin by using intraperitoneal injections of blocking antibodies for three months resulted in an increase in body weight, muscle mass, muscle size and absolute muscle strength in mdx mouse muscle along with a significant decrease in muscle degeneration and concentrations of serum creatine kinase. The functional improvement of dystrophic muscle by myostatin blockade provides a novel, pharmacological strategy for treatment of diseases associated with muscle wasting such as DMD, and circumvents the major problems associated with conventional gene therapy in these disorders.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; Wyeth Res, Musculoskeletal Sci Dept, Cambridge, MA 02140 USA; Univ Penn, Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pfizer; University of Pennsylvania	Khurana, TS (corresponding author), Univ Penn, Sch Med, Dept Physiol, 3700 Hamilton Walk,Richards A-601, Philadelphia, PA 19104 USA.		Ahima, Rexford/W-1394-2019; Krag, Thomas/AAD-3307-2021	Krag, Thomas/0000-0001-9330-668X				Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Brown SE, 1997, DYSTROPHIN GENE PROT; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Ebihara S, 2000, PHYSIOL GENOMICS, V3, P133, DOI 10.1152/physiolgenomics.2000.3.3.133; Engel A., 1994, MYOLOGY; Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Guyton A., 1995, TXB MED PHYSL; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1987, SCIENCE, V238, P347, DOI 10.1126/science.3659917; Jalenak M, 2002, J NEUROL SCI, V199, pS83; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lozier JN, 2002, HUM GENE THER, V13, P113, DOI 10.1089/10430340152712665; MATSUDA R, 1995, J BIOCHEM-TOKYO, V118, P959, DOI 10.1093/jb/118.5.959; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Moustakas A, 2001, J CELL SCI, V114, P4359; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Thies RS, 2001, GROWTH FACTORS, V18, P251; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	30	621	744	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 28	2002	420	6914					418	421		10.1038/nature01154	http://dx.doi.org/10.1038/nature01154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459784				2022-12-24	WOS:000179494700040
J	Cleland, JGF; Cohen-Solal, A; Aguilar, JC; Dietz, R; Eastaugh, J; Follath, F; Freemantle, N; Gavazzi, A; van Gilst, WH; Hobbs, FDR; Korewicki, J; Madeira, HC; Preda, I; Swedberg, K; Widimsky, J				Cleland, JGF; Cohen-Solal, A; Aguilar, JC; Dietz, R; Eastaugh, J; Follath, F; Freemantle, N; Gavazzi, A; van Gilst, WH; Hobbs, FDR; Korewicki, J; Madeira, HC; Preda, I; Swedberg, K; Widimsky, J		IMPROVEMENT Heart Failure Progra; Study Grp Diagnosis Working Grp He	Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey	LANCET			English	Article							ACE-INHIBITORS; MYOCARDIAL-INFARCTION; BETA-BLOCKERS; DIAGNOSIS; ETIOLOGY; PATTERNS	Background Heart failure is a prevalent condition that is generally treated in primary care. The aim of this study was to assess how primary-care physicians think that heart failure should be managed, how they implement their knowledge, and whether differences exist in practice between countries. Methods The survey was undertaken in 15 countries that had membership of the European Society of Cardiology (ESC) between Sept 1, 1999, and May 31, 2000. Primary-care physicians' knowledge and perceptions about the management of heart failure were assessed with a perception survey and how a representative sample of patients was managed with an actual practice survey. Findings 1363 physicians provided data for 11062 patients, of whom 54% were older than 70 years and 45% were women. 82% of patients had had an echocardiogram but only 51% of these showed left ventricular systolic dysfunction. Ischaemic heart disease, hypertension, diabetes mellitus, atrial fibrillation, and major valve disease were all common. Physicians gave roughly equal priority to improvement of symptoms and prognosis. Most were aware of the benefits of ACE inhibitors and beta blockers. 60% of patients were prescribed ACE inhibitors, 34% beta blockers but only 20% received these drugs in combination. Doses given. were about 50% of targets suggested in the ESC guidelines. If systolic dysfunction was documented, ACE inhibitors were more likely and beta blockers less likely to be prescribed than when there was no evidence of systolic dysfunction. Interpretation Results from this survey suggest that most patients with heart failure are appropriately investigated, although this finding might be as a result of high rates of hospital admissions. However, treatment seems to be less than optimum, and there are substantial variations in practice between countries. The inconsistencies between physicians' knowledge and the treatment that they deliver suggests that improved organisation of care for heart failure is required.	Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England; Hop Beaujon, Dept Cardiol, Clichy, France; Hosp La Fe, E-46009 Valencia, Spain; Humboldt Univ, Max Delbruck Centrum, Franz Volhard Klin, Berlin, Germany; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham, W Midlands, England; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Osped Riuniti Bergamo, Unita Operat Cardiol, Dipartimento Cardiovasc, I-24100 Bergamo, Italy; Univ Groningen, Dept Clin Pharmacol, Groningen, Netherlands; Natl Inst Cardiol, Warsaw, Poland; Fac Med Lisbon, Cadeira Med 3, Lisbon, Portugal; Semmelweis Univ, Dept Cardiol & Internal Med, Budapest, Hungary; Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden; Postgrad Med Sch, Dept Cardiol, Prague, Czech Republic	University of Hull; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Universitari i Politecnic La Fe; Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; University of Birmingham; University of Zurich; University Zurich Hospital; Ospedali Riuniti di Bergamo; University of Groningen; Institute of Cardiology - Poland; Universidade de Lisboa; Semmelweis University; Sahlgrenska University Hospital	Cleland, JGF (corresponding author), Univ Hull, Castle Hill Hosp, Dept Cardiol, Kingston Upon Hull HU16 5JQ, Yorks, England.	j.g.cleland@hull.ac.uk	van Gilst, Wiek H/C-3828-2008; van Gilst, Wiek/R-1806-2019; Cleland, John G./AAZ-4185-2020; Swedberg, Karl/B-2475-2008	van Gilst, Wiek/0000-0003-2968-8585; Cleland, John G./0000-0002-1471-7016; Madeira, Hugo/0000-0003-4291-2289; hobbs, richard/0000-0001-7976-7172; Freemantle, Nick/0000-0001-5807-5740				Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Clark AL, 2000, POSTGRAD MED J, V76, P289, DOI 10.1136/pmj.76.895.289; CLARK AL, 1995, BRIT MED J, V310, P973, DOI 10.1136/bmj.310.6985.973; CLELAND JG, 1995, EUR HEART J, V16, P741; Cleland JGF, 1999, EUR J HEART FAIL, V1, P211, DOI 10.1016/S1388-9842(99)00039-2; Cleland JGF, 1999, BRIT MED J, V318, P824, DOI 10.1136/bmj.318.7187.824; Cleland JGF, 1998, LANCET, V352, P19; Cleland JGF, 1999, J CARDIOVASC RISK, V6, P131; Cleland JGF, 2001, EUR HEART J, V22, P623, DOI 10.1053/euhj.2000.2493; Cleland JGF, 1999, CARDIOLOGY, V92, P10, DOI 10.1159/000047289; Cleland JGF, 1999, EUR J HEART FAIL, V1, P139; Cleland JGF, 1999, EUR J HEART FAIL, V1, P229, DOI 10.1016/S1388-9842(99)00032-X; Collett D., 1991, MODELLING BINARY DAT; Cowie MR, 1997, EUR HEART J, V18, P208; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; DAVIE AP, 1995, CORONARY ARTERY DIS, V6, P315, DOI 10.1097/00019501-199504000-00008; Davie AP, 1999, POSTGRAD MED J, V75, P219, DOI 10.1136/pgmj.75.882.219; Follath F, 1998, J AM COLL CARDIOL, V32, P1167, DOI 10.1016/S0735-1097(98)00400-8; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Hillis GS, 1996, HEART, V76, P427, DOI 10.1136/hrt.76.5.427; Hjalmarson A, 1999, LANCET, V353, P2001; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; Houghton T, 2000, EUR J HEART FAIL, V2, P333, DOI 10.1016/S1388-9842(00)00100-8; Lechat P, 1999, LANCET, V353, P9; Philbin EF, 1996, AM J CARDIOL, V77, P832, DOI 10.1016/S0002-9149(97)89177-1; Philbin EF, 1998, CLIN CARDIOL, V21, P103, DOI 10.1002/clc.4960210208; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Rothman K, 1986, MODERN EPIDEMIOLOGY; *TAS FORC WORK GRO, 1997, EUR HEART J, V18, P736; Toal M, 2000, EUR J HEART FAIL, V2, P201, DOI 10.1016/S1388-9842(00)00071-4; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	33	427	448	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2002	360	9346					1631	1639		10.1016/S0140-6736(02)11601-1	http://dx.doi.org/10.1016/S0140-6736(02)11601-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618AE	12457785				2022-12-24	WOS:000179393900007
J	Titus, TN; Kieffer, HH; Christensen, PR				Titus, TN; Kieffer, HH; Christensen, PR			Exposed water ice discovered near the south pole of Mars	SCIENCE			English	Article							THERMAL MAPPER OBSERVATIONS; GROUND ICE; SUMMER TEMPERATURES; LAYERED DEPOSITS; CARBON-DIOXIDE; NEAR-SURFACE; BEHAVIOR; VAPOR; ALBEDO; SUBSURFACE	The Mars Odyssey Thermal Emission Imaging System (THEMIS) has discovered water ice exposed near the edge of Mars' southern perennial polar cap. The surface H2O ice was first observed by THEMIS as a region that was cooler than expected for dry soil at that latitude during the summer season. Diurnal and seasonal temperature trends derived from Mars Global Surveyor Thermal Emission Spectrometer observations indicate that there is H2O ice at the surface. Viking observations, and the few other relevant THEMIS observations, indicate that surface H2O ice may be widespread around and under the perennial CO2 cap.	US Geol Survey, Branch Astrogeol, Flagstaff, AZ 86001 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe	Titus, TN (corresponding author), US Geol Survey, Branch Astrogeol, 2255 N Gemini Dr, Flagstaff, AZ 86001 USA.	ttitus@usgs.gov						BARKER ES, 1970, SCIENCE, V170, P1308, DOI 10.1126/science.170.3964.1308; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; Forget F, 1998, ASTROPHYS SPACE SC L, V227, P477, DOI 10.1007/978-94-011-5252-5_20; HERKENHOFF KE, 1990, J GEOPHYS RES-SOLID, V95, P1343, DOI 10.1029/JB095iB02p01343; HERKENHOFF KE, 2001, USGS MISC INV SERI I, V2686; HOFSTADTER MD, 1990, ICARUS, V84, P352, DOI 10.1016/0019-1035(90)90043-9; JAKOSKY BM, 1990, J GEOPHYS RES-SOLID, V95, P1359, DOI 10.1029/JB095iB02p01359; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; JAKOSKY BM, 1992, MARS, pCH28; JAMES PB, 1992, MARS, pCH27; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; MOROZ VI, 1964, SOV ASTRON, V8, P273; PAIGE DA, 1990, J GEOPHYS RES-SOLID, V95, P1319, DOI 10.1029/JB095iB02p01319; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; SMITH MD, 2002, ANN M DIV PLAN SCI B; THOMAS P, 1992, MARS, pCH23; TILLMAN JE, 1993, J GEOPHYS RES-PLANET, V98, P10963, DOI 10.1029/93JE01084; ZENT AP, 1986, ICARUS, V67, P19, DOI 10.1016/0019-1035(86)90171-5	31	164	167	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1048	1051		10.1126/science.1080497	http://dx.doi.org/10.1126/science.1080497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12471268				2022-12-24	WOS:000180960000042
J	Etchegaray, JP; Lee, C; Wade, PA; Reppert, SM				Etchegaray, JP; Lee, C; Wade, PA; Reppert, SM			Rhythmic histone acetylation underlies transcription in the mammalian circadian clock	NATURE			English	Article							GENE-EXPRESSION; MECHANISMS; MOUSE; COMPONENTS; HDA1; LIMB	In the mouse circadian clock, a transcriptional feedback loop is at the centre of the clockwork mechanism. Clock and Bmal1 are essential transcription factors that drive the expression of three period genes (Per1-3) and two cryptochrome genes (Cry1 and Cry2)(1-5). The Cry proteins feedback to inhibit Clock/Bmal1-mediated transcription by a mechanism that does not alter Clock/Bmal1 binding to DNA(6). Here we show that transcriptional regulation of the core clock mechanism in mouse liver is accompanied by rhythms in H3 histone acetylation, and that H3 acetylation is a potential target of the inhibitory action of Cry. The promoter regions of the Per1, Per2 and Cry1 genes exhibit circadian rhythms in H3 acetylation and RNA polymerase II binding that are synchronous with the corresponding steady-state messenger RNA rhythms. The histone acetyltransferase p300 precipitates together with Clock in vivo in a time-dependent manner. Moreover, the Cry proteins inhibit a p300-induced increase in Clock/Bmal1-mediated transcription. The delayed timing of the Cry1 mRNA rhythm, relative to the Per rhythms, is due to the coordinated activities of Rev-Erbalpha and Clock/Bmal1, and defines a new mechanism for circadian phase control.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Massachusetts System; University of Massachusetts Worcester; Emory University	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, LRB-728,364 Plantat St, Worcester, MA 01605 USA.	steven.reppert@umassmed.edu	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pfeifer GP, 1999, METHOD ENZYMOL, V304, P548; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wade PA, 1999, METHOD ENZYMOL, V304, P715; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	23	517	536	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					177	182		10.1038/nature01314	http://dx.doi.org/10.1038/nature01314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12483227				2022-12-24	WOS:000180267200044
J	Gerard, C				Gerard, C			Complement C5a in the sepsis syndrome - too much of a good thing?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Div Pulm, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Gerard, C (corresponding author), Childrens Hosp, Div Pulm, Enders Bldg,Rm 144,300 Longwood Ave, Boston, MA 02115 USA.							Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506	5	66	74	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					167	169		10.1056/NEJMcibr022995	http://dx.doi.org/10.1056/NEJMcibr022995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519929				2022-12-24	WOS:000180263900011
J	Martinez, LO; Jacquet, S; Esteve, JP; Rolland, C; Cabezon, E; Champagne, E; Pineau, T; Georgeaud, V; Walker, JE; Terce, F; Collet, X; Perret, B; Barbaras, R				Martinez, LO; Jacquet, S; Esteve, JP; Rolland, C; Cabezon, E; Champagne, E; Pineau, T; Georgeaud, V; Walker, JE; Terce, F; Collet, X; Perret, B; Barbaras, R			Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis	NATURE			English	Article							DENSITY-LIPOPROTEIN HDL; HIGH-AFFINITY BINDING; SCAVENGER RECEPTOR; CHOLESTEROL EFFLUX; BOVINE F-1-ATPASE; INHIBITOR PROTEIN; SR-BI; SURFACE; SUBUNIT; SITES	The effect of high-density lipoprotein (HDL) in protecting against atherosclerosis is usually attributed to its role in 'reverse cholesterol transport'(1). In this process, HDL particles mediate the efflux and the transport of cholesterol from peripheral cells to the liver for further metabolism and bile excretion. Thus, cell-surface receptors for HDL on hepatocytes are chief partners in the regulation of cholesterol homeostasis(2). A high-affinity HDL receptor for apolipoprotein A-I (apoA-I) was previously identified on the surface of hepatocytes(3,4). Here we show that this receptor is identical to the beta-chain of ATP synthase, a principal protein complex of the mitochondrial inner membrane. Different experimental approaches confirm this ectopic localization of components of the ATP synthase complex and the presence of ATP hydrolase activity at the hepatocyte cell surface. Receptor stimulation by apoA-I triggers the endocytosis of holo-HDL particles (protein plus lipid) by a mechanism that depends strictly on the generation of ADP. We confirm this effect on endocytosis in perfused rat liver ex vivo by using a specific inhibitor of ATP synthase. Thus, membrane-bound ATP synthase has a previously unsuspected role in modulating the concentrations of extracellular ADP and is regulated by a principal plasma apolipoprotein.	Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Lipoprot & Med Lipid, F-31059 Toulouse, France; Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Immunol Mol & Biol Lymphocyte T, F-31059 Toulouse, France; Hop Rangueil, IFR 31, INSERM,U531, Inst Federatif REch Louis Bugnard, F-31403 Toulouse, France; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; INRA, Lab Pharmacol & Toxicol, F-31931 Toulouse 9, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; INRAE	Barbaras, R (corresponding author), Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Lipoprot & Med Lipid, F-31059 Toulouse, France.	Ronald.Barbaras@toulouse.inserm.fr	Martinez, Laurent O./ABD-6880-2020; Cabezon, Elena/K-5874-2014; Eckhardt, Erik/G-1567-2010; Collet, Xavier/M-6938-2017; Martinez, Laurent O/B-8343-2015; Champagne, Eric/M-1543-2014; Tercé, François/M-5863-2018	Martinez, Laurent O./0000-0002-0985-3152; Martinez, Laurent O/0000-0002-0985-3152; Champagne, Eric/0000-0002-8852-0734; Tercé, François/0000-0003-4488-2167; Walker, John/0000-0001-7929-2162; Bertrand, PERRET/0000-0001-7568-445X; Cabezon, Elena/0000-0002-6177-5016				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; BARBARAS R, 1994, BIOCHEMISTRY-US, V33, P2335, DOI 10.1021/bi00174a047; BARRANS A, 1994, J BIOL CHEM, V269, P11572; BEISIEGEL U, 1988, ARTERIOSCLEROSIS, V8, P288, DOI 10.1161/01.ATV.8.3.288; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Burgess JW, 2002, J BIOL CHEM, V277, P31318, DOI 10.1074/jbc.M204200200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Ferrini JB, 1997, CHEM-BIOL INTERACT, V107, P31, DOI 10.1016/S0009-2797(97)00072-0; Fidge NH, 1999, J LIPID RES, V40, P187; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Guendouzi K, 1998, BIOCHEMISTRY-US, V37, P14974, DOI 10.1021/bi9810508; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; MAHLEY RW, 1989, ARTERIOSCLEROSIS, V9, pI14; Martinez LO, 2000, BIOCHEMISTRY-US, V39, P1076, DOI 10.1021/bi991971y; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; WILLIAMS N, 1984, ANAL BIOCHEM, V140, P581, DOI 10.1016/0003-2697(84)90210-0	29	370	400	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					75	79		10.1038/nature01250	http://dx.doi.org/10.1038/nature01250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511957				2022-12-24	WOS:000180165500040
J	Check, E				Check, E			Gene therapy - Shining hopes dented - but not dashed	NATURE			English	Editorial Material																			0	17	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					735	735		10.1038/420735b	http://dx.doi.org/10.1038/420735b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490910	Bronze			2022-12-24	WOS:000179897300020
J	Free, C; Lee, RM; Ogden, J				Free, C; Lee, RM; Ogden, J			Young women's accounts of factors influencing their use and non-use of emergency contraception: in-depth interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							KNOWLEDGE	Objectives To explore young women's accounts of their use and non-use of emergency contraception. Design Qualitative study using in-depth interviews. Participants 30 women aged 16-25; participants from socially deprived inner city areas were specifically included. Setting Community, service, and educational settings in the London area. Results Young women's accounts of their non-use of emergency contraception principally concerned evaluations of the risk conferred by different contraceptive behaviours, their evaluations of themselves in needing emergency contraception, and personal difficulties in asking for emergency contraception. Conclusions The attitudes and concerns of young women, especially those from disadvantaged backgrounds, may make them less able or willing than others to take advantage of recent increases in access to emergency contraception. Interventions that aim to increase the use of emergency contraception need to address the factors that influence young women's non-use of emergency contraception.	Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; Royal Holloway Univ London, Dept Social & Polit Sci, Egham TW20 0EX, Surrey, England	University of London; King's College London; University of London; Royal Holloway University London	Free, C (corresponding author), Guys Kings & St Thomas Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England.	caroline.free@kcl.ac.uk		Ogden, Jane/0000-0003-4271-5621; Free, Caroline/0000-0003-1711-0006				ANDERSON C, 2001, LAMBETH SOUTHWORK LE; Barrett G, 2000, SOCIOL HEALTH ILL, V22, P197, DOI 10.1111/1467-9566.00199; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Crosier A, 1996, BRIT J FAM PLAN, V22, P87; Crosier A., 1997, EMERGENCY CONTRACEPT; Department of the Environment Transport and the Regions, 2000, IND DEPR 2000 REG RE; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567; HALPER C, 1995, FAM PLANN PERSPECT, V27, P149, DOI 10.2307/2136258; Harrison-Woolrych M, 2001, BRIT MED J, V322, P186; Rosenstock IM, 1974, HLTH ED MONOGRAPHS, V2, P328, DOI [DOI 10.1177/109019817400200403, 10.1177/109019817400200403]; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; Trussell J, 1998, J Am Med Womens Assoc (1972), V53, P247; WEINSTEIN ND, 1984, HEALTH PSYCHOL, V3, P431, DOI 10.1037/0278-6133.3.5.431; Ziebland S, 1996, BRIT J FAM PLAN, V22, P84	15	75	77	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2002	325	7377					1393	1396		10.1136/bmj.325.7377.1393	http://dx.doi.org/10.1136/bmj.325.7377.1393			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CP	12480855	Green Published, Green Accepted			2022-12-24	WOS:000179975000024
J	Gilman, AG; Simon, MI; Bourne, HR; Harris, BA; Long, R; Ross, EM; Stull, JT; Taussig, R; Bourne, HR; Arkin, AP; Cobb, MH; Cyster, JG; Devreotes, PN; Ferrell, JE; Fruman, D; Gold, M; Weiss, A; Stull, JT; Berridge, MJ; Cantley, LC; Catterall, WA; Coughlin, SR; Olson, EN; Smith, TF; Brugge, JS; Botstein, D; Dixon, JE; Hunter, T; Lefkowitz, RJ; Pawson, AJ; Sternberg, PW; Varmus, H; Subramaniam, S; Sinkovits, RS; Li, J; Mock, D; Ning, YH; Saunders, B; Sternweis, PC; Hilgemann, D; Scheuermann, RH; DeCamp, D; Hsueh, R; Lin, KM; Ni, Y; Seaman, WE; Simpson, PC; O'Connell, TD; Roach, T; Simon, MI; Choi, S; Eversole-Cire, P; Fraser, I; Mumby, MC; Zhao, YM; Brekken, D; Shu, HJ; Meyer, T; Chandy, G; Do Heo, W; Liou, J; O'Rourke, N; Verghese, M; Mumby, SM; Han, HP; Brown, HA; Forrester, JS; Ivanova, P; Milne, SB; Casey, PJ; Harden, TK; Arkin, AP; Doyle, J; Gray, ML; Meyer, T; Michnick, S; Schmidt, MA; Toner, M; Tsien, RY; Natarajan, M; Ranganathan, R; Sambrano, GR				Gilman, AG; Simon, MI; Bourne, HR; Harris, BA; Long, R; Ross, EM; Stull, JT; Taussig, R; Bourne, HR; Arkin, AP; Cobb, MH; Cyster, JG; Devreotes, PN; Ferrell, JE; Fruman, D; Gold, M; Weiss, A; Stull, JT; Berridge, MJ; Cantley, LC; Catterall, WA; Coughlin, SR; Olson, EN; Smith, TF; Brugge, JS; Botstein, D; Dixon, JE; Hunter, T; Lefkowitz, RJ; Pawson, AJ; Sternberg, PW; Varmus, H; Subramaniam, S; Sinkovits, RS; Li, J; Mock, D; Ning, YH; Saunders, B; Sternweis, PC; Hilgemann, D; Scheuermann, RH; DeCamp, D; Hsueh, R; Lin, KM; Ni, Y; Seaman, WE; Simpson, PC; O'Connell, TD; Roach, T; Simon, MI; Choi, S; Eversole-Cire, P; Fraser, I; Mumby, MC; Zhao, YM; Brekken, D; Shu, HJ; Meyer, T; Chandy, G; Do Heo, W; Liou, J; O'Rourke, N; Verghese, M; Mumby, SM; Han, HP; Brown, HA; Forrester, JS; Ivanova, P; Milne, SB; Casey, PJ; Harden, TK; Arkin, AP; Doyle, J; Gray, ML; Meyer, T; Michnick, S; Schmidt, MA; Toner, M; Tsien, RY; Natarajan, M; Ranganathan, R; Sambrano, GR		Alliance Cellular Signaling	Overview of the Alliance for Cellular Signaling	NATURE			English	Editorial Material								The Alliance for Cellular Signaling is a large-scale collaboration designed to answer global questions about signalling networks. Pathways will be studied intensively in two cells-B lymphocytes (the cells of the immune system) and cardiac myocytes-to facilitate quantitative modelling. One goal is to catalyse complementary research in individual laboratories; to facilitate this, all alliance data are freely available for use by the entire research community.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol & Oncol, Dallas, TX 75390 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Dept Biol, Pasadena, CA 91125 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Aventis Pharmaceut, Bridgewater, NJ 08807 USA; NIGMS, Pharmacol Physiol & Biol Chem Div, NIH, Bethesda, MD 20892 USA; Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, EO Lawrence Berkeley Natl Lab, Dept Chem, Berkeley, CA 94720 USA; Johns Hopkins Univ, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Ctr Clin Sci Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Babraham Inst, Cambridge CB2 4AT, England; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Cell Biol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Boston Univ, BMERC, Boston, MA 02215 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Salk Inst Biol Studies, San Diego, CA 92186 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92037 USA; Vet Affairs Med Ctr, Dept Rheumatol, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, Dept Cardiol, San Francisco, CA 94121 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Dept Elect & Med Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Dept Elect & Med Engn, Cambridge, MA 02139 USA; Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; Shriners Burn Hosp, Boston, MA 02114 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Johns Hopkins University; Stanford University; Stanford University; Stanford University; University of California System; University of California Irvine; University of British Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Boston University; University of Michigan System; University of Michigan; Salk Institute; Duke University; Howard Hughes Medical Institute; Duke University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Universite de Montreal; Howard Hughes Medical Institute; University of California System; University of California San Diego	Gilman, AG (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.		Gold, Michael/AAF-2081-2021; O'Connell, Timothy/D-5048-2013; Ivanova, Pavlina/K-8307-2012; Brekken, Deirdre/I-7999-2012; Lefkowitz, Robert/AAW-2649-2021; Arkin, Adam/M-9941-2019; Fraser, Iain DC/L-4735-2017; Cantley, Lewis C/D-1800-2014; Arkin, Adam P/A-6751-2008	Gold, Michael/0000-0003-1222-3191; Arkin, Adam/0000-0002-4999-2931; Fraser, Iain DC/0000-0003-2272-3907; Cantley, Lewis C/0000-0002-1298-7653; Arkin, Adam P/0000-0002-4999-2931; Meyer, Tobias/0000-0003-4339-3804; Cobb, Melanie/0000-0003-0833-5473; Casey, Patrick/0000-0002-7366-9309; Sinkovits, Robert/0000-0001-7377-9762; Brekken, Deirdre/0000-0003-2790-0108; Natarajan, Madhusudan/0000-0003-1607-2917	NCI NIH HHS [T32 CA121938] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	89	92	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					703	706		10.1038/nature01304	http://dx.doi.org/10.1038/nature01304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478301	Bronze, Green Published			2022-12-24	WOS:000179751800054
J	Buckley, NA; McManus, PR				Buckley, NA; McManus, PR			Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data	BRITISH MEDICAL JOURNAL			English	Article							OVERDOSE		Canberra Hosp, Dept Clin Pharmacol & Therapeut, Woden, ACT 2606, Australia; Canberra Hosp, Dept Pharm, Woden, ACT, Australia	Australian National University; Canberra Hospital; Australian National University; Canberra Hospital	Buckley, NA (corresponding author), Canberra Hosp, Dept Clin Pharmacol & Therapeut, POB 11, Woden, ACT 2606, Australia.		Buckley, Nicholas A/D-4030-2012	Buckley, Nicholas A/0000-0002-6326-4711				Buckley NA, 1998, DRUG SAFETY, V18, P369, DOI 10.2165/00002018-199818050-00006; HENRY JA, 1995, BRIT MED J, V310, P221, DOI 10.1136/bmj.310.6974.221; ISACSSON G, 1994, BRIT MED J, V309, P1546, DOI 10.1136/bmj.309.6968.1546; OWENS D, 1994, BRIT J PSYCHIAT, V165, P797, DOI 10.1192/bjp.165.6.797; Sarko J, 2000, EMERG MED CLIN N AM, V18, P637, DOI 10.1016/S0733-8627(05)70151-6	5	122	123	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2002	325	7376					1332	1333		10.1136/bmj.325.7376.1332	http://dx.doi.org/10.1136/bmj.325.7376.1332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625LC	12468481	Bronze, Green Published			2022-12-24	WOS:000179817100019
J	Belkaid, Y; Piccirillo, CA; Mendez, S; Shevach, EM; Sacks, DL				Belkaid, Y; Piccirillo, CA; Mendez, S; Shevach, EM; Sacks, DL			CD4(+)CD25(+) regulatory T cells control Leishmania major persistence and immunity	NATURE			English	Article							AZAR DERMAL LEISHMANIASIS; INTERFERON-GAMMA; KALA-AZAR; DENDRITIC CELLS; ACTIVATION; INTERLEUKIN-10; IL-10; SKIN; EXPRESSION; DISEASE	The long-term persistence of pathogens in a host that is also able to maintain strong resistance to reinfection, referred to as concomitant immunity, is a hallmark of certain infectious diseases, including tuberculosis and leishmaniasis. The ability of pathogens to establish latency in immune individuals often has severe consequences for disease reactivation(1-3). Here we show that the persistence of Leishmania major in the skin after healing in resistant C57BL/6 mice is controlled by an endogenous population of CD4(+)CD25(+) regulatory T cells. These cells constitute 5-10% of peripheral CD4(+) T cells in naive mice and humans, and suppress several potentially pathogenic responses in vivo, particularly T-cell responses directed against self-antigens(4). During infection by L. major, CD4(+)CD25(+) T cells accumulate in the dermis, where they suppress-by both interleukin-10-dependent and interleukin-10-independent mechanisms-the ability of CD4(+)CD25(-) effector T cells to eliminate the parasite from the site. The sterilizing immunity achieved in mice with impaired IL-10 activity is followed by the loss of immunity to reinfection, indicating that the equilibrium established between effector and regulatory T cells in sites of chronic infection might reflect both parasite and host survival strategies.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), Childrens Hosp, Div Mol Immunol, Res Fdn, 3333 Burnet Ave,MLC 7021, Cincinnati, OH 45229 USA.			Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000494, ZIAAI000224, Z01AI000224, Z01AI000494] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; ELHASSAN AM, 1992, T ROY SOC TROP MED H, V86, P245, DOI 10.1016/0035-9203(92)90294-M; Gasim S, 1998, CLIN EXP IMMUNOL, V111, P64; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Jankovic D, 2002, IMMUNITY, V16, P429, DOI 10.1016/S1074-7613(02)00278-9; KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mendez S, 2001, J IMMUNOL, V166, P5122, DOI 10.4049/jimmunol.166.8.5122; MOMENI AZ, 1994, INT J DERMATOL, V33, P260, DOI 10.1111/j.1365-4362.1994.tb01039.x; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Plebanski M, 1999, IMMUNITY, V10, P651, DOI 10.1016/S1074-7613(00)80064-3; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; von Stebut E, 1998, J EXP MED, V188, P1547, DOI 10.1084/jem.188.8.1547	26	1348	1429	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					502	507		10.1038/nature01152	http://dx.doi.org/10.1038/nature01152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466842				2022-12-24	WOS:000179611600045
J	Piskorowski, R; Aldrich, RW				Piskorowski, R; Aldrich, RW			Calcium activation of BKCa potassium channels lacking the calcium bowl and RCK domains	NATURE			English	Article							ALLOSTERIC GATING MECHANISM; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; CA CHANNELS; HAIR-CELLS; VOLTAGE; SENSITIVITY; CURRENTS; IDENTIFICATION; SUBUNIT	In many physiological systems such as neurotransmitter release, smooth muscle relaxation and frequency tuning of auditory hair cells, large-conductance calcium-activated potassium (BKCa) channels create a connection between calcium signalling pathways and membrane excitability(1-4). BKCa channels are activated by voltage and by micromolar concentrations of intracellular calcium. Although it is possible to open BKCa channels in the absence of calcium(5-9), calcium binding is essential for their activation under physiological conditions. In the presence of intracellular calcium, BKCa channels open at more negative membrane potentials(5,10-14). Many experiments investigating the molecular mechanism of calcium activation of the BKCa channel have focused on the large intracellular carboxy terminus, and much evidence supports the hypothesis that calcium-binding sites are located in this region of the channel. Here we show that BKCa channels that lack the whole intracellular C terminus retain wild-type calcium sensitivity. These results show that the intracellular C terminus, including the 'calcium bowl' and the RCK domain, is not necessary for the calcium-activated opening of these channels.	Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Aldrich, RW (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Sch Med, Stanford, CA 94305 USA.		Piskorowski, Rebecca Ann/G-6610-2017	Piskorowski, Rebecca Ann/0000-0003-0120-2360				Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; Braun AP, 2001, J PHYSIOL-LONDON, V533, P681, DOI 10.1111/j.1469-7793.2001.00681.x; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cox DH, 1997, J GEN PHYSIOL, V110, P257, DOI 10.1085/jgp.110.3.257; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krauss J K, 1996, Parkinsonism Relat Disord, V2, P35, DOI 10.1016/1353-8020(95)00018-6; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; MARTY A, 1981, NATURE, V291, P597; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Niu XW, 2002, P NATL ACAD SCI USA, V99, P11441, DOI 10.1073/pnas.172254699; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Rothberg BS, 1999, J GEN PHYSIOL, V114, P93, DOI 10.1085/jgp.114.1.93; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Stefani E, 1997, P NATL ACAD SCI USA, V94, P5427, DOI 10.1073/pnas.94.10.5427; Talukder G, 2000, BIOPHYS J, V78, P761, DOI 10.1016/S0006-3495(00)76634-3; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	30	56	57	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					499	502		10.1038/nature01199	http://dx.doi.org/10.1038/nature01199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466841				2022-12-24	WOS:000179611600044
J	de Quadros, CA; Epstein, D				de Quadros, CA; Epstein, D			Health as a bridge for peace: PAHO's experience	LANCET			English	Article									Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC 20037 USA; Pan Amer Hlth Org, Off Publ Informat, Washington, DC 20037 USA	Pan American Health Organization; Pan American Health Organization	de Quadros, CA (corresponding author), Pan Amer Hlth Org, Div Vaccines & Immunizat, 525 23rd St NW, Washington, DC 20037 USA.								0	11	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S25	S26		10.1016/S0140-6736(02)11808-3	http://dx.doi.org/10.1016/S0140-6736(02)11808-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504491				2022-12-24	WOS:000180064500012
J	Hogg, PJ; McLachlan, EM				Hogg, PJ; McLachlan, EM			Blood vessels and nerves: together or not?	LANCET			English	Editorial Material							GROWTH-FACTOR; ENDOTHELIAL-CELLS; BIOLOGY; PROLIFERATION; ANGIOGENESIS; REGENERATION; EXPRESSION		Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Med Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Prince Wales Medical Research Institute	Hogg, PJ (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.		McLachlan, Elspeth M/A-1844-2013	McLachlan, Elspeth M/0000-0003-0755-8747; Hogg, Philip/0000-0001-6486-2863				Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Jackman A, 2000, J COMP NEUROL, V418, P281; MITCHELL BS, 1994, TUMOR BIOL, V15, P269, DOI 10.1159/000217901; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Pincelli C, 2000, EUR J DERMATOL, V10, P85; Raychaudhuri SK, 2001, ARCH DERMATOL RES, V293, P291, DOI 10.1007/s004030100224; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Shima DT, 2000, CURR OPIN GENET DEV, V10, P536, DOI 10.1016/S0959-437X(00)00124-6; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Smith PG, 2002, CELL TISSUE RES, V307, P281, DOI 10.1007/s00441-001-0477-8; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709	14	6	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 30	2002	360	9347					1714	1714		10.1016/S0140-6736(02)11726-0	http://dx.doi.org/10.1016/S0140-6736(02)11726-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480422				2022-12-24	WOS:000179636800006
J	Bonduriansky, R; Brassil, CE				Bonduriansky, R; Brassil, CE			Rapid and costly ageing in wild male flies	NATURE			English	Article							EVOLUTIONARY; SENESCENCE; MORTALITY		Univ Toronto, Dept Zool, Evolutionary Ecol Grp, Toronto, ON M5S 3G5, Canada	University of Toronto	Bonduriansky, R (corresponding author), Univ Toronto, Dept Zool, Evolutionary Ecol Grp, Toronto, ON M5S 3G5, Canada.	russell.bonduriansky@utoronto.ca	Brassil, Chad E/A-1193-2008; Brassil, Chad/AAD-5244-2022	Brassil, Chad E/0000-0002-9611-7283; Brassil, Chad/0000-0002-9611-7283; Bonduriansky, Russell/0000-0002-5786-6951				ABRAMS PA, 1991, EVOL ECOL, V5, P343, DOI 10.1007/BF02214152; Bonduriansky R, 1997, CAN ENTOMOL, V129, P827, DOI 10.4039/Ent129827-5; Bonduriansky R, 1998, CAN ENTOMOL, V130, P399, DOI 10.4039/Ent130399-4; Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Partridge L, 1996, P ROY SOC B-BIOL SCI, V263, P1365, DOI 10.1098/rspb.1996.0200; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Roach DA, 2001, EXP GERONTOL, V36, P687, DOI 10.1016/S0531-5565(00)00235-7; Service PM, 2000, AM NAT, V156, P1, DOI 10.1086/303371; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	11	114	125	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					377	377		10.1038/420377a	http://dx.doi.org/10.1038/420377a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459773				2022-12-24	WOS:000179494700027
J	Fried, SI; Munch, TA; Werblin, FS				Fried, SI; Munch, TA; Werblin, FS			Mechanisms and circuitry underlying directional selectivity in the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; GANGLION-CELLS; MAMMALIAN RETINA; ACETYLCHOLINE; IMMUNOREACTIVITY; IDENTIFICATION; COMPUTATION; MORPHOLOGY; RESPONSES	In the retina, directionally selective ganglion cells respond with robust spiking to movement in their preferred direction, but show minimal response to movement in the opposite, or null, direction(1,2). The mechanisms and circuitry underlying this computation have remained controversial(3). Here we show, by isolating the excitatory and inhibitory inputs to directionally selective cells and measuring direct connections between these cells and presynaptic neurons, that a presynaptic interneuron, the starburst amacrine cell, delivers direct inhibition to directionally selective cells. The processes of starburst cells are connected asymmetrically to directionally selective cells: those pointing in the null direction deliver inhibition; those pointing in the preferred direction do not. Starburst cells project inhibition laterally ahead of a stimulus moving in the null direction. In addition, starburst inhibition is itself directionally selective: it is stronger for movement in the null direction. Excitation in response to null direction movement is reduced by an inhibitory signal acting at a site that is presynaptic to the directionally selective cell. The interplay of these components generates reduced excitation and enhanced inhibition in the null direction, thereby ensuring robust directional selectivity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Werblin, FS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 145 LSA, Berkeley, CA 94720 USA.		Fried, Shelley/S-7954-2016	Fried, Shelley/0000-0001-6456-8656; Munch, Thomas/0000-0002-8884-6961				BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; FAMIGLIETTI EV, 1992, J COMP NEUROL, V324, P322, DOI 10.1002/cne.903240303; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; LINN DM, 1991, J NEUROSCI, V11, P111; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1979, J CELL BIOL, V83, P159, DOI 10.1083/jcb.83.1.159; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; MILLS SL, 1992, J COMP NEUROL, V321, P133, DOI 10.1002/cne.903210112; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; POZNANSKI RR, 1992, B MATH BIOL, V54, P905; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vaney DI, 2000, J COMP NEUROL, V421, P1; Vaney DI, 2001, MOTION VISION, P13; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	28	270	277	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 28	2002	420	6914					411	414		10.1038/nature01179	http://dx.doi.org/10.1038/nature01179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459782				2022-12-24	WOS:000179494700038
J	Hedley, AJ; Wong, CM; Thach, TQ; Ma, S; Lam, TH; Anderson, HR				Hedley, AJ; Wong, CM; Thach, TQ; Ma, S; Lam, TH; Anderson, HR			Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; AIR-POLLUTION INTERVENTION; TIME-SERIES; HOSPITAL ADMISSIONS; RESPIRATORY HEALTH; CITIES; PARTICLES; CHILDREN; DIOXIDE; DEATHS	Background In July, 1990, a restriction was introduced over one weekend that required all power plants and road vehicles in Hong Kong to use fuel oil with a sulphur content of not more than 0.5% by weight. This intervention led to an immediate fall in ambient sulphur dioxide (SO2). We assessed the effect of this intervention on mortality over the next 5 years. Methods Changes in trends in deaths were estimated by a Poisson regression model of deaths each month between 1985 and 1995. Changes in seasonal deaths immediately after the intervention were measured by the increase in deaths from warm to cool season. We also estimated the annual proportional change in number of deaths before and after the intervention. We used age-specific death rates to estimate person-years of life gained. Findings In the first 12 months after introduction of the restriction, a substantial reduction in seasonal deaths was noted, followed by a peak in the cool-season death rate between 13 and 24 months, returning to the expected pattern during years 3-5. Compared with predictions, the intervention led to a significant decline in the average annual trend in deaths from all causes (2.1%; p=0.001), respiratory (3.9%; p=0.0014) and cardiovascular (2.0%; p=0.0214) diseases, but not from other causes. The average gain in life expectancy per year of exposure to the lower pollutant concentration was 20 days (females) to 41 days (males). Interpretation Pollution resulting from sulphur-rich fuels has an effect on death rates, especially respiratory and cardiovascular deaths. The outcome of the Hong Kong intervention provides direct evidence that control of this pollution has immediate and long-term health benefits.	Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; Univ London, St Georges Hosp Med Sch, Dept Publ Hlth Sci, London, England	University of Hong Kong; St Georges University London; University of London	Hedley, AJ (corresponding author), Univ Hong Kong, Dept Community Med, 5-F Acad & Adm Block,Fac Med Bldg,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	commed@hkucc.hku.hk	Wong, Chit Ming/C-4438-2009; Thach, Thuan-Quoc/C-4416-2009; Hedley, Anthony J/A-9113-2013; Anderson, Hugh R/A-7417-2016; Hedley, Anthony/C-4305-2009; Lam, Tai Hing/C-4317-2009	Thach, Thuan-Quoc/0000-0003-3404-3888; Lam, Tai Hing/0000-0002-2033-9971				Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; ANDERSON HR, 1999, AIR POLLUTION HLTH, P461; ANDERSON HR, 1976, BRIT MED J, V312, P649; Atkinson RW, 1999, ARCH ENVIRON HEALTH, V54, P398, DOI 10.1080/00039899909603371; BARRON WF, 1995, CONTEMP ECON POLICY, V13, P105, DOI 10.1111/j.1465-7287.1995.tb00736.x; Brunekreef B, 2000, AM J EPIDEMIOL, V151, P449; Brunekreef B, 1997, OCCUP ENVIRON MED, V54, P781, DOI 10.1136/oem.54.11.781; Buringh E, 2000, INHAL TOXICOL, V12, P55, DOI 10.1080/0895-8378.1987.11463181; DERRIENNIC F, 1989, INT J EPIDEMIOL, V18, P186, DOI 10.1093/ije/18.1.186; Gemmell I, 2000, INT J EPIDEMIOL, V29, P274, DOI 10.1093/ije/29.2.274; HEDLEY AJ, LANCET; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; KUHN L, 1994, AM J EPIDEMIOL, V140, P943, DOI 10.1093/oxfordjournals.aje.a117183; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450; OSTRO BD, 1999, AIR POLLUTION HLTH, P899; Peters J, 1996, INT J EPIDEMIOL, V25, P821, DOI 10.1093/ije/28.5.859; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; POPE CA, 1995, INHAL TOXICOL, V7, P1, DOI 10.3109/08958379509014267; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schlesinger R.B., 1999, AIR POLLUTION HLTH, P585, DOI [10.1016/B978-012352335-8/50101-0., DOI 10.1016/B978-012352335-8/50101-0]; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; Schwartz J, 2000, OCCUP ENVIRON MED, V57, P692, DOI 10.1136/oem.57.10.692; Spengler JD, 1996, ENVIRON HEALTH PERSP, V104, P492, DOI 10.2307/3432989; Wong CM, 2002, ENVIRON HEALTH PERSP, V110, P67, DOI 10.1289/ehp.0211067; Wong CM, 2001, ENVIRON HEALTH PERSP, V109, P335, DOI 10.2307/3454891; Wong CM, 1998, J EPIDEMIOL COMMUN H, V52, P571, DOI 10.1136/jech.52.9.571; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	28	212	217	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2002	360	9346					1646	1652		10.1016/S0140-6736(02)11612-6	http://dx.doi.org/10.1016/S0140-6736(02)11612-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618AE	12457788				2022-12-24	WOS:000179393900010
J	Wang, XC; Yang, CL; Chai, JJ; Shi, YG; Xue, D				Wang, XC; Yang, CL; Chai, JJ; Shi, YG; Xue, D			Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans	SCIENCE			English	Article							PROGRAMMED CELL DEATHS; CYTOCHROME-C RELEASE; SERINE-PROTEASE; ENDONUCLEASE-G; MITOCHONDRIA; IDENTIFICATION; ACTIVATION; MUTATIONS; INDUCTION; INTERACTS	Apoptosis-inducing factor (AIF), a mitochondrial oxidoreductase, is released into the cytoplasm to induce cell death in response to apoptotic signals. However, the mechanisms underlying this process have not been resolved. We report that inactivation of the Caenorhabditis elegans AIF homolog wah-1 by RNA interference delayed the normal progression of apoptosis and caused a defect in apoptotic DNA degradation. WAH-1 localized in C. elegans mitochondria and was released into the cytosol and nucleus by the BH3-domain protein EGL-1 in a caspase (CED-3)-dependent manner. In addition, WAH-1 associated and cooperated with the mitochondrial endonuclease CPS-6/endonuclease G (EndoG) to promote DNA degradation and apoptosis. Thus, AIF and EndoG de. ne a single, mitochondria-initiated apoptotic DNA degradation pathway that is conserved between C. elegans and mammals.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Colorado System; University of Colorado Boulder; Princeton University	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu		Chai, Jijie/0000-0001-7591-3873; XUE, DING/0000-0002-8429-8136; Shi, Yigong/0000-0003-2030-168X				Arnoult D, 2001, MOL BIOL CELL, V12, P3016, DOI 10.1091/mbc.12.10.3016; CAI J, UNPUB; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Horvitz HR, 1999, CANCER RES, V59, p1701S; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; SAVAGE C, 1994, J CELL SCI, V107, P2165; Song ZW, 1999, TRENDS CELL BIOL, V9, pM49, DOI 10.1016/S0968-0004(99)01485-1; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WANG X, UNPUB; Wang XD, 2001, GENE DEV, V15, P2922; Wu YC, 2000, GENE DEV, V14, P536	33	316	343	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1587	1592		10.1126/science.1076194	http://dx.doi.org/10.1126/science.1076194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446902				2022-12-24	WOS:000179361600040
J	Dalton, R				Dalton, R			Dinosaur curators plot mating game	NATURE			English	News Item																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					259	259		10.1038/420259b	http://dx.doi.org/10.1038/420259b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447410	Bronze			2022-12-24	WOS:000179340400011
J	Guan, ZH; Giustetto, M; Lomvardas, S; Kim, JH; Miniaci, MC; Schwartz, JH; Thanos, D; Kandel, ER				Guan, ZH; Giustetto, M; Lomvardas, S; Kim, JH; Miniaci, MC; Schwartz, JH; Thanos, D; Kandel, ER			Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; MOTOR SYNAPSES; IN-VIVO; FACILITATION; APLYSIA; CELL; FORM; IMMUNOPRECIPITATION; ACTIVATOR; TRANSIENT	Excitatory and inhibitory inputs converge on single neurons and are integrated into a coherent output. Although much is known about short-term integration, little is known about how neurons sum opposing signals for long-term synaptic plasticity and memory storage. In Aplysia, we find that when a sensory neuron simultaneously receives inputs from the facilitatory transmitter 5-HT at one set of synapses and the inhibitory transmitter FMRFamide at another, long-term facilitation is blocked and synapse-specific long-term depression dominates. Chromatin immunoprecipitation assays show that 5-HT induces the downstream gene C/EBP by activating CREB1, which recruits CBP for histone acetylation, whereas FMRFa leads to CREB1 displacement by CREB2 and recruitment of HDAC5 to deacetylate histones. When the two transmitters are applied together, facilitation is blocked because CREB2 and HDAC5 displace CREB1-CBP, thereby deacetylating histones.	Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute; Columbia University	Kandel, ER (corresponding author), Columbia Univ, Howard Hughes Med Inst, 1051 Riverside Dr, New York, NY 10032 USA.		Schwartz, John/AAO-8158-2021; giustetto, maurizio/D-6606-2011; Thanos, Dimitris/AAE-5720-2019	Schwartz, John/0000-0002-1660-8681; giustetto, maurizio/0000-0003-1323-4060; Lomvardas, Stavros/0000-0002-7668-3026; Miniaci, Maria/0000-0003-3844-0581	NIMH NIH HHS [MH48850] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Goodman RH, 2000, GENE DEV, V14, P1553; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee JA, 2001, LEARN MEMORY, V8, P220, DOI 10.1101/lm.40201; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MONTAROLO PG, 1988, NATURE, V333, P171, DOI 10.1038/333171a0; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Wagner BL, 2000, J BIOL CHEM, V275, P8263, DOI 10.1074/jbc.275.12.8263; Yamamoto N, 1999, J NEUROCHEM, V73, P2415, DOI 10.1046/j.1471-4159.1999.0732415.x	23	379	399	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 15	2002	111	4					483	493		10.1016/S0092-8674(02)01074-7	http://dx.doi.org/10.1016/S0092-8674(02)01074-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437922	Bronze			2022-12-24	WOS:000179346900002
J	Halloran, ME; Longini, IM; Nizam, A; Yang, Y				Halloran, ME; Longini, IM; Nizam, A; Yang, Y			Containing bioterrorist smallpox	SCIENCE			English	Article							TRANSMISSION	The need for a planned response to a deliberate introduction of smallpox has recently become urgent. We constructed a stochastic simulator of the spread of smallpox in structured communities to compare the effectiveness of mass vaccination versus targeted vaccination of close contacts of cases. Mass vaccination before smallpox introduction or immediately after the first cases was more effective than targeted vaccination in preventing and containing epidemics if there was no prior herd immunity (that is, no prior immunologic protection within the population). The effectiveness of postrelease targeted and mass vaccinations increased if we assumed that there was residual immunity in adults vaccinated before 1972, but the effectiveness of targeted vaccination increased more than that of mass vaccination. Under all scenarios, targeted vaccination prevented more cases per dose of vaccine than did mass vaccination. Although further research with larger-scale structured models is needed, our results suggest that increasing herd immunity, perhaps with a combination of preemptive voluntary vaccination and vaccination of first responders, could enhance the effectiveness of postattack intervention. It could also help targeted vaccination be more competitive with mass vaccination at both preventing and containing a deliberate introduction of smallpox.	Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Halloran, ME (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI32042] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bailey NTJ, 1957, MATH THEORY EPIDEMIC; Bicknell WJ, 2002, NEW ENGL J MED, V346, P1323, DOI 10.1056/NEJMsb020357; BROAD WJ, 2002, NY TIMES A      0615, P1; CHIN J, 2000, CONTROL COMMUNICABLE; DIECKMANN O, 1990, J MATH BIOL, V28, P365; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Fauci AS, 2002, NEW ENGL J MED, V346, P1319, DOI 10.1056/NEJM200204253461711; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; Frelinger JA, 2002, NEW ENGL J MED, V347, P689; Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Halloran ME, 2002, VACCINE, V20, P3254; HENDERSO.RH, 1969, AM J EPIDEMIOL, V90, P423, DOI 10.1093/oxfordjournals.aje.a121088; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; MACK TM, 1972, J INFECT DIS, V125, P161, DOI 10.1093/infdis/125.2.161; THOMAS DB, 1971, AM J EPIDEMIOL, V93, P373, DOI 10.1093/oxfordjournals.aje.a121270	17	221	229	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 15	2002	298	5597					1428	1432		10.1126/science.1074674	http://dx.doi.org/10.1126/science.1074674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615AF	12434061				2022-12-24	WOS:000179223100054
J	Sauer, FG; Pinkner, JS; Waksman, G; Hultgren, SJ				Sauer, FG; Pinkner, JS; Waksman, G; Hultgren, SJ			Chaperone priming of pilus subunits facilitates a topological transition that drives fiber formation	CELL			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PAPD-LIKE CHAPERONES; STRUCTURAL BASIS; P-PILI; URINARY-TRACT; BIOGENESIS; PROTEIN; ADHESIN; RECOGNITION; EXPRESSION	Periplasmic chaperones direct the assembly of adhesive, multi-subunit pilus fibers that play critical roles in bacterial pathogenesis. Pilus assembly occurs via a donor strand exchange mechanism in which the N-terminal extension of one subunit replaces the chaperone G(1) strand that transiently occupies a groove in the neighboring subunit. Here, we show that the chaperone primes the subunit for assembly by holding the groove in an open, activated conformation. During donor strand exchange, the subunit undergoes a topological transition that triggers the closure of the groove and seals the N-terminal extension in place. It is this topological transition, made possible only by the priming action of the chaperone that drives subunit assembly into the fiber.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63105 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63105 USA; UCL, Ludwig Inst Canc Res, London W1W 7BS, England; Univ London Birkbeck Coll, London WC1E 7HX, England	Washington University (WUSTL); Washington University (WUSTL); Ludwig Institute for Cancer Research; University of London; University College London; University of London; Birkbeck University London	Waksman, G (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave, St Louis, MO 63105 USA.	waksman@biochem.wustl.edu		Pinkner, Jerome/0000-0002-7389-7440	NIAID NIH HHS [R01AI48689, R01AI49950, R01AI29549] Funding Source: Medline; NIDDK NIH HHS [R01DK51406] Funding Source: Medline; NIGMS NIH HHS [R01GM54033, R01GM60231] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689, R01AI029549, R01AI049950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054033, R01GM060231] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Connell H, 1996, P NATL ACAD SCI USA, V93, P9827, DOI 10.1073/pnas.93.18.9827; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; GONG MF, 1992, J MOL BIOL, V228, P735, DOI 10.1016/0022-2836(92)90860-M; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hooton TM, 2000, URINARY TRACT INFECT, P1; HULL RA, 1981, INFECT IMMUN, V33, P933, DOI 10.1128/IAI.33.3.933-938.1981; HULTGREN SJ, 1996, ESCHERICHIA COLI SAL, P2730; Hung DL, 1996, EMBO J, V15, P3792, DOI 10.1002/j.1460-2075.1996.tb00753.x; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; KUEHN MJ, 1991, P NATL ACAD SCI USA, V88, P10586, DOI 10.1073/pnas.88.23.10586; KUEHN MJ, 1993, SCIENCE, V262, P1234, DOI 10.1126/science.7901913; LINDBERG F, 1989, J BACTERIOL, V171, P6052, DOI 10.1128/jb.171.11.6052-6058.1989; LUND B, 1987, P NATL ACAD SCI USA, V84, P5898, DOI 10.1073/pnas.84.16.5898; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MUHLDORFER I, 2001, MOL MED MICROBIOLOGY, P1515; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; SLONIM LN, 1992, EMBO J, V11, P4747, DOI 10.1002/j.1460-2075.1992.tb05580.x; Soto GE, 1998, EMBO J, V17, P6155, DOI 10.1093/emboj/17.21.6155; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; STANTON SL, 2000, URINARY TRACT INFECT, pR11; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; STRIKER R, 1994, J BIOL CHEM, V269, P12233; SUSSMAN M, 2001, MOL MED MICROBIOLOGY, P1507; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; Warren John W., 1996, P3	45	210	214	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 15	2002	111	4					543	551		10.1016/S0092-8674(02)01050-4	http://dx.doi.org/10.1016/S0092-8674(02)01050-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437927	Bronze			2022-12-24	WOS:000179346900007
J	Liu, CW; Corboy, MJ; DeMartino, GN; Thomas, PJ				Liu, CW; Corboy, MJ; DeMartino, GN; Thomas, PJ			Endoproteolytic activity of the proteasome	SCIENCE			English	Article							HIGH-MOLECULAR-WEIGHT; TRANSCRIPTION FACTOR; 26S PROTEASOME; 20S PROTEASOME; CORE PARTICLE; UBIQUITIN; DEGRADATION; ACTIVATION; CHAPERONE; PROTEINS	The proteasome plays a central role in the degradation of regulatory and misfolded proteins. Current models suggest that substrates access the internal catalytic sites by processively threading their termini through the gated substrate channel. Here, we found that latent (closed) and activated (open) proteasomes degraded two natively disordered substrates at internal peptide bonds even when they lacked accessible termini, suggesting that these substrates themselves promoted gating of the proteasome. This endoproteolysis provides a molecular mechanism for regulated release of transcription factors from inactive precursors as well as a means of accessing internal folding defects of misfolded multidomain proteins.	Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.		Thomas, Philip J/F-7115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049835, R37DK049835] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK049835, R01 DK049835, DK49835, DK46818] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Evans TC, 1999, J BIOL CHEM, V274, P18359, DOI 10.1074/jbc.274.26.18359; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1994, J BIOL CHEM, V269, P3539; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	30	315	320	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					408	411		10.1126/science.1079293	http://dx.doi.org/10.1126/science.1079293			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12481023	Green Accepted			2022-12-24	WOS:000180426800050
J	Kamath, RS; Fraser, AG; Dong, Y; Poulin, G; Durbin, R; Gotta, M; Kanapin, A; Le Bot, N; Moreno, S; Sohrmann, M; Welchman, DP; Zipperlen, P; Ahringer, J				Kamath, RS; Fraser, AG; Dong, Y; Poulin, G; Durbin, R; Gotta, M; Kanapin, A; Le Bot, N; Moreno, S; Sohrmann, M; Welchman, DP; Zipperlen, P; Ahringer, J			Systematic functional analysis of the Caenorhabditis elegans genome using RNAi	NATURE			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; GENE-EXPRESSION; C-ELEGANS; INTERFERENCE; SEQUENCE; DATABASE; GERMLINE; DOMAINS; SIRNAS	A principal challenge currently facing biologists is how to connect the complete DNA sequence of an organism to its development and behaviour. Large-scale targeted-deletions have been successful in defining gene functions in the single-celled yeast Saccharomyces cerevisiae, but comparable analyses have yet to be performed in an animal. Here we describe the use of RNA interference to inhibit the function of similar to86% of the 19,427 predicted genes of C. elegans. We identified mutant phenotypes for 1,722 genes, about two-thirds of which were not previously associated with a phenotype. We find that genes of similar functions are clustered in distinct, multi-megabase regions of individual chromosomes; genes in these regions tend to share transcriptional profiles. Our resulting data set and reusable RNAi library of 16,757 bacterial clones will facilitate systematic analyses of the connections among gene sequence, chromosomal location and gene function in C. elegans.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca 37007, Spain	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Ahringer, J (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	jaa@mole.bio.cam.ac.uk	Moreno, Sergio/K-3671-2014; Kanapin, Alexander/E-7632-2013; Kanapin, Alexander A/Q-7590-2016; Durbin, Richard/AAE-7178-2019	Moreno, Sergio/0000-0002-8039-1413; Kanapin, Alexander A/0000-0001-9802-5297; Durbin, Richard/0000-0002-9130-1006; Ahringer, Julie/0000-0002-7074-4051; Fraser, Andrew/0000-0001-9939-6014; Poulin, Gino/0000-0003-1016-348X; Le Bot, Nathalie/0000-0002-5258-2837	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; BARNES TM, 1995, GENETICS, V141, P159; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Kuwabara PE, 1999, CURR TOP DEV BIOL, V41, P99; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; SPELLMAN PT, 2002, J BIOL, V1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	40	2551	3034	9	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					231	237		10.1038/nature01278	http://dx.doi.org/10.1038/nature01278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529635				2022-12-24	WOS:000180397600038
J	Rosenstiel, TN; Potosnak, MJ; Griffin, KL; Fall, R; Monson, RK				Rosenstiel, TN; Potosnak, MJ; Griffin, KL; Fall, R; Monson, RK			Increased CO2 uncouples growth from isoprene emission in an agriforest ecosystem	NATURE			English	Article							BIOGENIC HYDROCARBONS; ATMOSPHERIC CO2; PLANTS; IMPACT; PATHWAY; LEAVES; OZONE; OAK	The emission of isoprene from the leaves of forest trees is a fundamental component of biosphere-atmosphere interactions, controlling many aspects of photochemistry in the lower atmosphere(1-3). As almost all commercial agriforest species emit high levels of isoprene(4), proliferation of agriforest plantations has significant potential to increase regional ozone pollution(5-7) and enhance the lifetime of methane(8), an important determinant of global climate. Here we show that growth of an intact Populus deltoides plantation under increased CO2 (800 mumol mol(-1) and 1,200 mumol mol(-1)) reduced ecosystem isoprene production by 21% and 41%, while above-ground biomass accumulation was enhanced by 60% and 82%, respectively. Exposure to increased CO2 significantly reduced the cellular content of dimethylallyl diphosphate, the substrate for isoprene synthesis, in both leaves and leaf protoplasts. We identify intracellular metabolic competition for phosphoenolpyruvate as a possible control point in explaining the suppression of isoprene emission under increased CO2. Our results highlight the potential for uncoupling isoprene emission from biomass accumulation in an agriforest species, and show that negative air-quality effects of proliferating agriforests may be offset by increases in CO2.	Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Columbia University	Rosenstiel, TN (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.		TATSUTA, HARUKI/F-2997-2010; Griffin, Kevin Lee/GWZ-4828-2022; Griffin, Kevin L./B-2629-2013	Griffin, Kevin L./0000-0003-4124-3757				BROWN S, 1996, CLIMATE CHANGE 1995, P776; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Crutzen PJ, 1999, TELLUS A, V51, P123, DOI 10.1034/j.1600-0870.1999.t01-1-00010.x; EDWARDS GE, 1978, ARCH BIOCHEM BIOPHYS, V190, P421, DOI 10.1016/0003-9861(78)90295-3; *FAO, 1995, FAO FOR SER, V30; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Fenning TM, 2002, TRENDS BIOTECHNOL, V20, P291, DOI 10.1016/S0167-7799(02)01983-2; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Gielen B, 2001, ENVIRON POLLUT, V115, P335, DOI 10.1016/S0269-7491(01)00226-3; Griffin KL, 2002, GLOBAL CHANGE BIOL, V8, P479, DOI 10.1046/j.1365-2486.2002.00487.x; Griffin KL, 2001, P NATL ACAD SCI USA, V98, P2473, DOI 10.1073/pnas.041620898; Harley P, 1997, TREE PHYSIOL, V17, P705; Harley PC, 1999, OECOLOGIA, V118, P109, DOI 10.1007/s004420050709; JENKINS CLD, 1989, PLANT PHYSIOL, V91, P1356, DOI 10.1104/pp.91.4.1356; Karl T, 2002, PLANTA, V215, P894, DOI 10.1007/s00425-002-0825-2; Lerdau M, 2002, TRENDS ECOL EVOL, V17, P309, DOI 10.1016/S0169-5347(02)02535-1; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; MAGIN NC, 1997, PLANT PHYSIOL, V115, P1681; MARINO BDV, 1999, BIOSPHERE 2 RES PRES; Monson RK, 2001, ANNU REV ECOL SYST, V32, P547, DOI 10.1146/annurev.ecolsys.32.081501.114136; MULLER JF, 1992, J GEOPHYS RES-ATMOS, V97, P3787, DOI 10.1029/91JD02757; Pierce T, 1998, J GEOPHYS RES-ATMOS, V103, P25611, DOI 10.1029/98JD01804; Poisson N, 2000, J ATMOS CHEM, V36, P157, DOI 10.1023/A:1006300616544; Rosenstiel TN, 2002, PLANT PHYSIOL, V129, P1276, DOI 10.1104/pp.002717; SANADZE GA, 1990, SOV PLANT PHYSIOL+, V37, P1; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; SHARKEY TD, 1991, PLANT CELL ENVIRON, V14, P333, DOI 10.1111/j.1365-3040.1991.tb01509.x; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998	30	245	250	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					256	259		10.1038/nature01312	http://dx.doi.org/10.1038/nature01312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529640				2022-12-24	WOS:000180397600044
J	Inoue, A; Saijo, Y; Maemondo, M; Gomi, K; Tokue, Y; Kimura, Y; Ebina, M; Kikuchi, T; Moriya, T; Nukiwa, T				Inoue, A; Saijo, Y; Maemondo, M; Gomi, K; Tokue, Y; Kimura, Y; Ebina, M; Kikuchi, T; Moriya, T; Nukiwa, T			Severe acute interstitial pneumonia and gefitinib	LANCET			English	Article								Gefitinib is an oral selective inhibitor of the epidermal growth factor receptor tyrosine kinase that is an effective treatment for patients with advanced non-small cell lung cancer who do not respond to platinum-based chemotherapy. We assessed four patients who had non-small cell lung cancer causing severe acute interstitial pneumonia in association with gefitinib. Although two patients recovered after treatment with steroids, the other two died from progressive respiratory dysfunction. On the basis of autopsies and bilateral distribution of diffuse ground-glass opacities In chest CTs, we diagnosed diffuse alveolar damage, which was consistent with acute interstitial pneumonia. Patients with interstitial pneumonia also had other pulmonary disorders such as previous thoracic irradiation and poor performance status. Physicians should be aware of the alveolar damage induced by gefitinib, especially for patients with these characteristic features.	Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Mol Med & Gene Transfer Res, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University	Inoue, A (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Aoba Ku, Sendai, Miyagi 9808575, Japan.	akinoue@idac.tohoku.ac.jp	Moriya, Takuya/AAM-6974-2020					FUKUOKA M, 2002, P AN M AM SOC CLIN, V22, pA298; Giaccone G, 2002, ANN ONCOL, V13, P217, DOI 10.1093/annonc/mdf663; Kris MG, 2002, P AN M AM SOC CLIN, V21, p292a; *PMDEC, 2002, REV GEF; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081	5	348	361	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					137	139		10.1016/S0140-6736(03)12190-3	http://dx.doi.org/10.1016/S0140-6736(03)12190-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531582				2022-12-24	WOS:000180428000014
J	Sutcliffe, SJ; Fox, KF; Wood, DA; Sutcliffe, A; Stock, K; Wright, M; Akhras, F; Langford, E				Sutcliffe, SJ; Fox, KF; Wood, DA; Sutcliffe, A; Stock, K; Wright, M; Akhras, F; Langford, E			Incidence of coronary heart disease in a health authority in London: review of a community register	BRITISH MEDICAL JOURNAL			English	Article							ANGINA-PECTORIS; PROGNOSIS		Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Natl Heart & Lung Inst, Cardiovasc Res Grp, London W6 8RF, England; Bromley Hosp, Bromley Hosp NHS Trust, London BR2 9AQ, England	Imperial College London	Wood, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Natl Heart & Lung Inst, Cardiovasc Res Grp, London W6 8RF, England.							*DEP HLTH, 1999, SAV LIV OUR HLTH NAT; *DEP HLTH, 2000, NAT SERV FRAM COR HE; GANDHI MM, 1995, BRIT HEART J, V73, P193; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Wood D, 1998, HEART, V80, pS1	5	19	19	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					20	20		10.1136/bmj.326.7379.20	http://dx.doi.org/10.1136/bmj.326.7379.20			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511455	Bronze, Green Published			2022-12-24	WOS:000180302000019
J	Abbott, A				Abbott, A			Genomics - Sorry, dogs - man's got a new best friend	NATURE			English	Editorial Material																		Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 26	2002	420	6917					729	729		10.1038/420729a	http://dx.doi.org/10.1038/420729a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490903	Bronze			2022-12-24	WOS:000179897300012
J	Crowcroft, NS; Catchpole, M				Crowcroft, NS; Catchpole, M			Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates	BRITISH MEDICAL JOURNAL			English	Article									Off Natl Stat, London SW1V 2QQ, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England	Public Health England	Crowcroft, NS (corresponding author), Off Natl Stat, London SW1V 2QQ, England.							*DEP HLTH STAT HEA, HOSP ACQ INF; PRATT SJ, 2001, J HOSP INFECT S, V47, pS3; Reacher MH, 2000, BMJ-BRIT MED J, V320, P213, DOI 10.1136/bmj.320.7229.213; Rooney C, 1999, HLTH STAT Q, P21; Speller DCE, 1997, LANCET, V350, P323, DOI 10.1016/S0140-6736(97)12148-1	5	44	45	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2002	325	7377					1390	1391		10.1136/bmj.325.7377.1390	http://dx.doi.org/10.1136/bmj.325.7377.1390			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CP	12480853	Green Published			2022-12-24	WOS:000179975000022
J	Funes, S; Davidson, E; Reyes-Prieto, A; Magallon, S; Herion, P; King, MP; Gonzalez-Halphen, D				Funes, S; Davidson, E; Reyes-Prieto, A; Magallon, S; Herion, P; King, MP; Gonzalez-Halphen, D			A green algal apicoplast ancestor	SCIENCE			English	Article							MITOCHONDRIAL GENOME; PARASITES; NUCLEAR; GENES; APICOMPLEXAN; EVOLUTION; PLASTIDS; ORIGIN; DNA		Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Jefferson University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Gonzalez-Halphen, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.		Gonzalez-Halphen, Diego/C-2664-2013; Funes, Soledad/A-1278-2010	Gonzalez-Halphen, Diego/0000-0003-0654-655X; Funes, Soledad/0000-0003-1815-1977; Magallon, Susana/0000-0002-6838-7497	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059646] Funding Source: NIH RePORTER; FIC NIH HHS [TW01176] Funding Source: Medline; NHLBI NIH HHS [HL59646] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; Fast NM, 2001, MOL BIOL EVOL, V18, P418, DOI 10.1093/oxfordjournals.molbev.a003818; Feagin JE, 2000, INT J PARASITOL, V30, P371, DOI 10.1016/S0020-7519(99)00190-3; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; McFadden GI, 1997, BIOESSAYS, V19, P1033, DOI 10.1002/bies.950191114; Nedelcu AM, 2000, GENOME RES, V10, P819, DOI 10.1101/gr.10.6.819; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	9	105	116	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2155	2155		10.1126/science.1076003	http://dx.doi.org/10.1126/science.1076003			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481129				2022-12-24	WOS:000179773700038
J	Lawlor, DA; Smith, GD; Leon, DA; Sterne, JAC; Ebrahim, S				Lawlor, DA; Smith, GD; Leon, DA; Sterne, JAC; Ebrahim, S			Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis	LANCET			English	Article							ACUTE CEREBROVASCULAR-DISEASE; CORONARY HEART-DISEASE; CIGARETTE-SMOKING; PROJECT 1981-86; ISCHEMIC STROKE; COMMUNITY; WOMEN; RISK; RENFREW/PAISLEY; POPULATIONS	Background Since both cerebral infarction and coronary heart disease are caused by atherosclerosis, they would be expected to have similar secular trends in mortality. Because differential diagnosis of stroke subtype on routine death certificates is inaccurate, we aimed to estimate secular trends in cerebral infarct and haemorrhage throughout the 20th century, for England and Wales, with data from autopsy studies. Methods We calculated the ratio of cerebral infarct to cerebral haemorrhage from all available sources of autopsy data from the 20th century. These data were used to estimate the ratio of cerebral infarct to haemorrhage for every year, and hence to estimate rates of cerebral infarct and cerebral haemorrhage from the total stroke mortality rate, obtained from the UK Office for National Statistics. Findings Data about stroke subtypes from autopsies were available from 1932 to 1999. The ratio of cerebral infarct to cerebral haemorrhage increased fourfold from 0.5 in the 1930s to 2.0 by the 1990s; most of the increase took place between the 1930s and the 1970s. Estimated secular trends suggested that there was a steady fall in mortality from cerebral haemorrhage throughout the 20th century, whereas mortality from cerebral infarct increased to a peak in the 1970s and then fell. Trends in estimated cerebral infarct mortality closely matched those for coronary heart disease mortality. Interpretation The closely related trends in cerebral infarct and coronary heart disease suggest common causes, but the very different trend in cerebral haemorrhage shows that its cause probably differs importantly from these conditions.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; London Sch Hyg & Trop Med, London WC1, England	University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	D.A.Lawlor@bristol.ac.uk	Leon, David A/G-2195-2010; Sterne, Jonathan/Z-3106-2019; Davey Smith, George/A-7407-2013	Leon, David A/0000-0001-9747-1762; Sterne, Jonathan/0000-0001-8496-6053; Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				ALLEN CMC, 1983, Q J MED, V52, P515; ANDERSON TW, 1968, LANCET, V1, P1137; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Charlton J., 1997, HLTH ADULT BRITAIN 1, VVolume 2, P60; CROFTON E, 1963, BRIT MED J, P1161, DOI 10.1136/bmj.2.5366.1161; Eriksson JG, 2000, STROKE, V31, P869, DOI 10.1161/01.STR.31.4.869; Falkeborn M, 1996, EPIDEMIOLOGY, V7, P67, DOI 10.1097/00001648-199601000-00012; Gale CR, 1997, J ROY SOC MED, V90, P138, DOI 10.1177/014107689709000307; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; HART CL, IN PRESS J EPIDEMIOL; *HER MAJ STAT OFF, 1956, REG GEN STAT REV ENG; Hypponen E, 2001, BRIT MED J, V323, P1033, DOI 10.1136/bmj.323.7320.1033; Kodama K, 1993, Ann Epidemiol, V3, P524; KULLER L, 1971, AM J EPIDEMIOL, V93, P1; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; McCarron P, 2001, J EPIDEMIOL COMMUN H, V55, P404, DOI 10.1136/jech.55.6.404; MITCHINSON MJ, 1980, LANCET, V1, P244; Newson R., 2000, STATA TECHNICAL B, V57, P20; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; SAKUGAWA H, 1999, J CLIN PATHOL, V47, P31; SANDERCOCK P, 1985, BRIT MED J, V290, P193, DOI 10.1136/bmj.290.6463.193; Shinton R, 1997, J EPIDEMIOL COMMUN H, V51, P138, DOI 10.1136/jech.51.2.138; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Smith GD, 1997, J EPIDEMIOL COMMUN H, V51, P134, DOI 10.1136/jech.51.2.134; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; TERENT A, 1988, STROKE, V19, P598, DOI 10.1161/01.STR.19.5.598; YATES PO, 1964, LANCET, V1, P65; YATES PO, 1961, MED RES COUNCIL SPEC, V300; [No title captured]	30	97	105	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2002	360	9348					1818	1823		10.1016/S0140-6736(02)11769-7	http://dx.doi.org/10.1016/S0140-6736(02)11769-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480358				2022-12-24	WOS:000179706100008
J	Fitzsimons, EJ; Sturrock, RD				Fitzsimons, EJ; Sturrock, RD			The chronic anaemia of rheumatoid arthritis: iron banking or blocking?	LANCET			English	Editorial Material							CHRONIC DISEASE		Univ Glasgow, Dept Haematol, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Fac Med, Ctr Rheumat Dis, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow; University of Glasgow	Fitzsimons, EJ (corresponding author), Univ Glasgow, Dept Haematol, Glasgow G11 6NT, Lanark, Scotland.	ejf1s@clinmed.gla.ac.uk						Davis D, 1997, BRIT J RHEUMATOL, V36, P950; DROSOS AA, 1990, CLIN RHEUMATOL, V9, P333, DOI 10.1007/BF02114393; Fitzsimons EJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P166, DOI 10.1002/art.10247; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08806.x; Leandro MJ, 2002, ANN RHEUM DIS, V61, P883, DOI 10.1136/ard.61.10.883; Papadaki HA, 2002, BLOOD, V99, P1610, DOI 10.1182/blood.V99.5.1610; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; Suominen P, 2000, ARTHRITIS RHEUM, V43, P1016, DOI 10.1002/1529-0131(200005)43:5<1016::AID-ANR9>3.0.CO;2-3	9	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2002	360	9347					1713	1714		10.1016/S0140-6736(02)11725-9	http://dx.doi.org/10.1016/S0140-6736(02)11725-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622FU	12480421				2022-12-24	WOS:000179636800005
J	Molinari, F; Rio, M; Meskenaite, V; Encha-Razavi, F; Auge, J; Bacq, D; Briault, S; Vekemans, M; Munnich, A; Attie-Bitach, T; Sonderegger, P; Colleaux, L				Molinari, F; Rio, M; Meskenaite, V; Encha-Razavi, F; Auge, J; Bacq, D; Briault, S; Vekemans, M; Munnich, A; Attie-Bitach, T; Sonderegger, P; Colleaux, L			Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation	SCIENCE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SERINE-PROTEASE; CHROMOSOMAL LOCALIZATION; GENE; POTENTIATION	A 4-base pair deletion in the neuronal serine protease neurotrypsin gene was associated with autosomal recessive nonsyndromic mental retardation (MR). In situ hybridization experiments on human fetal brains showed that neurotrypsin was highly expressed in brain structures involved in learning and memory. Immunoelectron microscopy on adult human brain sections revealed that neurotrypsin is located in presynaptic nerve endings, particularly over the presynaptic membrane lining the synaptic cleft. These findings suggest that neurotrypsin-mediated proteolysis is required for normal synaptic function and suggest potential insights into the pathophysiological bases of mental retardation.	INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France; Hop Necker Enfants Malad, Dept Genet, Paris, France; Univ Zurich, Inst Biochem, CH-8006 Zurich, Switzerland; Ctr Natl Genotypage, Evry, France; Hop Bretonneau, CHU Tours, Serv Genet, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Zurich; CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU Tours	Colleaux, L (corresponding author), INSERM, U393, Unite Rech Handicaps Genet Enfant, Paris, France.	colleaux@necker.fr	Molinari, Florence/M-7683-2016; COLLEAUX, LAURENCE/AAA-8144-2022; COLLEAUX, Laurence/H-6455-2017; ATTIE-BITACH, Tania/K-1453-2017	Molinari, Florence/0000-0001-5111-7215; COLLEAUX, LAURENCE/0000-0002-0987-7648; ATTIE-BITACH, Tania/0000-0002-1155-3626; Rio, Marlene/0000-0003-2049-5058				Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Carrie A, 1999, NAT GENET, V23, P25, DOI 10.1038/12623; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Frey U, 1996, J NEUROSCI, V16, P2057; GEZC J, 1996, NAT GENET, V13, P105; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; HIRATA A, 2000, CELL NEUROSCI, V17, P600; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; LAN Q, 1994, BBA-GENE STRUCT EXPR, V1218, P460, DOI 10.1016/0167-4781(94)90206-2; Luthi A, 1997, J NEUROSCI, V17, P4688; Meloni I, 2002, NAT GENET, V30, P436, DOI 10.1038/ng857; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; MOLINARI F, UNPUB; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; Stromme P, 2000, DEV MED CHILD NEUROL, V42, P76, DOI 10.1017/S0012162200000165; Tiso N, 1996, BIOCHEM BIOPH RES CO, V225, P983, DOI 10.1006/bbrc.1996.1282; Tombes RM, 1997, BBA-MOL CELL RES, V1355, P281, DOI 10.1016/S0167-4889(96)00141-3; TSE WT, 1991, GENOMICS, V10, P858, DOI 10.1016/0888-7543(91)90173-C; Wolfer DP, 2001, MOL CELL NEUROSCI, V18, P407, DOI 10.1006/mcne.2001.1029; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Yamamura Y, 1997, BIOCHEM BIOPH RES CO, V239, P386, DOI 10.1006/bbrc.1997.7417; Yoshida S, 1999, INT J MOL MED, V3, P405; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	30	151	161	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1779	1781		10.1126/science.1076521	http://dx.doi.org/10.1126/science.1076521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459588				2022-12-24	WOS:000179494800042
J	Pellizzoni, L; Yong, J; Dreyfuss, G				Pellizzoni, L; Yong, J; Dreyfuss, G			Essential role for the SMN complex in the specificity of snRNP assembly	SCIENCE			English	Article							SPINAL MUSCULAR-ATROPHY; SPLICEOSOMAL-U-SNRNP; DISEASE GENE-PRODUCT; FUNCTIONAL-ANALYSIS; PROTEINS ASSEMBLE; RNA-BINDING; CORE DOMAIN; M3G CAP; IDENTIFICATION; COMPONENT	The Survival of Motor Neurons (SMN) protein, the product of the spinal muscular atrophy-determining gene, is part of a large macromolecular complex (SMN complex) that functions in the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs). Using cell extracts and purified components, we demonstrated that the SMN complex is necessary and sufficient to mediate the ATP-dependent assembly of the core of seven Sm proteins on uridine-rich, small nuclear ribonucleic acids (U snRNAs). In vitro experiments revealed strict requirements for ordered binding of the Sm proteins and the U snRNAs to the SMN complex. Importantly, the SMN complex is necessary to ensure that Sm cores assemble only on correct RNA targets and prevent their otherwise promiscuous association with other RNAs. Thus, the SMN complex functions as a specificity factor essential for the efficient assembly of Sm proteins on U snRNAs and likely protects cells from illicit, and potentially deleterious, nonspecific binding of Sm proteins to RNAs.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.		Dreyfuss, Gideon/D-1218-2013	Dreyfuss, Gideon/0000-0001-8129-8774; Pellizzoni, Livio/0000-0002-9168-5628				Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Buhler D, 1999, HUM MOL GENET, V8, P2351, DOI 10.1093/hmg/8.13.2351; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; FISCHER U, 1990, SCIENCE, V249, P786, DOI 10.1126/science.2143847; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; FISCHER U, 1993, EMBO J, V12, P573, DOI 10.1002/j.1460-2075.1993.tb05689.x; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; KLEINSCHMIDT AM, 1989, NUCLEIC ACIDS RES, V17, P4817, DOI 10.1093/nar/17.12.4817; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; MATTAJ IW, 1985, CELL, V40, P111, DOI 10.1016/0092-8674(85)90314-9; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Palfi Z, 2000, P NATL ACAD SCI USA, V97, P8967, DOI 10.1073/pnas.150236097; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; SUMPTER V, 1992, MOL BIOL REP, V16, P229, DOI 10.1007/BF00419662; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; YONG J, UNPUB; Yong JS, 2002, EMBO J, V21, P1188, DOI 10.1093/emboj/21.5.1188	43	416	426	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1775	1779		10.1126/science.1074962	http://dx.doi.org/10.1126/science.1074962			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459587				2022-12-24	WOS:000179494800041
J	Rogina, B; Helfand, SL; Frankel, S				Rogina, B; Helfand, SL; Frankel, S			Longevity regulation by Drosophila Rpd3 deacetylase and caloric restriction	SCIENCE			English	Article							HISTONE DEACETYLASE; LIFE-SPAN		Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Univ Connecticut, Ctr Hlth, Sch Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Yale University; University of Connecticut	Frankel, S (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.	stewart.frankel@yale.edu		Rogina, Blanka/0000-0003-1195-905X	NIA NIH HHS [R37 AG016667] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG016667] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; DORN R, 1986, CHROMOSOMA, V93, P398, DOI 10.1007/BF00285820; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; PLETCHER S, COMMUNICATION; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3	9	209	227	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1745	1745		10.1126/science.1078986	http://dx.doi.org/10.1126/science.1078986			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459580				2022-12-24	WOS:000179494800032
J	Verghese, J; Lipton, RB; Hall, CB; Kuslansky, G; Katz, MJ; Buschke, H				Verghese, J; Lipton, RB; Hall, CB; Kuslansky, G; Katz, MJ; Buschke, H			Abnormality of gait as a predictor of non-Alzheimer's dementia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASCULAR DEMENTIA; DIAGNOSTIC-CRITERIA; CLINICAL-DIAGNOSIS; DISEASE; DISORDERS; DIFFERENTIATION; DISTURBANCES; PREVALENCE; DECLINE; MATTER	Background: Neurologic abnormalities affecting gait occur early in several types of non-Alzheimer's dementias, but their value in predicting the development of dementia is uncertain. Methods: We analyzed the relation between neurologic gait status at base line and the development of dementia in a prospective study involving 422 subjects older than 75 years of age who lived in the community and did not have dementia at base line. Cox proportional-hazards regression analysis was used to calculate hazard ratios with adjustment for potential confounding demographic, medical, and cognitive variables. Results: At enrollment, 85 subjects had neurologic gait abnormalities of the following types: unsteady gait (in 31 subjects), frontal gait (in 12 subjects), hemiparetic gait (in 11 subjects), neuropathic gait (in 11 subjects), ataxic gait (in 10 subjects), parkinsonian gait (in 8 subjects), and spastic gait (in 2 subjects). During follow-up (median duration, 6.6 years), there were 125 newly diagnosed cases of dementia, 70 of them cases of Alzheimer's disease and 55 cases of non-Alzheimer's dementia (47 of which involved vascular dementia and 8 of which involved other types of dementia). Subjects with neurologic gait abnormalities had a greater risk of development of dementia (hazard ratio, 1.96 [95 percent confidence interval, 1.30 to 2.96]). These subjects had an increased risk of non-Alzheimer's dementia (hazard ratio, 3.51 [95 percent confidence interval, 1.98 to 6.24]), but not of Alzheimer's dementia (hazard ratio, 1.07 [95 percent confidence interval, 0.57 to 2.02]). Of non-Alzheimer's dementias, abnormal gait predicted the development of vascular dementia (hazard ratio, 3.46 [95 percent confidence interval, 1.86 to 6.42]). Among the types of abnormal gait, unsteady gait predicted vascular dementia (hazard ratio, 2.61), as did frontal gait (hazard ratio, 4.32) and hemiparetic gait (hazard ratio, 13.13). Conclusions: The presence of neurologic gait abnormalities in elderly persons without dementia at base line is a significant predictor of the risk of development of dementia, especially non-Alzheimer's dementia.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA; Innovat Med Res & Ctr Healthier Aging Adv PCS, Hunt Valley, MD USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Verghese, J (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, 1165 Morris Pk Ave, Bronx, NY 10461 USA.	jverghes@aecom.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Lipton, Richard B/B-5060-2011; Hall, Charles B./AAX-8216-2020	Hall, Charles/0000-0001-9982-8120	NIA NIH HHS [AGO3949-15] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALA TA, 1995, ALZ DIS ASSOC DIS, V9, P152; Alexander NB, 1996, CLIN GERIATR MED, V12, P689; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; ARONSON MK, 1990, NEUROLOGY, V40, P1102, DOI 10.1212/WNL.40.7.1102; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bloem B R, 1992, J Geriatr Psychiatry Neurol, V5, P78; BRAAK H, 1989, NEUROPATH APPL NEURO, V15, P13, DOI 10.1111/j.1365-2990.1989.tb01146.x; Carmelli D, 2000, J GERONTOL A-BIOL, V55, pM103; Chui H, 2000, NEUROL CLIN, V18, P951, DOI 10.1016/S0733-8619(05)70234-6; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Chui HC, 2000, ARCH NEUROL-CHICAGO, V57, P191, DOI 10.1001/archneur.57.2.191; COX DR, 1972, J R STAT SOC B, V34, P187; Crystal HA, 2000, ARCH NEUROL-CHICAGO, V57, P713, DOI 10.1001/archneur.57.5.713; DAWSON D, 1987, NATIONAL CTR HLTH ST, V133, P1; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Esiri MM, 2000, ANN NY ACAD SCI, V903, P239, DOI 10.1111/j.1749-6632.2000.tb06373.x; Fleiss J, 1981, STAT METHODS RATES P, P38; Fratiglioni L, 1999, DRUG AGING, V15, P365, DOI 10.2165/00002512-199915050-00004; Fuh J L, 1994, J Geriatr Psychiatry Neurol, V7, P89; FULD PA, 1990, J CLIN EXP NEUROPSYC, V12, P520, DOI 10.1080/01688639008400998; Fuld PA., 1978, ALZHEIMERS DIS SENIL, V7, P185; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Groves WC, 2000, J NEUROPSYCH CLIN N, V12, P305, DOI 10.1176/appi.neuropsych.12.3.305; Hall CB, 2000, STAT MED, V19, P1555, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1555::AID-SIM445>3.0.CO;2-3; HENNERICI MG, 1994, DEMENTIA, V5, P197, DOI 10.1159/000106723; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikeda M, 2001, NEUROLOGY, V57, P839, DOI 10.1212/WNL.57.5.839; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KOTSORIS H, 1987, STROKE, V18, P138, DOI 10.1161/01.STR.18.1.138; Looi JCL, 1999, NEUROLOGY, V53, P670, DOI 10.1212/WNL.53.4.670; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; National Collaborative Group for the Revision of the Wechsler Adult Intelligence Scale, 1983, MANUAL WECHSLER ADUL, V03, P362; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; RAVEN JC, 1977, GUIDE STANDARD PROGR; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Skoog I, 1998, NEUROEPIDEMIOLOGY, V17, P2, DOI 10.1159/000026147; SUDARSKY L, 1990, NEW ENGL J MED, V322, P1441; TATEMICHI TK, 1994, NEUROLOGY, V44, P1885, DOI 10.1212/WNL.44.10.1885; Tiffin J., 1948, PURDUE PEGBOARD TEST; Verghese J, 1999, NEUROLOGY, V53, P1974, DOI 10.1212/WNL.53.9.1974; Waite LM, 2001, J NEUROL NEUROSUR PS, V71, P296, DOI 10.1136/jnnp.71.3.296; Whitman GT, 2001, NEUROLOGY, V57, P1942; ZUNG WWK, 1967, PSYCHOSOMATICS, V8, P287	50	463	477	2	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2002	347	22					1761	1768		10.1056/NEJMoa020441	http://dx.doi.org/10.1056/NEJMoa020441			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	619GU	12456852				2022-12-24	WOS:000179468600006
J	Li, QL; Park, PW; Wilson, CL; Parks, WC				Li, QL; Park, PW; Wilson, CL; Parks, WC			Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury	CELL			English	Article							MACROPHAGE-INFLAMMATORY PROTEIN-2; HEPARAN-SULFATE PROTEOGLYCANS; MEDIATED HOST-DEFENSE; CXC CHEMOKINE; METALLOPROTEINASE MATRILYSIN; RECEPTOR-2 LIGANDS; FAS LIGAND; MATRIX METALLOPROTEINASE-7; INCREASED SUSCEPTIBILITY; PULMONARY-FIBROSIS	The influx of inflammatory cells to sites of injury is largely directed by signals from the epithelium, but how these cells form chemotactic gradients is not known. In matrilysin null mice, neutrophils remained confined in the interstitium of injured lungs and did not advance into the alveolar space. Impaired transepithelial migration was accompanied by a lack of both shed syndecan-1, a heparan sulfate proteoglycan, and KC, a CXC chemokine, in the alveolar fluid. KC was bound to shed syndecan-1, and it was not detected in the lavage of syndecan-1 null mice. In vitro, matrilysin cleaved syndecan-1 from the surface of cells. Thus, matrilysin-mediated shedding of syndecan-1/KC complexes from the mucosal surface directs and confines neutrophil influx to sites of injury.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine	Parks, WC (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	parks_w@kids.wustl.edu	Sawant, Kirti V/H-3778-2013; Parks, William C./AAH-6786-2021	Park, Pyong Woo/0000-0002-7979-4979	NHLBI NIH HHS [HL69050, HL29594, R01 HL069050, HL54619] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069050, P01HL029594] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Aoshiba K, 2000, AM J RESP CRIT CARE, V162, P695, DOI 10.1164/ajrccm.162.2.9907012; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Corry DB, 2002, NAT IMMUNOL, V3, P347, DOI 10.1038/ni773; Cosgrove GP, 2002, CHEST, V121, p25S, DOI 10.1378/chest.121.3_suppl.25S-a; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Dumin JA, 2001, J BIOL CHEM, V276, P29368, DOI 10.1074/jbc.M104179200; Dunsmore SE, 1998, J CLIN INVEST, V102, P1321, DOI 10.1172/JCI1516; Endlich B, 2002, J IMMUNOL, V168, P3586, DOI 10.4049/jimmunol.168.7.3586; Fingleton B, 2001, NEOPLASIA, V3, P459, DOI 10.1038/sj.neo.7900190; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Keane MP, 1999, J IMMUNOL, V162, P5511; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Mehrad B, 1999, J IMMUNOL, V163, P6086; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mitsiades N, 2001, CANCER RES, V61, P577; Moore TA, 2000, J IMMUNOL, V164, P908, DOI 10.4049/jimmunol.164.2.908; Olszyna DP, 2001, J INFECT DIS, V184, P301, DOI 10.1086/322030; Ortiz LA, 1998, EXP LUNG RES, V24, P721, DOI 10.3109/01902149809099592; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Parks WC, 1999, WOUND REPAIR REGEN, V7, P423, DOI 10.1046/j.1524-475X.1999.00423.x; Piccolo MTS, 1999, EXP MOL PATHOL, V66, P220, DOI 10.1006/exmp.1999.2263; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wiekowski MT, 2001, J IMMUNOL, V167, P7102, DOI 10.4049/jimmunol.167.12.7102; WILSON CL, 1995, MOL BIOL CELL, V6, P851, DOI 10.1091/mbc.6.7.851; Wilson CL, 1998, BIOL EXTRAC, P149; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yoshidome H, 1999, J SURG RES, V81, P33, DOI 10.1006/jsre.1998.5490; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	49	611	631	6	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 27	2002	111	5					635	646		10.1016/S0092-8674(02)01079-6	http://dx.doi.org/10.1016/S0092-8674(02)01079-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464176	Bronze			2022-12-24	WOS:000179594500006
J	Harkins, L; Volk, AL; Samanta, M; Mikolaenko, I; Britt, WJ; Bland, KI; Cobbs, CS				Harkins, L; Volk, AL; Samanta, M; Mikolaenko, I; Britt, WJ; Bland, KI; Cobbs, CS			Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer	LANCET			English	Article							IE2 PROTEINS; INFECTION; EXPRESSION; COLON; ADENOCARCINOMA; INHIBITION; APOPTOSIS; PROMOTER; LESSONS; BCL-2	Background Colorectal cancer is the second most frequent cause of death from cancer in the USA, and most tumours arise sporadically with no clear cause or genetic predisposition. Human cytomegalovirus is a beta-herpesvirus that is endemic in the human population and can cause life-threatening disease in immunosuppressed adults. In vitro, human cytomegalovirus can transform cells and dysregulate many cellular pathways relevant to colon adenocarcinoma pathogenesis, especially those affecting the cell cycle, mutagenesis, apoptosis, angiogenesis, and cyclo-oxygenase2 (COX-2) expression. We aimed to assess whether gene products of human cytomegalovirus could be detected in colorectal cancers. Methods We obtained formalin-fixed, paraffin-embedded pathological specimens of colorectal polyps, adenocarcinomas, and adjacent normal mucosa from 29 patients. To detect human cytomegalovirus proteins and nucleic acids, we used immunohistochemistry with two different monoclonal antibodies, in-situ hybridisation, and PCR with DNA sequencing. Findings Human cytomegalovirus proteins lE1-72 and pp65 were detected in a tumour cell-specific pattern in 14 (82%) of 17 and seven (78%) of nine colorectal polyps, respectively, and 12 (80%) of 15 and 11 (92%) of 12 adenocarcinomas, respectively, but not in adjacent non-neoplastic colon biopsy samples from the same patients (none of seven and none of two, respectively). Human cytomegalovirus infection of colon-cancer cells (Caco-2) in vitro resulted in specific induction of Bcl-2 and cyclo-oxygenase-2 proteins, both of which are thought to contribute to progression of colon cancer. Interpretation Human cytomegalovirus nucleic acids and proteins can be found that, specifically localise to neoplastic cells in human colorectal polyps and adenocarcinomas, and virus infection can induce important oncogenic pathways in colon-cancer cells.	Birmingham Vet Affairs Hosp, Pathol Serv, Birmingham, AL USA; Birmingham Vet Affairs Hosp, Surg Serv, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Dept Paediat, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Dept Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cobbs, CS (corresponding author), UAB Med Ctr, Dept Surg, MEB 519,1813 6th Ave S, Birmingham, AL 35294 USA.	cscobbs@uabmc.edu						BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Bresnahan WA, 1998, J BIOL CHEM, V273, P22075, DOI 10.1074/jbc.273.34.22075; Britt W J, 1996, VIROLOGY, V3, P2493; Castillo JP, 2000, J VIROL, V74, P8028, DOI 10.1128/JVI.74.17.8028-8037.2000; Chen ZP, 2001, J VIROL, V75, P3613, DOI 10.1128/JVI.75.8.3613-3625.2001; Cinatl J, 1998, CANCER RES, V58, P367; Cinatl J, 1996, INTERVIROLOGY, V39, P259, DOI 10.1159/000150527; Cobbs CS, 2002, CANCER RES, V62, P3347; Doniger J, 1999, CLIN MICROBIOL REV, V12, P367, DOI 10.1128/CMR.12.3.367; FEARON ER, 2001, CANC PRINCIPLES PRAC, P1037; HAGEMEIER C, 1992, J GEN VIROL, V73, P2385, DOI 10.1099/0022-1317-73-9-2385; HART H, 1982, GUT, V23, P21, DOI 10.1136/gut.23.1.21; HASHIRO GM, 1979, INTERVIROLOGY, V12, P84, DOI 10.1159/000149072; Howley PM, 2001, CANC PRINCIPLES PRAC, P168; HUANG ES, 1978, LANCET, V1, P957, DOI 10.1016/s0140-6736(78)90248-9; Jarvis MA, 1999, J VIROL, V73, P4552, DOI 10.1128/JVI.73.6.4552-4560.1999; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KUHN JE, 1995, J MED VIROL, V47, P70, DOI 10.1002/jmv.1890470114; Loenen WAM, 2001, SEMIN IMMUNOL, V13, P41, DOI 10.1006/smim.2001.0294; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Muralidhar S, 1996, J VIROL, V70, P8691, DOI 10.1128/JVI.70.12.8691-8700.1996; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; RUGER R, 1985, KLIN WOCHENSCHR, V63, P405, DOI 10.1007/BF01733665; Shen YQ, 1997, P NATL ACAD SCI USA, V94, P3341, DOI 10.1073/pnas.94.7.3341; Sheng HM, 1998, CANCER RES, V58, P362; Sturzl M, 2001, ADV CANCER RES, V81, P125, DOI 10.1016/S0065-230X(01)81004-6; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Williams C, 1999, ANN NY ACAD SCI, V889, P72, DOI 10.1111/j.1749-6632.1999.tb08725.x; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	36	274	284	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2002	360	9345					1557	1563		10.1016/S0140-6736(02)11524-8	http://dx.doi.org/10.1016/S0140-6736(02)11524-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443594				2022-12-24	WOS:000179292400012
J	Heilig, R; Eckenberg, R; Petit, JL; Fonknechten, NR; Da Silva, C; Cattolico, L; Levy, M; Barbe, V; de Berardinis, V; Ureta-Vidal, A; Pelletier, E; Vico, V; Anthouard, V; Rowen, L; Madan, A; Qin, SZ; Sun, H; Du, H; Pepin, K; Artiguenave, F; Robert, C; Cruaud, C; Bruls, T; Jaillon, O; Friedlander, L; Samson, G; Brottier, P; Cure, S; Segurens, B; Aniere, F; Samain, S; Crespeau, H; Abbasi, N; Alach, N; Boscus, D; Dickhoff, R; Dors, M; Dubois, I; Friedman, C; Gouyvenoux, M; James, R; Madan, A; Malrey-Estrada, B; Mangenot, S; Martins, N; Menard, M; Oztas, S; Ratcliffe, A; Shaffer, T; Trask, B; Vacherle, B; Bellemere, C; Belser, C; Besnard-Gonnet, M; Bartol-Mavel, D; Boutard, M; Briez-Silla, S; Combette, S; Dufosse-Laurent, V; Ferron, C; Lechaplais, C; Louesse, C; Muselet, D; Magdelenat, G; Pateau, E; Petit, E; Sirvain-Trukniewicz, P; Trybou, A; Vega-Czarny, N; Bataille, E; Bluet, E; Bordelais, I; Dubois, M; Dumont, C; Guerin, T; Haffray, S; Hammadi, R; Muanga, J; Pellouin, V; Robert, D; Wunderle, E; Gauguet, G; Roy, A; Sainte-Marthe, L; Verdier, J; Verdier-Discala, C; Hillier, L; Fulton, L; McPherson, J; Matsuda, F; Wilson, R; Scarpelli, C; Gyapay, G; Wincker, P; Saurin, W; Quetier, F; Waterston, R; Hood, L; Weissenbach, J				Heilig, R; Eckenberg, R; Petit, JL; Fonknechten, NR; Da Silva, C; Cattolico, L; Levy, M; Barbe, V; de Berardinis, V; Ureta-Vidal, A; Pelletier, E; Vico, V; Anthouard, V; Rowen, L; Madan, A; Qin, SZ; Sun, H; Du, H; Pepin, K; Artiguenave, F; Robert, C; Cruaud, C; Bruls, T; Jaillon, O; Friedlander, L; Samson, G; Brottier, P; Cure, S; Segurens, B; Aniere, F; Samain, S; Crespeau, H; Abbasi, N; Alach, N; Boscus, D; Dickhoff, R; Dors, M; Dubois, I; Friedman, C; Gouyvenoux, M; James, R; Madan, A; Malrey-Estrada, B; Mangenot, S; Martins, N; Menard, M; Oztas, S; Ratcliffe, A; Shaffer, T; Trask, B; Vacherle, B; Bellemere, C; Belser, C; Besnard-Gonnet, M; Bartol-Mavel, D; Boutard, M; Briez-Silla, S; Combette, S; Dufosse-Laurent, V; Ferron, C; Lechaplais, C; Louesse, C; Muselet, D; Magdelenat, G; Pateau, E; Petit, E; Sirvain-Trukniewicz, P; Trybou, A; Vega-Czarny, N; Bataille, E; Bluet, E; Bordelais, I; Dubois, M; Dumont, C; Guerin, T; Haffray, S; Hammadi, R; Muanga, J; Pellouin, V; Robert, D; Wunderle, E; Gauguet, G; Roy, A; Sainte-Marthe, L; Verdier, J; Verdier-Discala, C; Hillier, L; Fulton, L; McPherson, J; Matsuda, F; Wilson, R; Scarpelli, C; Gyapay, G; Wincker, P; Saurin, W; Quetier, F; Waterston, R; Hood, L; Weissenbach, J			The DNA sequence and analysis of human chromosome 14	NATURE			English	Article							GENE; MAP; IDENTIFICATION; RECOMBINATION; LOCALIZATION; POLYMORPHISM; TRANSCRIPTS; MUTATIONS; FORM	Chromosome 14 is one of five acrocentric chromosomes in the human genome. These chromosomes are characterized by a heterochromatic short arm that contains essentially ribosomal RNA genes, and a euchromatic long arm in which most, if not all, of the protein-coding genes are located. The finished sequence of human chromosome 14 comprises 87,410,661 base pairs, representing 100% of its euchromatic portion, in a single continuous segment covering the entire long arm with no gaps. Two loci of crucial importance for the immune system, as well as more than 60 disease genes, have been localized so far on chromosome 14. We identified 1,050 genes and gene fragments, and 393 pseudogenes. On the basis of comparisons with other vertebrate genomes, we estimate that more than 96% of the chromosome 14 genes have been annotated. From an analysis of the CpG island occurrences, we estimate that 70% of these annotated genes are complete at their 5' end.	Genoscope Ctr Natl Sequencage, F-91000 Evry, France; CNRS, UMR 8030, F-91000 Evry, France; Univ Evry, F-91000 Evry, France; Ctr Natl Genotypage, F-91000 Evry, France; Inst Syst Biol, Seattle, WA 98103 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institute for Systems Biology (ISB); Washington University (WUSTL)	Heilig, R (corresponding author), Genoscope Ctr Natl Sequencage, F-91000 Evry, France.	heilig@genoscope.cns.fr	Belser, Caroline/X-5482-2019; Wilson, Richard K./AAF-4139-2019; Matsuda, Fumihiko/B-9893-2009; McPherson, John D/D-2633-2017; Jaillon, Olivier/GRY-6287-2022	Belser, Caroline/0000-0002-8108-9910; Wilson, Richard K./0000-0002-1992-1358; McPherson, John D/0000-0001-8049-9347; Petit, Jean-Louis/0000-0002-8566-0571; Vacherie, Benoit/0000-0002-1564-0575; Cruaud, Corinne/0000-0002-4752-7278; Pelletier, Eric/0000-0003-4228-1712; de Berardinis, Veronique/0000-0002-3273-4135; DA SILVA, Corinne/0000-0002-7618-7831				Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; Araki O, 1999, CYTOGENET CELL GENET, V84, P73, DOI 10.1159/000015218; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Chen CQ, 1997, J IMMUNOL, V159, P1310; Chu FF, 1996, GENOMICS, V32, P272, DOI 10.1006/geno.1996.0115; Clay O, 2001, GENE, V276, P25, DOI 10.1016/S0378-1119(01)00668-0; Dear PH, 1998, GENOMICS, V48, P232, DOI 10.1006/geno.1997.5140; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Erdmann VA, 1999, NUCLEIC ACIDS RES, V27, P192, DOI 10.1093/nar/27.1.192; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hernandez A, 1998, GENOMICS, V53, P119, DOI 10.1006/geno.1998.5505; Kamnasaran D, 2002, J MED GENET, V39, P81, DOI 10.1136/jmg.39.2.81; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wintle RF, 1997, GENOMICS, V40, P409, DOI 10.1006/geno.1996.4572; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhen YY, 2002, J CELL SCI, V115, P3207	39	83	589	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					601	U1		10.1038/nature01348	http://dx.doi.org/10.1038/nature01348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12508121	Bronze			2022-12-24	WOS:000180803200034
J	Casalino, L; Gillies, RR; Shortell, SM; Schmittdiel, JA; Bodenheimer, T; Robinson, JC; Rundall, T; Oswald, N; Schauffler, H; Wang, MC				Casalino, L; Gillies, RR; Shortell, SM; Schmittdiel, JA; Bodenheimer, T; Robinson, JC; Rundall, T; Oswald, N; Schauffler, H; Wang, MC			External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ILLNESS CARE; MANAGEMENT PROGRAMS; SELF-MANAGEMENT; DEPRESSION; INTERVENTIONS; ASTHMA; MODEL; PERFORMANCE; OUTCOMES; IMPACT	Context Organized care management processes (CMPs) can Improve healthcare quality for patients with chronic diseases. The Institute of Medicine of the National Academy of Sciences has called for public and private purchasers of health care to create incentives for physician organizations (POs) to use CMPs and for the government to assist POs in implementing information technology (IT) to facilitate CMP use. Research is lacking about the extent to which POs use CMPs or about the degree to which incentives, IT, or other factors are associated with their use. Objectives To determine the extent to which POs with 20 or more physicians use CMPs and to identify key factors associated with CMP use for 4 chronic diseases (asthma, congestive heart failure, depression, and diabetes). Design, Setting, and Participants One thousand five hundred eighty-seven US POs (medical groups and independent practice associations) with 20 or more physicians were identified using 5 large databases. one thousand one hundred four of these POs (70%) agreed to participate in a telephone survey conducted between September 2000 and September 2001. Sixty-four responding POs were excluded because they did not treat any of the 4 diseases, leaving 1040 POs. Main Outcome Measures Extent of use of CMPs as calculated on the basis of a summary measure, a PO care management index (POCMI; range, 0-6) and factors associated with CMP use. Results Physician organizations' mean use of CMPs was 5.1 of a possible 16; 50% used 4 or fewer. External incentives and clinical IT were most strongly associated with CMP use, Controlling for other factors, use of the 2 most strongly associated incentives-public recognition and better contracts for health care quality-was associated with use of 1.3 and 0.7 additional CMPs, respectively (P<.001 and P=.007). Each additional IT capability was associated with 0.37 additional CMPs (P<.001). However, 33% of POs reported no external incentives and 50% reported no clinical IT capability. Conclusions The use of CMPs varies greatly among POs, but it is low on average. Government and private purchasers of health care may increase CMP use by providing external incentives for improvement of health care quality to POs and by assisting them in improving their clinical IT capability.	Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; Healthcare Consulting, Berkeley, CA USA	University of Chicago; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Casalino, L (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	casalino@health.bsd.uchicago.edu	Casalino, Lawrence/ABE-1245-2020; Greiver, Michelle/N-8764-2015; Young, Alexander/A-1523-2009; Tao, Youyou/D-2367-2014	Casalino, Lawrence/0000-0002-7927-7859; Greiver, Michelle/0000-0001-8957-0285; Young, Alexander/0000-0002-9367-9213; 				*AG HEALTHC RES QU, PARTN QUAL; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Becher EC, 2001, HEALTH AFFAIR, V20, P68, DOI 10.1377/hlthaff.20.3.68; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bonomi AE, 2002, HEALTH SERV RES, V37, P791, DOI 10.1111/1475-6773.00049; BURNES B, 1995, LOGISTICS FOCUS, V3, P10; Burns LR, 2000, AD HEA CA M, V1, P273; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Christianson JB, 2002, HEALTH AFFAIR, V21, P76, DOI 10.1377/hlthaff.21.1.76; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; Dudley RA, 2000, MED CARE RES REV, V57, P116, DOI 10.1177/107755800773743754; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Enthoven AC, 2002, J HEALTH POLIT POLIC, V27, P37, DOI 10.1215/03616878-27-1-37; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; GRIFFIN S, 2000, COCHRANE REV; Griffin SJ, 2001, BRIT MED J, V323, P946, DOI 10.1136/bmj.323.7319.946; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Hersh WR, 2002, JAMA-J AM MED ASSOC, V288, P1955, DOI 10.1001/jama.288.16.1955; Holloway F, 2001, INT J SOC PSYCHIATR, V47, P21, DOI 10.1177/002076400104700303; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2002, LEAD EX COORD GOV RO; Jessup M, 2001, NEW ENGL J MED, V345, P1490, DOI 10.1056/NEJMed010109; Jowers JR, 2000, AM J MANAG CARE, V6, P585; Kerr EA, 1996, JAMA-J AM MED ASSOC, V276, P1236, DOI 10.1001/jama.276.15.1236; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P1377, DOI 10.1001/jama.279.17.1377; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Leatherman ST, 2002, QUALITY HLTH CARE US; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Maxwell J, 2002, J HEALTH POLIT POLIC, V27, P5, DOI 10.1215/03616878-27-1-5; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McGlynn EA, 2001, HEALTH AFFAIR, V20, P82, DOI 10.1377/hlthaff.20.3.82; Miller RH, 2002, J HEALTH POLIT POLIC, V27, P401, DOI 10.1215/03616878-27-3-401; *NAT COMM QUAL ASS, HLTH PLAN EMPL DAT I; *NAT HEART LUNG BL, 1996, CONGESTIVE HEART FAI; Newhouse JP, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.4.13; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; OBRIEN MAT, 2002, COCHRANE REV; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Philbin EF, 1999, J GEN INTERN MED, V14, P130, DOI 10.1046/j.1525-1497.1999.00291.x; *R WOOD JOHNS FDN, REW RES AL INC HIGH; Renders CM, 2001, DIABETES CARE, V24, P1365, DOI 10.2337/diacare.24.8.1365; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rich MW, 2001, AM J MED, V110, P410, DOI 10.1016/S0002-9343(01)00632-5; ROBINSON JC, 1999, CALIF MILBANK S, P1; Rossiter LF, 2000, INQUIRY-J HEALTH CAR, V37, P188; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Schoenbaum M, 2001, JAMA-J AM MED ASSOC, V286, P1325, DOI 10.1001/jama.286.11.1325; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shortell SM, 2001, MED CARE, V39, pI62; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P171; Songer TJ, 1998, STUDIES COST DIABETE; Thomson O'Brien MA, 2000, COCHRANE DB SYST REV, V2; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; WAGNER EH, 2001, IT COMM J QUAL IMPRO, V27, P63; WEINGARTEN S, 2002, BMJ-BRIT MED J, V325; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wholey DR, 1997, HEALTH AFFAIR, V16, P75, DOI 10.1377/hlthaff.16.6.75	74	358	359	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					434	441		10.1001/jama.289.4.434	http://dx.doi.org/10.1001/jama.289.4.434			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533122	Bronze, Green Published			2022-12-24	WOS:000180472300024
J	Rajagopal, J; Anderson, WJ; Kume, S; Martinez, OI; Melton, DA				Rajagopal, J; Anderson, WJ; Kume, S; Martinez, OI; Melton, DA			Insulin staining of ES cell progeny from insulin uptake	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; PANCREATIC-ISLETS; IN-VITRO		Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Young, Richard A/F-6495-2012; Kume, Shoen/M-4356-2016	Young, Richard A/0000-0001-8855-8647; Kume, Shoen/0000-0002-4292-205X; Anderson, William/0000-0001-7823-8340				Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; BENVENISTY N, COMMUNICATION; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Ramiya VK, 2000, NAT MED, V6, P278; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	9	372	446	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					363	363						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532008				2022-12-24	WOS:000180426800035
J	Chen, YH; Xu, SJ; Bendahhou, S; Wang, XL; Wang, Y; Xu, WY; Jin, HW; Sun, H; Su, XY; Zhuang, QN; Yang, YQ; Li, YB; Liu, Y; Xu, HJ; Li, XF; Ma, N; Mou, CP; Chen, Z; Barhanin, J; Huang, W				Chen, YH; Xu, SJ; Bendahhou, S; Wang, XL; Wang, Y; Xu, WY; Jin, HW; Sun, H; Su, XY; Zhuang, QN; Yang, YQ; Li, YB; Liu, Y; Xu, HJ; Li, XF; Ma, N; Mou, CP; Chen, Z; Barhanin, J; Huang, W			KCNQ1 gain-of-function mutation in familial atrial fibrillation	SCIENCE			English	Article							LONG QT SYNDROME; CARDIAC-ARRHYTHMIAS; POTASSIUM CHANNEL; KVLQT1; INTERVAL	Atrial fibrillation (AF) is a common cardiac arrhythmia whose molecular etiology is poorly understood. We studied a family with hereditary persistent AF and identified the causative mutation (S140G) in the KCNQ1 (KvLQT1) gene on chromosome 11p15.5. The KCNQ1 gene encodes the pore-forming alpha subunit of the cardiac I-Ks channel (KCNQ1/KCNE1), the KCNQ1/KCNE2 and the KCNQ1/KCNE3 potassium channels. Functional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome. Thus, the S140G mutation is likely to initiate and maintain AF by reducing action potential duration and effective refractory period in atrial myocytes.	Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China; Tongji Univ, Inst Med Genet, Shanghai 200065, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Hlth Sci Ctr, Inst Biol Sci, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Shanghai 200025, Peoples R China; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Sophia Antipolis, France; Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom, Shanghai 200025, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Chen, YH (corresponding author), Tongji Hosp, Dept Cardiol, 399 Xin Cun Rd, Shanghai 200065, Peoples R China.	drchen@public7.sta.net.cn; xusj@chgc.sh.cn						Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Cannom DS, 2000, AM J CARDIOL, V85, p25D; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lai LP, 2002, AM HEART J, V144, P485, DOI 10.1067/mhj.2002.123573; Mazhari R, 2002, J CLIN INVEST, V109, P1083, DOI 10.1172/JCI200215062; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; PAI GR, 1989, BRIT HEART J, V61, P510; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SEED WA, 1987, BRIT HEART J, V57, P32; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x	21	718	772	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					251	254		10.1126/science.1077771	http://dx.doi.org/10.1126/science.1077771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522251				2022-12-24	WOS:000180284000039
J	Wakabayashi, C; Adachi, T; Wienands, R; Tsubata, T				Wakabayashi, C; Adachi, T; Wienands, R; Tsubata, T			A distinct signaling pathway used by the IgG-containing B cell antigen receptor	SCIENCE			English	Article							CO-RECEPTORS; CD22; ACTIVATION; LYMPHOCYTES; CD72; ASSOCIATION; RESPONSES; COMPLEX; ROLES; MICE	The immunoglobulin G (IgG)-containing B lymphocyte antigen receptor (IgG-BCR) transmits a signal distinct from that of IgM-BCR or IgD-BCR, although all three use the same signal-transducing component, Igalpha/Igbeta. Here we demonstrate that the inhibitory coreceptor CD22 down-modulates signaling through IgM-BCR and IgD-BCR, but not that through IgG-BCR, because of the IgG cytoplasmic tail, which prevents CD22 phosphorylation. These results suggest that the cytoplasmic tail of IgG specifically enhances IgG-BCR signaling by preventing CD22-mediated signal inhibition. Enhanced signaling through IgG-BCR may be involved in efficient IgG production, which is crucial for immunity to pathogens.	Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan; Univ Freiburg, Dept Mol Immunol Biol 3, D-79108 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Tokyo Medical & Dental University (TMDU); University of Freiburg; Max Planck Society	Tsubata, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo 1138510, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258				Adachi T, 2000, J IMMUNOL, V164, P1223, DOI 10.4049/jimmunol.164.3.1223; Adachi T, 1998, J IMMUNOL, V160, P4662; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; LEPRINCE C, 1993, P NATL ACAD SCI USA, V90, P3236, DOI 10.1073/pnas.90.8.3236; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; ORourke L, 1997, CURR OPIN IMMUNOL, V9, P324, DOI 10.1016/S0952-7915(97)80077-5; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pan C, 1999, IMMUNITY, V11, P495, DOI 10.1016/S1074-7613(00)80124-7; PEAKER CJG, 1993, EUR J IMMUNOL, V23, P1358, DOI 10.1002/eji.1830230626; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Tsubata T, 1999, CURR OPIN IMMUNOL, V11, P249, DOI 10.1016/S0952-7915(99)80041-7; WAKABAYASHI C, UNPUB; WEISER P, 1994, EUR J IMMUNOL, V24, P665, DOI 10.1002/eji.1830240327; WIENANDS J, 1990, EMBO J, V9, P449, DOI 10.1002/j.1460-2075.1990.tb08130.x	23	139	145	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2392	2395		10.1126/science.1076963	http://dx.doi.org/10.1126/science.1076963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493916				2022-12-24	WOS:000179915900058
J	Willner, I				Willner, I			Biomaterials for sensors, fuel cells, and circuitry	SCIENCE			English	Article							GLUCOSE-OXIDASE; DNA; IMMUNOSENSOR; ELECTRODES		Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Willner, I (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	willnea@vms.huji.ac.il						Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Caruana DJ, 1999, J AM CHEM SOC, V121, P769, DOI 10.1021/ja983328p; Chen T, 2001, J AM CHEM SOC, V123, P8630, DOI 10.1021/ja0163164; DIGLERIA K, 1986, ANAL CHEM, V58, P1203, DOI 10.1021/ac00297a050; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; HELLER A, 1992, J PHYS CHEM-US, V96, P3579, DOI 10.1021/j100188a007; Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8; Katz E, 2001, J AM CHEM SOC, V123, P10752, DOI 10.1021/ja0167102; KONIG B, 1993, ANAL CHIM ACTA, V280, P37, DOI 10.1016/0003-2670(93)80238-G; Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S; Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P2323, DOI 10.1002/1521-3773(20020703)41:13<2323::AID-ANIE2323>3.0.CO;2-H; Patolsky F, 2002, J AM CHEM SOC, V124, P770, DOI 10.1021/ja0119752; Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P3398, DOI 10.1002/1521-3773(20020916)41:18<3398::AID-ANIE3398>3.0.CO;2-W; Patolsky F, 2001, ANGEW CHEM INT EDIT, V40, P2261, DOI 10.1002/1521-3773(20010618)40:12<2261::AID-ANIE2261>3.0.CO;2-P; Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704; RISHPON J, 1989, BIOSENSORS, V4, P61, DOI 10.1016/0265-928X(89)80023-9; SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048; Takenaka S, 2000, ANAL CHEM, V72, P1334, DOI 10.1021/ac991031j; Wang LM, 2000, J AM CHEM SOC, V122, P7435, DOI 10.1021/ja0010195; Weizmann Y, 2001, ANALYST, V126, P1502, DOI 10.1039/b106613g; Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611; Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E; Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1; Willner I, 2001, ANGEW CHEM INT EDIT, V40, P1861; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698	26	279	289	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2407	2408		10.1126/science.298.5602.2407	http://dx.doi.org/10.1126/science.298.5602.2407			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493919				2022-12-24	WOS:000179915900062
J	Annas, GJ				Annas, GJ			Moral progress, mental retardation, and the death penalty	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CAPITAL-PUNISHMENT; PARTICIPATION		Boston Univ, Sch Publ Hlth, Dept Hlth Law, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ALLEN DF, 1979, ETHICAL ISSUES MENTA, P17; ANNAS GJ, 1985, AM J PUBLIC HEALTH, V75, P1096, DOI 10.2105/AJPH.75.9.1096; BERTHOFF W, 1966, GREAT SHORT WORKS H, P419; *BRIT MED ASS, 2001, MED PROF HUM RIGHTS, P163; CURRAN WJ, 1980, NEW ENGL J MED, V302, P226, DOI 10.1056/NEJM198001243020410; FRADY M, 1993, NEW YORKER      0222, P132; Glover J, 2000, HUMANITY MORAL HIST; KAMINER W, 2002, NY TIMES MAGAZI 0707, P7; LeGraw JM, 2002, HUM RIGHTS QUART, V24, P382, DOI 10.1353/hrq.2002.0027; Lichtblau E., 2002, NY TIMES, pA1; MAILER N, 1979, EXECUTIONERS SONG, P985; Olgiati C., 1993, GUARDIAN        1012, P18; ROOT J, 1909, FT WORTH STAR T 0413, P12; SHAPIRO B, 2002, NATION          0722, P14; TRUOG RD, 1993, NEW ENGL J MED, V329, P1346, DOI 10.1056/NEJM199310283291812	15	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2002	347	22					1814	1818		10.1056/NEJMlim021990	http://dx.doi.org/10.1056/NEJMlim021990			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	619GU	12456866	Green Published			2022-12-24	WOS:000179468600033
J	Savolainen, P; Zhang, YP; Luo, J; Lundeberg, J; Leitner, T				Savolainen, P; Zhang, YP; Luo, J; Lundeberg, J; Leitner, T			Genetic evidence for an East Asian origin of domestic dogs	SCIENCE			English	Article							WOLF	The origin of the domestic dog from wolves has been established, but the number of founding events, as well as where and when these occurred, is not known. To address these questions, we examined the mitochondrial DNA (mtDNA) sequence variation among 654 domestic dogs representing all major dog populations worldwide. Although our data indicate several maternal origins from wolf, >95% of all sequences belonged to three phylogenetic groups universally represented at similar frequencies, suggesting a common origin from a single gene pool for all dog populations. A larger genetic variation in East Asia than in other regions and the pattern of phylogeographic variation suggest an East Asian origin for the domestic dog, similar to15,000 years ago.	Royal Inst Technol KTH, Dept Biotechnol, S-10691 Stockholm, Sweden; Chinese Acad Sci, Kunming Inst Zool, Yunnan Lab Mol Biol Domest Anim, Kunming 650223, Peoples R China; Chinese Acad Sci, Kunming Inst Zool, Lab Mol Evolut & Genome Divers, Kunming 650223, Peoples R China; Swedish Inst Infect Dis Control, Dept Virol, S-17182 Solna, Sweden	Royal Institute of Technology; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Swedish Institute for Infectious Disease Control	Savolainen, P (corresponding author), Royal Inst Technol KTH, Dept Biotechnol, S-10691 Stockholm, Sweden.							BENECKE N, 1987, J ARCHAEOL SCI, V14, P31, DOI 10.1016/S0305-4403(87)80004-3; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Clutton-Brock Juliet, 1995, P7; CLUTTONBROCK J, 1990, J ARCHAEOL SCI, V17, P643, DOI 10.1016/0305-4403(90)90046-8; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; DEGERBOL M, 1961, P PREHIST SOC, V27, P35, DOI 10.1017/S0079497X0001598X; Fu YX, 1997, GENETICS, V147, P915; Kurten B., 1980, PLEISTOCENE MAMMALS; LAWRENCE BARBARA, 1967, Z SAUGETIERKUNDE, V32, P44; LI Q, 1990, CHIN J CYNOLOGY, V2, P25; NOBIS G, 1979, UMSCHAU, V79, P610; Okumura N, 1996, ANIM GENET, V27, P397, DOI 10.1111/j.1365-2052.1996.tb00506.x; Olsen S, 1985, ORIGINS DOMESTIC DOG; OLSEN SJ, 1977, SCIENCE, V197, P533, DOI 10.1126/science.197.4303.533; POSADA D, 2001, MODELTEST 3 06; Swofford D., 2002, PAUP 4 0B10; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; WAYNE RK, 1993, TRENDS GENET, V9, P218, DOI 10.1016/0168-9525(93)90122-X	20	597	640	9	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 22	2002	298	5598					1610	1613		10.1126/science.1073906	http://dx.doi.org/10.1126/science.1073906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446907				2022-12-24	WOS:000179361600046
J	Yu, MK; Wu, P; Widelitz, RB; Chuong, CM				Yu, MK; Wu, P; Widelitz, RB; Chuong, CM			The morphogenesis of feathers	NATURE			English	Article							INTEGUMENTARY STRUCTURES; ADHESION MOLECULES; DINOSAUR; ORIGIN; CHINA; EXPRESSION; EVOLUTION; INDUCTION	Feathers are highly ordered, hierarchical branched structures(1,2) that confer birds with the ability of flight(3-5). Discoveries of fossilized dinosaurs in China bearing 'feather-like' structures have prompted interest in the origin and evolution of feathers(6-14). However, there is uncertainty about whether the irregularly branched integumentary fibres on dinosaurs such as Sinornithosaurus are truly feathers(11), and whether an integumentary appendage with a major central shaft and notched edges is a non-avian feather or a proto-feather(8-10). Here, we use a developmental approach to analyse molecular mechanisms in feather-branching morphogenesis. We have used the replication-competent avian sarcoma retrovirus(15) to deliver exogenous genes to regenerating flight feather follicles of chickens. We show that the antagonistic balance between noggin and bone morphogenetic protein 4 (BMP4) has a critical role in feather branching, with BMP4 promoting rachis formation and barb fusion, and noggin enhancing rachis and barb branching. Furthermore, we show that sonic hedgehog (Shh) is essential for inducing apoptosis of the marginal plate epithelia, which results in spaces between barbs. Our analyses identify the molecular pathways underlying the topological transformation of feathers from cylindrical epithelia to the hierarchical branched structures, and provide insights on the possible developmental mechanisms in the evolution of feather forms.	Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California	Chuong, CM (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 2011 Zonal Ave, Los Angeles, CA 90033 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR042177-07S1, R01 AR042177-05, R01 AR042177, R01 AR042177-06, R01 AR042177-06S1, R01 AR042177-07] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Calabretta R, 2000, ARTIF LIFE, V6, P69, DOI 10.1162/106454600568320; Chatterjee S., 1997, THE RISE OF BIRDS; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chuong C-M, 1998, MOL BASIS EPITHELIAL; CHUONG CM, 1985, J CELL BIOL, V101, P1027, DOI 10.1083/jcb.101.3.1027; CHUONG CM, 1993, BIOESSAYS, V15, P513, DOI 10.1002/bies.950150804; Chuong CM, 2001, EUR J DERMATOL, V11, P286; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dudley AT, 2000, CURR OPIN GENET DEV, V10, P387, DOI 10.1016/S0959-437X(00)00101-5; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Gill FB, 1994, ORNITHOLOGY, V2nd; Harris MP, 2002, J EXP ZOOL, V294, P160, DOI 10.1002/jez.10157; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; LUCAS AM, 1972, AGR HDB USDA, V362; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2001, J EXP ZOOL, V291, P30, DOI 10.1002/jez.4; Prum RO, 2001, SCIENCE, V291, P1899; REGAL PJ, 1975, Q REV BIOL, V50, P35, DOI 10.1086/408299; TingBerreth SA, 1996, DEV DYNAM, V207, P157, DOI 10.1002/(SICI)1097-0177(199610)207:2<157::AID-AJA4>3.0.CO;2-G; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955	30	164	175	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					308	312		10.1038/nature01196	http://dx.doi.org/10.1038/nature01196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12442169	Green Accepted			2022-12-24	WOS:000179340400040
J	Jain, A; Brennan, F; Nanchahal, J				Jain, A; Brennan, F; Nanchahal, J			Treatment of rheumatoid tenosynovitis with cytokine inhibitors	LANCET			English	Article								Hand function depends on tendon integrity, but in rheumatoid arthritis tenosynovitis can result in tendon adhesions and rupture. Cytokine inhibitors have proved effective in rheumatoid joint disease; however, their effect on the tenosynovium is not well understood. We investigated the ability of inhibitors of tumour necrosis factor alpha and interleukin 1 to reduce production of collagenolytic matrix metalloproteinases 1 and 13 in tenosynovial tissue obtained from patients with rheumatoid arthritis. Our data show that cytokine blockade can reduce collagenase concentrations in tenosynovial tissue, suggesting cytokine inhibitors could be effective in reduction of tendon damage.	Imperial Coll Sch Med, Kennedy Inst Rheumatol, London W6 8LH, England; Imperial Coll Sch Med, Dept Musculoskeletal Surg, London W6 8LH, England	Imperial College London; University of Oxford; Imperial College London	Jain, A (corresponding author), Imperial Coll Sch Med, Kennedy Inst Rheumatol, Charing Cross Hosp Campus,Arthrit Res Campaign Bl, London W6 8LH, England.	AJainUK@aol.com		Nanchahal, Jagdeep/0000-0002-9579-9411				BROWN FE, 1988, J HAND SURG-AM, V13A, P704, DOI 10.1016/S0363-5023(88)80129-1; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Jain A, 2001, ARTHRITIS RHEUM, V44, P1754, DOI 10.1002/1529-0131(200108)44:8<1754::AID-ART310>3.0.CO;2-8; Kaiser MJ, 2002, ARTHRITIS RHEUM, V46, P559, DOI 10.1002/art.10082; Woessner J.F., 2000, PROTEIN PROFILE SER	5	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2002	360	9345					1565	1566		10.1016/S0140-6736(02)11529-7	http://dx.doi.org/10.1016/S0140-6736(02)11529-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443596				2022-12-24	WOS:000179292400014
J	LaBarge, MA; Blau, HM				LaBarge, MA; Blau, HM			Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury	CELL			English	Article							SATELLITE CELL; CARDIAC-MUSCLE; X-IRRADIATION; SKELETAL; REGENERATION; EXPRESSION; TRANSPLANTATION; MYOBLASTS; PROLIFERATION; PURIFICATION	Adult bone marrow-derived cells (BMDC) are shown to contribute to muscle tissue in a step-wise biological progression. Following irradiation-induced damage, transplanted GFP-labeled BMDC become satellite cells: membrane-ensheathed mononucleate muscle stem cells. Following a subsequent exercise-induced damage, GFP-labeled multinucleate myofibers are detected. Isolated GFP-labeled satellite cells are heritably myogenic. They express three characteristic muscle markers, are karyotypically diploid, and form clones that can fuse into multinucleate cells in culture or into myofibers; after injection into mouse muscles. These results suggest that two temporally distinct injury-related signals first induce BMDC to occupy the muscle stem cell niche and then to help regenerate mature muscle fibers. The stress-induced progression of BMDC to muscle satellite cell to muscle fiber results in a contribution to as many as 3.5% of muscle fibers and is due to developmental plasticity in response to environmental cues.	Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, CCSR 4215, Stanford, CA 94305 USA.	hblau@stanford.edu	LaBarge, Mark A/E-2621-2013	LaBarge, Mark/0000-0003-2405-4719	NHLBI NIH HHS [HL65572] Funding Source: Medline; NIA NIH HHS [AG20961, AG00259, AG09521] Funding Source: Medline; NICHD NIH HHS [HD18179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020961, R37AG009521, R01AG009521] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; BAO ZZ, 1993, J CELL SCI, V106, P579; Baroffio A, 1996, DIFFERENTIATION, V60, P47, DOI 10.1046/j.1432-0436.1996.6010047.x; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Bittner RE, 1999, ANAT EMBRYOL, V199, P391, DOI 10.1007/s004290050237; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Ferrari G, 2001, NATURE, V411, P1014, DOI 10.1038/35082631; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; GOYER RA, 1967, RADIAT RES, V30, P301, DOI 10.2307/3572054; Grounds MD, 1999, CURR OPIN NEUROL, V12, P535, DOI 10.1097/00019052-199910000-00007; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; GULATI AK, 1987, J NEUROL SCI, V78, P111, DOI 10.1016/0022-510X(87)90083-9; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Heslop L, 2000, J CELL SCI, V113, P2299; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Warren S, 1943, ARCH PATHOL, V35, P304; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x	46	600	649	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2002	111	4					589	601		10.1016/S0092-8674(02)01078-4	http://dx.doi.org/10.1016/S0092-8674(02)01078-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437931	Bronze			2022-12-24	WOS:000179346900011
J	Mikkola, HKA; Klintman, J; Yang, HD; Hock, H; Schlaeger, TM; Fujiwara, Y; Orkin, SH				Mikkola, HKA; Klintman, J; Yang, HD; Hock, H; Schlaeger, TM; Fujiwara, Y; Orkin, SH			Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene	NATURE			English	Article							TRANSCRIPTION FACTOR SCL; HEMATOPOIETIC LINEAGES; MICE; PROGENITOR; ERYTHROPOIESIS; MESODERM; PROTEINS; BINDING	The production of blood cells is sustained throughout the lifetime of an individual by haematopoietic stem cells (HSCs)(1). Specification of HSCs from mesoderm during embryonic development requires the stem cell leukaemia SCL/tal-1 gene product(2-6). Forced expression of SCL/tal-1 strongly induces blood formation in embryos, indicating that this gene has a dominant role in commitment to haematopoiesis(7,8). In the adult haematopoietic system, expression of SCL/tal-1 is enriched in HSCs and multipotent progenitors, and in erythroid and megakaryocytic lineages(9-11), consistent with roles for this factor in adult haematopoiesis. Here we assess by conditional gene targeting whether SCL/tal-1 is required continuously for the identity and function of HSCs. We find that SCL/tal-1 is dispensable for HSC engraftment, self-renewal and differentiation into myeloid and lymphoid lineages; however, the proper differentiation of erythroid and megakaryocytic precursors is dependent on SCL/tal-1. Thus, SCL/tal-1 is essential for the genesis of HSCs, but its continued expression is not essential for HSC functions. These findings contrast with lineage choice mechanisms, in which the identity of haematopoietic lineages requires continuous transcription factor expression(12,13).	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat Oncol, Boston, MA 02115 USA.			Schlaeger, Thorsten/0000-0002-1599-9908; Klintman, Jenny/0000-0002-9544-5058				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Cantor AB, 2002, MOL CELL BIOL, V22, P4268, DOI 10.1128/MCB.22.12.4268-4279.2002; Choi K, 1998, DEVELOPMENT, V125, P725; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Faloon P, 2000, DEVELOPMENT, V127, P1931; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Mead PE, 2001, DEVELOPMENT, V128, P2301; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Porcher C, 1999, DEVELOPMENT, V126, P4603; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Robertson SM, 2000, DEVELOPMENT, V127, P2447; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yamamoto Hiroyuki, 1995, Journal of Marine Biotechnology, V2, P95; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	24	295	299	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 30	2003	421	6922					547	551		10.1038/nature01345	http://dx.doi.org/10.1038/nature01345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640DB	12540851				2022-12-24	WOS:000180670600049
J	Hyman, SE; Fenton, WS				Hyman, SE; Fenton, WS			Medicine: What are the right targets for psychopharmacology?	SCIENCE			English	Editorial Material							SCHIZOPHRENIA; DYSFUNCTION; DEFICITS		NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA; Harvard Univ, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University	Fenton, WS (corresponding author), NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA.	SEH@harvard.edu; wfenton@mail.nih.gov						American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Center for Mental Health Services and National Institute of Mental Health, 1999, MENT HLTH REP SURG G; Cowan WM, 2002, ANNU REV NEUROSCI, V25, P1, DOI 10.1146/annurev.neuro.25.112701.142853; Freedman R, 2000, AM J MED GENET, V97, P58, DOI 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO;2-Y; Friedman JI, 1999, BIOL PSYCHIAT, V45, P1, DOI 10.1016/S0006-3223(98)00287-X; Friedman JI, 2001, AM J PSYCHIAT, V158, P1441, DOI 10.1176/appi.ajp.158.9.1441; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hyman SE, 2002, PSYCHOPATHOLOGY, V35, P139, DOI 10.1159/000065134; KENDLER KS, 1995, AM J PSYCHIAT, V152, P749; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kindermann SS, 1997, SCHIZOPHR RES, V27, P143, DOI 10.1016/S0920-9964(97)00063-7; Merikangas K, 2002, ACTA PSYCHIAT SCAND, V105, P3, DOI 10.1034/j.1600-0447.2002.01001.x; Mitchell RLC, 2001, TRENDS COGN SCI, V5, P71, DOI 10.1016/S1364-6613(00)01599-0; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838; World Health Organisation, 1993, ICD 10 CLASS MENT BE	22	215	224	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					350	351		10.1126/science.1077141	http://dx.doi.org/10.1126/science.1077141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532001				2022-12-24	WOS:000180426800028
J	Lyte, M; Freestone, PPE; Neal, CP; Olson, BA; Haigh, RD; Bayston, R; Williams, PH				Lyte, M; Freestone, PPE; Neal, CP; Olson, BA; Haigh, RD; Bayston, R; Williams, PH			Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes	LANCET			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INTENSIVE-CARE UNIT; BACTERIAL BIOFILMS; INFECTIONS; ADHERENCE; MORTALITY; ADHESION; RP62A; IRON	Background Bacterial colonisation of indwelling medical devices by coagulase-negative staphylococci is a prevalent risk in intensive-care units. Factors determining biofilm formation and progression to catheter related infection are incompletely understood. We postulated that administration of inotropic agents via indwelling intravenous catheters may stimulate growth and formation of biofilms by Staphylococcus epidermidis. Methods Inocula representing physiologically relevant infecting doses of S epidermidis were incubated in a minimum medium supplemented with fresh human plasma in the presence or absence of pharmacological concentrations of norepinephrine or dobutamine. Biofilm formation on polystyrene and medical-grade silicone was examined. After incubation, cultures were assessed for growth and formation of biofilms by colony counting and scanning electronmicroscopy. The production of exopolysaccharide, a major constituent of S epidermidis biofilms, was also assessed by use of immunofluorescence microscopy. Findings Incubation of S epidermidis with catecholamine inotropes in the presence of human plasma resulted in a significant increase in growth compared with control on both polystyrene and silicone surfaces, with pronounced increases in biofilm formation as visualised by scanning electronmicroscopy. Experiments with transferrin labelled with radioactive iron showed the ability of catecholamine inotropes to facilitate acquisition of iron by S epidermidis. Immunofluorescence microscopy revealed extensive exopolysaccharide production associated with S epidermidis biofilms. Interpretation The ability of catecholamine inotropic drugs to stimulate bacterial proliferation and biofilm formation may be an aetiological factor in the development of intravascular catheter colonisation and catheter-related infection. The removal of iron from transferrin for subsequent use by S epidermidis is a possible mechanism by which catecholamine inotropes stimulate bacterial growth as biofilms.	Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Dept Surg, Minneapolis, MN 55404 USA; Minnesota State Univ Mankato, Dept Biol Sci, Mankato, MN USA; Univ Leicester, Dept Microbiol & Immunol, Leicester, Leics, England; Univ Nottingham, Div Orthopaed & Accid Surg, Biomat Related Infect Grp, Nottingham NG7 2RD, England	Hennepin County Medical Center; Minneapolis Medical Research Foundation; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Leicester; University of Nottingham	Lyte, M (corresponding author), Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Dept Surg, 914 S 8th St,D3, Minneapolis, MN 55404 USA.	lytex001@umn.edu	Lyte, Mark/AAI-7602-2020; Bayston, Roger/E-7699-2019; Bayston, Roger/AAD-5427-2019; Lyte, Mark/C-3865-2008	Lyte, Mark/0000-0001-8512-2581; Bayston, Roger/0000-0002-8312-3844; Haigh, Richard/0000-0001-8597-9980	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050431] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50431] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CLAWSON CC, 1971, AM J PATHOL, V65, P381; COOPER EV, 1946, LANCET, V250, P459; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442, DOI 10.1128/JCM.28.11.2442-2447.1990; EVANS DG, 1948, BRIT J EXP PATHOL, V29, P20; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Galloway MT, 1998, AM HEART J, V135, P888, DOI 10.1016/S0002-8703(98)70051-1; GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877; INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0; Linton CJ, 1999, J APPL MICROBIOL, V86, P194, DOI 10.1046/j.1365-2672.1999.00650.x; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; LYTE M, 1992, LIFE SCI, V50, P203, DOI 10.1016/0024-3205(92)90273-R; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9; Neal CP, 2001, FEMS MICROBIOL LETT, V194, P163, DOI 10.1016/S0378-1097(00)00523-1; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; RELLO J, 1994, INTENS CARE MED, V20, P94, DOI 10.1007/BF01707661; Renaud M, 1930, CR SOC BIOL, V103, P1052; Roberts A, 2002, ORAL MICROBIOL IMMUN, V17, P296, DOI 10.1034/j.1399-302X.2002.170506.x; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; SMYTHE MA, 1993, CRIT CARE MED, V21, P1319, DOI 10.1097/00003246-199309000-00014; Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000	30	145	158	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					130	135		10.1016/S0140-6736(03)12231-3	http://dx.doi.org/10.1016/S0140-6736(03)12231-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531580				2022-12-24	WOS:000180428000012
J	Kikuchi, K; Terauchi, K; Wada, M; Hirano, HY				Kikuchi, K; Terauchi, K; Wada, M; Hirano, HY			The plant MITE mPing is mobilized in anther culture	NATURE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; REPETITIVE-DNA ELEMENTS; ARABIDOPSIS-THALIANA; FAMILY; RICE; GENOME; MAIZE; TOURIST; GENE; AMPLIFICATION	Transposable elements constitute a large portion of eukaryotic genomes and contribute to their evolution and diversification. Miniature inverted-repeat transposable elements (MITEs) constitute one of the main groups of transposable elements and are distributed ubiquitously in the genomes of plants and animals 1 such as maize(2-5), rice(3), Arabidopsis(6,7), human(8), insect(9,10) and nematode(11). Because active MITEs have not been identified, the transposition mechanism of MITEs and their accumulation in eukaryotic genomes remain poorly understood. Here we describe a new class of MITE, called miniature Ping (mPing), in the genome of Oryza sativa (rice). mPing elements are activated in cells derived from anther culture, where they are excised efficiently from original sites and reinserted into new loci. An mPing-associated Ping element, which has a putative PIF family(5) transposase, is implicated in the recent proliferation of this MITE family in a subspecies of rice.	Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Tokyo 1920397, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Metropolitan University	Hirano, HY (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.		Hirano, Hiro-Yuki/G-4928-2014	Hirano, Hiro-Yuki/0000-0001-7364-8893				Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; BUREAU TE, 1994, P NATL ACAD SCI USA, V91, P1411, DOI 10.1073/pnas.91.4.1411; Casacuberta E, 1998, PLANT J, V16, P79, DOI 10.1046/j.1365-313x.1998.00267.x; Feschotte C, 2000, MOL BIOL EVOL, V17, P730, DOI 10.1093/oxfordjournals.molbev.a026351; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2000, GENE, V250, P109, DOI 10.1016/S0378-1119(00)00187-6; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano HY, 1998, MOL BIOL EVOL, V15, P978, DOI 10.1093/oxfordjournals.molbev.a026013; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Morishima H., 1992, OXFORD SURV EVOL BIO, V8, P135; NEGISHI T, 1994, Patent No. 06036698; Raina SK, 1997, PL BRED RE, V15, P141; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Surzycki SA, 2000, P NATL ACAD SCI USA, V97, P245, DOI 10.1073/pnas.97.1.245; Surzycki SA, 1999, J MOL EVOL, V48, P684, DOI 10.1007/PL00006512; Tu ZJ, 2000, MOL BIOL EVOL, V17, P1313, DOI 10.1093/oxfordjournals.molbev.a026415; WESSLER S, 1990, P NATL ACAD SCI USA, V87, P8731, DOI 10.1073/pnas.87.22.8731; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	23	212	240	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					167	170		10.1038/nature01218	http://dx.doi.org/10.1038/nature01218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520303				2022-12-24	WOS:000180267200041
J	Nelson, C; Goto, S; Lund, K; Hung, W; Sadowski, I				Nelson, C; Goto, S; Lund, K; Hung, W; Sadowski, I			Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12	NATURE			English	Article							POLYMERASE-II HOLOENZYME; SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; CELL-TYPE; KINASE; ACTIVATION	The budding yeast Saccharomyces cerevisiae differentiates into filamentous invasively growing forms under conditions of nutrient limitation(1,2). This response is dependent on the transcription factor Ste12 and on the mating pheromone-response mitogen-activated protein (MAP) kinase cascade 1, but a mechanism for regulation of Ste12 by nutrient limitation has not been defined. Here we show that Ste12 function in filamentous growth is regulated by the cyclin-dependent kinase Srb10 (also known as Cdk8), which is associated with the RNA polymerase II holoenzyme. Srb10 inhibits filamentous growth in cells growing in rich medium by phosphorylating Ste12 and decreasing its stability. Under conditions of limiting nitrogen, loss of Srb10 protein and kinase activity occurs, with a corresponding loss of Ste12 phosphorylation. Mutation of the Srb10-dependent phosphorylation sites increases pseudohyphal development but has no effect on the pheromone response of haploid yeast. Srb10 kinase activity is also regulated independently of the mating pheromone-response pathway. This indicates that Srb10 controls Ste12 activity for filamentous growth in response to nitrogen limitation and is consistent with the hypothesis that Srb10 regulates gene-specific activators in response to physiological signals to coordinate gene expression with growth potential.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Sadowski, I (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	sadowski@interchange.ubc.ca						BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chang YW, 2001, GENETICS, V157, P17; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; FIELDS S, 1987, MOL CELL BIOL, V7, P3818, DOI 10.1128/MCB.7.10.3818; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hung W, 1997, EUR J BIOCHEM, V245, P241, DOI 10.1111/j.1432-1033.1997.00241.x; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Morillon S, 2000, MOL CELL BIOL, V20, P5766, DOI 10.1128/MCB.20.15.5766-5776.2000; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000	15	120	125	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					187	190		10.1038/nature01243	http://dx.doi.org/10.1038/nature01243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520306				2022-12-24	WOS:000180267200046
J	Boles, LC; Lohmann, KJ				Boles, LC; Lohmann, KJ			True navigation and magnetic maps in spiny lobsters	NATURE			English	Article							SEA-TURTLES; COIL SYSTEMS; ORIENTATION; INFORMATION; FIELDS; SENSE	Animals are capable of true navigation if, after displacement to a location where they have never been, they can determine their position relative to a goal without relying on familiar surroundings, cues that emanate from the destination, or information collected during the outward journey(1,2). So far, only a few animals, all vertebrates, have been shown to possess true navigation(3). Those few invertebrates that have been carefully studied return to target areas using path integration, landmark recognition, compass orientation and other mechanisms that cannot compensate for displacements into unfamiliar territory(4,5). Here we report, however, that the spiny lobster Panulirus argus oriented reliably towards a capture site when displaced 12-37 km to unfamiliar locations, even when deprived of all known orientation cues en route. Little is known about how lobsters and other animals determine position during true navigation. To test the hypothesis that lobsters derive positional information from the Earth's magnetic field, lobsters were exposed to fields replicating those that exist at specific locations in their environment. Lobsters tested in a field north of the capture site oriented themselves southwards, whereas those tested in a field south of the capture site oriented themselves northwards. These results imply that true navigation in spiny lobsters, and perhaps in other animals, is based on a magnetic map sense.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Boles, LC (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Able KP, 2001, J AVIAN BIOL, V32, P174, DOI 10.1034/j.1600-048X.2001.320211.x; ABLE KP, 1991, AM ZOOL, V31, P157; CREASER EP, 1950, SCIENCE, V112, P169, DOI 10.1126/science.112.2902.169; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; GREGORY DR, 1986, CAN J FISH AQUAT SCI, V43, P2228, DOI 10.1139/f86-273; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Groeneveld JC, 2002, MAR ECOL PROG SER, V232, P225, DOI 10.3354/meps232225; Herrnkind W.F., 1980, P349; Herrnkind W.F., 1975, Science Bull nat Hist Mus Los Ang Cty, VNo. 20, P31; Kirschvink J. L., 1985, MAGNETITE BIOMINERAL, V1st; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; LOHMANN KJ, 1984, J EXP BIOL, V113, P29; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Papi F, 2001, ITAL J ZOOL, V68, P171, DOI 10.1080/11250000109356405; Phillips JB, 1996, J THEOR BIOL, V180, P309, DOI 10.1006/jtbi.1996.0105; PHILLIPS JB, 1995, ANIM BEHAV, V50, P855, DOI 10.1016/0003-3472(95)80146-4; Walcott C, 1996, J EXP BIOL, V199, P21; Walcott C., 1991, ORIENTATION BIRDS, P38; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1997, ORIENTATION COMMUNIC, P187; Wehner R, 1996, J EXP BIOL, V199, P129; Wiltschko R., 1995, TIEROSYCHOL; Zar JH, 1996, BIOSTATISTICAL ANAL	30	251	261	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					60	63		10.1038/nature01226	http://dx.doi.org/10.1038/nature01226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511953				2022-12-24	WOS:000180165500036
J	McDowell, N				McDowell, N			Joint European plan will tackle Africa's killer diseases	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					5	5		10.1038/421005b	http://dx.doi.org/10.1038/421005b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511923	Bronze			2022-12-24	WOS:000180165500008
J	Kazmierczak, J; Altermann, W				Kazmierczak, J; Altermann, W			Neoarchean biomineralization by benthic cyanobacteria	SCIENCE			English	Article							TRANSVAAL SUPERGROUP; MICROFOSSILS		Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa; Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	University of Pretoria; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Altermann, W (corresponding author), Univ Pretoria, Dept Geol, ZA-0002 Pretoria, South Africa.	wlady.altermann@iaag.geo.uni-muenchen.de	Altermann, Wladyslaw/AAV-7520-2021; Altermann, Wladyslaw/B-4336-2008	Altermann, Wladyslaw/0000-0002-9499-424X; Altermann, Wladyslaw/0000-0002-9499-424X				Altermann W, 1998, SEDIMENT GEOL, V120, P225, DOI 10.1016/S0037-0738(98)00034-7; ALTERMANN W, 1995, PRECAMBRIAN RES, V75, P65, DOI 10.1016/0301-9268(95)00018-Z; Barker WW, 1998, GEOMICROBIOL J, V15, P223, DOI 10.1080/01490459809378078; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; HORODYSKI RJ, 1975, J SEDIMENT PETROL, V45, P894; KEMPE S, 1991, NATURE, V349, P605, DOI 10.1038/349605a0; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KLEIN C, 1987, PRECAMBRIAN RES, V36, P81, DOI 10.1016/0301-9268(87)90018-0; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a	10	60	65	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2351	2351		10.1126/science.1075933	http://dx.doi.org/10.1126/science.1075933			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493906				2022-12-24	WOS:000179915900045
J	Li, F; Xiong, Y; Wang, JM; Cho, HD; Tomita, K; Weiner, AM; Steitz, TA				Li, F; Xiong, Y; Wang, JM; Cho, HD; Tomita, K; Weiner, AM; Steitz, TA			Crystal structures of the Bacillus stearothermophilus CCA-adding enzyme and its complexes with ATP or CTP	CELL			English	Article							TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; MAMMALIAN POLY(A) POLYMERASE; DNA-POLYMERASE; BINDING; PRIMER; REGION; BETA; END	CCA-adding enzymes polymerize CCA onto the 3' terminus of immature tRNAs without using a nucleic acid template. The 3.0 Angstrom resolution crystal structures of the CCA-adding enzyme from Bacillus stearothermophilus and its complexes with ATP or CTP reveal a sea-horse-shaped subunit consisting of four domains: head, neck, body, and tail. The head is structurally homologous to the palm domain of DNA polymerase beta but has additional structural features and functions. The neck, body, and tail represent new protein folding motifs. The neck provides a specific template for the incoming ATP or CTP, whereas the body and tail may bind tRNA. Each subunit has one active site capable of switching its base specificity between ATP and CTP, an important component of the CCA-adding mechanism.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Washington; University of Washington Seattle	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Tomita, Kozo/J-5746-2013; Steitz, Thomas A./C-6559-2009; Tomita, Kozo/E-9390-2017	Tomita, Kozo/0000-0002-7374-3898	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510, R01GM059804] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57510, GM59804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBI M, 1990, J BIOL CHEM, V265, P16216; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EVANS JA, 1978, J BIOL CHEM, V253, P7276; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; MILLER JP, 1971, J BIOL CHEM, V246, P1280; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAKON J, 1993, BIOCHEMISTRY-US, V32, P11977, DOI 10.1021/bi00096a006; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; SPRINZL M, 1977, EUR J BIOCHEM, V81, P579, DOI 10.1111/j.1432-1033.1977.tb11985.x; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	38	97	98	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					815	824		10.1016/S0092-8674(02)01115-7	http://dx.doi.org/10.1016/S0092-8674(02)01115-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526808	Bronze			2022-12-24	WOS:000179862600008
J	Boutanaev, AM; Kalmykova, AI; Shevelyov, YY; Nurminsky, DI				Boutanaev, AM; Kalmykova, AI; Shevelyov, YY; Nurminsky, DI			Large clusters of co-expressed genes in the Drosophila genome	NATURE			English	Article							DOSAGE COMPENSATION; HISTONE ACETYLATION; TRANSCRIPTION; LOCUS; POTENTIATION; ACTIVATION	Clustering of co-expressed, non-homologous genes on chromosomes implies their co-regulation. In lower eukaryotes, coexpressed genes are often found in pairs(1,2). Clustering of genes that share aspects of transcriptional regulation has also been reported in higher eukaryotes(3,4). To advance our understanding of the mode of coordinated gene regulation in multicellular organisms, we performed a genome-wide analysis of the chromosomal distribution of co-expressed genes in Drosophila. We identified a total of 1,661 testes-specific genes, one-third of which are clustered on chromosomes. The number of clusters of three or more genes is much higher than expected by chance. We observed a similar trend for genes upregulated in the embryo and in the adult head, although the expression pattern of individual genes cannot be predicted on the basis of chromosomal position alone. Our data suggest that the prevalent mechanism of transcriptional co-regulation in higher eukaryotes operates with extensive chromatin domains that comprise multiple genes.	Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Anim, Moscow 123182, Russia	Tufts University; Russian Academy of Sciences	Nurminsky, DI (corresponding author), Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA.	dmitry.nurminsky@tufts.edu	Kalmykova, Alla/AAG-2381-2021; Boutanaev, Alexander/AAO-7132-2021	Shevelyov, Yuri/0000-0002-0568-9236	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061549] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061549-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bhadra U, 1999, GENETICS, V152, P249; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kramer JA, 1998, DEVELOPMENT, V125, P4749; Kramer JA, 2000, MOL REPROD DEV, V56, P254, DOI 10.1002/(SICI)1098-2795(200006)56:2+<254::AID-MRD9>3.0.CO;2-#; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; MEIKLEJOHN CD, 2002, 43 ANN DROS RES C GE; Meller VH, 2000, TRENDS CELL BIOL, V10, P54, DOI 10.1016/S0962-8924(99)01693-1; PARISI MJ, 2002, 43 ANN DROS RES C GE; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schubeler D, 2000, GENE DEV, V14, P940; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Soury E, 2001, IMMUNOGENETICS, V53, P634, DOI 10.1007/s00251-001-0374-z; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Wynn SL, 2000, GENOMICS, V68, P57, DOI 10.1006/geno.2000.6254	22	256	263	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					666	669		10.1038/nature01216	http://dx.doi.org/10.1038/nature01216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478293				2022-12-24	WOS:000179751800045
J	Check, E				Check, E			Safety panel backs principle of gene-therapy trials	NATURE			English	News Item																			0	13	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 12	2002	420	6916					595	595		10.1038/420595b	http://dx.doi.org/10.1038/420595b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478252	Bronze			2022-12-24	WOS:000179751800008
J	Groppe, J; Greenwald, J; Wiater, E; Rodriguez-Leon, J; Economides, AN; Kwiatkowski, W; Affolter, M; Vale, WW; Belmonte, JCI; Choe, S				Groppe, J; Greenwald, J; Wiater, E; Rodriguez-Leon, J; Economides, AN; Kwiatkowski, W; Affolter, M; Vale, WW; Belmonte, JCI; Choe, S			Structural basis of BMP signalling inhibition by the cystine knot protein Noggin	NATURE			English	Article							BONE-MORPHOGENETIC PROTEIN; PROGRAMMED CELL-DEATH; TGF-BETA-S; SEQUENCE ALIGNMENT; SPEMANN ORGANIZER; DIRECT BINDING; LIMB; MUTATIONS; EXPRESSION; RECEPTOR	The interplay between bone morphogenetic proteins (BMPs) and their antagonists governs developmental and cellular processes as diverse as establishment of the embryonic dorsal-ventral axis, induction of neural tissue, formation of joints in the skeletal system and neurogenesis in the adult brain. So far, the three-dimensional structures of BMP antagonists and the structural basis for inactivation have remained unknown. Here we report the crystal structure of the antagonist Noggin bound to BMP-7, which shows that Noggin inhibits BMP signalling by blocking the molecular interfaces of the binding epitopes for both type I and type II receptors. The BMP-7-binding affinity of site-specific variants of Noggin is correlated with alterations in bone formation and apoptosis in chick limb development, showing that Noggin functions by sequestering its ligand in an inactive complex. The scaffold of Noggin contains a cystine (the oxidized form of cysteine) knot topology similar to that of BMPs; thus, ligand and antagonist seem to have evolved from a common ancestral gene.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Inst Gulbenkian Ciencias, P-2780901 Oeiras, Portugal; Biozentrum, CH-4056 Basel, Switzerland; Regeneron Pharmaceut Inc, New York, NY 10591 USA	Salk Institute; Salk Institute; Salk Institute; Instituto Gulbenkian de Ciencia; Regeneron	Choe, S (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	choe@salk.edu	Leon, Joaquin Maria Rodriguez/S-9814-2019; Leon, Joaquin Maria Rodriguez/C-6957-2013	Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Affolter, Markus/0000-0002-5171-0016; Economides, Aris/0000-0002-6508-8942				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Capdevila J, 1998, DEV BIOL, V197, P205, DOI 10.1006/dbio.1997.8824; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; ECONOMIDES AN, 2000, Patent No. 6075007; Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Hatta T, 2000, BIOPOLYMERS, V55, P399, DOI 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Macias D, 1997, DEVELOPMENT, V124, P1109; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016.abs; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Merino R, 1999, DEVELOPMENT, V126, P5515; Ogawa K, 2002, DEV BIOL, V250, P59, DOI 10.1006/dbio.2002.0790; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SAMPATH TK, 1992, J BIOL CHEM, V267, P20352; Smith WC, 1999, TRENDS GENET, V15, P3, DOI 10.1016/S0168-9525(98)01641-2; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stanley E, 1998, MECH DEVELOP, V77, P173, DOI 10.1016/S0925-4773(98)00139-7; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	49	411	476	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2002	420	6916					636	642		10.1038/nature01245	http://dx.doi.org/10.1038/nature01245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624GK	12478285				2022-12-24	WOS:000179751800037
J	Bae, M; Watanabe, C; Inaoka, T; Sekiyama, M; Sudo, N; Bokul, MH; Ohtsuka, R				Bae, M; Watanabe, C; Inaoka, T; Sekiyama, M; Sudo, N; Bokul, MH; Ohtsuka, R			Arsenic in cooked rice in Bangladesh	LANCET			English	Article								In Bangladesh, rice Is boiled with an excessive amount of water, and the water remaining after cooking will be discarded. We did an on-site experiment to assess the effect of this cooking method on the amount of arsenic retained in cooked rice. The concentration of arsenic in cooked rice was higher than that in raw rice and absorbed water combined, suggesting a chelating effect by rice grains, or concentration of arsenic because of water evaporation during cooking, or both. The method of cooking and water used can affect the amount of arsenic in cooked rice, which will have implications for the assessment of the health risks of arsenic.	Univ Tokyo, Grad Sch Med Sci, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Tokyo 1130033, Japan; Saga Univ, Fac Agr, Dept Environm Sociol, Saga 840, Japan; Natl Inst Publ Hlth, Dept Hlth Promot & Res, Wako, Saitama, Japan; Directorate Gen Hlth Serv, Dhaka, Bangladesh	University of Tokyo; Saga University; National Institute of Public Health - Japan	Watanabe, C (corresponding author), Univ Tokyo, Grad Sch Med Sci, Sch Int Hlth, Dept Human Ecol,Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.			Sekiyama, Makiko/0000-0002-2104-9140				JAHAN K, 1998, NATURE EXTENT MALNUT, P10; Schoof RA, 1998, HUM ECOL RISK ASSESS, V4, P117, DOI 10.1080/10807039891284235; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; YAMAZAKI K, 1983, COOKERY ITS THEORY	4	143	148	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1839	1840		10.1016/S0140-6736(02)11738-7	http://dx.doi.org/10.1016/S0140-6736(02)11738-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480363				2022-12-24	WOS:000179706100013
J	Lakka, HM; Laaksonen, DE; Lakka, TA; Niskanen, LK; Kumpusalo, E; Tuomilehto, J; Salonen, JT				Lakka, HM; Laaksonen, DE; Lakka, TA; Niskanen, LK; Kumpusalo, E; Tuomilehto, J; Salonen, JT			The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; TIME PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; DIABETES-MELLITUS; PROVISIONAL REPORT; SYNDROME PREDICTS; LIFE-STYLE	Context The metabolic syndrome, a concurrence of disturbed glucose and insulin metabolism, overweight and abdominal fat distribution, mild dyslipidemia, and hypertension, is associated with subsequent development of type 2 diabetes mellitus and cardiovascular disease (CVD). Despite its high prevalence, little is known of the prospective association of the metabolic syndrome with cardiovascular and overall mortality. Objective To assess the association of the metabolic syndrome with cardiovascular and overall mortality using recently proposed definitions and factor analysis. Design, Setting, and Participants The Kuopio Ischaemic Heart Disease Risk Factor Study, a population-based, prospective cohort study of 1209 Finnish men aged 42 to 60 years at baseline (1984-1989) who were initially without CVD, cancer, or diabetes. Follow-up continued through December 1998. Main Outcome Measures Death due to coronary heart disease (CHID), CVD, and any cause among men with vs without the metabolic syndrome, using 4 definitions based on the National Cholesterol Education Program (NCEP) and the World Health Organization (WHO). Results The prevalence of the metabolic syndrome ranged from 8.8% to 14.3%, depending on the definition. There were 109 deaths during the approximately 11.4-year follow-up, of which 46 and 27 were due.,to CVD and CHD, respectively. Men with the metabolic syndrome as defined by the. NCEP were 2.9 (95% confidence interval [Cl], 1.2-7.2) to 4.2 (95% Cl, 1.6-10.8) times more likely and , as defined by the WHO, 2.9 (95% Cl, 1.2-6.8) to 3.3 (95% Cl, 1.4-7.7) times more likely to die of CHD after adjustment for conventional cardiovascular risk factors. The metabolic syndrome as defined by the WHO was associated with 2.6 (95 % Cl, 1.4-5.1) to 3.0 (95% Cl, 1.5-5.7) times higher CVD mortality and 1.9 (95% Cl, 1.2-3.0) to 2.1 (95% Cl, 1.3-3.3) times higher all-cause mortality. The NCEP definition less consistently predicted CVD and all-cause mortality. Factor analysis using 13 variables associated with metabolic or cardiovascular risk yielded a metabolic syndrome factor that explained 18% of total variance. Men with loadings on the metabolic factor in the highest quarter were 3.6 (95% Cl, 1.7-7.9),3.2 (95% Cl, 1.7-5.8), and 2.3 (95% Cl, 1.5-3.4) times more likely to die of CHD, CVD, and any cause, respectively. Conclusions Cardiovascular disease and all-cause mortality are increased in men with the metabolic syndrome, even in the absence of baseline CVD and diabetes. Early identification, treatment, and prevention of the metabolic syndrome present a major challenge for health care professionals facing an epidemic of overweight and sedentary lifestyle.	Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Physiol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Med, Kuopio, Finland; Kuopio Res Inst Exercise Med, Kuopio, Finland; Inner Savo Hlth Ctr, Suonenjoki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Helsinki, Finland	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; Finland National Institute for Health & Welfare	Lakka, HM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	lakkah@pbrc.edu		Lakka, Timo/0000-0002-9199-2871	NHLBI NIH HHS [HL44199] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Balkau B, 1999, DIABETIC MED, V16, P442; BOUCHARD C, 1995, INT J OBESITY, V19, pS52; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chalmers J, 1999, J HYPERTENS, V17, P151; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cureton E.E., 1983, FACTOR ANAL APPL APP; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jenkins DJA, 2000, BRIT J NUTR, V83, pS157; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; LAAKSONEN DE, IN PRESS AM J EPIDEM; Lahti-Koski M, 2000, AM J CLIN NUTR, V72, P1436; Lahti-Koski M, 2001, INT J OBESITY, V25, P727, DOI 10.1038/sj.ijo.0801588; Lakka HM, 2002, EUR HEART J, V23, P706, DOI 10.1053/euhj.2001.2889; Lakka HM, 2000, ARCH INTERN MED, V160, P1160, DOI 10.1001/archinte.160.8.1160; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Liese AD, 1998, EPIDEMIOL REV, V20, P157, DOI 10.1093/oxfordjournals.epirev.a017978; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SALONEN JT, 1988, ANN CLIN RES, V20, P46; SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803; SELBY JV, 1991, JAMA-J AM MED ASSOC, V265, P2079, DOI 10.1001/jama.265.16.2079; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; STEVENS J, 1986, APPL MULTIVARIATE ST; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; TUOMILEHTO J, 1992, EUR HEART J, V13, P577, DOI 10.1093/oxfordjournals.eurheartj.a060219; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; TUOMILEHTO J, 1992, AM J EPIDEMIOL, V135, P1259, DOI 10.1093/oxfordjournals.aje.a116232; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; *WHO MONICA PROJ, 2002, MONICA MAN 4	42	3471	3728	2	272	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2002	288	21					2709	2716		10.1001/jama.288.21.2709	http://dx.doi.org/10.1001/jama.288.21.2709			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620UA	12460094				2022-12-24	WOS:000179549800030
J	Deveras, RAE; Kessler, CM				Deveras, RAE; Kessler, CM			Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate	ANNALS OF INTERNAL MEDICINE			English	Article							COAGULOPATHY	Background: Bleeding associated with warfarin anticoagulation correlates directly to duration and degree of international normalized ratio (INR) elevation above the therapeutic range. Safe and rapid reversal of excessive anticoagulation is occasionally needed to treat or avoid hemorrhagic complications. Objective: To evaluate the efficacy and safety of human recombinant factor VIIa (rFVIIa) concentrate in persons requiring rapid reversal of the effects of warfarin. Design: Uncontrolled case series. Setting: Academic medical center. Patients: 13 patients with critically increased INRs requiring immediate reversal of warfarin-induced anti coagulation. Measurements: Prothrombin time and INR were measured before and after administration of varying doses of rFVIIa. Results: Critically prolonged INR and bleeding complications were treated successively and rapidly in all patients, regardless of rFVIIa dose (range, 15 to 90 mug/kg of body weight). Indications for use of rFVIIa included an INR greater than 10 in high-risk persons (n = 5), clinical hemorrhage (n = 4), and diagnostic or therapeutic procedures (n = 4). Conclusion: Safe, rapid, and effective administration of rFVIIa corrects critically prolonged INRs; and can avert or reverse bleeding associated with warfarin anticoagulation.	Georgetown Univ, Med Ctr, Div Hematol & Oncol, Washington, DC 20007 USA	Georgetown University	Deveras, RAE (corresponding author), Georgetown Univ, Med Ctr, Div Hematol & Oncol, 3800 Reservoir Rd NW, Washington, DC 20007 USA.	rad@georgetown.edu						Abu-Hajir M, 2001, BLOOD, V98, p79B; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Berntorp E, 2000, BLOOD COAGUL FIBRIN, V11, pS113, DOI 10.1097/00001721-200004001-00021; Bird LA, 1998, S AFR MED J, V88, P1344; Crowther MA, 2000, LANCET, V356, P1551, DOI 10.1016/S0140-6736(00)03125-1; DINESS V, 1990, THROMB RES, V59, P921, DOI 10.1016/0049-3848(90)90116-T; FIHN SD, 1996, ANN INTERN MED; Girard P, 1998, THROMB HAEMOSTASIS, V80, P109; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Hylck EM, 2000, ARCH INTERN MED, V160, P1612, DOI 10.1001/archinte.160.11.1612; Kessler CM, 2000, CURR OPIN HEMATOL, V7, P408, DOI 10.1097/00062752-200011000-00015; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; LUSHER JM, 1991, SEMIN HEMATOL, V28, P3; *NOV NORD, 2002, NOV COAG FACT VIIA R; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Peerlinck K, 1999, THROMB HAEMOSTASIS, V82, P1775, DOI 10.1055/s-0037-1614918; Pindur G, 1999, THROMB RES, V95, pS57, DOI 10.1016/S0049-3848(99)00085-7; Seitz R, 1999, THROMB RES, V95, pS19, DOI 10.1016/S0049-3848(99)00080-8; SERLIN MJ, 1983, DRUGS, V25, P610, DOI 10.2165/00003495-198325060-00004; Shopnick RI, 2001, BLOOD, V98, p99B	20	181	186	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2002	137	11					884	888		10.7326/0003-4819-137-11-200212030-00009	http://dx.doi.org/10.7326/0003-4819-137-11-200212030-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622GY	12458988				2022-12-24	WOS:000179639700004
J	Donovan, P				Donovan, P			Rape and HIV/AIDS in Rwanda	LANCET			English	Article											Donovan, P (corresponding author), POB 39773, Nairobi, Kenya.								0	41	42	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S17	S18		10.1016/S0140-6736(02)11804-6	http://dx.doi.org/10.1016/S0140-6736(02)11804-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504487				2022-12-24	WOS:000180064500008
J	Stefanova, I; Dorfman, JR; Germain, RN				Stefanova, I; Dorfman, JR; Germain, RN			Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes	NATURE			English	Article							SINGLE-CELL ANALYSIS; TRANSGENIC MICE; DEFICIENT MICE; RECEPTOR; CD4; MOLECULES; RESPONSES; THRESHOLDS; ACTIVATION; SURVIVAL	Major histocompatibility complex (MHC) class I and II molecules are highly polymorphic proteins that bind and present foreign peptides to the clonally distributed alphabeta receptors (TCR) of T lymphocytes. As a population, the immature T lymphocytes generated in the thymus express a very diverse set of TCR specificities. A process of positive selection filters this broad repertoire to optimize peripheral T cells for antigen recognition in the context of available MHC products. Only those precursor T cells whose TCRs generate an adequate but not excessive signalling response to self-peptides bound to the expressed MHC proteins undergo successful maturation(1). Here we show that post-thymic self-recognition facilitates the antigen reactivity of mature T cells. Both experimental and physiological interruption of T-cell contact with self-peptide MHC ligands leads to a rapid decline in signalling and response sensitivity to foreign stimuli. Because the adaptive immune system must be recruited early in an infectious process when antigen is limiting(2), these findings suggest that positive selection ensures predictable T-cell recognition of available self-ligands, which in turn promotes efficient responses to pathogens.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@nih.gov	Dorfman, Jeffrey R/M-4218-2017; Germain, Ronald N./Z-1945-2019; Dorfman, Jeffrey R/B-4854-2011; Germain, Ronald/ABE-7090-2020	Dorfman, Jeffrey R/0000-0001-9938-8911; 				Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; DING L, 1993, J IMMUNOL, V151, P1224; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Gascoigne N R, 1993, Semin Immunol, V5, P13, DOI 10.1006/smim.1993.1003; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Hemmer B, 1998, J IMMUNOL, V160, P5807; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kersh EN, 1999, J EXP MED, V190, P1627, DOI 10.1084/jem.190.11.1627; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Micheletti F, 2000, J IMMUNOL, V165, P4264, DOI 10.4049/jimmunol.165.8.4264; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Zell T, 2001, P NATL ACAD SCI USA, V98, P10805, DOI 10.1073/pnas.191567898	30	312	315	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2002	420	6914					429	434		10.1038/nature01146	http://dx.doi.org/10.1038/nature01146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459785	Green Published			2022-12-24	WOS:000179494700043
J	Michaelsson, K; Lithell, H; Vessby, B; Melhus, H				Michaelsson, K; Lithell, H; Vessby, B; Melhus, H			Serum retinol levels and the risk of fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; VITAMIN-A INTAKE; BONE-MINERAL DENSITY; HIP FRACTURE; ALPHA-TOCOPHEROL; BETA-CAROTENE; HYPERVITAMINOSIS-A; GENE-EXPRESSION; PLASMA RETINOL	BACKGROUND Although studies in animals and epidemiologic studies have indicated that a high vitamin A intake is associated with increased bone fragility, no biologic marker of vitamin A status has thus far been used to assess the risk of fractures in humans. METHODS We enrolled 2322 men, 49 to 51 years of age, in a population-based, longitudinal cohort study. Serum retinol and beta carotene were analyzed in samples obtained at enrollment. Fractures were documented in 266 men during 30 years of follow-up. Cox regression analysis was used to determine the risk of fracture according to the serum retinol level. RESULTS The risk of fracture was highest among men with the highest levels of serum retinol. Multivariate analysis of the risk of fracture in the highest quintile for serum retinol (>75.62 microg per deciliter [2.64 micromol per liter]) as compared with the middle quintile (62.16 to 67.60 microg per deciliter [2.17 to 2.36 micromol per liter]) showed that the rate ratio was 1.64 (95 percent confidence interval, 1.12 to 2.41) for any fracture and 2.47 (95 percent confidence interval, 1.15 to 5.28) for hip fracture. The risk of fracture was further increased within the highest quintile for serum retinol. Men with retinol levels in the 99th percentile (>103.12 microg per deciliter [3.60 micromol per liter]) had an overall risk of fracture that exceeded the risk among men with lower levels by a factor of seven (P<0.001). The level of serum beta carotene was not associated with the risk of fracture. CONCLUSIONS Our findings, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed.	Univ Uppsala Hosp, Dept Surg Sci, Sect Orthoped, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Sect Geriatr, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Sect Clin Nutr Res, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, Clin Pharmacol Sect, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Michaelsson, K (corresponding author), Univ Uppsala Hosp, Dept Surg Sci, Sect Orthoped, S-75185 Uppsala, Sweden.	karl.michaelsson@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217				Ballew C, 2001, J BONE MINER RES, V16, P2306, DOI 10.1359/jbmr.2001.16.12.2306; Ballew C, 2001, AM J CLIN NUTR, V73, P586; Baron JA, 2001, ARCH INTERN MED, V161, P983, DOI 10.1001/archinte.161.7.983; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; BERSHAD S, 1985, NEW ENGL J MED, V313, P981, DOI 10.1056/NEJM198510173131604; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; BITZEN U, 1994, SCAND J CLIN LAB INV, V54, P611, DOI 10.3109/00365519409087540; COMSTOCK GW, 1993, CLIN CHEM, V39, P1075; CRUZ JAA, 1991, EUR J CLIN NUTR, V45, P121; Cumming RG, 1997, EPIDEMIOL REV, V19, P244, DOI 10.1093/oxfordjournals.epirev.a017956; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Denke MA, 2002, JAMA-J AM MED ASSOC, V287, P102, DOI 10.1001/jama.287.1.102; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; FRAME B, 1974, ANN INTERN MED, V80, P44, DOI 10.7326/0003-4819-80-1-44; GARRY PJ, 1987, AM J CLIN NUTR, V46, P989, DOI 10.1093/ajcn/46.6.989; Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171; HALLFRISCH J, 1994, AM J CLIN NUTR, V60, P176, DOI 10.1093/ajcn/60.2.176; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Johansson S, 2001, J BONE MINER RES, V16, P1899, DOI 10.1359/jbmr.2001.16.10.1899; JOHANSSON S, IN PRESS BONE; JOHNELL O, 1992, OSTEOPOROSIS INT, V2, P298, DOI 10.1007/BF01623186; JOHNSON EJ, 1992, J AM COLL NUTR, V11, P682; KATZ CM, 1972, METABOLISM, V21, P1171, DOI 10.1016/0026-0495(72)90112-6; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; KINDMARK A, 1993, BIOCHEM BIOPH RES CO, V192, P1367, DOI 10.1006/bbrc.1993.1567; KRASINSKI SD, 1990, METABOLISM, V39, P357, DOI 10.1016/0026-0495(90)90249-C; Leo MA, 1999, AM J CLIN NUTR, V69, P1071; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; MILNE DB, 1986, CLIN CHEM, V32, P874; MURRAY JC, 1983, ARCH DERMATOL, V119, P675, DOI 10.1001/archderm.119.8.675; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; Neuhouser ML, 2001, J NUTR, V131, P2184, DOI 10.1093/jn/131.8.2184; Nierenberg DW, 1997, AM J CLIN NUTR, V66, P315, DOI 10.1093/ajcn/66.2.315; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; ROIDT L, 1988, AM J EPIDEMIOL, V128, P645, DOI 10.1093/oxfordjournals.aje.a115012; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; STAUBER PM, 1991, AM J CLIN NUTR, V54, P878, DOI 10.1093/ajcn/54.5.878; Stephensen CB, 2000, AM J CLIN NUTR, V72, P1170; Sundstrom J, 2001, CIRCULATION, V103, P836, DOI 10.1161/01.CIR.103.6.836; Underwood BA, 1984, RETINOIDS, P281; vonReinersdorff D, 1996, J LIPID RES, V37, P1875; WILLETT WC, 1983, AM J CLIN NUTR, V38, P631, DOI 10.1093/ajcn/38.4.631	51	234	246	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					287	294		10.1056/NEJMoa021171	http://dx.doi.org/10.1056/NEJMoa021171			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540641				2022-12-24	WOS:000180507200003
J	Dale, JK; Maroto, M; Dequeant, ML; Malapert, P; McGrew, M; Pourquie, O				Dale, JK; Maroto, M; Dequeant, ML; Malapert, P; McGrew, M; Pourquie, O			Periodic Notch inhibition by lunatic fringe underlies the chick segmentation clock	NATURE			English	Article							SOMITE BOUNDARY FORMATION; INTRACELLULAR DOMAIN; DELTA-HOMOLOG; EXPRESSION; GENE; GLYCOSYLTRANSFERASE; REQUIRES; SOMITOGENESIS; OSCILLATOR; RELEASE	The segmented aspect of the vertebrate body plan first arises through the sequential formation of somites. The periodicity of somitogenesis is thought to be regulated by a molecular oscillator, the segmentation clock, which functions in presomitic mesoderm cells. This oscillator controls the periodic expression of 'cyclic genes', which are all related to the Notch pathway(1-7). The mechanism underlying this oscillator is not understood. Here we show that the protein product of the cyclic gene lunatic fringe (Lfng), which encodes a glycosyltransferase that can modify Notch activity, oscillates in the chick presomitic mesoderm. Overexpressing Lfng in the paraxial mesoderm abolishes the expression of cyclic genes including endogenous Lfng and leads to defects in segmentation. This effect on cyclic genes phenocopies inhibition of Notch signalling in the presomitic mesoderm. We therefore propose that Lfng establishes a negative feedback loop that implements periodic inhibition of Notch, which in turn controls the rhythmic expression of cyclic genes in the chick presomitic mesoderm. This feedback loop provides a molecular basis for the oscillator underlying the avian segmentation clock.	Univ Mediterranee AP Marseille, Lab Genet & Phys Dev, Inst Biol Dev Marseille, CNRS,INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Pourquié, Olivier/CAJ-5443-2022; Dale, Kim/A-4480-2016	Pourquié, Olivier/0000-0001-5189-1227; Dale, Kim/0000-0002-9294-947X				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; CONLON RA, 1995, DEVELOPMENT, V121, P1533; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Maroto M, 2001, CURR TOP DEV BIOL, V51, P221, DOI 10.1016/S0070-2153(01)51007-8; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Sato Y, 2002, DEVELOPMENT, V129, P3633; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	29	252	259	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					275	278		10.1038/nature01244	http://dx.doi.org/10.1038/nature01244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529645				2022-12-24	WOS:000180397600049
J	Srinivasan, A; Wolfenden, LL; Song, XY; Mackie, K; Hartsell, TL; Jones, HD; Diette, GB; Orens, JB; Yung, RC; Ross, TL; Merz, W; Scheel, PJ; Haponik, EF; Perl, TM				Srinivasan, A; Wolfenden, LL; Song, XY; Mackie, K; Hartsell, TL; Jones, HD; Diette, GB; Orens, JB; Yung, RC; Ross, TL; Merz, W; Scheel, PJ; Haponik, EF; Perl, TM			An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; CONTAMINATION; ENDOSCOPY	Background: Endoscopes, including bronchoscopes, are the medical devices most frequently associated with outbreaks of nosocomial infections. We investigated an outbreak of Pseudomonas aeruginosa infections after bronchoscopic procedures. Methods: Microbiologic results were reviewed to determine the rates of recovery of P. aeruginosa from bronchoalveolar-lavage specimens. Environmental samples from endoscopes and the endoscopy suite were cultured. Medical records were reviewed to identify infections in the 14 days after a bronchoscopy. Results: The rate of recovery of P. aeruginosa from bronchoalveolar-lavage specimens obtained with use of endoscopy-suite bronchoscopes increased from 10.4 percent at base line to 31.0 percent during the outbreak (relative risk, 2.97; 95 percent confidence interval, 2.28 to 3.90). Cultures of samples from three bronchoscopes grew P. aeruginosa, whereas cultures of samples from the environment, instrument-cleaning machines, and gastrointestinal endoscopes did not. The three bronchoscopes had been part of a nationwide recall. A total of 414 patients underwent bronchoscopy during the outbreak, and there were 48 respiratory tract and bloodstream infections among 39 of these patients (9.4 percent). In 32 infections (66.7 percent), P. aeruginosa was confirmed as a potentially causative organism. Exposure to a potentially contaminated bronchoscope may have had a role in the death of three patients. The rate of recovery of P. aeruginosa returned to base line after the instruments were removed from service. Conclusions: This large outbreak of P. aeruginosa infections related to bronchoscopy was apparently caused by a loose biopsy-port cap in the bronchoscopes. Instrument safety and surveillance methods for bronchoscopy must be improved, and better recall procedures are needed for medical devices.	Johns Hopkins Med Inst, Dept Hosp Epidemiol & Infect Control, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Nephrol, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Srinivasan, A (corresponding author), Johns Hopkins Univ Hosp, Off Antibiot Management, 600 N Wolfe St,Carnegie Bldg,Rm 284, Baltimore, MD 21287 USA.				ODCDC CDC HHS [UR8/CCU315092] Funding Source: Medline	ODCDC CDC HHS		Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; [Anonymous], 1994, NNIS MAN NAT NOS INF; Colt HG, 2000, CHEST, V118, P183, DOI 10.1378/chest.118.1.183; Diette GB, 1999, CHEST, V115, P397, DOI 10.1378/chest.115.2.397; *FDA, 2002, FDA REC POL; GOERING RV, 1993, INFECT CONT HOSP EP, V14, P595; Kirkpatrick BD, 1999, CLIN INFECT DIS, V29, P1268, DOI 10.1086/313456; Kirschke DL, 2003, NEW ENGL J MED, V348, P214, DOI 10.1056/NEJMoa021791; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, DOI 10.17226/9728; MARKOVITZ A, 1979, WESTERN J MED, V131, P550; MARTIN MA, 1994, AM J INFECT CONTROL, V22, P19, DOI 10.1016/0196-6553(94)90087-6; Mehta AC, 1999, CLIN CHEST MED, V20, P19, DOI 10.1016/S0272-5231(05)70123-4; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; NELSON KE, 1983, AM REV RESPIR DIS, V127, P97, DOI 10.1164/arrd.1983.127.1.97; PAPPAS SA, 1983, AM REV RESPIR DIS, V127, P391; PEREIRA W, 1975, AM REV RESPIR DIS, V112, P59; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Walter V A, 2000, Gastrointest Endosc Clin N Am, V10, P265; WEBB SF, 1975, CHEST, V68, P703, DOI 10.1378/chest.68.5.703; WHEELER PW, 1989, J INFECT DIS, V159, P954, DOI 10.1093/infdis/159.5.954	20	126	137	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					221	227		10.1056/NEJMoa021808	http://dx.doi.org/10.1056/NEJMoa021808			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529462				2022-12-24	WOS:000180390600006
J	Druss, BG; Marcus, SC; Olfson, M; Tanielian, T; Pincus, HA				Druss, BG; Marcus, SC; Olfson, M; Tanielian, T; Pincus, HA			Trends in care by nonphysician clinicians in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSE PRACTITIONERS; PATIENT-CARE; PHYSICIAN ASSISTANTS; OUTCOMES	BACKGROUND: The 1990s saw rising numbers of graduates of training programs for nonphysician clinicians, passage of legislation expanding their scope of practice, and a proliferation of managed-care models that emphasized the use of these providers as a strategy for containing health care costs. METHODS: We used two nationally representative surveys to examine trends in outpatient care provided by physicians and nonphysician clinicians between 1987 and 1997, adjusting for the case mix. Analyses examined care provided by 10 categories of nonphysician clinicians: chiropractors, midwives, nurses or nurse practitioners, optometrists, podiatrists, physician assistants, physical or occupational therapists, psychologists, social workers, and others. RESULTS: Between 1987 and 1997, the proportion of patients who saw a nonphysician clinician rose from 30.6 percent to 36.1 percent (adjusted relative risk for 1997 as compared with 1987, 1.42 [95 percent confidence interval, 1.35 to 1.50]). The trend was driven by an increase in the proportion of persons who visited both a physician and a nonphysician clinician (from 23.5 percent to 30.9 percent; adjusted relative risk, 1.49 [95 percent confidence interval, 1.40 to 1.58]), rather than an increase in the proportion who saw only a nonphysician clinician (from 7.2 percent to 5.3 percent; adjusted relative risk, 0.81 [95 percent confidence interval, 0.70 to 0.93]). This pattern was consistent in analyses of specific medical conditions and specific types of nonphysician clinicians. There was an increase in the proportion of patients obtaining preventive services from nonphysician clinicians and a decline in the proportion receiving acute care services from such clinicians. CONCLUSIONS: From 1987 to 1997, there was a degree of differentiation between physicians and nonphysician clinicians with respect to the services they provided but not with respect to the patients they treated. The implications of these findings hinge on the degree to which the increase in conjoint service delivery represents growing coordination or fragmentation of care.	Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; RAND, Washington, DC USA; RAND, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Emory University; Rollins School Public Health; University of Pennsylvania; Columbia University; RAND Corporation; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Druss, BG (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.		Olfson, Mark/AAA-8547-2021		NIMH NIH HHS [K08-MH01556-01A] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001556] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HEALTHC RES QU, 2002, CLIN CLASS SOFTW ICD; COHEN SB, 2000, AHRQ PUBLICATION; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P795, DOI 10.1001/jama.280.9.795; DIAL TH, 1995, HEALTH AFFAIR, V14, P168, DOI 10.1377/hlthaff.14.2.168; EDWARDS WS, 1989, DHHS PUBLICATION PHS; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; GOODE E, 2002, NY TIMES        0611, pF1; Grumbach K, 1998, JAMA-J AM MED ASSOC, V280, P825, DOI 10.1001/jama.280.9.825; *HLTH POL TRACK SE, 2002, NAT C STAT LEG JUN; HOFFMAN C, 1994, HEALTH AFFAIR, V13, P140, DOI 10.1377/hlthaff.13.4.140; Hooker RS, 2001, HEALTH AFFAIR, V20, P231, DOI 10.1377/hlthaff.20.4.231; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; KIRBY JB, 2001, AHRQ PUBLICATION; MELFI C, 1995, J CLIN EPIDEMIOL, V48, P917, DOI 10.1016/0895-4356(94)00202-2; Mundinger, 2000, JAMA, V283, P2521; SEKSCENSKI ES, 1994, NEW ENGL J MED, V331, P1266, DOI 10.1056/NEJM199411103311905; Shah BV, 1997, SUDAAN USERS MANUAL; SOX HC, 1979, ANN INTERN MED, V91, P459, DOI 10.7326/0003-4819-91-3-459; STARFIELD B, 1998, PRIMARY CARE BALANCI, P94; STARFIELD BH, 1976, MED CARE, V14, P625, DOI 10.1097/00005650-197607000-00008; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; *WHO, 1977, 9 REV C 1975 GEN WHO; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zuvekas SH, 2002, INQUIRY-J HEALTH CAR, V39, P76, DOI 10.5034/inquiryjrnl_39.1.76	25	117	118	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					130	137		10.1056/NEJMsa020993	http://dx.doi.org/10.1056/NEJMsa020993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519924				2022-12-24	WOS:000180263900006
J	Dalton, R				Dalton, R			Palaeoanthropology - Face to face with our past	NATURE			English	Editorial Material																		Brunet M, 2002, NATURE, V419, P582, DOI 10.1038/419582a; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wolpoff MH, 2002, NATURE, V419, P581, DOI 10.1038/419581a	5	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					735	736		10.1038/420735a	http://dx.doi.org/10.1038/420735a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490911				2022-12-24	WOS:000179897300019
J	Dennis, C				Dennis, C			Small RNAs - The genome's guiding hand?	NATURE			English	Editorial Material							ELEGANS											Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	14	19	35	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					732	732		10.1038/420732a	http://dx.doi.org/10.1038/420732a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490907				2022-12-24	WOS:000179897300016
J	Kasahara, M; Kagawa, T; Oikawa, K; Suetsugu, N; Miyao, M; Wada, M				Kasahara, M; Kagawa, T; Oikawa, K; Suetsugu, N; Miyao, M; Wada, M			Chloroplast avoidance movement reduces photodamage in plants	NATURE			English	Article							BLUE-LIGHT; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; PHOTOSYSTEM-II; STRESS; NPL1; PHOTOPROTECTION; PHOTOSYNTHESIS; RELOCATION; MEDIATE	When plants are exposed to light levels higher than those required for photosynthesis, reactive oxygen species are generated in the chloroplasts and cause photodamage. This can occur even under natural growth conditions. To mitigate photodamage, plants have developed several protective mechanisms(1-3). One is chloroplast avoidance movement(4-6), in which chloroplasts move from the cell surface to the side walls of cells under high light conditions, although experimental support is still awaited(7,8). Here, using different classes of mutant defective in chloroplast avoidance movement, we show that these mutants are more susceptible to damage in high light than wild-type plants. Damage of the photosynthetic apparatus and subsequent bleaching of leaf colour and necrosis occur faster under high light conditions in the mutants than in wild-type plants. We conclude that chloroplast avoidance movement actually decreases the amount of light absorption by chloroplasts, and might therefore be important to the survival of plants under natural growth conditions.	Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, PRESTO, Unit Proc & combined Circuit, Kawaguchi, Saitama 3320012, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Japan Science & Technology Agency (JST); Tokyo Metropolitan University; National Institute of Agrobiological Sciences - Japan	Wada, M (corresponding author), Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Okazaki, Aichi 4448585, Japan.		Suetsugu, Noriyuki/AAB-5274-2019	Suetsugu, Noriyuki/0000-0002-3328-3313; Oikawa, Kazusato/0000-0002-1033-9089				Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; BRUGNOLI E, 1992, PHOTOSYNTH RES, V32, P23, DOI 10.1007/BF00028795; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; KADOTA A, 1992, BOT MAG TOKYO, V105, P265, DOI 10.1007/BF02489420; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Miyagawa Y, 2000, PLANT CELL PHYSIOL, V41, P311, DOI 10.1093/pcp/41.3.311; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Park YI, 1996, PLANT PHYSIOL, V111, P867, DOI 10.1104/pp.111.3.867; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; SUKENIK A, 1987, NATURE, V327, P704, DOI 10.1038/327704a0; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; WADA M, 2001, PHOTOMOVEMENT, P897; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50	22	411	444	6	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					829	832		10.1038/nature01213	http://dx.doi.org/10.1038/nature01213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490952				2022-12-24	WOS:000179897300060
J	Rudenko, G; Henry, L; Henderson, K; Ichtchenko, K; Brown, MS; Goldstein, JL; Deisenhofer, J				Rudenko, G; Henry, L; Henderson, K; Ichtchenko, K; Brown, MS; Goldstein, JL; Deisenhofer, J			Structure of the LDL receptor extracellular domain at endosomal pH	SCIENCE			English	Article							LOW-DENSITY-LIPOPROTEIN; DEPENDENT LIGAND DISSOCIATION; CYSTEINE-RICH REPEAT; NMR STRUCTURE; FAMILIAL HYPERCHOLESTEROLEMIA; 3-DIMENSIONAL STRUCTURE; APOLIPOPROTEIN B-100; BACKBONE DYNAMICS; BINDING MODULES; CALCIUM-BINDING	The low-density lipoprotein receptor mediates cholesterol homeostasis through endocytosis of lipoproteins. It discharges its ligand in the endosome at pH<6. In the crystal structure at pH=5.3, the ligand-binding domain (modules R2 to R7) folds back as an arc over the epidermal growth factor precursor homology domain (the modules A, B, beta propeller, and C). The modules R4 and R5, which are critical for lipoprotein binding, associate with the beta propeller via their calcium-binding loop. We propose a mechanism for lipoprotein release in the endosome whereby the beta propeller functions as an alternate substrate for the ligand-binding domain, binding in a calcium-dependent way and promoting lipoprotein release.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd Y4-206, Dallas, TX 75390 USA.	Johann.Deisenhofer@UTSouthwestern.edu	Rudenko, Gabrielle (Gabby)/O-7938-2018	Rudenko, Gabrielle (Gabby)/0000-0002-7372-0530; Ichtchenko, Konstantin/0000-0002-2198-1325	NHLBI NIH HHS [HL20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J SUPRAMOL STR CELL, V8, P223, DOI 10.1002/jss.400080302; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAPPELL DA, 1993, J BIOL CHEM, V268, P25487; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clayton D, 2000, FEBS LETT, V479, P118, DOI 10.1016/S0014-5793(00)01842-1; Cooper AD, 1997, J LIPID RES, V38, P2173; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DOI T, 1994, J BIOL CHEM, V269, P25598; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Gabriel JCP, 1997, J SOLID STATE CHEM, V129, P257, DOI 10.1006/jssc.1996.7230; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; INNERARITY TL, 1987, ACTA MED SCAND, P51; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Jeon H, 2000, J BIOL CHEM, V275, P30458, DOI 10.1074/jbc.M002583200; KEIDAR S, 1989, J LIPID RES, V30, P1331; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; McNamara JR, 1996, J LIPID RES, V37, P1924; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mikhailenko I, 1999, J CELL SCI, V112, P3269; MIYAKE Y, 1989, J BIOL CHEM, V264, P16584; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raussens V, 2002, J BIOL CHEM, V277, P29172, DOI 10.1074/jbc.M204043200; RUDENKO G, UNPUB; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; SCHNEIDER WJ, 1979, P NATL ACAD SCI USA, V76, P5577, DOI 10.1073/pnas.76.11.5577; Segrest JP, 2001, J LIPID RES, V42, P1346; Simmons T, 1997, J BIOL CHEM, V272, P25531, DOI 10.1074/jbc.272.41.25531; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyota Y, 1999, ATHEROSCLEROSIS, V147, P77, DOI 10.1016/S0021-9150(99)00166-5; VANDERWESTHUYZEN DR, 1991, BIOCHEM J, V277, P677, DOI 10.1042/bj2770677; Wang XY, 2000, ARTERIOSCL THROM VAS, V20, P1301, DOI 10.1161/01.ATV.20.5.1301; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574	48	365	398	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2353	2358		10.1126/science.1078124	http://dx.doi.org/10.1126/science.1078124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12459547	Green Submitted			2022-12-24	WOS:000179915900046
J	Dehal, P; Satou, Y; Campbell, RK; Chapman, J; Degnan, B; De Tomaso, A; Davidson, B; Di Gregorio, A; Gelpke, M; Goodstein, DM; Harafuji, N; Hastings, KEM; Ho, I; Hotta, K; Huang, W; Kawashima, T; Lemaire, P; Martinez, D; Meinertzhagen, IA; Necula, S; Nonaka, M; Putnam, N; Rash, S; Saiga, H; Satake, M; Terry, A; Yamada, L; Wang, HG; Awazu, S; Azumi, K; Boore, J; Branno, M; Chin-bow, S; DeSantis, R; Doyle, S; Francino, P; Keys, DN; Haga, S; Hayashi, H; Hino, K; Imai, KS; Inaba, K; Kano, S; Kobayashi, K; Kobayashi, M; Lee, BI; Makabe, KW; Manohar, C; Matassi, G; Medina, M; Mochizuki, Y; Mount, S; Morishita, T; Miura, S; Nakayama, A; Nishizaka, S; Nomoto, H; Ohta, F; Oishi, K; Rigoutsos, I; Sano, M; Sasaki, A; Sasakura, Y; Shoguchi, E; Shin-i, T; Spagnuolo, A; Stainier, D; Suzuki, MM; Tassy, O; Takatori, N; Tokuoka, M; Yagi, K; Yoshizaki, F; Wada, S; Zhang, C; Hyatt, PD; Larimer, F; Detter, C; Doggett, N; Glavina, T; Hawkins, T; Richardson, P; Lucas, S; Kohara, Y; Levine, M; Satoh, N; Rokhsar, DS				Dehal, P; Satou, Y; Campbell, RK; Chapman, J; Degnan, B; De Tomaso, A; Davidson, B; Di Gregorio, A; Gelpke, M; Goodstein, DM; Harafuji, N; Hastings, KEM; Ho, I; Hotta, K; Huang, W; Kawashima, T; Lemaire, P; Martinez, D; Meinertzhagen, IA; Necula, S; Nonaka, M; Putnam, N; Rash, S; Saiga, H; Satake, M; Terry, A; Yamada, L; Wang, HG; Awazu, S; Azumi, K; Boore, J; Branno, M; Chin-bow, S; DeSantis, R; Doyle, S; Francino, P; Keys, DN; Haga, S; Hayashi, H; Hino, K; Imai, KS; Inaba, K; Kano, S; Kobayashi, K; Kobayashi, M; Lee, BI; Makabe, KW; Manohar, C; Matassi, G; Medina, M; Mochizuki, Y; Mount, S; Morishita, T; Miura, S; Nakayama, A; Nishizaka, S; Nomoto, H; Ohta, F; Oishi, K; Rigoutsos, I; Sano, M; Sasaki, A; Sasakura, Y; Shoguchi, E; Shin-i, T; Spagnuolo, A; Stainier, D; Suzuki, MM; Tassy, O; Takatori, N; Tokuoka, M; Yagi, K; Yoshizaki, F; Wada, S; Zhang, C; Hyatt, PD; Larimer, F; Detter, C; Doggett, N; Glavina, T; Hawkins, T; Richardson, P; Lucas, S; Kohara, Y; Levine, M; Satoh, N; Rokhsar, DS			The draft genome of Ciona intestinalis: Insights into chordate and vertebrate origins	SCIENCE			English	Article							GENE-EXPRESSION PROFILES; ASCIDIAN EMBRYOS; HOMEOBOX GENES; EVOLUTION; CLUSTER; SYSTEM; DROSOPHILA; SEQUENCE; BIOLOGY; PLANT	The first chordates appear in the fossil record at the time of the Cambrian explosion, nearly 550 million years ago. The modern ascidian tadpole represents a plausible approximation to these ancestral chordates. To illuminate the origins of chordate and vertebrates, we generated a draft of the protein-coding portion of the genome of the most studied ascidian, Ciona intestinalis. The Ciona genome contains similar to16,000 protein-coding genes, similar to the number in other invertebrates, but only half that found in vertebrates. Vertebrate gene families are typically found in simplified form in Ciona, suggesting that ascidians contain the basic ancestral complement of genes involved in cell signaling and development. The ascidian genome has also acquired a number of lineage-specific innovations, including a group of genes engaged in cellulose metabolism that are related to those in bacteria and fungi.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto 6068502, Japan; Marine Biol Labs, Woods Hole, MA 02543 USA; Serono Reprod Biol Inst, Rockland, MA 02370 USA; Univ Queensland, Dept Zool & Entomol, Brisbane, Qld 4072, Australia; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 93950 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Genet, Berkeley, CA 94720 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2T5, Canada; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 6110011, Japan; IBDM, LGPD, F-13288 Marseille 09, France; Dalhousie Univ, Life Sci Ctr, Halifax, NS B3H 4J1, Canada; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan; H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0600812, Japan; Stn Zool Anton Dohrn, I-80121 Naples, Italy; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Tohoku Univ, Grad Sch Sci, Asamushi Marine Biol Stn, Asamushi, Aomori 0393501, Japan; Univ Maryland, College Pk, MD 20742 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Programs Dev Biol Genet & Human Genet, San Francisco, CA 94143 USA; Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Kyoto University; Marine Biological Laboratory - Woods Hole; University of Queensland; Stanford University; University of California System; University of California Berkeley; McGill University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; UDICE-French Research Universities; Aix-Marseille Universite; Dalhousie University; University of Tokyo; Tokyo Metropolitan University; Tohoku University; H Lee Moffitt Cancer Center & Research Institute; Hokkaido University; Stazione Zoologica Anton Dohrn di Napoli; International Business Machines (IBM); Tohoku University; University System of Maryland; University of Maryland College Park; University of California System; University of California San Francisco; University of Edinburgh; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Berkeley	Kohara, Y (corresponding author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	ykohara@lab.nig.ac.jp; mlevine@uclink4.berkeley.edu; satoh@ascidian.zool.kyoto-u.ac.jp; dsrokhsar@lbl.gov	Putnam, Nicholas/B-9968-2008; Satou, Yutaka/AAJ-2194-2021; Rigoutsos, Isidore/C-5381-2012; Hotta, Kohji/D-1162-2014; Matassi, Giorgio/G-6301-2014; Lemaire, Patrick/P-8228-2019; Wang, Hong-Gang/A-3018-2015; Terry, Astrid Y/A-2538-2011; Campbell, Robert/G-4112-2012; Necula, Sabina/P-7113-2019; Lemaire, Patrick/B-5560-2012; Satou, Yutaka/K-7131-2012; Satoh, Nori/C-4123-2009; NONAKA, MASARU/G-4929-2014; Kawashima, Takeshi/M-4510-2015; Francino, M.Pilar/H-9090-2015; Di Gregorio, Anna/C-4766-2008; Lemaire, Patrick/D-4237-2009	Putnam, Nicholas/0000-0002-1315-782X; Satou, Yutaka/0000-0001-5193-0708; Hotta, Kohji/0000-0003-4614-7473; Matassi, Giorgio/0000-0003-4923-226X; Lemaire, Patrick/0000-0003-4925-2009; Wang, Hong-Gang/0000-0003-0551-0571; Terry, Astrid Y/0000-0002-5234-1224; Necula, Sabina/0000-0001-6912-2450; Lemaire, Patrick/0000-0003-4925-2009; Satou, Yutaka/0000-0001-5193-0708; Satoh, Nori/0000-0002-4480-3572; Francino, M.Pilar/0000-0002-4510-5653; Rokhsar, Daniel/0000-0002-8704-2224; Mount, Steve/0000-0003-2748-8205; Davidson, Brad/0000-0001-5082-7872; Goodstein, David/0000-0001-6287-2697; Meinertzhagen, Ian/0000-0002-6578-4526; Imai, Kaoru/0000-0001-9113-6074; Rigoutsos, Isidore/0000-0003-1529-8631; Stainier, Didier/0000-0002-0382-0026; Levine, Michael/0000-0001-7629-0081; Kobayashi, Kenji/0000-0002-9312-7857; Degnan, Bernard/0000-0001-7573-8518; Spagnuolo, Antonietta/0000-0001-6660-071X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-37105] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Brennan K, 2002, BIOESSAYS, V24, P405, DOI 10.1002/bies.10089; Burglin T.R, 1994, EVOLUTION HOMEOBOX G, P27; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cameron RA, 2000, P NATL ACAD SCI USA, V97, P9514, DOI 10.1073/pnas.160261897; Capponi AM, 2002, TRENDS ENDOCRIN MET, V13, P118, DOI 10.1016/S1043-2760(01)00538-0; CHOURROUT D, COMMUNICATION; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Conklin E.G., 1905, J ACAD NAT SCI PHILA, V12, P1, DOI DOI 10.5962/BHL.TITLE.4801; Corbo JC, 1997, DEVELOPMENT, V124, P589; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Darwin Charles, 1871, DESCENT MAN; Di Gregorio A, 2002, DIFFERENTIATION, V70, P132; DIGREGORIO A, 1995, GENE, V156, P253, DOI 10.1016/0378-1119(95)00035-5; DOLLE P, 1994, DEVELOPMENT, P143; Dunn JT, 2001, THYROID, V11, P407, DOI 10.1089/105072501300176363; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gee H., 1996, BACKBONE VIEWS ORIGI; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; HAFAFUJI N, 2002, P NATL ACAD SCI USA, V99, P6802; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hill CS, 1999, INT J BIOCHEM CELL B, V31, P1249, DOI 10.1016/S1357-2725(99)00093-X; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOLLAND PWH, 1994, DEVELOPMENT, P125; Imai KS, 2002, DEVELOPMENT, V129, P3441; Jeffery WR, 2001, INT REV CYTOL, V203, P3; JOOST P, IN PRESS GENOME BIOL; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]; KEYS DN, UNPUB; Kirsten D, 2000, Neonatal Netw, V19, P11; KOVILUR S, 1993, J MOL EVOL, V36, P361; Kowalevsky A., 1866, Mem. Acad. Imp. des Sciences de St. Petersbourg, tome, Vx, P1; KRISHNAN G, 1975, INDIAN J EXP BIOL, V13, P172; Kusakabe T, 2002, DEV BIOL, V242, P188, DOI 10.1006/dbio.2002.0538; Lacroix L, 2001, THYROID, V11, P1017, DOI 10.1089/105072501753271699; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; MEEDEL TH, 1984, DEV BIOL, V105, P479, DOI 10.1016/0012-1606(84)90305-1; Meinertzhagen LA, 2001, TRENDS NEUROSCI, V24, P401, DOI 10.1016/S0166-2236(00)01851-8; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; NISHIDA H, 1997, INT REV CYTOL, V176, P24; Nishino A, 2001, GENESIS, V29, P36, DOI 10.1002/1526-968X(200101)29:1<36::AID-GENE1003>3.0.CO;2-J; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; Oota S, 1999, MOL BIOL EVOL, V16, P856, DOI 10.1093/oxfordjournals.molbev.a026170; Ornitz DM, 2001, GENOME BIOL, V2; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Pennisi E, 2000, SCIENCE, V287, P2182, DOI 10.1126/science.287.5461.2182; PUTNAM N, UNPUB; Read SM, 2002, SCIENCE, V295, P59, DOI 10.1126/science.1068155; Romer AS., 1970, VERTEBRATE BODY; Ruvinsky I, 2000, DEVELOPMENT, V127, P5233; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Satoh N, 2001, DIFFERENTIATION, V68, P1, DOI 10.1046/j.1432-0436.2001.068001001.x; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 2002, DEV GENES EVOL, V212, P432, DOI 10.1007/s00427-002-0266-8; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Satou Y, 2001, DEVELOPMENT, V128, P2893; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Simmen MW, 1998, P NATL ACAD SCI USA, V95, P4437, DOI 10.1073/pnas.95.8.4437; Sordino P, 2000, SARSIA, V85, P173, DOI 10.1080/00364827.2000.10414567; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Takahashi H, 1999, GENE DEV, V13, P1519, DOI 10.1101/gad.13.12.1519; Tomarev SI, 1997, INT J DEV BIOL, V41, P835; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ulrich HD, 2002, CURR TOP MICROBIOL, V268, P137; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; VANDEKERCKHOVE J, 1984, J MOL BIOL, V179, P391, DOI 10.1016/0022-2836(84)90072-X; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Weichert C.K., 1953, ELEMENTS CHORDATE AN; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	90	1304	1349	3	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2157	2167		10.1126/science.1080049	http://dx.doi.org/10.1126/science.1080049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481130				2022-12-24	WOS:000179773700039
J	Mironov, AS; Gusarov, I; Rafikov, R; Lopez, LE; Shatalin, K; Kreneva, RA; Perumov, DA; Nudler, E				Mironov, AS; Gusarov, I; Rafikov, R; Lopez, LE; Shatalin, K; Kreneva, RA; Perumov, DA; Nudler, E			Sensing small molecules by nascent RNA: A mechanism to control transcription in bacteria	CELL			English	Article							SUBTILIS RIBOFLAVIN OPERON; BACILLUS-SUBTILIS; SALMONELLA-TYPHIMURIUM; TERMINATION CONTROL; BIOSYNTHESIS GENES; MESSENGER-RNA; EXPRESSION; BOX; ANTITERMINATION; SYNTHETASE	Thiamin and riboflavin are precursors of essential coenzymes-thiamin pyrophosphate (TPP) and flavin mononucleotide (FMN)/flavin adenine dinucleotide (FAD), respectively. In Bacillus spp, genes responsible for thiamin and riboflavin biosynthesis are organized in tightly controllable operons. Here, we demonstrate that the feedback regulation of riboflavin and thiamin genes relies on a novel transcription attenuation mechanism. A unique feature of this mechanism is the formation of specific complexes between a conserved leader region of the cognate RNA and FMN or TPP. In each case, the complex allows the termination hairpin to form and interrupt transcription prematurely. Thus, sensing small molecules by nascent RNA controls transcription elongation of riboflavin and thiamin operons and possibly other bacterial operons as well.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; State Res Inst Genet & Select Ind Microorganisms, Moscow 113545, Russia; Integrated Genom Inc, Chicago, IL 60612 USA; BP Konstantinov Nucl Phys Inst, Dept Mol & Radiat Biophys, St Petersburg 188350, Russia	New York University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Nudler, E (corresponding author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.		Rafikov, Ruslan/AAG-9352-2019; Gusarov, Ivan/AAJ-6282-2020; Mironov, Alexander/G-8531-2013	Rafikov, Ruslan/0000-0001-5950-4076; Mironov, Alexander/0000-0003-3914-1380; Nudler, Evgeny/0000-0002-8811-3071	NIGMS NIH HHS [GM58750] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anthony LC, 2000, PROTEIN EXPRES PURIF, V19, P350, DOI 10.1006/prep.2000.1272; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; BRESLER SE, 1973, GENETIKA+, V9, P84; FULLER TE, 1995, J BACTERIOL, V177, P7265, DOI 10.1128/jb.177.24.7265-7270.1995; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Grundy FJ, 1997, J BACTERIOL, V179, P2587, DOI 10.1128/jb.179.8.2587-2594.1997; Grundy FJ, 1997, J BACTERIOL, V179, P3767, DOI 10.1128/jb.179.11.3767-3772.1997; Grundy FJ, 2002, P NATL ACAD SCI USA, V99, P11121, DOI 10.1073/pnas.162366799; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gusarov I. I., 1997, Molekulyarnaya Biologiya (Moscow), V31, P820; Gusarov I. I., 1997, Molekulyarnaya Biologiya (Moscow), V31, P446; Henkin TM, 2000, CURR OPIN MICROBIOL, V3, P149, DOI 10.1016/S1369-5274(00)00067-9; KIL YV, 1992, MOL GEN GENET, V233, P483, DOI 10.1007/BF00265448; KRENEVA RA, 1990, MOL GEN GENET, V222, P467, DOI 10.1007/BF00633858; LANDICK R, 1996, ESCHERICHIA COLI SAL; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; MIRONOV VN, 1990, MOL BIOL MOSK, P256; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Perkins JB, 2002, BACILLUS SUBTILIS IT, P271, DOI DOI 10.1128/9781555817992.CH20; Ravnum S, 2001, MOL MICROBIOL, V39, P1585, DOI 10.1046/j.1365-2958.2001.02346.x; Solovieva IM, 1999, MICROBIOL-SGM, V145, P67, DOI 10.1099/13500872-145-1-67; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; van de Guchte M, 1998, MOL MICROBIOL, V29, P61, DOI 10.1046/j.1365-2958.1998.00903.x; Webb E, 1996, J BACTERIOL, V178, P2533, DOI 10.1128/jb.178.9.2533-2538.1996; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yanofsky C, 1996, BIOCHIMIE, V78, P1017, DOI 10.1016/S0300-9084(97)86725-9; Zuker M., 1999, V70, P11	32	495	530	1	66	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 27	2002	111	5					747	756		10.1016/S0092-8674(02)01134-0	http://dx.doi.org/10.1016/S0092-8674(02)01134-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	621MV	12464185	Bronze			2022-12-24	WOS:000179594500015
J	Pellegrini, L; Yu, DS; Lo, T; Anand, S; Lee, M; Blundell, TL; Venkitaraman, AR				Pellegrini, L; Yu, DS; Lo, T; Anand, S; Lee, M; Blundell, TL; Venkitaraman, AR			Insights into DNA recombination from the structure of a RAD51-BRCA2 complex	NATURE			English	Article							BRC REPEATS; CANCER SUSCEPTIBILITY; RAD51 RECOMBINATION; PROTEIN; RECA; EXPRESSION; FILAMENT; EXCHANGE; REPAIR; CELLS	The breast cancer susceptibility protein BRCA2 controls the function of RAD51, a recombinase enzyme, in pathways for DNA repair by homologous recombination. We report here the structure of a complex between an evolutionarily conserved sequence in BRCA2 ( the BRC repeat) and the RecA-homology domain of RAD51. The BRC repeat mimics a motif in RAD51 that serves as an interface for oligomerization between individual RAD51 monomers, thus enabling BRCA2 to control the assembly of the RAD51 nucleoprotein filament, which is essential for strand-pairing reactions during DNA recombination. The RAD51 oligomerization motif is highly conserved among RecA-like recombinases, highlighting a common evolutionary origin for the mechanism of nucleoprotein filament formation, mirrored in the BRC repeat. Cancer-associated mutations that affect the BRC repeat disrupt its predicted interaction with RAD51, yielding structural insight into mechanisms for cancer susceptibility.	Univ Cambridge, CR UK Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, CR UK Dept Oncol, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk	Lee, MiYoung/G-3748-2014; Pellegrini, Luca/AAE-2312-2022	Pellegrini, Luca/0000-0002-9300-497X				Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Deacon AM, 1998, P NATL ACAD SCI USA, V95, P9284, DOI 10.1073/pnas.95.16.9284; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; MURSHUDOV GN, 1997, ACTA CRYSTALLOGR D, V54, P905; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Warren M, 2002, HUM MOL GENET, V11, P841, DOI 10.1093/hmg/11.7.841; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Yu VPCC, 2000, GENE DEV, V14, P1400; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	35	507	527	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2002	420	6913					287	293		10.1038/nature01230	http://dx.doi.org/10.1038/nature01230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12442171				2022-12-24	WOS:000179340400034
J	Szabo, P; Scheuring, I; Czaran, T; Szathmary, E				Szabo, P; Scheuring, I; Czaran, T; Szathmary, E			In silico simulations reveal that replicators with limited dispersal evolve towards higher efficiency and fidelity	NATURE			English	Article							DNA-POLYMERASE; CRYSTAL-STRUCTURE; EVOLUTION; POLYMERIZATION; MECHANISMS; LIFE	The emergence of functional replicases, acting quickly and with high accuracy, was crucial to the origin of life(1). Although where the first RNA molecules came from is still unknown, it is nevertheless assumed that catalytic RNA enzymes (ribozymes) with replicase function emerged at some early stage of evolution(1). The fidelity of copying is especially important because the mutation load limits the length of replicating templates that can be maintained by natural selection(2). An increase in template length is disadvantageous for a fixed digit copying fidelity, however, longer molecules are expected to be better replicases. An iteration for longer molecules with better replicase function has been suggested(3,4) and analysed mathematically(5). Here we show that more efficient replicases can spread, provided they are adsorbed to a prebiotic mineral surface. A cellular automaton(6) simulation reveals that copying fidelity, replicase speed and template efficiency all increase with evolution, despite the presence of molecular parasites, essentially because of reciprocal atruism(7) ('within-species mutualism') on the surface(8), thus making a gradual improvement of replicase function more plausible.	Eotvos Lorand Univ, Dept Plant Taxon & Ecol, Res Grp Ecol & Theoret Biol, H-1117 Budapest, Hungary; Int Inst Appl Syst Anal, Adapt Dynam Network, A-2361 Laxenburg, Austria; Collegium Budapest Inst Adv Study, H-1014 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University; International Institute for Applied Systems Analysis (IIASA)	Szathmary, E (corresponding author), Eotvos Lorand Univ, Dept Plant Taxon & Ecol, Res Grp Ecol & Theoret Biol, 1-C Pazmany P Setany, H-1117 Budapest, Hungary.	szathmary@colbud.hu	Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021; Czárán, Tamás/P-4297-2019; Scheuring, Istvan/A-5368-2011; Czárán, Tamás/A-1169-2008	Szathmary, Eors/0000-0001-5227-2997; Czárán, Tamás/0000-0002-2722-6208; Scheuring, Istvan/0000-0002-8108-8897; Czárán, Tamás/0000-0002-2722-6208; Szabo, Peter/0000-0002-0521-3094				BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Czaran T, 2000, GEOMETRY ECOLOGICAL, P116, DOI 10.1613/jair.301; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Florentz Catherine, 1995, P141; GALAS DJ, 1978, J MOL BIOL, V124, P653, DOI 10.1016/0022-2836(78)90176-6; Goodman MF, 1998, GENETICS, V148, P1475; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; James KD, 1999, ORIGINS LIFE EVOL B, V29, P375, DOI 10.1023/A:1006544611320; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Orgel LE, 1998, ORIGINS LIFE EVOL B, V28, P227, DOI 10.1023/A:1006595411403; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Scheuring I, 2000, SELECTION, V1, P135; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; SZATHMARY E, 1993, J THEOR BIOL, V164, P447, DOI 10.1006/jtbi.1993.1166; TOFFOLI T, 1987, CELLULAR AUTOMATA MA, P155; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; von Kiedrowski G., 2000, SELECTION, V1, P173, DOI DOI 10.1556/SELECT.1.2000.1-3.17); vonKiedrowski G, 1996, NATURE, V381, P20, DOI 10.1038/381020a0; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wolfram S., 2002, NEW KIND SCI	27	107	108	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					340	343		10.1038/nature01187	http://dx.doi.org/10.1038/nature01187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447445				2022-12-24	WOS:000179340400048
J	Xie, DY; Sharma, SB; Paiva, NL; Ferreira, D; Dixon, RA				Xie, DY; Sharma, SB; Paiva, NL; Ferreira, D; Dixon, RA			Role of anthocyanidin reductase, encoded by BANYULS in plant flavonoid biosynthesis	SCIENCE			English	Article							CONDENSED TANNINS; GENE ENCODES; FLAVAN-3-OL BIOSYNTHESIS; FORAGE LEGUMES; DOMAIN PROTEIN; PROANTHOCYANIDINS; CONVERSION; LEUCOCYANIDIN; ACCUMULATION; EXPRESSION	Condensed tannins (CTs) are flavonoid oligomers, many of which have beneficial effects on animal and human health. The flavanol (-)-epicatechin is a component of many CTs and contributes to flavor and astringency in tea and wine. We show that the BANYULS ( BAN) genes from Arabidopsis thaliana and Medicago truncatula encode anthocyanidin reductase, which converts anthocyanidins to their corresponding 2,3-cis-avan-3-ols. Ectopic expression of BAN in tobacco flower petals and Arabidopsis leaves results in loss of anthocyanins and accumulation of CTs.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA	Noble Research Institute; University of Mississippi	Dixon, RA (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	radixon@noble.org		XIE, DE-YU/0000-0002-3054-1188				Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; ALBRECHT KA, 1991, CROP SCI, V31, P464, DOI 10.2135/cropsci1991.0011183X003100020048x; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Barry TN, 1999, BRIT J NUTR, V81, P263, DOI 10.1017/S0007114599000501; BRODERICK GA, 1995, J ANIM SCI, V73, P2760; Dalzell SA, 1998, J SCI FOOD AGR, V78, P405, DOI [10.1002/(SICI)1097-0010(199811)78:3<405::AID-JSFA133>3.0.CO;2-G, 10.1002/(SICI)1097-0010(199811)78:3&lt;405::AID-JSFA133&gt;3.0.CO;2-G]; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Douglas GB, 1999, NEW ZEAL J AGR RES, V42, P55, DOI 10.1080/00288233.1999.9513353; Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7; FOO LY, 1983, J CHEM SOC PERK T 1, P1535, DOI 10.1039/p19830001535; KORVER O, 1971, TETRAHEDRON, V27, P5459, DOI 10.1016/S0040-4020(01)91712-0; KRISTIANSEN KN, 1986, CARLSBERG RES COMMUN, V51, P51, DOI 10.1007/BF02907995; Lin LC, 2002, J NAT PROD, V65, P505, DOI 10.1021/np010414l; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050; NEL RJJ, 1999, J CHEM RES S, P606; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Pataki T, 2002, AM J CLIN NUTR, V75, P894, DOI 10.1093/ajcn/75.5.894; Porter L.J., 1989, TANNINS METHODS PLAN, V1, P389; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Singh S, 1997, PHYTOCHEMISTRY, V44, P425, DOI 10.1016/S0031-9422(96)00415-3; Skadhauge B, 1997, AM J BOT, V84, P494, DOI 10.2307/2446026; STAFFORD HA, 1985, PLANT PHYSIOL, V78, P791, DOI 10.1104/pp.78.4.791; STAFFORD HA, 1983, PHYTOCHEMISTRY, V22, P2643, DOI 10.1016/S0031-9422(00)97664-7; STAFFORD HA, 1984, PLANT PHYSIOL, V76, P184, DOI 10.1104/pp.76.1.184; Stafford HA, 1990, FLAVONOID METABOLISM, P63; TANNER GJ, 1993, ANAL BIOCHEM, V209, P274, DOI 10.1006/abio.1993.1119; van Rensburg H, 1999, J CHEM RES-S, P450, DOI 10.1039/a901599j; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485	33	526	619	16	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					396	399		10.1126/science.1078540	http://dx.doi.org/10.1126/science.1078540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532018	Green Submitted			2022-12-24	WOS:000180426800046
J	Katan, MB; de Roos, NM				Katan, MB; de Roos, NM			Public health - Toward evidence-based health claims for foods	SCIENCE			English	Editorial Material							TRENDS		Wageningen Univ, Div Human Nutr & Epidemiol, Wageningen, Netherlands; Univ Med Ctr, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Katan, MB (corresponding author), Wageningen Univ, Div Human Nutr & Epidemiol, Wageningen, Netherlands.	wcfs1@wur.nl						Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; *EUR COMM, SANCO18322002 EUR CO; GUTHRIE JF, 1999, AM EATING HABITS CHA, P269; HELLER IR, 1999, FUNCTIONAL FOODS PUB, P9; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; *I MED, 2002, PROP FRAM EV SAF DIE; Jacobson MF, 1999, BMJ-BRIT MED J, V319, P205, DOI 10.1136/bmj.319.7204.205; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; NESTLE M, 2002, FOOD POLITICS FOOD I, P316; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Sloan AE, 2002, FOOD TECHNOL-CHICAGO, V56, P32; Southon S, 2000, ROY SOC CH, P3; Truswell AS, 2001, LANCET, V357, P1061, DOI 10.1016/S0140-6736(00)04308-7; *US GEN ACC OFF, 2000, GAORCED00156; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5	17	26	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					206	207		10.1126/science.1078638	http://dx.doi.org/10.1126/science.1078638			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522235				2022-12-24	WOS:000180284000022
J	Hove, JR; Koster, RW; Forouhar, AS; Acevedo-Bolton, G; Fraser, SE; Gharib, M				Hove, JR; Koster, RW; Forouhar, AS; Acevedo-Bolton, G; Fraser, SE; Gharib, M			Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis	NATURE			English	Article							SHEAR-STRESS; BLOOD-FLOW; CARDIAC DEVELOPMENT; ENDOTHELIAL-CELLS; ZEBRAFISH; MECHANOTRANSDUCTION; EXPRESSION; SYSTEM; HEART; GENE	The pattern of blood flow in the developing heart has long been proposed to play a significant role in cardiac morphogenesis. In response to flow-induced forces, cultured cardiac endothelial cells rearrange their cytoskeletal structure and change their gene expression profiles(1,2). To link such in vitro data to the intact heart, we performed quantitative in vivo analyses of intracardiac flow forces in zebrafish embryos. Using in vivo imaging, here we show the presence of high-shear, vortical flow at two key stages in the developing heart, and predict flow-induced forces much greater than might have been expected for micro-scale structures at low Reynolds numbers. To test the relevance of these shear forces in vivo, flow was occluded at either the cardiac inflow or outflow tracts, resulting in hearts with an abnormal third chamber, diminished looping and impaired valve formation. The similarity of these defects to those observed in some congenital heart diseases argues for the importance of intracardiac haemodynamics as a key epigenetic factor in embryonic cardiogenesis.	CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Hove, JR (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	jhove@caltech.edu; rkoeste1@gg.caltech.edu	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Koster, Reinhard/0000-0001-6593-8196; Gharib, Mohammed/0000-0001-9611-1693				Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Di Stefano I, 1998, J VASC RES, V35, P1, DOI 10.1159/000025559; HELMLINGER G, 1991, J BIOMECH ENG-T ASME, V113, P123, DOI 10.1115/1.2891226; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; HOU PCL, 1995, AM J PHYSIOL-REG I, V269, pR1126, DOI 10.1152/ajpregu.1995.269.5.R1126; Icardo JM, 1996, J EXP ZOOL, V275, P144, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<144::AID-JEZ7>3.3.CO;2-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langille BL, 1995, FLOW DEPENDENT REGUL, P277; Liao EC, 2002, DEVELOPMENT, V129, P649; Long QM, 1997, DEVELOPMENT, V124, P4105; MANASEK FJ, 1972, DEV BIOL, V27, P584, DOI 10.1016/0012-1606(72)90196-0; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; NEREM RM, 1993, J CARDIOVASC PHARM, V21, pS6, DOI 10.1097/00005344-199321001-00002; OBRIEN SPM, 1999, FETAL PROGRAMMING IN; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; STAINIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207, DOI 10.1016/1050-1738(94)90036-1; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Taber LA, 1998, PROG BIOPHYS MOL BIO, V69, P237, DOI 10.1016/S0079-6107(98)00010-8; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WESTERFIELD M, 1995, ZEBRAFISH BOOK; WILLERT CE, 1991, EXP FLUIDS, V10, P181	29	771	786	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					172	177		10.1038/nature01282	http://dx.doi.org/10.1038/nature01282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520305				2022-12-24	WOS:000180267200043
J	Pearson, H				Pearson, H			Stem cells - Articles of faith adulterated	NATURE			English	Editorial Material							BONE-MARROW; BRAIN											Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	14	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					734	735		10.1038/420734a	http://dx.doi.org/10.1038/420734a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490909				2022-12-24	WOS:000179897300018
J	Chan, D; Rossor, MN				Chan, D; Rossor, MN			"-but who is that on the other side of you?" - Extracampine hallucinations revisited	LANCET			English	Editorial Material							PARKINSONS-DISEASE; LEWY BODIES; DEMENTIA; AREA; BODY		Inst Neurol, Dept Clin Neurol, Dementia Res Grp, London WC1N 3BG, England; Univ London Imperial Coll Sci & Technol, Fac Med, Div Neurosci, London, England	University of London; University College London; Imperial College London	Chan, D (corresponding author), Natl Hosp Neurol & Neurosurg, Dementia Res Grp, Queen Sq, London WC1N 3BG, England.		Rossor, Martin/C-1598-2008	Rossor, Martin/0000-0001-8215-3120				Aarsland D, 2001, INT J GERIATR PSYCH, V16, P528, DOI 10.1002/gps.389; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; CELESIA GG, 1970, ARCH NEUROL-CHICAGO, V23, P193, DOI 10.1001/archneur.1970.00480270003001; Critchley M, 1943, SHIPWRECK SURVIVORS; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733; Harding AJ, 2002, BRAIN, V125, P391, DOI 10.1093/brain/awf033; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; PERRY EK, 1993, J NEURAL TRANSM-PARK, V6, P167, DOI 10.1007/BF02260919; Shackleton E, 1919, SOUTH; Ungerleider L.G., 1982, ANAL VISUAL BEHAV	13	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2064	2066		10.1016/S0140-6736(02)11998-2	http://dx.doi.org/10.1016/S0140-6736(02)11998-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504418				2022-12-24	WOS:000179974200029
J	Sharp, D				Sharp, D			Cholera and climate - the evidence grows	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Patz JA, 2002, P NATL ACAD SCI USA, V99, P12506, DOI 10.1073/pnas.212467899; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999	4	0	0	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 14	2002	360	9349					1902	1902		10.1016/S0140-6736(02)11937-4	http://dx.doi.org/10.1016/S0140-6736(02)11937-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626KC	12493254				2022-12-24	WOS:000179870200006
J	Panda, S; Sato, TK; Castrucci, AM; Rollag, MD; DeGrip, WJ; Hogenesch, JB; Provencio, I; Kay, SA				Panda, S; Sato, TK; Castrucci, AM; Rollag, MD; DeGrip, WJ; Hogenesch, JB; Provencio, I; Kay, SA			Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting	SCIENCE			English	Article							RETINOHYPOTHALAMIC TRACT; OCULAR PHOTORECEPTION; CRYPTOCHROMES; ENTRAINMENT; RHYTHMS; BLIND; MOUSE; CELLS; NIGHT; OPSIN	The master circadian oscillator in the hypothalamic suprachiasmatic nucleus is entrained to the day/night cycle by retinal photoreceptors. Melanopsin (Opn4), an opsin-based photopigment, is a primary candidate for photoreceptor-mediated entrainment. To investigate the functional role of melanopsin in light resetting of the oscillator, we generated melanopsin-null mice (Opn4(-/-)). These mice entrain to a light/dark cycle and do not exhibit any overt defect in circadian activity rhythms under constant darkness. However, they display severely attenuated phase resetting in response to brief pulses of monochromatic light, highlighting the critical role of melanopsin in circadian photoentrainment in mammals.	Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Sao Paulo, Dept Physiol, BR-05422 Sao Paulo, Brazil; Univ Nijmegen, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	Uniformed Services University of the Health Sciences - USA; Novartis; Scripps Research Institute; Universidade de Sao Paulo; Radboud University Nijmegen	Provencio, I (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.		Jansen, Heiko T./A-5770-2008; Castrucci, Ana Maria L/C-3296-2014; de Grip, W.J./L-4335-2015; Panda, Satchidananda/J-6891-2012; Kay, Steve A/F-6025-2011	Jansen, Heiko T./0000-0003-0178-396X; Kay, Steve A/0000-0002-0402-2878; Castrucci, Ana Maria/0000-0002-2065-8198	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062405, R01MH051573] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51573, MH 62405] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J BIOL RHYTHM, V16, P457, DOI 10.1177/074873001129002132; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Nielsen HS, 2001, NEUROSCIENCE, V103, P433, DOI 10.1016/S0306-4522(00)00563-7; PICKARD GE, 1994, NEUROREPORT, V5, P2186, DOI 10.1097/00001756-199410270-00049; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Yanovsky MJ, 2000, CURR BIOL, V10, P1013, DOI 10.1016/S0960-9822(00)00651-5	24	604	624	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2213	2216		10.1126/science.1076848	http://dx.doi.org/10.1126/science.1076848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481141				2022-12-24	WOS:000179773700055
J	Ruby, NF; Brennan, TJ; Xie, XM; Cao, V; Franken, P; Heller, HC; O'Hara, BF				Ruby, NF; Brennan, TJ; Xie, XM; Cao, V; Franken, P; Heller, HC; O'Hara, BF			Role of melanopsin in circadian responses to light	SCIENCE			English	Article							RETINAL GANGLION-CELLS; OCULAR PHOTORECEPTION; MICE; CRYPTOCHROMES; PROJECTIONS; EXPRESSION; MELATONIN; SYSTEM; BLIND	Melanopsin has been proposed as an important photoreceptive molecule for the mammalian circadian system. Its importance in this role was tested in melanopsin knockout mice. These mice entrained to a light/dark cycle, phase-shifted after a light pulse, and increased circadian period when light intensity increased. Induction of the immediate-early gene c-fos was observed after a nighttime light pulse in both wild-type and knockout mice. However, the magnitude of these behavioral responses in knockout mice was 40% lower than in wild-type mice. Although melanopsin is not essential for the circadian clock to receive photic input, it contributes significantly to the magnitude of photic responses.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Deltagen Inc, Redwood City, CA 94063 USA	Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	ruby@stanford.edu; bfo@stanford.edu	Franken, Paul/A-9633-2018; Heller, H. Craig/C-9785-2011	Franken, Paul/0000-0002-2500-2921; Heller, H Craig/0000-0003-4479-5880; Xie, Xinmin Simon/0000-0002-4049-6499	NHLBI NIH HHS [HL64148] Funding Source: Medline; NIDA NIH HHS [DA13349] Funding Source: Medline; NIMH NIH HHS [MH60385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013349] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2001, J NEUROSCI, V21, P6405; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lucas RJ, 1999, J BIOL RHYTHM, V14, P4, DOI 10.1177/074873099129000380; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruby NF, 1998, J BIOL RHYTHM, V13, P506, DOI 10.1177/074873098129000336; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SUTIN EL, 1992, MOL BRAIN RES, V15, P281, DOI 10.1016/0169-328X(92)90119-V; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; UNDERWOOD H, 1990, EXPERIENTIA, V46, P120, DOI 10.1007/BF01955437; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; YOSHIMURA T, 1994, J BIOL RHYTHM, V9, P51, DOI 10.1177/074873049400900105	26	475	491	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2002	298	5601					2211	2213		10.1126/science.1076701	http://dx.doi.org/10.1126/science.1076701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481140				2022-12-24	WOS:000179773700054
J	Aristegui, J; Duarte, CM; Agusti, S; Doval, M; Alvarez-Salgado, XA; Hansell, DA				Aristegui, J; Duarte, CM; Agusti, S; Doval, M; Alvarez-Salgado, XA; Hansell, DA			Dissolved organic carbon support of respiration in the dark ocean	SCIENCE			English	Article							FLUX		Univ Las Palmas Gran Canaria, Fac Ciencias Mar, Las Palmas Gran Canaria 35017, Spain; UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Oslas Baleares, Spain; CCCMM XUGA, Vilagarcia De Arousa, Spain; CSIC, IIM, Vigo 36208, Spain; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Miami	Aristegui, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Ciencias Mar, Campus Univ Tafira, Las Palmas Gran Canaria 35017, Spain.		Duarte Quesada, Carlos Manuel/ABD-6208-2021; Duarte, Carlos M/A-7670-2013; Alvarez-Salgado, Xose Anton/A-8365-2012; Agusti, Susana/G-2864-2017; Arístegui, Javier/D-5833-2013; Hansell, Dennis A./AAC-1271-2019; Agusti, Susana/H-8421-2012	Duarte, Carlos M/0000-0002-1213-1361; Alvarez-Salgado, Xose Anton/0000-0002-2387-9201; Agusti, Susana/0000-0003-0536-7293; Arístegui, Javier/0000-0002-7526-7741; Hansell, Dennis A./0000-0001-9275-3445; Doval, Marylo/0000-0002-8565-8703				Alvarez-Salgado XA, 2001, SCI MAR, V65, P1; CARLSON CA, 1994, NATURE, V371, P405, DOI 10.1038/371405a0; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Doval MD, 2000, MAR CHEM, V68, P249, DOI 10.1016/S0304-4203(99)00081-X; Hansell D.A., 2002, BIOGEOCHEMISTRY MARI, P685716, DOI [10.1016/B978-012323841-2/50017-8, DOI 10.1016/B978-012323841-2/50017-8]; Hansell DA, 1998, GLOBAL BIOGEOCHEM CY, V12, P443, DOI 10.1029/98GB01928; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Jahnke RA, 1996, GLOBAL BIOGEOCHEM CY, V10, P71, DOI 10.1029/95GB03525; PELTZER ET, 1996, DEEP SEA RES 2, V43, P155; SCHOLTEN JC, 2001, DEEP SEA RES 2, V48, P243	10	100	102	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1967	1967		10.1126/science.1076746	http://dx.doi.org/10.1126/science.1076746			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471250	Green Submitted			2022-12-24	WOS:000179629200037
J	Levinger, NE				Levinger, NE			Water in confinement	SCIENCE			English	Editorial Material							AQUEOUS REVERSE MICELLES; MOLECULAR SIMULATION; SOLVATION DYNAMICS; LIQUID WATER; SOLVENTS; SIZE		Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Levinger, NE (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.							Boyd JE, 2002, J PHYS CHEM B, V106, P6346, DOI 10.1021/jp0255740; Boyd JE, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.147401; Bursing H, 2001, PHYS CHEM CHEM PHYS, V3, P2378, DOI 10.1039/b009301g; DE TK, 1995, ADV COLLOID INTERFAC, V59, P95, DOI 10.1016/0001-8686(95)80005-N; Faeder J, 2000, J PHYS CHEM B, V104, P1033, DOI 10.1021/jp993076u; Faeder J, 2001, J PHYS CHEM B, V105, P11148, DOI 10.1021/jp010632n; Luisi P.L., 1984, REVERSE MICELLES BIO; OWRUTSKY JC, 1991, CHEM PHYS LETT, V184, P368, DOI 10.1016/0009-2614(91)80002-F; Pileni MP, 1997, BER BUNSEN PHYS CHEM, V101, P1578, DOI 10.1002/bbpc.19971011105; Salaniwal S, 1999, LANGMUIR, V15, P5188, DOI 10.1021/la9904556; Salaniwal S, 2001, LANGMUIR, V17, P1773, DOI 10.1021/la000554f; Senapati S, 2002, LANGMUIR, V18, P7371, DOI 10.1021/la025952s; Silber JJ, 1999, ADV COLLOID INTERFAC, V82, P189, DOI 10.1016/S0001-8686(99)00018-4; Venables DS, 2001, J PHYS CHEM B, V105, P9132, DOI 10.1021/jp0112065; Zhong Q, 2002, LANGMUIR, V18, P7401, DOI 10.1021/la0260234	15	282	284	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 29	2002	298	5599					1722	1723		10.1126/science.1079322	http://dx.doi.org/10.1126/science.1079322			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459570				2022-12-24	WOS:000179494800023
J	Page, DL; Schuyler, PA; Dupont, WD; Jensen, RA; Plummer, WD; Simpson, JF				Page, DL; Schuyler, PA; Dupont, WD; Jensen, RA; Plummer, WD; Simpson, JF			Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study	LANCET			English	Article							TOTAL GLANDULAR MASTECTOMY; FOLLOW-UP; PROPHYLACTIC MASTECTOMY; CARCINOMA INSITU; DISEASE; WOMEN; NEOPLASIA	Background Clinical decisions about atypical lobular hyperplasia are based on the belief that later invasive breast-cancer risk is equal in both breasts. We aimed to show laterality and subsequent risk implications of invasive breast cancer in women with atypical lobular hyperplasia. Methods We did a retrospective cohort study of 252 women who had undergone 261 benign surgical biopsies that showed atypical lobular hyperplasia from 1950 to 1985, as part of the Nashville Breast Studies. Primary outcomes were development of invasive breast cancer and laterality of cancer compared with side of the biopsied breast. Findings 50 (20%) of 252 women treated by biopsy only developed invasive breast cancer. Relative risk of breast cancer in women with atypical lobular hyperplasia was 3.1 (95% Cl 2.3-4.3, p<0.0001). Of these 50 women, the breast with invasive cancer was the same breast diagnosed with atypical lobular hyperplasia (ipsilateral) in 34 (68%) and the contralateral breast in 12 (24%). The ratio of ipsilateral/ contralateral cancers for atypical lobular hyperplasia without other atypical lesions was 17/5. For six women with atypical lobular hyperplasia plus atypical ductal hyperplasia, the ratio was 1/1. Interpretation Invasive carcinoma after atypical lobular hyperplasia is about three times more likely to arise in the breast diagnosed with atypical lobular hyperplasia than in the opposite breast without these initial findings. Our findings suggest a model of premalignancy for atypical lobular hyperplasia intermediate between a local precursor and a generalised risk for both breasts.	Vanderbilt Univ, Med Ctr, Dept Anat Pathol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Page, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, MCN, C-3311, Nashville, TN 37232 USA.		Dupont, William D./I-4430-2012; Jensen, Roy A/B-9739-2011	Jensen, Roy A/0000-0003-4430-2281	NATIONAL CANCER INSTITUTE [R01CA062212, R01CA050468] Funding Source: NIH RePORTER; NCI NIH HHS [CA-62212, CA-50468, CA-31698] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acs G, 2001, AM J CLIN PATHOL, V115, P85; BARTON FE, 1991, PLAST RECONSTR SURG, V88, P389, DOI 10.1097/00006534-199109000-00001; Beller F K, 1988, Recent Results Cancer Res, V106, P73; Bodian CA, 1996, CANCER, V78, P1024, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4; Brinton LA, 2001, CANCER, V91, P478, DOI 10.1002/1097-0142(20010201)91:3<478::AID-CNCR1025>3.3.CO;2-X; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Fleiss J.L., 1981, STAT METHODS RATES P, V2nd ed., P321; FREEMAN BS, 1978, PLAST RECONSTR SURG, V62, P167, DOI 10.1097/00006534-197808000-00003; Gobbi H, 1999, J NATL CANCER I, V91, P2096, DOI 10.1093/jnci/91.24.2096; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HUTTER RVP, 1969, CANCER, V24, P1081, DOI 10.1002/1097-0142(196911)24:5<1081::AID-CNCR2820240534>3.0.CO;2-D; LAMBIRD PA, 1969, J AMER MED ASSOC, V210, P689; Lawless J.F, 1982, STAT MODELS METHODS; Lishman SC, 1999, HISTOPATHOLOGY, V35, P195; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Marshall LM, 1997, CANCER EPIDEM BIOMAR, V6, P297; MCDIVITT RW, 1992, CANCER-AM CANCER SOC, V69, P1408, DOI 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C; MCDIVITT RW, 1967, J AMER MED ASSOC, V201, P82, DOI 10.1001/jama.201.2.82; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Newman LA, 2000, J AM COLL SURGEONS, V191, P322, DOI 10.1016/S1072-7515(00)00361-6; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1988, HUM PATHOL, V19, P201, DOI 10.1016/S0046-8177(88)80350-2; PAGE DL, 1991, HUM PATHOL, V22, P1232, DOI 10.1016/0046-8177(91)90105-X; ROSEN PP, 1978, AM J SURG PATHOL, V2, P225, DOI 10.1097/00000478-197809000-00001; ROSEN PP, 1981, CANCER, V47, P813, DOI 10.1002/1097-0142(19810215)47:4<813::AID-CNCR2820470431>3.0.CO;2-J; Rothman K., 1998, MODERN EPIDEMIOLOGY; SIMPSON JF, 1998, BREAST, P91; SLOANE JP, 1995, PATHOLOGY REPORTING, P21	29	218	226	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					125	129		10.1016/S0140-6736(03)12230-1	http://dx.doi.org/10.1016/S0140-6736(03)12230-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531579				2022-12-24	WOS:000180428000011
J	Van Gelder, RN; Wee, R; Lee, JA; Tu, DC				Van Gelder, RN; Wee, R; Lee, JA; Tu, DC			Reduced pupillary light responses in mice lacking cryptochromes	SCIENCE			English	Article							OCULAR PHOTORECEPTORS; NON-CONE; NON-ROD		Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63131 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63131 USA	Washington University (WUSTL); Washington University (WUSTL)	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave, St Louis, MO 63131 USA.		Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659	NATIONAL EYE INSTITUTE [K08EY000403] Funding Source: NIH RePORTER; NEI NIH HHS [K08EY00403] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Van Gelder RN, 2002, J BIOL RHYTHM, V17, P110, DOI 10.1177/074873002129002401; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301	13	82	83	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					222	222		10.1126/science.1079536	http://dx.doi.org/10.1126/science.1079536			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522242				2022-12-24	WOS:000180284000029
J	Wentz, KU; Frohlich, JM; von Weymarn, C; Patak, MA; Jenelten, R; Zollikofer, CL				Wentz, KU; Frohlich, JM; von Weymarn, C; Patak, MA; Jenelten, R; Zollikofer, CL			High-resolution magnetic resonance angiography of hands with timed arterial compression (tac-MRA)	LANCET			English	Article								Timed arterial compression (tac) of blood flow can be achieved by inflation of a blood-pressure cuff. We postulated that this technique might improve contrast-enhanced magnetic resonance angiography (MRA) of the arteries of the hands. We studied eight volunteers and six patients with occlusive arterial disease of the hands with standard MRA and tac-MRA. Compared with standard MRA, acquisition time was extended with the blood-pressure cuff by a factor of four, leading to quadrupled image resolution (512x1024). Furthermore, flow-related artifacts were not seen. Tac-MRA permits visualisation of the peripheral arterial system in finer detail than that achieved with standard MRA.	Cantonal Hosp, Dept Radiol, Inst Radiol, MR Res Grp, CH-8401 Winterthur, Switzerland; Cantonal Hosp, Dept Internal Med, Div Angiol, CH-8401 Winterthur, Switzerland; Univ Witten Herdecke, Dept Radiol & MicroTherapy, Witten, Germany	Witten Herdecke University	Wentz, KU (corresponding author), Cantonal Hosp, Dept Radiol, Inst Radiol, MR Res Grp, CH-8401 Winterthur, Switzerland.							Earls JP, 1996, RADIOLOGY, V201, P705, DOI 10.1148/radiology.201.3.8939219; Goldfarb JW, 2001, AM J ROENTGENOL, V177, P1177, DOI 10.2214/ajr.177.5.1771177; Rofsky N M, 1995, Magn Reson Imaging Clin N Am, V3, P345; Winterer JT, 2000, J COMPUT ASSIST TOMO, V24, P903, DOI 10.1097/00004728-200011000-00017	4	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					49	50		10.1016/S0140-6736(03)12112-5	http://dx.doi.org/10.1016/S0140-6736(03)12112-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517469				2022-12-24	WOS:000180191600023
J	Gruber, N; Keeling, CD; Bates, NR				Gruber, N; Keeling, CD; Bates, NR			Interannual variability in the North Atlantic Ocean carbon sink	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; SARGASSO SEA; EL-NINO; INORGANIC CARBON; C-13; CO2; OSCILLATION; SEAWATER; BERMUDA; DIOXIDE	The North Atlantic is believed to represent the largest ocean sink for atmospheric carbon dioxide in the Northern Hemisphere, yet little is known about its temporal variability. We report an 18-year time series of upper-ocean inorganic carbon observations from the northwestern subtropical North Atlantic near Bermuda that indicates substantial variability in this sink. We deduce that the carbon variability at this site is largely driven by variations in winter mixed-layer depths and by sea surface temperature anomalies. Because these variations tend to occur in a basinwide coordinated pattern associated with the North Atlantic Oscillation, it is plausible that the entire North Atlantic Ocean may vary in concert, resulting in a variability of the strength of the North Atlantic carbon sink of about +/-0.3 petagrams of carbon per year (1 petagram=10(15) grams) or nearly +/-50%. This extrapolation is supported by basin-wide estimates from atmospheric carbon dioxide inversions.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Atmospher Sci, Los Angeles, CA 90095 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Bermuda Biol Stn Res Inc, Ferry Reach GE01, Bermuda	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Scripps Institution of Oceanography	Gruber, N (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	ngruber@igpp.ucla.edu	Gruber, Nicolas/B-7013-2009	Gruber, Nicolas/0000-0002-2085-2310				Bacastow RB, 1996, GLOBAL BIOGEOCHEM CY, V10, P335, DOI 10.1029/96GB00192; Bates NR, 1998, J GEOPHYS RES-OCEANS, V103, P15567, DOI 10.1029/98JC00247; Bates NR, 2002, NATURE, V420, P489, DOI 10.1038/nature01253; Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; CAYAN DR, 1992, J PHYS OCEANOGR, V22, P859, DOI 10.1175/1520-0485(1992)022<0859:LASHFA>2.0.CO;2; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; Cullen HM, 2001, PALEOCEANOGRAPHY, V16, P27, DOI 10.1029/1999PA000434; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; Feely RA, 1999, NATURE, V398, P597, DOI 10.1038/19273; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; GLOOR M, IN PRESS GEOPHYS RES; Gruber N, 1999, GLOBAL BIOGEOCHEM CY, V13, P307, DOI 10.1029/1999GB900019; Gruber N, 1998, DEEP-SEA RES PT I, V45, P673, DOI 10.1016/S0967-0637(97)00098-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Joyce TM, 1996, J CLIMATE, V9, P3121, DOI 10.1175/1520-0442(1996)009<3121:TLTHRA>2.0.CO;2; KAWAMURA R, 1994, J PHYS OCEANOGR, V24, P707, DOI 10.1175/1520-0485(1994)024<0707:AREAOG>2.0.CO;2; Keeling C. D., 1993, GLOBAL CARBON CYCLE, P413; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Le Quere C, 2000, GLOBAL BIOGEOCHEM CY, V14, P1247, DOI 10.1029/1999GB900049; Lee K, 1998, NATURE, V396, P155, DOI 10.1038/24139; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Molinari RL, 1997, J GEOPHYS RES-OCEANS, V102, P3267, DOI 10.1029/96JC03544; Rubinstein R. Y., 1981, SIMULATION MONTE CAR; Siegel DA, 1997, DEEP-SEA RES PT I, V44, P1519, DOI 10.1016/S0967-0637(97)00028-9; Sonnerup RE, 1999, GLOBAL BIOGEOCHEM CY, V13, P857, DOI 10.1029/1999GB900027; Stammer D, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000888; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; *US DOE, 1994, ORNLCDIAC74 US DEP E; WINGUTH AME, 1994, GLOBAL BIOGEOCHEM CY, V8, P39, DOI 10.1029/93GB03134	36	184	188	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 20	2002	298	5602					2374	2378		10.1126/science.1077077	http://dx.doi.org/10.1126/science.1077077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12493911				2022-12-24	WOS:000179915900052
J	Alberti, A; Noventa, F; Benvegnu, L; Boccato, S; Gatta, A				Alberti, A; Noventa, F; Benvegnu, L; Boccato, S; Gatta, A			Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection	ANNALS OF INTERNAL MEDICINE			English	Article							NATURAL-HISTORY; BLOOD-DONORS; AMINOTRANSFERASE LEVELS; PROGRESSION; FIBROSIS	Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons. Design: Population-based cross-sectional study. Setting: Northeastern Italy. Patients: 4820 apparently healthy Telecom Italy employees or their relatives who underwent screening for cardiovascular risk factors. Measurements: Initial screening for anti-HCV by enzyme-linked immunosorbent assay followed by HCV RNA testing by polymerase chain reaction and monitoring of alanine aminotransferase levels in viremic persons (92% of viremic persons also had liver biopsies to assess their METAVIR scores). Results: 116 persons (2.4% [95% Cl, 1.97% to 2.84%]) were positive for anti-HCV and 85 (1.76% [Cl, 1.39% to 2.14%]) were also viremic. The ALT level was persistently normal in 39 (46%) of viremic patients and elevated in 46 (54%). Significant hepatic histologic abnormalities were detected in 19% (Cl, 7.21% to 36.4%) of persons with persistently normal ALT levels and in 61% (Cl, 45.4% to 74.9%) of viremic persons who had elevated ALT levels (P < 0.001). The prevalence of HCV infection and number of persons with chronic liver fibrosis increased with age (P = 0.003). Conclusions: Hepatitis C is histologically active and progressive in up to 40% of asymptomatic persons with HCV infection. The severity of liver disease correlates with abnormal ALT levels and increases with age.	Univ Padua, Clin Med 5, Dept Clin & Expt Med, I-35100 Padua, Italy	University of Padua	Alberti, A (corresponding author), Univ Padua, Clin Med 5, Dept Clin & Expt Med, Via Giustiniani 2, I-35100 Padua, Italy.	alfredo.alberti@unipd.it	Noventa, Franco/C-1202-2008	Noventa, Franco/0000-0003-4622-5523; ALBERTI, ALFREDO/0000-0001-9926-2382				Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; ALBERTI A, 1991, ANN INTERN MED, V114, P1010, DOI 10.7326/0003-4819-114-12-1010; ALBERTI A, 1992, LANCET, V340, P697, DOI 10.1016/0140-6736(92)92234-7; Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528; ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443; Hirsch KR, 2000, AM J MED, V109, P66, DOI 10.1016/S0002-9343(00)00456-3; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mathurin P, 1998, HEPATOLOGY, V27, P868, DOI 10.1002/hep.510270333; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; Pagliaro L, 1999, ITAL J GASTROENTEROL, V31, P28; Persico M, 2000, GASTROENTEROLOGY, V118, P760, DOI 10.1016/S0016-5085(00)70145-4; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2000, SEMIN LIVER DIS, V20, P47, DOI 10.1055/s-2000-9258; RoudotThoraval F, 1997, HEPATOLOGY, V26, P485, DOI 10.1002/hep.510260233; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; 1999, EASL INT CONS C HEP, V31, P3	20	117	122	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 17	2002	137	12					961	964		10.7326/0003-4819-137-12-200212170-00009	http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626DR	12484711				2022-12-24	WOS:000179857500004
J	Gong, ZH; Morales-Ruiz, T; Ariza, RR; Roldan-Arjona, T; David, L; Zhu, JK				Gong, ZH; Morales-Ruiz, T; Ariza, RR; Roldan-Arjona, T; David, L; Zhu, JK			ROS1, a repressor of transcriptional gene silencing in Arabidopsis, encodes a DNA glycosylase/lyase	CELL			English	Article							BASE EXCISION-REPAIR; DE-NOVO METHYLATION; ESCHERICHIA-COLI; RNA; MAINTENANCE; MECHANISMS; DEMETHYLATION; DISRUPTION; INITIATION; MUTATIONS	Mutations in the Arabidopsis ROS1 locus cause transcriptional silencing of a transgene and a homologous endogenous gene. In the ros1 mutants, the promoter of the silenced loci is hypermethylated, which may be triggered by small RNAs produced from the transgene repeats. The transcriptional silencing in ros1 mutants can be released by the ddm1 mutation or the application of the DNA methylation inhibitor 5-aza-2'-deoxycytidine. ROS1 encodes an endonuclease III domain nuclear protein with bifunctional DNA glycosylase/lyase activity against methylated but not unmethylated DNA. The ros1 mutant shows enhanced sensitivity to genotoxic agents methyl methanesulfonate and hydrogen peroxide. We suggest that ROS1 is a DNA repair protein that represses homology-dependent transcriptional gene silencing by demethylating the target promoter DNA.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain	University of Arizona; Universidad de Cordoba	Zhu, JK (corresponding author), Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA.		Zhu, Jian-Kang/F-7658-2011; Gong, Zhizhong/AAS-4796-2021; Morales-Ruiz, Teresa/L-4842-2014; Roldan-Arjona, Teresa/H-5976-2015	Zhu, Jian-Kang/0000-0001-5134-731X; Morales-Ruiz, Teresa/0000-0002-6357-6977; Roldan-Arjona, Teresa/0000-0003-2842-3956; Rodriguez Ariza, Rafael/0000-0002-0338-7306				Adams S, 2000, DEVELOPMENT, V127, P2493; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Habu Y, 2001, CURR OPIN GENET DEV, V11, P215, DOI 10.1016/S0959-437X(00)00182-9; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rine J, 1999, P NATL ACAD SCI USA, V96, P8309, DOI 10.1073/pnas.96.15.8309; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	39	499	551	14	176	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					803	814		10.1016/S0092-8674(02)01133-9	http://dx.doi.org/10.1016/S0092-8674(02)01133-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526807	Green Published, Bronze			2022-12-24	WOS:000179862600007
J	Poss, KD; Wilson, LG; Keating, MT				Poss, KD; Wilson, LG; Keating, MT			Heart regeneration in zebrafish	SCIENCE			English	Article							MITOTIC CHECKPOINT; MPS1	Cardiac injury in mammals and amphibians typically leads to scarring, with minimal regeneration of heart muscle. Here, we demonstrate histologically that zebrafish fully regenerate hearts within 2 months of 20% ventricular resection. Regeneration occurs through robust proliferation of cardiomyocytes localized at the leading epicardial edge of the new myocardium. The hearts of zebrafish with mutations in the Mps1 mitotic checkpoint kinase, a critical cell cycle regulator, failed to regenerate and formed scars. Thus, injury-induced cardiomyocyte proliferation in zebrafish can overcome scar formation, allowing cardiac muscle regeneration. These findings indicate that zebrafish will be useful for genetically dissecting the molecular mechanisms of cardiac regeneration.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Poss, KD (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst,Dept Cell Biol,Dept Cardio, 320 Longwood Ave, Boston, MA 02115 USA.			Poss, Kenneth/0000-0002-6743-5709				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; BADER D, 1978, J MORPHOL, V155, P349, DOI 10.1002/jmor.1051550307; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Flink IL, 2002, ANAT EMBRYOL, V205, P235, DOI 10.1007/s00429-002-0249-6; HOGG D, 1994, ONCOGENE, V9, P89; JOHNSON SL, 1995, GENETICS, V141, P1583; Kurth T, 1996, CELL TISSUE RES, V286, P1, DOI 10.1007/s004410050669; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Neff AW, 1996, INT J DEV BIOL, V40, P719; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poss KD, 2002, DEVELOPMENT, V129, P5141; POSS KD, UNPUB; RUMYANTSEV PP, 1973, Z ZELLFORSCH MIK ANA, V139, P431, DOI 10.1007/BF00306596; SCHNITT SJ, 1993, CIRC RES, V72, P914, DOI 10.1161/01.RES.72.4.914; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111	17	1268	1309	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 13	2002	298	5601					2188	2190		10.1126/science.1077857	http://dx.doi.org/10.1126/science.1077857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624RA	12481136				2022-12-24	WOS:000179773700047
J	Yamada, Y; Izawa, H; Ichihara, S; Takatsu, F; Ishihara, H; Hirayama, H; Sone, T; Tanaka, M; Yokota, M				Yamada, Y; Izawa, H; Ichihara, S; Takatsu, F; Ishihara, H; Hirayama, H; Sone, T; Tanaka, M; Yokota, M			Prediction of the risk of myocardial infarction from polymorphisms in candidate genes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY ATHEROSCLEROSIS; HEART-DISEASE; PROMOTER; PROGRESSION; STROMELYSIN-1; THROMBOSIS; VARIANT; WOMEN	Background: Although epidemiologic studies have suggested that several genetic variants increase the risk of myocardial infarction, large-scale association studies that examine many polymorphisms simultaneously are required to allow reliable prediction of the genetic risk of myocardial infarction. Methods: We used a fluorescence- or colorimetry-based allele-specific DNA-primer-probe assay system to determine the genotypes of 112 polymorphisms of 71 candidate genes in 2819 unrelated Japanese patients with myocardial infarction (2003 men and 816 women) and 2242 unrelated Japanese controls (1306 men and 936 women). Results: In an initial screening of the 112 polymorphisms for an association with myocardial infarction in 909 subjects, 19 polymorphisms were selected in men and 18 in women by means of logistic-regression analysis, after adjustment for age, body-mass index, and the prevalence of smoking, hypertension, diabetes mellitus, hypercholesterolemia, and hyperuricemia. In a large-scale study involving the selected polymorphisms and the remaining 4152 subjects, similar logistic-regression analysis revealed that the risk of myocardial infarction was significantly associated with the C1019T polymorphism in the connexin 37 gene (P<0.001) in men and the 4G-668/5G polymorphism in the plasminogen-activator inhibitor type 1 gene (P<0.001) and the 5A-1171/6A polymorphism in the stromelysin-1 gene (P<0.001) in women. Conclusions: Determination of the genotypes of the connexin 37, plasminogen-activator inhibitor type 1, and stromelysin-1 genes may prove reliable in predicting the genetic risk of myocardial infarction and might thus contribute to the primary prevention of this condition.	Gifu Int Inst Biotechnol, Dept Gene Therapy, Mitake, Tokyo, Japan; Nagoya Univ, Grad Sch Med, Dept Pathophysiol, Div Cardiovasc, Nagoya, Aichi, Japan; Kosei Hosp, Div Cardiol, Anjo, Japan; Okazaki City Hosp, Div Cardiol, Okazaki, Aichi, Japan; Nagoya Daini Red Cross Hosp, Ctr Cardiovasc, Nagoya, Aichi, Japan; Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan	Nagoya University; Japanese Red Cross Nagoya Daini Hospital; Ogaki Municipal Hospital	Yokota, M (corresponding author), Nagoya Univ Hosp, Dept Clin Lab & Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.							Boerma M, 1999, J INTERN MED, V246, P211, DOI 10.1046/j.1365-2796.1999.00564.x; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cahilly C, 2000, CIRC RES, V86, P391, DOI 10.1161/01.RES.86.4.391; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Guetta V, 1996, CIRCULATION, V93, P1928, DOI 10.1161/01.CIR.93.10.1928; Guzik TJ, 2000, CIRCULATION, V102, P1744; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Inoue N, 1998, CIRCULATION, V97, P135, DOI 10.1161/01.CIR.97.2.135; KNIVENHOVEN JA, 1998, NEW ENGL J MED, V338, P86; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Rauramaa R, 2000, ARTERIOSCL THROM VAS, V20, P2657, DOI 10.1161/01.ATV.20.12.2657; Richard G, 1997, J INVEST DERMATOL, V109, P666, DOI 10.1111/1523-1747.ep12337713; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; Roest M, 2000, CIRCULATION, V101, P67, DOI 10.1161/01.CIR.101.1.67; Rundek T, 2002, STROKE, V33, P1420, DOI 10.1161/01.STR.0000015558.63492.B6; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; YE S, 1995, BRIT HEART J, V73, P209; Yeh HI, 2001, INT J CARDIOL, V81, P251, DOI 10.1016/S0167-5273(01)00574-5	22	545	592	1	21	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2002	347	24					1916	1923		10.1056/NEJMoa021445	http://dx.doi.org/10.1056/NEJMoa021445			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623ZX	12477941				2022-12-24	WOS:000179735800003
J	Echeverri, K; Tanaka, EM				Echeverri, K; Tanaka, EM			Ectoderm to mesoderm lineage switching during axolotl tail regeneration	SCIENCE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD REGENERATION; NERVOUS-SYSTEM; IN-VIVO; BRAIN; NEUROGENESIS; BLASTEMA; DERMIS	Foreign environments may induce adult stem cells to switch lineages and populate multiple tissue types, but whether this mechanism is used for tissue repair remains uncertain. Urodele amphibians can regenerate fully functional, multitissue structures including the limb and tail. To determine whether lineage switching is an integral feature of this regeneration, we followed individual spinal cord cells live during tail regeneration in the axolotl. Spinal cord cells frequently migrate into surrounding tissue to form regenerating muscle and cartilage. Thus, in axolotls, cells switch lineage during a real example of regeneration.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Tanaka, EM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Echeverri, Karen/F-5422-2010; Tanaka, Elly M/F-8572-2010	Tanaka, Elly/0000-0003-4240-2158				Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; ARSANTO JP, 1992, J EXP ZOOL, V264, P273, DOI 10.1002/jez.1402640307; Benraiss A, 1999, DEV GENES EVOL, V209, P363, DOI 10.1007/s004270050265; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; CLARKE JDW, 1988, NEUROSCI LETT, V89, P1, DOI 10.1016/0304-3940(88)90471-5; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; ECHEVERRI K, UNPUB; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; GERAUDIE J, 1988, AM J ANAT, V183, P359, DOI 10.1002/aja.1001830409; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; HOLDER N, 1988, TRENDS NEUROSCI, V11, P94, DOI 10.1016/0166-2236(88)90151-8; HOLTZER HOWARD, 1955, J MORPH, V96, P145, DOI 10.1002/jmor.1050960107; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Nolte C, 2001, GLIA, V33, P72; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	25	170	177	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1993	1996		10.1126/science.1077804	http://dx.doi.org/10.1126/science.1077804			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471259				2022-12-24	WOS:000179629200046
J	Kashiwabara, S; Noguchi, J; Zhuang, T; Ohmura, K; Honda, A; Sugiura, S; Miyamoto, K; Takahashi, S; Inoue, K; Ogura, A; Baba, T				Kashiwabara, S; Noguchi, J; Zhuang, T; Ohmura, K; Honda, A; Sugiura, S; Miyamoto, K; Takahashi, S; Inoue, K; Ogura, A; Baba, T			Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP	SCIENCE			English	Article							GERM-CELL APOPTOSIS; MICE LACKING; SPERMIOGENESIS DEFICIENCY; GENE; TRANSCRIPTION; MOUSE; CREM; DIFFERENTIATION; TRANSLATION; EXPRESSION	Spermatogenesis is a highly specialized process of cellular differentiation to produce spermatozoa. This differentiation process accompanies morphological changes that are controlled by a number of genes expressed in a stage-specific manner during spermatogenesis. Here we show that in mice, the absence of a testis-specific, cytoplasmic polyadenylate [poly(A)] polymerase, TPAP, results in the arrest of spermiogenesis. TPAP-deficient mice display impaired expression of haploid-specific genes that are required for the morphogenesis of germ cells. The TPAP deficiency also causes incomplete elongation of poly(A) tails of particular transcription factor messenger RNAs. Although the overall cellular level of the transcription factor TAF10 is unaffected, TAF10 is insufficiently transported into the nucleus of germ cells. We propose that TPAP governs germ cell morphogenesis by modulating specific transcription factors at posttranscriptional and posttranslational levels.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058572, Japan; Natl Inst Agrobiol Resources, Germ Cell Conservat Lab, Tsukuba, Ibaraki 3058602, Japan; Inst Phys & Chem Res RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	University of Tsukuba; University of Tsukuba; National Institute of Agrobiological Sciences - Japan; RIKEN	Baba, T (corresponding author), Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan.	acroman@sakura.cc.tsukuba.ac.jp	Ogura, Atsuo/J-3916-2014	Ogura, Atsuo/0000-0003-0447-1988				Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Chen Z, 2000, MOL CELL BIOL, V20, P5064, DOI 10.1128/MCB.20.14.5064-5076.2000; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Fimia GM, 2001, MOL CELL ENDOCRINOL, V179, P17, DOI 10.1016/S0303-7207(01)00463-4; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Han SY, 2001, BIOL REPROD, V64, P507, DOI 10.1095/biolreprod64.2.507; Hecht NB, 1998, BIOESSAYS, V20, P555, DOI 10.1002/(SICI)1521-1878(199807)20:7<555::AID-BIES6>3.3.CO;2-J; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Metzger D, 1999, EMBO J, V18, P4823, DOI 10.1093/emboj/18.17.4823; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	22	99	104	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2002	298	5600					1999	2002		10.1126/science.1074632	http://dx.doi.org/10.1126/science.1074632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471261				2022-12-24	WOS:000179629200048
J	Buckling, A; Rainey, PB				Buckling, A; Rainey, PB			The role of parasites in sympatric and allopatric host diversification	NATURE			English	Article							ESCHERICHIA-COLI; DIVERSITY; COEVOLUTION; COMPETITION; ADAPTATION; DIVERGENCE; PREDATION; EVOLUTION; MODEL	Exploiters (parasites and predators) are thought to play a significant role in diversification, and ultimately speciation, of their hosts or prey(1-3). Exploiters may drive sympatric (within-population) diversification if there are a variety of exploiter-resistance strategies or fitness costs associated with exploiter resistance(4-8). Exploiters may also drive allopatric (between-population) diversification by creating different selection pressures and increasing the rate of random divergence(9,10). We examined the effect of a virulent viral parasite (phage) on the diversification of the bacterium Pseudomonas fluorescens in spatially structured microcosms(11). Here we show that in the absence of phages, bacteria rapidly diversified into spatial niche specialists with similar patterns of diversity across replicate populations. In the presence of phages, sympatric diversity was greatly reduced, as a result of phage-imposed reductions in host density decreasing competition for resources. In contrast, allopatric diversity was greatly increased as a result of phage-imposed selection for resistance, which caused populations to follow divergent evolutionary trajectories. These results show that exploiters can drive diversification between populations, but may inhibit diversification within populations by opposing diversifying selection that arises from resource competition.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Bath; University of Oxford; University of Auckland	Buckling, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssagjb@bath.ac.uk	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Buckling, Angus/0000-0003-1170-4604				Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BROWN JS, 1992, EVOLUTION, V46, P1269, DOI 10.1111/j.1558-5646.1992.tb01123.x; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; Darwin C, 1872, ORIGIN SPECIES; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; HELLING RB, 1987, GENETICS, V116, P349; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Lack D., 1947, DARWINS FINCHES; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHLUTER D, 2000, ECOLOGY ADAPTIVE RAD, V157, pS4; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stone HMI, 1998, PALAEONTOLOGY, V41, P1051; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Travis J, 1996, AM NAT, V148, pS1, DOI 10.1086/285899; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1006/bijl.1996.9999	29	203	209	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2002	420	6915					496	499		10.1038/nature01164	http://dx.doi.org/10.1038/nature01164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466840				2022-12-24	WOS:000179611600043
J	Butler, D				Butler, D			Prion data suggest BSE link to sporadic CJD	NATURE			English	News Item																		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; 2002, NATURE, V418, P266	3	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					450	450		10.1038/420450a	http://dx.doi.org/10.1038/420450a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466801	Bronze			2022-12-24	WOS:000179611600004
J	Jiang, R; Manson, JE; Stampfer, MJ; Liu, SM; Willett, WC; Hu, FB				Jiang, R; Manson, JE; Stampfer, MJ; Liu, SM; Willett, WC; Hu, FB			Nut and peanut butter consumption and risk of type 2 diabetes in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; SATURATED FATTY-ACIDS; LOW-CARBOHYDRATE DIET; INSULIN SENSITIVITY; MONOUNSATURATED-FAT; GLUCOSE-TOLERANCE; GLYCEMIC LOAD; LIFE-STYLE; PLASMA-CHOLESTEROL; SERUM-LIPOPROTEIN	Context Nuts are high in unsaturated (polyunsaturated and monounsaturated) fat and other nutrients that may,improve glucose and insulin homeostasis. Objective To examine prospectively the relationship between nut consumption and risk of type 2 diabetes. Design, Setting, and Participants. Prospective cohort study of 83 818 women from 11 states in the Nurses' Health Study. The women were aged 34 to 59 years, had no history of diabetes, cardiovascular disease, or cancer, completed a validated dietary questionnaire at baseline in 1980, and were followed up for 16 years. Main Outcome Measure Incident cases of type 2 diabetes. Results We documented 3206 new cases of type 2 diabetes. Nut consumption was inversely associated with risk of type 2 diabetes after adjustment for age, body mass index (BMI), family history of diabetes, physical activity, smoking, alcohol use, and total energy intake. The multivariate relative risks (RRs) across categories of nut consumption (never/almost never, <once/week, 1-4 times/week, and >= 5 times/week) for a 28-g (1 oz) serving size were 1.0, 0.92 (95% confidence interval [CI], 0.85-1.00), 0.84 (0.95% CI, 0.76-0.93), and 0.73 (95% CI, 0.60-0.89) (P for trend <.001). Further adjustment for-intakes of dietary fats, cereal fiber, and other dietary factors did not appreciably change the results. The inverse association persisted within strata defined by levels of BMI, smoking, alcohol use, and other diabetes risk factors. Consumption of peanut butter was also inversely associated with type 2 diabetes. The multivariate RR was 0.79 (95% CI, 0.68-0.91; P for trend <.001) in women consuming peanut butter 5 times or more a week (equivalent to >= 140 g [5 oz] of peanuts/week) compared with those who never/almost never ate peanut butter. Conclusions Our findings suggest potential benefits of higher nut and peanut butter consumption in lowering risk of type 2 diabetes in women. To avoid increasing caloric intake, regular nut consumption can be recommended as a replacement for consumption of refined grain products or red or processed meats.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Jiang, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	rjiang@hsph.harvard.edu	Liu, Simin/GSN-4159-2022; Hu, Frank/C-1919-2013; Liu, Simin/I-3689-2014	Liu, Simin/0000-0003-2098-3844	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK58845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBEY M, 1994, AM J CLIN NUTR, V59, P995, DOI 10.1093/ajcn/59.5.995; *AM DIAB ASS, 2002, DIAB FACTS FIG 2000; ANDERSON JW, 1987, J AM DIET ASSOC, V87, P1189; BORKMAN M, 1991, J CLIN ENDOCR METAB, V72, P432, DOI 10.1210/jcem-72-2-432; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Christiansen E, 1997, DIABETES CARE, V20, P881, DOI 10.2337/diacare.20.5.881; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Cox D. R., 1984, ANAL SURVIVAL DATA; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; FESKENS EJM, 1990, INT J EPIDEMIOL, V19, P953, DOI 10.1093/ije/19.4.953; FESKENS EJM, 1994, AM J EPIDEMIOL, V140, P350, DOI 10.1093/oxfordjournals.aje.a117257; FESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437; FESKENS EJM, 1995, DIABETES CARE, V18, P1104, DOI 10.2337/diacare.18.8.1104; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; Fraser GE, 1997, EPIDEMIOLOGY, V8, P168, DOI 10.1097/00001648-199703000-00008; Gavin JR, 1997, DIABETES CARE, V20, P1183; GRUNDY SM, 1990, J LIPID RES, V31, P1149; HARRIS M, 1979, DIABETES, V28, P1039; HEINE RJ, 1989, AM J CLIN NUTR, V49, P448, DOI 10.1093/ajcn/49.3.448; HOUTSMULLER AJ, 1980, NUTR METAB, V24, P105; HOWARD BV, 1991, DIABETES CARE, V14, P786, DOI 10.2337/diacare.14.9.786; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kleinbaum D, 1988, APPL REGRESSION ANAL; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Louheranta AM, 1998, METABOLISM, V47, P529, DOI 10.1016/S0026-0495(98)90235-9; LUNDGREN H, 1989, AM J CLIN NUTR, V49, P708, DOI 10.1093/ajcn/49.4.708; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MARSHALL JA, 1991, AM J EPIDEMIOL, V134, P590, DOI 10.1093/oxfordjournals.aje.a116132; MayerDavis EJ, 1997, AM J CLIN NUTR, V65, P79, DOI 10.1093/ajcn/65.1.79; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; OByrne DJ, 1997, LIPIDS, V32, P687, DOI 10.1007/s11745-997-0088-y; PAOLISSO G, 1989, DIABETES CARE, V12, P265, DOI 10.2337/diacare.12.4.265; PAOLISSO G, 1990, DIABETOLOGIA, V33, P511, DOI 10.1007/BF00404136; PAOLISSO G, 1992, AM J CLIN NUTR, V55, P1161, DOI 10.1093/ajcn/55.6.1161; PARILLO M, 1992, METABOLISM, V41, P1373, DOI 10.1016/0026-0495(92)90111-M; PRINEAS RJ, 1993, NEW ENGL J MED, V329, P359; RESNICK LM, 1993, AM J HYPERTENS, V6, pS123, DOI 10.1093/ajh/6.4S.123S; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIVELLESE A, 1980, LANCET, V2, P447; SABATE J, 1993, NEW ENGL J MED, V328, P603, DOI 10.1056/NEJM199303043280902; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; SCHWAB US, 1995, J NUTR, V125, P466; SIMPSON HCR, 1981, LANCET, V1, P1; SJOGREN A, 1988, MAGNESIUM, V7, P117; SPILLER GA, 1992, J AM COLL NUTR, V11, P126; Storlien LH, 1996, DIABETOLOGIA, V39, P621, DOI 10.1007/BF00418533; SWINBURN BA, 1991, J CLIN ENDOCR METAB, V73, P156, DOI 10.1210/jcem-73-1-156; TREVISAN M, 1990, JAMA-J AM MED ASSOC, V263, P688, DOI 10.1001/jama.263.5.688; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; *USDA, 1993, COMP FOODS RAW PROC; UUSITUPA M, 1994, AM J CLIN NUTR, V59, P1310, DOI 10.1093/ajcn/59.6.1310; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623	65	336	346	3	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2002	288	20					2554	2560		10.1001/jama.288.20.2554	http://dx.doi.org/10.1001/jama.288.20.2554			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618AL	12444862	Bronze			2022-12-24	WOS:000179394500022
J	Ozaki, K; Spolski, R; Feng, CG; Qi, CF; Cheng, J; Sher, A; Morse, HC; Liu, CY; Schwartzberg, PL; Leonard, WJ				Ozaki, K; Spolski, R; Feng, CG; Qi, CF; Cheng, J; Sher, A; Morse, HC; Liu, CY; Schwartzberg, PL; Leonard, WJ			A critical role for IL-21 in regulating immunoglobulin production	SCIENCE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; B-CELL FUNCTION; LYMPHOID DEVELOPMENT; CYTOKINE RECEPTOR; NATURAL-KILLER; GAMMA-CHAIN; EXPRESSION; MEMORY; MICE; TRANSPLANTATION	The cytokine interleukin-21 (IL-21) is closely related to IL-2 and IL-15, and their receptors all share the common cytokine receptor gamma chain, gamma(c), which is mutated in humans with X-linked severe combined immunodeficiency disease (XSCID). We demonstrate that, although mice deficient in the receptor for IL-21 (IL-21R) have normal lymphoid development, after immunization, these animals have higher production of the immunoglobulin IgE, but lower IgG1, than wild-type animals. Mice lacking both IL-4 and IL-21R exhibited a significantly more pronounced phenotype, with dysgammaglobulinemia, characterized primarily by a severely impaired IgG response. Thus, IL-21 has a significant influence on the regulation of B cell function in vivo and cooperates with IL-4. This suggests that these gamma(c)-dependent cytokines may be those whose inactivation is primarily responsible for the B cell defect in humans with XSCID.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; NHLBI, Transgen Facil, NIH, Bethesda, MD 20892 USA; NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NIAID, Immunopathol Lab, NIH, Bethesda, MD 20892 USA; NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 49,Room 4A38, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Leonard, Warren/AAA-1397-2022	Morse, Herbert/0000-0002-9331-3705; feng, carl/0000-0003-4301-4640	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005401, ZIAHL005401] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000858, ZIAAI000858] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; BUCKLEY R, 1993, FASEB J, V7, pA95; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; BUCKLEY RH, COMMUNICATION; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; CavazzanaCalvo M, 1996, BLOOD, V88, P3901, DOI 10.1182/blood.V88.10.3901.bloodjournal88103901; CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; CONLEY ME, 1991, CLIN IMMUNOL IMMUNOP, V61, pS94, DOI 10.1016/S0090-1229(05)80043-1; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; Feng C. J., UNPUB; FINKELMAN FD, 1987, J IMMUNOL, V138, P2826; GOUGEON ML, 1990, J IMMUNOL, V145, P2873; Haddad E, 1999, BLOOD, V94, P2923, DOI 10.1182/blood.V94.8.2923.420k44_2923_2930; Hartnett BJ, 2000, VET IMMUNOL IMMUNOP, V75, P121, DOI 10.1016/S0165-2427(00)00193-8; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997; OZAKI K, UNPUB; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; SMALL TN, 1989, HUM IMMUNOL, V25, P181, DOI 10.1016/0198-8859(89)90081-5; Suzuki Y, 1996, J IMMUNOL, V157, P2564; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; White H, 2000, EUR J IMMUNOL, V30, P732; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	32	766	804	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2002	298	5598					1630	1634		10.1126/science.1077002	http://dx.doi.org/10.1126/science.1077002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617KV	12446913	Green Published			2022-12-24	WOS:000179361600052
J	Hirosumi, J; Tuncman, G; Chang, LF; Gorgun, CZ; Uysal, KT; Maeda, K; Karin, M; Hotamisligil, GS				Hirosumi, J; Tuncman, G; Chang, LF; Gorgun, CZ; Uysal, KT; Maeda, K; Karin, M; Hotamisligil, GS			A central role for JNK in obesity and insulin resistance	NATURE			English	Article							C-JUN ACTIVATION; PROTEIN-KINASE; TNF-ALPHA; LIPID-METABOLISM; DIFFERENTIATION; APOPTOSIS; GLUCOSE; STRESS	Obesity is closely associated with insulin resistance and establishes the leading risk factor for type 2 diabetes mellitus, yet the molecular mechanisms of this association are poorly understood(1). The c-Jun amino-terminal kinases (JNKs) can interfere with insulin action in cultured cells(2) and are activated by inflammatory cytokines and free fatty acids, molecules that have been implicated in the development of type 2 diabetes(3,4). Here we show that JNK activity is abnormally elevated in obesity. Furthermore, an absence of JNK1 results in decreased adiposity, significantly improved insulin sensitivity and enhanced insulin receptor signalling capacity in two different models of mouse obesity. Thus, JNK is a crucial mediator of obesity and insulin resistance and a potential target for therapeutics.	Harvard Univ, Sch Publ Hlth, Div Biol Sci, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Div Biol Sci, 665 Huntington Ave, Boston, MA 02115 USA.							Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hotamisligil G.S, 2000, DIABETES MELLITUS, P651; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Rizzo MT, 1999, PROSTAG LEUKOTR ESS, V60, P187, DOI 10.1054/plef.1999.0024; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shin EA, 1999, FEBS LETT, V452, P355, DOI 10.1016/S0014-5793(99)00657-2; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	26	2469	2630	2	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	2002	420	6913					333	336		10.1038/nature01137	http://dx.doi.org/10.1038/nature01137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617BM	12447443				2022-12-24	WOS:000179340400046
J	Pinn, VW				Pinn, VW			Sex and gender factors in medical studies - Implications for health and clinical practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMENS HEALTH; MYOCARDIAL-INFARCTION; TRIALS; HEART; CARE; REPRESENTATION; PROLONGATION; DELIVERY; TRENDS		NIH, Off Res Womens Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Pinn, VW (corresponding author), NIH, Off Res Womens Hlth, 9000 Rockville Pike,Bldg 1,Room 201, Bethesda, MD 20892 USA.	orwh-research@od.nih.gov						*AM PSYCH ASS, 2002, SUMM WOM DEPR P REC; Anthony Marietta, 2002, J Womens Health Gend Based Med, V11, P601, DOI 10.1089/152460902760360559; Arnold K, 2000, J NATL CANCER I, V92, P1561, DOI 10.1093/jnci/92.19.1561; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; BERG MJ, 1999, NIH PUBLICATION, V2; BLEHAR MC, 2001, TEN, V3, P42; Brandt E N Jr, 1998, J Gend Specif Med, V1, P48; Buring JE, 2000, NEW ENGL J MED, V343, P505, DOI 10.1056/NEJM200008173430711; Campaigne B N, 2000, J Gend Specif Med, V3, P51; CARLSON KJ, 1997, TXB WOMENS HLTH, P33; *CDCP, HIV AIDS SURV WOM; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V285, P1508, DOI 10.1001/jama.285.11.1508; Desai H D, 2000, J Am Pharm Assoc (Wash), V40, P525; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; FISHMAN JR, 1999, NIH PUBLICATION, V2; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; Gesensway D, 2001, ANN INTERN MED, V135, P935, DOI 10.7326/0003-4819-135-10-200111200-00032; Gwinn DE, 2000, AM J SPORT MED, V28, P98, DOI 10.1177/03635465000280012901; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hobbs F. B., ELDERLY POPULATION; Hoffman E, 1995, J Am Med Womens Assoc (1972), V50, P17; Hoffman E, 1997, WOMEN HEALTH ISS, V7, P362, DOI 10.1016/S1049-3867(97)00074-1; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Horwitz BJ, 2001, NEW ENGL J MED, V344, P1846, DOI 10.1056/NEJM200106143442407; KASPER AS, 1997, TXB WOMENS HLTH, P3; Kendler K S, 1998, J Gend Specif Med, V1, P28; Krummel DA, 2001, J WOMEN HEALTH GEN-B, V10, P117, DOI 10.1089/152460901300039467; LaRosa J H, 1993, J Am Med Womens Assoc (1972), V48, P145; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Legato M J, 2000, J Gend Specif Med, V3, P15; LEGATO MJ, 2000, J GEND SPECIF MED, V3, P12; LENFANT C, 1999, NIH PUBLICATION, V2; Mastroianni AC, 1994, WOMEN HLTH RES ETHIC; Mehilli J, 2002, JAMA-J AM MED ASSOC, V287, P210, DOI 10.1001/jama.287.2.210; Meinert CL, 2000, CONTROL CLIN TRIALS, V21, P462, DOI 10.1016/S0197-2456(00)00086-6; Natelson BH, 2001, JAMA-J AM MED ASSOC, V285, P2557, DOI 10.1001/jama.285.20.2557; *NIH OFF RES WOM H, 1999, NIH PUBL, V2; Perkins KA, 2001, CNS DRUGS, V15, P391, DOI 10.2165/00023210-200115050-00005; Phelan EA, 2000, J GEN INTERN MED, V15, P8, DOI 10.1046/j.1525-1497.2000.12178.x; Pinn V W, 1998, J Gend Specif Med, V1, P50; Pinn VW, 1999, ACAD MED, V74, P1104, DOI 10.1097/00001888-199910000-00013; PINN VW, 1997, TXB WOMENS HLTH, P971; PINN VW, 2002, MONITORING ADHERENCE; Prout M N, 2001, Medscape Womens Health, V6, P1; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Romanzi L J, 2001, J Gend Specif Med, V4, P14; Shlipak MG, 2001, ANN INTERN MED, V134, P1043, DOI 10.7326/0003-4819-134-11-200106050-00010; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; *US GEN ACC OFF, 2001, WOM HLTH WOM CLIN DR; *US GEN ACC OFF, 2000, WOMENS HLTH NIH INCR; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Weisman C S, 2000, J Gend Specif Med, V3, P22; Weisman CS, 1997, HEALTH AFFAIR, V16, P276, DOI 10.1377/hlthaff.16.3.276-a; Weisman CS, 2000, ACAD MED, V75, P1107, DOI 10.1097/00001888-200011000-00016; Wizemann T. M., 2001, EXPLORING BIOL CONTR; 2000, HARV WOMENS HLTH WAT, V7, P4; [No title captured]	59	118	123	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					397	400		10.1001/jama.289.4.397	http://dx.doi.org/10.1001/jama.289.4.397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TD	12533102				2022-12-24	WOS:000180472300001
J	Gomez-Roman, N; Grandori, C; Eisenman, RN; White, RJ				Gomez-Roman, N; Grandori, C; Eisenman, RN; White, RJ			Direct activation of RNA polymerase III transcription by c-Myc	NATURE			English	Article							TATA-BINDING-PROTEIN; CELL-GROWTH; RIBOSOME BIOGENESIS; GENES; EXPRESSION; TARGET; CYCLE; P107; TRANSACTIVATION; FIBROBLASTS	The proto-oncogene product c-Myc has a direct role in both metazoan cell growth and division(1-4). RNA polymerase III (pol III) is involved in the generation of transfer RNA and 5S ribosomal RNA, and these molecules must be produced in bulk to meet the need for protein synthesis in growing cells(5). We demonstrate here that c-Myc binds to TFIIIB, a pol III-specific general transcription factor, and directly activates pol III transcription. Chromatin immunoprecipitation reveals that endogenous c-Myc is present at tRNA and 5S rRNA genes in cultured mammalian cells. These results suggest that activation of pol III may have a role in the ability of c-Myc to stimulate cell growth.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Fred Hutchinson Cancer Center; University of Glasgow	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.			Gomez-Roman, Natividad/0000-0002-2325-7517				Beier R, 2000, EMBO J, V19, P5813, DOI 10.1093/emboj/19.21.5813; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Brown TRP, 2000, GENE EXPRESSION, V9, P15; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dang CV, 1999, MOL CELL BIOL, V19, P1; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HATEBOER G, 1993, P NATL ACAD SCI USA, V90, P8489, DOI 10.1073/pnas.90.18.8489; Hirst SK, 2000, ONCOGENE, V19, P5189, DOI 10.1038/sj.onc.1203904; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Schubeler D, 2000, GENE DEV, V14, P940; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Scott PH, 2001, J BIOL CHEM, V276, P1005, DOI 10.1074/jbc.M005417200; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; Sutcliffe JE, 1999, MOL CELL BIOL, V19, P4255; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097	30	313	320	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					290	294		10.1038/nature01327	http://dx.doi.org/10.1038/nature01327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529648				2022-12-24	WOS:000180397600053
J	Schneider, AT; Pancioli, AM; Khoury, JC; Rademacher, E; Tuchfarber, A; Miller, R; Woo, D; Kissela, B; Broderick, JP				Schneider, AT; Pancioli, AM; Khoury, JC; Rademacher, E; Tuchfarber, A; Miller, R; Woo, D; Kissela, B; Broderick, JP			Trends in community knowledge of the warning signs and risk factors for stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NORTHERN MANHATTAN STROKE; HEALTH-CARE DASH; ALCOHOL-CONSUMPTION; ISCHEMIC STROKE; SYMPTOMS; EMERGENCY; DELAYS; DETERMINANTS; INFARCTION; POPULATION	Context Poor public knowledge of stroke warning signs and risk factors limits effective stroke intervention and prevention. Objective To examine temporal trends in public knowledge of stroke warning signs and risk factors. Design and Setting Population-based random-digit telephone survey conducted in July-November 2000 among individuals in the greater Cincinnati, Ohio, region. Participants A total of 2173 survey respondents (69% response rate) were randomly identified based on their demographic similarities to the ischemic stroke population with regard to age, race, and sex. Main Outcome Measures Spontaneous recall of at least 1 important stroke warning sign and 1 established stroke risk factor in comparison with findings from the same survey in 1995. Results In 2000, 70% of respondents correctly named at least 1 established stroke warning sign vs 57% in 1995 (P<.001), and 72% correctly named at least 1 established stroke risk factor vs 68% in 1995. Groups of individuals with the highest risk and incidence of stroke, such as persons at least 75 years old, blacks, and men, were the least knowledgeable about warning signs and risk factors. Television was the most frequently cited source of knowledge, 32% in 2000 vs 24% in 1995 (P<.001). Conclusions Public knowledge of stroke warning signs within the greater Cincinnati region has significantly improved from 1995 to 2000, although knowledge of stroke risk factors did not improve significantly during the same time period. Public education efforts must continue and should focus on groups at the highest risk of stroke.	Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Inst Policy Res, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Schneider, AT (corresponding author), Univ Cincinnati, Dept Neurol, Med Sci Bldg 0525,231 Albert Sabin Way, Cincinnati, OH 45267 USA.		Khoury, Jane/O-2068-2015	Kissela, Brett/0000-0002-9773-4013	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030678, U10NS077311] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS30678-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM STROK ASS, KNOW WARN SIGNS STRO; Amarenco P, 2001, NEUROLOGY, V57, pS35, DOI 10.1212/WNL.57.suppl_2.S35; BARSAN WG, 1993, ARCH INTERN MED, V153, P2558, DOI 10.1001/archinte.153.22.2558; BARSAN WG, 1994, STROKE, V25, P2132, DOI 10.1161/01.STR.25.11.2132; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Caicoya M, 1999, J CLIN EPIDEMIOL, V52, P677, DOI 10.1016/S0895-4356(98)00074-2; Di Mascio R, 2000, CEREBROVASC DIS, V10, P85, DOI 10.1159/000016035; Evenson KR, 2001, NEUROEPIDEMIOLOGY, V20, P65, DOI 10.1159/000054763; Ezzati TM, 1992, VITAL HLTH STAT 2, V2, P1; FELDMANN E, 1993, STROKE, V24, P1805, DOI 10.1161/01.STR.24.12.1805; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; Kothari R, 1999, ANN EMERG MED, V33, P3, DOI 10.1016/S0196-0644(99)70431-2; Morris DL, 2000, STROKE, V31, P2585, DOI 10.1161/01.STR.31.11.2585; *NAT STROK ASS, REC STROK SYMPT; Pancioli AM, 1998, JAMA-J AM MED ASSOC, V279, P1288, DOI 10.1001/jama.279.16.1288; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosamond WD, 1998, ACAD EMERG MED, V5, P45, DOI 10.1111/j.1553-2712.1998.tb02574.x; Rowe AE, 2001, SOUTHERN MED J, V94, P613, DOI 10.1097/00007611-200194060-00014; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; Samsa GP, 1997, STROKE, V28, P916, DOI 10.1161/01.STR.28.5.916; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; *US CENS BUR, 1990 CENS QUICK TABL; Whisnant JP, 1997, STROKE, V28, P1840, DOI 10.1161/01.STR.28.9.1840; Williams LS, 1997, STROKE, V28, P912, DOI 10.1161/01.STR.28.5.912; Yoon SS, 2001, STROKE, V32, P1926, DOI 10.1161/01.STR.32.8.1926	29	253	261	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					343	346		10.1001/jama.289.3.343	http://dx.doi.org/10.1001/jama.289.3.343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525235	Bronze			2022-12-24	WOS:000180345100029
J	Adams, MD; McVey, M; Sekelsky, JJ				Adams, MD; McVey, M; Sekelsky, JJ			Drosophila BLM in double-strand break repair by synthesis-dependent strand annealing	SCIENCE			English	Article							SYNDROME GENE-PRODUCT; INDUCED GAP REPAIR; BLOOM-SYNDROME; IN-VIVO; RECOMBINATION; MELANOGASTER; JUNCTIONS; MECHANISM; HELICASE; PROTEIN	Bloom syndrome, characterized by a predisposition to cancer, is caused by mutation of the RecQ DNA helicase gene BLM. The precise function of BLM remains unclear. Previous research suggested that Drosophila BLM functions in the repair of DNA double-strand breaks. Most double-strand breaks in flies are repaired by homologous recombination through the synthesis-dependent strand-annealing pathway. Here, we demonstrate that Drosophila BLM mutants are severely impaired in their ability to carry out repair DNA synthesis during synthesis-dependent strand annealing. Consequently, repair in the mutants is completed by error-prone pathways that create large deletions. These results suggest a model in which BLM maintains genomic stability by promoting efficient repair DNA synthesis and thereby prevents double-strand break repair by less precise pathways.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, SPIRE Program, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sekelsky, JJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Sekelsky, Jeff J/F-9892-2010		NIGMS NIH HHS [GM000678] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Beall EL, 1997, GENE DEV, V11, P2137, DOI 10.1101/gad.11.16.2137; BOYD JB, 1981, GENETICS, V97, P607; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; KAUFMAN PD, 1992, CELL, V69, P27, DOI 10.1016/0092-8674(92)90116-T; KURKULOS M, 1994, GENETICS, V136, P1001; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2001, NUCLEIC ACIDS RES, V29, P4378, DOI 10.1093/nar/29.21.4378; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; STAVELEY BE, 1995, GENETICS, V139, P1321; Welzel N, 2001, CANCER RES, V61, P1629; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200	24	194	200	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					265	267		10.1126/science.1077198	http://dx.doi.org/10.1126/science.1077198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522255				2022-12-24	WOS:000180284000044
J	Lyder, CH				Lyder, CH			Pressure ulcer prevention and management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS; RISK		Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA; Yale Univ, Sch Nursing, Program Advancement Chron Wound Care, New Haven, CT 06536 USA	University of Virginia; Yale University	Lyder, CH (corresponding author), Univ Virginia, Sch Nursing, McLeod Hall,POB 800782, Charlottesville, VA 22908 USA.							*AG HEALTHC RES QU, 2002, CLIN PRACT GUID ONL; ALLMAN RM, 1999, PRINCIPLES GERIATRIC, P1577; [Anonymous], 1975, INVESTIGATION GERIAT; Baker Lucinda L., 1996, Wound Repair and Regeneration, V4, P21, DOI 10.1046/j.1524-475X.1996.40106.x; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; Bello YM, 2000, JAMA-J AM MED ASSOC, V283, P716, DOI 10.1001/jama.283.6.716; Bennett RG, 2000, J AM GERIATR SOC, V48, P73, DOI 10.1111/j.1532-5415.2000.tb03033.x; BERGSTROM N, 1994, AHCPR PUBL; Bergstrom N, 1992, CLIN PRACTICE GUIDEL; Bliss M R, 1998, J Tissue Viability, V8, P4; COLWELL S, 1993, NEW STATESMAN SOC, V6, P28; CUDDIGAN J, 2001, PRESSURE ULCERS AM P; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Kloth L C, 1996, Adv Wound Care, V9, P42; Kloth L C, 2000, Adv Skin Wound Care, V13, P69; Knox D M, 1994, Adv Wound Care, V7, P48; Knox DM, 1994, ADV WOUND CARE, V7, P54; Lyder C H, 1998, Ostomy Wound Manage, V44, p42S; Lyder CH, 2001, ARCH INTERN MED, V161, P1549, DOI 10.1001/archinte.161.12.1549; Lyder Courtney H, 2002, Ostomy Wound Manage, V48, P52; *NAT PRESS ULC ADV, 1989, S N PUBL, P3; Philippidis TP, 1999, COMPOS STRUCT, V45, P41, DOI 10.1016/S0263-8223(99)00012-4; RACKETT SC, 1993, J AM ACAD DERMATOL, V29, P447, DOI 10.1016/0190-9622(93)70210-K; Stotts NA, 2001, J GERONTOL A-BIOL, V56, pM795, DOI 10.1093/gerona/56.12.M795; Strauss E A, 1996, Adv Wound Care, V9, P37; Thomas DR, 1996, J AM GERIATR SOC, V44, P1435, DOI 10.1111/j.1532-5415.1996.tb04067.x; Thomas DR, 2001, NUTRITION, V17, P121, DOI 10.1016/S0899-9007(00)00514-1; Xakellis G C Jr, 1998, Adv Wound Care, V11, P22; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463; Xia ZD, 2000, WOUND REPAIR REGEN, V8, P138, DOI 10.1046/j.1524-475x.2000.00138.x	30	261	272	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					223	226		10.1001/jama.289.2.223	http://dx.doi.org/10.1001/jama.289.2.223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517234				2022-12-24	WOS:000180226400034
J	Rawat, UBS; Zavialov, AV; Sengupta, J; Valle, M; Grassucci, RA; Linde, J; Vestergaard, B; Ehrenberg, M; Frank, J				Rawat, UBS; Zavialov, AV; Sengupta, J; Valle, M; Grassucci, RA; Linde, J; Vestergaard, B; Ehrenberg, M; Frank, J			A cryo-electron microscopic study of ribosome-bound termination factor RF2	NATURE			English	Article							MESSENGER-RNA; TRANSLATION TERMINATION; CHAIN TERMINATION; CODON RECOGNITION; FACTOR-II; RELEASE; RESOLUTION; PROTEINS; LOCATION; BINDING	Protein synthesis takes place on the ribosome, where genetic information carried by messenger RNA is translated into a sequence of amino acids. This process is terminated when a stop codon moves into the ribosomal decoding centre (DC) and is recognized by a class-1 release factor (RF). RFs have a conserved GGQ amino-acid motif, which is crucial for peptide release and is believed to interact directly with the peptidyl-transferase centre (PTC) of the 50S ribosomal subunit(1),(2). Another conserved motif of RFs (SPF in RF2) has been proposed to interact directly with stop codons in the DC of the 30S subunit(3). The distance between the DC and PTC is, 73 Angstrom. However, in the X-ray structure of RF2, SPF and GGQ are only 23 Angstrom apart(4), indicating that they cannot be at DC and PTC simultaneously. Here we show that RF2 is in an open conformation when bound to the ribosome, allowing GGQ to reach the PTC while still allowing SPF-stop-codon interaction. The results indicate new interpretations of accuracy in termination, and have implications for how the presence of a stop codon in the DC is signalled to PTC.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr, Albany, NY 12201 USA; Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus, Denmark; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; Uppsala University; Aarhus University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.		Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Zavialov, Andrey/0000-0001-6420-0368; Vestergaard, Bente/0000-0001-8011-6414				Arkov AL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1354; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; Drugeon G, 1997, NUCLEIC ACIDS RES, V25, P2254, DOI 10.1093/nar/25.12.2254; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; TATE WP, 1984, J BIOL CHEM, V259, P7317; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; YUSUPOV MM, 2001, SCIENCE, V4, P897; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	28	199	202	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					87	90		10.1038/nature01224	http://dx.doi.org/10.1038/nature01224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511960				2022-12-24	WOS:000180165500043
J	Dioum, EM; Rutter, J; Tuckerman, JR; Gonzalez, G; Gilles-Gonzalez, MA; McKnight, SL				Dioum, EM; Rutter, J; Tuckerman, JR; Gonzalez, G; Gilles-Gonzalez, MA; McKnight, SL			NPAS2: A gas-responsive transcription factor	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; OXYGEN SENSOR; HEME PROTEIN; BINDING; LIGHT; CLOCK; RECEPTOR; DOMAINS; NEURONS; GENES	Neuronal PAS domain protein 2 (NPAS2) is a mammalian transcription factor that binds DNA as an obligate dimeric partner of BMAL1 and is implicated in the regulation of circadian rhythm. Here we show that both PAS domains of NPAS2 bind heme as a prosthetic group and that the heme status controls DNA binding in vitro. NPAS2-BMAL1 heterodimers, existing in either the apo (heme-free) or holo (heme-loaded) state, bound DNA avidly under favorably reducing ratios of the reduced and oxidized forms of nicotinamide adenine dinucleotide phosphate. Low micromolar concentrations of carbon monoxide inhibited the DNA binding activity of holo-NPAS2 but not that of apo-NPAS2. Upon exposure to carbon monoxide, inactive BMAL1 homodimers were formed at the expense of NPAS2-BMAL1 heterodimers. These results indicate that the heterodimerization of NPAS2, and presumably the expression of its target genes, are regulated by a gas through the heme-based sensor described here.	Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Dept Plant Biol, Columbus, OH 43210 USA; Ohio State Univ, Ctr Plant Biotechnol, Columbus, OH 43210 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gilles-Gonzalez, MA (corresponding author), Ohio State Univ, Dept Biochem, 1060 Carmack Rd, Columbus, OH 43210 USA.	magg@biochem.swmed.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL640381] Funding Source: Medline; NIGMS NIH HHS [NIH5-T32-GM08-291-12] Funding Source: Medline; NIMH NIH HHS [R01 MH5938805] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Appleby C. A., 1980, Methods for evaluating biological nitrogen fixation., P315; Ascoli F, 1981, Methods Enzymol, V76, P72; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Gilles-Gonzalez MA, 2001, IUBMB LIFE, V51, P165, DOI 10.1080/152165401753544232; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hill S, 1996, P NATL ACAD SCI USA, V93, P2143, DOI 10.1073/pnas.93.5.2143; HOFF WD, 1994, BIOCHEMISTRY-US, V33, P13959, DOI 10.1021/bi00251a001; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Ingi T, 1996, J NEUROSCI, V16, P5621; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	27	366	379	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2002	298	5602					2385	2387		10.1126/science.1078456	http://dx.doi.org/10.1126/science.1078456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627DG	12446832				2022-12-24	WOS:000179915900055
J	Bassand, JP; Martin, J; Ryden, L; Sirnoons, M				Bassand, JP; Martin, J; Ryden, L; Sirnoons, M			The need for resources for clinical research: the European Society of Cardiology calls for European, international collaboration	LANCET			English	Editorial Material							PHARMACEUTICAL-INDUSTRY; ACADEMIC MEDICINE; EUROASPIRE-II; HEART SURVEY; GUIDELINES; COUNTRIES		Univ Hosp Jean Minjoz, Dept Cardiol, F-25030 Besancon, France; UCL, London, England; Karolinska Hosp, S-10401 Stockholm, Sweden; Erasmus Univ, Thoraxctr, NL-3000 DR Rotterdam, Netherlands	Universite de Franche-Comte; CHU Besancon; University of London; University College London; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	Bassand, JP (corresponding author), Univ Hosp Jean Minjoz, Dept Cardiol, F-25030 Besancon, France.	jean-pierre.bassand@ufc-chu.univ-fcomte.fr						Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Bell JI, 1999, NAT MED, V5, P477, DOI 10.1038/8353; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; KAITIN KI, 1993, J CLIN PHARMACOL, V33, P412, DOI 10.1002/j.1552-4604.1993.tb04680.x; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2001, LANCET, V357, P995, DOI 10.1016/S0140-6736(00)04235-5; Lindahl S, 2000, LANCET, V356, pS54, DOI 10.1016/S0140-6736(00)92040-3; Montaner JSG, 2001, LANCET, V358, P1893, DOI 10.1016/S0140-6736(01)06891-X; Sans S, 1997, EUR HEART J, V18, P1231; Simoons ML, 2002, EUR HEART J, V23, P1148, DOI 10.1053/euhj.2002.3269; Williams N, 2002, CURR BIOL, V12, pR267, DOI 10.1016/S0960-9822(02)00795-9	13	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 7	2002	360	9348					1866	1869		10.1016/S0140-6736(02)11776-4	http://dx.doi.org/10.1016/S0140-6736(02)11776-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	623MB	12480378				2022-12-24	WOS:000179706100028
J	Iratni, R; Yan, YT; Chen, CH; Ding, JX; Zhang, Y; Price, SM; Reinberg, D; Shen, MM				Iratni, R; Yan, YT; Chen, CH; Ding, JX; Zhang, Y; Price, SM; Reinberg, D; Shen, MM			Inhibition of excess nodal signaling during mouse gastrulation by the transcriptional corepressor DRAP1	SCIENCE			English	Article							IN-VIVO; EXPRESSION; REPRESSION; PROTEINS; ACTIVIN; PATTERNS; PROMOTER; BINDING; HOMOLOG; LEFTY2	The formation and patterning of mesoderm during mammalian gastrulation require the activity of Nodal, a secreted mesoderm-inducing factor of the transforming growth factor-beta (TGF-beta) family. Here we show that the transcriptional corepressor DRAP1 has a very specific role in regulation of Nodal activity during mouse embryogenesis. We find that loss of Drap1 leads to severe gastrulation defects that are consistent with increased expression of Nodal and can be partially suppressed by Nodal heterozygosity. Biochemical studies indicate that DRAP1 interacts with and inhibits DNA binding by the winged-helix transcription factor FoxH1 (FAST), a critical component of a positive feedback loop for Nodal activity. We propose that DRAP1 limits the spread of a morphogenetic signal by down-modulating the response to the Nodal autoregulatory loop.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, 679 Hoes Lane, Piscataway, NJ 08854 USA.		Shen, Michael M/C-7546-2009; Yan, Yu-Ting/Q-3065-2018	Shen, Michael M/0000-0002-4042-1657; Yan, Yu-Ting/0000-0002-9559-706X; Reinberg, Danny/0000-0003-4288-2016; Zhang, Yi/0000-0002-2789-0811				Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Kim S, 2000, MOL CELL BIOL, V20, P2455, DOI 10.1128/MCB.20.7.2455-2465.2000; Kim S, 1997, P NATL ACAD SCI USA, V94, P820, DOI 10.1073/pnas.94.3.820; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Maldonado E, 1999, CELL, V99, P455, DOI 10.1016/S0092-8674(00)81533-0; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mermelstein F, 1996, GENE DEV, V10, P1033, DOI 10.1101/gad.10.8.1033; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Norris DP, 2002, DEVELOPMENT, V129, P3455; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Prelich G, 1997, MOL CELL BIOL, V17, P2057, DOI 10.1128/MCB.17.4.2057; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Yamamoto M, 2001, GENE DEV, V15, P1242, DOI 10.1101/gad.883901; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	26	65	68	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	2002	298	5600					1996	1999		10.1126/science.1073405	http://dx.doi.org/10.1126/science.1073405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CP	12471260				2022-12-24	WOS:000179629200047
J	Khan, K; Muennig, P; Behta, M; Zivin, JG				Khan, K; Muennig, P; Behta, M; Zivin, JG			Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; ISONIAZID PREVENTIVE THERAPY; HEPATOTOXICITY; PREVALENCE; POPULATION; TRENDS	Background: In the United States, an increasingly disproportionate burden of tuberculosis among the foreign-born population has led to calls for improvements in the detection and treatment of latent infection in new immigrants. Current treatment guidelines do not take into account global differences in drug-resistance patterns or their implications for the treatment of immigrants. The use of multinational surveillance systems to guide the management of latent infection according to region-specific drug-resistance profiles could improve the efficiency of efforts to reduce the burden of tuberculosis in immigrants to the United States. Methods: We constructed a decision-analysis model by using a hypothetical cohort of all documented immigrants entering the United States from developing nations. Region-specific drug-resistance profiles were derived from data on 30,388 cases of infection. The model examined the effectiveness and cost effectiveness of four strategies: no intervention or tuberculin skin testing followed by treatment with isoniazid, treatment with rifampin, or treatment with rifampin plus pyrazinamide for those with a positive test result. Results: A strategy of detecting and treating latent tuberculosis infection was cost-saving among immigrants from Mexico, Haiti, sub-Saharan Africa, South Asia, and developing nations in East Asia and the Pacific. This strategy was highly cost effective among immigrants from other developing nations. Rifampin plus pyrazinamide was the preferred strategy for treating latent infection in immigrants from Vietnam, Haiti, and the Philippines. Conclusions: For new immigrants to the United States from developing nations, a strategy of detecting and treating latent tuberculosis infection would lead to substantial health and economic benefits. Because of the high prevalence of resistance to isoniazid, treatment with a rifampin-containing regimen should be strongly considered for immigrants from Vietnam, Haiti, and the Philippines.	New York Presbyterian Hosp, Dept Publ Hlth, New York, NY USA; New York Presbyterian Hosp, Dept Med, Div Int Med & Infect Dis, New York, NY USA; New York Presbyterian Hosp, Dept Pharm, New York, NY USA; Cornell Univ, Weill Med Coll, New York, NY USA; Columbia Univ, Program Gen Publ Hlth, New York, NY USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; Columbia Univ, Int Ctr Hlth Outcomes & Innovat Res, New York, NY USA; CUNY, Sophie Davis Sch Biomed Educ, New York, NY 10021 USA	NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Cornell University; Columbia University; Columbia University; Columbia University; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Khan, K (corresponding author), Univ Toronto, St Michaels Hosp, Inner City Hlth Res Unit, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Zivin, Joshua Graff/ABF-1697-2020	Graff Zivin, Joshua/0000-0002-0820-4900; Muennig, Peter/0000-0002-4234-0498				*AG HEALTHC RES QU, 2002, HEALTC COST UT PROJ; *AM PUBL TRANSP AS, 2002, PASS FAR SUMM; [Anonymous], 2001, MMWR MORB MORTAL WKL, V50, P733; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; BROWN RE, 1995, ARCH INTERN MED, V155, P1595, DOI 10.1001/archinte.155.15.1595; *BUR LAB STAT DEP, 2002, CONS PRIC IND; *BUR LAB STAT DEP, 2002, NAT EMPL WAG DAT OCC; *CDCP, 1996, NAT TUB SURV SYST; *CDCP, 2002, TUB CAS FOR BORN PER; *CDCP, 2002, TUB CAS CAS RAT 1000; *CENS BUR, JOURN WORK PLAC WORK; *CENS BUR, 2002, 2000 DEC CENS; Chaisson RE, 2002, JAMA-J AM MED ASSOC, V288, P165, DOI 10.1001/jama.288.2.165; Coker R, 2001, Lancet Infect Dis, V1, P270, DOI 10.1016/S1473-3099(01)00122-0; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827; COOK PP, 2001, INF DIS SOC AM 39 AN, P1147; *CTR MED MED SERV, 2002, MED PAYM SYST CLIN L; *CTR MED MED SERV, 2000, NAT PHYS FEE SCHED P; *CTR MED MED SERV, 2002, MED PROV AN REV MEDP; *DEP EN, 2002, MOT GAS RET PRIC; *DEP EN, 2002, MOT VEH MIL FUEL CON; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; *EUROTB, 2002, SURV DRUG RES EUR; FAIRSHTER RD, 1975, AM REV RESPIR DIS, V112, P37; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; GEITER L, 2000, ENDING NEGLECT ELIMI; GEITER LJ, 1997, THESIS JOHNS HOPKINS, P180; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; GIRLING DJ, 1991, AM REV RESPIR DIS, V143, P262; Gold MR, 1996, COST EFFECTIVENESS H; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Granich RM, 2001, INT J TUBERC LUNG D, V5, P53; Gushulak BD, 2000, CLIN INFECT DIS, V31, P776, DOI 10.1086/313998; *IMM NAT SERV, 2002, STATISTICS; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; KING MD, 2001, INF DIS SOC AM 39 AN, P1146; Kochanek K.D., 2001, NATL VITAL STAT REPO, V49; LOLLOCK L, 1908, P20534 CENS BUR; MCGLYNN KA, 1986, AM REV RESPIR DIS, V134, P666; *MED EC, 2000, DRUG TOP RED BOOK PH; Moore M, 1998, JAMA-J AM MED ASSOC, V279, P656; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; *NAT CTR HLTH STAT, 1997, MULT CAUSE DEATH PUB; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Sadaphal P, 2001, CLIN INFECT DIS, V33, P1687, DOI 10.1086/323896; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Weis SE, 2001, AM J RESP CRIT CARE, V164, P953, DOI 10.1164/ajrccm.164.6.2102132; *WORLD BANK GROUP, 2002, COUNTR REG; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304; 2000, MMWR MORB MORTAL WKL, V49, P1	55	126	129	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2002	347	23					1850	1859		10.1056/NEJMsa021099	http://dx.doi.org/10.1056/NEJMsa021099			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NW	12466510	Green Published			2022-12-24	WOS:000179596900007
J	Peyton, R				Peyton, R			Punishment beatings and the rule of law	LANCET			English	Article									S Tyrone Hosp, Dungannon BT71 6AU, North Ireland; Royal Coll Surgeons England, London, England	Royal College of Surgeons of England	Peyton, R (corresponding author), S Tyrone Hosp, Carland Rd, Dungannon BT71 6AU, North Ireland.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S53	S54		10.1016/S0140-6736(02)11822-8	http://dx.doi.org/10.1016/S0140-6736(02)11822-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504505	Bronze			2022-12-24	WOS:000180064500026
J	Bennett, IM; Farfano, HMV; Bogani, F; Primak, A; Liddell, PA; Otero, L; Sereno, L; Silber, JJ; Moore, AL; Moore, TA; Gust, D				Bennett, IM; Farfano, HMV; Bogani, F; Primak, A; Liddell, PA; Otero, L; Sereno, L; Silber, JJ; Moore, AL; Moore, TA; Gust, D			Active transport of Ca2+ by an artificial photosynthetic membrane	NATURE			English	Article							ELECTRON-TRANSFER; LIQUID MEMBRANES; DERIVATIVES	Transport of calcium ions across membranes and against a thermodynamic gradient is essential to many biological processes, including muscle contraction, the citric acid cycle, glycogen metabolism, release of neurotransmitters, vision, biological signal transduction and immune response. Synthetic systems that transport metal ions across lipid or liquid membranes are well known(1-6), and in some cases light has been used to facilitate transport(7). Typically, a carrier molecule located in a symmetric membrane binds the ion from aqueous solution on one side and releases it on the other. The thermodynamic driving force is provided by an ion concentration difference between the two aqueous solutions, coupling to such a gradient in an auxiliary species, or photomodulation of the carrier by an asymmetric photon flux(7). Here we report a different approach, in which active transport is driven not by concentration gradients, but by light-induced electron transfer in a photoactive molecule that is asymmetrically disposed across a lipid bilayer. The system comprises a synthetic, light-driven transmembrane Ca2+ pump based on a redox-sensitive, lipophilic Ca2+-binding shuttle molecule whose function is powered by an intramembrane artificial photosynthetic reaction centre. The resulting structure transports calcium ions across the bilayer of a liposome to develop both a calcium ion concentration gradient and a membrane potential, expanding Mitchell's concept of a redox loop mechanism for protons(8) to include divalent cations. Although the quantum yield is relatively low (similar to1 per cent), the Ca2+ electrochemical potential developed is significant.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Study Early Events Photosynthesis, Tempe, AZ 85287 USA; Univ Natl Rio Cuarto, Dept Quim & Fis, Rio Cuarto, Argentina	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Universidad Nacional Rio Cuarto	Gust, D (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.			Otero, Luis/0000-0002-7347-8107; Silber, Juana/0000-0001-9395-9939				BARTSCH RA, 1996, CHEM SEPARATIONS LIQ; DADFARNIA S, 1993, J MEMBRANE SCI, V78, P115, DOI 10.1016/0376-7388(93)85253-S; de Gyves J, 1999, IND ENG CHEM RES, V38, P2182, DOI 10.1021/ie980374p; Hirose T, 1998, RRD PURE APPL CHEM, V2, P527; LAMRABTE A, 1991, PHOTOCHEM PHOTOBIOL, V54, P123, DOI 10.1111/j.1751-1097.1991.tb01994.x; Longin TL, 2001, CHEM INNOV, V31, P23; MINTA A, 1989, J BIOL CHEM, V264, P8171; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Steinberg-Yfrach G, 1998, NATURE, V392, P479, DOI 10.1038/33116; SteinbergYfrach G, 1997, NATURE, V385, P239, DOI 10.1038/385239a0; Sullivan B.W., 1990, P45; ZHAO ZG, 1992, PHOTOCHEM PHOTOBIOL, V55, P611, DOI 10.1111/j.1751-1097.1992.tb04284.x	12	133	135	7	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 28	2002	420	6914					398	401		10.1038/nature01209	http://dx.doi.org/10.1038/nature01209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619TZ	12459780				2022-12-24	WOS:000179494700034
J	Richards, DA; Meakins, J; Tawfik, J; Godfrey, L; Dutton, E; Richardson, G; Russell, D				Richards, DA; Meakins, J; Tawfik, J; Godfrey, L; Dutton, E; Richardson, G; Russell, D			Nurse telephone triage for same day appointments in general practice: multiple interrupted time series trial of effect on workload and costs	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; PRIMARY-CARE; CONSULTATION	Objective To compare the workloads of general practitioners and nurses and costs of patient care for nurse telephone triage and standard management of requests for same day appointments in routine primary care. Design Multiple interrupted time series using sequential introduction of experimental triage system in different sites with repeated measures taken one week in every month for 12 months. Setting Three primary care sites in York. Participants 4685 patients: 1233 in standard management, 3452 in the triage system. All patients requesting same day appointments during study weeks were included in the trial. Main outcome measures Type of consultation (telephone, appointment, or visit), time taken for consultation, presenting complaints, use of services during the month after same day contact, and costs of drugs and same day, follow up, and emergency care. Results The triage system reduced appointments with general practitioner by 29-44%. Compared with standard management, the triage system had a relative risk (95% confidence interval) of 0.85 (0.72 to 1.00) for home visits, 2.41 (2.08 to 2.80) for telephone care, and 3.79 (3.21 to 4.48) for nurse care. Mean overall time in the triage system was 1.70 minutes longer, but mean general practitioner time was reduced by 2.45 minutes. Routine appointments and nursing time increased, as did out of hours and accident and emergency attendance. Costs did not differ significantly between standard management and triage: mean difference pound1.48 more per patient for triage (95% confidence interval -0.19 to 3.15). Conclusions Triage reduced the number of same day appointments with general practitioners but resulted in busier routine surgeries, increased nursing time, and a small but significant increase in out of hours and accident and emergency attendance. Consequently, triage does not reduce overall costs per patient for managing same day appointments.	Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England; Rawcliffe Surg, Priory Med Grp, York YO30 6ND, N Yorkshire, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Univ York, Dept Hlth Sci, York YO1 5DD, N Yorkshire, England	University of Manchester; University of York - UK; University of York - UK	Richards, DA (corresponding author), Univ Manchester, Sch Nursing Midwifery & Hlth Visiting, Manchester M13 9PL, Lancs, England.		Richards, David/B-4807-2009	Richards, David/0000-0002-8821-5027				*BRIT MED ASS, 1996, GEN MED SERV COMM ME; *DEP HLTH, 1989, GEN PRACT NAT HLTH S; Gallagher M, 1998, BRIT J GEN PRACT, V48, P1141; HALLAM L, 1994, BRIT MED J, V308, P249, DOI 10.1136/bmj.308.6923.249; Jones K, 1998, BRIT J GEN PRACT, V48, P1303; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Lattimer V, 1997, BRIT MED J, V314, P198; Thompson F, 1999, BMJ-BRIT MED J, V319, P1408, DOI 10.1136/bmj.319.7222.1408	8	53	54	2	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 23	2002	325	7374					1214	1217		10.1136/bmj.325.7374.1214	http://dx.doi.org/10.1136/bmj.325.7374.1214			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	619YU	12446539	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000179506200022
J	Zilberman, D; Cao, XF; Jacobsen, SE				Zilberman, D; Cao, XF; Jacobsen, SE			ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation	SCIENCE			English	Article							EPIGENETIC ALLELES; GENE; ARABIDOPSIS; PROTEINS; RNA	Proteins of the ARGONAUTE family are important in diverse posttranscriptional RNA-mediated gene-silencing systems as well as in transcriptional gene silencing in Drosophila and fission yeast and in programmed DNA elimination in Tetrahymena. We cloned ARGONAUTE4 (AGO4) from a screen for mutants that suppress silencing of the Arabidopsis SUPERMAN (SUP) gene. The ago4-1 mutant reactivated silent SUP alleles and decreased CpNpG and asymmetric DNA methylation as well as histone H3 lysine-9 methylation. In addition, ago4-1 blocked histone and DNA methylation and the accumulation of 25-nucleotide small interfering RNAs (siRNAs) that correspond to the retroelement AtSN1. These results suggest that AGO4 and long siRNAs direct chromatin modifications, including histone methylation and non-CpG DNA methylation.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.			Zilberman, Daniel/0000-0002-0123-8649	NIGMS NIH HHS [GM60398, GM07185] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398, T32GM007185] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAULCOMBE D, COMMUNICATION; CAO X, 2002, P NATL ACAD SCI US; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	22	799	876	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					716	719		10.1126/science.1079695	http://dx.doi.org/10.1126/science.1079695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12522258				2022-12-24	WOS:000180687700050
J	Whiting, MF; Bradler, S; Maxwell, T				Whiting, MF; Bradler, S; Maxwell, T			Loss and recovery of wings in stick insects	NATURE			English	Article							CHARACTER STATES; DNA-SEQUENCES; PHYLOGENY; FLIGHTLESSNESS	The evolution of wings was the central adaptation allowing insects to escape predators, exploit scattered resources, and disperse into new niches, resulting in radiations into vast numbers of species(1). Despite the presumed evolutionary advantages associated with full-sized wings (macroptery), nearly all pterygote (winged) orders have many partially winged (brachypterous) or wingless (apterous) lineages, and some entire orders are secondarily wingless (for example, fleas, lice, grylloblattids and mantophasmatids), with about 5% of extant pterygote species being flightless(2,3). Thousands of independent transitions from a winged form to winglessness have occurred during the course of insect evolution; however, an evolutionary reversal from a flightless to a volant form has never been demonstrated clearly for any pterygote lineage. Such a reversal is considered highly unlikely because complex interactions between nerves, muscles, sclerites and wing foils are required to accommodate flight(4). Here we show that stick insects (order Phasmatodea) diversified as wingless insects and that wings were derived secondarily, perhaps on many occasions. These results suggest that wing developmental pathways are conserved in wingless phasmids, and that 're-evolution' of wings has had an unrecognized role in insect diversification.	Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA; Univ Gottingen, Inst Zool & Anthropol, D-3400 Gottingen, Germany; Washington Univ, Dept Biol, St Louis, MO 63130 USA	Brigham Young University; University of Gottingen; Washington University (WUSTL)	Whiting, MF (corresponding author), Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA.	Michael_Whiting@byu.edu	Bradler, Sven/D-8655-2015	Bradler, Sven/0000-0001-9307-1032				Andersen Nils Moller, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P91; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Bradler S., 2001, ZOOLOGY S3, V104, P69, DOI DOI 10.1016/J.CRVI.2011.01.006; COHEN B, 1993, DEVELOPMENT, V117, P597; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dudley R., 2000, BIOMECHANICS INSECT; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Gunther K., 1953, Beitraege zur Entomologie Berlin, V3, P541; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; KAMP JW, 1973, CAN ENTOMOL, V105, P1235, DOI 10.4039/Ent1051235-9; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kristensen N.P., 1991, P125; KUTSCH W, 1991, J COMP PHYSIOL A, V168, P483, DOI 10.1007/BF00199608; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Maddison WP, 2000, MACCLADE 4 ANAL PHYL; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1999, DISCRETE; ROFF DA, 1994, EVOL ECOL, V8, P639, DOI 10.1007/BF01237847; Sorenson MD, 1999, TREEROT VERSION 2; SWOFFORD DL, 2000, PAUP STAR PHYLOGENET; Tilgner EH, 1999, DEUT ENTOMOL Z, V46, P149, DOI 10.1002/mmnd.19990460203; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Wheeler W, 1999, CLADISTICS, V15, P379, DOI 10.1111/j.1096-0031.1999.tb00274.x; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Whiting MF, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P69; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1	29	322	336	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					264	267		10.1038/nature01313	http://dx.doi.org/10.1038/nature01313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529642				2022-12-24	WOS:000180397600046
J	Bedinghaus, JM				Bedinghaus, JM			Family history	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		POSKANZER DC, 1977, HARRISONS PRINCIPLES, P1903	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					142	142		10.1001/jama.289.2.142	http://dx.doi.org/10.1001/jama.289.2.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517205				2022-12-24	WOS:000180226400001
J	Villanueva, P; Peiro, S; Librero, J; Pereiro, I				Villanueva, P; Peiro, S; Librero, J; Pereiro, I			Accuracy of pharmaceutical advertisements in medical journals	LANCET			English	Article							SELF-REGULATION; PROMOTION; INDUSTRY; EDITORS; CODES	Background Because of the effect of the ever-growing evidence-based medicine movement on prescribing behaviour of doctors, the pharmaceutical industry incorporates bibliographical references to clinical trials that endorse their products in their advertisements. We aimed to assess whether the references about efficacy, safety, convenience, or cost of anti hypertensive and lipid-lowering drugs included in advertisements supported the promotional claims. Methods We assessed all advertisements for anti hypertensive and lipid-lowering drugs published in six Spanish medical journals in 1997 that had at least one bibliographical reference. Two pairs of investigators independently reviewed the advertisements to see whether the studies quoted to endorse the advertising messages supported the corresponding claims. Findings We identified 264 different advertisements for anti hypertensive drugs and 23 different advertisements for lipid-lowering drugs. We recorded at least one reference in 31 advertisements in the anti hypertensive group and at least one reference in every seven advertisements in the lipid-lowering group, providing a total of 125 promotional claims with references. We could not retrieve 23 (18%) references from monographic works and non-published data on file. 79 (63%) of the 125 references were from journals with a high impact factor; 84 (82%) of the 102 references retrieved were from randomised clinical trials. In 45 claims (44.1%; 95% CI 34.3-54.3) the promotional statement was not supported by the reference, most frequently because the slogan recommended the drug in a patient group other than that assessed in the study. Interpretation Doctors should be cautious in assessment of advertisements that claim a drug has greater efficacy, safety, or convenience, even though these claims are accompanied by bibliographical references to randomised clinical trials published in reputable medical journals and seem to be evidence-based.	Escuela Valenciana Estudios Salud, Conselleria Sanitat, Generalitat Valenciana, Fdn Inst Invest Serv Salud, Valencia 46017, Spain; Inst Social Marina, Valencia, Spain		Peiro, S (corresponding author), Escuela Valenciana Estudios Salud, Conselleria Sanitat, Generalitat Valenciana, Fdn Inst Invest Serv Salud, Juan de Garay 21, Valencia 46017, Spain.		Librero, Julian/F-4947-2017; Peiro, Salvador/H-5778-2017	Librero, Julian/0000-0002-4859-9054; Peiro, Salvador/0000-0002-3902-569X				Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; CARANDANG ED, 1994, MED J AUSTRALIA, V161, P671, DOI 10.5694/j.1326-5377.1994.tb126915.x; CAUDILL TS, 1992, J DRUG ISSUES, V22, P331, DOI 10.1177/002204269202200212; Greenhalgh T, 1997, BRIT MED J, V315, P1623, DOI 10.1136/bmj.315.7122.1623; HEALING E, 1994, BRIT MED J, V308, P474, DOI 10.1136/bmj.308.6926.474a; HERXHEIMER A, 1990, BRIT MED J, V300, P307, DOI 10.1136/bmj.300.6720.307; KESSLER DA, 1990, JAMA-J AM MED ASSOC, V264, P2409, DOI 10.1001/jama.264.18.2409; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; LEXCHIN J, 1994, INT J HEALTH SERV, V24, P91, DOI 10.2190/EKEP-D9JE-31A4-KTE5; Lexchin J, 1997, CAN FAM PHYSICIAN, V43, P1997; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; Mansfield PR, 1997, MED J AUSTRALIA, V167, P590, DOI 10.5694/j.1326-5377.1997.tb138906.x; Mindell J, 1997, BRIT MED J, V315, P1622; PERMAN E, 1990, NEW ENGL J MED, V323, P616, DOI 10.1056/NEJM199008303230921; RENNIE D, 1991, JAMA-J AM MED ASSOC, V265, P2394, DOI 10.1001/jama.265.18.2394; Roughead EE, 1998, INT J HEALTH SERV, V28, P269, DOI 10.2190/B81X-4A53-TY5M-C2HR; Sackett DL, 1997, EVIDENCE BASED MED P; Smart S, 1997, BRIT MED J, V315, P1622; SMITH MC, 1977, AM J HOSP PHARM, V34, P1208, DOI 10.1093/ajhp/34.11.1208; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912; WILKES MS, 1995, J GEN INTERN MED, V10, P443, DOI 10.1007/BF02599916; 1894, JAMA, V22, P958; 1982, LANCET, V2, P1257; 1994, B OFICIAL ESTADO	27	105	111	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					27	32		10.1016/S0140-6736(03)12118-6	http://dx.doi.org/10.1016/S0140-6736(03)12118-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517463				2022-12-24	WOS:000180191600017
J	Cook, DL; Schwindt, PC; Grande, LA; Spain, WJ				Cook, DL; Schwindt, PC; Grande, LA; Spain, WJ			Synaptic depression in the localization of sound	NATURE			English	Article							INTERAURAL TIME DIFFERENCES; STEM AUDITORY NUCLEI; COINCIDENCE DETECTION; BRAIN-STEM; PHASE-LOCKING; LAMINARIS; NEURONS; MAGNOCELLULARIS; LATERALIZATION; ORGANIZATION	Short-term synaptic plasticity, which is common in the central nervous system, may contribute to the signal processing functions of both temporal integration and coincidence detection(1-3). For temporal integrators, whose output firng rate depends on a running average of recent synaptic inputs, plasticity modulates input synaptic strength and thus may directly control signalling gain(2) and the function of neural networks(1-4). But the firing probability of an ideal coincidence detector would depend on the temporal coincidence of events rather than on the average frequency of synaptic events. Here we have examined a specific case of how synaptic plasticity can affect temporal coincidence detection, by experimentally characterizing synaptic depression at the synapse between neurons in the nucleus magnocellularis and coincidence detection neurons in the nucleus laminaris in the chick auditory brainstem(5). We combine an empirical description of this depression with a biophysical model of signalling in the nucleus laminaris. The resulting model predicts that synaptic depression provides an adaptive mechanism for preserving interaural time-delay information (a proxy for the location of sound in space) despite the confounding effects of sound-intensity-related information. This mechanism may help nucleus laminaris neurons to pass specific sound localization information to higher processing centres.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA; Univ Washington, Dept Neurol, Seattle, WA 98105 USA; Univ Washington, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98105 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Spain, WJ (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA.	spain@u.washington.edu			BLRD VA [I01 BX000386] Funding Source: Medline; Veterans Affairs [I01BX000386] Funding Source: NIH RePORTER	BLRD VA; Veterans Affairs(US Department of Veterans Affairs)		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; Bruckner S, 1998, EUR J NEUROSCI, V10, P3438, DOI 10.1046/j.1460-9568.1998.00353.x; CARR CE, 1990, J NEUROSCI, V10, P3227; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; JACKSON H, 1978, J COMP PHYSIOL PSYCH, V92, P682, DOI 10.1037/h0077496; JEFFRESS LA, 1968, J ACOUST SOC AM, V44, P187, DOI 10.1121/1.1911053; Koppl C, 1997, J NEUROSCI, V17, P3312; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Nadim F, 1999, P NATL ACAD SCI USA, V96, P8206, DOI 10.1073/pnas.96.14.8206; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; Pena JL, 1996, J NEUROSCI, V16, P7046; REYES AD, 1994, J NEUROSCI, V14, P5352; Reyes AD, 1996, J NEUROSCI, V16, P993; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; TOBIAS JV, 1959, J ACOUST SOC AM, V31, P1591, DOI 10.1121/1.1907664; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Yang LC, 1999, J NEUROSCI, V19, P2313; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; ZHOU N, 1991, HEARING RES, V52, P195, DOI 10.1016/0378-5955(91)90199-J	30	139	139	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					66	70		10.1038/nature01248	http://dx.doi.org/10.1038/nature01248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511955				2022-12-24	WOS:000180165500038
J	Speck, O; Hughes, SC; Noren, NK; Kulikauskas, RM; Fehon, RG				Speck, O; Hughes, SC; Noren, NK; Kulikauskas, RM; Fehon, RG			Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity	NATURE			English	Article							EZRIN/RADIXIN/MOESIN ERM PROTEINS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CELL POLARITY; DROSOPHILA; PHOSPHORYLATION; LOCALIZATION; ASSOCIATION; FIBROBLASTS; EXPRESSION	Two prominent characteristics of epithelial cells, apical-basal polarity and a highly ordered cytoskeleton, depend on the existence of precisely localized protein complexes associated with the apical plasma membrane(1,2), and on a separate machinery that regulates the spatial order of actin assembly(3). ERM (ezrin, radixin, moesin) proteins have been proposed to link transmembrane proteins to the actin cytoskeleton(4) in the apical domain, suggesting a structural role in epithelial cells, and they have been implicated in signalling pathways(5). Here, we show that the sole Drosophila ERM protein Moesin functions to promote cortical actin assembly and apical-basal polarity. As a result, cells lacking Moesin lose epithelial characteristics and adopt invasive migratory behaviour. Our data demonstrate that Moesin facilitates epithelial morphology not by providing an essential structural function, but rather by antagonizing activity of the small GTPase Rho. Thus, Moesin functions in maintaining epithelial integrity by regulating cell-signalling events that affect actin organization and polarity. Furthermore, our results show that there is negative feedback between ERM activation and activity of the Rho pathway.	Duke Univ, Dept Biol, DCMB Grp, Durham, NC 27708 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fehon, RG (corresponding author), Duke Univ, Dept Biol, DCMB Grp, Box 91000, Durham, NC 27708 USA.		Noren Hooten, Nicole/J-5498-2019; Hughes, Sarah/D-3677-2009	Noren Hooten, Nicole/0000-0002-1683-3838; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034783] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; FEHON RG, 1994, DEVELOPMENT, V120, P545; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Halsell SR, 2000, GENETICS, V156, P469; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7	30	200	210	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					83	87		10.1038/nature01295	http://dx.doi.org/10.1038/nature01295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511959				2022-12-24	WOS:000180165500042
J	Andrulis, ED; Werner, J; Nazarian, A; Erdjument-Bromage, H; Tempst, P; Lis, JT				Andrulis, ED; Werner, J; Nazarian, A; Erdjument-Bromage, H; Tempst, P; Lis, JT			The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila	NATURE			English	Article							HEAT-SHOCK LOCI; TRANSCRIPTION ELONGATION; PROMOTER; SPT5; IDENTIFICATION; INFORMATION; RECRUITMENT; COMPLEX; HSF	The RNA polymerase II elongation complex contains several factors that facilitate transcription elongation and catalyse the processing of precursor messenger RNAs (pre-mRNAs)(1-3). The conserved elongation factor Spt6 is recruited rapidly and robustly to sites of active transcription(4,5). Here we show that Drosophila Spt6 (dSpt6) co-purifies with the exosome, a complex of 3' to 5' exoribonucleases that is implicated in the processing of structural RNA and in the degradation of improperly processed pre-mRNA(6-10). Immunoprecipitation assays of Drosophila nuclear extracts show that the exosome also associates with the elongation factor dSpt5 and RNA polymerase II. In vivo, exosome subunits colocalize with dSpt6 at transcriptionally active loci on polytene chromosomes during normal development and are strongly recruited to heat-shock loci on gene induction. At higher resolution, chromatin immunoprecipitation analysis shows that the exosome is recruited to transcriptionally active units of heat-shock genes. These data provide a physical basis for the hypothesis that exosome-mediated pre-mRNA surveillance accompanies transcription elongation.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.			Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geromanos S, 2000, ANAL CHEM, V72, P777, DOI 10.1021/ac991071n; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hirose Y, 2000, GENE DEV, V14, P1415; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Lis JT, 2000, GENE DEV, V14, P792; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272	23	206	210	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					837	841		10.1038/nature01181	http://dx.doi.org/10.1038/nature01181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490954				2022-12-24	WOS:000179897300062
J	Shinkai, K; Mohrs, M; Locksley, RM				Shinkai, K; Mohrs, M; Locksley, RM			Helper T cells regulate type-2 innate immunity in vivo	NATURE			English	Article							NIPPOSTRONGYLUS-BRASILIENSIS; AIRWAY HYPERRESPONSIVENESS; EOSINOPHILS; DEGRANULATION; IL-5; INTERLEUKIN-5; EXPRESSION; RESPONSES; INDUCTION; PROTEINS	Type-2 immunity requires orchestration of innate and adaptive immune responses to protect mucosal sites from pathogens. Dysregulated type-2 responses result in allergy or asthma(1). T helper 2 (T(H)2) cells elaborate cytokines, such as interleukin (IL)-4, IL-5, IL-9 and IL-13, which work with toxic mediators of innate immune cells to establish environments that are inhospitable to helminth or arthropod invaders(2). The importance of T(H)2 cells in coordinating innate immune cells at sites of inflammation is not known. Here we show that polarized type-2 immune responses are initiated independently of adaptive immunity. In the absence of B and T cells, IL-4-expressing eosinophils were recruited to tissues of mice infected with the helminth Nippostrongylus brasiliensis, but eosinophils failed to degranulate. Reconstitution with CD4 T cells promoted accumulation of degranulated IL-4-expressing cells, but only if T cells were stimulated with cognate antigen. Degranulation correlated with tissue destruction, which was attenuated if eosinophils were depleted. Helper T cells confer antigen specificity on eosinophil cytotoxicity, but not cytokine responses, so defining a novel mechanism that focuses tissue injury at sites of immune challenge.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.							Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; CONRAD DH, 1990, J EXP MED, V171, P1497, DOI 10.1084/jem.171.5.1497; DENT LA, 1990, J EXP MED, V172, P1425, DOI 10.1084/jem.172.5.1425; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Dvorak AM, 1998, INT REV CYTOL, V180, P87; Dvorak AM, 2000, CHEM IMMUNOL, V76, P1; Erjefalt JS, 2000, AM J RESP CRIT CARE, V161, P2074, DOI 10.1164/ajrccm.161.6.9906085; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Foster PS, 2002, TRENDS MOL MED, V8, P162, DOI 10.1016/S1471-4914(02)02302-X; Foster PS, 2001, IMMUNOL REV, V179, P173, DOI 10.1034/j.1600-065X.2001.790117.x; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Karawajczyk M, 2000, AM J RESP CELL MOL, V23, P521, DOI 10.1165/ajrcmb.23.4.4025; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee NA, 1997, J IMMUNOL, V158, P1332; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mould AW, 2000, J IMMUNOL, V164, P2142, DOI 10.4049/jimmunol.164.4.2142; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rumbley CA, 1999, J IMMUNOL, V162, P1003; Sabin EA, 1996, J EXP MED, V184, P1871, DOI 10.1084/jem.184.5.1871; SCHNARE M, 2001, NAT IMMUNOL, V29, P47; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Walsh GM, 2001, CURR OPIN HEMATOL, V8, P28, DOI 10.1097/00062752-200101000-00006; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255	30	158	165	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					825	829		10.1038/nature01202	http://dx.doi.org/10.1038/nature01202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490951				2022-12-24	WOS:000179897300059
J	Williams, KA; Veenhuizen, PTM; de la Torre, BG; Eritja, R; Dekker, C				Williams, KA; Veenhuizen, PTM; de la Torre, BG; Eritja, R; Dekker, C			Nanotechnology - Carbon nanotubes with DNA recognition	NATURE			English	Article							ROOM-TEMPERATURE; TRANSISTORS		Delft Univ Technol, Dept Nanosci, NL-2628 CJ Delft, Netherlands; CSIC, Inst Biol Mol Barcelona, Barcelona 08034, Spain	Delft University of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Williams, KA (corresponding author), Delft Univ Technol, Dept Nanosci, NL-2628 CJ Delft, Netherlands.		de la Torre, Beatriz G./N-6995-2019; de la Torre, Beatriz G/AAF-1419-2020; Eritja, Ramon/B-5613-2008	de la Torre, Beatriz G./0000-0001-8521-9172; Eritja, Ramon/0000-0001-5383-9334; Dekker, Cees/0000-0001-6273-071X				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95; Derycke V, 2001, NANO LETT, V1, P453, DOI 10.1021/nl015606f; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Huang WJ, 2002, NANO LETT, V2, P311, DOI [10.1021/nl010095i, 10.1021/n1010095i]; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Wang J, 1998, BIOSENS BIOELECTRON, V13, P757, DOI 10.1016/S0956-5663(98)00039-6; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873	12	459	482	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 26	2002	420	6917					761	761		10.1038/420761a	http://dx.doi.org/10.1038/420761a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626WR	12490938	Green Submitted			2022-12-24	WOS:000179897300045
J	Blat, Y; Protacio, RU; Hunter, N; Kleckner, N				Blat, Y; Protacio, RU; Hunter, N; Kleckner, N			Physical and functional interactions among basic chromosome organizational features govern early steps of meiotic chiasma formation	CELL			English	Article							SISTER-CHROMATID COHESION; YEAST SACCHAROMYCES-CEREVISIAE; DOUBLE-STRAND BREAKS; RECOMBINATION INITIATION; CROSSOVER INTERFERENCE; SYNAPTONEMAL COMPLEXES; AXIAL ELEMENT; MEIOSIS; PROTEIN; SITES	Analysis of meiotic recombination by functional genomic approaches reveals prominent spatial and functional interactions among diverse organizational determinants. Recombination occurs between chromatin loop sequences; however, these sequences are spatially tethered to underlying chromosome axes via their recombinosomes. Meiotic chromosomal protein, Red1, localizes to chromosome axes; however, Red1 loading is modulated by R/G-bands isochores and thus by bulk chromatin state. Recombination is also modulated by isochore determinants: R-bands differentially favor double-strand break (DSB) formation but disfavor subsequent loading of meiotic RecA homolog, Dmc1. Red1 promotes DSB formation in both R- and G-bands and then promotes Dmc1 loading, specifically counteracting disfavoring R-band effects. These complexities are discussed in the context of chiasma formation as a series of coordinated local changes at the DNA and chromosome-axis levels.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM44794] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blumental-Perry A, 2000, EMBO REP, V1, P232, DOI 10.1093/embo-reports/kvd047; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Debrauwere H, 1999, NAT GENET, V23, P367, DOI 10.1038/15557; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; John B., 1990, MEIOSIS; Kaback DB, 1999, GENETICS, V152, P1475; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; KING JS, 1990, GENETICS, V126, P1127; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; MaoDraayer Y, 1996, GENETICS, V144, P71; MOENS PB, 1988, BIOESSAYS, V9, P151, DOI 10.1002/bies.950090503; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; ROCKMILL B, 1990, GENETICS, V126, P563; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; TEASE C, 1978, NATURE, V272, P823, DOI 10.1038/272823a0; Thompson DA, 1999, GENETICS, V153, P621; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; VONWETTS.D, 1971, P NATL ACAD SCI USA, V68, P851, DOI 10.1073/pnas.68.4.851; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203; ZENVIRTH D, 1992, EMBO J, V11, P3441, DOI 10.1002/j.1460-2075.1992.tb05423.x; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	53	246	252	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					791	802		10.1016/S0092-8674(02)01167-4	http://dx.doi.org/10.1016/S0092-8674(02)01167-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526806	Bronze			2022-12-24	WOS:000179862600006
J	Casper, AM; Nghiem, P; Arlt, MF; Glover, TW				Casper, AM; Nghiem, P; Arlt, MF; Glover, TW			ATR regulates fragile site stability	CELL			English	Article							DNA-REPLICATION; ATAXIA-TELANGIECTASIA; FHIT GENE; MOLECULAR CHARACTERIZATION; FREQUENT DELETIONS; INTEGRATION SITE; CANCER-CELLS; CHECKPOINT; FRA3B; EXPRESSION	Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Dana Farber Canc Inst, Cutaneous Oncol Unit, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Glover, TW (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.		Nghiem, Paul T/A-9210-2011	Nghiem, Paul T/0000-0003-2784-963X; Casper, Anne/0000-0003-4975-5749	NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038627, R01GM038627] Funding Source: NIH RePORTER; NCI NIH HHS [CA43222] Funding Source: Medline; NIAMS NIH HHS [K08-AR02087] Funding Source: Medline; NIGMS NIH HHS [GM38627] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Bednarek AK, 2001, CANCER RES, V61, P8068; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brown EJ, 2000, GENE DEV, V14, P397; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Corbin S, 2002, CANCER RES, V62, P3477; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Druck T, 1997, CANCER RES, V57, P504; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Glover TW, 1998, RECENT RES CANCER, V154, P185; GLOVER TW, 1987, AM J HUM GENET, V41, P882; Glover TW, 1998, CANCER RES, V58, P3409; GLOVER TW, 1986, CANCER GENET CYTOGEN, V19, P141, DOI 10.1016/0165-4608(86)90381-X; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Harborth J, 2001, J CELL SCI, V114, P4557; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michael D, 1997, ONCOGENE, V15, P1653; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Paige AJW, 2000, CANCER RES, V60, P1690; Pincheira J, 2001, MUTAGENESIS, V16, P419, DOI 10.1093/mutage/16.5.419; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiraishi T, 2001, P NATL ACAD SCI USA, V98, P5722, DOI 10.1073/pnas.091095898; SMEETS DFCM, 1990, CYTOGENET CELL GENET, V53, P8, DOI 10.1159/000132885; Sutherland GR, 1998, TRENDS GENET, V14, P501, DOI 10.1016/S0168-9525(98)01628-X; Telatar M, 1996, AM J HUM GENET, V59, P40; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Thorland EC, 2000, CANCER RES, V60, P5916; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; Wang L, 1999, HUM MOL GENET, V8, P431, DOI 10.1093/hmg/8.3.431; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Wright J, 1996, AM J HUM GENET, V59, P839; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	62	450	459	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					779	789		10.1016/S0092-8674(02)01113-3	http://dx.doi.org/10.1016/S0092-8674(02)01113-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526805	Bronze			2022-12-24	WOS:000179862600005
J	Shumyatsky, GP; Tsvetkov, E; Malleret, G; Vronskaya, S; Hatton, M; Hampton, L; Battey, JF; Dulac, C; Kandel, ER; Bolshakov, VY				Shumyatsky, GP; Tsvetkov, E; Malleret, G; Vronskaya, S; Hatton, M; Hampton, L; Battey, JF; Dulac, C; Kandel, ER; Bolshakov, VY			Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear	CELL			English	Article							LONG-TERM POTENTIATION; BOMBESIN-LIKE PEPTIDES; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; CA3-CA1 SYNAPSES; KINASE PATHWAYS; DEFICIENT MICE; MESSENGER-RNA; RECEPTOR; PROTEIN	We identified the Grp gene, encoding gastrin-releasing peptide, as being highly expressed both in the lateral nucleus of the amygdala, the nucleus where associations for Pavlovian learned fear are formed, and in the regions that convey fearful auditory information to the lateral nucleus. Moreover, we found that GRP receptor (GRPR) is expressed in GABAergic interneurons of the lateral nucleus. GRP excites these interneurons and increases their inhibition of principal neurons. GRPR-deficient mice showed decreased inhibition of principal neurons by the interneurons, enhanced long-term potentiation (LTP), and greater and more persistent long-term fear memory. By contrast, these mice performed normally in hippocampus-dependent Morris maze. These experiments provide genetic evidence that GRP and its neural circuitry operate as a negative feedback regulating fear and establish a causal relationship between Grpr gene expression, LTP, and amygdala-dependent memory for fear.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; NINDS, NIH, Bethesda, MD 20892 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA	Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Howard Hughes Medical Institute; Harvard University; McLean Hospital	Kandel, ER (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu	Tsvetkov, Evgeny A/B-6573-2016; Tsvetkov, Evgeny/C-1085-2016	Tsvetkov, Evgeny A/0000-0002-6784-0907; Tsvetkov, Evgeny/0000-0001-9339-1677; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15098] Funding Source: Medline; NINDS NIH HHS [NS44185] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachevalier J, 2001, BEHAV NEUROSCI, V115, P545, DOI 10.1037//0735-7044.115.3.545; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Bast T, 2001, EXP BRAIN RES, V139, P39, DOI 10.1007/s002210100746; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; HARRELL AV, 2001, 31 ANN M SAN DIEG CA; Hellmich MR, 1999, J BIOL CHEM, V274, P23901, DOI 10.1074/jbc.274.34.23901; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; IshikawaBrush Y, 1997, HUM MOL GENET, V6, P1241, DOI 10.1093/hmg/6.8.1241; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KAPP B S, 1992, P229; Krezel W, 2001, P NATL ACAD SCI USA, V98, P12278, DOI 10.1073/pnas.221451898; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee K, 1999, J PHYSIOL-LONDON, V518, P791, DOI 10.1111/j.1469-7793.1999.0791p.x; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Merali Z, 1998, J NEUROSCI, V18, P4758; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Parent MB, 2002, BIOCHEM PHARMACOL, V63, P57, DOI 10.1016/S0006-2952(01)00856-5; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharif TR, 1997, MOL CELL ENDOCRINOL, V130, P119, DOI 10.1016/S0303-7207(97)00080-4; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418; Wang C, 2001, J NEUROPHYSIOL, V86, P1422, DOI 10.1152/jn.2001.86.3.1422; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Woodson W, 2000, SYNAPSE, V38, P124, DOI 10.1002/1098-2396(200011)38:2<124::AID-SYN3>3.0.CO;2-N; Yu BJ, 1997, J NEUROPHYSIOL, V77, P690, DOI 10.1152/jn.1997.77.2.690	49	243	257	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					905	918		10.1016/S0092-8674(02)01116-9	http://dx.doi.org/10.1016/S0092-8674(02)01116-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526815	Bronze			2022-12-24	WOS:000179862600015
J	Greig, D; Louis, EJ; Borts, RH; Travisano, M				Greig, D; Louis, EJ; Borts, RH; Travisano, M			Hybrid speciation in experimental populations of yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC MATERIAL; STERILITY; SELECTION; EVOLUTION	Most models of speciation require gradual change and geographic or ecological isolation for new species to arise. Homoploid hybrid speciation occurred readily between Saccharomyces cerevisiae and Saccharomyces paradoxus. Hybrids had high self-fertility (about 82%), low fertility when backcrossed to either parental species (about 7.5%), and vigorous growth under different thermal environments that favored one or the other of the parental species. Extensive karyotypic changes (tetrasomy) were observed in the hybrids, although genic incompatibilities accounted for 50% of the variation in self-fertility.	Univ Houston, Dept Biol, Houston, TX 77204 USA; UCL, Dept Biol, Galton Lab, London WC1E 6BT, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Houston System; University of Houston; University of London; University College London; University of Leicester	Travisano, M (corresponding author), Univ Houston, Dept Biol, 4800 Calhoun Rd, Houston, TX 77204 USA.	mtrav@uh.edu	Louis, Edward/B-7920-2008; Travisano, Michael/AAI-4809-2020; Greig, Duncan/AAW-3139-2020	Louis, Edward/0000-0003-1157-3608; Greig, Duncan/0000-0002-8907-0253				BUSH GL, 1975, ANNU REV ECOL SYST, V6, P339, DOI 10.1146/annurev.es.06.110175.002011; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Grant V., 1971, PLANT SPECIATION; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Johnson PA, 1996, EVOL ECOL, V10, P187, DOI 10.1007/BF01241784; LOIDL J, 1995, GENETICS, V139, P1511; Marinoni G, 1999, J BACTERIOL, V181, P6488, DOI 10.1128/JB.181.20.6488-6496.1999; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; NAUMOV G I, 1987, Studies in Mycology, P469; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Sebastiani F, 2002, RES MICROBIOL, V153, P53, DOI 10.1016/S0923-2508(01)01286-4; Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299; TEMPLETON AR, 1981, ANNU REV ECOL SYST, V12, P23, DOI 10.1146/annurev.es.12.110181.000323; White M., 1978, MODELS SPECIATION	22	133	139	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2002	298	5599					1773	1775		10.1126/science.1076374	http://dx.doi.org/10.1126/science.1076374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619UA	12459586				2022-12-24	WOS:000179494800040
J	Lee, JS; FitzGibbon, E; Butman, JA; Dufresne, CR; Kushner, H; Wientroub, S; Robey, PG; Collins, MT				Lee, JS; FitzGibbon, E; Butman, JA; Dufresne, CR; Kushner, H; Wientroub, S; Robey, PG; Collins, MT			Normal vision despite narrowing of the optic canal in fibrous dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MCCUNE-ALBRIGHT-SYNDROME; ACTIVATING G(S)ALPHA MUTATION; REVERSIBLE VISUAL-LOSS; STIMULATORY G-PROTEIN; NERVE DECOMPRESSION; SKULL BASE; BONE; GENE; BLINDNESS; CHILDHOOD	Background: Fibrous dysplasia of bone frequently involves the anterior base of the cranium and results in encasement of the optic-nerve canals. It has been assumed that such encasement leads to constriction and eventual blindness. There is controversy about whether patients should be regularly monitored or whether they should undergo prophylactic decompression of the optic nerve. This question is of particular concern in patients with normal vision, since the risks associated with surgical decompression include blindness. Methods: We studied 38 patients with fibrous dysplasia of the lesser wing of the sphenoid bone. The patients underwent a detailed neuro-ophthalmologic examination and computed tomography of the face and skull, reformatted to measure the extent of involvement of the optic canal and the area of the canals. The results were compared with those of 38 age- and sex-matched controls. Results: Of the 38 patients, 15 were male and 23 female, and their mean age was 26 years. Twelve had polyostotic fibrous dysplasia, and 26 had the McCune-Albright syndrome. Sixty-seven optic canals were affected by fibrous dysplasia; in 49 of them (73 percent) there was complete encasement. The mean (+/-SD) areas of the right and left canals were 9.6+/-3.8 mm(sup 2) and 9.9+/-3.6 mm(sup 2), respectively, in the patients, as compared with 12.0+/-2.9 mm(sup 2) and 11.9+/-2.7 mm(sup 2) in the controls (P=0.009 for the comparison of the right areas and P=0.03 for the comparison of the left areas by the paired t-test). In all but two of the patients, the results of neuro-ophthalmologic examination were normal. In the two patients with monocular visual impairment, the areas of the optic canals were similar on the normal and abnormal sides. Conclusions: Encasement of the optic canal in fibrous dysplasia causes narrowing of the canal, but that in itself does not result in visual loss. Therefore, prophylactic decompression of the optic nerve does not appear to be indicated on the basis of the presence of fibrous dysplasia on diagnostic images alone, since it does not correlate with visual loss.	NEI, Vraniofacial & Skeleton Dis Branch, Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; NIH, Warren G Magnuson Clin Ctr, Dept Diagnost Radiol, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Div Plast Surg, Washington, DC 20007 USA; Biomed Comp Res Inst, Philadelphia, PA USA; Tel Aviv Med Ctr & Sch Med, Dana Childrens Hosp, Dept Pediat Orthoped Surg, IL-64239 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; Georgetown University; Tel Aviv University; Sackler Faculty of Medicine	Lee, JS (corresponding author), Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, 521 Parnassus Ave,C-522, San Francisco, CA 94143 USA.		Butman, John/J-2780-2013; Robey, Pamela Gehron/H-1429-2011; Dufresne, Craig R/B-2172-2019; Butman, John A/A-2694-2008	Butman, John/0000-0002-1547-9195; Robey, Pamela Gehron/0000-0002-5316-5576; Dufresne, Craig R/0000-0001-6051-348X; 	NATIONAL EYE INSTITUTE [ZIAEY000388, Z01EY000388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000649] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Albright F, 1937, NEW ENGL J MED, V216, P727, DOI 10.1056/NEJM193704292161701; Alman BA, 1996, J ORTHOPAED RES, V14, P311, DOI 10.1002/jor.1100140221; ARROYO JG, 1991, J CLIN NEURO-OPHTHAL, V11, P259; Bianco P, 2000, J BONE MINER RES, V15, P120, DOI 10.1359/jbmr.2000.15.1.120; Bocca G, 1998, ACTA PAEDIATR, V87, P599, DOI 10.1080/08035259850158371; Chen YR, 1997, PLAST RECONSTR SURG, V99, P22, DOI 10.1097/00006534-199701000-00004; DORFMAN HD, 1998, BONE TUMORS, P441; Edelstein C, 1998, AM J OPHTHALMOL, V126, P469, DOI 10.1016/S0002-9394(98)00118-4; Lichtenstein L, 1942, ARCH PATHOL, V33, P777; Marie PJ, 1997, AM J PATHOL, V150, P1059; McCune D, 1936, AM J DIS CHILD, V52, P743; Michael CB, 2000, J NEUROSURG, V92, P350, DOI 10.3171/jns.2000.92.2.0350; MOORE AT, 1985, OPHTHALMOLOGY, V92, P12; Papadopoulos MC, 1998, BRIT J NEUROSURG, V12, P159; PAPAY FA, 1995, J CRANIOFAC SURG, V6, P5, DOI 10.1097/00001665-199501000-00004; POSNICK JC, 1993, PEDIATR NEUROSURG, V19, P260, DOI 10.1159/000120742; Ricalde P, 2001, J ORAL MAXIL SURG, V59, P157, DOI 10.1053/joms.2001.20487; Riminucci M, 1999, J PATHOL, V187, P249, DOI 10.1002/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J; Riminucci M, 1997, AM J PATHOL, V151, P1587; SASSIN JF, 1968, ARCH NEUROL-CHICAGO, V18, P363, DOI 10.1001/archneur.1968.00470340049004; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Seiff SR, 1997, PLAST RECONSTR SURG, V100, P1611, DOI 10.1097/00006534-199711000-00045; SHENKER A, 1994, J CLIN ENDOCR METAB, V79, P750, DOI 10.1210/jc.79.3.750; Spiegel AM, 1997, J INHERIT METAB DIS, V20, P113, DOI 10.1023/A:1005393501786; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WEISMAN JS, 1990, AM J OPHTHALMOL, V110, P244, DOI 10.1016/S0002-9394(14)76338-X	26	120	133	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2002	347	21					1670	1676		10.1056/NEJMoa020742	http://dx.doi.org/10.1056/NEJMoa020742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BL	12444181				2022-12-24	WOS:000179339900005
J	Tulzer, G; Arzt, W; Franklin, RCG; Loughna, PV; Mair, R; Gardiner, HM				Tulzer, G; Arzt, W; Franklin, RCG; Loughna, PV; Mair, R; Gardiner, HM			Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum	LANCET			English	Article							VENTRICULAR SEPTUM	Progressive stenosis of the semilunar valves in utero can be life threatening. We treated two fetuses with complete or almost complete pulmonary atresia and imminent hydrops (increased cardiothoracic ratio, pericardial effusion, holosystolic tricuspid regurgitation extending into diastole, and abnormal venous Dopplers). We dilated the pulmonary valve of two fetuses in utero at 28 and 30 weeks' gestation, through the mothers' abdomens. After the procedure, the fetuses had decreased signs of circulatory failure and gestation continued until near term. In the neonatal period, we did a repeat valvuloplasty with systemic-to-pulmonary arterial shunt. Both children. (now aged 18 months and 12 months) now have biventricular circulation. Surgery on selected fetuses with semilunar valve stenosis or atresia, or both, can extend pregnancy and favourably change the postnatal surgical options.	Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, Fac Med,Inst Reprod & Dev Biol, Div Paediat Obstet & Gynaecol, London W12 0NN, England; Childrens Hosp Linz, Childrnes Heart Ctr Linz, Linz, Austria; Matern Hosp, Dept Prenatal Med, Linz, Austria; Royal Brompton & Harefield NHS Trust, London, England; Natl Heart & Lung Inst, London, England	Imperial College London; Kepler University Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Gardiner, HM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Queen Charlottes & Chelsea Hosp, Fac Med,Inst Reprod & Dev Biol, Div Paediat Obstet & Gynaecol, London W12 0NN, England.							BULL C, 1994, J THORAC CARDIOV SUR, V107, P359, DOI 10.1016/S0022-5223(94)70080-X; Daubeney PEF, 1998, CIRCULATION, V98, P562, DOI 10.1161/01.CIR.98.6.562; DELEVAL MR, 1985, CIRCULATION, V72, P1152; Huhta JC, 2001, J PERINAT MED, V29, P381, DOI 10.1515/JPM.2001.054; Kohl T, 2000, AM J CARDIOL, V85, P1230, DOI 10.1016/S0002-9149(00)00733-5	5	125	137	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 16	2002	360	9345					1567	1568		10.1016/S0140-6736(02)11531-5	http://dx.doi.org/10.1016/S0140-6736(02)11531-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	616FC	12443597				2022-12-24	WOS:000179292400015
J	Volkman, BF; Prehoda, KE; Scott, JA; Peterson, FC; Lim, WA				Volkman, BF; Prehoda, KE; Scott, JA; Peterson, FC; Lim, WA			Structure of the N-WASP EVH1 domain-WIP complex: Insight into the molecular basis of Wiskott-Aldrich Syndrome	CELL			English	Article							SYNDROME PROTEIN WASP; ACTIN-DEPOLYMERIZING PROTEIN; PLECKSTRIN HOMOLOGY DOMAINS; X-LINKED THROMBOCYTOPENIA; CHEMICAL-SHIFT INDEX; ARP2/3 COMPLEX; T-CELL; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; FILOPODIUM FORMATION; SECONDARY STRUCTURE	Missense mutants that cause the immune disorder Wiskott-Aldrich Syndrome (WAS) map primarily to the Enabled/VASP homology 1 (EVH1) domain of the actin regulatory protein WASP. This domain has been implicated in both peptide and phospholipid binding. We show here that the N-WASP EVH1 domain does not bind phosphatidyl inositol-(4,5)-bisphosphate, as previously reported, but does specifically bind a 25 residue motif from the WASP Interacting Protein (WIP). The NMR structure of the complex reveals a novel recognition mechanism-the WIP ligand, which is far longer than canonical EVH1 ligands, wraps around the domain, contacting a narrow but extended surface. This recognition mechanism provides a basis for understanding the effects of mutations that cause WAS.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of California System; University of California San Francisco; Medical College of Wisconsin	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179; Prehoda, Ken/0000-0003-4214-6158				Ball LJ, 2000, EMBO J, V19, P4903, DOI 10.1093/emboj/19.18.4903; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Barzik M, 2001, J MOL BIOL, V309, P155, DOI 10.1006/jmbi.2001.4640; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Callebaut I, 1998, FEBS LETT, V441, P181, DOI 10.1016/S0014-5793(98)01541-5; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Coppolino MG, 2001, J CELL SCI, V114, P4307; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; El-Hakeh Jazmin, 2002, Hum Mutat, V19, P186, DOI 10.1002/humu.9013; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Greer WL, 1996, HUM GENET, V98, P685, DOI 10.1007/s004390050285; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Imai K, 1999, CLIN IMMUNOL, V92, P128, DOI 10.1006/clim.1999.4746; Insall R, 1999, TRENDS CELL BIOL, V9, P211; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KOLLURI R, 1995, HUM MOL GENET, V4, P1119, DOI 10.1093/hmg/4.7.1119; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leverrier Y, 2001, J IMMUNOL, V166, P4831, DOI 10.4049/jimmunol.166.8.4831; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Martinez-Quiles N, 2001, NAT CELL BIOL, V3, P484, DOI 10.1038/35074551; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Millard TH, 2001, TRENDS BIOCHEM SCI, V26, P198, DOI 10.1016/S0968-0004(01)01788-1; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Naqvi SN, 1998, CURR BIOL, V8, P959, DOI 10.1016/S0960-9822(98)70396-3; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Ramesh N, 1997, P NATL ACAD SCI USA, V94, P14671, DOI 10.1073/pnas.94.26.14671; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; Savoy DN, 2000, J IMMUNOL, V164, P2866, DOI 10.4049/jimmunol.164.6.2866; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snapper SB, 1999, ANNU REV IMMUNOL, V17, P905, DOI 10.1146/annurev.immunol.17.1.905; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Stewart DM, 1999, J IMMUNOL, V162, P5019; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	72	125	132	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 15	2002	111	4					565	576		10.1016/S0092-8674(02)01076-0	http://dx.doi.org/10.1016/S0092-8674(02)01076-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	617DY	12437929	Bronze			2022-12-24	WOS:000179346900009
J	Wilson, AM; Watson, JC; Lichtwark, GA				Wilson, AM; Watson, JC; Lichtwark, GA			Biomechanics: A catapult action for rapid limb protraction	NATURE			English	Article							HORSE; MUSCLE		Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; UCL, Inst Human Performance, Stanmore HA7 4LP, Middx, England	University of London; University of London Royal Veterinary College; University of London; University College London	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	Lichtwark, Glen A/B-6002-2008	Lichtwark, Glen A/0000-0001-7366-3348; Wilson, Alan/0000-0001-9914-3455				Alexander RM., 1988, ELASTIC MECH ANIMAL; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; DYCE KM, 1987, TXB VET ANATOMY, P542; HERMANSON JW, 1990, ACTA ANAT, V137, P146, DOI 10.1159/000146875; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Peplowski MM, 1997, J EXP BIOL, V200, P2861; PRATT GW, 1978, AM J VET RES, V39, P249; ROME LC, 1990, J PHYSIOL-LONDON, V431, P173, DOI 10.1113/jphysiol.1990.sp018325; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; WOLEDGE R, 1985, MONOGR PHYSL SOC, V41	13	107	111	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					35	36		10.1038/421035a	http://dx.doi.org/10.1038/421035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12569935				2022-12-24	WOS:000180165500027
J	Adam, D				Adam, D			Royal Institution's director blasts scientific sexism	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					453	453						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466806				2022-12-24	WOS:000179611600011
J	Adam, D				Adam, D			Field trials excluded from UK crop appraisal	NATURE			English	News Item																		Gura T, 2001, NATURE, V412, P760, DOI 10.1038/35090645; 2002, NATURE, V419, P327	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 5	2002	420	6915					453	453						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621VK	12466806				2022-12-24	WOS:000179611600010
